Citrus Sinensis ID: 006004
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | no | no | 0.8 | 0.745 | 0.566 | 1e-178 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.562 | 0.653 | 0.683 | 1e-159 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.493 | 0.639 | 0.532 | 1e-102 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.493 | 0.649 | 0.537 | 1e-102 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.493 | 0.631 | 0.524 | 1e-100 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.497 | 0.645 | 0.521 | 1e-99 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.476 | 0.212 | 0.454 | 4e-78 | |
| E1BB52 | 1512 | Cyclin-dependent kinase 1 | no | no | 0.541 | 0.238 | 0.426 | 1e-77 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.476 | 0.212 | 0.454 | 1e-77 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.476 | 0.213 | 0.451 | 2e-77 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 341/602 (56%), Positives = 412/602 (68%), Gaps = 70/602 (11%)
Query: 103 TGTETTIVAVGL--QPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAF 160
TG E +G QP+M+RI + G G +V+AGWPSWL SVAGEAI GW PR+AD+F
Sbjct: 104 TGIEVGANNIGTLQQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSF 163
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
EK++KIGQGTYSSVYKARDLET ++VALKKVRFANMDP+SVRFMAREI ILR+LDHPNVM
Sbjct: 164 EKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVM 223
Query: 221 KLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
KLEGL+TSR SGS+YL+FEYMEHDLAGLA+TPGI F+E QIKCYM+QLL GLEHCHSRG+
Sbjct: 224 KLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGV 283
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
LHRDIKGSNLL+++ LKIGDFGLA Y Q PLTSRVVTLWYR PELLLG+T YG
Sbjct: 284 LHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGV 343
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399
+D+WS GCILAELF GKPIMPGRTEVEQ+HKIFKLCGSPSE+YW+ SK HAT FKPQQ
Sbjct: 344 TVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQ 403
Query: 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYP 459
PYKR V ETF++ P SALALV+ LL +EP+ RG+ ASAL SEFF T PL DPS+LPKY
Sbjct: 404 PYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQ 463
Query: 460 PSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTP----EFIPS-----GQS 510
P KE+D K +++EA++++ + + + V SR+ AV P E + S GQ
Sbjct: 464 PRKEIDVKAQEEEAKRKKDTSSKQNDSKQV---SRESKAVPAPDSNAESLTSIQKRQGQH 520
Query: 511 KPTSISHKFHNQEDSCSGFRIEPPTVGRQNVNSHSSTAVHPSASWNKSTV---STRN-NS 566
S S KF+ ED+ S FRIEP G + H+ V S + N V S+R+
Sbjct: 521 NQVSNSDKFNPGEDAAS-FRIEPLKSGTAK-DGHTRYGV-SSVNRNGENVMMGSSRSPRK 577
Query: 567 ELRTQRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVP---------------------- 604
ELRTQRS + + A S R ++ V RD + +
Sbjct: 578 ELRTQRSFVQRGTAQLS----RFSNSVAARDGSHFAIANPRWFEDSYNNNNGRQNGGAWS 633
Query: 605 ----------------------KKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVRKARL 642
KK R+H SGPL+ GGN++++LKEHERQIQ AVRKAR+
Sbjct: 634 QRLVVKHKEFTKHKESITVNGEKKERMHCSGPLVSAGGNLDEMLKEHERQIQLAVRKARV 693
Query: 643 EK 644
+K
Sbjct: 694 DK 695
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 562 bits (1449), Expect = e-159, Method: Compositional matrix adjust.
Identities = 257/376 (68%), Positives = 316/376 (84%), Gaps = 2/376 (0%)
Query: 130 GDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK 189
G++V AGWPSWL+ GEA+ GW PR+AD FEKIDKIGQGTYS+VYKA+D+ TGKIVALK
Sbjct: 88 GEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALK 147
Query: 190 KVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLA 248
KVRF N++PESV+FMAREI +LR+LDHPNV+KLEGLVTSR S SLYLVF+YM+HDLAGLA
Sbjct: 148 KVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLA 207
Query: 249 TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308
++P +KF+E ++KC M+QL+ GLEHCHSRG+LHRDIKGSNLLI++ GVLKI DFGLAT +
Sbjct: 208 SSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIF 267
Query: 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368
DP+ P+TSRVVTLWYRAPELLLGAT YG ID+WSAGCILAEL AG+PIMPGRTEVEQ
Sbjct: 268 DPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQ 327
Query: 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP 428
+HKI+KLCGSPSEDYW+K K H +KP++PYKR + ETF++FP S+L L+D LL+IEP
Sbjct: 328 LHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEP 387
Query: 429 ENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEA-VRGRGPE 487
E+R +A++AL+SEFF +EP C+P++LPKYPPSKE+DAK RD+E R+Q A + +G G
Sbjct: 388 EDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGAR 447
Query: 488 SVRRGSRDFSAVRTPE 503
R R A+ PE
Sbjct: 448 KNRHRDRSNRALPAPE 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-102, Method: Compositional matrix adjust.
Identities = 187/351 (53%), Positives = 241/351 (68%), Gaps = 23/351 (6%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF---MAREI 208
W R D FEK+++IG+GTY VY A++ ET +IVALKK+R MD E F REI
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIR---MDNEREGFPITAIREI 73
Query: 209 HILRKLDHPNVMKLEGLVTS----------------RSGSLYLVFEYMEHDLAGLATTPG 252
IL+KL H NV++L+ +VTS GS+Y+VFEYM+HDL GLA PG
Sbjct: 74 KILKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPG 133
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
++FT PQIKCYM+QLL GL +CH +LHRDIKGSNLLI+N G LK+ DFGLA ++
Sbjct: 134 MRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDH 193
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
N LT+RV+TLWYR PELLLG+T+YG A+DMWS GCI AEL GKPI+ G+ E EQ+ KI
Sbjct: 194 NGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKI 253
Query: 373 FKLCGSPSEDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
F+LCG+P E W +K +FKPQ+P KR+V E+F++F Q AL L++K+LT++P R
Sbjct: 254 FELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQR 313
Query: 432 GSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
SA AL +E+F T+PLPCDP +LPKY S E K + Q+ R+ E A R
Sbjct: 314 ISAKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAKR 364
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (955), Expect = e-102, Method: Compositional matrix adjust.
Identities = 188/350 (53%), Positives = 238/350 (68%), Gaps = 22/350 (6%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF---MAREI 208
W R D FEK+++IG+GTY VY A++++TG+IVALKK+R MD E F REI
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIR---MDNEREGFPITAIREI 74
Query: 209 HILRKLDHPNVMKLEGLVTS---------------RSGSLYLVFEYMEHDLAGLATTPGI 253
IL+KL H NV++L+ +VTS G +Y+VFEYM+HDL GLA PG+
Sbjct: 75 KILKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGL 134
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313
+FT PQIKCYM+QLL GL +CH +LHRDIKGSNLLI+N G LK+ DFGLA +Y
Sbjct: 135 RFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHT 194
Query: 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
LT+RV+TLWYR PELLLGATKYG AIDMWS GCI AEL KPI+PG+ E EQ++KIF
Sbjct: 195 GNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIF 254
Query: 374 KLCGSPSEDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
+LCGSP E W SK +FKP +P KR+V E FR+F + AL L++K+L ++P R
Sbjct: 255 ELCGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRI 314
Query: 433 SAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
SA AL +E+F T+PLPCDP +LP Y S E K + Q+ R+ E A R
Sbjct: 315 SAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEAAKR 364
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 184/351 (52%), Positives = 238/351 (67%), Gaps = 23/351 (6%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF---MAREI 208
W R D FEK+++IG+GTY VY AR+ ET +IVALKK+R MD E F REI
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIR---MDNEREGFPITAIREI 73
Query: 209 HILRKLDHPNVMKLEGLVTS----------------RSGSLYLVFEYMEHDLAGLATTPG 252
IL+KL H NV++L+ +VTS GS+Y+VFEYM+HDL GLA PG
Sbjct: 74 KILKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPG 133
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
++FT PQIKCYM+QLL GL +CH +LHRDIKGSNLLI+N G LK+ DFGLA ++
Sbjct: 134 MRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDH 193
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
N LT+RV+TLWYR PELLLG+TKYG A+DMWS GCI AEL GKPI+PG+ E EQ+ KI
Sbjct: 194 NGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKI 253
Query: 373 FKLCGSPSEDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
F +CG+P E W +K +FKP + KR+V E F++F + AL L++K+LT++P R
Sbjct: 254 FDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQR 313
Query: 432 GSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
SA AL +E+F ++PLPCDP +LPKY S E K + Q+ R+ + A R
Sbjct: 314 ISAQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKR 364
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 181/347 (52%), Positives = 231/347 (66%), Gaps = 16/347 (4%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W R D FEK+++IG+GTY VY A++++TG+IVALKK+R N REI IL
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKIL 77
Query: 212 RKLDHPNVMKLEGLVTS---------------RSGSLYLVFEYMEHDLAGLATTPGIKFT 256
+KL H NV+ L+ +VTS G +Y+VFEYM+HDL GLA PG++FT
Sbjct: 78 KKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFT 137
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316
PQIKCYM+QLL GL +CH +LHRDIKGSNLLI+N G LK+ DFGLA +Y L
Sbjct: 138 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNL 197
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376
T+RV+TLWYR PELLLGATKYG AIDMWS GCI AEL GKPI+PG+TE EQ++KI++LC
Sbjct: 198 TNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELC 257
Query: 377 GSPSEDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435
GSP E W SK K +P KR+V E +R+F + AL L++K+L ++P R A
Sbjct: 258 GSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAK 317
Query: 436 SALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
AL +E+F T+PLPCDP +LP Y S E K + Q+ R E A +
Sbjct: 318 DALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRHNEEAAKK 364
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 150/330 (45%), Positives = 209/330 (63%), Gaps = 13/330 (3%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
W R D F+ I IG+GTY VYKA+D +TG++VALKKVR N + E A REI I
Sbjct: 720 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 778
Query: 211 LRKLDHPNVMKLEGLVTSRS---------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIK 261
LR+L H +V+ ++ +VT + G+ YLVFEYM+HDL GL + + F+E IK
Sbjct: 779 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 838
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321
+M+QL+ GL++CH + LHRDIK SN+L+NN+G +K+ DFGLA Y+ ++ P T++V+
Sbjct: 839 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 898
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
TLWYR PELLLG +Y AID+WS GCIL ELF KPI E+ Q+ I +LCGSP
Sbjct: 899 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 958
Query: 382 DYWRKS-KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + + KP++ Y+R++ E F P +AL L+D +LT++P R +A L+S
Sbjct: 959 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1018
Query: 441 EFFKTEPLP-CDPSNLPKYPPSKELDAKLR 469
+F K L DP +LP + EL +K R
Sbjct: 1019 DFLKDVELSKMDPPDLPHWQDCHELWSKKR 1048
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|E1BB52|CDK13_BOVIN Cyclin-dependent kinase 13 OS=Bos taurus GN=CDK13 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 160/375 (42%), Positives = 222/375 (59%), Gaps = 15/375 (4%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
W R D F+ I IG+GTY VYKARD +TG++VALKKVR N + E A REI I
Sbjct: 698 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKI 756
Query: 211 LRKLDHPNVMKLEGLVTSRS---------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIK 261
LR+L H +++ ++ +VT + G+ YLVFEYM+HDL GL + + F E IK
Sbjct: 757 LRQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIK 816
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321
+M+QL+ GL++CH + LHRDIK SN+L+NN G +K+ DFGLA Y ++ P T++V+
Sbjct: 817 SFMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVI 876
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
TLWYR PELLLG +Y AID+WS GCIL ELF KPI E+ Q+ I ++CGSP
Sbjct: 877 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCP 936
Query: 382 DYWRKS-KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + + KP++ Y+RK+ E F P +AL L D +L ++P R +A AL+
Sbjct: 937 AVWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQC 996
Query: 441 EFFK-TEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRG-RGPESVRRGSRDFSA 498
EF + EP P +LP + EL +K R ++ + + V + P D S
Sbjct: 997 EFLRDVEPSKMPPPDLPLWQDCHELWSKKRRRQKQMGMTDDVSTVKAPRKDLSLGMDDSR 1056
Query: 499 VRTPE-FIPSGQSKP 512
TP+ +PS Q KP
Sbjct: 1057 TSTPQSVLPSSQLKP 1071
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (745), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 150/330 (45%), Positives = 208/330 (63%), Gaps = 13/330 (3%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
W R D F+ I IG+GTY VYKA+D +TG++VALKKVR N + E A REI I
Sbjct: 719 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 777
Query: 211 LRKLDHPNVMKLEGLVTSRS---------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIK 261
LR+L H +V+ ++ +VT + G+ YLVFEYM+HDL GL + + F+E IK
Sbjct: 778 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 837
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321
+M+QL+ GLE+CH + LHRDIK SN+L+NN+G +K+ DFGLA Y+ ++ P T++V+
Sbjct: 838 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 897
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
TLWYR PELLLG +Y AID+WS GCIL ELF KPI E+ Q+ I +LCGSP
Sbjct: 898 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 957
Query: 382 DYWRKS-KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + + KP++ Y+R++ E F P +AL L+D +LT++P R +A L+S
Sbjct: 958 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1017
Query: 441 EFFKTEPLP-CDPSNLPKYPPSKELDAKLR 469
+F K L P +LP + EL +K R
Sbjct: 1018 DFLKDVELSKMAPPDLPHWQDCHELWSKKR 1047
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 149/330 (45%), Positives = 208/330 (63%), Gaps = 13/330 (3%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
W R D F+ I IG+GTY VYKA+D +TG++VALKKVR N + E A REI I
Sbjct: 715 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 773
Query: 211 LRKLDHPNVMKLEGLVTSRS---------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIK 261
LR+L H +V+ ++ +VT + G+ YLVFEYM+HDL GL + + F+E IK
Sbjct: 774 LRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 833
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321
+M+QL+ GL++CH + LHRDIK SN+L+NN+G +K+ DFGLA Y+ ++ P T++V+
Sbjct: 834 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 893
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
TLWYR PELLLG +Y AID+WS GCIL ELF KPI E+ Q+ I +LCGSP
Sbjct: 894 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 953
Query: 382 DYWRKS-KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + + KP++ Y+R++ E F P +AL L+D +LT++P R +A L+S
Sbjct: 954 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1013
Query: 441 EFFKTEPLP-CDPSNLPKYPPSKELDAKLR 469
+F K L P +LP + EL +K R
Sbjct: 1014 DFLKDVELSKMAPPDLPHWQDCHELWSKKR 1043
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | ||||||
| 255574269 | 676 | Cell division protein kinase, putative [ | 0.950 | 0.934 | 0.657 | 0.0 | |
| 449447771 | 652 | PREDICTED: probable serine/threonine-pro | 0.912 | 0.930 | 0.639 | 0.0 | |
| 449506847 | 632 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.912 | 0.960 | 0.638 | 0.0 | |
| 359495293 | 895 | PREDICTED: uncharacterized protein LOC10 | 0.950 | 0.706 | 0.628 | 0.0 | |
| 4539004 | 649 | putative protein kinase [Arabidopsis tha | 0.953 | 0.976 | 0.626 | 0.0 | |
| 297741044 | 615 | unnamed protein product [Vitis vinifera] | 0.881 | 0.952 | 0.616 | 0.0 | |
| 224146272 | 517 | predicted protein [Populus trichocarpa] | 0.771 | 0.992 | 0.743 | 0.0 | |
| 147806286 | 656 | hypothetical protein VITISV_007388 [Viti | 0.935 | 0.948 | 0.613 | 0.0 | |
| 334183831 | 655 | protein kinase domain-containing protein | 0.774 | 0.786 | 0.706 | 0.0 | |
| 359486237 | 741 | PREDICTED: probable serine/threonine-pro | 0.954 | 0.856 | 0.556 | 0.0 |
| >gi|255574269|ref|XP_002528049.1| Cell division protein kinase, putative [Ricinus communis] gi|223532579|gb|EEF34367.1| Cell division protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/663 (65%), Positives = 512/663 (77%), Gaps = 31/663 (4%)
Query: 1 MGCICSKGAPEDEIHASDRDKQ----LNISSVQLVAPAPSLREHPGGIVVGNEGSVRRGQ 56
MGCICSKGA ++E+H ++ ++Q + SSVQLVAP S + G++ V G+
Sbjct: 1 MGCICSKGAADEEVHDNENERQKENEFDKSSVQLVAPVHSKK--------GDDFVVDHGR 52
Query: 57 QQQQQPGL-KANV---TVPFDEGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAV 112
+ + KAN VP D GE + + HQR ATMD+G +G++
Sbjct: 53 KDGSGRNVSKANAGAAIVPLDGGEKNAHFVDASSRGRHHQRRATMDLG-SSGSQ------ 105
Query: 113 GLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYS 172
Q R+ LP+ E + ++AGWP WLTS AGEAIKG P RAD++EK++KIGQGTYS
Sbjct: 106 --QHHGFRLTALPLAAENELIIAGWPQWLTSAAGEAIKGSVPLRADSYEKLEKIGQGTYS 163
Query: 173 SVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231
SVYKAR+L+TGKIVA+KKVRF NMDPESVRFMAREIHILRKLDHPNVMKLEG+VTSR SG
Sbjct: 164 SVYKARELDTGKIVAMKKVRFMNMDPESVRFMAREIHILRKLDHPNVMKLEGIVTSRMSG 223
Query: 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
SLYLVF+YMEHDLAGLA PGIKF+E QIKCYMQQLL GLEHCHSRG+LHRDIKGSNLLI
Sbjct: 224 SLYLVFQYMEHDLAGLAAKPGIKFSESQIKCYMQQLLHGLEHCHSRGVLHRDIKGSNLLI 283
Query: 292 NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILA 351
++ GVLKIGDFGLAT Y P QN LTSRVVTLWYRAPELLLGAT+YG AIDMWS GCILA
Sbjct: 284 DDKGVLKIGDFGLATLYQPDQNQALTSRVVTLWYRAPELLLGATEYGVAIDMWSVGCILA 343
Query: 352 ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRN 411
ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW+K+K HATSFKPQ YKR V ETF+N
Sbjct: 344 ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWQKTKLPHATSFKPQLSYKRCVAETFKN 403
Query: 412 FPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQ 471
P SAL+LVDKLL++EPE RGSA SAL SEFF EP PCDPS LPKYPPSKELDAK+R++
Sbjct: 404 IPPSALSLVDKLLSMEPEARGSATSALSSEFFNREPFPCDPSCLPKYPPSKELDAKVREE 463
Query: 472 EARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRI 531
EAR++ EA + RG ESVRRGSRD A +PEFIP GQ+K TS S+K+ QED SGFRI
Sbjct: 464 EARRKREEAGKVRGAESVRRGSRDLKA-ESPEFIPQGQTKTTSTSYKYDIQEDGGSGFRI 522
Query: 532 EPPTVGRQNVNSHSSTAVHPSA---SWNKSTVSTR-NNSELRTQRSHLPQTAADFSNNNN 587
EPP + V S S+ +HP A S NK+ S+R NN E RT++SH PQ A D S ++
Sbjct: 523 EPPRGAKHPVISQCSSMIHPCAVQSSINKNVGSSRHNNMESRTEKSHKPQAAIDVSISSI 582
Query: 588 RMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVRKARLEKSGT 647
+ ++RV +D+N+GYV +KNRI+YSGPL+PPGGN+E+ILKEHERQIQHAVRKARLEKSGT
Sbjct: 583 KKDERVHAKDNNLGYVRRKNRINYSGPLLPPGGNIEEILKEHERQIQHAVRKARLEKSGT 642
Query: 648 NNN 650
+N
Sbjct: 643 KSN 645
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447771|ref|XP_004141641.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2103), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/672 (63%), Positives = 495/672 (73%), Gaps = 65/672 (9%)
Query: 1 MGCICSKGA--PEDEIHASDRDKQLNISSVQLVAPAPSLREH--------------PGGI 44
MGCICS+ + PED H + +K+LN SSVQLVAP+PS RE GG
Sbjct: 1 MGCICSRDSSEPEDSSH-KEPEKELNKSSVQLVAPSPSKREDMLLEIQLTRQASKANGGS 59
Query: 45 VVG---NEGSVRRGQQQQQQPGLKANVTVPFDEGENPRTTIVERPKRNRHQRCATMDMGM 101
V N GSV R ++ DE EN K + + + +
Sbjct: 60 VHKAKVNGGSVHRAKED--------------DESEN---------KSVKAAKANNDNASV 96
Query: 102 GTGTETTIVAVGLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFE 161
G G QP + R+ L G E + V+AGWPSWL SVAGEAIKGW PRRAD+FE
Sbjct: 97 G----------GKQPDIFRLASLSKGAETELVMAGWPSWLASVAGEAIKGWVPRRADSFE 146
Query: 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
K+DKIGQGTYSSVYKARDLETGKIVALKKVRF NMDPESVRFMAREI+ILRKLDHPNVMK
Sbjct: 147 KLDKIGQGTYSSVYKARDLETGKIVALKKVRFVNMDPESVRFMAREIYILRKLDHPNVMK 206
Query: 222 LEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
LE LVTSR SGSLYLVFEYMEHDLAGLA PG KFTE QIKCY+QQLL GLEHCHSRGIL
Sbjct: 207 LESLVTSRMSGSLYLVFEYMEHDLAGLAAVPGHKFTEAQIKCYVQQLLHGLEHCHSRGIL 266
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
HRDIKGSNLL++N GVLKIGDFGLAT + P Q PLTSRVVTLWYRAPELLLGAT+YG
Sbjct: 267 HRDIKGSNLLVDNNGVLKIGDFGLATFFQPDQKQPLTSRVVTLWYRAPELLLGATQYGPG 326
Query: 341 IDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400
ID+WS GCI+AELFAGKPIMPGRTEVEQMHKIFKLCGSPSE++WR++K HATSFKPQ
Sbjct: 327 IDLWSCGCIVAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEEFWRRTKLPHATSFKPQHR 386
Query: 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPP 460
YK + ETF++FP SALALV+KLL IEPE+RGSA ALRSEFF+TEPLPCDPS+LPKYPP
Sbjct: 387 YKSCLSETFKSFPPSALALVNKLLAIEPEHRGSATLALRSEFFRTEPLPCDPSSLPKYPP 446
Query: 461 SKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFH 520
SKE DAKLR++E RK++AEAV+GR PESVRRGSRD AV TPEF G +K TS KF+
Sbjct: 447 SKEFDAKLRNEEERKKKAEAVKGRHPESVRRGSRDTKAVPTPEFNTQGDTKKTST--KFN 504
Query: 521 NQEDSCSGFRIEPPTVGRQNVNSHSSTAVHPSA--SWNKSTVSTRNNSELRTQRSHLPQT 578
QED EP V QN +HS++ VHP+ SW K T + RN++EL+TQ+S + ++
Sbjct: 505 PQEDG------EPSRV-VQNRYNHSTSMVHPTVAGSWGKPTGALRNHAELKTQKSQMHRS 557
Query: 579 AADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVR 638
D S ++ + D V +DS MGYV KKNRIHYSGPL+P GG +ED+LKEHERQIQ A R
Sbjct: 558 VGDLSASSLKKEDSVSNKDSGMGYVQKKNRIHYSGPLVPTGGTIEDMLKEHERQIQQAFR 617
Query: 639 KARLEKSGTNNN 650
KARL+K+ T N
Sbjct: 618 KARLDKAKTTKN 629
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449506847|ref|XP_004162865.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2103), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/672 (63%), Positives = 496/672 (73%), Gaps = 65/672 (9%)
Query: 1 MGCICSKGA--PEDEIHASDRDKQLNISSVQLVAPAPSLREH--------------PGGI 44
MGCICS+ + PED H + +K+LN SSVQLVAP+PS RE GG
Sbjct: 1 MGCICSRDSSEPEDSSH-KEPEKELNKSSVQLVAPSPSKREDMLLEIQLTRQASKANGGS 59
Query: 45 VVG---NEGSVRRGQQQQQQPGLKANVTVPFDEGENPRTTIVERPKRNRHQRCATMDMGM 101
V N GSV R ++ DE EN K + + + +
Sbjct: 60 VHKAKVNGGSVHRAKED--------------DESEN---------KSVKAAKANNDNASV 96
Query: 102 GTGTETTIVAVGLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFE 161
G G QP + R+ L G E + V+AGWPSWL SVAGEAIKGW PRRAD+FE
Sbjct: 97 G----------GKQPDIFRLASLSKGAETEVVMAGWPSWLASVAGEAIKGWVPRRADSFE 146
Query: 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
K+DKIGQGTYSSVYKARDLETGKIVALKKVRF NMDPESVRFMAREI+ILRKLDHPNVMK
Sbjct: 147 KLDKIGQGTYSSVYKARDLETGKIVALKKVRFVNMDPESVRFMAREIYILRKLDHPNVMK 206
Query: 222 LEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
LE LVTSR SGSLYLVFEYMEHDLAGLA PG KFTE QIKCY+QQLL GLEHCHSRGIL
Sbjct: 207 LESLVTSRMSGSLYLVFEYMEHDLAGLAAVPGHKFTEAQIKCYVQQLLHGLEHCHSRGIL 266
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
HRDIKGSNLL++N GVLKIGDFGLAT + P Q PLTSRVVTLWYRAPELLLGAT+YG
Sbjct: 267 HRDIKGSNLLVDNNGVLKIGDFGLATFFQPDQKQPLTSRVVTLWYRAPELLLGATQYGPG 326
Query: 341 IDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400
ID+WS GCI+AELFAGKPIMPGRTEVEQMHKIFKLCGSPSE++WR++K HATSFKPQ
Sbjct: 327 IDLWSCGCIVAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEEFWRRTKLPHATSFKPQHR 386
Query: 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPP 460
YK + ETF++FP SALALV+KLL IEPE+RGSA ALRSEFF+TEPLPCDPS+LPKYPP
Sbjct: 387 YKSCLSETFKSFPPSALALVNKLLAIEPEHRGSATLALRSEFFRTEPLPCDPSSLPKYPP 446
Query: 461 SKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFH 520
SKE DAKLR++E RK++AEAV+GR PESVRRGSRD AV TPEF G +K TS KF+
Sbjct: 447 SKEFDAKLRNEEERKKKAEAVKGRHPESVRRGSRDTKAVPTPEFNTQGDTKKTST--KFN 504
Query: 521 NQEDSCSGFRIEPPTVGRQNVNSHSSTAVHPS--ASWNKSTVSTRNNSELRTQRSHLPQT 578
QED EP V QN +HS++ VHP+ SW K T + RN++EL+TQ+S + ++
Sbjct: 505 PQEDG------EPSRV-VQNRYNHSTSMVHPTVAGSWGKPTGALRNHAELKTQKSQMHRS 557
Query: 579 AADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVR 638
D S ++ + D + +DS MGYV KKNRIHYSGPL+P GGN+ED+LKEHERQIQ A R
Sbjct: 558 VGDLSASSLKKEDSMSNKDSGMGYVQKKNRIHYSGPLVPTGGNIEDMLKEHERQIQQAFR 617
Query: 639 KARLEKSGTNNN 650
KARL+K+ T +
Sbjct: 618 KARLDKAKTTKS 629
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495293|ref|XP_002277016.2| PREDICTED: uncharacterized protein LOC100265500 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/675 (62%), Positives = 504/675 (74%), Gaps = 43/675 (6%)
Query: 1 MGCICSKGAPEDEI-----HASDRDKQLNISSVQLVAPAPSLREHPGGIVVGNEGSVRRG 55
MGCICSK A DE ++ K+LN SVQLVAP+ G G G
Sbjct: 230 MGCICSKEASVDEYVDYNEREKEKGKELNKDSVQLVAPSTGEEFVMGPGGGGGHGRTGGS 289
Query: 56 QQQQQQPGLKANV-TVPFD--EGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAV 112
+ L+ NV + P EGE T +RP + HQR T+DM V
Sbjct: 290 VHPISKSALQGNVGSAPIRAMEGEKKAMT-ADRPTKASHQRRLTLDMENN---------V 339
Query: 113 GLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYS 172
G P MSRIV +P G +G+++VAGWPSWL+SVAGEAI+GW P R +++EK+DKIGQGTYS
Sbjct: 340 GPSP-MSRIVSMPNGAKGEQIVAGWPSWLSSVAGEAIQGWVPLRPESYEKLDKIGQGTYS 398
Query: 173 SVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231
+VY+ARDL++GKIVALKKVRF NMDPESVRFMAREIH+LRKLDHPNVMKLEGL+TSR SG
Sbjct: 399 TVYRARDLDSGKIVALKKVRFGNMDPESVRFMAREIHVLRKLDHPNVMKLEGLITSRTSG 458
Query: 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
+LYLVFEYMEHDLAGL+ TPGIKFTEPQIKCYMQQLLRGLEHCHSRG+LHRDIKGSNLLI
Sbjct: 459 TLYLVFEYMEHDLAGLSATPGIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLI 518
Query: 292 NNAGVLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCIL 350
+N GVLKIGDFGLA+ DPSQ PLTSRVVTLWYR PELLLGATKYGA++D+WS GCI+
Sbjct: 519 DNKGVLKIGDFGLASFRSDPSQ--PLTSRVVTLWYRPPELLLGATKYGASVDLWSTGCII 576
Query: 351 AELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR 410
AELFAG PIMPG TEVEQ+HKIFKLCGSPSE+YW+KSK AHA+SFKPQ PYKR++ ETFR
Sbjct: 577 AELFAGSPIMPGSTEVEQIHKIFKLCGSPSEEYWQKSKLAHASSFKPQHPYKRRLAETFR 636
Query: 411 NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRD 470
NFP SALALVD LL++EP+ RG+AASAL+SEFF T+PLPCDPS+LPKY PSKE DAKLR+
Sbjct: 637 NFPSSALALVDVLLSVEPDARGTAASALKSEFFTTKPLPCDPSSLPKYVPSKEYDAKLRN 696
Query: 471 QEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIP------SGQSKPTSISHKFHNQED 524
+EAR+Q AEAV+GRG ESVRRGSR V TPEF P GQ+ IS K+ ED
Sbjct: 697 EEARRQRAEAVKGRGAESVRRGSRQSKDVPTPEFKPQAQASLQGQTNTKCISEKYKPGED 756
Query: 525 SCSGFRIEPPTVGRQNVNSHSSTAVHPSA--------------SWNKSTVSTRNNSELRT 570
S S FR+EP N SHS+ ++ +A + + S+RN ELRT
Sbjct: 757 SGSNFRMEPHRGTVPNGLSHSTLMINQNAVGSSEKKVEDEAQLGYGNTFDSSRNKVELRT 816
Query: 571 QRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHE 630
SH+P AA SN+++R ++R+ ++S GYVPKKNR+HYSGPLMP GGN+E++LK+HE
Sbjct: 817 HGSHMPHGAAGVSNSSHRKDERISGKESVTGYVPKKNRMHYSGPLMPSGGNIEEMLKDHE 876
Query: 631 RQIQHAVRKARLEKS 645
RQIQ AVRKAR++K+
Sbjct: 877 RQIQEAVRKARIDKT 891
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4539004|emb|CAB39625.1| putative protein kinase [Arabidopsis thaliana] gi|7267697|emb|CAB78124.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/659 (62%), Positives = 495/659 (75%), Gaps = 25/659 (3%)
Query: 1 MGCICSKGAPEDEI---HASDRDKQLNISSVQLVAPAPSLREHPGGIVVGNEGSVRRGQQ 57
MGCICSKG E+E+ H ++ SSVQL+AP S ++ V R+
Sbjct: 1 MGCICSKGTAEEEVSDQHEKPKENWNKTSSVQLIAPVTSKKDEFSHKSVDGSSGGRKADG 60
Query: 58 QQQQPGLKAN-VTVPFDEGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGLQP 116
+P +A+ + VP D+ + +T IVERP R H+R T D+G G G + P
Sbjct: 61 LAHKPSARASGLIVPVDDSDG-KTVIVERPTRC-HRRWPTADIGTGGG------GFNIFP 112
Query: 117 QMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYK 176
+ +P PE + + AGWPSWLTSVAGEAIKGW PRRA++FEK+DKIGQGTYSSVY+
Sbjct: 113 PSNIPTSVPHSPEAELIAAGWPSWLTSVAGEAIKGWVPRRAESFEKLDKIGQGTYSSVYR 172
Query: 177 ARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYL 235
ARDLETGK+VA+KKVRF NMDPESVRFMAREI+ILRKLDHPNVMKLE LVTS+ SGSLYL
Sbjct: 173 ARDLETGKMVAMKKVRFVNMDPESVRFMAREINILRKLDHPNVMKLECLVTSKLSGSLYL 232
Query: 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG 295
VFEYMEHDL+GLA PG+KFTE QIKCYM+QLL GLEHCHSRGILHRDIKG NLL+NN G
Sbjct: 233 VFEYMEHDLSGLALRPGVKFTESQIKCYMKQLLSGLEHCHSRGILHRDIKGPNLLVNNDG 292
Query: 296 VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
VLKIGDFGLA Y P Q+ PLTSRVVTLWYRAPELLLGAT+YG ID+WS GCIL ELF
Sbjct: 293 VLKIGDFGLANIYHPEQDQPLTSRVVTLWYRAPELLLGATEYGPGIDLWSVGCILTELFL 352
Query: 356 GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQS 415
GKPIMPGRTEVEQMHKIFK CGSPS+DYW+K+K ATSFKPQQPYKR +LETF+N P S
Sbjct: 353 GKPIMPGRTEVEQMHKIFKFCGSPSDDYWQKTKLPLATSFKPQQPYKRVLLETFKNLPPS 412
Query: 416 ALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARK 475
ALALVDKLL++EP RG+A+S L S+FF EPLPC+ S+LPKYPPSKELDAK+RD+EAR+
Sbjct: 413 ALALVDKLLSLEPAKRGTASSTLSSKFFTMEPLPCNVSSLPKYPPSKELDAKVRDEEARR 472
Query: 476 QEAEAVRGRGPESVRRGSRDF-SAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPP 534
+++E V+GRGPESVRRGSRDF S TPEF+ SGQSK T + +F+ QEDS +G R +
Sbjct: 473 KKSETVKGRGPESVRRGSRDFKSTATTPEFVASGQSKDTITTKRFNPQEDSRTGLRGD-- 530
Query: 535 TVGRQNVNSHSSTAVHPS--ASWNKSTVSTRNNSELRTQR-SHLPQTAADFSNNNNRMND 591
Q SH+++ +HPS A+W+K+ N EL+ R S++P T S ++ +
Sbjct: 531 --RDQKGFSHTNSMIHPSITATWSKNESCRNNVVELKATRSSNVPMTGRYLSPSH---KE 585
Query: 592 RVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVRKARLEKSGTNNN 650
V ++ + YV KKNR+H SGPLMPPGGN+EDILK+HERQIQ AVRK+RLEKS T N
Sbjct: 586 DVAVQTTTT-YVRKKNRMHCSGPLMPPGGNIEDILKDHERQIQEAVRKSRLEKSATRKN 643
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741044|emb|CBI31356.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/670 (61%), Positives = 489/670 (72%), Gaps = 84/670 (12%)
Query: 1 MGCICSKGAPEDEI-----HASDRDKQLNISSVQLVAPAPSLREHPGGIVVGNEGSVRRG 55
MGCICSK A DE ++ K+LN SVQLVAP+
Sbjct: 1 MGCICSKEASVDEYVDYNEREKEKGKELNKDSVQLVAPSTG------------------- 41
Query: 56 QQQQQQPGLKANVTVPFDEGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGLQ 115
E P + HQR T+DM VG
Sbjct: 42 ----------------------------EEPTKASHQRRLTLDMENN---------VGPS 64
Query: 116 PQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVY 175
P MSRIV +P G +G+++VAGWPSWL+SVAGEAI+GW P R +++EK+DKIGQGTYS+VY
Sbjct: 65 P-MSRIVSMPNGAKGEQIVAGWPSWLSSVAGEAIQGWVPLRPESYEKLDKIGQGTYSTVY 123
Query: 176 KARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234
+ARDL++GKIVALKKVRF NMDPESVRFMAREIH+LRKLDHPNVMKLEGL+TSR SG+LY
Sbjct: 124 RARDLDSGKIVALKKVRFGNMDPESVRFMAREIHVLRKLDHPNVMKLEGLITSRTSGTLY 183
Query: 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294
LVFEYMEHDLAGL+ TPGIKFTEPQIKCYMQQLLRGLEHCHSRG+LHRDIKGSNLLI+N
Sbjct: 184 LVFEYMEHDLAGLSATPGIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLIDNK 243
Query: 295 GVLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL 353
GVLKIGDFGLA+ DPSQ PLTSRVVTLWYR PELLLGATKYGA++D+WS GCI+AEL
Sbjct: 244 GVLKIGDFGLASFRSDPSQ--PLTSRVVTLWYRPPELLLGATKYGASVDLWSTGCIIAEL 301
Query: 354 FAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFP 413
FAG PIMPG TEVEQ+HKIFKLCGSPSE+YW+KSK AHA+SFKPQ PYKR++ ETFRNFP
Sbjct: 302 FAGSPIMPGSTEVEQIHKIFKLCGSPSEEYWQKSKLAHASSFKPQHPYKRRLAETFRNFP 361
Query: 414 QSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEA 473
SALALVD LL++EP+ RG+AASAL+SEFF T+PLPCDPS+LPKY PSKE DAKLR++EA
Sbjct: 362 SSALALVDVLLSVEPDARGTAASALKSEFFTTKPLPCDPSSLPKYVPSKEYDAKLRNEEA 421
Query: 474 RKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIP----SGQSKPTSISHKFHNQEDSCSGF 529
R+Q AEAV+GRG ESVRRGSR V TPEF P S Q+ IS K+ EDS S F
Sbjct: 422 RRQRAEAVKGRGAESVRRGSRQSKDVPTPEFKPQAQASLQTNTKCISEKYKPGEDSGSNF 481
Query: 530 RIEPPTVGRQNVNSHSSTAVHPSA--------------SWNKSTVSTRNNSELRTQRSHL 575
R+EP N SHS+ ++ +A + + S+RN ELRT SH+
Sbjct: 482 RMEPHRGTVPNGLSHSTLMINQNAVGSSEKKVEDEAQLGYGNTFDSSRNKVELRTHGSHM 541
Query: 576 PQTAADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQH 635
P AA SN+++R ++R+ ++S GYVPKKNR+HYSGPLMP GGN+E++LK+HERQIQ
Sbjct: 542 PHGAAGVSNSSHRKDERISGKESVTGYVPKKNRMHYSGPLMPSGGNIEEMLKDHERQIQE 601
Query: 636 AVRKARLEKS 645
AVRKAR++K+
Sbjct: 602 AVRKARIDKT 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146272|ref|XP_002325944.1| predicted protein [Populus trichocarpa] gi|222862819|gb|EEF00326.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/518 (74%), Positives = 433/518 (83%), Gaps = 5/518 (0%)
Query: 137 WPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM 196
WP WLT+ AGEA+KGW PRRAD+FEK+DKIGQGTYS+V+KARDLETGKIVA+KKVRF NM
Sbjct: 1 WPQWLTAAAGEAVKGWLPRRADSFEKLDKIGQGTYSTVFKARDLETGKIVAMKKVRFVNM 60
Query: 197 DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKF 255
DPESVRFMAREI ILR+LDH NVMKLEG+VTSR SGSLYLVFEYMEHDLAGLA P IK+
Sbjct: 61 DPESVRFMAREIVILRRLDHLNVMKLEGIVTSRMSGSLYLVFEYMEHDLAGLAANPSIKY 120
Query: 256 TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315
TE QIKCYMQQLLRGLEHCH G+LHRDIKGSNLLINN GVLKI DFGLAT+Y P Q+LP
Sbjct: 121 TEAQIKCYMQQLLRGLEHCHKHGVLHRDIKGSNLLINNDGVLKIADFGLATSYQPDQSLP 180
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
LTSRVVTLWYRAPELLLGAT+YG AIDMWSAGCILAELF GKPIMPGRTEVEQMHKIFKL
Sbjct: 181 LTSRVVTLWYRAPELLLGATEYGPAIDMWSAGCILAELFTGKPIMPGRTEVEQMHKIFKL 240
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435
CGSPSE YW K K HATSFKPQQPY R+ ETF+NFP SAL LVDKLL++EP++RGSA
Sbjct: 241 CGSPSEAYWTKKKFPHATSFKPQQPYIRRTAETFKNFPPSALTLVDKLLSMEPQDRGSAT 300
Query: 436 SALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRD 495
SALRSEFF+ EPLP DPS+LPKYPPSKELDAK+RDQEAR+Q+AEAV+GRGPESVRRGS D
Sbjct: 301 SALRSEFFRIEPLPSDPSSLPKYPPSKELDAKMRDQEARRQKAEAVKGRGPESVRRGSGD 360
Query: 496 FSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVGRQNVNSHSSTAVHPSA-- 553
T EF GQ K S+K++ QED S FRIEPP V ++N HS++ +H SA
Sbjct: 361 TKKAPTSEFTAQGQPKTICSSYKYNIQEDGGSSFRIEPPRVSKKNGLEHSASVIHHSAVG 420
Query: 554 -SWNKSTVSTRNNSELRTQRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYS 612
S NKS T NN ELR+++S + Q+ S++ + +R DS+ G+VP+K RIHYS
Sbjct: 421 LSLNKSVDCTENNPELRSKKSRVSQSGEISSSSLKK-KERAPSIDSSAGFVPRKTRIHYS 479
Query: 613 GPLMPPGGNMEDILKEHERQIQHAVRKARLEKSGTNNN 650
GPLMPPGGNME+ILKEHERQIQ AVRKARLEKSGT +N
Sbjct: 480 GPLMPPGGNMEEILKEHERQIQQAVRKARLEKSGTKDN 517
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147806286|emb|CAN67625.1| hypothetical protein VITISV_007388 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/675 (61%), Positives = 495/675 (73%), Gaps = 53/675 (7%)
Query: 1 MGCICSKGAPEDE-IHASDRDKQ----LNISSVQLVAPAPSLREHPGGIVVGNEGSVRRG 55
MGCICSK A DE + ++R+K+ LN SVQLVAP+ G G G
Sbjct: 1 MGCICSKEASVDEYVDYNEREKEKXKELNKDSVQLVAPSTGEEFVMGPGGGGGHGRTGGS 60
Query: 56 QQQQQQPGLKANV-TVPFD--EGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAV 112
+ L+ NV + P EGE + +RP + HQR T+DM V
Sbjct: 61 VHPISKSALQGNVGSAPIRAMEGEK-KAMTADRPTKASHQRRLTLDMENN---------V 110
Query: 113 GLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYS 172
G P MSRIV +P G +G+++VAGWPSWL+SVAGEAI+GW P R +++EK+DK G T
Sbjct: 111 GPSP-MSRIVSMPNGAKGEQIVAGWPSWLSSVAGEAIQGWVPLRPESYEKLDK-GPCT-- 166
Query: 173 SVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231
L++GKIVALKKVRF NMDPESVRFMAREIH+LRKLDHPNVMKLEGL+TSR SG
Sbjct: 167 -------LDSGKIVALKKVRFGNMDPESVRFMAREIHVLRKLDHPNVMKLEGLITSRTSG 219
Query: 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
+LYLVFEYMEHDLAGL+ TPGIKFTEPQIKCYMQQLLRGLEHCHSRG+LHRDIKGSNLLI
Sbjct: 220 TLYLVFEYMEHDLAGLSATPGIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLI 279
Query: 292 NNAGVLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCIL 350
+N GVLKIGDFGLA+ DPSQ PLTSRVVTLWYR PELLLGATKYGA++D+WS GCI+
Sbjct: 280 DNKGVLKIGDFGLASFRSDPSQ--PLTSRVVTLWYRPPELLLGATKYGASVDLWSTGCII 337
Query: 351 AELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR 410
AELFAG PIMPG TEVEQ+HKIFKLCGSPSE+YW+KSK AHA+SFKPQ PYKR++ ETFR
Sbjct: 338 AELFAGSPIMPGSTEVEQIHKIFKLCGSPSEEYWQKSKLAHASSFKPQHPYKRRLAETFR 397
Query: 411 NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRD 470
NFP SALALVD LL++EP+ RG+AASAL+SEFF T+PLPCDPS+LPKY PSKE DAKLR+
Sbjct: 398 NFPSSALALVDVLLSVEPDARGTAASALKSEFFTTKPLPCDPSSLPKYVPSKEYDAKLRN 457
Query: 471 QEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIP------SGQSKPTSISHKFHNQED 524
+EAR+Q AEAV+GRG ESVRRGSR V TPEF P GQ+ IS K+ ED
Sbjct: 458 EEARRQRAEAVKGRGAESVRRGSRQSKDVPTPEFKPQAQASLQGQTNTKCISEKYKPGED 517
Query: 525 SCSGFRIEPPTVGRQNVNSHSSTAVHPSA--------------SWNKSTVSTRNNSELRT 570
S S FR+EP N SHS+ ++ +A + + S+RN ELRT
Sbjct: 518 SGSNFRMEPHRGTVPNGLSHSTLMINQNAVGSSEKKVEDEAQLGYGNTFDSSRNKVELRT 577
Query: 571 QRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSGPLMPPGGNMEDILKEHE 630
SH+P AA SN+++R ++R+ ++S GYVPKKNR+HYSGPLMP GGN+E++LK+HE
Sbjct: 578 HGSHMPHGAAGVSNSSHRKDERISGKESVTGYVPKKNRMHYSGPLMPSGGNIEEMLKDHE 637
Query: 631 RQIQHAVRKARLEKS 645
RQIQ AVRKAR++K+
Sbjct: 638 RQIQEAVRKARIDKT 652
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334183831|ref|NP_177308.3| protein kinase domain-containing protein [Arabidopsis thaliana] gi|12323730|gb|AAG51826.1|AC016163_15 putative protein kinase; 36307-33767 [Arabidopsis thaliana] gi|332197089|gb|AEE35210.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1949), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/529 (70%), Positives = 425/529 (80%), Gaps = 14/529 (2%)
Query: 134 VAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRF 193
A WPSWL SVAGEAIKGW PR A++FEK+DKIGQGTYSSVYKARDLETGKIVA+KKVRF
Sbjct: 121 AAEWPSWLASVAGEAIKGWVPRCAESFEKLDKIGQGTYSSVYKARDLETGKIVAMKKVRF 180
Query: 194 ANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPG 252
NMDPESVRFMAREI ILRKLDHPNVMKLEGLVTSR SGSLYLVFEYMEHDLAGLA TPG
Sbjct: 181 VNMDPESVRFMAREILILRKLDHPNVMKLEGLVTSRLSGSLYLVFEYMEHDLAGLAATPG 240
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
IKF+EPQIKCYMQQL RGLEHCH RGILHRDIKGSNLLINN GVLKIGDFGLA Y
Sbjct: 241 IKFSEPQIKCYMQQLFRGLEHCHRRGILHRDIKGSNLLINNEGVLKIGDFGLANFYRGDG 300
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
+L LTSRVVTLWYRAPELLLGAT+YG AID+WSAGCIL ELFAGKPIMPGRTEVEQMHKI
Sbjct: 301 DLQLTSRVVTLWYRAPELLLGATEYGPAIDLWSAGCILTELFAGKPIMPGRTEVEQMHKI 360
Query: 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
FKLCGSPSEDYWR++ ATSFKP PYK + ETF +FP SAL L++KLL IEPE RG
Sbjct: 361 FKLCGSPSEDYWRRATLPLATSFKPSHPYKPVLAETFNHFPSSALMLINKLLAIEPEKRG 420
Query: 433 SAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRG 492
SAAS LRSEFF TEPLP +PSNLP+YPPSKELDAKLR++EARK AE + RG E+V RG
Sbjct: 421 SAASTLRSEFFTTEPLPANPSNLPRYPPSKELDAKLRNEEARKLRAEGNKRRGGETVTRG 480
Query: 493 S-RDFSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVG-RQNVNSHSSTAVH 550
+D +TPEF+ +GQSK T ISHKF E+ +GFRIEPP G +QN +H+S+ VH
Sbjct: 481 RPKDLKTAQTPEFMAAGQSKVTCISHKFKTDEEGGTGFRIEPPRRGIQQNGKAHASSMVH 540
Query: 551 PSAS---WN-KSTVSTRNNSELRTQRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVPKK 606
P+ + WN ++ + N+E++++ S D S + R + RD + G P+K
Sbjct: 541 PTVADTEWNGGGSIKRQTNAEMKSRTSQ----TGDLSGESYRRDPN---RDYSTGNAPRK 593
Query: 607 NRIHYSGPLMPPGGNMEDILKEHERQIQHAVRKARLEKSGTNNNGLVVG 655
NRI+YSGPLMPPGGN+ED+LKEHE+QIQ AVRKAR+EKS + N + G
Sbjct: 594 NRINYSGPLMPPGGNLEDLLKEHEKQIQQAVRKARVEKSASRKNQALTG 642
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486237|ref|XP_002264491.2| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] gi|297739502|emb|CBI29684.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/744 (55%), Positives = 500/744 (67%), Gaps = 109/744 (14%)
Query: 1 MGCICSKGAPEDE-IHASDRDKQLNI-SSVQLVAPAPSLREHPGGIVV----GNEGSVRR 54
MGCICSKG+ +E + + RDK+L+ SS +LVA S RE G+VV G+ + R
Sbjct: 1 MGCICSKGSSVNEYVEKNARDKELSKKSSKRLVAS--SRRE---GVVVEGYGGSNDATAR 55
Query: 55 GQQQQQQPGLKANVTVPFDEGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGL 114
Q A+ V +D+ + ++ ++ R Q+ +TM++GM G
Sbjct: 56 LIPTQSAEDNAASTPVSWDKRQK-KSMAIDNSTRAAVQKPSTMEVGMNAG---------- 104
Query: 115 QPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSV 174
QPQM+RIV + G E + AGWPSWLT+VA EAI GW PR+AD+FE++DKIGQGTYSSV
Sbjct: 105 QPQMTRIVSMGNGVEAAQAAAGWPSWLTAVAAEAIDGWVPRKADSFERLDKIGQGTYSSV 164
Query: 175 YKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233
YKARDLETGK VALKKVRFANMDPESVRFMAREIHILR+LDHPNVMKLEGL+TSR SGSL
Sbjct: 165 YKARDLETGKTVALKKVRFANMDPESVRFMAREIHILRRLDHPNVMKLEGLITSRMSGSL 224
Query: 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293
YLVFEYM+HDLAGLA++P IKFTEPQIKCYMQQLLRGLEHCHSRG+LHRDIKGSNLLI+N
Sbjct: 225 YLVFEYMDHDLAGLASSPKIKFTEPQIKCYMQQLLRGLEHCHSRGVLHRDIKGSNLLIDN 284
Query: 294 AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL 353
G LKIGDFGLAT + P Q PLTSRVVTLWYR PELLLGAT YG A+D+WSAGCILAEL
Sbjct: 285 NGNLKIGDFGLATFFQPYQKQPLTSRVVTLWYRPPELLLGATSYGVAVDLWSAGCILAEL 344
Query: 354 FAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFP 413
+AGKPIM GRTEVEQ+H+IFKLCGSPSE+YW+++K HAT FKPQ PY+R V ETF +FP
Sbjct: 345 YAGKPIMQGRTEVEQLHRIFKLCGSPSEEYWKRAKLPHATIFKPQHPYRRCVAETFSDFP 404
Query: 414 QSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEA 473
AL+L+D LL IEPE RGSA+SAL +EFF T+PLPCD SNLPKYPPSKE DAKLR++EA
Sbjct: 405 SPALSLMDVLLAIEPERRGSASSALHNEFFTTKPLPCDTSNLPKYPPSKEFDAKLREEEA 464
Query: 474 RKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPS---------GQSKPTSISHKFHNQED 524
R++ A +GRG ES R+ SR+ AV P+ QS P S S KF +ED
Sbjct: 465 RRRRAAGSKGRGHESTRKVSRESKAVPAPDANAELQVSIQKRREQSNPKSKSEKFIPEED 524
Query: 525 SCSGFRIEPPTVGRQNVNSHSSTAVHPSASWN----------------KSTVSTRNNSEL 568
SGF IEP +N SHS ++HP+A + + + S+RN +EL
Sbjct: 525 GGSGFPIEPTKGTTRNGFSHSGKSIHPTAFGSARNMDVNEDEAQMGPGRGSNSSRNGAEL 584
Query: 569 RTQRSH---------------LPQTAADFSNN-NNRMN-----DRVFIRDSNM------- 600
R Q+S+ Q ++ F N+ N MN +R R + +
Sbjct: 585 RIQKSYSHRGGSQLSMFSGSVAVQGSSRFDNDRENGMNRHWPEERCNARYNELGGAESSE 644
Query: 601 -----------------------------GYVPKKNRIHYSGPLMPPGGNMEDILKEHER 631
GY PKKNRIHYSGPLMPPGGN+E++LKEHE+
Sbjct: 645 KHQWSHHLLDRPKSSHKKDEQPSEKGSSMGYAPKKNRIHYSGPLMPPGGNLEEMLKEHEK 704
Query: 632 QIQHAVRKARLEKSGT----NNNG 651
QIQ AVRKARL+K T N+NG
Sbjct: 705 QIQLAVRKARLDKVKTKKAYNDNG 728
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | ||||||
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.756 | 0.819 | 0.626 | 2e-175 | |
| TAIR|locus:2140543 | 469 | AT4G10010 [Arabidopsis thalian | 0.687 | 0.974 | 0.692 | 2.8e-169 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.876 | 0.816 | 0.534 | 1.1e-168 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.679 | 0.651 | 0.646 | 1.8e-159 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.562 | 0.652 | 0.683 | 1.1e-146 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.556 | 0.574 | 0.656 | 7.1e-141 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.628 | 0.589 | 0.579 | 1.7e-139 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.684 | 0.614 | 0.577 | 6.5e-138 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.553 | 0.634 | 0.678 | 6.5e-138 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.657 | 0.625 | 0.551 | 1.5e-136 |
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1590 (564.8 bits), Expect = 2.0e-175, Sum P(2) = 2.0e-175
Identities = 334/533 (62%), Positives = 395/533 (74%)
Query: 63 GLKAN-VTVPFDEGENPRTTIVERPKRNRHQRCAXXXXXXXXXXXXXIVAVGLQPQMSRI 121
G +A+ + VP D+ + +T IVERP R++ R GL +S +
Sbjct: 58 GRRASGLIVPIDDSHDGKTVIVERPSRSQRGRRVSDNGKGG----------GLI--ISNV 105
Query: 122 VCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLE 181
P E + + AGWP WLTSVAGEAIKGW PRRAD+FEK+DKIGQGTYS VYKARDLE
Sbjct: 106 ---PRSAEAELIAAGWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLE 162
Query: 182 TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYM 240
TGKIVA+KKVRFANMDPESVRFMAREI+ILRKLDHPNVMKL+ LVTS+ SGSL+LVFEYM
Sbjct: 163 TGKIVAMKKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYM 222
Query: 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIG 300
EHDL+GLA PG+KFTEPQIKC+M+QLL GLEHCHSRGILHRDIKGSNLL+NN GVLKIG
Sbjct: 223 EHDLSGLALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIG 282
Query: 301 DFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIM 360
DFGLA+ Y P Q+ PLTSRVVTLWYRAPELLLG+T+YG AID+WS GCILAELF KPIM
Sbjct: 283 DFGLASFYKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIM 342
Query: 361 PGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALV 420
PGRTEVEQMHKIFKLCGSPSE++W +K ATS+KPQ PYKR +LETF+N S+L L+
Sbjct: 343 PGRTEVEQMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLL 402
Query: 421 DKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEA 480
DKLL++EPE R SA+S L SEFF TEPLPC S+LPKYPPSKELDAK+RD+EA++++AEA
Sbjct: 403 DKLLSVEPEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKRKKAEA 462
Query: 481 VRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVGRQN 540
V+ RG ESVRRG RD S V TPEFI SG S + + F ++ + P+ R N
Sbjct: 463 VKWRGHESVRRGLRD-SKV-TPEFIASGNSNVSLTTPSFKKEKRFTDTNSVIHPS-SRSN 519
Query: 541 VNSHSSTAVHPSASWN-KSTVST--RNNSELRTQRSHLPQTAADFSNNNNRMN 590
V V PS S N +T+ ++S+ S P T + NRM+
Sbjct: 520 VGE-----VKPSRSNNVPATMGDYLASSSQKENIVSRAPATT--YMRKKNRMH 565
|
|
| TAIR|locus:2140543 AT4G10010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
Identities = 327/472 (69%), Positives = 384/472 (81%)
Query: 185 IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHD 243
+VA+KKVRF NMDPESVRFMAREI+ILRKLDHPNVMKLE LVTS+ SGSLYLVFEYMEHD
Sbjct: 1 MVAMKKVRFVNMDPESVRFMAREINILRKLDHPNVMKLECLVTSKLSGSLYLVFEYMEHD 60
Query: 244 LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303
L+GLA PG+KFTE QIKCYM+QLL GLEHCHSRGILHRDIKG NLL+NN GVLKIGDFG
Sbjct: 61 LSGLALRPGVKFTESQIKCYMKQLLSGLEHCHSRGILHRDIKGPNLLVNNDGVLKIGDFG 120
Query: 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR 363
LA Y P Q+ PLTSRVVTLWYRAPELLLGAT+YG ID+WS GCIL ELF GKPIMPGR
Sbjct: 121 LANIYHPEQDQPLTSRVVTLWYRAPELLLGATEYGPGIDLWSVGCILTELFLGKPIMPGR 180
Query: 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKL 423
TEVEQMHKIFK CGSPS+DYW+K+K ATSFKPQQPYKR +LETF+N P SALALVDKL
Sbjct: 181 TEVEQMHKIFKFCGSPSDDYWQKTKLPLATSFKPQQPYKRVLLETFKNLPPSALALVDKL 240
Query: 424 LTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRG 483
L++EP RG+A+S L S+FF EPLPC+ S+LPKYPPSKELDAK+RD+EAR++++E V+G
Sbjct: 241 LSLEPAKRGTASSTLSSKFFTMEPLPCNVSSLPKYPPSKELDAKVRDEEARRKKSETVKG 300
Query: 484 RGPESVRRGSRDF-SAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVGRQNVN 542
RGPESVRRGSRDF S TPEF+ SGQSK T + +F+ QEDS +G R + G
Sbjct: 301 RGPESVRRGSRDFKSTATTPEFVASGQSKDTITTKRFNPQEDSRTGLRGDRDQKGF---- 356
Query: 543 SHSSTAVHPS--ASWNKSTVSTRNNS-ELR-TQRSHLPQTAADFSNNNNRMNDRVFIRDS 598
SH+++ +HPS A+W+K+ S RNN EL+ T+ S++P T S ++ + V ++ +
Sbjct: 357 SHTNSMIHPSITATWSKNE-SCRNNVVELKATRSSNVPMTGRYLSPSHK---EDVAVQTT 412
Query: 599 NMGYVPKKNRIHYSGPLMPPGGNMEDILKEHERQIQHAVRKARLEKSGTNNN 650
YV KKNR+H SGPLMPPGGN+EDILK+HERQIQ AVRK+RLEKS T N
Sbjct: 413 TT-YVRKKNRMHCSGPLMPPGGNIEDILKDHERQIQEAVRKSRLEKSATRKN 463
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1515 (538.4 bits), Expect = 1.1e-168, Sum P(2) = 1.1e-168
Identities = 327/612 (53%), Positives = 407/612 (66%)
Query: 1 MGCICSKGAPEDEIHASDRDKQLNISSVQLVAPAPSLREHPGGIVVGNEGSVRR----GX 56
MGC C+KG D + D + +S+V + ++ P S + G
Sbjct: 1 MGCNCTKGTRPDNDNV-DNSNSI-VSNVNVKERRSKPKKTPKKKKKSKSASSSKDNNVGF 58
Query: 57 XXXXXPGLKANVT--VPFD---EGENPRTTIVERPKRNRHQRCAXXXXXXXXXXXXXIVA 111
+A++T +P D + E+ + +ER + R +
Sbjct: 59 EERSNDNKEASLTLLIPIDAKKDDESEKKVNLER----KSSRLVFQRRPTGIEVGANNIG 114
Query: 112 VGLQPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTY 171
QP+M+RI + G G +V+AGWPSWL SVAGEAI GW PR+AD+FEK++KIGQGTY
Sbjct: 115 TLQQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTY 174
Query: 172 SSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-S 230
SSVYKARDLET ++VALKKVRFANMDP+SVRFMAREI ILR+LDHPNVMKLEGL+TSR S
Sbjct: 175 SSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVS 234
Query: 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLL 290
GS+YL+FEYMEHDLAGLA+TPGI F+E QIKCYM+QLL GLEHCHSRG+LHRDIKGSNLL
Sbjct: 235 GSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLL 294
Query: 291 INNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCIL 350
+++ LKIGDFGLA Y Q PLTSRVVTLWYR PELLLG+T YG +D+WS GCIL
Sbjct: 295 LDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCIL 354
Query: 351 AELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR 410
AELF GKPIMPGRTEVEQ+HKIFKLCGSPSE+YW+ SK HAT FKPQQPYKR V ETF+
Sbjct: 355 AELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFK 414
Query: 411 NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRD 470
+ P SALALV+ LL +EP+ RG+ ASAL SEFF T PL DPS+LPKY P KE+D K ++
Sbjct: 415 SLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQE 474
Query: 471 QEARKQEAEAVRGRGPESVRRGSRDFSAVRT-PEFIPS-----GQSKPTSISHKFHNQED 524
+EA++++ + + + V R S+ A + E + S GQ S S KF+ ED
Sbjct: 475 EEAKRKKDTSSKQNDSKQVSRESKAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPGED 534
Query: 525 SCSGFRIEPPTVGRQNVNSHSSTAVHPSASWNKSTV---STRN-NSELRTQRSHLPQTAA 580
+ S FRIEP G + H+ V S + N V S+R+ ELRTQRS + + A
Sbjct: 535 AAS-FRIEPLKSGTAK-DGHTRYGVS-SVNRNGENVMMGSSRSPRKELRTQRSFVQRGTA 591
Query: 581 DFSNNNNRMNDR 592
S +N + R
Sbjct: 592 QLSRFSNSVAAR 603
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 1.8e-159, Sum P(2) = 1.8e-159
Identities = 306/473 (64%), Positives = 367/473 (77%)
Query: 129 EGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVAL 188
EG+ V AGWP WL SVAGEAI+GW PRRAD+FEK+DKIGQGTYS+VY+ARDL+ KIVAL
Sbjct: 103 EGEYVAAGWPPWLASVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVAL 162
Query: 189 KKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGL 247
KKVRF N++PESVRFMAREI ILR+LDHPN++KLEGLVTSR S SLYLVFEYMEHDLAGL
Sbjct: 163 KKVRFDNLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 222
Query: 248 ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307
A+ P IKF+E Q+KCY+QQLL GL+HCHSRG+LHRDIKGSNLLI+N+GVLKI DFGLA+
Sbjct: 223 ASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASF 282
Query: 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE 367
+DP Q PLTSRVVTLWYR PELLLGAT+YGAA+D+WSAGCILAEL+AGKPIMPGRTEVE
Sbjct: 283 FDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVE 342
Query: 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
Q+HKIFKLCGSP+EDYW KS+ HAT FKP QPYKR V ETF+ FPQ ALAL++ LL++
Sbjct: 343 QLHKIFKLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVN 402
Query: 428 PENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPE 487
P++RG+A +AL+SEFF T PLPCDPS+LPKYPPSKELDA++RD+E+R+Q R E
Sbjct: 403 PDDRGTATAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQE 462
Query: 488 SVRRGSRDFSAVRTP----EFIPS---GQSKPT--SISHKFH-NQEDSCSGFRIEPPTVG 537
RRG+++ A+ P E + S QS+ T S S KF+ + E+ SGF I+PP
Sbjct: 463 --RRGTKESRAIPAPDANAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPS 520
Query: 538 RQ----NVNSHSSTAVHPSASWNKSTVSTRNNS---ELRTQRSHLPQTAADFS 583
Q N S + H AS + +S R+ S Q S + AD+S
Sbjct: 521 SQAFEPNRESQGNIIPHKRAS-HSGPLSRRSASAKGRRNYQDSQKVSSIADYS 572
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1413 (502.5 bits), Expect = 1.1e-146, Sum P(2) = 1.1e-146
Identities = 257/376 (68%), Positives = 316/376 (84%)
Query: 130 GDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK 189
G++V AGWPSWL+ GEA+ GW PR+AD FEKIDKIGQGTYS+VYKA+D+ TGKIVALK
Sbjct: 88 GEQVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALK 147
Query: 190 KVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLA 248
KVRF N++PESV+FMAREI +LR+LDHPNV+KLEGLVTSR S SLYLVF+YM+HDLAGLA
Sbjct: 148 KVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLA 207
Query: 249 TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308
++P +KF+E ++KC M+QL+ GLEHCHSRG+LHRDIKGSNLLI++ GVLKI DFGLAT +
Sbjct: 208 SSPVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIF 267
Query: 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368
DP+ P+TSRVVTLWYRAPELLLGAT YG ID+WSAGCILAEL AG+PIMPGRTEVEQ
Sbjct: 268 DPNHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQ 327
Query: 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP 428
+HKI+KLCGSPSEDYW+K K H +KP++PYKR + ETF++FP S+L L+D LL+IEP
Sbjct: 328 LHKIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEP 387
Query: 429 ENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEA-VRGRGPE 487
E+R +A++AL+SEFF +EP C+P++LPKYPPSKE+DAK RD+E R+Q A + +G G
Sbjct: 388 EDRQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGAR 447
Query: 488 SVRRGSRDFSAVRTPE 503
R R A+ PE
Sbjct: 448 KNRHRDRSNRALPAPE 463
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1322 (470.4 bits), Expect = 7.1e-141, Sum P(2) = 7.1e-141
Identities = 246/375 (65%), Positives = 297/375 (79%)
Query: 122 VCLPVGPEG----DEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKA 177
V +P PE E+ AGWP+WL SVAGEA+ W PRRA FEK++KIGQGTYSSVYKA
Sbjct: 95 VVIPPSPETVSKEAELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKA 154
Query: 178 RDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVT-SRSGSLYLV 236
RDL KIVALK+VRF D ESV+FMAREI ++R+LDHPNV+KLEGL+T S S SLYLV
Sbjct: 155 RDLTNNKIVALKRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLV 214
Query: 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296
FEYM+HDL GLA+ PGIKF+EPQ+KCYMQQLL GL HCHSRG+LHRDIKGSNLLI++ GV
Sbjct: 215 FEYMDHDLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGV 274
Query: 297 LKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG 356
LKI DFGLAT +DP +PLTSRVVTLWYR PELLLGA YG +D+WS GCIL EL++G
Sbjct: 275 LKIADFGLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSG 334
Query: 357 KPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSA 416
KPI+ G+TEVEQ+HKIFKLCGSP+EDYWRK K + +F+P PY R+V E F++ P +
Sbjct: 335 KPILAGKTEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNV 394
Query: 417 LALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQ 476
L+L++ LL+I+P+ RGSAA AL SE+F+TEP CDPS+LPKYPPSKE+DAK+RD R++
Sbjct: 395 LSLLEALLSIDPDRRGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQR 454
Query: 477 EAEAVRGRGPESVRR 491
+ R RR
Sbjct: 455 PTQEKHERQDSQTRR 469
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 1.7e-139, Sum P(3) = 1.7e-139
Identities = 249/430 (57%), Positives = 320/430 (74%)
Query: 129 EGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVAL 188
E ++V AGWP+WL++VAGEAI GW P R+DAFEK++KIGQGTYSSV++AR+ ETG+IVAL
Sbjct: 100 EAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVAL 159
Query: 189 KKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGL 247
KKVRF N +PESVRFMAREI ILRKL+HPN++KLEG+VTS+ S S++LVFEYMEHDL GL
Sbjct: 160 KKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGL 219
Query: 248 ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307
++P I FT PQIKCYM+QLL GL+HCH+RG++HRDIKGSNLL+NN G+LK+ DFGLA
Sbjct: 220 LSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANF 279
Query: 308 YDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV 366
+ S N PLTSRVVTLWYR PELLLGAT+YGA++D+WS GC+ AEL GKP++ GRTEV
Sbjct: 280 CNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEV 339
Query: 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR--NFPQSALALVDKLL 424
EQ+HKIFKLCGSP EDYW+KSK HA FKPQQ Y + ET + + + L++ LL
Sbjct: 340 EQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLL 399
Query: 425 TIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGR 484
+I+P RG+A++AL S++F ++P CDPS+LP Y PSKE+DAK R+ RK+ + R R
Sbjct: 400 SIQPHKRGTASTALVSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGR-R 458
Query: 485 GPESVRRGSRD---FSAVRTPEFIPSGQSK-PTSISHKFHNQEDSCSGF--RIEPPTVGR 538
G ES R+ +R F+ + E + K H HN DS S +++ P+
Sbjct: 459 GTES-RKPTRKPPAFAKLAPAEDVRHHSQKFQKRNGHSVHNSIDSDSTLFEKMQKPSNHE 517
Query: 539 QNVNSHSSTA 548
++ SH A
Sbjct: 518 KDEASHVKNA 527
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1350 (480.3 bits), Expect = 6.5e-138, P = 6.5e-138
Identities = 271/469 (57%), Positives = 342/469 (72%)
Query: 119 SRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKAR 178
S IV P E +V AGWPSWL SVAGE++ W PRRA+ FEK++KIGQGTYSSVY+AR
Sbjct: 173 SSIVS-PKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRAR 231
Query: 179 DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVF 237
DL KIVALKKVRF D ESV+FMAREI ++R+LDHPNV+KLEGL+T+ S SLYLVF
Sbjct: 232 DLLHNKIVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVF 291
Query: 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297
EYM+HDL GL++ PG+KFTEPQ+KCYM+QLL GLEHCHSRG+LHRDIKGSNLLI++ GVL
Sbjct: 292 EYMDHDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVL 351
Query: 298 KIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK 357
KI DFGLAT +DP++++ LTS VVTLWYR PELLLGA+ YG +D+WS GCIL EL+AGK
Sbjct: 352 KIADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGK 411
Query: 358 PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSAL 417
PI+PG+TEVEQ+HKIFKLCGSP+E+YWRK K + FK PY+RKV E F++FP S L
Sbjct: 412 PILPGKTEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVL 471
Query: 418 ALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQE 477
+L++ LL+I+P++R SA AL SE+FKT+P CDPSNLPKYPPSKE+DAK+RD+ R+Q
Sbjct: 472 SLLETLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQP 531
Query: 478 AEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHK-FHNQEDSCSGFRIE--P- 533
A + +S+ R S + V P + S +K ++ DS F+ E P
Sbjct: 532 MRAEKQERQDSMTRISHERKFV-PPVKANNSLSMTMEKQYKDLRSRNDSFKSFKEERTPH 590
Query: 534 -PTVGRQNV--NSHSSTAVHPSASWNKSTVSTRN--NSELRTQRSHLPQ 577
P QN+ N ++ T V S S +S RN S + + + LP+
Sbjct: 591 GPVPDYQNMQHNRNNQTGVRISHSG--PLMSNRNMAKSTMHVKENALPR 637
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1350 (480.3 bits), Expect = 6.5e-138, P = 6.5e-138
Identities = 253/373 (67%), Positives = 303/373 (81%)
Query: 136 GWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN 195
GWP WL + G++IK PRRA +EK++KIGQGTYS+VYKA+DL +GKIVALKKVRF N
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 196 MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIK 254
++ ESV+FMAREI +LR+L+HPNV+KL+GLVTSR S SLYLVFEYMEHDL+GLA T G+K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 255 FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314
F PQ+KC+M+QLL GLEHCHSRG+LHRDIKGSNLLI+N G+LKI DFGLAT YDP Q
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
+TSRVVTLWYR PELLLGAT YG +D+WSAGCI+AEL AGKP+MPGRTEVEQ+HKIFK
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
LCGSPS+ YW+K + +AT FKPQ PYKR V E F F S++ LV+ LLTI+P +RG++
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 435 ASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRR--- 491
SAL SEFF TEPLPCDPS+LPKYPPSKEL+ KLRD+E R+Q+ A +G G + RR
Sbjct: 390 TSALNSEFFTTEPLPCDPSSLPKYPPSKELNVKLRDEELRRQKGLAGKGSGIDGARRIRY 449
Query: 492 -GSRDFSAVRTPE 503
G R A+ PE
Sbjct: 450 RGDRTGRAIPAPE 462
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.5e-136, Sum P(2) = 1.5e-136
Identities = 245/444 (55%), Positives = 326/444 (73%)
Query: 129 EGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVAL 188
E ++V AGWP+WL++VAGEAI GW P R+DAFEK++KIGQGTYS+V++A + ETG+IVAL
Sbjct: 90 EAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVETETGRIVAL 149
Query: 189 KKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGL 247
KKVRF N +PESV+FMAREI ILR+L+HPN++KLEGL+TS+ S ++ LVFEYMEHDL GL
Sbjct: 150 KKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFEYMEHDLTGL 209
Query: 248 ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307
++P IKFT PQIKCYM+QLL GL+HCHSRG++HRDIKGSNLL++N G+LK+ DFGLA
Sbjct: 210 LSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKVADFGLANF 269
Query: 308 YDPS--QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE 365
+ S + PLTSRVVTLWYR PELLLGAT YGA++D+WS GC+ AEL GKPI+ GRTE
Sbjct: 270 SNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGKPILRGRTE 329
Query: 366 VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLT 425
VEQ+HKIFKLCGSP EDYW+KSK HA FKPQQ Y + ET ++ ++ + L++ LL+
Sbjct: 330 VEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEINLIETLLS 389
Query: 426 IEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQ-EAEAVRGR 484
I+P RG+A+SAL S++F T+P CDPS+LP YPPSKE+D K RD+ ARK+ RG
Sbjct: 390 IDPHKRGTASSALVSQYFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKISGNGRRGI 449
Query: 485 GPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGF--RIEPPTVGRQNVN 542
P R + F+ + P+ ++ I H H+ +S + +++ P +++
Sbjct: 450 DPRKPSRKAHSFNRL-APDVRHQTETFQKRIGHLVHSSIESDARLCGKLQNPLDHKKDEA 508
Query: 543 SHSSTAVHPSASWNKSTVSTRNNS 566
SH A ++ +++NS
Sbjct: 509 SHVKHASQGDVPFSGPLQVSKSNS 532
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 665 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-164 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-121 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-118 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-113 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-109 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-106 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-105 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-96 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-96 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-95 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-94 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-93 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-92 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-90 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-90 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-87 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-81 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-81 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-80 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-80 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-79 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-78 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-78 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-77 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-75 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-74 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-72 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-70 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-67 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-67 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-65 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-65 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-64 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-64 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-63 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-62 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-61 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-60 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-60 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-59 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-59 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-55 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-53 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-52 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-52 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-52 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-49 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-48 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-46 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-44 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-41 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-40 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-40 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-39 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-37 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-31 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-18 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 470 bits (1213), Expect = e-164
Identities = 166/287 (57%), Positives = 216/287 (75%), Gaps = 3/287 (1%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+EKI +IG+GTY VYKAR+ +TG++VALKK+R N REI +L+KL HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 220 MKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++L+ +VTS+ GS+Y+VFEYM+HDL GL +P +KFTE QIKCYM+QLL GL++ HS G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
ILHRDIKGSN+LINN GVLK+ DFGLA Y + T+RV+TLWYR PELLLGAT+YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATSFKP 397
+DMWS GCILAELF GKPI G TE+EQ+ KIF+LCGSP+++ W SK + KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 398 QQPYKRKVLETFRNF-PQSALALVDKLLTIEPENRGSAASALRSEFF 443
++PYKR++ E F++ SAL L+DKLLT++P+ R SA AL+ E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 127/292 (43%), Positives = 178/292 (60%), Gaps = 18/292 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD----PESVRFMAREIHILRKLD 215
+EK++K+G+GTY VYKARD +TG+IVALKK+R N + ++R EI +L++L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
HPN++KL ++ + LYLVFEY + DL + IK M QLLRGL +CH
Sbjct: 57 HPNIVKLLDVIHTER-KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELLL 332
S ILHRD+K N+LIN GVLK+ DFGLA + +PL T VVTLWYRAPE+LL
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYRAPEILL 171
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAH 391
G+ Y A+D+WS GCI AE+ GKP+ PG +E++Q+ KIF++ G+P+E+ W +K
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P+ P K + + + L+ K+L P R SA AL+ +F
Sbjct: 232 YKPTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 355 bits (913), Expect = e-118
Identities = 137/301 (45%), Positives = 185/301 (61%), Gaps = 8/301 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN--MDPESVRFMA-REIHILRKLDH 216
+EK K+G+GTY+ VYKARD ETG+IVA+KK++ + + F A REI +L++L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
PN++ L + +S ++ LVFE+ME DL + I T IK YM LRGLE+ HS
Sbjct: 62 PNIIGLLDVFGHKS-NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
ILHRD+K +NLLI + GVLK+ DFGLA ++ S N +T +VVT WYRAPELL GA
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TSF 395
YG +DMWS GCI AEL P +PG ++++Q+ KIF+ G+P+E+ W S F
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
KP P K + F AL L+ +LLT+ P R +A AL +F +P P PS L
Sbjct: 240 KPFPPTPLK--QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQL 297
Query: 456 P 456
P
Sbjct: 298 P 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-113
Identities = 151/313 (48%), Positives = 203/313 (64%), Gaps = 25/313 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN----MDPESVRFMAREIHILRKLD 215
FEK+++IG+GTY VY+ARD +G+IVALKKVR N + S+R EI +L L
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----EITLLLNLR 64
Query: 216 HPNVMKLEGLVTSRS-GSLYLVFEYMEHDLAGL---ATTPGIKFTEPQIKCYMQQLLRGL 271
HPN+++L+ +V + S++LV EY E DLA L TP F+E Q+KC M QLLRGL
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGL 121
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
++ H I+HRD+K SNLL+ + G LKI DFGLA TY P+T +VVTLWYRAPELL
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELL 180
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSA 390
LG T Y AIDMW+ GCILAEL A KP++PG++E+EQ+ I +L G+P+E W S
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240
Query: 391 HATSFK-PQQPYKRKVLETFRNFP---QSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
F P+QPY L+ FP ++ L L++ LL +P+ R +A AL S +FK +
Sbjct: 241 LVGKFTLPKQPYNN--LK--HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
Query: 447 PLPCDPSNLPKYP 459
PLPC+P +P +P
Sbjct: 297 PLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 332 bits (853), Expect = e-109
Identities = 139/297 (46%), Positives = 188/297 (63%), Gaps = 13/297 (4%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF---MAREIHIL 211
R D +EK+++I +GTY VY+ARD +TG+IVALKK++ M+ E F REI+IL
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINIL 58
Query: 212 RKLDHPNVMKL-EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
KL HPN++ + E +V S +Y+V EY+EHDL L T F + ++KC M QLL G
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPE 329
+ H H ILHRD+K SNLL+NN G+LKI DFGLA Y P + P T VVTLWYRAPE
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPE 176
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SK 388
LLLGA +Y AIDMWS GCI AEL KP+ PG++E++Q++KIFKL G+P+E W S+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 389 SAHATSFKPQQPYKRKVLETFRNFP--QSALALVDKLLTIEPENRGSAASALRSEFF 443
A + ++ + F + L+++LLT +P R SA AL+ +F
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 324 bits (831), Expect = e-106
Identities = 144/302 (47%), Positives = 195/302 (64%), Gaps = 12/302 (3%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
W R D F+ I +IG+GTY VYKARD +TG++VALKKVR N + E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 211 LRKLDHPNVMKLEGLVTSRS---------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIK 261
LR+L+H N++ L+ +VT + G+ YLVFEYM+HDL GL + + F+E IK
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321
+M+QLL GL +CH + LHRDIK SN+L+NN G +K+ DFGLA Y+ ++ P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
TLWYR PELLLG +YG AID+WS GCIL ELF KPI E+ Q+ I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 382 DYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + + KP++ Y+R++ E F P AL L+D +LT++P R +A AL S
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 441 EF 442
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 322 bits (827), Expect = e-105
Identities = 134/305 (43%), Positives = 185/305 (60%), Gaps = 24/305 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
+E + K+G+GT+ VYKAR ++TG++VALKK+ N + + A REI IL+KL HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 219 VMKLEGLVTSRS-------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
V+ L + R GS+Y+V YM+HDL+GL P +K TE QIKCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLP---------LTSRVV 321
+ H ILHRDIK +N+LI+N G+LKI DFGLA YD P N T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
T WYR PELLLG +Y A+D+W GC+ AE+F +PI+ G+++++Q+H IFKLCG+P+E
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 382 DY---WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
+ WR Y R + E F L L+ KLL+++P R +A+ AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFT--NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 439 RSEFF 443
+F
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 297 bits (763), Expect = 1e-96
Identities = 108/285 (37%), Positives = 159/285 (55%), Gaps = 32/285 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E ++K+G+G++ VY ARD +TGK+VA+K ++ + + R + REI IL+KL HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNI 59
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++L + LYLV EY E DL L G + +E + + Y++Q+L LE+ HS+G
Sbjct: 60 VRLYDVFEDE-DKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKG 117
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
I+HRD+K N+L++ G +K+ DFGLA DP + LT+ V T Y APE+LLG YG
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGYG 174
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
A+D+WS G IL EL GKP PG +Q+ ++FK G P +
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEW---------- 221
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ A L+ KLL +PE R +A AL+ FF
Sbjct: 222 ------------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 296 bits (760), Expect = 5e-96
Identities = 129/286 (45%), Positives = 176/286 (61%), Gaps = 5/286 (1%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++K+ KIG+GTY VYKARD TG+IVA+KK++ + REI +L++L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+KL + + G LYLVFE+M+ DL L E IK Y+ QLL+GL CHS GI
Sbjct: 61 IKLLDVFRHK-GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
LHRD+K NLLIN GVLK+ DFGLA ++ P T VVT WYRAPELLLG Y
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYST 178
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399
+D+WS GCI AEL + +P+ PG++E++Q+ KIF+ G+P + W K S A ++K
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-ARNYKFSF 237
Query: 400 PYKRKV-LET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P K + L F N AL L+ ++L +P R +A AL +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 9e-95
Identities = 132/324 (40%), Positives = 182/324 (56%), Gaps = 31/324 (9%)
Query: 160 FEKIDK-IGQGTYSSVYKARDLETGKIVALKKVR------FANMDPESV-----RFMA-R 206
+ + +G+GTY V KA D TGKIVA+KKV+ D + V F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
E+ I+ ++ H N+M L + + LV + M DL + I+ TE Q+KC + Q
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEG-DFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQ 127
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-------------DPSQN 313
+L GL H +HRD+ +N+ IN+ G+ KI DFGLA Y +
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
+TS+VVTLWYRAPELL+GA KY A+DMWS GCI AEL GKP+ PG E++Q+ +IF
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247
Query: 374 KLCGSPSEDYWRKSKSAHA-TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
+L G+P+ED W ++K T F P++P K F N A+ L+ LL + P R
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK--TIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 433 SAASALRSEFFKTEPLPCDPSNLP 456
SA AL+ E+FK++PLPCDPS LP
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 294 bits (754), Expect = 1e-94
Identities = 139/300 (46%), Positives = 179/300 (59%), Gaps = 15/300 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
+EK+ KIGQGT+ V+KAR +T +IVALKKV N + E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 217 PNVMKL------EGLVTSRS-GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLR 269
NV+ L + +R GS YLVFE+ EHDLAGL + +KFT +IK M+ LL
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP---LTSRVVTLWYR 326
GL + H ILHRD+K +N+LI G+LK+ DFGLA + S+N T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
PELLLG YG IDMW AGCI+AE++ PIM G TE Q+ I +LCGS + + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 387 -SKSAHATSFKPQQPYKRKVLETFRNF--PQSALALVDKLLTIEPENRGSAASALRSEFF 443
K + Q KRKV E + + AL L+DKLL ++P R A +AL +FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 3e-93
Identities = 128/291 (43%), Positives = 186/291 (63%), Gaps = 15/291 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
++K++KIG+GTY VYKARD TG+IVALKK+R D E V A REI +L++L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPN 59
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++L +V S + LYLVFE+++ DL + ++P P IK Y+ QLL+G+ +CHS
Sbjct: 60 IVRLLDVVHSEN-KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELLLGA 334
+LHRD+K NLLI+ G LK+ DFGLA + +P+ T VVTLWYRAPE+LLG+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
+Y +D+WS GCI AE+ +P+ PG +E++Q+ +IF+ G+P ED W S
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS--LPD 232
Query: 395 FKPQQP-YKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+KP P + R+ L N + L L+ K+L +P R SA +AL+ +F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 287 bits (737), Expect = 2e-92
Identities = 127/295 (43%), Positives = 175/295 (59%), Gaps = 19/295 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKLD- 215
+E++ +IG+G Y +VYKARDL TG+ VALKKVR + P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 216 --HPNVMKL----EGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLL 268
HPN+++L G T R L LVFE+++ DLA L+ P IK M+QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
RG++ HS I+HRD+K N+L+ + G +KI DFGLA Y + LTS VVTLWYRAP
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAP 175
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
E+LL ++ Y +DMWS GCI AELF +P+ G +E +Q+ KIF + G PSE+ W ++
Sbjct: 176 EVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
S +SF P R + L L+ K+LT P R SA AL+ +F
Sbjct: 235 SLPRSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 1e-90
Identities = 114/290 (39%), Positives = 164/290 (56%), Gaps = 12/290 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKLDH 216
++ + +IG+G + V+KA+D ETG+ VALKKV ++ P REI L+ H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQH 58
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
P V+KL V LV EYM DL+ + E Q+K YM+ LL+G+ + H+
Sbjct: 59 PYVVKLLD-VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
GI+HRD+K +NLLI+ GVLKI DFGLA + + + +V T WYRAPELL GA K
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS---AHAT 393
Y +D+W+ GCI AEL G P+ PG ++EQ+ +F+ G+P+E+ W S +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+F +P + + F + AL L+ LL +P R SAA ALR +F
Sbjct: 238 TFPESKPIPLEEI--FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 6e-90
Identities = 116/313 (37%), Positives = 174/313 (55%), Gaps = 15/313 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E + IG G Y V A D TG+ VA+KK+ D + + REI +LR L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 220 MKLEGLVTSRS----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+ L ++ S +Y+V E ME DL + +P T+ I+ ++ Q+LRGL++ H
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSRVVTLWYRAPELLLG 333
S ++HRD+K SN+L+N+ LKI DFGLA DP ++ LT VVT WYRAPELLL
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
+++Y AID+WS GCI AEL KP+ PGR ++Q++ I ++ G+PSE+ + S A
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 394 SFKPQQPYKRKV-LET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT------ 445
++ P K K L F A+ L++K+L +P+ R +A AL +
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300
Query: 446 EPLPCDPSNLPKY 458
EP+ P + +
Sbjct: 301 EPVAKPPFDFDFF 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 5e-87
Identities = 103/286 (36%), Positives = 148/286 (51%), Gaps = 28/286 (9%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E + K+G G++ +VYKA+ TGKIVA+K ++ + + + REI ILR+L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++L LYLV EY E DL + G +E + K Q+LRGLE+ HS G
Sbjct: 61 VRLIDAFE-DKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
I+HRD+K N+L++ GV+KI DFGLA S + LT+ V T WY APE+LLG YG
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS-SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK-LCGSPSEDYWRKSKSAHATSFKP 397
+D+WS G IL EL GKP G ++Q+ I + L D
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP------------- 224
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ + + A L+ K L +P R +A L+ +F
Sbjct: 225 ----------KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 2e-81
Identities = 122/291 (41%), Positives = 177/291 (60%), Gaps = 15/291 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
F+K++KIG+GTY VYKAR+ TG++VALKK+R + + E V A REI +L++L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPN 60
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++KL ++ + + LYLVFE++ DL + +P P IK Y+ QLL+GL CHS
Sbjct: 61 IVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELLLGA 334
+LHRD+K NLLIN G +K+ DFGLA + +P+ T VVTLWYRAPE+LLG
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y A+D+WS GCI AE+ + + PG +E++Q+ +IF+ G+P E W S
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPD 233
Query: 395 FKPQQP-YKRKVLETF-RNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+KP P + R+ + L+ ++L +P R SA +AL FF
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 3e-81
Identities = 114/292 (39%), Positives = 173/292 (59%), Gaps = 17/292 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKV--RFANMDPESVRFMAREIHILRKL-DH 216
++ I ++G GT+ SVY AR+ ETG++VA+KK+ +F + + E + RE+ LRKL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 217 PNVMKL-EGLVTSRSGSLYLVFEYMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHC 274
PN++KL E V + LY VFEYME +L L G F+E I+ + Q+L+GL H
Sbjct: 58 PNIVKLKE--VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H G HRD+K NLL++ V+KI DFGLA P T V T WYRAPE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYVSTRWYRAPEILLRS 173
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS-AHAT 393
T Y + +D+W+ GCI+AEL+ +P+ PG +E++Q++KI + G+P++ W + A
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 394 SFK-PQQPYKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
F+ PQ L N A+ L+ +L +P+ R +A+ AL+ +F
Sbjct: 234 GFRFPQFAPTS--LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 256 bits (655), Expect = 2e-80
Identities = 116/288 (40%), Positives = 166/288 (57%), Gaps = 9/288 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+EK++KIG+GTY +V+KA++ ET +IVALK+VR + D REI +L++L H N+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
++L ++ S L LVFEY + DL + +K +M QLL+GL CHS +
Sbjct: 62 VRLYDVLHSDK-KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELLLGATK 336
LHRD+K NLLIN G LK+ DFGLA + +P+ ++ VVTLWYR P++L GA
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 337 YGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y +IDMWSAGCI AEL AG+P+ PG +Q+ +IF+L G+P+E+ W
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P P ++ + L+ LL P R SA AL+ +F
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 4e-80
Identities = 105/290 (36%), Positives = 162/290 (55%), Gaps = 6/290 (2%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +E + +G+G Y V K R+ TG+IVA+KK + + D + + RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ L+ R G LYLVFEY+E L L +PG ++ Y+ QLL+ + +CHS
Sbjct: 61 NIVNLKE-AFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHS 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
I+HRDIK N+L++ +GVLK+ DFG A PLT V T WYRAPELL+G T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS-PSEDYWRKSKSAHATSF 395
YG +D+W+ GCI+AEL G+P+ PG ++++Q++ I K G P S +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 396 KPQQPYKRKVLET-FRN-FPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+P + + LE + AL + L ++P+ R + L+ +F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 9e-79
Identities = 121/292 (41%), Positives = 187/292 (64%), Gaps = 16/292 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
+ KI+KIG+GTY VYK R+ +TG+IVA+KK+R + + E V A REI +L++L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPN 60
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQ-IKCYMQQLLRGLEHCHS 276
++ L+ ++ S LYL+FE++ DL L + P ++ + + +K Y+ Q+L+G+ CHS
Sbjct: 61 IVCLQDVLMQES-RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELLLG 333
R +LHRD+K NLLI+N GV+K+ DFGLA + +P+ T VVTLWYRAPE+LLG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF----GIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
+ +Y +D+WS G I AE+ KP+ G +E++Q+ +IF++ G+P+ED W S
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LP 233
Query: 394 SFKPQQP-YKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+K P +K+ L + +N + L L++K+L +P R SA AL +F
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 2e-78
Identities = 126/303 (41%), Positives = 176/303 (58%), Gaps = 26/303 (8%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
DA+EK++KIG+GTY VYKARD TGK+VALKK R MD E + A REI +L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSE 59
Query: 217 -PNVMKLEGL--VTSRSG--SLYLVFEYMEHDLA----GLATTPGIKFTEPQIKCYMQQL 267
+++L + V ++G SLYLVFEY++ DL PG IK +M QL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLPL---TSRVVTL 323
L+G+ HCH G++HRD+K NLL++ G+LKI D GL + ++P+ T +VTL
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF----SIPVKSYTHEIVTL 175
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383
WYRAPE+LLG+T Y +D+WS GCI AE+ +P+ PG +E++Q+ IFKL G+P+E
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 384 W---RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W K + H Q R + L L+ K+L +P R SA +AL
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSR----AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
Query: 441 EFF 443
+F
Sbjct: 292 PYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 8e-78
Identities = 115/297 (38%), Positives = 179/297 (60%), Gaps = 17/297 (5%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKL 214
+ + ++K+DK+G+G+Y++VYK R TG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDL 60
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEH 273
H N++ L ++ ++ +L LVFEY++ DL + G + ++ ++ QLLRGL +
Sbjct: 61 KHANIVTLHDIIHTKK-TLTLVFEYLDTDLKQYMDDCGGG-LSMHNVRLFLFQLLRGLAY 118
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLPLTSRVVTLWYRAPELLL 332
CH R +LHRD+K NLLI+ G LK+ DFGLA PS+ ++ VVTLWYR P++LL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY--SNEVVTLWYRPPDVLL 176
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSEDYWRKSKS-- 389
G+T+Y ++DMW GCI E+ G+P+ PG T+V +Q+HKIF++ G+P+E+ W S
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236
Query: 390 ---AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
++ F P +P R L K L EP+ R SAA A++ +F
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDR--IPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 4e-77
Identities = 112/289 (38%), Positives = 178/289 (61%), Gaps = 11/289 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE--SVRFMAREIHILRKLDHP 217
F++++K+G+GTY++VYK R+ TG+IVALK++ ++D E + REI ++++L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHE 58
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEP--QIKCYMQQLLRGLEHCH 275
N+++L ++ + + L LVFEYM+ DL T G++ +K + QLL+G+ CH
Sbjct: 59 NIVRLHDVIHTEN-KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+LHRD+K NLLIN G LK+ DFGLA + N ++ VVTLWYRAP++LLG+
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSR 176
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW-RKSKSAHATS 394
Y +ID+WS GCI+AE+ G+P+ PG +Q+ KIF++ G+P+E W S+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P+ P + + + F + + L+ +LL + PE R SA AL+ +F
Sbjct: 237 TFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 2e-75
Identities = 123/295 (41%), Positives = 182/295 (61%), Gaps = 16/295 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
D +EK++KIG+GTY VYKARD T + +ALKK+R D E V A REI +L+++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQH 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N+++L+ +V S LYLVFEY++ DL + ++P IK Y+ Q+LRG+ +CH
Sbjct: 61 GNIVRLQDVVHSEK-RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 276 SRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPL---TSRVVTLWYRAPELL 331
S +LHRD+K NLLI+ LK+ DFGLA + +P+ T VVTLWYRAPE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVVTLWYRAPEIL 175
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
LG+ Y +D+WS GCI AE+ KP+ PG +E++++ KIF++ G+P+E+ W S
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS-- 233
Query: 392 ATSFKPQQP-YKRKVLETF-RNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+K P + K L T + + L+ K+L ++P R +A +AL E+FK
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 4e-74
Identities = 115/308 (37%), Positives = 168/308 (54%), Gaps = 26/308 (8%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPN 218
+E + K+G+G Y V+KA D T ++VALKK+ A + + REI L++L DHPN
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 219 VMKLEGLVTSRSGS-LYLVFEYMEHDL-----AGLATTPGIKFTEPQIKCY-MQQLLRGL 271
++KL ++ + + +YLVFEYME DL A + E K Y M QLL+ L
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI--------LEDVHKRYIMYQLLKAL 120
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA----TTYDPSQNLPLTSRVVTLWYRA 327
++ HS ++HRD+K SN+L+N+ +K+ DFGLA + +N LT V T WYRA
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
PE+LLG+T+Y +DMWS GCIL E+ GKP+ PG + + Q+ KI ++ G PS +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 388 KSAHATSF--KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR----SE 441
KS A + ++ + E AL L+ KLL P R +A AL ++
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
Query: 442 FFKTEPLP 449
F P
Sbjct: 301 FHNPSDEP 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 5e-72
Identities = 107/316 (33%), Positives = 153/316 (48%), Gaps = 33/316 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLE--TGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
+E IG+GTY VYKA+ GK A+KK + + A REI +LR+L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 217 PNVMKL-EGLVTSRSGSLYLVFEYMEHDLAGL----ATTPGIKFTEPQIKCYMQQLLRGL 271
NV+ L E + S+YL+F+Y EHDL + + +K + Q+L G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 272 EHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYDPSQNLPLTSR--VVTLWY 325
+ HS +LHRD+K +N+L+ GV+KIGD GLA ++ VVT+WY
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKLC 376
RAPELLLGA Y AID+W+ GCI AEL +PI GR +Q+ +IF++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 377 GSPSED---------YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
G+P+E + T P K +E + L+ KLL +
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLA-KWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 428 PENRGSAASALRSEFF 443
P R +A AL +F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 1e-70
Identities = 112/325 (34%), Positives = 163/325 (50%), Gaps = 14/325 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++ I+ IG G Y V A D +GK VA+KK+ A P + RE+ ILR H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 218 NVMKLEGLVTSRSG---SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
N++ + ++ +Y+V + ME DL + + TE I+ ++ QLLRGL++
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI 123
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ---NLPLTSRVVTLWYRAPELL 331
HS ++HRD+K SNLL+N L+IGDFG+A S +T V T WYRAPELL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
L +Y AIDMWS GCI AE+ + + PG+ V Q+ I + GSPSE+ + S
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 392 A----TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447
+ +QP + F AL L+ ++L +PE R + AL+ F
Sbjct: 244 VRKYIQNLPRKQPVPWSKI--FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 448 LPCD-PSNLPKYPPSKELDAKLRDQ 471
P D P+ P + E R+Q
Sbjct: 302 DPDDEPTCPPPFDFDFEAIELSREQ 326
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 6e-67
Identities = 108/293 (36%), Positives = 161/293 (54%), Gaps = 26/293 (8%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALK--KVRFANMDPESVRFMAREIHILRKL-DHPNV 219
+ KIG+GT+S V KA+ +TGK A+K K F +++ + REI LR+L HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 220 MKL-EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK-----FTEPQIKCYMQQLLRGLEH 273
++L E L ++G L LVFE M+ +L L IK E ++K YM QLL+ L+H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYEL-----IKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
H GI HRDIK N+LI + +LK+ DFG P T + T WYRAPE LL
Sbjct: 116 MHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY--SKPPYTEYISTRWYRAPECLLT 172
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
YG +D+W+ GC+ E+ + P+ PG E++Q+ KI + G+P + +K + +
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 394 SFK--PQQPYK-RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
++ ++ RK+L N L L+ KLL +P+ R +A ALR +F
Sbjct: 233 NYNFPSKKGTGLRKLLP---NASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 8e-67
Identities = 119/292 (40%), Positives = 164/292 (56%), Gaps = 13/292 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL---DH 216
+E + +IG G Y +VYKARD +G VALK VR + RE+ +L++L DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 217 PNVMKL----EGLVTSRSGSLYLVFEYMEHDL-AGLATTPGIKFTEPQIKCYMQQLLRGL 271
PN+++L T R + LVFE+++ DL L P IK M+Q LRGL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
+ H+ I+HRD+K N+L+ + G +K+ DFGLA Y S + LT VVTLWYRAPE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVL 179
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
L +T Y +DMWS GCI AE+F KP+ G +E +Q+ KIF L G P ED W + +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+F P+ P R V +S L+ ++LT P R SA AL+ FF
Sbjct: 239 RGAFSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 1e-65
Identities = 113/299 (37%), Positives = 167/299 (55%), Gaps = 15/299 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
IG+G Y V A++ ET + VA+KK+ A + + REI +LR LDH NV+ ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 226 VTSRS----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
+ +Y+V+E M+ DL + + ++ + ++ QLLRGL++ HS +LH
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLRGLKYIHSANVLH 131
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAI 341
RD+K SNLL+N LKI DFGLA T + +T VVT WYRAPELLL ++Y AI
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAI 190
Query: 342 DMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401
D+WS GCI AEL KP+ PG+ V Q+ I +L GSPSE+ ++ A + PY
Sbjct: 191 DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY 250
Query: 402 KRKVLETFRN-FPQS---ALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456
+ +F FP + A+ L++K+L +P R + AL + L DPS+ P
Sbjct: 251 TPRQ--SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL--ASLH-DPSDEP 304
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 111/294 (37%), Positives = 162/294 (55%), Gaps = 16/294 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +EK+ KIG+G+Y V+K R+ ETG+IVA+KK + DP + REI +L++L HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 218 NVMKL-EGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N++ L E V R L+LVFEY +H L L P E IK + Q L+ + CH
Sbjct: 61 NLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH 117
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+HRD+K N+LI G +K+ DFG A T V T WYRAPELL+G T
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDT 176
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS- 394
+YG +D+W+ GC+ AEL G+P+ PG+++V+Q++ I K G D + + +T+
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQIFSTNQ 232
Query: 395 -FKPQQ---PYKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
FK P R+ LE+ F N AL+ + L ++P R S L +F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 216 bits (550), Expect = 5e-65
Identities = 117/298 (39%), Positives = 175/298 (58%), Gaps = 22/298 (7%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ + + K+DK+G+GTY++V+K R T +VALK++R + + + RE+ +L+ L
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLK 61
Query: 216 HPNVMKLEGLV-TSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
H N++ L ++ T R L LVFEY++ DL G + +K +M QLLRGL +C
Sbjct: 62 HANIVTLHDIIHTERC--LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLPLTSRVVTLWYRAPELLLG 333
H R ILHRD+K NLLIN G LK+ DFGLA P++ ++ VVTLWYR P++LLG
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLG 177
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW------RKS 387
+T+Y IDMW GCIL E+ G+P+ PG T E++H IF+L G+P+E+ W +
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237
Query: 388 KSAHATSFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+S ++ QP L+T + L+ LL E ++R SA +ALR +F
Sbjct: 238 RSYLFPQYRA-QPLINHAPRLDT------DGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 2e-64
Identities = 116/320 (36%), Positives = 168/320 (52%), Gaps = 25/320 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG+G Y V A TG VA+KK+ R + REI ILR+ H N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKHENI 65
Query: 220 MKLEGLVTSRS----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+ + ++ S +Y+V E ME DL L T + I+ ++ Q+LRGL++ H
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH 123
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSRVVTLWYRAPELLLG 333
S +LHRD+K SNLL+N LKI DFGLA DP + LT V T WYRAPE++L
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
+ Y AID+WS GCILAE+ + +P+ PG+ + Q++ I + G+PS++ S A
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243
Query: 394 SFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT------ 445
++ P+K KV + F N AL L+DK+LT P R + AL + +
Sbjct: 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303
Query: 446 -----EPLPCD---PSNLPK 457
EP P D +LPK
Sbjct: 304 EPVAEEPFPFDFELFDDLPK 323
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 8e-64
Identities = 110/292 (37%), Positives = 166/292 (56%), Gaps = 10/292 (3%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ + + K+DK+G+GTY++VYK R T +VALK++R + + + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
H N++ L ++ + SL LVFEY++ DL G +K ++ QLLRGL +CH
Sbjct: 63 HANIVTLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP---LTSRVVTLWYRAPELLL 332
R +LHRD+K NLLIN G LK+ DFGLA ++++P ++ VVTLWYR P++LL
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
G+T Y IDMW GCI E+ G+P+ PG T EQ+H IF++ G+P+E+ W S
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237
Query: 393 -TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
S+ + + L+ KLL E R SA A++ +F
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 8e-64
Identities = 79/190 (41%), Positives = 113/190 (59%), Gaps = 5/190 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
+G+G + +VY ARD +TGK VA+K ++ + + REI IL+KL+HPN++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 226 VTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284
LYLV EY E L L K +E +I + Q+L GLE+ HS GI+HRD+
Sbjct: 60 FEDE-NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 285 KGSNLLINNA-GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
K N+L+++ G +K+ DFGL+ ++L L + V T Y APE+LLG Y D+
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 344 WSAGCILAEL 353
WS G IL EL
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 2e-63
Identities = 109/313 (34%), Positives = 163/313 (52%), Gaps = 13/313 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D ++ + +G G Y V A D +TG+ VA+KK+ + RE+ +L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 218 NVMKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
NV+ L + T S +YLV M DL + K ++ I+ + Q+LRGL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLK 132
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ HS GI+HRD+K SN+ +N LKI DFGLA D +T V T WYRAPE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 188
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
Y +D+WS GCI+AEL GK + PG ++Q+ +I L G+P E+ +K S A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 393 TSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
++ P K+ E F A+ L++K+L ++P+ R +AA AL + P
Sbjct: 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308
Query: 451 DPSNLPKYPPSKE 463
D P Y S E
Sbjct: 309 DEPVAPPYDQSFE 321
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 111/289 (38%), Positives = 158/289 (54%), Gaps = 10/289 (3%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
+G G + V ARD TG+ VA+KK+ P + RE+ +L+ L H N++ L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 226 VTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQ-IKCYMQQLLRGLEHCHSRGILHRDI 284
S +Y V E + DL L T+ + E Q I+ ++ Q+LRGL++ HS G++HRD+
Sbjct: 78 FISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDL 134
Query: 285 KGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMW 344
K SN+LIN LKI DFGLA DP +T V T +YRAPE++L KY +D+W
Sbjct: 135 KPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190
Query: 345 SAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRK 404
SAGCI AE+ GKP+ PG+ V Q I L G+P +D S + F P +
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP 250
Query: 405 V--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCD 451
V E F+N SA+ L++K+L +P+ R SAA AL + P D
Sbjct: 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 7e-62
Identities = 110/291 (37%), Positives = 174/291 (59%), Gaps = 14/291 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
+E + +G+G+Y V K + ETG+IVA+KK + D + V+ +A REI +L++L H N
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 219 VMKL-EGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
++ L E V R LYLVFE+++H L L P E +++ Y+ Q+LRG+E CHS
Sbjct: 62 LVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHS 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
I+HRDIK N+L++ +GV+K+ DFG A T + T V T WYRAPELL+G TK
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDTK 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATSF 395
YG A+D+W+ GC++ E+ G+P+ PG ++++Q++ I K G+ + K+
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 396 KPQQPYKRKVLETFRNFPQ---SALALVDKLLTIEPENRGSAASALRSEFF 443
+ + + + LE + FP+ L L + L I+P++R S++ L EFF
Sbjct: 238 RLPEVKEIEPLE--KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 107/297 (36%), Positives = 175/297 (58%), Gaps = 16/297 (5%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ + + K++K+G+GTY++V+K R T +VALK++R + + + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
H N++ L +V + SL LVFEY++ DL G + +K ++ Q+LRGL +CH
Sbjct: 63 HANIVTLHDIVHT-DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLPLTSRVVTLWYRAPELLLGA 334
R +LHRD+K NLLIN G LK+ DFGLA P++ ++ VVTLWYR P++LLG+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGS 179
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW------RKSK 388
++Y IDMW GCI E+ +G+P+ PG T +++H IF+L G+P+E+ W + K
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445
+ + +KPQ ++ + L+ K L E + R SA A++ +F++
Sbjct: 240 NYNFPKYKPQ-----PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 108/292 (36%), Positives = 158/292 (54%), Gaps = 16/292 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLET--GKIVALKKVRFANMDPESVRFMAREIHILRKL-DH 216
+E I ++GQG Y V AR+ ET + VA+KK+ + RE+ +LR H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 217 PNVMKLEGLVTSRSGS---LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
N+ L + G+ LYL E ME DL + + G T+ + ++ Q+L GL++
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY 120
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLP-LTSRVVTLWYRAPEL 330
HS +LHRD+K NLL+N LKI DFGLA + +P +N +T V T WYRAPE+
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
+L Y AID+WS GCILAEL KP+ G+ V+Q+++I ++ G+P E+ + S
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240
Query: 391 HATSFKPQQPYKRKV-LETFRNFPQS---ALALVDKLLTIEPENRGSAASAL 438
A ++ P K E+ FP + AL L++KLL +P R S AL
Sbjct: 241 KAQNYIRSLPNIPKKPFES--IFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 4e-60
Identities = 121/301 (40%), Positives = 176/301 (58%), Gaps = 17/301 (5%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKL 214
+AD++EK++K+G+G+Y++VYK + GK+VALK +R + E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIREASLLKGL 60
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEH 273
H N++ L ++ ++ +L LVFEY+ DL + PG +K ++ QLLRGL +
Sbjct: 61 KHANIVLLHDIIHTKE-TLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSY 118
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLPLTSRVVTLWYRAPELLL 332
H R ILHRD+K NLLI++ G LK+ DFGLA PS ++ VVTLWYR P++LL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVVTLWYRPPDVLL 176
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWRKSKSAH 391
G+T+Y +DMW GCI E+ G PG +++ Q+ +IF + G+P+ED W S
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS-- 234
Query: 392 ATSFKPQQ--PYKRKVLETFRN---FPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
FKP++ Y K L N + A L KLL P+NR SA +AL E+F
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294
Query: 447 P 447
P
Sbjct: 295 P 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 2e-59
Identities = 117/294 (39%), Positives = 173/294 (58%), Gaps = 13/294 (4%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLD 215
A ++ ++K+G+G+Y++VYK G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHC 274
H N++ L ++ ++ +L VFEYM DLA + PG ++ +M QLLRGL +
Sbjct: 62 HANIVLLHDIIHTKE-TLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYI 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-PSQNLPLTSRVVTLWYRAPELLLG 333
H + ILHRD+K NLLI+ G LK+ DFGLA PSQ +S VVTLWYR P++LLG
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLG 177
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSEDYW---RKSKS 389
AT Y +A+D+W AGCI E+ G+P PG ++V EQ+ KI+ + G P+ED W K +
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
F P +P + +V+ + P A L ++L + P++R SA AL +F
Sbjct: 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 4e-59
Identities = 125/333 (37%), Positives = 173/333 (51%), Gaps = 46/333 (13%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL-EG 224
+G G+ V+ A D + K VA+KK+ DP+SV+ REI I+R+LDH N++K+ E
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 225 LVTSRS------------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
L S S S+Y+V EYME DLA + + +E + +M QLLRGL+
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQLLRGLK 128
Query: 273 HCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDP--SQNLPLTSRVVTLWYRAPE 329
+ HS +LHRD+K +N+ IN VLKIGDFGLA DP S L+ +VT WYR+P
Sbjct: 129 YIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK-------------LC 376
LLL Y AIDMW+AGCI AE+ GKP+ G E+EQM I + L
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248
Query: 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS 436
PS + R +P++P R +L AL ++++LT P +R +A
Sbjct: 249 VIPS--FVRNDGG------EPRRPL-RDLLPGVNP---EALDFLEQILTFNPMDRLTAEE 296
Query: 437 ALRSEFFKTEPLPCD-PSNLPKYPPSKELDAKL 468
AL + P D P +L + ELD L
Sbjct: 297 ALMHPYMSCYSCPFDEPVSLHPFHIEDELDDIL 329
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 93/289 (32%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E I +IG+G++ VY R GK+ LK++ +NM + E+ IL+KL+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 220 MKL-EGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+K E G L +V EY + DL+ G F E QI + QL L++
Sbjct: 62 IKYYESFEEK--GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HSR ILHRDIK N+ + + G++K+GDFG++ + +L + V T +Y +PEL
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNK 178
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y D+WS GC+L EL K G +E KI K
Sbjct: 179 -PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-------------------- 217
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P + RN LV LL +PE R S A L+S F
Sbjct: 218 -GQYPPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-56
Identities = 89/287 (31%), Positives = 143/287 (49%), Gaps = 31/287 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + + +G+G++ SVY A D +TG+++A+K V + E + + REI IL L HPN+
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVF-EYM-EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++ G + +F EY+ L+ L G K EP I+ Y +Q+L GL + HS
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPELLLGATK 336
GI+HRDIKG+N+L+++ GV+K+ DFG A D S T ++ APE++ G +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EE 179
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
YG A D+WS GC + E+ GKP P M ++K+ +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKP--PWSELGNPMAALYKI--------------GSSGE-P 222
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P+ P + + A + K L +P+ R +A L+ F
Sbjct: 223 PEIP---------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 118/295 (40%), Positives = 169/295 (57%), Gaps = 18/295 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAREIHILRKLD--- 215
+E + +IG+G Y V+KARDL+ G + VALK+VR + RE+ +LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 216 HPNVMKLEGLVT----SRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRG 270
HPNV++L + T R L LVFE+++ DL L P IK M QLLRG
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPEL 330
L+ HS ++HRD+K N+L+ ++G +K+ DFGLA Y S + LTS VVTLWYRAPE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
LL ++ Y +D+WS GCI AE+F KP+ G ++V+Q+ KI + G P E+ W + +
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 391 HATSF--KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+F K QP ++ V + + L+ K LT P R SA SAL +F
Sbjct: 240 PRQAFHSKSAQPIEKFV----TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 110/299 (36%), Positives = 165/299 (55%), Gaps = 32/299 (10%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G+Y V A D TG+ VA+KK+ F ++ ++ R + REI +LR L HP++++++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHPDIVEIK 65
Query: 224 GLVTSRS----GSLYLVFEYMEHDLAGLATTPGIK----FTEPQIKCYMQQLLRGLEHCH 275
++ S +Y+VFE ME DL + IK T + ++ QLLR L++ H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQV-----IKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA--TTYDPSQNLPLTSRVVTLWYRAPELLLG 333
+ + HRD+K N+L N LKI DFGLA D + T V T WYRAPEL G
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-G 179
Query: 334 A--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
+ +KY AID+WS GCI AE+ GKP+ PG+ V Q+ I L G+PS + + ++
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239
Query: 392 ATSF------KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
A + K P+ +K F N AL L+++LL +P++R +A AL +FK
Sbjct: 240 ARRYLSSMRKKQPVPFSQK----FPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 3e-53
Identities = 107/317 (33%), Positives = 170/317 (53%), Gaps = 15/317 (4%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ D + + ++G G Y +V A D TG VA+KK+ + RE+ +L
Sbjct: 11 WEVP--DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 212 RKLDHPNVMKLEGLVTS-----RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
+ + H NV+ L + T R YLV +M DL L K +E +I+ + Q
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQ 126
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
+L+GL++ H+ GI+HRD+K NL +N LKI DFGLA D +T VVT WYR
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYR 182
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
APE++L Y +D+WS GCI+AE+ GKP+ G ++Q+ +I K+ G+PS+++ +K
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 387 SKSAHATSFKPQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+S A ++ + P K+ N A+ +++K+L ++ E+R +AA AL +F+
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 445 TEPLPCDPSNLPKYPPS 461
P D + P Y S
Sbjct: 303 EFHDPEDETEAPPYDDS 319
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 76/216 (35%), Positives = 125/216 (57%), Gaps = 9/216 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ D IG+G + VYK +LETG VA+K++ + E+++ + +EI +L+ L HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+K G + + S SLY++ EY E+ L + G F E + Y+ Q+L+GL + H +G
Sbjct: 62 VKYIGSIET-SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL--GATK 336
++HRDIK +N+L GV+K+ DFG+AT + + S V T ++ APE++ GA+
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGAS- 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
A D+WS GC + EL G P + + +I
Sbjct: 178 --TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 110/320 (34%), Positives = 169/320 (52%), Gaps = 30/320 (9%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ P R + + ++G G Y SV A D TG+ VA+KK+ + RE+ +
Sbjct: 11 WELPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67
Query: 211 LRKLDHPNVMKLEGLVTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQ 265
L+ + H NV+ L + TS YLV YM+ DL + G +E +++ +
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVY 124
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
Q+L GL++ HS GI+HRD+K NL +N LKI DFGLA D +T VVT WY
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 180
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
RAPE++L Y +D+WS GCI+AE+ GK + G+ ++Q+ +I K+ G P ++ +
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 386 KSKSAHATSFKPQQP-YKRKVLETFRNFPQS---ALALVDKLLTIEPENRGSAASALRSE 441
K + A S+ P Y RK T FP++ A+ L++K+L ++ + R +A AL
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTL--FPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298
Query: 442 FF--------KTEPLPCDPS 453
+F +TE P D S
Sbjct: 299 YFDSFRDADEETEQQPYDDS 318
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 102/288 (35%), Positives = 156/288 (54%), Gaps = 10/288 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
E IG G + V+ D GK VALKK+ + S + + RE+ +L H NV
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 220 MK-LEGLVTSRSG---SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+ L+ L +Y+V E M+ DL + +P + +K ++ Q+LRGL++ H
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH 120
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S GILHRDIK NLL+N+ VLKI DFGLA +P ++ +T VVT +YRAPE+L+G+
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y +A+D+WS GCI AEL + + ++ ++Q+ I L G+PS + R + A +
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-ARAH 239
Query: 396 KPQQPYKRKVLETFRNFP----QSALALVDKLLTIEPENRGSAASALR 439
+ P+K L A+ L+ ++L +P+ R SAA AL
Sbjct: 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 5e-52
Identities = 90/284 (31%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
FE ++KIG+G + VYKAR TGK VA+K ++ + E + EI IL+K HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+K G + L++V E+ L L + TE QI ++LL+GLE+ HS G
Sbjct: 60 VKYYGSYL-KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
I+HRDIK +N+L+ + G +K+ DFGL+ S + V T ++ APE++ G Y
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
D+WS G EL GKP ++ + KI P + S
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLRNPEKWSDE------- 226
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
F++F + K L PE R +A L+ F
Sbjct: 227 ----------FKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 110/334 (32%), Positives = 174/334 (52%), Gaps = 21/334 (6%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ P R ++ + +G G Y SV A D + VA+KK+ R RE+ +
Sbjct: 11 WEVPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 211 LRKLDHPNVMKLEGLVTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQ 265
L+ + H NV+ L + T + +YLV M DL + K ++ ++ +
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIY 125
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
QLLRGL++ HS GI+HRD+K SN+ +N L+I DFGLA D +T V T WY
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
RAPE++L Y +D+WS GCI+AEL GK + PG ++Q+ +I ++ G+PS + +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 386 KSKSAHATSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
K S HA + P+ ++ + + FR A+ L++K+L ++ + R SA+ AL +F
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
Query: 444 KTEPLPCDPSNLPKYPPSKE-LDAKLRDQEARKQ 476
DP + P+ P E + K R E K+
Sbjct: 302 SQYH---DPEDEPEAEPYDESPENKERTIEEWKE 332
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-49
Identities = 94/225 (41%), Positives = 133/225 (59%), Gaps = 3/225 (1%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ FE + +G+G Y V K R ET +IVA+KK + + + E RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
N+++L+ R G LYLVFEY+E ++ L +++ Y+ QL++ + CH
Sbjct: 61 NIVELKE-AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
I+HRDIK NLLI++ VLK+ DFG A N T V T WYR+PELLLGA Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PY 178
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS-PSE 381
G A+DMWS GCIL EL G+P+ PG +E++Q+ I K+ G P+E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (448), Expect = 2e-49
Identities = 106/382 (27%), Positives = 155/382 (40%), Gaps = 42/382 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHP- 217
+ + K+G+G++ VY ARD K+VALK + + V REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGI--KFTEPQIKCYMQQLLRGLEHC 274
N++KL GSLYLV EY++ L L G +E + + Q+L LE+
Sbjct: 59 NIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 275 HSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQ-----NLPLTSRVVTLWYRAP 328
HS+GI+HRDIK N+L++ + V+K+ DFGLA ++ V T Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 329 ELLLGAT--KYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSPSEDY 383
E+LLG + ++ D+WS G L EL G P G Q KI +PS
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS--- 234
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
S + S ++A L+ KLL +P+NR S++S L +
Sbjct: 235 ---LASPLSPSNPE-------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
Query: 444 KTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPE 503
L + P EA + + + E
Sbjct: 279 AHLKLKESDLSDLLKPDDSAPLRLSLP---PSLEALISSLNSLAISGSDLKLDDSNFSKE 335
Query: 504 FIPSGQSKPTSISHKFHNQEDS 525
P+G S S S
Sbjct: 336 LAPNGVSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 105/321 (32%), Positives = 162/321 (50%), Gaps = 22/321 (6%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ ++ + +G G Y SV A D +TG VA+KK+ + RE+ +L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 218 NVMKLEGLVT-SRS----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
NV+ L + T +RS +YLV M DL + K T+ ++ + Q+LRGL+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 134
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ HS I+HRD+K SNL +N LKI DFGLA D +T V T WYRAPE++L
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 190
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
Y +D+WS GCI+AEL G+ + PG ++Q+ I +L G+P + +K S A
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 393 TSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
++ K F A+ L++K+L ++ + R +AA AL +F
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH--- 307
Query: 451 DPSNLPKYPP------SKELD 465
DP + P P S++L
Sbjct: 308 DPDDEPVADPYDQSFESRDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-47
Identities = 100/290 (34%), Positives = 142/290 (48%), Gaps = 37/290 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
E++ +GQG+ VYK R TGKI ALKK+ + D E + + RE+ LR + P V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESPYV 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-R 277
+K G + G + +V EYM+ LA L G K EP + +Q+L+GL++ H+ R
Sbjct: 62 VKCYG-AFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKR 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
I+HRDIK SNLLIN+ G +KI DFG++ + + + T V T+ Y +PE + G + Y
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGES-Y 177
Query: 338 GAAIDMWSAGCILAELFAGK-PIMPGRTE--VEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
A D+WS G L E GK P +P E M I C P
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP-------------- 220
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
P P + FR+F + L +P+ R SAA L+ F K
Sbjct: 221 --PSLPAEEF-SPEFRDF-------ISACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 89/301 (29%), Positives = 141/301 (46%), Gaps = 40/301 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ ++KIG+G VYKA D TGK VA+KK+R + E + EI I++ HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNI 77
Query: 220 MKLEG--LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+ LV L++V EYM+ L + T ++ EPQI +++L+GLE+ HS
Sbjct: 78 VDYYDSYLV---GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+ ++HRDIK N+L++ G +K+ DFG A ++ S V T ++ APE++
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKR-KD 192
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
YG +D+WS G + E+ G+P P + +F + T
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEP--P-YLREPPLRALFLI----------------TTKGI 233
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456
P K F++F ++K L +PE R SA L+ F K C
Sbjct: 234 PPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEEFA 283
Query: 457 K 457
Sbjct: 284 P 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 109/314 (34%), Positives = 166/314 (52%), Gaps = 39/314 (12%)
Query: 165 KIGQGTYSSVYKAR--DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
K+G+GTY VYKA+ D + + ALK++ + + REI +LR+L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 223 EGLVTSRSG-SLYLVFEYMEHDL--------AGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ + S + ++L+F+Y EHDL A A ++ +K + Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 274 CHSRGILHRDIKGSNLLINNAGV----LKIGDFGLATTYD-PSQNLP-LTSRVVTLWYRA 327
H+ +LHRD+K +N+L+ G +KI D G A ++ P + L L VVT WYRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKLCGS 378
PELLLGA Y AID+W+ GCI AEL +PI R E +Q+ +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 379 PSEDYWR--KSKSAHATSFKP--QQPYKR----KVLETFRNFPQS-ALALVDKLLTIEPE 429
P++ W K H+T K + Y K +E + P S A L+ KLLT++P
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 430 NRGSAASALRSEFF 443
R ++ A++ +F
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 89/320 (27%), Positives = 132/320 (41%), Gaps = 78/320 (24%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK-----------KVRFANMDPESVRFMAREI 208
F+ IG+G++S+V A++ ET K A+K KV++ + E
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----------EK 52
Query: 209 HILRKLD-HPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQ 266
+L +L+ HP ++KL +LY V EY + +L G E + Y +
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAE 110
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP---------------S 311
+L LE+ HS+GI+HRD+K N+L++ +KI DFG A DP S
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 312 QNLPLTSR----VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE 367
Q R V T Y +PELL G + D+W+ GCI+ ++ GKP G E
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
KI KL P NFP A L++KLL ++
Sbjct: 230 TFQKILKLE--------------------YSFP---------PNFPPDAKDLIEKLLVLD 260
Query: 428 PENR----GSAASALRSEFF 443
P++R FF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 108/315 (34%), Positives = 164/315 (52%), Gaps = 41/315 (13%)
Query: 165 KIGQGTYSSVYKAR--DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
K+G+GTY VYKA+ D + K ALK++ + + REI +LR+L HPNV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 223 EGLVTSRSG-SLYLVFEYMEHDL--------AGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ + S S ++L+F+Y EHDL A A ++ +K + Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 274 CHSRGILHRDIKGSNLLINNAGV----LKIGDFGLATTYD-PSQNLP-LTSRVVTLWYRA 327
H+ +LHRD+K +N+L+ G +KI D G A ++ P + L L VVT WYRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKLCGS 378
PELLLGA Y AID+W+ GCI AEL +PI R E +Q+ +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 379 PSEDYWRKSKSAHATSFKPQQPYKR---------KVLETFRNFPQS-ALALVDKLLTIEP 428
P++ W + Q+ ++R K +E + P S L+ KLLT++P
Sbjct: 244 PADKDWEDIRKMPEYP-TLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302
Query: 429 ENRGSAASALRSEFF 443
R ++ AL+ +F
Sbjct: 303 TKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 92/290 (31%), Positives = 147/290 (50%), Gaps = 43/290 (14%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+KIG GT+ VY A +L+TG+++A+K++R + DP++++ +A E+ +L L HPN++K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 224 GLVTSRSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
G+ R +Y+ EY L L I E I+ Y QLL GL + HS GI+HR
Sbjct: 66 GVEVHRE-KVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 283 DIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
DIK +N+ +++ GV+K+GDFG A TT S T Y APE++ G
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ----SLAGTPAYMAPEVITGGK 179
Query: 336 K--YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI-FKLCGSPSEDYWRKSKSAHA 392
+G A D+WS GC++ E+ GK E++ +I F + A
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVG-------------AGH 223
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
KP P ++ ++F +D+ L +P+ R +A+ L+ F
Sbjct: 224 ---KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 72/223 (32%), Positives = 118/223 (52%), Gaps = 12/223 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E ++ IG+G++ +V K R GKI+ K++ + NM + + + E++ILR+L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEHC 274
++ + ++ + +LY+V EY E DLA L E I + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 275 HSRG-----ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
H+R +LHRD+K +N+ ++ +K+GDFGLA + + V T +Y +PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
L Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 9e-41
Identities = 75/211 (35%), Positives = 117/211 (55%), Gaps = 8/211 (3%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDP---ESVRFMAREIHILRKLDHPNVMKL 222
+G G++ SVY+ +L+ G A+K+V A+ E+V+ + +EI +L KL HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 223 EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G +LY+ E + LA L G F EP I+ Y +Q+L GLE+ H R +H
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAI 341
RDIKG+N+L++ GV+K+ DFG+A + S + ++ APE++ YG A
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 342 DMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
D+WS GC + E+ GKP V + KI
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKI 214
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-40
Identities = 110/356 (30%), Positives = 169/356 (47%), Gaps = 35/356 (9%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
IG G++ VY+A ++T + VA+KKV DP+ + RE+ I++ L+H N++ L+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQ---YKNRELLIMKNLNHINIIFLKDY 127
Query: 226 VTSRS-----GSLYL----------VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
+ +++L V +YM+H P +K Y QL R
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 271 LEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
L + HS+ I HRD+K NLLI+ N LK+ DFG A Q S + + +YRAPE
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPE 240
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
L+LGAT Y ID+WS GCI+AE+ G PI G++ V+Q+ +I ++ G+P+ED ++
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300
Query: 390 AHATSFKPQQPYK--RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447
+A P K +KV + P A+ + + L EP R + AL FF
Sbjct: 301 NYADIKFPDVKPKDLKKVFP--KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358
Query: 448 LPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPE 503
PC LPKY D E ++ R P+ ++F +
Sbjct: 359 DPC--IKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDEND 412
|
Length = 440 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 35/268 (13%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+G++ V R +TGK+ A+K ++ + + V E +IL +++HP ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 225 LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ LYLV EY +L + G +F+E + + Y +++ LE+ HS GI++RD
Sbjct: 61 AFQTEE-KLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K N+L++ G +K+ DFGLA S+ + T Y APE+LLG YG A+D
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKE-LSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDW 176
Query: 344 WSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKR 403
WS G +L E+ GKP E KI +
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKI-----------------------------LK 207
Query: 404 KVLETFRNFPQSALALVDKLLTIEPENR 431
L A L+ LL +P R
Sbjct: 208 DPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 97/326 (29%), Positives = 162/326 (49%), Gaps = 29/326 (8%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
IG G V A D TG+ VA+KK+ + + RE+ +++ ++H N++ L +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 226 VTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
T + +YLV E M+ +L + + ++ + Q+L G++H HS GI+
Sbjct: 84 FTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAGII 140
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
HRD+K SN+++ + LKI DFGLA T + +T VVT +YRAPE++LG Y
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKEN 197
Query: 341 IDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT---SFKP 397
+D+WS GCI+ E+ G + PG ++Q +KI + G+PS+++ + + +
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257
Query: 398 QQPYKRKVLETFRNFPQS-----------ALALVDKLLTIEPENRGSAASALRSEFFKTE 446
Y + L FP A L+ K+L I+PE R S AL+ +
Sbjct: 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN-- 315
Query: 447 PLPCDPSNLPKYPPSKELDAKLRDQE 472
+ DPS + + PP D + ++E
Sbjct: 316 -VWYDPSEV-EAPPPAPYDHSIDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 93/292 (31%), Positives = 150/292 (51%), Gaps = 44/292 (15%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKV----RFANMDPESVRFMAR----EIHILRKLDHP 217
IG+GTY VY A ++ TG+++A+K+V A + M + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 218 NVMKLEGLVTSR-SGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N+++ G T+ S++L EY+ + T G +F E ++ + +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH 125
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGL----ATTYDPSQNLPLTSRVVTLWYRAPELL 331
S+GILHRD+K NLL++ G+ KI DFG+ YD QN+ + ++++ APE++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG---SVFWMAPEVI 182
Query: 332 LGATK-YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
++ Y A +D+WS GC++ E+FAG+ P E E + +FKL +SA
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL---------GNKRSA 230
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
P P + N AL ++ TI P+NR +A L+ F
Sbjct: 231 ------PPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 6e-39
Identities = 101/331 (30%), Positives = 165/331 (49%), Gaps = 28/331 (8%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++++ IG G V A D G VA+KK+ + + RE+ +L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 220 MKLEGLVTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +YLV E M+ A L ++ ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIHMELDHERMSYLLYQMLCGIKHL 139
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T N +T VVT +YRAPE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILG- 196
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS-----------EDY 383
Y +D+WS GCI+ EL G I G ++Q +K+ + G+PS +Y
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALA--LVDKLLTIEPENRGSAASALRSE 441
SF+ P E+ R+ +++ A L+ K+L I+P+ R S ALR
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316
Query: 442 FFKTEPLPCDPSNLPKYPPSKELDAKLRDQE 472
+ P + + PP + DA+L ++E
Sbjct: 317 YITVWYDPAE----AEAPPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 48/294 (16%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ F+ ++K+G+G+Y SVYKA ETG++VA+K V ++ + + +EI IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQE-IIKEISILKQCDSP 58
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAG----LATTPGIKFTEPQIKCYMQQLLRGLEH 273
++K G ++ L++V ME+ AG + TE +I + Q L+GLE+
Sbjct: 59 YIVKYYGSY-FKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEY 114
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT----TYDPSQNLPLTSRVVTLWYRAPE 329
HS +HRDIK N+L+N G K+ DFG++ T + + T ++ APE
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-----IGTPFWMAPE 169
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
++ Y D+WS G E+ GKP P +++ M IF + P
Sbjct: 170 VIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YSDIHPMRAIFMIPNKPPP-------- 217
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ + K F +F V K L +PE R SA L+ F
Sbjct: 218 ----TLSDPE----KWSPEFNDF-------VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 78/204 (38%), Positives = 112/204 (54%), Gaps = 10/204 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILRKLDH 216
F+ KIG+G +S VYKA L G++VALKKV+ F MD ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 217 PNVMK-LEGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGL 271
PNV+K L + + L +V E + DL+ + E I Y QL L
Sbjct: 62 PNVIKYLASFI--ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
EH HS+ I+HRDIK +N+ I GV+K+GD GL + S+ S V T +Y +PE +
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 332 LGATKYGAAIDMWSAGCILAELFA 355
Y D+WS GC+L E+ A
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 88/298 (29%), Positives = 143/298 (47%), Gaps = 51/298 (17%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDH 216
+ +E I +IG GTY VYKARD+ TG++VA+K + ++P + + +EI +L++ H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRH 59
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
PN++ G R L++V EY D+ + P +E QI ++ L+GL
Sbjct: 60 PNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLA 115
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR---VVTLWYRAPE 329
+ H G +HRDIKG+N+L+ G +K+ DFG++ + + R + T ++ APE
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT----IAKRKSFIGTPYWMAPE 171
Query: 330 LLLGATK--YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
+ K Y D+W+ G EL +P M ++ M +F + S
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM---FDLHPMRALFLI-----------S 217
Query: 388 KSAHATSFKPQQPY---KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
KS +F P P K K F +F + K LT +P+ R +A L+ F
Sbjct: 218 KS----NFPP--PKLKDKEKWSPVFHDF-------IKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 160 FEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
E K+G+G + VYK T VA+K ++ + E F+ E I++KL
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
HPN+++L G+ T + LY+V EYM DL G K T + Q+ +G+E+
Sbjct: 60 HPNIVRLLGVCT-QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTL-WYRAPELLL 332
S+ +HRD+ N L+ V+KI DFGL+ Y+ + + W APE L
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLK 177
Query: 333 GATKYGAAIDMWSAGCILAELF 354
K+ + D+WS G +L E+F
Sbjct: 178 -DGKFTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 2e-36
Identities = 95/337 (28%), Positives = 160/337 (47%), Gaps = 28/337 (8%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG G V A D + VA+KK+ + + RE+ +++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 220 MKLEGLVTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +Y+V E M+ A L ++ ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T S +T VVT +YRAPE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG- 199
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+ E+ G + PG ++Q +K+ + G+P ++ +K + T
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 395 FKPQQPYKRKVLETFRNFP---------------QSALALVDKLLTIEPENRGSAASALR 439
+ + Y E FP A L+ K+L I+ R S AL+
Sbjct: 260 VENRPKYAGYSFEKL--FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 440 SEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQ 476
+ P + P P K+LD + E K+
Sbjct: 318 HPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 99/338 (29%), Positives = 170/338 (50%), Gaps = 32/338 (9%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG G V A D + VA+KK+ + + RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 220 MKLEGLVTSRSG-----SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +YLV E M+ A L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T S +T VVT +YRAPE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG- 192
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRN 251
Query: 395 FKPQQPYKRKVLETFRNFPQS---------------ALALVDKLLTIEPENRGSAASALR 439
+ +P K L + FP S A L+ K+L I+P R S AL+
Sbjct: 252 YVENRP-KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 440 SEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQE 477
+ + DP+ + + PP + D +L ++E +E
Sbjct: 311 HPYIN---VWYDPAEV-EAPPPQIYDKQLDEREHTIEE 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 91/282 (32%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESV--RFMAREIHILRKLDHPNVMKLE 223
I +G Y V+ A+ TG I A+K ++ A+M ++ + + E IL + P V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 224 GLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
+ +LYLV EY+ DLA L G E + Y+ +++ LE+ HS GI+HR
Sbjct: 60 YSFQGKK-NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 283 DIKGSNLLINNAGVLKIGDFGLATT--YDPSQNLPLTS----RVV-TLWYRAPELLLGAT 335
D+K N+LI++ G LK+ DFGL+ NL R+V T Y APE++LG
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-Q 176
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
+ +D WS GCIL E G P G T E I L G + W
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNG---KIEW----------- 220
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA 437
P+ A+ L+ KLL +PE R A S
Sbjct: 221 -PEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD--PESVRFMAREIHILRKLD 215
D +E I+ IG G + VY A L + VA+K++ +++ SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
HPNV+K L+LV Y+ D+ + G E I ++++L+GL
Sbjct: 58 HPNVVKYYTSFVVGD-ELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGL 115
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL-ATTYDPSQNLPLTSRVV--TLWYRAP 328
E+ HS G +HRDIK N+L+ G +KI DFG+ A+ D + T + AP
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
E++ Y D+WS G EL G P K P + +
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAA--PY-------SKYP-----PMKVLMLTLQ 221
Query: 389 SAHATSFKPQQPY---KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ P +K ++FR + L +P R +A L+ +FF
Sbjct: 222 ND-----PPSLETGADYKKYSKSFRKM-------ISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 58/299 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP--ESVRFMAREIHILRKLDHP 217
F ++ IG+G++ VYKA D T ++VA+K + +++ + + + +EI L + P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ K G S L+++ EY DL PG K E I ++++L GLE+
Sbjct: 60 YITKYYGSFLKGS-KLWIIMEYCGGGSCLDL----LKPG-KLDETYIAFILREVLLGLEY 113
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR-------VVTLWYR 326
H G +HRDIK +N+L++ G +K+ DFG++ LTS V T ++
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQ--------LTSTMSKRNTFVGTPFWM 165
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
APE++ + Y D+WS G EL G+P P +++ M +F +
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI----------- 210
Query: 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445
K+ P K + F++F V L +P+ R SA L+ +F K
Sbjct: 211 PKN------NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 73/230 (31%), Positives = 129/230 (56%), Gaps = 19/230 (8%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-------VRFMAREIHILRKLDHPN 218
IG G++ SVY + +G+++A+K+V ++ S + +AREI +L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++ G + + L + EY+ +A L G F E ++ +++Q+L+GL + H+R
Sbjct: 68 IVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR 125
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGL-----ATTYDPSQNLPLTSRVVTLWYRAPELLL 332
GI+HRDIKG+N+L++N G +KI DFG+ A + N S ++++ APE ++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-VV 184
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382
T Y D+WS GC++ E+ GK P + Q+ IFK+ + S +
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 71/218 (32%), Positives = 112/218 (51%), Gaps = 11/218 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
F+ + K+G+G+Y SVYK + L + ALK+V +M + EI IL ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 220 MKL-EGLVTSRSGSLYLVFEYME-HDLAGLATTPGIK---FTEPQIKCYMQQLLRGLEHC 274
+ E + L +V EY DL+ + K E +I QLLRGL+
Sbjct: 62 ISYKEAFLDGNK--LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H + ILHRD+K +N+L+ ++KIGD G++ +N+ T ++ T Y APE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKT-QIGTPHYMAPEVWKG- 175
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 78/239 (32%), Positives = 123/239 (51%), Gaps = 18/239 (7%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES---VRFMAREIHILRKLDHPNVMKL 222
+GQG + VY D++TG+ +A+K+V F PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK----FTEPQIKCYMQQLLRGLEHCHSRG 278
G + +L + EYM G + +K TE + Y +Q+L G+E+ HS
Sbjct: 70 YGCLRDD-ETLSIFMEYM----PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDP--SQNLPLTSRVVTLWYRAPELLLGATK 336
I+HRDIKG+N+L ++AG +K+GDFG + S + S T ++ +PE++ G
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG- 183
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG D+WS GC + E+ KP E E M IFK+ P+ S A +F
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 161 EKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
K+G+G + VYK VA+K ++ + + F+ RE I+RKLDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHC 274
PN++KL G+ T L +V EYM DL L + + + + Q+ RG+E+
Sbjct: 61 PNIVKLLGVCTE-EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPE 329
S+ +HRD+ N L+ V+KI DFGL+ Y + L R W APE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WM-APE 174
Query: 330 -LLLGATKYGAAIDMWSAGCILAELF 354
L G K+ + D+WS G +L E+F
Sbjct: 175 SLKEG--KFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 164 DKIGQGTYSSVYKAR---DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
K+G+G + VYK + VA+K ++ + E + +E +++KL HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-DL--------AGLATTPGIKFTEPQIKCYMQQLLRGL 271
+L G+ T LYLV EYME DL + + + + Q+ +G+
Sbjct: 60 RLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--------LPLTSRVVTL 323
E+ S+ +HRD+ N L+ V+KI DFGL+ LP+ R
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--R---- 172
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELF 354
W APE L + + D+WS G +L E+F
Sbjct: 173 WM-APESLKDG-IFTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 161 EKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
K+G+G + VYK + + VA+K ++ + + F+ RE I+RKLDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
PNV+KL G+ T LY+V EYME DL K + + + Q+ RG+E+
Sbjct: 61 PNVVKLLGVCTE-EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPE- 329
S+ +HRD+ N L+ V+KI DFGL+ Y + L R W APE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WM-APES 174
Query: 330 LLLGATKYGAAIDMWSAGCILAELF 354
L G K+ + D+WS G +L E+F
Sbjct: 175 LKEG--KFTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-32
Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 34/287 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E I KIG+G++ +Y A+ + +K++ M + +E+ +L K+ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+ +G L++V EY + DL + G+ F+E QI + Q+ GL+H H R
Sbjct: 62 VTFFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 278 GILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
ILHRDIK N+ ++ G V K+GDFG+A + S L T V T +Y +PE+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQN-RP 178
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y D+WS GC+L EL K G + K+C + F
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKIC------------QGY---FA 220
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P P NF + +L+ +L + P +R S S L+ F
Sbjct: 221 PISP----------NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 26/234 (11%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-D 215
FE ++ IG+GTY VYKAR +TG++VA+K ++ + + E +ILRK +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSN 61
Query: 216 HPNVMKLEGLVTSRS-----GSLYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQ 266
HPN+ G ++ L+LV E DL G + E I +++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
LRGL + H ++HRDIKG N+L+ +K+ DFG++ D + T + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWM 180
Query: 327 APELLLGATK----YGAAIDMWSAGCILAELFAGKP----IMPGRTEVEQMHKI 372
APE++ + Y A D+WS G EL GKP + P R + KI
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPN 218
FE + IG+G + V + +T K+ A+K + SVR + E IL++L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAG---LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
++ L ++YLV + + L G + +KF+E Q+K ++ +++ LE+ H
Sbjct: 62 LVNLWYSFQDEE-NMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S+GI+HRDIK N+L++ G + I DF +AT P TS T Y APE+L
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ- 174
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y A+D WS G E GK G + + + K ++A
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSR------------TIRDQIRAKQETADVLYP 222
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
A+ ++KLL +P+ R
Sbjct: 223 ATW--------------STEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 71/205 (34%), Positives = 119/205 (58%), Gaps = 18/205 (8%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRF----ANMDPESVRFMAREIHILRKLDHPNVMK 221
+G G +SS Y+ARD++TG ++A+K+V + ++ E V + +EI ++ +L+HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK----FTEPQIKCYMQQLLRGLEHCHSR 277
+ G T L E+M AG + + + F E I Y +QLLRGL + H
Sbjct: 68 MLG-ATCEDSHFNLFVEWM----AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 278 GILHRDIKGSNLLINNAG-VLKIGDFGLAT--TYDPSQNLPLTSRVV-TLWYRAPELLLG 333
I+HRD+KG+NLLI++ G L+I DFG A + +++ T+ + APE+L G
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 334 ATKYGAAIDMWSAGCILAELFAGKP 358
+YG + D+WS GC++ E+ KP
Sbjct: 183 -EQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 85/294 (28%), Positives = 143/294 (48%), Gaps = 41/294 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +VY A D+ TG+ VA+K++ + + + EI ++R+ HPN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNI 78
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCH 275
+ L+ + L++V EY LAG + T + T E QI ++ L+ LE H
Sbjct: 79 VNYLDSYLVGDE--LWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S ++HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-RK 190
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG +D+WS G + E+ G+P + ++ I AT+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG 231
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TEPL 448
P+ K+ FR+F +++ L ++ E RGSA L+ F K +PL
Sbjct: 232 TPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 107/340 (31%), Positives = 151/340 (44%), Gaps = 57/340 (16%)
Query: 115 QPQMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAF---EKIDKIGQGTY 171
Q S V LP+ P S +S + + G P A + E++++IG G
Sbjct: 36 QRDPSLAVPLPLPPP--------SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAG 87
Query: 172 SSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231
+VYK TG++ ALK V + N + R + REI ILR ++HPNV+K + +G
Sbjct: 88 GTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNG 145
Query: 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
+ ++ E+M D L T E + +Q+L G+ + H R I+HRDIK SNLLI
Sbjct: 146 EIQVLLEFM--DGGSLEGTHIAD--EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201
Query: 292 NNAGVLKIGDFG----LATTYDPSQNLPLTSRVVTLWYRAPELL---LGATKY-GAAIDM 343
N+A +KI DFG LA T DP S V T+ Y +PE + L Y G A D+
Sbjct: 202 NSAKNVKIADFGVSRILAQTMDPCN-----SSVGTIAYMSPERINTDLNHGAYDGYAGDI 256
Query: 344 WSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402
WS G + E + G+ P GR + W A S P+ P
Sbjct: 257 WSLGVSILEFYLGRFPFGVGR-----------------QGDWASLMCAICMSQPPEAP-- 297
Query: 403 RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
FR+F + L EP R SA L+ F
Sbjct: 298 ATASREFRHF-------ISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 88/286 (30%), Positives = 131/286 (45%), Gaps = 43/286 (15%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
+G+GTY VY ARDL T +A+K++ + V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 226 VTSRSGSLYLVFEYMEHDLAG-----LATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ + +F ME G L + G +K E I Y +Q+L GL++ H I
Sbjct: 74 DSE--NGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 280 LHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELL-LGATK 336
+HRDIKG N+L+N +GV+KI DFG T+ + P T TL Y APE++ G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFG--TSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
YGA D+WS GC + E+ GKP P F G P ++ FK
Sbjct: 188 YGAPADIWSLGCTIVEMATGKP--P-----------FIELGEPQAAMFK------VGMFK 228
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
+ +NF + + +P+ R SA L+ F
Sbjct: 229 IHPEIPESLSAEAKNF-------ILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 86/292 (29%), Positives = 126/292 (43%), Gaps = 45/292 (15%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES----VRFMAREIHILRKLDHPN 218
+ I +G + SVY A+ TG A+K ++ ++M ++ V+ + I + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG--ESPY 58
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V KL S+ LYLV EY+ D A L T G E K Y+ +++ G+E H R
Sbjct: 59 VAKLYYSFQSKD-YLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQR 116
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATK 336
GI+HRDIK NLLI+ G LK+ DFGL S+N + V T Y APE +LG
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGL------SRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
D WS GC++ E G P T I W + +
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-----RRINWPEEVKEFCSP-- 222
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA--ASALRSE-FFKT 445
A+ L+++LL ++P R A ++S FFK+
Sbjct: 223 ------------------EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
FE ++KIG+G++ V+K ++ A+K++ + M+ E +L KLD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 220 MK-----LEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQI-KCYMQQLLR 269
++ L+ G L +V EY E H L L G E Q+ + ++Q LL
Sbjct: 62 IRYYESFLDK------GKLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILL- 112
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
GL H HS+ ILHRDIK NL ++ +KIGD G+A + N T V T +Y +PE
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE 171
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
L Y D+W+ G +L E GK + + KI +
Sbjct: 172 -LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 47/297 (15%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
KIG+G+ V A D TG+ VA+KK+ + F E+ I+R HPN++++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHPNIVEMYS 83
Query: 225 --LVTSRSGSLYLVFEYMEHDLAGLATTPGI---KFTEPQIKCYMQQLLRGLEHCHSRGI 279
LV L++V E++E G A T + + E QI +L+ L H++G+
Sbjct: 84 SYLVGDE---LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP-LTSRVVTLWYRAPELLLGATKYG 338
+HRDIK ++L+ + G +K+ DFG S+ +P S V T ++ APE ++ YG
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPE-VISRLPYG 193
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+D+WS G ++ E+ G+P ++ M +I ++ K K+ H S
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------RDNLPPKLKNLHKVS---- 242
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
L +F +D++L +P R +AA L F PS++
Sbjct: 243 -----PRLRSF----------LDRMLVRDPAQRATAAELLNHPFLA---KAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 33/281 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ I +G+G + R E +V K+V + + R EI IL L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+ +L + EY L + G F E + Y+ Q++ + + H
Sbjct: 62 IAYYNHFM-DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
GILHRDIK N+ + AG++K+GDFG++ S+ + V T +Y +PEL G KY
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQGV-KY 178
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
D+W+ GC+L EL K + + KI + +P
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS--------------- 223
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
Y +++ LV LL +PE R +A L
Sbjct: 224 --VYSSELIS-----------LVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 5/196 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ K+ KIG+G++ + E GK +K++ + M P+ +E+ +L + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DL-AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++ + +G+LY+V +Y E DL + G+ F E QI + Q+ L+H H R
Sbjct: 62 VQYQESF-EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
ILHRDIK N+ + G +K+GDFG+A + + L T + T +Y +PE+ Y
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICEN-RPY 178
Query: 338 GAAIDMWSAGCILAEL 353
D+W+ GC+L E+
Sbjct: 179 NNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 104/356 (29%), Positives = 144/356 (40%), Gaps = 80/356 (22%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLD 215
D FE I IG+G + V+ RD +TG++ A+K +R ++M + A E IL D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILADAD 59
Query: 216 HPNVMKLEGLVTSRSGS-LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
P ++KL + + LYLV EYM DL L + F E + Y+ +L+ L+
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDS 116
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY----------DPSQNLPLTSRVVTL 323
H G +HRDIK N+LI+ G +K+ DFGL + S NL V+
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 324 W------------------YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE 365
Y APE+L G T YG D WS G IL E+ G P T
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235
Query: 366 VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLT 425
E +KI W++S F P P A+ L+ +LL
Sbjct: 236 QETYNKIIN---------WKES-----LRFPPDPPV-----------SPEAIDLICRLLC 270
Query: 426 IEPENR-GSAASALRSEFFKT--------EPLPC--------DPSNLPKYPPSKEL 464
+PE+R GS FFK P D SN + K+L
Sbjct: 271 -DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDDFEDDKDL 325
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 76/236 (32%), Positives = 118/236 (50%), Gaps = 10/236 (4%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES---VRFMAREIHILRKLDHPNVMKL 222
+GQG + VY D++TG+ +A K+V+F PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 223 EGLVTSRSGSLYLVF-EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G + R+ +F EYM TE + Y +Q+L G+ + HS I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDP--SQNLPLTSRVVTLWYRAPELLLGATKYGA 339
RDIKG+N+L ++AG +K+GDFG + + S T ++ +PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGR 188
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
D+WS GC + E+ KP E E M IFK+ P+ S HA F
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 82/251 (32%), Positives = 125/251 (49%), Gaps = 42/251 (16%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILRKLDHPNVMK-L 222
KIG+G +S VY+A L K VALKKV+ F MD ++ + +EI +L++L+HPNV+K L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 223 EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKC--------YMQQLLRGLEH 273
+ + L +V E + DL+ + IK+ + Q + Y QL +EH
Sbjct: 69 DSFI--EDNELNIVLELADAGDLSQM-----IKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
HSR ++HRDIK +N+ I GV+K+GD GL + S+ S V T +Y +PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIH 179
Query: 334 ATKYGAAIDMWSAGCILAEL------FAGK----------------PIMPGRTEVEQMHK 371
Y D+WS GC+L E+ F G P +P E++ +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 372 IFKLCGSPSED 382
+ +C P D
Sbjct: 240 LVSMCIYPDPD 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 40/288 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFA-NMDPESVRFMAREIHILRKLDHPN 218
F + +IG G++ +VY ARD+ T ++VA+KK+ ++ E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++ +G R + +LV EY + + E +I L+GL + HS
Sbjct: 77 TIEYKGCYL-REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT--K 336
+HRDIK N+L+ G +K+ DFG A+ P+ S V T ++ APE++L +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAMDEGQ 190
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP--SEDYWRKSKSAHATS 394
Y +D+WS G EL KP + + ++ I + SP S + W
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLSSNDWS--------- 240
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
+ FRNF VD L P++R S+ L+ F
Sbjct: 241 ------------DYFRNF-------VDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 81/292 (27%), Positives = 135/292 (46%), Gaps = 40/292 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDHPN 218
F + +IG G++ +VY ARD+ ++VA+KK+ ++ E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++ G R + +LV EY + L E +I L+GL + HS
Sbjct: 77 TIQYRGCYL-REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT--K 336
++HRD+K N+L++ G++K+GDFG A+ P+ V T ++ APE++L +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----XFVGTPYWMAPEVILAMDEGQ 190
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP--SEDYWRKSKSAHATS 394
Y +D+WS G EL KP + + ++ I + SP +W
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHWS--------- 240
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
E FRNF VD L P++R ++ L+ F E
Sbjct: 241 ------------EYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 79/226 (34%), Positives = 116/226 (51%), Gaps = 19/226 (8%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILRKLDHPNVMKLE 223
KIG+G +S VY+A L G VALKKV+ F MD ++ +EI +L++L+HPNV+K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 224 GLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKC--------YMQQLLRGLEHC 274
+ L +V E + DL+ + IK + Q + Y QL LEH
Sbjct: 69 ASFIEDN-ELNIVLELADAGDLSRM-----IKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HSR ++HRDIK +N+ I GV+K+GD GL + S+ S V T +Y +PE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHE 180
Query: 335 TKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379
Y D+WS GC+L E+ A P + + + K + C P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 13/222 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D E + ++G G V K TGKI+A+K +R ++ + + RE+ IL K + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSP 59
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
++ G +G + + EYM+ L + + E + +L+GL + H
Sbjct: 60 YIVGFYGAFY-NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 277 -RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
I+HRD+K SN+L+N+ G +K+ DFG++ S L T V T Y APE + G
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTF-VGTSSYMAPERIQG-N 174
Query: 336 KYGAAIDMWSAGCILAELFAGK-----PIMPGRTEVEQMHKI 372
Y D+WS G L EL G+ P E + I
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKL 214
D FE I +G G++ V R +GK ALK K + + V + E IL+ +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQSI 58
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYME-------HDLAGLATTPGIKFTEPQIKCYMQQL 267
HP ++ L G +LYLV EY+ +G +F EP + Y Q+
Sbjct: 59 RHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQV 110
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW--- 324
+ LE+ HS I++RD+K NLL+++ G +KI DFG A + R TL
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTP 162
Query: 325 -YRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358
Y APE++L YG A+D W+ G ++ E+ AG P
Sbjct: 163 EYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 7e-26
Identities = 75/239 (31%), Positives = 118/239 (49%), Gaps = 16/239 (6%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES---VRFMAREIHILRKLDHPNVMKL 222
+GQG + VY D +TG+ +A+K+V+F PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 223 EG-LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G L +L + E+M TE + Y +Q+L G+ + HS I+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT-----SRVVTLWYRAPELLLGATK 336
RDIKG+N+L ++ G +K+GDFG + Q + L+ S T ++ +PE++ G
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYWMSPEVISG-EG 185
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG D+WS GC + E+ KP E E M IFK+ P+ S H F
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 42/293 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
F+ + ++GQG Y V+ A+ +TG+IVALK+ M + + H+L + D
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKR-----MKKSLLFKLNEVRHVLTERDILTT 57
Query: 220 MKLEGLVT-----SRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
K E LV LYL EY+ D L G+ +E + YM ++ ++
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDA 116
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
H G +HRD+K N LI+ +G +K+ DFGL+ N S V + Y APE+L G
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN----SVVGSPDYMAPEVLRG 172
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
Y +D WS GC+L E G P G T E + YW+++
Sbjct: 173 -KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKET------ 216
Query: 394 SFKPQQPYKRKVLETFR-NFPQSALALVDKLLTIEPENR-GSAASALRSEFFK 444
+R V + R N A L+ KL+ +P R GS FFK
Sbjct: 217 -------LQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 74/269 (27%), Positives = 131/269 (48%), Gaps = 17/269 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFA-NMDPESVRFMAREIHILRKLDHPN 218
F + +IG G++ +VY ARD+ T ++VA+KK+ ++ E + + +E+ L+++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++ +G R + +LV EY + L E +I L+GL + HS
Sbjct: 87 SIEYKGCYL-REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT--K 336
++HRDIK N+L+ G +K+ DFG A+ P+ S V T ++ APE++L +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-----SFVGTPYWMAPEVILAMDEGQ 200
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK-----LCGSPSEDYWRKSKSAH 391
Y +D+WS G EL KP + + ++ I + L + DY+R +
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260
Query: 392 ATSFKPQQPYKRKVLE---TFRNFPQSAL 417
+P ++L+ R P++ L
Sbjct: 261 LQKIPQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 83/294 (28%), Positives = 144/294 (48%), Gaps = 41/294 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +VY A D+ TG+ VA++++ + + + EI ++R+ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNI 79
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCH 275
+ L+ + L++V EY LAG + T + T E QI ++ L+ LE H
Sbjct: 80 VNYLDSYLVG--DELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S ++HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-RK 191
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG +D+WS G + E+ G+P + ++ I AT+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNG 232
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TEPL 448
P+ K+ FR+F +++ L ++ E RGSA L+ +F K +PL
Sbjct: 233 TPELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES--VRFMAREIHILRKLDH- 216
+++++ IG+G Y +VY+ + + TG++VALK + N+D V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQS 59
Query: 217 --PNVMKLEG--LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
PN+ K G L R L+++ EY E G E I ++++L L+
Sbjct: 60 QPPNITKYYGSYLKGPR---LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALK 115
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ H G++HRDIK +N+L+ N G +K+ DFG+A + + ++ V T ++ APE++
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVIT 174
Query: 333 GATKYGAAIDMWSAGCILAELFAGKP 358
Y D+WS G + E+ G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 82/294 (27%), Positives = 144/294 (48%), Gaps = 41/294 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +V+ A D+ TG+ VA+K++ + + + EI ++++L +PN+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNI 78
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCH 275
+ L+ + L++V EY LAG + T + T E QI ++ L+ LE H
Sbjct: 79 VNFLDSFLVG--DELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+ ++HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-RK 190
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG +D+WS G + E+ G+P + ++ I AT+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG 231
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TEPL 448
P+ K+ FR+F +++ L ++ E RGSA L+ F K +PL
Sbjct: 232 TPELQNPEKLSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 49/307 (15%)
Query: 154 PRRADAFEKID---------KIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRF 203
P AD F K D +IG G++ +VY A + T ++VA+KK+ ++ E +
Sbjct: 8 PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67
Query: 204 MAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCY 263
+ +E+ L++L HPN ++ +G + + +LV EY + L E +I
Sbjct: 68 IIKEVKFLQQLKHPNTIEYKGCYL-KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 126
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
L+GL + HS ++HRDIK N+L+ G +K+ DFG A+ P+ S V T
Sbjct: 127 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----SFVGTP 181
Query: 324 WYRAPELLLGAT--KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS- 380
++ APE++L +Y +D+WS G EL KP + + ++ I + SP+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTL 240
Query: 381 -EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ W S FR F VD L P+ R ++A LR
Sbjct: 241 QSNEWTDS---------------------FRGF-------VDYCLQKIPQERPASAELLR 272
Query: 440 SEFFKTE 446
+F + +
Sbjct: 273 HDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 91/299 (30%), Positives = 144/299 (48%), Gaps = 47/299 (15%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +E I ++G G + VYKA++ ETG + A K + + + E +M EI IL +HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYMV-EIEILATCNHP 69
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH---DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
++KL G G L+++ E+ D L G+ TEPQI+ +Q+L L++
Sbjct: 70 YIVKLLG-AFYWDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVICRQMLEALQYL 126
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR----VVTLWYRAPEL 330
HS I+HRD+K N+L+ G +K+ DFG++ ++N+ R + T ++ APE+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 331 LLGAT----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
++ T Y D+WS G L E+ I P E+ M + K+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKI----------- 227
Query: 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445
+KS T +P K FR+F ++AL DK PE R SAA L F +
Sbjct: 228 AKSEPPTLSQPS-----KWSMEFRDFLKTAL---DK----HPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 81/294 (27%), Positives = 143/294 (48%), Gaps = 41/294 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +VY A D+ TG+ VA+K++ + + + EI ++R+ +PN+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNI 78
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCH 275
+ L+ + L++V EY LAG + T + T E QI ++ L+ L+ H
Sbjct: 79 VNYLDSYLVG--DELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S ++HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT-RK 190
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
YG +D+WS G + E+ G+P + ++ I AT+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNG 231
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TEPL 448
P+ ++ FR+F +++ L ++ + RGSA L+ F K +PL
Sbjct: 232 TPELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 68/216 (31%), Positives = 118/216 (54%), Gaps = 8/216 (3%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ F K++KIG+G++ V+K D T K+VA+K + + E + + +EI +L + D P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSP 62
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V K G + L+++ EY+ A PG E QI ++++L+GL++ HS
Sbjct: 63 YVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
+HRDIK +N+L++ G +K+ DFG+A +Q + + V T ++ APE ++ + Y
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPE-VIKQSAY 178
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
+ D+WS G EL G+ P +E+ M +F
Sbjct: 179 DSKADIWSLGITAIELAKGE---PPHSELHPMKVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 83/293 (28%), Positives = 131/293 (44%), Gaps = 37/293 (12%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
D +E I ++G G + VYKA+ ETG A K ++ + + E FM EI IL + H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-ELEDFMV-EIDILSECKH 61
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
PN++ L L+++ E+ + L + TEPQI+ +Q+L L H
Sbjct: 62 PNIVGLYE-AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGL-ATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
S ++HRD+K N+L+ G +K+ DFG+ A Q + + T ++ APE++
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACE 178
Query: 335 T----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
T Y D+WS G L EL +P P E+ M + K+ S
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP---------- 225
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P K +F +F +S L K +P++R +AA L+ F
Sbjct: 226 ------PTLDQPSKWSSSFNDFLKSCL---VK----DPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 162 KIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
I ++G+G + V R TG+ VA+K + + + + REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHE 66
Query: 218 NVMKLEGLVTSRSG-SLYLVFEY-----MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
N++K +G+ G SL L+ EY + L + ++ + Q+ +G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT--------- 322
++ S+ +HRD+ N+L+ + ++KI DFGLA + LP
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLA------KVLPEDKDYYYVKEPGESPI 176
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
WY APE L +K+ +A D+WS G L ELF
Sbjct: 177 FWY-APECLR-TSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 75/283 (26%), Positives = 136/283 (48%), Gaps = 33/283 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
F K+++IG+G++ V+K D T ++VA+K + + E + + +EI +L + D P V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
K G + L+++ EY+ A L F E QI ++++L+GL++ HS
Sbjct: 65 TKYYGSYL-KGTKLWIIMEYLGGGSA-LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
+HRDIK +N+L++ G +K+ DFG+A +Q + + V T ++ APE ++ + Y +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPE-VIQQSAYDS 180
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399
D+WS G EL G+ P +++ M +F + P+
Sbjct: 181 KADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI---------------------PKN 216
Query: 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
E + F + +D L +P R +A L+ +F
Sbjct: 217 NPPTLTGEFSKPFKE----FIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 28/264 (10%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES------VRFMAREIHILRKLDHPNV 219
+G+G + VY D +TG+ +A+K+V F DP+S V + EI +L+ L H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPF---DPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 220 MKLEG-LVTSRSGSLYLVFEYMEHDLAGLATTPGIK----FTEPQIKCYMQQLLRGLEHC 274
++ G L L + EYM G + +K TE + Y +Q+L+G+ +
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFG----LATTYDPSQNLPLTSRVVTLWYRAPEL 330
HS I+HRDIKG+N+L ++AG +K+GDFG + T + S T ++ +PE+
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--IKSVTGTPYWMSPEV 180
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
+ G YG D+WS C + E+ KP E E M IFK+ P++ S
Sbjct: 181 ISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 391 HATSFKPQQPYKRKVLETFRNFPQ 414
F Q + K T +
Sbjct: 237 ACRDFLKQIFVEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 75/240 (31%), Positives = 119/240 (49%), Gaps = 22/240 (9%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILR 212
P +D +E I+ IG+GTY V+K + + G A+K + ++D E + E +IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILK 69
Query: 213 KL-DHPNVMKLEGLVTSRS----GSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCY 263
L DHPNV+K G+ + L+LV E DL G + EP I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
+ + L GL+H H +HRD+KG+N+L+ G +K+ DFG++ S L + V T
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTP 188
Query: 324 WYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379
++ APE++ + Y A D+WS G EL G P + ++ M +FK+ +P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 86/287 (29%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E I ++G GTY VYKAR+L TG++ A+K ++ D S+ + +EI ++++ H N+
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+ G SR L++ EY L + G +E QI ++ L+GL + HS+G
Sbjct: 69 VAYFGSYLSRE-KLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKG 126
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK-- 336
+HRDIKG+N+L+ + G +K+ DFG+A + S + T ++ APE+
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y D+W+ G EL +P M ++ M +F + SKS +F+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM---FDLHPMRALFLM-----------SKS----NFQ 227
Query: 397 PQQ-PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
P + K K TF NF + + LT P+ R +A L F
Sbjct: 228 PPKLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-23
Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 36/288 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDHPN 218
FE I +IG GTY VYKAR++ TG++ A+K ++ ++P E + +EI +++ H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++ G R L++ E+ L + G +E QI ++ L+GL + HS+
Sbjct: 68 IVAYFGSYLRRD-KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK 125
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK- 336
G +HRDIKG+N+L+ + G +K+ DFG++ + S + T ++ APE+ K
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKG 184
Query: 337 -YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y D+W+ G EL +P M ++ M +F + S +F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM---FDLHPMRALFLMTKS---------------NF 226
Query: 396 KPQQ-PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
+P + K K +F +F + A LT P+ R +A L+ F
Sbjct: 227 QPPKLKDKMKWSNSFHHFVKMA-------LTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 86/295 (29%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR----FANMDPESVRFMAREIHILRKLDHPNVMK 221
+G G + V + + ALK V+ E + E IL + +HP ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 222 LEGLVTSRS----GSLYLVFEYME--------HDLAGLATTPGIKFTEPQIKCYMQQLLR 269
L R+ +Y++ EY D F E + Y+ ++
Sbjct: 58 LY-----RTFKDKKYIYMLMEYCLGGELWTILRDRG--------LFDEYTARFYIACVVL 104
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQNLPLTSRVVT 322
E+ H+RGI++RD+K NLL+++ G +K+ DFG A T+ + T
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---------TFCGT 155
Query: 323 LWYRAPELLLGATK-YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
Y APE++L K Y ++D WS G +L EL G+P P F G E
Sbjct: 156 PEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRP--P-----------F---GEDDE 197
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFR-NFPQ----SALALVDKLLTIEPENR 431
D P + Y + + FP +A L+ +LL PE R
Sbjct: 198 D--------------PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 74/242 (30%), Positives = 121/242 (50%), Gaps = 24/242 (9%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILR 212
D +E I+ IG+GTY VYK + + G + A+K + +++D E + E +IL+
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQ 73
Query: 213 KL-DHPNVMKLEGLVTSRS----GSLYLVFEY-----MEHDLAGLATTPGIKFTEPQIKC 262
L +HPNV+K G+ G L+LV E + + GL G + E I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISY 132
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322
+ L GL+H H+ I+HRD+KG+N+L+ G +K+ DFG++ S L + V T
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGT 191
Query: 323 LWYRAPELLLGATK----YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS 378
++ APE++ + Y A D+WS G EL G P + ++ + +FK+ +
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPRN 248
Query: 379 PS 380
P
Sbjct: 249 PP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-23
Identities = 61/199 (30%), Positives = 109/199 (54%), Gaps = 5/199 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
F K+++IG+G++ VYK D T ++VA+K + + E + + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ G + L+++ EY+ A PG E I ++++L+GL++ HS
Sbjct: 65 TRYYGSYL-KGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERK 122
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
+HRDIK +N+L++ G +K+ DFG+A +Q + + V T ++ APE ++ + Y
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPE-VIKQSAYDF 180
Query: 340 AIDMWSAGCILAELFAGKP 358
D+WS G EL G+P
Sbjct: 181 KADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ ++ ++G+G SV K R TG I ALK + +P+ + + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 218 NVMKLEGLVTS-RSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
++K G S S+ + EY E + G + E + + +L+GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ HSR I+HRDIK SN+L+ G +K+ DFG++ S T T +Y APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQ 176
Query: 333 GATKYGAAIDMWSAGCILAELFAGK-PIMP 361
G Y D+WS G L E+ + P P
Sbjct: 177 GKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIH------IL 211
D E+I +G GT+ V+ RD + ALK + PE +R + +E H +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIR-LKQEQHVHNEKRVL 55
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
+++ HP +++L LY++ EY+ +L G +F+ Y +++
Sbjct: 56 KEVSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCA 113
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YR 326
LE+ HS+ I++RD+K N+L++ G +K+ DFG A L R TL Y
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTWTLCGTPEYL 165
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
APE ++ + + A+D W+ G ++ E+ G P KI
Sbjct: 166 APE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 85/296 (28%), Positives = 141/296 (47%), Gaps = 44/296 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
E KIG+G+ V AR+ +G+ VA+K + + F E+ I+R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 220 MKL--EGLVTSRSGSLYLVFEYMEHDLAGLATT---PGIKFTEPQIKCYMQQLLRGLEHC 274
+++ LV L+++ E+++ G A T + E QI + +L+ L +
Sbjct: 81 VEMYKSYLVGEE---LWVLMEFLQ----GGALTDIVSQTRLNEEQIATVCESVLQALCYL 133
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLG 333
HS+G++HRDIK ++L+ G +K+ DFG S+++P +V T ++ APE ++
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPE-VIS 190
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
T YG +D+WS G ++ E+ G+P + V+ M +L SP K K+AH
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPP----KLKNAHKI 243
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
S VL F ++++LT EP+ R +A L F LP
Sbjct: 244 S---------PVLRDF----------LERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 165 KIGQGTYSSVY-----KARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++G+G++ +VY KA E K+ LK++ ++P +E +L KLDHP +
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKV--LKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 220 MKLEGLVTSRSGSLYLVFEYME-HDL---AGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+K R + ++ EY E DL G +E Q+ + QLL G+ + H
Sbjct: 65 VKFHASFLERD-AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
R ILHRD+K N+ + N +LKIGDFG++ S +L T+ T +Y +PE L
Sbjct: 124 QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPE-ALKHQ 180
Query: 336 KYGAAIDMWSAGCILAEL 353
Y + D+WS GCIL E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 78/280 (27%), Positives = 124/280 (44%), Gaps = 42/280 (15%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ PR + E+ K+G G + V+ T K VA+K ++ M PE+ +E I
Sbjct: 1 WEIPRESLKLER--KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQI 54
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLL 268
++KL H +++L + + +Y+V EYM L L + G K PQ+ Q+
Sbjct: 55 MKKLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
G+ + SR +HRD+ N+L+ V KI DFGLA + + + + AP
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 329 ELLLGATKYGA-AI--DMWSAGCILAELFA-GKPIMPGRT------EVEQMHKIFKLCGS 378
E A YG I D+WS G +L E+ G+ PG T +VE+ +++ +
Sbjct: 174 E----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNC 229
Query: 379 PSEDY------WRKSKSAHATSFKPQQPYKRKVLETFRNF 412
P E Y W K P +R E ++F
Sbjct: 230 PEELYDLMLQCWDKD------------PEERPTFEYLQSF 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 6e-22
Identities = 77/256 (30%), Positives = 108/256 (42%), Gaps = 46/256 (17%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D FE I IG+G + V + +TG I A+KK+R + M + E V + E IL + D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK---FTEPQIKCYMQQLLRGLEH 273
P V+KL + LYL+ EY+ G T +K FTE + + Y+ + + ++
Sbjct: 61 PWVVKLYYSFQDEN-YLYLIMEYLP---GGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS----------QNLPLTSRVVTL 323
H G +HRDIK NLL++ G +K+ DFGL T S LP
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 324 -----------W----------------YRAPELLLGATKYGAAIDMWSAGCILAELFAG 356
W Y APE+ L T Y D WS G I+ E+ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVG 235
Query: 357 KPIMPGRTEVEQMHKI 372
P E KI
Sbjct: 236 YPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 82/291 (28%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
KIG+G+ V A + TGK VA+KK+ + F E+ I+R H NV+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 225 --LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCHSRGI 279
LV L++V E++E G A T + T E QI +LR L + H++G+
Sbjct: 87 SYLV---GDELWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYG 338
+HRDIK ++L+ + G +K+ DFG S+ +P +V T ++ APE ++ YG
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPE-VISRLPYG 196
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+D+WS G ++ E+ G+P ++ M +I + P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------------RDNLPPR 237
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
KV R F +D +L EP R +A L+ F K P
Sbjct: 238 VKDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANMD--------PESVRFMAREIHI 210
+ ++ +G G + VYK R G ++ALK++ N +S+ + E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 211 LRK-LDHPNVMK-----LEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQI 260
+++ L HPN+++ LE LY+V + +E + +FTE +I
Sbjct: 62 IKEQLRHPNIVRYYKTFLEN------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 261 KCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319
Q++ L + H + I+HRD+ +N+++ + I DFGLA P LTS
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKLTSV 173
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358
V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 8/222 (3%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
F+ +G+G + V R+ TG I A+K ++ + + E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P + +L+ +LYLV EY DL L +F E + Y+ +L+ + H
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL--- 332
G +HRDIK N+LI+ G +K+ DFG A ++ + V T Y APE+L
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 333 --GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
G YG D WS G I E+ G+ T + + I
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
A FE ++ +G GTY VYK R ++TG++ A+K + + E ++ EI++L+K H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 217 -PNVMKLEGLVTSRS-----GSLYLVFEYMEHDLAGLAT-----TPGIKFTEPQIKCYMQ 265
N+ G +S L+LV E+ AG T T G E I +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCG---AGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
++LRGL H H+ ++HRDIKG N+L+ +K+ DFG++ D + T + T ++
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYW 187
Query: 326 RAPELLL----GATKYGAAIDMWSAGCILAELFAGKP 358
APE++ Y D+WS G E+ G P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+EKI +G+G + V+ R K+V +K++ M + E +L+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 220 MK-LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIK-FTEPQIKCYMQQLLRGLEHCHS 276
++ E + ++ L +V EY LA E I + Q+L L H H+
Sbjct: 62 IEYYENFLEDKA--LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 277 RGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTL----WYRAPELL 331
+ ILHRD+K N+L++ + V+KIGDFG+ S+ L S+ T+ Y +PEL
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGI------SKILSSKSKAYTVVGTPCYISPELC 173
Query: 332 LGATKYGAAIDMWSAGCILAEL 353
G Y D+W+ GC+L EL
Sbjct: 174 EG-KPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 88/340 (25%), Positives = 133/340 (39%), Gaps = 100/340 (29%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-VRFMAREIHILRKLDH 216
F+KI +G+G V+ R TGK+ ALK + M + V+ + E IL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEY-MEHDL-AGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
P + L + L LV +Y +L L PG +E + Y ++L LE+
Sbjct: 61 PFLPTLYASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLAT----------------TYDPSQNLPLTS 318
H GI++RD+K N+L++ +G + + DF L+ + S N +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 319 RVV------------TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV 366
T Y APE++ G +G+A+D W+ G +L E+ + G T
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEM------LYGTT-- 230
Query: 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK---RKVLETFRN-------FPQ-- 414
P+K R ETF N FP
Sbjct: 231 ---------------------------------PFKGSNRD--ETFSNILKKEVTFPGSP 255
Query: 415 --SALA--LVDKLLTIEPENR-GSAASALRSE-----FFK 444
S+ A L+ KLL +P R GS A +E FF+
Sbjct: 256 PVSSSARDLIRKLLVKDPSKRLGSKRGA--AEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 73/254 (28%), Positives = 120/254 (47%), Gaps = 25/254 (9%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
A FE ++ +G GTY VYK R ++TG++ A+K + + E ++ +EI++L+K H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 217 -PNVMKLEGLVTSRS-----GSLYLVFEYMEHDLAGLAT-----TPGIKFTEPQIKCYMQ 265
N+ G ++ L+LV E+ AG T T G E I +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCG---AGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
++LRGL H H ++HRDIKG N+L+ +K+ DFG++ D + T + T ++
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYW 177
Query: 326 RAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
APE++ Y D+WS G E+ G P + ++ M +F + +P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPAP 234
Query: 382 DYWRKSKSAHATSF 395
K S SF
Sbjct: 235 RLKSKKWSKKFQSF 248
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 79/300 (26%), Positives = 118/300 (39%), Gaps = 61/300 (20%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPNVMKLEG 224
+G+G + V + TGK+ A KK+ + MA E IL K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 225 LVTSRSGSLYLVFEYM----------EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
++ L LV M G F E + Y Q++ GLEH
Sbjct: 61 AFETKD-DLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHL 111
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H R I++RD+K N+L+++ G ++I D GLA + + R T Y APE+L G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAV--ELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y ++D ++ GC L E+ AG+ SP K
Sbjct: 170 -VYDFSVDWFALGCTLYEMIAGR--------------------SPFRQRKEK-------- 200
Query: 395 FKPQQPYKRKVLETFRNFP----QSALALVDKLLTIEPENR-----GSAASALRSEFFKT 445
++ KR+ LE +P A L + LL +PE R GSA FK
Sbjct: 201 -VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 29/209 (13%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
I ++G+G + SV R D TG++VA+KK++ + E +R REI IL+ L H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHD 65
Query: 218 NVMKLEGLVTSRS-GSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N++K +G+ S +L LV EY+ + L + ++ Y Q+ +G+E+
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA----------TTYDPSQNLPLTSRVVTLWY 325
S+ +HRD+ N+L+ + +KIGDFGL +P ++ P+ WY
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-PI------FWY 178
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELF 354
APE L +K+ A D+WS G +L ELF
Sbjct: 179 -APE-SLTESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 78/312 (25%), Positives = 126/312 (40%), Gaps = 57/312 (18%)
Query: 167 GQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLV 226
+ K + T +VA+KK+ + E ++ + +EI R+L HPN++
Sbjct: 11 EDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 227 TSRSGSLYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
S LY+V M + DL L T E I ++ +L L++ HS+G +HR
Sbjct: 69 IVDS-ELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 283 DIKGSNLLINNAGVLKI-----------GDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
+K S++L++ G + + +D + S V L + +PE+L
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK-----SSVKNLPWLSPEVL 180
Query: 332 ----LGATKYGAAIDMWSAGCILAELFAGKPIMP-GRTEVEQMHKIFKLCGSP------- 379
G Y D++S G EL G +P QM + K+ G+
Sbjct: 181 QQNLQG---YNEKSDIYSVGITACELANG--HVPFKDMPATQML-LEKVRGTVPCLLDKS 234
Query: 380 ----SEDYWRKSKSA--HATSFKPQQ-PYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
ED +S+S+ H + PY R E F F V+ L +PE+R
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESRP 287
Query: 433 SAASALRSEFFK 444
SA+ L FFK
Sbjct: 288 SASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 78/277 (28%), Positives = 134/277 (48%), Gaps = 36/277 (12%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ PR + + + K+G G + V+ K VA+K ++ +M PE+ F+A E ++
Sbjct: 1 WEVPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANL 54
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLL 268
+++L HP +++L +VT +Y++ EYME+ + L T GIK T ++ Q+
Sbjct: 55 MKQLQHPRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
G+ + +HRD++ +N+L++ KI DFGLA + ++ + + AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 329 ELLLGATKYGA---AIDMWSAGCILAELFA-GKPIMPGRT--EV----EQMHKIFKLCGS 378
E A YG D+WS G +L E+ G+ PG T EV E+ +++ +
Sbjct: 173 E----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNC 228
Query: 379 PSEDY------WRKSKSAHATSFKPQQPYKRKVLETF 409
P E Y W++ +P Y R VLE F
Sbjct: 229 PEELYELMRLCWKEKPEE-----RPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 28/234 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +E I ++G G + VYKA++ ETG ++A KV + E +M EI IL DHP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMV-EIDILASCDHP 62
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGI-----KFTEPQIKCYMQQLLRGLE 272
N++KL + +L+++ E+ AG A + TEPQI+ +Q L L
Sbjct: 63 NIVKLLDAFYYEN-NLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR----VVTLWYRAP 328
+ H I+HRD+K N+L G +K+ DFG++ ++N R + T ++ AP
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAP 172
Query: 329 ELLLGATK----YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS 378
E+++ T Y D+WS G L E+ I P E+ M + K+ S
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 160 FEKIDKIGQGTYSSV----YKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+KI +G+G + V Y + TG++VA+K ++ ++ +EI+IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLY 64
Query: 216 HPNVMKLEGLVTSRSG-SLYLVFEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEH 273
H N++K +G + + G L L+ EY+ L L P K Q+ + QQ+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT-------YDPSQNLPLTSRVVTLWYR 326
HS+ +HRD+ N+L++N ++KIGDFGLA Y ++ WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED----GDSPVFWY- 177
Query: 327 APELLLGATKYGAAIDMWSAGCILAELF 354
A E L K+ A D+WS G L EL
Sbjct: 178 AVE-CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 160 FEKIDKIGQGTYSSV----YKARDLETGKIVALKKVRFANMDPES----VRFMAREIHIL 211
++I +G+G + V Y TG+ VA+K ++ PES + + +EI IL
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEIL 60
Query: 212 RKLDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLR 269
R L H N++K +G+ T G + L+ E++ L K Q Y Q+ +
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL-----PLTSRVVTLW 324
G+++ SR +HRD+ N+L+ + +KIGDFGL + + L S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELF 354
Y APE L+ +K+ A D+WS G L EL
Sbjct: 179 Y-APECLI-QSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPNVMKLEG 224
+G+G + V + TGK+ A KK+ + MA E IL K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 225 LVTSRSGSLYLVFEYME--------HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
++ +L LV M +++ PG F E + Y ++ GLE H
Sbjct: 68 AYETKD-ALCLVLTLMNGGDLKFHIYNMG----NPG--FDEERAVFYAAEITCGLEDLHR 120
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
I++RD+K N+L+++ G ++I D GLA + + RV T+ Y APE ++ +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPE-VVKNER 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y + D W GC++ E+ GK R E + ++ + E+Y K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK---------- 227
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFKT 445
F ++A ++ +LLT +P R A FF+T
Sbjct: 228 ---------------FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 45/293 (15%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
KIG+G+ V A +GK+VA+KK+ + F E+ I+R H NV+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 225 --LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFT---EPQIKCYMQQLLRGLEHCHSRGI 279
LV L++V E++E G A T + T E QI +L+ L H++G+
Sbjct: 85 SYLV---GDELWVVMEFLE----GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYG 338
+HRDIK ++L+ + G +K+ DFG S+ +P +V T ++ APE L+ YG
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPE-LISRLPYG 194
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+D+WS G ++ E+ G+P ++ M I ++ K K+ H
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPPKLKNLH------- 240
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF-KTEPLPC 450
KV + + F +D+LL +P R +AA L+ F K P C
Sbjct: 241 -----KVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 162 KIDK-IGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
KI+K IG G + V R GK VA+K ++ + + F++ E I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ LEG+VT +S + +V EYME+ L +FT Q+ ++ + G+++
Sbjct: 66 NIIHLEGVVT-KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSRVVTLWYRAPELLLGA 334
G +HRD+ N+L+N+ V K+ DFGL+ DP + + + APE +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAY 183
Query: 335 TKYGAAIDMWSAGCILAELFA 355
K+ +A D+WS G ++ E+ +
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 166 IGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAR---EIHILRKLDHPNV 219
+GQG++ V+ R + + G++ A+K ++ A + VR R E IL +++HP +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFI 60
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+KL G LYL+ +++ + + FTE +K Y+ +L L+H HS GI
Sbjct: 61 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
++RD+K N+L++ G +K+ DFGL+ + S T+ Y APE ++ +
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPE-VVNRRGHTQ 177
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
+ D WS G ++ E+ G G+ E M I K
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 32/225 (14%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D E +D++G+G Y SVYK TG +A+K++R +D + E+ IL K P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSP 59
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHD-----LAGLATTPGIKFTEPQIKCYMQQLLRGL- 271
++ G G++Y+ EYM+ AG T GI E ++ +++GL
Sbjct: 60 YIVDFYGAFF-IEGAVYMCMEYMDAGSLDKLYAGGVATEGIP--EDVLRRITYAVVKGLK 116
Query: 272 ----EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS---QNLPLTSRVVTLW 324
EH I+HRD+K +N+L+N G +K+ DFG++ S N+ S
Sbjct: 117 FLKEEH----NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------ 166
Query: 325 YRAPELLLGATKYGAAI-----DMWSAGCILAELFAGKPIMPGRT 364
Y APE + D+WS G + E+ G+ P T
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+KIG+G + VYK L+ VA+K R + + P+ R +E IL++ DHPN++KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCR-STLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 224 GLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
G+ + +Y+V E + L + T ++ G+E+ S+ +HR
Sbjct: 59 GVCVQKQ-PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 283 DIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
D+ N L+ VLKI DFG++ Y S L + + + + APE L +Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL----KQIPIKWTAPE-ALNYGRY 172
Query: 338 GAAIDMWSAGCILAELFAG 356
+ D+WS G +L E F+
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRF--ANMDPESVRFMAREIHILRKLDHP 217
+ + +G+G++ + + + + A+K++R ++ E R +E +L K+ HP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR---KEAVLLAKMKHP 58
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N++ + + G LY+V EY + + + G F E I + Q+ G++H H
Sbjct: 59 NIVAFKESFEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+ +LHRDIK N+ + G +K+GDFG A T V T +Y PE+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWEN-M 175
Query: 336 KYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLC 376
Y D+WS GCIL EL K P + + I K+C
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 9e-19
Identities = 70/254 (27%), Positives = 106/254 (41%), Gaps = 23/254 (9%)
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
E +L+ ++HP+V++++ + +V + DL T Q +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA--TTYDPSQNLPLTSRVVTLW 324
+L GL + H++ I+HRD+K N+ IN+ + IGD G A P+ L L V T
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET-- 222
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFA----------GKPIMPGRTEVEQMHKIFK 374
APE+L KY + D+WSAG +L E+ A P ++ + KI
Sbjct: 223 -NAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
Query: 375 LCGSPSEDYWRKSKSAHATSF-----KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPE 429
E++ R S F +QPY R N P LV K+LT +
Sbjct: 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340
Query: 430 NRGSAASALRSEFF 443
R SA L F
Sbjct: 341 MRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 7/210 (3%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKV-RFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
IG+GT+ VY+ R +T +I A+K + + + + V E +IL + + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 225 LVTS--RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
L S LYLV +YM +F+E + K Y+ +L+ LEH H I++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 283 DIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAID 342
D+K N+L++ G + + DFGL+ + + N + T Y APE+LL Y +D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179
Query: 343 MWSAGCILAELFAG-KPIMPGRTEVEQMHK 371
WS G ++ E+ G P + +QM++
Sbjct: 180 FWSLGVLVFEMCCGWSPFYA--EDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-VRFMAREIHILRKLDHPNVMKLEG 224
IG+G++ V + R +T +I ALK +R A++ S V E +L +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 225 LVTSRSGSLYLVFEYME-----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
S LYLV ++ H L +F + + Y +LL LE+ H +
Sbjct: 61 SFQSP-EKLYLVLAFINGGELFHHLQREG-----RFDLSRARFYTAELLCALENLHKFNV 114
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YRAPELLLGAT 335
++RD+K N+L++ G + + DFGL N+ + T Y APELLLG
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKL-----NMKDDDKTNTFCGTPEYLAPELLLG-H 168
Query: 336 KYGAAIDMWSAGCILAELFAGKP 358
Y A+D W+ G +L E+ G P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 11/223 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +IG G + V+ LE K VA+K +R M E E ++ KL HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHP 59
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+++L G+ T RS + LVFE+MEH L+ KF++ + + G+ + S
Sbjct: 60 KLVQLYGVCTERS-PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
++HRD+ N L+ V+K+ DFG+ Q T + + +PE + +K
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 337 YGAAIDMWSAGCILAELFA-GKPIMPGRTE---VEQMHKIFKL 375
Y + D+WS G ++ E+F+ GK R+ VE ++ F+L
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 13/213 (6%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+G+G++ V+ A T + A+K ++ MD + M + + +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
++ +L+ V EY+ KF P+ Y +++ GL+ HS+GI++RD
Sbjct: 63 CTFQTKE-NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YRAPELLLGATKYGA 339
+K N+L++ G +KI DFG+ +N+ ++ T Y APE+LLG KY
Sbjct: 122 LKLDNILLDTDGHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEILLG-QKYNT 175
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
++D WS G +L E+ G+ G E E I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 76/257 (29%), Positives = 108/257 (42%), Gaps = 47/257 (18%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPN 218
F KI IG G + V R ++T + A+K +R A+ + + E IL + D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V+KL + +LY V +Y+ D+ L GI F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKM 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTY----------------------------- 308
G +HRDIK N+LI+ G +K+ DFGL T +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 309 DPSQNLPLTSR-------------VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
D + PL R V T Y APE+LL T Y D WS G IL E+
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLV 239
Query: 356 GKPIMPGRTEVEQMHKI 372
G+P T E K+
Sbjct: 240 GQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 74/305 (24%), Positives = 123/305 (40%), Gaps = 62/305 (20%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVR----FANMDPESVRFMAREIHILRKLD 215
F + +G+G + V A +TG++ A+K ++ A + ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEY------MEHDLAGLATTPGIKFTEPQIKCYMQQLLR 269
HP ++ L + + V EY M H + F+EP+ Y ++
Sbjct: 61 HPFLVNLFACFQTED-HVCFVMEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVVL 112
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----Y 325
GL++ H I++RD+K NLL++ G +KI DFGL + + R T +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-----KEGMGFGDRTSTFCGTPEF 167
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
APE+L T Y A+D W G ++ E+ G+ PG E E I
Sbjct: 168 LAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------------- 213
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GS----AASALRS 440
+ + + P R + A++++ +LL PE R GS A +
Sbjct: 214 -------VNDEVRYP---------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257
Query: 441 EFFKT 445
FF+
Sbjct: 258 PFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 183 GKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241
GKI VA+K +R M + F+ E ++ KL HPN+++L G+ T + +++V EYM
Sbjct: 27 GKIDVAIKMIREGAMSEDD--FI-EEAKVMMKLSHPNLVQLYGVCT-KQRPIFIVTEYMA 82
Query: 242 HD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKI 299
+ L L G TE + + +E+ S G +HRD+ N L+ V+K+
Sbjct: 83 NGCLLNYLRERKGKLGTE-WLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKV 141
Query: 300 GDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
DFGLA Y SQ ++ W PE+ +++ + D+WS G ++ E+F
Sbjct: 142 SDFGLARYVLDDQYTSSQG----TKFPVKW-APPEVFD-YSRFSSKSDVWSFGVLMWEVF 195
Query: 355 A-GKPIMPGRTE---VEQMHKIFKL 375
+ GK + VE + ++L
Sbjct: 196 SEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 89/344 (25%), Positives = 132/344 (38%), Gaps = 91/344 (26%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVA---LKKVRFANMDPESVRFMAREIHILRKLDH 216
FE + +G G++ V A+ TG+ A LKK M + V+ +A+E IL +L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM--KQVQHVAQEKSILMELSH 77
Query: 217 P---NVMKLEGLVTSRSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
P N+M +Y + E+ + +L G +F K Y +L+ E
Sbjct: 78 PFIVNMMC--SFQDENR--VYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFE 132
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YRAP 328
+ HS+ I++RD+K NLL++N G +K+ DFG A + R TL Y AP
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK--------VPDRTFTLCGTPEYLAP 184
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
E ++ + +G A+D W+ G +L E AG P
Sbjct: 185 E-VIQSKGHGKAVDWWTMGVLLYEFIAGYP------------------------------ 213
Query: 389 SAHATSFKPQQPYK--RKVLETFRNFPQ----SALALVDKLLTIEPENR-----GSAASA 437
F P++ K+L FP A LV LL + R G A
Sbjct: 214 -----PFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV 268
Query: 438 LRSEFFK------------TEPLPC------DPSNLPKYPPSKE 463
+F P+P D SN KYP S
Sbjct: 269 KNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPDSPV 312
|
Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 54/190 (28%), Positives = 91/190 (47%), Gaps = 4/190 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
+G+G+Y V R GK +KK+ N + +E +L +L HPN++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 226 VTSRSGSLYLVFEYMEH-DL-AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
G LY+V + E DL L G E Q+ + Q+ L++ H + ILHRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K N+ + ++K+GD G+A + +Q ++ + T +Y +PE L Y D+
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDV 185
Query: 344 WSAGCILAEL 353
W+ GC + E+
Sbjct: 186 WALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+ +G G +VYKA L T +I+A+K + ++ E + + E+ IL K D P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 224 G--LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G V +R + + E+M+ G + K E + +++GL + S ILH
Sbjct: 66 GAFFVENR---ISICTEFMD----GGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAI 341
RD+K SN+L+N G +K+ DFG++T N + V T Y APE + G +YG
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISG-EQYGIHS 174
Query: 342 DMWSAGCILAELFAGK 357
D+WS G EL G+
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 72/227 (31%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLD 215
FE I I G Y +VY R ET + A+KK+ N+ + V F+ R+I L +
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDI--LTFAE 59
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+P V+ + ++ L +V EY+E D A L G + + Y + + LE+
Sbjct: 60 NPFVVSMFCSFETKR-HLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLALEYL 117
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TT-----YDPSQNLPLTSRVV- 321
H+ GI+HRD+K NLLI + G +K+ DFGL+ TT + + V
Sbjct: 118 HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 322 -TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE 367
T Y APE++L YG +D W+ G IL E G G T E
Sbjct: 178 GTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 65/234 (27%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI-LRKLDH 216
D E I+++G+G Y V K R + TG I+A+K++R A ++ + + + ++ I +R +D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR-ATVNSQEQKRLLMDLDISMRSVDC 59
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEH 273
P + G + R G +++ E M+ L G+ E + +++ LE+
Sbjct: 60 PYTVTFYGALF-REGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 274 CHSR-GILHRDIKGSNLLINNAGVLKIGDFG--------LATTYDPSQNLPLTSRVVTLW 324
HS+ ++HRD+K SN+LIN G +K+ DFG +A T D P
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCK-P--------- 168
Query: 325 YRAPELLLGATK---YGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFK 374
Y APE + Y D+WS G + EL G+ P +T +Q+ ++ +
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKV-RFANMDPESVRFMAREIHILRKL 214
+A+ F+ I IG+G + V R + ++ A+K + +F + F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ +++L LY+V EYM DL L + I E + Y +++ L+
Sbjct: 101 NSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAEVVLALDA 157
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL- 332
HS G +HRD+K N+L++ +G LK+ DFG D + + + V T Y +PE+L
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 333 --GATKYGAAIDMWSAGCILAELFAGKP 358
G YG D WS G L E+ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 162 KIDK-IGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
I+K IG G + V + R GK VA+K ++ + D + + F+ E I+ + DHP
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHP 65
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAG--LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N+++LEG+VT + ++ EYME+ L G KFT Q+ ++ + G+++
Sbjct: 66 NIIRLEGVVTKSR-PVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS 123
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS--RVVTLWYRAPELLLG 333
+HRD+ N+L+N+ V K+ DFGL+ + S+ T ++ W APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPE-AIA 181
Query: 334 ATKYGAAIDMWSAGCILAEL--FAGKP 358
K+ +A D+WS G ++ E+ + +P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 10/215 (4%)
Query: 166 IGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVM 220
+G+G Y V++ R + +TGKI A+K ++ A + + + E +IL + HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
L G LYL+ EY+ +L GI F E Y+ ++ LEH H +GI
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQGI 121
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
++RD+K N+L++ G +K+ DFGL + + T+ Y APE+L+ + +G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILM-RSGHGK 179
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
A+D WS G ++ ++ G P + + KI K
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 9e-18
Identities = 76/265 (28%), Positives = 119/265 (44%), Gaps = 30/265 (11%)
Query: 205 AREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYM 264
A E HILR ++HP++++L+G T + ++ Y LA I + I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICD--ILAIE 188
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT-TYDPSQNLPLTSRVVTL 323
+ +LR +++ H I+HRDIK N+ IN+ G + +GDFG A D + N T+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTI 247
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAG------KPIMPGRTEVE-QMHKIFKLC 376
APE LL YG A+D+WSAG +L E+ K + G + + Q+ I +
Sbjct: 248 ATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306
Query: 377 GS-PSE-----------DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLL 424
G+ P+E Y +K +S KP R + P L+ K+L
Sbjct: 307 GTHPNEFPIDAQANLDEIYIGLAKK---SSRKPGS---RPLWTNLYELPIDLEYLICKML 360
Query: 425 TIEPENRGSAASALRSEFFKTEPLP 449
+ +R SA + L F+ P P
Sbjct: 361 AFDAHHRPSAEALLDFAAFQDIPDP 385
|
Length = 391 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAR-EIHILRKLDHPNVMK 221
IG+G + VY R +TGK+ A+K K R E++ R + ++ D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
+ + L + + M DL + G+ F+E +++ Y +++ GLEH H+R ++
Sbjct: 62 MSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
+RD+K +N+L++ G ++I D GLA + S+ P S V T Y APE+L Y ++
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176
Query: 341 IDMWSAGCILAELFAG 356
D +S GC+L +L G
Sbjct: 177 ADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 75/293 (25%), Positives = 135/293 (46%), Gaps = 52/293 (17%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESV-------RFMAREIHILRKLDHPN 218
+G+G Y +VY G+++A+K+V +D +V + E+ +L+ L H N
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVE---LDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK----FTEPQIKCYMQQLLRGLEHC 274
+++ G T + +F ME + G + + + EP Y +Q+L G+ +
Sbjct: 64 IVQYLG--TCLDDNTISIF--MEF-VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPE 329
H+ ++HRDIKG+N+++ G++K+ DFG A + + L S T ++ APE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
++ + YG D+WS GC + E+ GKP + ++++ +F +
Sbjct: 179 -VINESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYI-------------G 221
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
AH P+ P +F +A+ V LT + R SA LR +F
Sbjct: 222 AH-RGLMPRLP---------DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 60/207 (28%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 159 AFEKIDK-IGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKL 214
+ KI++ IG G + V + R GK VA+K ++ + + F++ E I+ +
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQF 62
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
DHPN++ LEG+VT +S + ++ E+ME+ L +FT Q+ ++ + G+++
Sbjct: 63 DHPNIIHLEGVVT-KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAP 328
+HRD+ N+L+N+ V K+ DFGL+ T DP+ L ++ W AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAP 180
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFA 355
E + K+ +A D+WS G ++ E+ +
Sbjct: 181 E-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 14/230 (6%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R ++ + I K+G G + V+ K VA+K ++ M PES E I+
Sbjct: 1 WEIPR-ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIM 55
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLR 269
+KL H +++L +V+ +Y+V EYM L L G P + Q+
Sbjct: 56 KKLRHDKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
G+ + +HRD++ +N+L+ + V KI DFGLA + ++ + + APE
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 330 LLLGATKYGAAIDMWSAGCILAELFA-GK---PIMPGRTEVEQMHKIFKL 375
L ++ D+WS G +L EL G+ P M R +EQ+ + +++
Sbjct: 174 AALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKL-DHPNVMKL 222
+G+G++ V A T ++ A+K ++ D + V E +L HP + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-DDVECTMTEKRVLALAGKHPFLTQL 61
Query: 223 EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
++ L+ V EY+ DL G +F EP+ + Y +++ GL+ H RGI++
Sbjct: 62 HSCFQTKD-RLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW------YRAPELLLGAT 335
RD+K N+L+++ G +KI DFG+ + V T Y APE+L
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKE-------GILGGVTTSTFCGTPDYIAPEILSY-Q 171
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
YG A+D W+ G +L E+ AG+ G E E I
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAR-EIHILRKLDHPNVMK 221
IG+G + VY R +TGK+ A+K K R E++ R + ++ D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
+ L + + M DL + G+ F+E +++ Y +++ GLEH H+R ++
Sbjct: 62 MT-YAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
+RD+K +N+L++ G ++I D GLA D S+ P S V T Y APE+L T Y ++
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 341 IDMWSAGCILAELFAG 356
D +S GC+L +L G
Sbjct: 177 ADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 75/291 (25%), Positives = 120/291 (41%), Gaps = 53/291 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D FE + IG+G + V + +TG I A+K +R A+M + E V + E IL + D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
V+K+ + +LYL+ E++ D+ L +E + Y+ + + ++ H
Sbjct: 61 AWVVKMFYSFQDKR-NLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH 118
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLAT--------------TYDPSQNLPL----T 317
G +HRDIK NLL++ G +K+ DFGL T T++P + +
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 318 SRVVTLW----------------YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP 361
R W Y APE+ + T Y D WS G I+ E+ G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 362 GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNF 412
T E K+ W+++ F P+ P K + F
Sbjct: 238 SETPQETYRKVMN---------WKET-----LVFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 73/277 (26%), Positives = 132/277 (47%), Gaps = 36/277 (12%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ PR + EK K+G G + V+ A + K VA+K ++ +M SV E ++
Sbjct: 1 WEIPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANV 54
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLL 268
++ L H ++KL +VT +Y++ E+M L L + G K P++ + Q+
Sbjct: 55 MKTLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
G+ R +HRD++ +N+L++ + V KI DFGLA + ++ + + AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 329 ELLLGATKYGAAI---DMWSAGCILAELFA-GKPIMPGRTE------VEQMHKIFKLCGS 378
E A +G+ D+WS G +L E+ G+ PG + +E+ +++ +
Sbjct: 173 E----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC 228
Query: 379 PSEDY------WRKSKSAHATSFKPQQPYKRKVLETF 409
P E Y W K++ +F+ Y + VL+ F
Sbjct: 229 PEELYNIMMRCW-KNRPEERPTFE----YIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 67/276 (24%), Positives = 131/276 (47%), Gaps = 33/276 (11%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R ++ + + K+G G + V+ + K VA+K ++ M SV+ E +++
Sbjct: 1 WEIPR-ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLM 55
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLR 269
+ L H +++L +VT + +Y++ EYM L L + G K P++ + Q+
Sbjct: 56 KTLQHDKLVRLYAVVT-KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
G+ + + +HRD++ +N+L++ + + KI DFGLA + ++ + + APE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 330 LLLGATKYGAAI---DMWSAGCILAELFA-GKPIMPGRTEVEQM------HKIFKLCGSP 379
A +G+ D+WS G +L E+ GK PG + + M +++ ++ P
Sbjct: 175 ----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP 230
Query: 380 SEDY------WRKSKSAHATSFKPQQPYKRKVLETF 409
E Y W++ +P Y + VL+ F
Sbjct: 231 DELYDIMKTCWKEKAEE-----RPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 76/263 (28%), Positives = 113/263 (42%), Gaps = 51/263 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPN 218
F KI +G G + V AR ++T + A+K +R + + V + E IL + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V++L + +LY V +Y+ D+ L GI F E + Y+ +L +E H
Sbjct: 63 VVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKM 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTY---------------------------DP 310
G +HRDIK N+LI+ G +K+ DFGL T + DP
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 311 S------QNLPLTSR-------------VVTLWYRAPELLLGATKYGAAIDMWSAGCILA 351
+ + PL R V T Y APE+LL T Y D WS G IL
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILY 239
Query: 352 ELFAGKPIMPGRTEVEQMHKIFK 374
E+ G+P +T +E K+
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 6/203 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL 214
FE + +G G Y V+ R + ++GK+ A+K ++ A + ++ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L+L+ +Y+ + +F E +++ Y +++ LEH
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H GI++RDIK N+L+++ G + + DFGL+ + + S T+ Y AP+++ G
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 335 -TKYGAAIDMWSAGCILAELFAG 356
+ A+D WS G ++ EL G
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-17
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 9/213 (4%)
Query: 149 IKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKV-RFANMDPESVRFMARE 207
I+ Q +A+ ++ + IG+G + V R + K+ A+K + +F + F E
Sbjct: 35 IRKLQ-MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 208 IHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQ 266
I+ + P V++L LY+V EYM DL L + + E K Y +
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAE 150
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
++ L+ HS G++HRD+K N+L++ G LK+ DFG D + + + V T Y
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210
Query: 327 APELLL---GATKYGAAIDMWSAGCILAELFAG 356
+PE+L G YG D WS G L E+ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 66/232 (28%), Positives = 106/232 (45%), Gaps = 11/232 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
F + +G+G + V + TGK+ A K++ + MA E IL K++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEHC 274
V+ L ++ +L LV M DL PG F E + Y ++L GLE
Sbjct: 62 VVNLAYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDL 118
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H ++RD+K N+L+++ G ++I D GLA P + RV T+ Y APE +L
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGES-IRGRVGTVGYMAPE-VLNN 175
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
+Y + D W GC++ E+ G+ GR E + ++ + E Y K
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKA--RDLETGK---IVALKKVRFANMDPESVRFMAREI 208
R ++G+G + V+ LE +VA+K ++ + F RE
Sbjct: 3 QRDTIVL--KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-REA 59
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL----------AGLATTPGIK--- 254
+L H N++K G+ T +VFEYMEH DL A +P
Sbjct: 60 ELLTNFQHENIVKFYGVCT-EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 255 FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314
T Q+ Q+ G+ + S+ +HRD+ N L+ V+KIGDFG+ S+++
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM------SRDV 172
Query: 315 PLT-------SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GK 357
T ++ + + PE ++ K+ D+WS G +L E+F GK
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 9/216 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
F K+G G + V++ + VA+K ++ ++ + +E+ L++L H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDL--LKQQDFQKEVQALKRLRHKHL 64
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+ L V S +Y++ E ME LA L + G + Q+ G+ + +
Sbjct: 65 ISLFA-VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
+HRD+ N+L+ V K+ DFGLA L ++ W APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTF 181
Query: 338 GAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
D+WS G +L E+F G+ PG E +I
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R D K K+G G Y VY+ + VA+K ++ M+ E F+ +E ++
Sbjct: 1 WEMERTDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 56
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYM-QQLLR 269
+++ HPN+++L G+ T R Y++ E+M + +L + + YM Q+
Sbjct: 57 KEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYRAP 328
+E+ + +HRD+ N L+ ++K+ DFGL+ + ++ W AP
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW-TAP 174
Query: 329 ELLLGATKYGAAIDMWSAGCILAEL 353
E L K+ D+W+ G +L E+
Sbjct: 175 E-SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 12/223 (5%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R + + + K+G G + V++ T VA+K ++ MDP+ F+ E I+
Sbjct: 1 WEIDR-TSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIM 55
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLR 269
+KL HP +++L V + +Y+V E M++ L L G PQ+ Q+
Sbjct: 56 KKLRHPKLIQLYA-VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
G+ + ++ +HRD+ N+L+ + K+ DFGLA + + APE
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 330 LLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRT--EVEQM 369
L ++ D+WS G +L E+ G+ PG T EV Q
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+ IG+G + +V + TG+ VA+K ++ D + F+ E ++ KL H N+++L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIK---CDVTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 224 GLVTSRSGSLYLVFEYMEH-DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G++ LY+V E M +L T G + Q+ + + G+E+ S+ ++H
Sbjct: 66 GVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAI 341
RD+ N+L++ GV K+ DFGLA + S++ W APE L K+ +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKW-TAPE-ALKHKKFSSKS 178
Query: 342 DMWSAGCILAELF----AGKPIMPGRTEVEQMHKIFKL 375
D+WS G +L E+F A P M + E + K +++
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 82/309 (26%), Positives = 128/309 (41%), Gaps = 29/309 (9%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRF-ANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+G++ V A T ++ A+K ++ + + V E +L D P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 225 LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
LY V EY+ DL G KF EPQ Y ++ GL H RGI++RD
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGAAI 341
+K N+++++ G +KI DFG+ +T+R T Y APE ++ YG ++
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYIAPE-IIAYQPYGKSV 182
Query: 342 DMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS----FKP 397
D W+ G +L E+ AG+P G E E I + S + KS S A S
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-----YPKSLSKEAVSICKGLMT 237
Query: 398 QQPYKR-----------KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
+ P KR + FR L + +P+ G A F + +
Sbjct: 238 KHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGAENFDKFFTRGQ 297
Query: 447 PLPCDPSNL 455
P+ P L
Sbjct: 298 PVLTPPDQL 306
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKV-RFANMDPESVRFMAREIHILRKL 214
+A+ +E + IG+G + V R T K+ A+K + +F + F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ P V++L LY+V EYM DL L + + E + Y +++ L+
Sbjct: 101 NSPWVVQL-FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EKWARFYTAEVVLALDA 157
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL- 332
HS G +HRD+K N+L++ +G LK+ DFG + + + V T Y +PE+L
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 333 --GATKYGAAIDMWSAGCILAELFAG 356
G YG D WS G L E+ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 53/225 (23%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYK--ARDLETGKI---VALKKVRFANMDPESVRFMAR 206
W+ R + I ++GQG++ VY+ A+ + G+ VA+K V E + F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGL--ATTPGIKFTEPQIKCY 263
E ++++ + +V++L G+V S +V E M DL + P +
Sbjct: 59 EASVMKEFNCHHVVRLLGVV-STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117
Query: 264 MQQLLR-------GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLP 315
+Q+ ++ G+ + ++ +HRD+ N ++ +KIGDFG+ Y+
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
++ + + APE L + D+WS G +L E+ A +P
Sbjct: 178 GGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 15/247 (6%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ D FE+I ++G G V K + +G I+A K + + P + RE+ +L + +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECN 61
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ G S G + + E+M+ + E + +LRGL +
Sbjct: 62 SPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 276 SR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
+ I+HRD+K SN+L+N+ G +K+ DFG++ S S V T Y +PE L G
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG- 176
Query: 335 TKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
T Y D+WS G L EL G+ PI P + +++ IF G P D + H+
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD--GEEGEPHSI 229
Query: 394 SFKPQQP 400
S +P+ P
Sbjct: 230 SPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 60/180 (33%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
LY V EY+ DL G KF EP Y ++ GL HS+GI++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 292 NNAGVLKIGDFGLATTYDPSQNL--PLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAG 347
+ G +KI DFG+ +N+ T+R T Y APE++ YG ++D W+ G
Sbjct: 135 DAEGHIKIADFGMC-----KENIFGGKTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFG 188
Query: 348 CILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS----FKPQQPYKR 403
+L E+ AG+P G E E I + S + KS S A S + P KR
Sbjct: 189 VLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-----YPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKL-DHPNVMKL 222
IG+G+Y+ V R +T +I A+K V+ N D E + ++ E H+ + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
+ S L+ V EY+ K E + Y ++ L + H RGI++R
Sbjct: 62 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 283 DIKGSNLLINNAGVLKIGDFGLATT-YDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAA 340
D+K N+L+++ G +K+ D+G+ P TS T Y APE+L G YG +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRG-EDYGFS 176
Query: 341 IDMWSAGCILAELFAGK 357
+D W+ G ++ E+ AG+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 5/202 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL 214
FE + +G G Y V+ R + +TGK+ A+K ++ A + ++V E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L+L+ +Y+ F+E +++ Y +++ LEH
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H GI++RDIK N+L+++ G + + DFGL+ + + S T+ Y APE++ G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 335 TKYGAAIDMWSAGCILAELFAG 356
+G A+D WS G ++ EL G
Sbjct: 182 GGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 76/290 (26%), Positives = 121/290 (41%), Gaps = 55/290 (18%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPN 218
FE + IG+G + V + +TG + A+K +R A+M + E V + E IL + D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V+K+ + +LYL+ E++ D+ L TE + + Y+ + + ++ H
Sbjct: 63 VVKMFYSFQDKL-NLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYD---------------PS----QNLPLTS 318
G +HRDIK NLL+++ G +K+ DFGL T PS QN+ +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN-SK 179
Query: 319 RVVTLWYR----------------APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362
R W R APE+ + T Y D WS G I+ E+ G P
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 363 RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNF 412
T E K+ W+++ F P+ P K + F
Sbjct: 239 ETPQETYKKVMN---------WKET-----LIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 74/265 (27%), Positives = 108/265 (40%), Gaps = 55/265 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
+ F + IG+G + V + +TGKI A+K + + M + + + E +L + D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK---FTEPQIKCYMQQLLRGLEH 273
P V+ L S + YL + ME G T IK F+E + YM + + +E
Sbjct: 61 PWVVSL---YYSFQDAQYL-YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT----TYDP------------------- 310
H G +HRDIK N+LI+ G +K+ DFGL+T +D
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 311 ------SQNLPLTSR-----------------VVTLWYRAPELLLGATKYGAAIDMWSAG 347
S NL ++S+ V T Y APE+ L YG D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235
Query: 348 CILAELFAGKPIMPGRTEVEQMHKI 372
I+ E G P E KI
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
++IG+G + V+ R VA+K R + P+ +E IL++ HPN+++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 224 GLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
G+ T + +Y+V E ++ D T G + ++ ++ G+E+ S+ +HR
Sbjct: 60 GVCTQKQ-PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 283 DIKGSNLLINNAGVLKIGDFGLAT-----TYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
D+ N L+ VLKI DFG++ Y + + + + + + APE L +Y
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM----KQIPVKWTAPE-ALNYGRY 173
Query: 338 GAAIDMWSAGCILAELFA 355
+ D+WS G +L E F+
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+ ++G G + V+ + K VA+K + M E F+ E ++ KL HP +++L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQL 64
Query: 223 EGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
G+ T + LY+V E+ME+ L L G K ++ + Q + G+E+ +
Sbjct: 65 YGVCTQQK-PLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
HRD+ N L+++ GV+K+ DFG+ + + + + PE+ +KY +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSK 181
Query: 341 IDMWSAGCILAELFA-GKPIMP 361
D+WS G ++ E+F GK MP
Sbjct: 182 SDVWSFGVLMWEVFTEGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL 214
FE + +G G Y V+ R + + GK+ A+K ++ A + ++ E +L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 215 DH-PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
P ++ L + + L+L+ +Y+ FTE +++ Y+ +++ L+H
Sbjct: 62 RRCPFLVTLHYAFQTDT-KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
H GI++RDIK N+L+++ G + + DFGL+ + + S T+ Y APE++ G
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 334 ATK-YGAAIDMWSAGCILAELFAG 356
+ + A+D WS G + EL G
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 17/247 (6%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ D FEKI ++G G V+K +G I+A K + + P + RE+ +L + +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECN 61
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ G S G + + E+M+ + E + +++GL +
Sbjct: 62 SPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 276 SR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
+ I+HRD+K SN+L+N+ G +K+ DFG++ S S V T Y +PE L G
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG- 176
Query: 335 TKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
T Y D+WS G L E+ G+ PI P + +++ +F G P E + T
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMF---GCPVE----GDPAESET 227
Query: 394 SFKPQQP 400
S +P+ P
Sbjct: 228 SPRPRPP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ PR + E K+GQG + V+ T + VA+K ++ M PE+ +E +
Sbjct: 1 WEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQV 54
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLL 268
++KL H +++L +V+ +Y+V EYM L L G PQ+ Q+
Sbjct: 55 MKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
G+ + +HRD++ +N+L+ V K+ DFGLA + ++ + + AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPG---RTEVEQMHKIFKLCGSPSE--- 381
E L ++ D+WS G +L EL G+ PG R ++Q+ + +++ P E
Sbjct: 173 EAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PCPPECPE 230
Query: 382 -------DYWRKSKSAHAT 393
WRK T
Sbjct: 231 SLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 7/230 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
F + +G+G + V + TGK+ A KK+ + MA E IL K++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHS 276
V+ L ++ +L LV M DL G F E + Y ++ GLE H
Sbjct: 62 VVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
I++RD+K N+L+++ G ++I D GLA Q + RV T+ Y APE++ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN-ER 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
Y + D W+ GC+L E+ AG+ R + + ++ +L E+Y K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 4/193 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRF-ANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+GT+ V R+ TG+ A+K +R + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 225 LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284
+ L V EY + FTE + + Y +++ LE+ HSR +++RDI
Sbjct: 63 AFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 285 KGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMW 344
K NL+++ G +KI DFGL S + + T Y APE +L YG A+D W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWW 179
Query: 345 SAGCILAELFAGK 357
G ++ E+ G+
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 43/235 (18%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREI 208
PR + E + IGQG + V++AR E +VA+K ++ F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------------AG 246
++ + DHPN++KL G V + + L+FEYM + DL A
Sbjct: 60 ALMAEFDHPNIVKLLG-VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 247 LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL-- 304
+ + + C +Q+ G+ + R +HRD+ N L+ V+KI DFGL
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 305 ----ATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
A Y S+N + R + PE + +Y D+W+ G +L E+F+
Sbjct: 179 NIYSADYYKASENDAIPIR-----WMPPESIFYN-RYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-15
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 181 ETGKIVALKKVRFANMDPESVRFMAR---EIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237
TG VA+K +R PE AR E + +L HPN++ L + G L+ VF
Sbjct: 1 MTGHEVAIKLLR--TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58
Query: 238 EYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296
EY+ L + G + M Q+L L H++GI+HRD+K N++++ GV
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 297 ---LKIGDFGLAT----TYDP-SQNLPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAG 347
K+ DFG+ T D L T+ V+ T Y APE L G + D+++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWG 176
Query: 348 CILAELFAGKPIMPGRTEVEQMHK 371
I E G+ ++ G + E +++
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 166 IGQGTYSSVYKARDLETGK---IVALKK-VRFANMDPESVRFMAREIHILRKLDHPNVMK 221
+G+G++ V A T + I ALKK V + D E + R + L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT-MVERRVLAL-AWEHPFLTH 60
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
L ++ L+ V EY+ DL + G +F E + + Y +++ GL+ H +GI+
Sbjct: 61 LFCTFQTKE-HLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGII 118
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YRAPELLLGATK 336
+RD+K N+L++ G +KI DFG+ +N+ + T Y APE+L G K
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMC-----KENMNGEGKASTFCGTPDYIAPEILKG-QK 172
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
Y ++D WS G +L E+ G+ G E E I
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 72/261 (27%), Positives = 108/261 (41%), Gaps = 51/261 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPN 218
F KI +G G + V A ++T + A+K +R + ++ V + E IL + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
V+KL + +LY V +Y+ D+ L + F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKM 120
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTY--------------------DPS------ 311
G +HRDIK N+LI+ G +K+ DFGL T + +PS
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 312 QNLPLTSRVVTLWYR--------------------APELLLGATKYGAAIDMWSAGCILA 351
N R+ TL R APE+LL Y D WS G IL
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239
Query: 352 ELFAGKPIMPGRTEVEQMHKI 372
E+ G+P T E K+
Sbjct: 240 EMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
+G+G + V+K L+ VA+K + ++F++ E IL++ DHPN++KL G+
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 226 VTSRSGSLYLVFEYMEHDLAGLATTPGIKF----TEPQIKCYMQQLLR-------GLEHC 274
T R +Y+V E + PG F + + + +QL++ G+ +
Sbjct: 61 CTQRQ-PIYIVMELV----------PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
S+ +HRD+ N L+ VLKI DFG++ D + + + + APE L
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNY 168
Query: 335 TKYGAAIDMWSAGCILAELFA----GKPIMPGRTEVEQMHKIFKL 375
+Y + D+WS G +L E F+ P M + EQ+ K +++
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 85/309 (27%), Positives = 137/309 (44%), Gaps = 47/309 (15%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAR-EIHILRKLDHPNVMKLEG 224
+G+G + V + TGK+ A KK+ + +S MA E IL K++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 225 LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTE-PQIKCYMQQLLRGLEHCHSRGILHR 282
S++ L LV M DL G + E ++ Y Q+ G+ H HS I++R
Sbjct: 61 AFESKT-HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 283 DIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAID 342
D+K N+L+++ G ++ D GLA + +T R T Y APE+L Y +D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEP-YSYPVD 176
Query: 343 MWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402
++ GC + E+ AG+ +P +D+ K K A ++ K
Sbjct: 177 WFAMGCSIYEMVAGR--------------------TPFKDH--KEKVA-------KEELK 207
Query: 403 RKVLE-----TFRNFPQSALALVDKLLTIEPENR-GSAASA---LRSEFFKTEPLPCDPS 453
R+ LE +NF + + + L +PE+R GS + EFFKT P +
Sbjct: 208 RRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267
Query: 454 NL--PKYPP 460
L P + P
Sbjct: 268 GLIPPPFVP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-15
Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 42/237 (17%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
R + +E I KIG G + V+ + T + K + + + + E++++R+L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 216 HPNVMK-LEGLVTSRSGSLYLVFEY-----MEHDLAGLATTPGIKFTEPQIKCYMQQLLR 269
H N+++ ++ + + LY++ E+ + ++ G K E I +QLL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLH 129
Query: 270 GLEHCHS-------RGILHRDIKGSNLL-----------------INNAGVLKIGDFGLA 305
L +CH+ +LHRD+K N+ +N + KIGDFGL
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL- 188
Query: 306 TTYDPSQNLPLTSR----VVTLWYRAPELLLGATK-YGAAIDMWSAGCILAELFAGK 357
S+N+ + S V T +Y +PELLL TK Y DMW+ GCI+ EL +GK
Sbjct: 189 -----SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-15
Identities = 77/271 (28%), Positives = 116/271 (42%), Gaps = 48/271 (17%)
Query: 184 KIVALKKVRFANMDPESVRFMAR-EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242
K+VA +F ++ E AR E+H L DH ++K S L L+ EY
Sbjct: 95 KVVA----KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-KLLLIMEYG-- 147
Query: 243 DLAGLATTPGIK--------FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294
+G IK F E ++ Q++ L+ HSR ++HRD+K +N+ +
Sbjct: 148 --SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 295 GVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAEL 353
G++K+GDFG + Y S +L + S T +Y APE L +Y DMWS G IL EL
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYEL 264
Query: 354 FAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFP 413
+H+ FK PS+ + + P+ V +
Sbjct: 265 LT-------------LHRPFK---GPSQ-----REIMQQVLYGKYDPFPCPVSSGMK--- 300
Query: 414 QSALALVDKLLTIEPENRGSAASALRSEFFK 444
AL+D LL+ P R + L +EF K
Sbjct: 301 ----ALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+ IG+G + V G+ VA+K ++ + ++ F+A E ++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIK-FTEPQIKCYMQQLLRGLEHCHSRG 278
+L G+V LY+V EYM L + G T Q + + G+E+ +
Sbjct: 64 QLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
+HRD+ N+L++ V K+ DFGLA + SQ + ++ W APE L K+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKW-TAPE-ALREKKFS 177
Query: 339 AAIDMWSAGCILAELFA 355
D+WS G +L E+++
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 4/193 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+GT+ V R+ TGK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 225 LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284
+ L V EY + F+E + + Y +++ L + HS +++RD+
Sbjct: 63 SFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 285 KGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMW 344
K NL+++ G +KI DFGL S + + T Y APE +L YG A+D W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWW 179
Query: 345 SAGCILAELFAGK 357
G ++ E+ G+
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 164 DKIGQGTYSSVYKAR-DLETGKI--VALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
K+G G++ V + GK+ VA+K ++ + F+ +E I+ LDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 221 KLEGLVTSRSGSLYLVFEYMEHDLAGLATT-----PGIKFTEPQIKCYMQQLLRGLEHCH 275
+L G+V + L +V E L L G F + Y Q+ G+ +
Sbjct: 60 RLYGVV--LTHPLMMVTELAP--LGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLE 114
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT--------SRVVTLWYRA 327
S+ +HRD+ N+L+ + +KIGDFGL + LP V + A
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGL------MRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
PE L + A D+W G L E+F G+ G + + + KI
Sbjct: 169 PE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 11/217 (5%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D FEK+ ++G G V K +G I+A K + + P + RE+ +L + + P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSP 59
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS- 276
++ G S G + + E+M+ + E + +LRGL +
Sbjct: 60 YIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
I+HRD+K SN+L+N+ G +K+ DFG++ D N S V T Y +PE L G T
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQG-T 173
Query: 336 KYGAAIDMWSAGCILAELFAGK-PI-MPGRTEVEQMH 370
Y D+WS G L E+ G+ PI P E+E M
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
K+GQG + V+ T K VA+K ++ M PE+ +E I++KL H ++ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 225 LVTSRSGSLYLVFEYMEHD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
+V+ +Y+V E+M L L G PQ+ Q+ G+ + +HR
Sbjct: 69 VVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 283 DIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAID 342
D++ +N+L+ + V KI DFGLA + ++ + + APE L ++ D
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSD 185
Query: 343 MWSAGCILAELFA-GKPIMPG---RTEVEQMHKIFKL 375
+WS G +L EL G+ PG R +EQ+ + +++
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 68/253 (26%), Positives = 108/253 (42%), Gaps = 16/253 (6%)
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
E +LR+L HP V+ L V G LV DL Q+ +Q
Sbjct: 210 EARLLRRLSHPAVLALLD-VRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ 268
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWY 325
LL +++ H GI+HRDIK N+L+N + +GDFG A S + P + T+
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 326 RAPELLLGATKYGAAIDMWSAGCIL-------AELFAGKPIMPGRTEVEQMHKIFKLCGS 378
APE+L G Y ++D+WSAG ++ A LF+ R Q+ +I +
Sbjct: 329 NAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV 387
Query: 379 PSEDYWRKSKSAHATSFKPQQ------PYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
+++ + + S + ++ + Y R + LV + LT + R
Sbjct: 388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP 447
Query: 433 SAASALRSEFFKT 445
SAA LR F++
Sbjct: 448 SAAELLRLPLFQS 460
|
Length = 461 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
R + E I +G G SV K + + TG ++A KKV + + RE+ I+ +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
P ++ G + ++ + E+M+ L + G + ++ GL +
Sbjct: 62 SPYIVSFYGAFLNE-NNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYL 119
Query: 275 HSR-GILHRDIKGSNLLINNAGVLKIGDFG--------LATTYDPSQNLPLTSRVVTLWY 325
++ I+HRDIK SN+L+N+ G +K+ DFG +A T+ V T Y
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF-----------VGTSTY 168
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGK 357
+PE + G KY D+WS G + EL GK
Sbjct: 169 MSPERIQGG-KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 49/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 166 IGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
IG G + V++ G+ VA+K ++ + + F++ E I+ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 223 EGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
EG+VT + ++ EYME+ L +F+ Q+ ++ + G+++ +H
Sbjct: 72 EGVVT-KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
RD+ N+L+N+ K+ DFGL+ DP + + + + APE + K+ +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFTS 189
Query: 340 AIDMWSAGCILAELFA 355
A D+WS G ++ E+ +
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLD-HPNVMKLE 223
IG+G+Y+ V R + +I A+K V+ + D E + ++ E H+ + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ S L+LV EY+ K E + Y ++ L H RGI++RD
Sbjct: 63 SCFQTTS-RLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATT-YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAID 342
+K N+L++ G +K+ D+G+ P ++ T Y APE+L G +YG ++D
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRG-EEYGFSVD 178
Query: 343 MWSAGCILAELFAGK 357
W+ G ++ E+ AG+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 43/121 (35%), Positives = 65/121 (53%), Gaps = 6/121 (4%)
Query: 251 PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310
PG F EP+ Y Q++ GLEH H R I++RD+K N+L++N G ++I D GLA
Sbjct: 92 PG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149
Query: 311 SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370
Q+ T + APELL G +Y ++D ++ G L E+ A + P R E++
Sbjct: 150 GQS-KTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARG--PFRARGEKVE 205
Query: 371 K 371
Sbjct: 206 N 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 22/256 (8%)
Query: 206 REIHILRKLDHPNVMKLEGLVTSRSGSLY-LVFEYMEHDLAGLATTPGIKFTEP----QI 260
REI IL+ + H ++ L + R S +V + DL + + P Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTY-----VDRSGPLPLEQA 187
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT-SR 319
++LL L + H RGI+HRD+K N+ ++ +GDFG A D + P
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR---TEVEQMHKIFKLC 376
TL +PE LL Y A D+WSAG +L E+ + G+ + Q+ I +
Sbjct: 248 SGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306
Query: 377 GSPSEDYWRKSKSAHATSFKPQQPYKRK---VLETFRNF--PQSALALVDKLLTIEPENR 431
++ + + FK R + R + L+ K+LT + E R
Sbjct: 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366
Query: 432 GSAASALRSEFFKTEP 447
SA L F EP
Sbjct: 367 PSAQDILSLPLFTKEP 382
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 203 FMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEP---- 258
+ EI L +L+H N++K+E ++ S + + Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
Q + M+QLL +E+ H + ++HRDIK N+ +N G + +GDFG A ++ +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327
Query: 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
V T+ +PE+L G Y D+WS G IL ++ +
Sbjct: 328 WVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLE 223
IG+G+Y+ V +T +I A+K ++ + D E + ++ E H+ +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ S L+ V E++ K E + Y ++ L H RGI++RD
Sbjct: 63 SCFQTES-RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNL---PLTSRVV-TLWYRAPELLLGATKYGA 339
+K N+L++ G +K+ D+G+ + + TS T Y APE+L G YG
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMC-----KEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGF 175
Query: 340 AIDMWSAGCILAELFAGK 357
++D W+ G ++ E+ AG+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 49/179 (27%), Positives = 92/179 (51%), Gaps = 11/179 (6%)
Query: 186 VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD-L 244
VA+K ++ +M + E ++ KL H +++L G V ++ +Y+V EYM + L
Sbjct: 31 VAIKMIKEGSMSEDE---FIEEAKVMMKLSHEKLVQLYG-VCTKQRPIYIVTEYMSNGCL 86
Query: 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304
G +F Q+ + + G+ + S+ +HRD+ N L+++ G +K+ DFGL
Sbjct: 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL 146
Query: 305 AT-TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMP 361
+ D + S+ W PE+LL +K+ + D+W+ G ++ E+++ GK MP
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRW-SPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 44/241 (18%)
Query: 166 IGQGTYSSVYKARDLETGK-----IVALKKVRFANMDPESVRFMAREIHILRKL-DHPNV 219
+G+G + V KA + VA+K ++ + + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH---------------DLAGLAT-TPGIKFTEPQIKCY 263
+ L G V ++ G LY+V EY H + P T+ + +
Sbjct: 79 INLLG-VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT------YDPSQN--LP 315
Q+ RG+E S+ +HRD+ N+L+ V+KI DFGLA Y + N LP
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKIF 373
+ W APE L Y D+WS G +L E+F G P PG VE++ K+
Sbjct: 198 VK------WM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLL 247
Query: 374 K 374
K
Sbjct: 248 K 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 4/193 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRF-ANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+GT+ V R+ +GK A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 225 LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284
++ L V EY+ + F+E + + Y +++ L++ HS I++RD+
Sbjct: 63 SFQTKD-RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 285 KGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMW 344
K NL+++ G +KI DFGL + + + T Y APE +L YG A+D W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDWW 179
Query: 345 SAGCILAELFAGK 357
G ++ E+ G+
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 67/254 (26%), Positives = 114/254 (44%), Gaps = 25/254 (9%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKI-----VALKKVRFANMDPESVRFMA 205
W+ PR +F K +G G + V +A K VA+K ++ E M+
Sbjct: 30 WEFPRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS 87
Query: 206 REIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKF-TEPQIKC 262
E+ I+ L +H N++ L G T G + ++ EY + DL F T +
Sbjct: 88 -ELKIMSHLGNHENIVNLLGACT-IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA--TTYDPSQNLPLTSRV 320
+ Q+ +G+ S+ +HRD+ N+L+ + ++KI DFGLA D + + +R+
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379
W APE + Y D+WS G +L E+F+ G PG + +K+ K
Sbjct: 206 PVKWM-APESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----- 258
Query: 380 SEDYWRKSKSAHAT 393
+ +R ++ HA
Sbjct: 259 --EGYRMAQPEHAP 270
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 159 AFEKIDKIGQGTYSSVYKAR---DLETGKI-VALKKVRFANMDPESVRFMAREIHILRKL 214
EKI +G G + +VYK + E KI VA+K +R P++ + + E +++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASV 66
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
DHP+V++L G+ S + L+ + M L + + Q+ +G+ +
Sbjct: 67 DHPHVVRLLGI--CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS--RVVTLWYRAPELL 331
+ ++HRD+ N+L+ +KI DFGLA D + +V W A E +
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESI 183
Query: 332 LGATKYGAAIDMWSAGCILAEL--FAGKP 358
L Y D+WS G + EL F KP
Sbjct: 184 L-HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 166 IGQGTYSSVYKARDLETGKI---VALKKV-RFANMDPESVRFMAREIHILRKLDHPNVMK 221
IG+G + VY +++ A+K + R ++ E V +E I++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLS 60
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
L G+ GS +V YM+H DL + T + + Q+ +G+E+ S+ +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTL---WYRAPELLLGATK 336
HRD+ N +++ + +K+ DFGLA YD L W A E L K
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM-ALE-SLQTQK 178
Query: 337 YGAAIDMWSAGCILAELFA-GKPIMP 361
+ D+WS G +L EL G P P
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291
LY V EY+ DL G +F EP Y ++ GL HS+GI++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 292 NNAGVLKIGDFGLATTYDPSQNL--PLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAG 347
++ G +KI DFG+ +N+ +T++ T Y APE ++ YG ++D W+ G
Sbjct: 135 DSEGHIKIADFGMC-----KENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFG 188
Query: 348 CILAELFAGKPIMPGRTEVEQMHKIFK 374
+L E+ AG+ G E E I +
Sbjct: 189 VLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 166 IGQGTYSSVYKARDLE-----TGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+G G + VY+ + +G I VA+K +R D E F+ E H++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLRGLE 272
+KL G V + Y++ E ME DL A + T ++ + +G
Sbjct: 62 VKLLG-VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 273 HCHSRGILHRDIKGSNLLINNAG-----VLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYR 326
+ +HRD+ N L++ G V+KIGDFGLA Y ++ + +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
APE LL K+ D+WS G ++ E+ G+ P E + +
Sbjct: 181 APESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 85/319 (26%), Positives = 130/319 (40%), Gaps = 50/319 (15%)
Query: 165 KIGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+IG+G +SVY AR TG +V ++ N E ++ + E+ + HPN+M
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAG--LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
+ T+ S L+++ +M + A L T +E I + LRGL + H G +
Sbjct: 65 WTVFTTGS-WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---------LPLTSRVVTLWYRAPELL 331
HR+IK S++LI+ G++ + GL+ Y +N P S V W +PELL
Sbjct: 124 HRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELL 180
Query: 332 -LGATKYGAAIDMWSAGCILAELFAGK-PI--MPGRTEVEQMHK----------IFKLCG 377
Y D++S G EL G+ P M + Q K F
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240
Query: 378 SP------------SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLT 425
S E + TS + + P + F+N LV+ L
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN-------LVELCLQ 293
Query: 426 IEPENRGSAASALRSEFFK 444
+PE R SA+S L FFK
Sbjct: 294 QDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 13/227 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPNVMKLEG 224
+G+G + V + TGK+ A KK+ + MA E IL K++ V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 225 LVTSRSGSLYLVFEYM-----EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+L LV M + + + PG F E + Y +L GLE I
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGN-PG--FDEQRAIFYAAELCCGLEDLQRERI 123
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
++RD+K N+L+++ G ++I D GLA + + RV T+ Y APE ++ KY
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPE-VINNEKYTF 180
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
+ D W GC++ E+ G+ R E + ++ + E+Y K
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 15/261 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL-EG 224
+G G +V A+ + G+ A+K V M E+ L D +++K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 225 LVTSRSGS------LYLVFEY-----MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ + LV +Y + ++ A T F E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHH 158
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLL 332
HS+ ++HRDIK +N+L+ + G++K+GDFG + Y + + + T +Y APE+
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
Y DM+S G +L EL K G E MHK P
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIV 277
Query: 393 TSFKPQQPYKRKVLETFRNFP 413
T+ P +R N P
Sbjct: 278 TALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
IG+G + V G VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIK---NDATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 226 VTSRSGSLYLVFEYM-EHDLAGLATTPG---------IKFTEPQIKCYMQQLLRGLEHCH 275
+ G LY+V EYM + L + G +KF+ + +E+
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--------LDVCEAMEYLE 119
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+ +HRD+ N+L++ V K+ DFGL +Q+ T ++ W APE L
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKW-TAPEALR-EK 174
Query: 336 KYGAAIDMWSAGCILAELFA-GK---PIMPGRTEVEQMHKIFKL 375
K+ D+WS G +L E+++ G+ P +P + V ++ K +K+
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 185 IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-D 243
+VA+K +R A++ + +EI I+ +L +PN+++L G V L ++ EYME+ D
Sbjct: 46 LVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLG-VCVSDDPLCMITEYMENGD 103
Query: 244 LAGLATTPGI--KFTEPQ-IKC-------YMQ-QLLRGLEHCHSRGILHRDIKGSNLLIN 292
L + I FT I YM Q+ G+++ S +HRD+ N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 293 NAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAGCIL 350
N +KI DFG++ + R V W +LLG K+ A D+W+ G L
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTL 221
Query: 351 AELF 354
E+F
Sbjct: 222 WEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 11/214 (5%)
Query: 166 IGQGTYSSVYKARDLETGKIVA---LKK-VRFANMDPESVRFMAREIHILRKLDHPNVMK 221
+G+G++ V AR E+G++ A LKK V + D E R + + R +HP + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFLTQ 60
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
L + L+ V E++ +F E + + Y ++ L H +GI++
Sbjct: 61 LYCCFQT-PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAA 340
RD+K N+L+++ G K+ DFG+ + N TS T Y APE +L YG +
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 341 IDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
+D W+ G +L E+ G E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 5/209 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G++ V A+ GK A+K ++ + E MA +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ LY V +Y+ F EP+ + Y ++ L + HS I++RD
Sbjct: 63 YSFQTAD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K N+L+++ G + + DFGL + ++ T Y APE+L Y +D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTVDW 179
Query: 344 WSAGCILAELFAGKPIMPGRTEVEQMHKI 372
W G +L E+ G P R E I
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 44/216 (20%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
IG+G + +V K +G I+A+K++R + E R + ++R D P ++K G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 226 VTSRSGSLYLVFEYMEHDLAGLATTPGIKFT-EPQIKCYMQQLL--------RGLEHCHS 276
R G ++ E M+ L K+ E +++L + L +
Sbjct: 72 -LFREGDCWICMELMDISLDKFY-----KYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 277 R-GILHRDIKGSNLLINNAGVLKIGDFGL--------ATTYD----PSQNLPLTSRVVTL 323
I+HRD+K SN+L++ G +K+ DFG+ A T D P
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP------------- 172
Query: 324 WYRAPELLL--GATKYGAAIDMWSAGCILAELFAGK 357
Y APE + Y D+WS G L E+ GK
Sbjct: 173 -YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 10/114 (8%)
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322
Y +++ GL+ HS+GI++RD+K N++++ G +KI DFG+ +N+ +R T
Sbjct: 101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMC-----KENVFGDNRAST 155
Query: 323 LW----YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
Y APE+L G KY ++D WS G +L E+ G+ G E E I
Sbjct: 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 15/224 (6%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G++ V A+ G A+K ++ + E MA +L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ + LY V +Y+ F EP+ + Y ++ + + HS I++RD
Sbjct: 63 YSFQT-AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATT-YDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAAI 341
+K N+L+++ G + + DFGL +P + TS T Y APE +L Y +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPE-VLRKEPYDRTV 177
Query: 342 DMWSAGCILAELFAGKPIMPGRTEVEQM-----HKIFKLCGSPS 380
D W G +L E+ G P R +V QM HK +L G +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 5/210 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK--KVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G++ V A+ GK A+K + + E MA +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ + LY V +++ F EP+ + Y ++ L + HS I++RD
Sbjct: 63 YSFQT-TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K N+L+++ G + + DFGL +Q+ T+ T Y APE++ Y +D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIR-KQPYDNTVDW 179
Query: 344 WSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
W G +L E+ G P R E I
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 16/224 (7%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR-FMAREIHILRKLDH 216
+ E + +IG GT VYK R +TG ++A+K++R E+ R M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQ----QLLRGLE 272
P ++K G + S +++ E M L L E I M + L L+
Sbjct: 74 PYIVKCYGYFITDS-DVFICMELMSTCLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLK 131
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
H G++HRD+K SN+L++ +G +K+ DFG++ S+ T Y APE +
Sbjct: 132 EKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPERID 187
Query: 333 GAT---KYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKI 372
KY D+WS G L EL G+ P +TE E + KI
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 28/231 (12%)
Query: 165 KIGQGTYSSVYKA--RDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
++G G + +V K + ++ K VA+K ++ N DP + RE +++++LD+P ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKF-------TEPQIKCYMQQLLRGLEHCH 275
G+ + S LV E LA L P KF TE I + Q+ G+++
Sbjct: 62 IGICEAES--WMLVME-----LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL---PLTSRVVTLWYRAPELLL 332
+HRD+ N+L+ KI DFGL+ +N + WY APE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CM 170
Query: 333 GATKYGAAIDMWSAGCILAELFA--GKPI--MPGRTEVEQMHKIFKLCGSP 379
K+ + D+WS G ++ E F+ KP M G EV QM + + P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 36/238 (15%)
Query: 166 IGQGTYSSVYKARDLETGK-------IVALKKVRFANMDPESVRFMAREIHILRKL-DHP 217
+G+G + V A L K VA+K ++ + + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 218 NVMKLEGLVTSRSGSLYLVFEY-----------------MEHDLAGLATTPGIKFTEPQI 260
N++ L G T + G LY++ EY ME+ +A P + T +
Sbjct: 82 NIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY-DIARVPDEQMTFKDL 139
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS-- 318
Q+ RG+E+ S+ +HRD+ N+L+ V+KI DFGLA + T+
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKIFK 374
R+ W APE L Y D+WS G ++ E+F G P PG VE++ K+ K
Sbjct: 200 RLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVR----FANMDPESVRFMAREIHILRKLDHPNVMK 221
+G+G++ V A T ++ A+K ++ + D + R + + K HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
L ++ L+ V EY+ KF EP+ + Y ++ L H G+++
Sbjct: 61 LHCCFQTKD-RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAI 341
RD+K N+L++ G K+ DFG+ + T+ T Y APE +L +YG ++
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPE-ILQELEYGPSV 177
Query: 342 DMWSAGCILAELFAGKP 358
D W+ G ++ E+ AG+P
Sbjct: 178 DWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 166 IGQGTYSSVYKARDLETG-----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+G+G + V KA VA+K ++ N +R + E ++L++++HP+V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-------------DLAGLAT----------TPGIK-FT 256
KL G + G L L+ EY ++ + L + P + T
Sbjct: 67 KLYGACSQ-DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLP 315
+ + Q+ RG+++ ++HRD+ N+L+ +KI DFGL+ Y+ +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL--FAGKPIMPG 362
+ + + + A E L Y D+WS G +L E+ G P PG
Sbjct: 186 RSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++++G+G + VYK + + VA+K ++ F +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR-QEAELMSDLQHP 68
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL----------AGLATTPGIKFTEPQIKC--YM 264
N++ L G+ T + ++FEY+ H DL + + G + + + C ++
Sbjct: 69 NIVCLLGVCT-KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 265 Q---QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRV 320
Q+ G+E+ S +HRD+ N L+ +KI DFGL+ Y + +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
+ + + PE +L K+ D+WS G +L E+F+
Sbjct: 188 LPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 153 QPRRADA-----FEKIDKIGQGTYSSV----YKARDLETGKIVALKKVRFANMDPESVRF 203
+P+R + F I +G G++ V YK D I +K + + + V
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDH 77
Query: 204 MAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATT---PGIKFTEPQI 260
+ E IL ++HP + L G S LYLV E++ + G T +F +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDES-YLYLVLEFV---IGGEFFTFLRRNKRFPN-DV 132
Query: 261 KC-YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319
C Y Q++ E+ S I++RD+K NLL++ G +K+ DFG A D +R
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TR 184
Query: 320 VVTLW----YRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358
TL Y APE+LL +G A D W+ G + E+ G P
Sbjct: 185 TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESV--RFMAREIHILRKLDHP 217
++ I IG+G VY A D + VALKK+R + + RF+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME-----HDLAGLATTPGIKFTEPQIKCYMQQLLR--- 269
++ + + S +Y Y+E L + + E K + L
Sbjct: 63 GIVPVYS-ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIFH 120
Query: 270 ----GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA----------------TTYD 309
+E+ HS+G+LHRD+K N+L+ G + I D+G A
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 310 PSQNLPLTSRVV-TLWYRAPELLLG--ATKYGAAIDMWSAGCIL 350
++ + ++V T Y APE LLG A++ + D+++ G IL
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASE---STDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 5/210 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G++ V AR K A+K ++ + E M+ +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ LY V +Y+ F EP+ + Y ++ L + HS I++RD
Sbjct: 63 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K N+L+++ G + + DFGL + N ++ T Y APE +L Y +D
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVDW 179
Query: 344 WSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
W G +L E+ G P R E I
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 9/222 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLD 215
D FE I IG+G + V + T +I A+K + M E+ F E ++L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR-EERNVLVNGD 59
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L LYLV +Y + DL L + + E + Y+ +++ +
Sbjct: 60 CQWITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL-- 332
H +HRDIK N+L++ G +++ DFG + + + V T Y +PE+L
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 333 --GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
G KYG D WS G + E+ G+ + VE KI
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 23/153 (15%)
Query: 165 KIGQGTYSSVYKA--RDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
IG+G + VY+ E KI VA+K + +F+ E +I+R+ DHP+++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 222 LEGLVTSRSGSLYLVFE---------YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
L G++T +++V E Y++ + L I + Y QL L
Sbjct: 72 LIGVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTALA 121
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
+ S+ +HRDI N+L+++ +K+GDFGL+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 164 DKIGQGTYSSVYKARDLETG--KIVALKKVR-FANMDPESVRFMAREIHILRKL-DHPNV 219
D IG+G + V KAR + G A+K+++ +A+ D R A E+ +L KL HPN+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 70
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH---------------DLA-GLATTPGIKFTEPQIKCY 263
+ L G R G LYL EY H D A +A + + Q+ +
Sbjct: 71 INLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
+ RG+++ + +HRD+ N+L+ V KI DFGL+ + + R+
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 188
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
W L + Y D+WS G +L E+ G P
Sbjct: 189 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 165 KIGQGTYSSVYKARDL----ETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++G+G + V+ A E KI VA+K ++ A+ + + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHI 69
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH------------DLAGLAT-TPGIKFTEPQIKCYMQQ 266
+K G V L +VFEYM+H D +A + T+ Q+ QQ
Sbjct: 70 VKFYG-VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTLWY 325
+ G+ + S+ +HRD+ N L+ ++KIGDFG++ Y ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELF 354
PE ++ K+ D+WS G +L E+F
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 9/222 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLD 215
D FE + IG+G + V + TG++ A+K + M E+ F E +L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR-EERDVLVNGD 59
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L +LYLV +Y + DL L + + E + Y+ +++ ++
Sbjct: 60 RRWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL-- 332
H G +HRDIK N+L++ G +++ DFG + V T Y +PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 333 --GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
G +YG D WS G + E+ G+ + VE KI
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 4/148 (2%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPN 218
F + I +G + VY R K+ A+K V+ A+M + V + E L P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 219 VMKLEGLVTSRSGSLYLVFEYM-EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++ L + S + ++YLV EY+ D+ L G F E Y+ ++ L++ H
Sbjct: 66 IVHLYYSLQSAN-NVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRH 123
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLA 305
GI+HRD+K N+LI+N G +K+ DFGL+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 165 KIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRF-MAREIHILRKLDHPN 218
++G+G + V+ A + +VA+K ++ A+ ES R RE +L L H +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQH 68
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHD---------------LAGLATTPGIKFTEPQIKCY 263
+++ G+ T L +VFEYM H LAG + T Q+
Sbjct: 69 IVRFYGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR-VVT 322
Q+ G+ + S +HRD+ N L+ V+KIGDFG++ + + R ++
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
+ + PE +L K+ D+WS G +L E+F
Sbjct: 188 IRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 163 IDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN 218
I +G+G + V+ A+ + E G+ + L K D RE+ + RKL H N
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 219 VMKLEGLVTSRSGSLYLVFEYME-HDLAG--LATTPGIKFTEP------QIKCYMQQLLR 269
V++L GL Y++ EY + DL AT + +P Q Q+
Sbjct: 70 VVRLLGLCREAE-PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
G++H + +HRD+ N L+++ +K+ L+ S+ L + ++ L + APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 330 LLLGATKYGAAIDMWSAGCILAELF 354
+ + D+WS G ++ E+F
Sbjct: 189 AVQ-EDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 166 IGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+G G + SV K L VA+K ++ ++ F+ RE ++ +LDHP +++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKF-------TEPQIKCYMQQLLRGLEHCH 275
G+ + L LV E LA L P +K+ +K Q+ G+ +
Sbjct: 62 IGV--CKGEPLMLVME-----LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE 112
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL---------PLTSRVVTLWYR 326
S+ +HRD+ N+L+ N KI DFG++ + PL WY
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------WY- 165
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFA--GKP 358
APE + K+ + D+WS G L E F+ KP
Sbjct: 166 APECINYG-KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 186 VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD-L 244
VA+ +R D + F+A E L + DH N+++LEG++T R ++ +V EYM + L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVIT-RGNTMMIVTEYMSNGAL 93
Query: 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304
+ Q+ + L G+++ G +H+ + +L+N+ V KI F
Sbjct: 94 DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153
Query: 305 ATTYDPSQNL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
D S+ + ++ + LW APE + + +A D+WS G ++ E+ +
Sbjct: 154 LQE-DKSEAIYTTMSGKSPVLW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 166 IGQGTYSSVYKARDLETGK-------IVALKKVRFANMDPESVRFMAREIHILRKLD-HP 217
+G+G + V +A K VA+K ++ D + ++ E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS-EMELMKLIGKHK 78
Query: 218 NVMKLEGLVTSRSGSLYLVFEYM------EHDLAGLATTPGIKFTEPQ-----------I 260
N++ L G+ T + G LY++ EY E A P F + +
Sbjct: 79 NIINLLGVCT-QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS-- 318
C Q+ RG+E+ SR +HRD+ N+L+ V+KI DFGLA TS
Sbjct: 138 SC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQM------- 369
R+ W APE L Y D+WS G ++ E+F G P PG VE++
Sbjct: 197 RLPVKWM-APEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP-YPG-IPVEELFKLLREG 252
Query: 370 HKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR 410
H++ K E Y + HA Q+P ++++E
Sbjct: 253 HRMDKPSNCTHELYMLMRECWHAVP--TQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 6/141 (4%)
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
PN++ L + S S++LV ++ E + + E +K + +++ L+ H
Sbjct: 45 PNMVCLHKYIVSED-SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR 103
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
GI+ RD+ +N+L+++ G +++ F + + S + + Y APE + G ++
Sbjct: 104 EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VGGISE 158
Query: 337 YGAAIDMWSAGCILAELFAGK 357
A D WS G IL EL GK
Sbjct: 159 ETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 40/240 (16%)
Query: 166 IGQGTYSSVYKARDLETGK-------IVALKKVRFANMDPESVRFMAREIHILRKL-DHP 217
+G+G + V A + K VA+K ++ D + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHK 78
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFT-------EPQIKCY--- 263
N++ L G T + G LY++ EY + PG+ ++ E Q+
Sbjct: 79 NIINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 264 --MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT------YDPSQNLP 315
Q+ RG+E+ S+ +HRD+ N+L+ V+KI DFGLA Y + N
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN-- 195
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374
R+ W APE L Y D+WS G +L E+F G PG VE++ K+ K
Sbjct: 196 --GRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 7/220 (3%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKV-RFANMDPESVRFMAREIHILRKLDHPN 218
FE + IG+G + V + K+ A+K + ++ + E +L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 219 VMKLEGLVTSRSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+ L +LYLV +Y + DL L + + E + Y+ +++ ++ H
Sbjct: 63 ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL----G 333
+HRDIK N+L++ G +++ DFG + + V T Y +PE+L G
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
KYG D WS G + E+ G+ + VE KI
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 5/194 (2%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+GT+ V ++ TG+ A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 225 LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRD 283
+ L V EY + F+E + + Y +++ L++ HS + +++RD
Sbjct: 63 SFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K NL+++ G +KI DFGL + + T Y APE +L YG A+D
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 179
Query: 344 WSAGCILAELFAGK 357
W G ++ E+ G+
Sbjct: 180 WGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 166 IGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
+G+G + SV + + D K VA+K ++ + E ++ DHPNVMK
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 222 LEGL-VTSRSG----SLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLR 269
L G+ + S ++ +M+H DL + L P K + +M +
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP-EKLPLQTLLKFMVDIAL 124
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307
G+E+ +R +HRD+ N ++ + + DFGL+
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 165 KIGQGTYSSVYKA-RDLETGKI-VALKKVRFANMDPESVR-FMAREIHILRKLDHPNVMK 221
++G G + V K + +I VA+K ++ N + +SVR M RE I+ +LD+P +++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--NENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKF--------TEPQIKCYMQQLLRGLEH 273
+ G+ + + L LV ME G P KF T + M Q+ G+++
Sbjct: 60 MIGVCEAEA--LMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW---YRAPEL 330
+ +HRD+ N+L+ N KI DFGL+ + +R W + APE
Sbjct: 111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPEC 169
Query: 331 LLGATKYGAAIDMWSAGCILAELFA--GKP 358
+ K+ + D+WS G + E F+ KP
Sbjct: 170 IN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 41/116 (35%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSR 319
CY Q+ RG+E SR +HRD+ N+L++ V+KI DFGLA DP ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374
+ W APE + Y D+WS G +L E+F+ G PG E+ + K
Sbjct: 238 LPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 154 PRRADAFEKIDKIGQGTYSSVY--KARDLETGK--------------IVALKKVRFANMD 197
PR+ F+ +K+G+G + V+ +A +E +VA+K +R + +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 198 PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME----------HDLAGL 247
+ +EI I+ +L PN+++L V S L ++ EYME H+
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLA-VCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 248 ATTPGIKFTEPQIKCYMQ-QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306
A + +M Q+ G+++ S +HRD+ N L+ +KI DFG++
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 307 TYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
+ R V W +LLG K+ A D+W+ G L E+
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 160 FEKIDKIGQGTYSSVYKA---RDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLD 215
F+KI +G G + +VYK + E KI VA+K++R A P++ + + E +++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+P+V +L G+ + ++ L+ + M L + + Q+ +G+ +
Sbjct: 68 NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLAT--TYDPSQNLPLTSRVVTLWYRAPELLL 332
R ++HRD+ N+L+ +KI DFGLA D + +V W A E +L
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESIL 184
Query: 333 GATKYGAAIDMWSAGCILAEL--FAGKP 358
Y D+WS G + EL F KP
Sbjct: 185 HRI-YTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 25/186 (13%)
Query: 186 VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL 244
VA+K +R D F+ +E+ IL +L PN+ +L G V + L ++ EYME+ DL
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLG-VCTVDPPLCMIMEYMENGDL 106
Query: 245 -----AGLATTPGIKFTEPQIK----CYM-QQLLRGLEHCHSRGILHRDIKGSNLLINNA 294
+A T G+ + YM Q+ G+ + S +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166
Query: 295 GVLKIGDFGLATT------YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGC 348
+KI DFG++ Y PL R W +LLG K+ D+W+ G
Sbjct: 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLG--KFTTKSDVWAFGV 220
Query: 349 ILAELF 354
L E+
Sbjct: 221 TLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 80/332 (24%), Positives = 134/332 (40%), Gaps = 63/332 (18%)
Query: 166 IGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
IG+G +V AR TG+ V ++++ E V F+ E+H+ + +HPN++
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 224 GLVTSRSGSLYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ + L++V +M + DL G+ +E I +Q +L+ L++ H G
Sbjct: 66 ATFIADN-ELWVVTSFMAYGSAKDLICTHFMDGM--SELAIAYILQGVLKALDYIHHMGY 122
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYD---------PSQNLPLTSRVVTLWYRAPEL 330
+HR +K S++LI+ G K+ GL + + P S V W +PE+
Sbjct: 123 VHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL-SPEV 179
Query: 331 LLGATK-YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS----------- 378
L + Y A D++S G EL G +P + + KL G+
Sbjct: 180 LQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237
Query: 379 PSEDYWRKSKSA---------------HATSFKPQQPYKRKVLETFRNFPQSALALVDKL 423
E + S+S + PY R F +F V++
Sbjct: 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF-------VEQC 290
Query: 424 LTIEPENRGSAASALRSEFFK------TEPLP 449
L P+ R SA++ L FFK +E LP
Sbjct: 291 LQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 35/184 (19%)
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFT-------------EP 258
H N++ L G T + G LY++ EY + PG+++ +
Sbjct: 83 HKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT------YDPSQ 312
+ C Q+ RG+E+ S+ +HRD+ N+L+ V+KI DFGLA Y +
Sbjct: 142 LVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMH 370
N R+ W APE L Y D+WS G +L E+F G P PG VE++
Sbjct: 201 N----GRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELF 252
Query: 371 KIFK 374
K+ K
Sbjct: 253 KLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSR 319
CY Q+ +G+E SR +HRD+ N+L++ V+KI DFGLA DP +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPG 362
+ W APE + Y D+WS G +L E+F+ G PG
Sbjct: 243 LPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 165 KIGQGTYSSVYKAR--DLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++G+G + V+ A +L K +VA+K ++ + + RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPG-----IKFTEP----------QIKCY 263
+K G V L +VFEYM+H DL G + +P Q+
Sbjct: 70 VKFYG-VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR-VVT 322
Q+ G+ + S+ +HRD+ N L+ ++KIGDFG++ + + ++
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
+ + PE ++ K+ D+WS G IL E+F
Sbjct: 189 IRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 166 IGQGTYSSVYKARDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+G+G + SV + + + I VA+K ++ A + E +++ DHPNVM+L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 224 GLV---TSRSG--SLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLRGL 271
G+ G S ++ +M+H DL + L P T+ +K +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
E+ S+ +HRD+ N ++N + + DFGL+
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSR 319
Y Q+ RG+E SR +HRD+ N+L++ V+KI DFGLA DP +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPG 362
+ W APE + Y D+WS G +L E+F+ G PG
Sbjct: 237 LPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 160 FEKIDKIGQGTYSSVYKA---RDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLD 215
+++ +G G + +VYK + ET KI VA+K + +V FM E I+ +D
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMD 67
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
HP++++L G+ S + + LV + M H L + + Q+ +G+ +
Sbjct: 68 HPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ--------NLPLTSRVVT-LWY 325
R ++HRD+ N+L+ + +KI DFGLA + + +P+ + + Y
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
R K+ D+WS G + EL F GKP
Sbjct: 186 R---------KFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 164 DKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMK 221
D IG+G + V +A + G K+ A K+ R A E+ +L KL HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQI--------KCYMQQLLR--- 269
L G +R G LY+ EY + +L + T+P QQLL+
Sbjct: 68 LLGACENR-GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 270 ----GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
G+++ + +HRD+ N+L+ KI DFGL+ + + R+ W
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRLPVRWM 185
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
L + Y D+WS G +L E+ G P
Sbjct: 186 AIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 22/158 (13%)
Query: 166 IGQGTYSSVYKAR---DLETGKIVALKKVR---FANMDPESVRFMAREIHILRKLDHPNV 219
+G+G + SV +A+ + + + VA+K ++ F++ D E F+ RE +++ DHPNV
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE--EFL-REAACMKEFDHPNV 63
Query: 220 MKLEGLVTSRS---GSL---YLVFEYMEH-DLAGLATTPGI---KFTEPQ--IKCYMQQL 267
+KL G V+ RS G L ++ +M+H DL I FT P + +M +
Sbjct: 64 IKLIG-VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
G+E+ S+ +HRD+ N ++N + + DFGL+
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 164 DKIGQGTYSSVY--KARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
D+IG G + V +A + V +K++R + E + F+ +E+ R+L+HPNV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQ---QLLRGLEHCHS 276
G S LV E+ DL L + G+ Q + ++ GL H
Sbjct: 60 CLGQCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTLWYRAPEL----- 330
+H D+ N + +KIGD+GLA Y + V L + APEL
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 331 --LLGA--TKYGAAIDMWSAGCILAELF 354
LL TK ++WS G + ELF
Sbjct: 179 QDLLPKDQTKKS---NIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 47/215 (21%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 163 IDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN 218
++++G+ + +YK ++ ++VA+K ++ N +P+ +E ++ +L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPN 68
Query: 219 VMKLEGLVTSRSGSLYLVFEYME-------------HDLAGLAT----TPGIKFTEPQIK 261
++ L G+VT + ++FEY+ H G ++ T
Sbjct: 69 IVCLLGVVTQEQ-PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR-V 320
Q+ G+E+ S +H+D+ N+LI +KI D GL+ + + + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
+ + + PE ++ K+ + D+WS G +L E+F+
Sbjct: 188 LPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 22/230 (9%)
Query: 158 DAFEKIDKIGQGTYSSVYKA----RDLETGKI-VALKKVRFANMDPESVRFMAREIHILR 212
D+ + +G G + VY+ RD + ++ VA+K + + + + F+ E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMS 64
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLR-- 269
K +H N+++L G V+ +++ E M DL + P M+ LL
Sbjct: 65 KFNHQNIVRLIG-VSFERLPRFILLELMAGGDLKSFLRENRPRPERPS-SLTMKDLLFCA 122
Query: 270 -----GLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLAT-TYDPSQNLPLTSRV 320
G ++ +HRDI N L+ G V KI DFG+A Y S +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQM 369
+ + + PE L + + D+WS G +L E+F+ G PGRT E M
Sbjct: 183 LPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 164 DKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMK 221
D IG+G + V KAR + G ++ A K + R A E+ +L KL HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQI--------KCYMQQLLR--- 269
L G R G LYL EY H +L + T+P QQLL
Sbjct: 61 LLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 270 ----GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
G+++ + +HRD+ N+L+ V KI DFGL+ + + R+ W
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWM 178
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
L + Y D+WS G +L E+ G P
Sbjct: 179 AIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 45/252 (17%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL----- 214
F+ + +G+GT+ V +A D + + A+K VR N+ P+ R EI + K+
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR--NV-PKYTRDAKIEIQFMEKVRQADP 187
Query: 215 -DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
D +MK++ + +G + +V L G F+ + + Q L++
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDY 246
Query: 274 CHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL---------------- 316
H+ ++H D+K N+L ++ D T DP N L
Sbjct: 247 FHTELHLMHTDLKPENIL------METSD----TVVDPVTNRALPPDPCRVRICDLGGCC 296
Query: 317 ------TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370
T+ V T YR+PE++LG + + DMWS GCI+ EL+ GK + +E +H
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355
Query: 371 KIFK-LCGSPSE 381
+ K L PSE
Sbjct: 356 LMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL--TSRVVTL 323
Q+ +G++ S+ +HRD+ N+L+ + V KI DFGLA N + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPG 362
W APE + Y D+WS G +L E+F+ GK PG
Sbjct: 280 WM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 160 FEKIDKIGQGTYSSVYK---ARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
+K+ +G G + +VYK D E KI KV N P++ + + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P V +L G+ + ++ LV + M + L + + + Q+ +G+ +
Sbjct: 69 PYVCRLLGICLT--STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSRVVTLWYRAPELLLG 333
++HRD+ N+L+ + +KI DFGLA D ++ +V W +L
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-- 184
Query: 334 ATKYGAAIDMWSAGCILAEL--FAGKP 358
++ D+WS G + EL F KP
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 168 QGTYSSVYKA--RDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+GT+ ++ D + GK V +K V+ + V + +E +L L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 224 GLVTSRSGSLYLVFEYME--------HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+ ++++ YM + Q+ Q+ G+ + H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS--------QNLPLTSRVVTLWYRA 327
RG++H+DI N +I+ +KI D L+ P +N P+ W A
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WM-A 187
Query: 328 PELLLGATKYGAAIDMWSAGCILAEL 353
E L+ +Y +A D+WS G +L EL
Sbjct: 188 LESLVN-KEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 41/131 (31%), Positives = 62/131 (47%), Gaps = 12/131 (9%)
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLW 324
Q+ G+E S+ +HRD+ N+LI ++KI DFGLA N + S + L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKIFKLCGSPSED 382
+ APE + Y D+WS G +L E+F G P P EQ + + +
Sbjct: 307 WMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------NAIKR 357
Query: 383 YWRKSKSAHAT 393
+R +K AHA+
Sbjct: 358 GYRMAKPAHAS 368
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 163 IDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++++G+ + VYK E + VA+K ++ P F E + +L HP
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF-KHEAMMRSRLQHP 68
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH--------------DLAGLATTPGIKFT--EPQIK 261
N++ L G+VT + L ++F Y H D+ +K T
Sbjct: 69 NIVCLLGVVT-KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL-ATTYDPSQNLPLTSRV 320
+ Q+ G+E S ++H+D+ N+L+ + +KI D GL Y + + +
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355
+ + + +PE ++ K+ D+WS G +L E+F+
Sbjct: 188 LPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 161 EKID---KIGQGTYSSVYK--ARDLETGKI---VALKKVRFANMDPESVRFMAREIHILR 212
EKI ++GQG++ VY+ ARD+ G+ VA+K V + E + F+ E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMK 64
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGL--------ATTPGIKFTEPQIKCY 263
+V++L G+V+ +L +V E M H DL PG P ++
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPG--RPPPTLQEM 121
Query: 264 MQ---QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSR 319
+Q ++ G+ + +++ +HRD+ N ++ + +KIGDFG+ Y+
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL 353
++ + + APE L + + DMWS G +L E+
Sbjct: 182 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVV 321
+ Q+ RG+E S+ +HRD+ N+L+ ++KI DFGLA N + S +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPS 380
+ + APE + Y D+WS G +L E+F+ G PG + K
Sbjct: 302 PVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK------ 354
Query: 381 EDYWRKSKSAHAT 393
+R +K HAT
Sbjct: 355 -SGYRMAKPDHAT 366
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 65/266 (24%), Positives = 105/266 (39%), Gaps = 40/266 (15%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKLDHPNVMKL 222
+IG G + V + ++ T VA V+ AN + ++ R L HPN+++
Sbjct: 2 EIGNGWFGKVLLS-EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 223 EGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQ---QLLRGLEHCHSRG 278
G L LVFEY E DL + Q+ + ++ G+ H H
Sbjct: 61 LGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTLWYRAPEL------- 330
LH D+ N + + +K+GD+G+ + Y + V L + APEL
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 331 LLGA--TKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
L+ A TK ++W+ G L ELF A +P ++ E ++ +
Sbjct: 180 LITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVI------------- 222
Query: 387 SKSAHATSFKPQ--QPYKRKVLETFR 410
K FKPQ PY + E +
Sbjct: 223 -KDQQVKLFKPQLELPYSERWYEVLQ 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 38/230 (16%)
Query: 166 IGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMA--REIHILRKLDHPN 218
+GQGT++++YK DL+ V + + +A ++ +L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKF-----TEPQIKCY---MQQLLRG 270
++KL G V R ++ +V EY++ P F + +QL
Sbjct: 63 LVKLYG-VCVRDENI-MVEEYVKFG-------PLDVFLHREKNNVSLHWKLDVAKQLASA 113
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGV-------LKIGDFGLATTYDPSQNLPLTSRVVTL 323
L + + ++H ++ G N+L+ G+ +K+ D G+ T L RV +
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-----LSREERVERI 168
Query: 324 WYRAPELL-LGATKYGAAIDMWSAGCILAELFAGKPI-MPGRTEVEQMHK 371
+ APE + G A D WS G L E+ + + + E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 25/46 (54%), Positives = 30/46 (65%)
Query: 260 IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
IK M+Q+L GL H GI+HRDIK NLL+ G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 5/112 (4%)
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL--TSRVVTL 323
Q+ +G+ S+ +HRD+ N+L+ + + KI DFGLA N + +R+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374
W APE + Y D+WS G +L E+F+ G PG + +K+ K
Sbjct: 282 WM-APESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 55/176 (31%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 208 IHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM-EHDLAGLATTPGIKFTEPQIKCYMQQ 266
+H L K D+PN +KL VT+ G + L+ +Y+ + DL L G K +E ++K ++Q
Sbjct: 61 VHQLMK-DNPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQ 117
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGV-LKIGDFGLA------TTYDPSQNLPLTSR 319
L+ L H I+H DIK N+L + A + + D+GL + YD
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG--------- 168
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTE---VEQMHK 371
TL Y +PE + G Y + D W+ G + EL GK P E +E + K
Sbjct: 169 --TLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 29/203 (14%)
Query: 173 SVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232
+V K R L +VA+K +R + + + +E+ IL +L PN+++L G+
Sbjct: 40 NVRKGRPL----LVAVKILR-PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDP 93
Query: 233 LYLVFEYMEH-DL------------------AGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
L ++ EYME+ DL A + + Q+ G+++
Sbjct: 94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELL 331
S +HRD+ N L+ +KI DFG++ + R V W +L
Sbjct: 154 LSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213
Query: 332 LGATKYGAAIDMWSAGCILAELF 354
+G K+ A D+W+ G L E+
Sbjct: 214 MG--KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR--FMAREIHILR- 212
+ K+ +G G + +V+K + G + + V + S R F H+L
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 213 -KLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQ-IKCYMQQLLRG 270
LDH +++L G+ SL LV + +PQ + + Q+ +G
Sbjct: 64 GSLDHAYIVRLLGICPG--ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT--LWYRAP 328
+ + ++HR++ N+L+ + +++I DFG+A P S T W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 329 ELLLGATKYGAAIDMWSAGCILAEL--FAGKP 358
+L G +Y D+WS G + E+ + +P
Sbjct: 182 SILFG--RYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 31/167 (18%)
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSL---YLVFEY-----------MEHDLAGLATTPG 252
EI LR++D N++K+ G + L L+ EY E DL+ T
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLS-FKTKLD 126
Query: 253 IKFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311
+ I C +GL + + ++++ + L+ LKI GL
Sbjct: 127 M-----AIDC-----CKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL--- 173
Query: 312 QNLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGK 357
+ P V + Y + ++L ++Y D++S G +L E+F GK
Sbjct: 174 -SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 52/212 (24%), Positives = 83/212 (39%), Gaps = 32/212 (15%)
Query: 165 KIGQGTYSSVYKAR---DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
+IG G + V ++V +K++R + + E R L H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVV-VKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 222 LEGLVTSRSGSLYLVFE---------YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
G T + L LV E Y+ TP T ++ C ++ GL
Sbjct: 60 CLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPT-TLQRMAC---EIALGLL 114
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTLWYRAPELL 331
H H +H D+ N L+ +KIGD+GL+ Y + V L + APEL+
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 332 ---------LGATKYGAAIDMWSAGCILAELF 354
+ TK ++WS G + ELF
Sbjct: 175 DEVHGNLLVVDQTKES---NVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225
I +G + YK + ++ G +K++ N P S EI + KL HPN++KL GL
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGL 751
Query: 226 VTSRSGSLYLVFEYME 241
S G+ YL+ EY+E
Sbjct: 752 CRSEKGA-YLIHEYIE 766
|
Length = 968 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 62/248 (25%), Positives = 98/248 (39%), Gaps = 55/248 (22%)
Query: 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293
Y V Y+ + L G++ I+ M+Q+L L+ HS GI+HRD+K N++ +
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 294 -AGVLKIGDFGLAT------TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA------ 340
+G KI D G A Y P + L L R Y APE + +T+ +A
Sbjct: 291 GSGSFKIIDLGAAADLRVGINYIPKEFL-LDPR-----YAAPEQYIMSTQTPSAPSAPVA 344
Query: 341 ---------------IDMWSAGCILAELFAGKPIMPG-RTEVE--QMHKIFKLCGSPSED 382
D++SAG I ++ P R++ Q ++ K D
Sbjct: 345 TALSPVLWQLNLPDRFDIYSAGLIFLQM-----AFPNLRSDSNLIQFNRQLKRND---YD 396
Query: 383 Y--WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
WRK A+ P R+ E + L+ ++ + R SA +AL
Sbjct: 397 LVAWRKLVEPRAS------PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450
Query: 441 EFFKTEPL 448
+F E L
Sbjct: 451 PYFDREGL 458
|
Length = 566 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 159 AFEKID---KIGQGTYSSVYKA------RDLETGKIVALKKVRFANMDPESVRFMAREIH 209
A EKI ++GQG++ VY+ +D E VA+K V A E + F+ E
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFL-NEAS 61
Query: 210 ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG--------LATTPGIKFTEPQIK 261
++++ + +V++L G+V+ +L ++ DL + P P +K
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ--APPSLK 119
Query: 262 CYMQ---QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLT 317
+Q ++ G+ + ++ +HRD+ N ++ +KIGDFG+ Y+
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL 353
++ + + +PE L + D+WS G +L E+
Sbjct: 180 KGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 31/143 (21%), Positives = 54/143 (37%), Gaps = 21/143 (14%)
Query: 174 VYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-----PNVMKLEGLVTS 228
VY + ++ K+ + RE+ IL+ L P V L +
Sbjct: 14 VYLLGTKDEDYVL---KINPSREKGADRE---REVAILQLLARKGLPVPKV-----LASG 62
Query: 229 RS-GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGS 287
S G YL+ E++E G + + I + +LL L + H D+
Sbjct: 63 ESDGWSYLLMEWIE----GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG 118
Query: 288 NLLINNAGVLKIGDFGLATTYDP 310
N+L+++ +L I D+ A P
Sbjct: 119 NILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-------LKIGDFGLATTYDPSQNLPLT 317
QQL L + + ++H ++ N+L+ G+ +K+ D G++ T L
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA-----LSRE 178
Query: 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL-FAGKPIMPGRTEVEQMH 370
RV + + APE + G A D WS G L E+ F G+ + RT E+
Sbjct: 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 18/54 (33%), Positives = 30/54 (55%)
Query: 255 FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308
+ IK M+ +L LE+ H GI H DIK N++++ I D+G+A+ +
Sbjct: 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.22 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.13 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.6 | |
| PLN02236 | 344 | choline kinase | 96.53 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.11 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.87 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.73 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.63 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.58 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.54 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.17 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.58 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.57 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.56 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.21 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.16 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-88 Score=718.81 Aligned_cols=432 Identities=64% Similarity=1.054 Sum_probs=388.0
Q ss_pred ceeecCCCCCCccccccCCccccccccccccCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH
Q 006004 120 RIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE 199 (665)
Q Consensus 120 r~~~~p~~~~g~~~~~~~p~~~~~~~g~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~ 199 (665)
+....+...++..++++||.|+...+|+++.+|.+++.+.|+.+++||+|+||.||+|++..||+.||+|++++.+..++
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~ 158 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG 158 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc
Confidence 44445556677889999999999999999999999999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 006004 200 SVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278 (665)
Q Consensus 200 ~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g 278 (665)
....+.|||.||++|+|||||+|.+++.+. .+.+|||||||++||..++...+.+|++.++++||+||+.||+|||.+|
T Consensus 159 ~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 159 FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999999999999999887 6799999999999999999999999999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCC
Q 006004 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358 (665)
Q Consensus 279 IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~ 358 (665)
|+|||||.+|||||++|.+||+|||||+++.......+++.+.|+||+|||+|+|...|+.++|+||+||||.||++|+|
T Consensus 239 vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99999999999999999999999999999988888889999999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 359 IMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 359 pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
+|+|.++++|+++|+++||+|.++||...+++....|++..+|++.+.+.+..++..+++|+..||.+||.+|.||.++|
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hCcCCCCCCCCCCCCCCCCCCCChHHHHHHHHHHHHHHHHHHhhCCCCCCCCCCCCCCCcCC-CCCCCCCCC---CCCCc
Q 006004 439 RSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVR-TPEFIPSGQ---SKPTS 514 (665)
Q Consensus 439 ~Hp~f~~~~~~~~p~~~p~~~~~~e~~~~~~~~e~~k~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~ 514 (665)
+|+||++.+.+|+|+.+|.|++.+|++.+.++++.+++...+.+.+......+..+...+.+ .++.....+ ++..+
T Consensus 399 ~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~~~~~~~~~r~~p~~~~~~~~~~~~~~~~~n~~~ 478 (560)
T KOG0600|consen 399 QSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRIRERGDRGSRAIPAQPANAESQASPQRRKSNSRS 478 (560)
T ss_pred cCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccccccccccccCCCCCCCCCHHHhccccccccCCcC
Confidence 99999999999999999999999999999999887776633334443333333333333222 233444444 77889
Q ss_pred cCCCCCCCCCCCCCcccCCCCCCCCCcccCCCcccCC
Q 006004 515 ISHKFHNQEDSCSGFRIEPPTVGRQNVNSHSSTAVHP 551 (665)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (665)
.+++|+++.+...||+++|.+.......++.+...++
T Consensus 479 ~s~kf~p~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 515 (560)
T KOG0600|consen 479 NSEKFPPPEQDGVGFPIGPSRRSQSKGPSRYSGPNSG 515 (560)
T ss_pred cccCCCCccccccCcccCCccccCCCCcccccCCCCc
Confidence 9999998777779999999887644455666444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-60 Score=484.39 Aligned_cols=306 Identities=45% Similarity=0.791 Sum_probs=268.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
..+.|+++.+|++|+||.||+|+++.|++.||+|+++........--.-.|||.+|.+++|||||.+..++... -..+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34579999999999999999999999999999999987653222222346999999999999999999988754 34799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||||++|+..++..-..+|.+.++++++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+.+... ..
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k 232 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LK 232 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999999998654 45
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc-
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT- 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~- 393 (665)
+++..+.|.||+|||++++...|+.++|+||+|||+.|||+++|.|+|..+.+|+.+|++++|.|.+..|.........
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 6788899999999999999999999999999999999999999999999999999999999999999999876554432
Q ss_pred -CCCCCCcchhhhhhhccC--CcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCCCCCChH
Q 006004 394 -SFKPQQPYKRKVLETFRN--FPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKE 463 (665)
Q Consensus 394 -~~~~~~p~~~~~~~~~~~--~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~~~~~~e 463 (665)
.-.+..||... ...|.. ++....+|+..||.+||.+|.||.|+|+|.||.+.|.|++|.-+|.+|...+
T Consensus 313 ~~~f~~~pyn~l-r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 313 KMTFSEHPYNNL-RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred ccccCCCCchhh-hhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 22234444332 223332 6699999999999999999999999999999999999999999999987544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-60 Score=469.22 Aligned_cols=297 Identities=44% Similarity=0.773 Sum_probs=263.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|..+++||+|.||.||+|++.+||+.||||+|+..+..........|||+.|+.++|+||+.|.++|-..+ .+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEEE
Confidence 4799999999999999999999999999999999887654334445789999999999999999999998866 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||+.+|...+......|+..+++.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+..... ..+
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~~ 159 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQT 159 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875433 344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc-cccCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA-HATSFK 396 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~-~~~~~~ 396 (665)
..+.|.||+|||++.|+..|+..+||||+|||+.||+.|.|.|+|.++.||+..|++.+|+|.++-|+..... ....+.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 4589999999999999999999999999999999999999999999999999999999999999999875432 222222
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKY 458 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~~ 458 (665)
..|. ......|...++++.||+.+||.+||.+|+|+.|+|+|+||++.|.|+.+..+|..
T Consensus 240 -~~P~-~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 240 -QFPK-PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred -cCCC-CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 1221 11223677889999999999999999999999999999999999999988888754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=498.46 Aligned_cols=287 Identities=39% Similarity=0.702 Sum_probs=257.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|.++++||.|+||.||+|+.+.+|..||||.++..-...+..-. +||+..|++|+ |||||+|.+++.+.+..+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46899999999999999999999999999999999765544444333 58999999998 99999999999887668999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||+.+|.+++..++..|++..++.||+||+.||+|+|.+|++||||||||||+.....+||+|||||+.+.. ..+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--kpP 165 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--KPP 165 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--CCC
Confidence 999999999999999999999999999999999999999999999999999999999989999999999998754 456
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh-hccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~-~~~~~~~~ 394 (665)
+|.++.|+||+|||+++....|+.++|||++|||++|+++-+|+|+|.++.|++.+|..++|+|..+.|.. .++.....
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999987 44555544
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
|.-...-...+...+...++++.+||.+||.+||.+||||.|+|+||||...
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 4332222334566677899999999999999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=455.21 Aligned_cols=285 Identities=34% Similarity=0.632 Sum_probs=248.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|+.+.++|+|+||+||+|+++.||+.||||++.....++...+-.+|||.+|++|+|+|+|.|+++|.... .++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-klhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-KLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-eeEEEe
Confidence 4699999999999999999999999999999999766656666666789999999999999999999997654 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||++..+..+...-..++...++.|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.. ....++
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YT 159 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYT 159 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhh
Confidence 9999998888877666799999999999999999999999999999999999999999999999999998863 334578
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH---HhhhccccccC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY---WRKSKSAHATS 394 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~---~~~~~~~~~~~ 394 (665)
.++.|+||+|||++.|...|+..+||||+||++.||++|.|.|+|..+.+|+..|.+.+|...+.- |.+....+...
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 899999999999999999999999999999999999999999999999999999999999887653 22221111111
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+ |...-...+...+++++.-+.||++.||..||.+|++.+|+|.|+||..
T Consensus 240 l-P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 240 L-PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred c-CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1 2222233455667789999999999999999999999999999999954
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=464.53 Aligned_cols=263 Identities=32% Similarity=0.476 Sum_probs=224.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.+.|.+.+.||+|+||.|.+|..+.||+.||||++.+..... .....+.+|++||++|+|||||+++++|+..+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 457899999999999999999999999999999998654321 12334679999999999999999999998866
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC---CcEEEEecccceec
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTY 308 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~---g~lKL~DFGlA~~~ 308 (665)
..|||||||+|+.+....-..+.+.|...+.|++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 789999999976555555555689999999999999999999999999999999999999876 68999999999987
Q ss_pred CCCCCCCcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhHHh
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~~~ 385 (665)
... ..+.+.||||.|.|||++.+. ..|..++||||||||||.+|+|.+||.+..... ...+|.+....+.+.+|+
T Consensus 330 g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 330 GEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 633 347889999999999999753 344558999999999999999999999876555 666676654444445554
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.++.++++||.+||.+||++|||+++||+||||+..+
T Consensus 408 -------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 408 -------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 5899999999999999999999999999999999764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-55 Score=452.78 Aligned_cols=292 Identities=38% Similarity=0.632 Sum_probs=253.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec----cCCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS----RSGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~~~~l~ 234 (665)
.|..++.||.|+||.|+.|.++.+|+.||||++...-...-..++..||+.+|+.++|+||+.+.+++.. .-..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 5777899999999999999999999999999997433345567778899999999999999999999876 234689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC-CC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS-QN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~-~~ 313 (665)
+|+|+|+.+|...+.... .|++..+..+++||+.||.|+|+.+|+||||||.|||++.+..+||||||+|+..... ..
T Consensus 103 iV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999999988888776543 6999999999999999999999999999999999999999999999999999988543 23
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
..++.++.|.||+|||+++....|+.++||||+||||.|||+|++.|+|.+..+|+..|...+|+|+++.+.......+.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 34688999999999999998899999999999999999999999999999999999999999999999988876644443
Q ss_pred CCCCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCC
Q 006004 394 SFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCD 451 (665)
Q Consensus 394 ~~~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~ 451 (665)
.+-...|. +......|++.++.|++|+++||..||.+|+|++|||+||||.....|.+
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 32222221 23356778899999999999999999999999999999999987655443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=470.84 Aligned_cols=257 Identities=32% Similarity=0.498 Sum_probs=231.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+|+..+.||+|+|+.||.+++..+|+.||+|+|.+..+ .....+.+.+||+|.++|+|||||+++++|++.+ ++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-NVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-ceEEE
Confidence 479999999999999999999999999999999987654 5566778999999999999999999999999865 89999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
+|+|..+.+..+.++.+.|+|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+..... ..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-rk 175 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-RK 175 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-cc
Confidence 99999877766666778999999999999999999999999999999999999999999999999999999864422 34
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
.+.||||.|+|||++.. ..++..+||||+|||||.||.|+|||...+-.+++.+|...-.
T Consensus 176 ~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------- 235 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------- 235 (592)
T ss_pred ceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-------------------
Confidence 56799999999999986 6789999999999999999999999999999999999865311
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..++.+|++||.+||..||.+|||+.++|.|+||+..
T Consensus 236 ----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 236 ----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 1223789999999999999999999999999999999544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=441.19 Aligned_cols=262 Identities=31% Similarity=0.474 Sum_probs=232.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||+||+++.+.|++.||+|++++..+ ....++.+..|..||..++||+||+++..|++.. .+|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-KLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-eEE
Confidence 35689999999999999999999999999999999988765 3446788899999999999999999999999976 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+||+.|+-+...+++.+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++..-... .
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-D 180 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-C
Confidence 999999998777777777799999999999999999999999999999999999999999999999999998643322 2
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...++|||+.|||||++.+ ..|+.++|+|||||++|+||+|.+||.+.+....+.+|.+.-.
T Consensus 181 ~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~----------------- 242 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL----------------- 242 (357)
T ss_pred ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----------------
Confidence 3456899999999999997 5899999999999999999999999999999999999876321
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc----CHHHHHhCcCCCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG----SAASALRSEFFKTEPL 448 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp----Ta~eaL~Hp~f~~~~~ 448 (665)
......++.++++||++||..||++|. .+.++-+||||....+
T Consensus 243 -----------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 243 -----------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred -----------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 111234899999999999999999995 7999999999997643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=438.21 Aligned_cols=290 Identities=41% Similarity=0.748 Sum_probs=248.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeeeeccCC-----
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN-VMKLEGLVTSRSG----- 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~----- 231 (665)
..|+.+++||+|+||+||+|+++.+|+.||+|+++.....+..-....+|+.+|+.|+|+| ||.|++++...+.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4688999999999999999999999999999999876542222234579999999999999 9999999987653
Q ss_pred cEEEEEEeccccchhhhcCCC---CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 232 SLYLVFEYMEHDLAGLATTPG---IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~---~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
.+|+||||++-++...+.... ..++...++.+|+||+.||+|||++||+||||||.||||++.|.+||+|||+|+.+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 799999999999888777654 35788899999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.-.. ..+++.++|.||+|||++++...|+..+||||+|||++||+++++.|+|..+.+++..|++.+|+|.++.|+...
T Consensus 171 ~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 171 SIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred cCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 5322 236777999999999999999899999999999999999999999999999999999999999999999998654
Q ss_pred cccccCC-CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 389 SAHATSF-KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 389 ~~~~~~~-~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
....... .+..+-...+....+...+++.+|+.+||.+||.+|.||..+|.||||...+.
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 2222111 11122234455666677789999999999999999999999999999997643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=432.59 Aligned_cols=258 Identities=33% Similarity=0.468 Sum_probs=227.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++.+.++.||+|..|+||+|+|+.|++.+|+|+|. .+.++...+++.+|++|++.++|||||++|++|......++|+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 346889999999999999999999999999999995 3456778889999999999999999999999999864259999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+++.++.+....++++|..+..++.+++.||.|||+ ++||||||||+||||+..|.+||||||.+..+..+ .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999998888888776789999999999999999999996 89999999999999999999999999999887654 4
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR-----TEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-----~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
..+++||..|||||.+.+ ..|+.++||||||++++||++|+.||+.. +..+.+..|.. .|++
T Consensus 234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP--------- 300 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP--------- 300 (364)
T ss_pred cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC---------
Confidence 578899999999999997 68999999999999999999999999875 44555555533 2222
Q ss_pred cccCCCCCCcchhhhhhhcc-CCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFR-NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~-~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
..| . .+|+++++||..||.+||.+|+|+.|+|+|||++...
T Consensus 301 -------~lP---------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 -------RLP---------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -------CCC---------cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 122 2 4899999999999999999999999999999998643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-52 Score=444.94 Aligned_cols=278 Identities=33% Similarity=0.495 Sum_probs=234.4
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
...++|+++..||+|+||.||+|+.+.||.+||+|++++..+ ...++..+..|..||...++|+||+|+..|++.+ .+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-YL 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-ee
Confidence 356789999999999999999999999999999999998765 5667889999999999999999999999999976 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC--
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS-- 311 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~-- 311 (665)
||||||++|+.+..++.....|+|..+++|+.+++.||+.||+.|+|||||||+|+|||..|++||.||||+.-+...
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999998655555555568999999999999999999999999999999999999999999999999998543110
Q ss_pred --------------------CCC------------------------CcccccccccccCcccccCCcccCcccchhhhH
Q 006004 312 --------------------QNL------------------------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAG 347 (665)
Q Consensus 312 --------------------~~~------------------------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG 347 (665)
... ...+.+|||.|||||++++ ..|+..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence 000 0124689999999999998 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccC
Q 006004 348 CILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427 (665)
Q Consensus 348 ~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~D 427 (665)
||+||||.|.|||.+.+..++..+|.. |+..- .|+. ...++++|+|||.+||. |
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l-----~fP~-----------~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVN---------WRETL-----KFPE-----------EVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHH---------Hhhhc-----cCCC-----------cCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999976 43210 0111 12467999999999999 9
Q ss_pred cCCCcC---HHHHHhCcCCCCCCCCCCCCCCCCCCC
Q 006004 428 PENRGS---AASALRSEFFKTEPLPCDPSNLPKYPP 460 (665)
Q Consensus 428 P~~RpT---a~eaL~Hp~f~~~~~~~~p~~~p~~~~ 460 (665)
|++|.. +.|+.+||||++..+..--..-|.|.|
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence 999975 999999999998877543333344443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=445.38 Aligned_cols=262 Identities=34% Similarity=0.525 Sum_probs=232.4
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
+...+|.+.+.||+|+|++|++|+++.+++.||||++.+.-+ .+..++.+.+|-.+|.+| .||.|++|+..|+++. .
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-S 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-c
Confidence 456689999999999999999999999999999999976654 444567788999999999 8999999999999976 8
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|+|+||+++ +|+.++..- +.|+|..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||.|..+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999985 566666554 58999999999999999999999999999999999999999999999999999987543
Q ss_pred CCC------------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 006004 312 QNL------------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 312 ~~~------------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
... ...++|||..|++||+|.. ...++.+|||+||||||.||.|.|||.+.++.-+.++|.++...+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 221 1256899999999999886 678999999999999999999999999999999999998864322
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
..+|++.++|||+++|..||.+|+|+.++.+||||.+..+
T Consensus 307 -----------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 307 -----------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred -----------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 2478999999999999999999999999999999987654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=425.58 Aligned_cols=281 Identities=40% Similarity=0.648 Sum_probs=238.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-C---cEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-G---SLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~---~l~ 234 (665)
.|+..+.+|.|+||.||+|...++++.||||++-.+.. .-.+|++||+.++|||||+|..+|.... . .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 59999999999999999999999999999999864331 1247999999999999999999887652 2 356
Q ss_pred EEEEeccccchhhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceecCC
Q 006004 235 LVFEYMEHDLAGLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDP 310 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~~~ 310 (665)
+|||||+.++...+.. .+.+++.-.++-|++||++||.|||..||+||||||.|||+|.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999988876663 35679999999999999999999999999999999999999966 9999999999999865
Q ss_pred CCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
+. +..++..|+.|+|||++.|...|+.+.||||+|||+.||+.|+|.|+|.+..+|+..|++++|.|+.+.....+..
T Consensus 179 ~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 GE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred CC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 44 3578899999999999999999999999999999999999999999999999999999999999999876654433
Q ss_pred cccCCCCCCcchhhhh-hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 391 HATSFKPQQPYKRKVL-ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~-~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.. .+.-..-....+. ......++++.+|+.++|.++|.+|.++.|+|.||||.+...
T Consensus 257 y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 22 1111111111111 245678999999999999999999999999999999986543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=411.36 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=232.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||.|+||.|.+++++.+|..||+|++.+... .-.+++...+|..||+.+.||+++++++.|.+.+ .+|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEE
Confidence 35689999999999999999999999999999999987654 5567788899999999999999999999998865 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||++|+-+..+++..++|++..++.|+.||+.||+|||.++|++|||||||||||.+|.+||+|||+|......
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999888888877779999999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
..+.||||.|+|||++.. ..|+.++|+|||||++|||+.|.+||...+...++++|....-.
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~---------------- 259 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK---------------- 259 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc----------------
Confidence 456799999999999986 78999999999999999999999999999999999999774221
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC-----cCHHHHHhCcCCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFKTEP 447 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R-----pTa~eaL~Hp~f~~~~ 447 (665)
.+..+++++++||++||+.|-.+| ....++..||||++..
T Consensus 260 -------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 260 -------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred -------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 224689999999999999999999 3578999999999753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=411.96 Aligned_cols=288 Identities=26% Similarity=0.423 Sum_probs=243.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..+.|++.+.||+|.|+.||++.+..+|+.+|+|++....+.....+.+.+|+.|-+.|+|||||+|++.+... +..||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-ceeEE
Confidence 45689999999999999999999999999999999987766666778899999999999999999999988765 48899
Q ss_pred EEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccceecCCC
Q 006004 236 VFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~~~~~ 311 (665)
|+|+|.|+ +...+.++ ..++|..+..+++||+++|.|||.+||||||+||+|+|+.. .--+||+|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999985 54555554 47899999999999999999999999999999999999964 3469999999999887
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......++|||.|||||++.. .+|+..+|||+.|||||.||.|.+||.+.+....++.|.+.....+..+|
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w------- 236 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW------- 236 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-------
Confidence 3334567899999999999986 78999999999999999999999999999999999999886655555454
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCCCCCChHHHHHHHHH
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQ 471 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~~~~~~e~~~~~~~~ 471 (665)
.++++++++||++||..||.+|+|+.|+|+|||+.+. ..........+.-..++..
T Consensus 237 ------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r------~~~As~~H~~dtvd~lrkf 292 (355)
T KOG0033|consen 237 ------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR------ERVASAIHRQDTVDCLKKF 292 (355)
T ss_pred ------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch------HHHHHHhhhHHHHHHHHHh
Confidence 4799999999999999999999999999999999753 2222222333444556666
Q ss_pred HHHHHHHH
Q 006004 472 EARKQEAE 479 (665)
Q Consensus 472 e~~k~~~~ 479 (665)
.++++-..
T Consensus 293 NarRKLKg 300 (355)
T KOG0033|consen 293 NARRKLKG 300 (355)
T ss_pred hHHHHHHH
Confidence 66665443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=420.62 Aligned_cols=266 Identities=30% Similarity=0.456 Sum_probs=231.8
Q ss_pred CccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 152 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
+.....++|.+.++||+|+||+||+|+++.++..||||.|.+..+..+.++.+..||+||+.|+|||||.|++++...+
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 3344567899999999999999999999999999999999988888888999999999999999999999999998865
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC------CcEEEEecccc
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA------GVLKIGDFGLA 305 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~------g~lKL~DFGlA 305 (665)
.+|||||||+|+.+..++...+.++|..++.+|.||+.||++||+++||||||||.||||+.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 899999999976666666666689999999999999999999999999999999999999865 46999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
+.+.+. ....+.||+|.|||||++.. ..|+.++|+||+|+|||+|++|++||...+..|.+..+.+....
T Consensus 163 R~L~~~--~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~------- 232 (429)
T KOG0595|consen 163 RFLQPG--SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI------- 232 (429)
T ss_pred hhCCch--hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-------
Confidence 998744 34677899999999999974 78999999999999999999999999999998888865442111
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+......+++...+|+..+|..+|..|.+..+-+.|++....+
T Consensus 233 -------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 -------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1111124667778999999999999999999999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=407.64 Aligned_cols=283 Identities=40% Similarity=0.725 Sum_probs=236.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||.|+||.||+|++..+++.||+|+++..... .....+.+|+.++++++||||+++++++.... .+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTER-CLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-eEEEE
Confidence 35799999999999999999999999999999999754321 22345678999999999999999999988754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+++...+...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~ 160 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY 160 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence 9999998887776666678999999999999999999999999999999999999999999999999998654322 223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc--cC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA--TS 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~--~~ 394 (665)
....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+..+.|+....... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 4457899999999998766789999999999999999999999999999999999999999999999876432211 00
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..+.. ...........+++++++||.+||.+||.+|+|+.|+|+||||
T Consensus 241 ~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 11110 0111223345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=422.10 Aligned_cols=258 Identities=30% Similarity=0.483 Sum_probs=224.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCC
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSG 231 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~ 231 (665)
..+.|.+.+.||+|+||+|++|++..++..||+|++...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 345899999999999999999999999999999987664221 123456779999999998 999999999999877
Q ss_pred cEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceecC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYD 309 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~~ 309 (665)
.+|+||||+.| +|+..+.. .+++.|.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 59999999997 67777766 6689999999999999999999999999999999999999999 999999999999874
Q ss_pred CCCCCCcccccccccccCcccccCCc-ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGAT-KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~-~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.....+.+.+||+.|+|||++.+.. +-+.++||||+||+||.|++|+.||...+......+|.+..-
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~----------- 240 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF----------- 240 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-----------
Confidence 3334578889999999999999865 446999999999999999999999999888888888655211
Q ss_pred cccccCCCCCCcchhhhhhhccCC-cHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNF-PQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~-s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+ ++++++||.+||..||.+|+|+.+++.||||+.
T Consensus 241 ------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 ------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 112235 999999999999999999999999999999997
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=401.92 Aligned_cols=284 Identities=35% Similarity=0.605 Sum_probs=235.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-KLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-EEEEEE
Confidence 3699999999999999999999999999999999865444445567889999999999999999999987754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99999888877665567999999999999999999999999999999999999999999999999999876543333344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc---ccC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH---ATS 394 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~---~~~ 394 (665)
...||+.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+..+.+.+....... ...
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 5678999999999986 568999999999999999999999999999888888888888887776654321110 000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
+................++.++.+||++||++||.+|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1100000111122234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=405.07 Aligned_cols=247 Identities=31% Similarity=0.514 Sum_probs=216.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeee-eeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG-LVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~-~~~~~~~~l~lV~ 237 (665)
+|+++++||.|+||+||++++..+|..+|+|.|.+..++....+.+..|+.+|++|+|||||++++ .|......++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 699999999999999999999999999999999999999899999999999999999999999998 5555555699999
Q ss_pred Eeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHh--CC--ccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 238 EYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHS--RG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 238 Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~--~g--IiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
|||+++.+..++ +.+..++|..+++|+.||+.||.+||. .. |+||||||.||+|+.+|.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999964443332 355679999999999999999999999 45 9999999999999999999999999999986
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .....+++|||.||+||.+.. .+|+.++|||||||++|||+.-++||.|++-.+...+|.+.-.+|-++
T Consensus 180 s~-~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------- 250 (375)
T KOG0591|consen 180 SK-TTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------- 250 (375)
T ss_pred ch-hHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-------
Confidence 54 344678899999999999987 789999999999999999999999999998888888886642221110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa 434 (665)
..+|.++..||..|+..||+.||+.
T Consensus 251 --------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 --------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2578899999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=373.02 Aligned_cols=286 Identities=41% Similarity=0.708 Sum_probs=251.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|..+++||+|+||+||++++.++++.||+|.++....++..-....+||-+|+.|+|.|||+++++..++. .+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-kltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-eeEEeHH
Confidence 578889999999999999999999999999999987655444455689999999999999999999987755 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
||..++...+..-++.+..+.++.+|.|++.||.|||+++|+||||||.|+||+.+|.+||+|||+|+.+.-... -...
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa 160 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA 160 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence 999999988888888899999999999999999999999999999999999999999999999999998754321 2344
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
.+.|.||++|.++.+..-|+...|+||.|||+.|+. .|+|.|+|.+..+|+.+|+..+|.|.++-|+..........-|
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 578999999999999999999999999999999996 5899999999999999999999999999998754333333334
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..|-...+..+.+.+...-+||++++|.-+|..|++|+.+|+||||...
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 4444455667777888899999999999999999999999999999863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=427.12 Aligned_cols=281 Identities=33% Similarity=0.554 Sum_probs=234.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-C-----CCcceeeeeeeccCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-H-----PNVMKLEGLVTSRSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIV~l~~~~~~~~~~ 232 (665)
+|++++.||+|+||.|.+|.+..|++.||||+++.. .....+...|+.||..|+ | -|||+++++|..++ +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-H 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-c
Confidence 699999999999999999999999999999999743 455666778999999996 4 48999999999876 8
Q ss_pred EEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC--cEEEEecccceecC
Q 006004 233 LYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG--VLKIGDFGLATTYD 309 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g--~lKL~DFGlA~~~~ 309 (665)
+|||+|+++.+|..++.... ..|+...++.++.||+.||.+||..||||+|||||||||.+.+ .|||+|||+|+...
T Consensus 263 lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99999999999999888754 4599999999999999999999999999999999999998644 69999999999864
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ..+++-++.|+|||+|+| .+|+.+.||||||||++||++|.|+|+|.++.+|+..|..++|.|+..+++..+.
T Consensus 343 q~----vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 343 QR----VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred Cc----ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 32 347888999999999998 7899999999999999999999999999999999999999999999887665432
Q ss_pred ccc--cC--CCCC----------------------------Cc-chhhhhhhcc-CCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 390 AHA--TS--FKPQ----------------------------QP-YKRKVLETFR-NFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 390 ~~~--~~--~~~~----------------------------~p-~~~~~~~~~~-~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
.+. +. ..+. .| ..+.+..... .-...+.|||.+||.+||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 211 00 0000 00 0011111111 1234579999999999999999999
Q ss_pred HHHhCcCCCCCCC
Q 006004 436 SALRSEFFKTEPL 448 (665)
Q Consensus 436 eaL~Hp~f~~~~~ 448 (665)
++|+||||+....
T Consensus 498 qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 498 QALNHPFLTGTSL 510 (586)
T ss_pred HHhcCcccccccc
Confidence 9999999996543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=427.35 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=228.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecC-CCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFA-NMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+-|++.+.||.|+-|.|.+|++.+||+.+|||+|.+. .........+.+||-||+.|.||||++||++|+... .+|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-HLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-eEEEE
Confidence 4588999999999999999999999999999999876 444444566889999999999999999999998865 89999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
+||++|+-+..+....++|++.++.+|++||+.|+.|||..+|+||||||+|+|||..+++||+|||+|..-.++ ..+
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klL 168 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLL 168 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--ccc
Confidence 999997666555555668999999999999999999999999999999999999999999999999999875443 347
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
.+.||+|.|.|||++.|..+.+.++||||+|||||.||+|+.||.+.+-...+.++.+.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--------------------- 227 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--------------------- 227 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC---------------------
Confidence 78899999999999999777899999999999999999999999988877777776542
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.++.+.++|++|++||.+||.+||.+|+|.+|+++|||+....
T Consensus 228 --------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 228 --------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred --------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 3344568999999999999999999999999999999997643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=402.73 Aligned_cols=285 Identities=38% Similarity=0.688 Sum_probs=232.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+++.||||+++..... .....+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-eEEEE
Confidence 46899999999999999999999999999999998754322 22334678999999999999999999998765 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 9999999888877666679999999999999999999999999999999999999999999999999997653222 223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhHHhhhccccc---
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGSPSEDYWRKSKSAHA--- 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~~~~~~~~~~--- 392 (665)
...++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..+....+.+....|........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 4567899999999988766789999999999999999999999988644 567778888888888887765332110
Q ss_pred cCCCCCCcchhhhhhhc--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETF--RNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+....+ ..+...+ ..+++.+.+||.+||++||.+|+|+.|+|+||||+..
T Consensus 241 ~~~~~~~~--~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSP--KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCC--ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000011 0111111 1356889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=427.04 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=231.4
Q ss_pred cCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 154 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
+...++|.+++.||+|+||+|+++..+.+++.||||++++..+ ..+.++..+.|..|+... +||+++.|+.+|++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~- 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE- 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-
Confidence 4567899999999999999999999999999999999998765 567788899999999988 5999999999999876
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
++|+||||+.|+.+..+. ....|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++.--.
T Consensus 443 ~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 899999999987744444 334899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......++||||.|||||++.+ ..|+.++|+|||||+|||||.|.+||+|.++.+....|...-
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--------------- 584 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--------------- 584 (694)
T ss_pred CCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 2224678899999999999987 789999999999999999999999999999999999986521
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~~ 448 (665)
..++..+|.++.+++++||.+||++|.. +.++.+||||++..+
T Consensus 585 --------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 585 --------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred --------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 1123468999999999999999999975 589999999998644
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=403.92 Aligned_cols=287 Identities=36% Similarity=0.582 Sum_probs=233.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l~ 234 (665)
+|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999998754333334456789999999999999999999876432 2489
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC--
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-- 312 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-- 312 (665)
+|||||.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999998877766543 469999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....|.++.+.+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1223456799999999988642 568999999999999999999999999999999999999999988877665432211
Q ss_pred ccC----CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 392 ATS----FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~----~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
... ..... .......++.+++.+.+||.+||..||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQ--PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccC--CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 100 00001 11123445578899999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=418.49 Aligned_cols=256 Identities=32% Similarity=0.513 Sum_probs=229.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+.....+.++.+.+|++|++.|+|||||.+++.|+... ++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-HLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-eEEEEe
Confidence 4799999999999999999999999999999999888877788899999999999999999999999999865 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.|+|...+.+.+ .++|++++.++++++.||.|||+++|+|||+||.|||++..|++|+||||+|+.+... ..-++
T Consensus 81 e~a~g~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vlt 158 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLT 158 (808)
T ss_pred hhhhhhHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeee
Confidence 999998777766554 8999999999999999999999999999999999999999999999999999987653 33456
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
+..|||.|||||++.+ ..|+..+|+||||||||||++|+|||....-.+....|...--.+
T Consensus 159 sikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~------------------ 219 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP------------------ 219 (808)
T ss_pred eccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC------------------
Confidence 7789999999999986 789999999999999999999999999988777777775521111
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+...+.++++||+.+|.+||.+|.|-.++|.|||.+..
T Consensus 220 -----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 220 -----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -----------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 12688999999999999999999999999999998753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=394.39 Aligned_cols=292 Identities=45% Similarity=0.765 Sum_probs=244.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-------C
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-------S 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-------~ 230 (665)
..|+.+.+||+|.||.||+|+.+.+|+.||+|++-..+.....-....+|+.||..|+|+|++.|++++... .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 358899999999999999999999999999998765443222223356899999999999999998876432 2
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
..+|+||.+|+++|..++.....+|+..+++.+|.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||+|+.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 35999999999999999999888999999999999999999999999999999999999999999999999999987754
Q ss_pred CCC---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 311 SQN---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 311 ~~~---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
..+ ..++.++.|+||++||.++|...|+++.|||..|||+.||+++.+.|.+.++..+++.|..+||+...+.|+..
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 433 34677889999999999999999999999999999999999999999999999999999999999999999874
Q ss_pred c-cccccCC--CCC-Ccchhhhhhhcc--CCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 388 K-SAHATSF--KPQ-QPYKRKVLETFR--NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 388 ~-~~~~~~~--~~~-~p~~~~~~~~~~--~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
. .+..... .|. ....+.+....+ .-.+++.+|++.||.+||.+|++++++|+|.||...+.|
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 2 2222111 110 111122222222 225689999999999999999999999999999987654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=402.81 Aligned_cols=273 Identities=27% Similarity=0.364 Sum_probs=231.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||.|.-|+||+|+...++..+|+|+|.+..+ ....+.+...|.+||+.++||.++.||..|+... .+|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-YSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-eeEE
Confidence 4579999999999999999999999999999999987765 3556677889999999999999999999999865 8999
Q ss_pred EEEeccccchhhhc--CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC---
Q 006004 236 VFEYMEHDLAGLAT--TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP--- 310 (665)
Q Consensus 236 V~Ey~~g~ll~~~~--~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~--- 310 (665)
|||||.|+.+..+. +++..|++..+++|+.+++.||+|||.+|||+||||||||||.++|++.|.||.|+.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999986665444 3567799999999999999999999999999999999999999999999999998743210
Q ss_pred ------------------------------C-C---------------------CCCcccccccccccCcccccCCcccC
Q 006004 311 ------------------------------S-Q---------------------NLPLTSRVVTLWYRAPELLLGATKYG 338 (665)
Q Consensus 311 ------------------------------~-~---------------------~~~~~~~~gT~~Y~APE~l~~~~~~~ 338 (665)
. . .....+++||-.|+|||++.| ...+
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHg 313 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHG 313 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCC
Confidence 0 0 012245789999999999998 5679
Q ss_pred cccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHH
Q 006004 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALA 418 (665)
Q Consensus 339 ~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~d 418 (665)
.++|+|+|||+|||||.|..||.|.+..+++..|...--.+ | ..+.++..++|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F--------------------p-------~~~~vs~~akD 366 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF--------------------P-------EEPEVSSAAKD 366 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC--------------------C-------CCCcchhHHHH
Confidence 99999999999999999999999999999999886521111 1 11267899999
Q ss_pred HHHHhcccCcCCCcC----HHHHHhCcCCCCCCCCCCCCCCCCC
Q 006004 419 LVDKLLTIEPENRGS----AASALRSEFFKTEPLPCDPSNLPKY 458 (665)
Q Consensus 419 LI~~lL~~DP~~RpT----a~eaL~Hp~f~~~~~~~~p~~~p~~ 458 (665)
||++||.+||.+|.. |+|+.+||||++..|+.-....|++
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999999999998 9999999999988776543334443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=406.23 Aligned_cols=264 Identities=32% Similarity=0.473 Sum_probs=224.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH------------HHHHHHHHHHHHHHhCCCCCcceee
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP------------ESVRFMAREIHILRKLDHPNVMKLE 223 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------------~~~~~~~~Ei~iL~~L~HpnIV~l~ 223 (665)
..++|++++.||+|.||.|.+|++..+++.||||++.+..... -.++.+.+||.||++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4568999999999999999999999999999999996432111 1135788999999999999999999
Q ss_pred eeeecc-CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEec
Q 006004 224 GLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302 (665)
Q Consensus 224 ~~~~~~-~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DF 302 (665)
++..+. +..+|||+|||..+-....-.....|++.+++.|++.++.||+|||.+|||||||||+|+||+.+|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 998876 6689999999998776666555434999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCC----CCCcccccccccccCcccccC---CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 006004 303 GLATTYDPSQ----NLPLTSRVVTLWYRAPELLLG---ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375 (665)
Q Consensus 303 GlA~~~~~~~----~~~~~~~~gT~~Y~APE~l~~---~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~ 375 (665)
|.+..+..+. ...+...+|||.|+|||++.+ ....+.+.|||||||+||.|+.|+.||-+....+...+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998773321 122344689999999999986 234578999999999999999999999999999999999763
Q ss_pred cCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
-- .+...+.+...++|||.+||.+||++|+++.++..|||....
T Consensus 335 pL---------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PL---------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cc---------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11 111223578899999999999999999999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=391.02 Aligned_cols=280 Identities=40% Similarity=0.685 Sum_probs=227.8
Q ss_pred CeeEEEEeeccCceEEEEEEECC-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeeeec----cC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLE-TGKIVALKKVRFANMDPESVRFMAREIHILRKL---DHPNVMKLEGLVTS----RS 230 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~----~~ 230 (665)
+|++++.||+|+||.||+|++.. +++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999865 468899999876543333334456788887776 69999999998752 23
Q ss_pred CcEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 231 GSLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
..+++||||+.+++...+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 468999999998887766543 3458999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.+|....+.+....|.....
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 162 FQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred CC--cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 33 22345578999999999876 5789999999999999999999999999999999999999998888777765322
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....+....+ ..+....+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKSA--QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCCC--CCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11111211111 11223345788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=408.16 Aligned_cols=287 Identities=34% Similarity=0.547 Sum_probs=237.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l~ 234 (665)
+|++++.||+|+||.||++++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999999999999999998654334445567889999999999999999999987653 2689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.+++...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999998877766544 47999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc---
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH--- 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~--- 391 (665)
.....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|...+|.+..+.+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 44556789999999999876678999999999999999999999999999999999999999998876554321100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
........+............++++.+||.+||.+||.+|||+.++|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000111111112223334678999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=395.04 Aligned_cols=286 Identities=36% Similarity=0.708 Sum_probs=238.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+++.||+|.++..... .....+.+|+.++++++||||+++++++.... .+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-SLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-eEEEE
Confidence 35799999999999999999999999999999999754322 22334678999999999999999999988754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+++...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ..
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 99999988887776666789999999999999999999999999999999999999999999999999986543222 22
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc---
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT--- 393 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~--- 393 (665)
....+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+..+.|+........
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 34467999999999887667899999999999999999999999999999999999999999999888764322110
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.+.... ..........+++++++||.+||..||.+|+|+.|+|+||||+...
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 242 NFPKYK--PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcCccC--CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 011100 1112234456899999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=417.35 Aligned_cols=282 Identities=32% Similarity=0.504 Sum_probs=228.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-------C
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-------S 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-------~ 230 (665)
.+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++|||||+++++|... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 47999999999999999999999999999999886432 1235799999999999999999877432 1
Q ss_pred CcEEEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccce
Q 006004 231 GSLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLAT 306 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~ 306 (665)
..+++||||+.+++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|.
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 2477999999987765443 3456799999999999999999999999999999999999999665 79999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.+.... .....+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+++.++...+|.|..+.+..
T Consensus 220 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 220 NLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 764332 234567899999999998766799999999999999999999999999999999999999999998877654
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
..........+...............++++++||.+||.+||.+|+|+.|+|+||||....
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 3221111111111101111112235788999999999999999999999999999998654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=391.18 Aligned_cols=291 Identities=38% Similarity=0.647 Sum_probs=238.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCC----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETG----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.|+.+.+||+|+||.||+|..+.+. +.||||+++........-....|||.+++.|+||||+.|..+|...+..+|
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 5999999999999999999755543 379999987653221222345689999999999999999999988667899
Q ss_pred EEEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC----CcEEEEecccce
Q 006004 235 LVFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA----GVLKIGDFGLAT 306 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~----g~lKL~DFGlA~ 306 (665)
+++||.++||+..+.- ....++...++.++.||+.|+.|||++-|+||||||.||||..+ |.|||+|||+|+
T Consensus 105 l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 105 LLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred EEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 9999999999987663 23568999999999999999999999999999999999999987 899999999999
Q ss_pred ecCCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHh
Q 006004 307 TYDPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT---------EVEQMHKIFKL 375 (665)
Q Consensus 307 ~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~---------~~e~l~kI~~~ 375 (665)
.+...-. ......+.|.||+|||+++|...|+.++|||++|||+.|||+..|.|.|.. ..+++.+|+++
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~v 264 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEV 264 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHH
Confidence 8854322 123456789999999999999999999999999999999999999998753 36899999999
Q ss_pred cCCCChhHHhhhccc-cc----cCCCCCCcch---hhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 376 CGSPSEDYWRKSKSA-HA----TSFKPQQPYK---RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~-~~----~~~~~~~p~~---~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+|.|.++.|...+.- +. ..|....... -......+.-++.+.+|+.+||.+||-+|.|+++||+|+||+..+
T Consensus 265 LG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 265 LGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred cCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 999999999876432 11 1111111111 112333444567799999999999999999999999999999887
Q ss_pred CC
Q 006004 448 LP 449 (665)
Q Consensus 448 ~~ 449 (665)
.|
T Consensus 345 lp 346 (438)
T KOG0666|consen 345 LP 346 (438)
T ss_pred CC
Confidence 66
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=391.96 Aligned_cols=301 Identities=48% Similarity=0.860 Sum_probs=249.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-CcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-GSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~l~l 235 (665)
.++|++++.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.++++++|+||+++++++.... ..+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45799999999999999999999999999999999765433333334568999999999999999999987642 46899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+++...+......+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999988777766655679999999999999999999999999999999999999999999999999998765332 12
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~ 394 (665)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|........ ..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23345688999999988766789999999999999999999999999999999999999999998888865432211 11
Q ss_pred CC-CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCCCC
Q 006004 395 FK-PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYP 459 (665)
Q Consensus 395 ~~-~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~~~ 459 (665)
+. ...++. .+...+..+++.+.+||.+||.+||.+|||+.++|.||||...+++|.+..+|.+|
T Consensus 245 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 245 FTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccCCCCC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11 111111 22233445789999999999999999999999999999999999999988888765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=402.19 Aligned_cols=291 Identities=29% Similarity=0.510 Sum_probs=235.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 35799999999999999999999999999999999765444455567789999999999999999999876432 3
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 5799999999988776642 5889999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. ......+|+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+.++....+.+..+++.......
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 F--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C--cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 2345678999999999986 678999999999999999999999999999999999999999999888766543211
Q ss_pred ccCCCCCCcc-----h--------hhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCC
Q 006004 392 ATSFKPQQPY-----K--------RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPS 453 (665)
Q Consensus 392 ~~~~~~~~p~-----~--------~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~ 453 (665)
.........+ . ..........+..+++||.+||..||.+|||+.++|+||||.....+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 1100000000 0 000111223467899999999999999999999999999998654444333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=400.11 Aligned_cols=287 Identities=31% Similarity=0.531 Sum_probs=232.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||.||++++..+|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35799999999999999999999999999999999765444455667789999999999999999999886542 2
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 5799999999987776542 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..++++......
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 22345678999999999986 678999999999999999999999999999999999999999999887765432111
Q ss_pred ccC--CCCCC---cchh--------hhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 392 ATS--FKPQQ---PYKR--------KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 392 ~~~--~~~~~---p~~~--------~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
... ..+.. .+.. .........++.+++||.+||.+||.+|||+.|+|+||||..+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 000 00000 0000 0011122356789999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=408.95 Aligned_cols=281 Identities=25% Similarity=0.367 Sum_probs=222.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++++.||+|+||.||+|++..+++.||||... ...+.+|+++|++|+|||||+++++|.... ..|+||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNK-FTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-eeEEEE
Confidence 47999999999999999999999999999999753 223578999999999999999999998754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|++.+++...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|............
T Consensus 163 e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 163 PRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 99998877766554 46899999999999999999999999999999999999999999999999999764333323344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR-------TEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-------~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
..+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+. +...++..+....|.++.++.......
T Consensus 242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 5689999999999876 57899999999999999999999777543 234677788888887765542111000
Q ss_pred ccc------CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 391 HAT------SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 391 ~~~------~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
... ......+..+........++.++.+||.+||++||.+||||.|+|+||||...+.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000 00001111111112223467889999999999999999999999999999876543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=404.47 Aligned_cols=259 Identities=34% Similarity=0.514 Sum_probs=227.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~l 235 (665)
+.|++.+.||.|.||.||+|+++.+|+.||+|++.+... .......+.+|+.||++|. |||||.++++|++.. .+|+
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~l 113 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVYL 113 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEEE
Confidence 479999999999999999999999999999999987654 2334567899999999998 999999999999876 8999
Q ss_pred EEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC----CcEEEEecccceecCC
Q 006004 236 VFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA----GVLKIGDFGLATTYDP 310 (665)
Q Consensus 236 V~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~----g~lKL~DFGlA~~~~~ 310 (665)
|||+|.|+.+. .+... .++|.++..++.||+.++.|||..||+||||||+|||+... +.+|++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999975544 44443 49999999999999999999999999999999999999743 4799999999999866
Q ss_pred CCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.......+||+.|+|||++.. ..|+..+||||+||++|.||+|.+||.+.++.+...+|......+..++|
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w------ 262 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW------ 262 (382)
T ss_pred --CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc------
Confidence 345677899999999999975 68999999999999999999999999999999888888765444444443
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
..++..+++||.+||..||.+|+|+.++|+|||++...
T Consensus 263 -------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 263 -------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred -------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 47899999999999999999999999999999998753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=384.61 Aligned_cols=280 Identities=40% Similarity=0.697 Sum_probs=227.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeeeecc----CC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL---DHPNVMKLEGLVTSR----SG 231 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~----~~ 231 (665)
+|++++.||+|+||.||+|+++.+++.||+|.++...........+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999875432222223345677777665 799999999987642 23
Q ss_pred cEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+++||||+.+++...+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 58999999998877766543 23589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++....+.+....|......
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 2344578999999999976 56899999999999999999999999999999999999998888877776543221
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
....+.+.. ........+.++..+.+||.+||++||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCC--CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 111222111 122334445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=397.25 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=213.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-cEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG-SLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-~l~lV~ 237 (665)
++...+.||+|+||.||++.+..+|..+|||.+..... ...+.+.+|+.+|.+|+|||||++++....... .++|+|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 58888999999999999999999999999999986632 226778999999999999999999997555544 689999
Q ss_pred EeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCC--CCC
Q 006004 238 EYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDP--SQN 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~--~~~ 313 (665)
||+.++.+..+... +..|+|..++.|.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... ...
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 99998766655544 338999999999999999999999999999999999999999 79999999999988763 222
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+.||+.|||||++......+.++|||||||++.||+||.+||... ...+.+-.|... .
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------------- 239 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------------- 239 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C-------------
Confidence 23456789999999999985233345999999999999999999999874 333333332211 0
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ....+..+|+++++||.+||.+||.+||||.++|+|||....
T Consensus 240 --~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 --S---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --C---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0 012335699999999999999999999999999999999764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=408.45 Aligned_cols=255 Identities=30% Similarity=0.531 Sum_probs=226.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|....+||+|.-|.||.|+...+++.||||.+.+.....+ +.+.+|+.+|+.++|+|||.+++.|...+ .+|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEEEe
Confidence 58899999999999999999999999999999987765433 44789999999999999999999888764 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
||+|+.+..+.... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... ...+
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 99998877776654 599999999999999999999999999999999999999999999999999999876554 3456
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
.+|||.|||||++.. ..|++++||||||++++||+-|.|||-.++....+..|.. .|.|.-.
T Consensus 429 mVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk---------------- 490 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK---------------- 490 (550)
T ss_pred ccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC----------------
Confidence 699999999999986 6899999999999999999999999999988888877755 3443221
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
....+|+.+++||.+||+.||.+|++|.++|+||||+.
T Consensus 491 ---------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ---------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ---------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 12469999999999999999999999999999999964
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=396.13 Aligned_cols=287 Identities=30% Similarity=0.509 Sum_probs=233.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45899999999999999999999999999999999765444555667789999999999999999999886432 3
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999987766542 5899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+++.+.....
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22345678999999999976 578999999999999999999999999999999999999999988887766532111
Q ss_pred ccCC-----------CCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 392 ATSF-----------KPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 392 ~~~~-----------~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
.... ....+. ...........+..+++||.+||..||.+|||+.|+|+||||.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 1000 000000 000011122356788999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.49 Aligned_cols=286 Identities=34% Similarity=0.598 Sum_probs=233.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~ 231 (665)
.++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+|++++||||+++++++... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3579999999999999999999999999999999875433334455677899999999999999999987643 13
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|++||++.+++...+. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 579999999777665543 236999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+++.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3456889999999999876678999999999999999999999999999999999999988888877765432222
Q ss_pred ccCCCCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
...+....+. ...+...+...++.+.+||.+||.+||.+|||+.++|+||||.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 1111110010 11123334567888999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=391.38 Aligned_cols=271 Identities=25% Similarity=0.405 Sum_probs=224.6
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
...+.|++...||.|.-++||+|++..++..||||++..+..+.+ ++.+.+|+..|+.++||||++++..|...+ .+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeE
Confidence 345689999999999999999999999999999999998775544 788999999999999999999999999876 799
Q ss_pred EEEEeccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 235 LVFEYMEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+||.||.++.+..+... ...|.|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||....+....
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999997655444432 1239999999999999999999999999999999999999999999999999887654322
Q ss_pred C---CCcccccccccccCcccc-cCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 N---LPLTSRVVTLWYRAPELL-LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~---~~~~~~~gT~~Y~APE~l-~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. ....+++||++|||||++ ..-..|+.++|||||||+..||.+|+.||....+...+..-. .+.|+.-.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~----- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLL----- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcc-----
Confidence 1 122567999999999995 445689999999999999999999999999887776554432 23332110
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+. ..-.+..+.++..++.+|..||.+||.+||||+++|+|+||+..
T Consensus 254 ----t~--------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 ----TS--------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ----cc--------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 00 11123335688899999999999999999999999999999865
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=381.94 Aligned_cols=283 Identities=40% Similarity=0.685 Sum_probs=234.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||+|+||.||+|++..+|+.||+|.++...........+.+|+.++++++||||+++++++.+.. .+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-KLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-ceEEEEe
Confidence 489999999999999999999999999999999765433334455778999999999999999999998755 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSA 158 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCC
Confidence 999988887766566799999999999999999999999999999999999999999999999999986643322 2334
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....|............+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 56789999999988766689999999999999999998765 67777788899999999988888776533222211112
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..+...........+++++.+||.+||..||.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 2222222334455789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=393.47 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=217.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|++++||||+++++++.... .+|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-RVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-EEEE
Confidence 4579999999999999999999999999999999975432 2344567889999999999999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 99999876555444445579999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+... .+
T Consensus 173 -~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~---------------- 232 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL---------------- 232 (329)
T ss_pred -ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc----------------
Confidence 34579999999999986 56799999999999999999999999988877766665431 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+|++ +.++++||||...
T Consensus 233 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 -----------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 011246788999999999999999997 7999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.04 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=216.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.. .+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-FLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-eEEEE
Confidence 369999999999999999999999999999999975432 2234566889999999999999999999887754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 999997655555445557999999999999999999999999999999999999999999999999999876432 2
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... .
T Consensus 156 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~----------------- 215 (291)
T cd05612 156 WTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--L----------------- 215 (291)
T ss_pred ccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--c-----------------
Confidence 34578999999999876 568999999999999999999999999988777766664311 0
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....+++.+++||++||..||.+|++ +.++++||||...
T Consensus 216 ----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 216 ----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 112346889999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=379.30 Aligned_cols=283 Identities=40% Similarity=0.732 Sum_probs=232.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||+|+||.||+|++..++..||||+++...........+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-RLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-eEEEEEe
Confidence 489999999999999999999999999999998765444344456788999999999999999999998754 7899999
Q ss_pred eccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.+++...+... +..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVY 158 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccc
Confidence 9998776665432 2579999999999999999999999999999999999999999999999999998654322 122
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 34467899999999877666889999999999999999999999999998888888888888888777643221110000
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
...............+++++.+||.+||..||.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00001112233445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=383.11 Aligned_cols=287 Identities=38% Similarity=0.691 Sum_probs=236.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||.|+||.||+|++..+++.||+|.++..... .....+.+|+.+++.|+||||+++++++.... .+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCC-eEEEE
Confidence 45799999999999999999999999999999998754322 22334678999999999999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ ..
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 99999988877776666799999999999999999999999999999999999999999999999999976533221 22
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~~ 395 (665)
....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.+....|+....... ..+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 3346789999999988766788999999999999999999999999999999999999999998888875422111 000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
....-....+......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000000111223334689999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=376.36 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=228.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC------CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM------DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
.|+--+.||.|..++|.+|.++.+|..+|+|+|..... ..+..+.-.+|+.||+++ .||||++|.++|++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 57777899999999999999999999999999864321 122344566899999998 6999999999999866
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+++|+|+|..+-+..++.....++|.+.+.+|+||++|+.|||.++|+||||||+|||++++.++||.|||+|+.+.++
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 88999999997766666666778999999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCcccccccccccCcccccC-----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 312 QNLPLTSRVVTLWYRAPELLLG-----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~-----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.. +...||||+|+|||.+.. ...|+..+|+|++|||||.||.|.|||..+...-.+..|......+...-|
T Consensus 177 ek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW-- 252 (411)
T KOG0599|consen 177 EK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW-- 252 (411)
T ss_pred hh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch--
Confidence 54 677899999999999864 357899999999999999999999999999998899999886655555444
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.+++.+++|||.+||+.||.+|.|++|+|+||||..
T Consensus 253 -----------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 253 -----------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -----------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 478999999999999999999999999999999953
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=391.11 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=212.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
+.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|++++||||+++++++.... .+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-EEEEEEeCCCC
Confidence 369999999999999999999999999975432 3344566789999999999999999999988765 79999999998
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
+.+.........+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt 158 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecC
Confidence 766555555568999999999999999999999999999999999999999999999999998754222 2223456799
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------------------- 211 (323)
T cd05571 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------- 211 (323)
T ss_pred ccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 99999999876 678999999999999999999999999877666555543210
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......+++++.+||.+||..||.+|+ ++.++|+||||...
T Consensus 212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 212 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011235789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=397.04 Aligned_cols=261 Identities=33% Similarity=0.471 Sum_probs=216.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+.. .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-YLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-eEEEE
Confidence 369999999999999999999999999999999975432 3345566889999999999999999999998765 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC--
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL-- 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~-- 314 (665)
|||+.++.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999987655554444557999999999999999999999999999999999999999999999999998765321100
Q ss_pred -----------------------------------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC
Q 006004 315 -----------------------------------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI 359 (665)
Q Consensus 315 -----------------------------------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p 359 (665)
...+.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCC
Confidence 1113479999999999876 6789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC---HHH
Q 006004 360 MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS---AAS 436 (665)
Q Consensus 360 F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT---a~e 436 (665)
|.+.+..+.+..+...... ..+ | ....+++++++||.+||. ||.+|++ +.+
T Consensus 239 f~~~~~~~~~~~i~~~~~~--------------~~~----~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 239 FCSDNPQETYRKIINWKET--------------LQF----P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred CCCCCHHHHHHHHHcCCCc--------------cCC----C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 9998887776666431100 000 0 011478999999999997 9999998 999
Q ss_pred HHhCcCCCCC
Q 006004 437 ALRSEFFKTE 446 (665)
Q Consensus 437 aL~Hp~f~~~ 446 (665)
+|+||||+..
T Consensus 293 ll~h~~~~~~ 302 (364)
T cd05599 293 IKSHPFFKGV 302 (364)
T ss_pred HhcCCCcCCC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=390.45 Aligned_cols=254 Identities=25% Similarity=0.458 Sum_probs=227.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+|++.+.||+|+||.|.+|++...|+.||||.|++..+ ++...-.+.+||+||..|+||||+++|++|+..+ .+.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-KIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-KIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-eEEEE
Confidence 369999999999999999999999999999999998776 4455667899999999999999999999999876 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||..++.+..+....+.|+|.+++.|++||.+|+.|||.++|+|||||.+|||||.++++||+||||+..+.... .+
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--fL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--FL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc--HH
Confidence 9999977666666666699999999999999999999999999999999999999999999999999999886543 47
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
+++||+|.|.+||++.|..+-++.+|.|||||+||.|+.|..||.|.+-...+.+|-.....
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr------------------ 271 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR------------------ 271 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc------------------
Confidence 89999999999999998766789999999999999999999999999988888887553110
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.+.-|.++..||+.||-+||++|.|+.++..|=|..
T Consensus 272 ------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 ------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 124577899999999999999999999999998875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=383.54 Aligned_cols=276 Identities=36% Similarity=0.642 Sum_probs=216.4
Q ss_pred EEeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~Ey~ 240 (665)
.+||+|+||.||+|+++ .+++.||+|.+...... ..+.+|+.+|++++||||+++++++... ...+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 58999999999999965 46789999998754322 3357899999999999999999988654 44689999999
Q ss_pred cccchhhhcC--------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE----cCCCcEEEEecccceec
Q 006004 241 EHDLAGLATT--------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTY 308 (665)
Q Consensus 241 ~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl----d~~g~lKL~DFGlA~~~ 308 (665)
.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 9887665432 12358999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 006004 309 DPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKLCG 377 (665)
Q Consensus 309 ~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~kI~~~~g 377 (665)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+... .+++..++..+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 43221 1234568899999999998766789999999999999999999999976543 467888999999
Q ss_pred CCChhHHhhhccccccC-----CCC----CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 378 SPSEDYWRKSKSAHATS-----FKP----QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~-----~~~----~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+....|.......... +.. .......+.......+..+.+||.+||.+||.+|+|++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99888887643211100 000 0000000111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.84 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=225.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE-SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++.+.||+|-||.||+|+.++++..||+|++-+..+... ....+.+|++|...|+||||+++|++|.+.. .+|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeE
Confidence 45789999999999999999999999999999999977654332 2356889999999999999999999999865 799
Q ss_pred EEEEecccc-chhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 235 LVFEYMEHD-LAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 235 lV~Ey~~g~-ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|++||...+ ++..+. ++..+|++.....|++|++.||.|||..+||||||||+|+|++..|.+||+|||.+.....+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 999999854 444433 36678999999999999999999999999999999999999999999999999999876422
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+.|||..|.|||+..+ ..++..+|+|++|++.||+|.|.+||...+..+.+.+|.+.--..
T Consensus 178 --kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~------------- 241 (281)
T KOG0580|consen 178 --KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF------------- 241 (281)
T ss_pred --CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC-------------
Confidence 2456799999999999987 678999999999999999999999999999999999997742211
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...++.++.|||.+||.++|.+|.+..|++.|||...
T Consensus 242 ----------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 242 ----------------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 1368999999999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=395.30 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=215.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++.+.+.. .+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-NLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-eEEEE
Confidence 379999999999999999999999999999999975432 2344567889999999999999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--- 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--- 313 (665)
|||+.|+.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999766555554556899999999999999999999999999999999999999999999999999876432110
Q ss_pred -------------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC
Q 006004 314 -------------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362 (665)
Q Consensus 314 -------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g 362 (665)
......+||+.|+|||++.+ ..++.++|||||||+||||++|++||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01134589999999999986 5789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC---CcCHHHHHh
Q 006004 363 RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN---RGSAASALR 439 (665)
Q Consensus 363 ~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~---RpTa~eaL~ 439 (665)
.+..+.+.++....... .+++ ...+++++++||.+||. +|.+ ||++.++++
T Consensus 239 ~~~~~~~~~i~~~~~~~--------------~~p~-----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 239 ETPQETYKKVMNWKETL--------------IFPP-----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCHHHHHHHHHcCcCcc--------------cCCC-----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 88887777765421100 0110 12478899999999886 5554 589999999
Q ss_pred CcCCCCC
Q 006004 440 SEFFKTE 446 (665)
Q Consensus 440 Hp~f~~~ 446 (665)
||||...
T Consensus 293 hp~f~~~ 299 (363)
T cd05628 293 NPFFEGV 299 (363)
T ss_pred CCCCCCC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=381.38 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=213.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.++++++|+||+++++++...+ .+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-eEEEEE
Confidence 388999999999999999999999999999998754432 223345778999999999999999999988755 799999
Q ss_pred Eeccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++.+. .+.. ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999976554 3322 23468999999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+.......+........
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05631 158 VRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------------- 221 (285)
T ss_pred ecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc---------------
Confidence 345578999999999986 6789999999999999999999999988765443333322211110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEP 447 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~ 447 (665)
......++.++.+||.+||+.||.+|++ ++++++||||....
T Consensus 222 ----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 222 ----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 1122368899999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=389.85 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=219.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.... .+||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-YLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-EEEEEE
Confidence 69999999999999999999999999999999975432 2234566889999999999999999999988755 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccC
Confidence 9999876666655556799999999999999999999999999999999999999999999999999987543 234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+........ .+
T Consensus 157 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------~~ 220 (333)
T cd05600 157 SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------------RP 220 (333)
T ss_pred CcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------CC
Confidence 5679999999999987 5789999999999999999999999999887777666543211000 00
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.. ......+++++.+||.+||..+|.+|+++.++++||||....
T Consensus 221 ~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 221 VY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred CC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 00 000135789999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=395.76 Aligned_cols=260 Identities=31% Similarity=0.426 Sum_probs=213.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++|||||++++++.+.. .+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-EEEEEE
Confidence 59999999999999999999999999999999975432 3345667889999999999999999999998765 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-----
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ----- 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~----- 312 (665)
|||.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999875554444444579999999999999999999999999999999999999999999999999975431100
Q ss_pred -----------------------------------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHH
Q 006004 313 -----------------------------------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILA 351 (665)
Q Consensus 313 -----------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLy 351 (665)
.....+.+||+.|+|||++.+ ..|+.++|||||||+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHH
Confidence 000123579999999999986 57899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC
Q 006004 352 ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431 (665)
Q Consensus 352 eLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R 431 (665)
||++|++||.+.+..+...++....... .+ .....+++++.+||.+|+ .||.+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~~-----------p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSL--------------HI-----------PPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCc--------------CC-----------CCcccCCHHHHHHHHHHc-cCHhHc
Confidence 9999999999988877766664311100 00 011357899999999987 599999
Q ss_pred cC---HHHHHhCcCCCCC
Q 006004 432 GS---AASALRSEFFKTE 446 (665)
Q Consensus 432 pT---a~eaL~Hp~f~~~ 446 (665)
++ +.++++||||+..
T Consensus 294 ~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 294 LGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCCHHHHhcCCCcCCc
Confidence 97 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=395.82 Aligned_cols=261 Identities=30% Similarity=0.412 Sum_probs=213.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++++.||+|+||+||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++.+.. .+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-EEEEEE
Confidence 59999999999999999999999999999999976543 3445667889999999999999999999998765 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC----
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---- 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~---- 313 (665)
||+.++.+..+......+++..++.++.||+.||.|||..||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9998765554444455799999999999999999999999999999999999999999999999999864321000
Q ss_pred ------------------------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHH
Q 006004 314 ------------------------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILA 351 (665)
Q Consensus 314 ------------------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLy 351 (665)
....+.+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHH
Confidence 01124579999999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhccc--CcC
Q 006004 352 ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTI--EPE 429 (665)
Q Consensus 352 eLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~--DP~ 429 (665)
||++|.+||.+.+..+...++....... . ......+++++++||.+||.. +|.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~-----------~~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTL--------------H-----------IPPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHcccccc--------------C-----------CCCCCCCCHHHHHHHHHHccCccccc
Confidence 9999999999888766666554311100 0 001125789999999997654 455
Q ss_pred CCcCHHHHHhCcCCCCC
Q 006004 430 NRGSAASALRSEFFKTE 446 (665)
Q Consensus 430 ~RpTa~eaL~Hp~f~~~ 446 (665)
.|+++.++|+||||...
T Consensus 295 ~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 295 GRNGADDIKAHPFFSEV 311 (381)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 59999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=406.39 Aligned_cols=282 Identities=23% Similarity=0.329 Sum_probs=222.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC------CCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH------PNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIV~l~~~~~~~~ 230 (665)
.++|++++.||+|+||+||+|++..+++.||||+++... .....+..|+.+++.+.| .+|++++++|....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 467999999999999999999999999999999996422 223345667777777754 45899999998776
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCC--------------
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAG-------------- 295 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g-------------- 295 (665)
..+|||||++.++++..+... ..+++.+++.++.||+.||.|||. .|||||||||+||||+.++
T Consensus 205 ~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 205 GHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 689999999988888777654 479999999999999999999998 5999999999999998765
Q ss_pred --cEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 006004 296 --VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373 (665)
Q Consensus 296 --~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~ 373 (665)
.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..+.
T Consensus 284 ~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CceEEECCCCccccCcc----ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999998864322 2345689999999999987 578999999999999999999999999999999999999
Q ss_pred HhcCCCChhHHhhhcccccc----CCCCCCc-ch-hhhhhh-----c--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 374 KLCGSPSEDYWRKSKSAHAT----SFKPQQP-YK-RKVLET-----F--RNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 374 ~~~g~p~~~~~~~~~~~~~~----~~~~~~p-~~-~~~~~~-----~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.+|.++.+++......... ......+ +. ..+... + ....+.+.+||.+||.+||.+|+|+.|+|+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 99999887765432111000 0000000 00 000000 0 0124668899999999999999999999999
Q ss_pred cCCCCCC
Q 006004 441 EFFKTEP 447 (665)
Q Consensus 441 p~f~~~~ 447 (665)
|||....
T Consensus 439 p~~~~~~ 445 (467)
T PTZ00284 439 PYVLKYY 445 (467)
T ss_pred ccccccC
Confidence 9998653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=390.87 Aligned_cols=256 Identities=26% Similarity=0.340 Sum_probs=217.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCC-cEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|++..++ ..||+|++..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-YL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-EE
Confidence 3467999999999999999999976655 6899999875432 3344567889999999999999999999998765 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999987666555555567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 185 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 245 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---------------- 245 (340)
T ss_pred --cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 234579999999999986 5689999999999999999999999999887776666643210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||++||+.||.+|+ |+.++++||||...
T Consensus 246 -------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 246 -------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 11235788999999999999999995 89999999999864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=390.81 Aligned_cols=262 Identities=33% Similarity=0.480 Sum_probs=218.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.++..++||||+++++++.+.. .+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-HLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-eEEEE
Confidence 369999999999999999999999999999999976433 2244567889999999999999999999988755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC----
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ---- 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~---- 312 (665)
|||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 9999875555444444679999999999999999999999999999999999999999999999999998764432
Q ss_pred ------------------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH
Q 006004 313 ------------------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368 (665)
Q Consensus 313 ------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~ 368 (665)
.......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 112344579999999999987 5789999999999999999999999999887777
Q ss_pred HHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-HHHHHhCcCCCCCC
Q 006004 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-AASALRSEFFKTEP 447 (665)
Q Consensus 369 l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-a~eaL~Hp~f~~~~ 447 (665)
..++....... . . .....+++++.+||.+||. ||.+|++ +.++|+||||+...
T Consensus 239 ~~~i~~~~~~~--------------~----~-------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 239 YNKIINWKESL--------------R----F-------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHHhccCCcc--------------c----C-------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 66665411100 0 0 0112378999999999997 9999999 99999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=394.81 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=213.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||++++++|.+.. .+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-YLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-eeEEE
Confidence 369999999999999999999999999999999875432 3345667889999999999999999999998765 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--- 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--- 313 (665)
|||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99998765554444556799999999999999999999999999999999999999999999999999964321000
Q ss_pred -------------------------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHH
Q 006004 314 -------------------------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCIL 350 (665)
Q Consensus 314 -------------------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iL 350 (665)
....+.+||+.|+|||++.+ ..++.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil 238 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIM 238 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhh
Confidence 00013579999999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC
Q 006004 351 AELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN 430 (665)
Q Consensus 351 yeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~ 430 (665)
|||++|.+||.+.+..+.+..+....... .+ | ....++.++.+||.+||. +|.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~~----p-------~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETL--------------YF----P-------DDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCcc--------------CC----C-------CCCCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999988777776664311000 00 0 112478899999999998 7777
Q ss_pred C---cCHHHHHhCcCCCCC
Q 006004 431 R---GSAASALRSEFFKTE 446 (665)
Q Consensus 431 R---pTa~eaL~Hp~f~~~ 446 (665)
| +|+.++|+||||+..
T Consensus 293 r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred cCCCCCHHHHhcCCCcCCC
Confidence 5 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=394.93 Aligned_cols=260 Identities=30% Similarity=0.411 Sum_probs=213.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++||||+++++.+.... .+||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-NLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-EEEEEE
Confidence 69999999999999999999999999999999865322 2234566889999999999999999999998755 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-----
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ----- 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~----- 312 (665)
||+.++.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999876555554445579999999999999999999999999999999999999999999999999985332100
Q ss_pred -------------------------------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh
Q 006004 313 -------------------------------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355 (665)
Q Consensus 313 -------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt 355 (665)
.......+||+.|+|||++.+ ..++.++|||||||+||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhh
Confidence 001123579999999999976 678999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc---
Q 006004 356 GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG--- 432 (665)
Q Consensus 356 G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp--- 432 (665)
|++||.+.+..+....+....... .......+++.+.+||.+|+ .+|.+|+
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTL-------------------------HIPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccc-------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 999999988776666553211000 00011357899999999987 5999999
Q ss_pred CHHHHHhCcCCCCC
Q 006004 433 SAASALRSEFFKTE 446 (665)
Q Consensus 433 Ta~eaL~Hp~f~~~ 446 (665)
|+.++|+||||+..
T Consensus 294 t~~ell~h~~~~~~ 307 (376)
T cd05598 294 GADEIKAHPFFKGI 307 (376)
T ss_pred CHHHHhCCCCcCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=391.90 Aligned_cols=264 Identities=26% Similarity=0.388 Sum_probs=219.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~-~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK-YLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-EEE
Confidence 45689999999999999999999999999999999975432 2234456788999999999999999999988755 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.|+.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999987655555443 36899999999999999999999999999999999999999999999999999876543332
Q ss_pred CcccccccccccCcccccCC---cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA---TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~---~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|++||.+.+....+.+|.......
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 266 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL------------ 266 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC------------
Confidence 33456799999999998753 347899999999999999999999999988877777765421100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~ 446 (665)
.+ .....++.++.+||.+||..+|.+ |+|+.++|+||||+..
T Consensus 267 --~~-----------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 267 --TF-----------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred --CC-----------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 00 011257899999999999999998 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=368.66 Aligned_cols=283 Identities=40% Similarity=0.694 Sum_probs=237.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-GFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-eeEEEec
Confidence 489999999999999999999999999999999876544455567889999999999999999999988754 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.............
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 99666666665555679999999999999999999999999999999999999999999999999998775443223445
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc---CC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT---SF 395 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~---~~ 395 (665)
..++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+....+.+....|......... .+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 578999999999877666799999999999999999999999999999999999999998888777653321110 11
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.... ...+...+.+.+..+.+||.+||..||.+|||+.++|+||||.
T Consensus 240 ~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESK--PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCC--cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111 1112344557789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=381.17 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=209.3
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||+|+||.||+|++..+++.||+|+++.... .......+.+|+.+|++++||||+++++++.... .+|+||||+.++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-KLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-eEEEEEcCCCCCc
Confidence 7999999999999999999999999975432 3345567789999999999999999999988754 7999999999866
Q ss_pred hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccccc
Q 006004 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW 324 (665)
Q Consensus 245 l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~ 324 (665)
+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~ 158 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPE 158 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcc
Confidence 65555555679999999999999999999999999999999999999999999999999998643222 22345679999
Q ss_pred ccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhh
Q 006004 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRK 404 (665)
Q Consensus 325 Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~ 404 (665)
|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 159 y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------------------------- 209 (312)
T cd05585 159 YLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------------------------- 209 (312)
T ss_pred cCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC----------------------------
Confidence 999999986 678999999999999999999999999887766665553310
Q ss_pred hhhhccCCcHHHHHHHHHhcccCcCCCc---CHHHHHhCcCCCC
Q 006004 405 VLETFRNFPQSALALVDKLLTIEPENRG---SAASALRSEFFKT 445 (665)
Q Consensus 405 ~~~~~~~~s~~a~dLI~~lL~~DP~~Rp---Ta~eaL~Hp~f~~ 445 (665)
......+++.+.+||.+||..||.+|+ ++.++|+||||..
T Consensus 210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 011235788999999999999999997 5899999999986
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.89 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=218.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||+|++..+|+.||||+++.... ..+....+.+|+.+++.++||||+++++++.... .+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-NLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-eEEEE
Confidence 369999999999999999999999999999999986543 3345567889999999999999999999988754 79999
Q ss_pred EEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999875544 444443679999999999999999999999999999999999999999999999999998775443333
Q ss_pred cccccccccccCcccccC-----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 316 LTSRVVTLWYRAPELLLG-----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~-----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+.++.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 228 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL----------- 228 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 334578999999999863 3567899999999999999999999999888777776664421000
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. . .....+++.+.+||..||. ||.+|+|+.++++||||...
T Consensus 229 ---~----~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 229 ---K----F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ---C----C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 0 0 0113578999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=384.15 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=209.5
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
+|++++.||+|+||.||++++. .+++.||+|++..... .....+.+.+|+.+|+.+ .||||+++++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-K 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC-E
Confidence 4899999999999999999864 5789999999975432 223345678899999999 5999999999988754 7
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 89999999976555444445579999999999999999999999999999999999999999999999999998764433
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......+||+.|+|||++.+...++.++|||||||+||+|++|+.||...........+......
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------- 225 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------------- 225 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--------------
Confidence 333345689999999999987556889999999999999999999999754322111111110000
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
..+ .....+++.+.+||.+||..||.+|+ ++.++|+||||+..
T Consensus 226 --~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 226 --CDP---------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred --CCC---------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 000 11135788999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=383.71 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=211.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.... .+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-EEEEEEeCCCC
Confidence 369999999999999999999999999975432 3345567789999999999999999999988765 79999999998
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+||
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt 158 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGT 158 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCC
Confidence 766655555567999999999999999999999999999999999999999999999999998764322 1223456799
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+....+....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------------------- 211 (328)
T cd05593 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------------------------- 211 (328)
T ss_pred cCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--------------------------
Confidence 99999999876 578999999999999999999999998877665555442210
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......+++++.+||.+||.+||.+|+ ++.++|+||||...
T Consensus 212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 212 ---IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ---ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 011235789999999999999999997 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=389.36 Aligned_cols=265 Identities=26% Similarity=0.372 Sum_probs=217.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK-YLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEE
Confidence 34679999999999999999999999999999999975322 2334456789999999999999999999998755 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999876555444433 6899999999999999999999999999999999999999999999999999877543333
Q ss_pred CcccccccccccCcccccCC---cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA---TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~---~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|++||.+.+....+.+|........
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------- 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN----------- 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC-----------
Confidence 33456899999999998753 2478999999999999999999999999888777777654211100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTEP 447 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~~ 447 (665)
. .....++..+++||..||..++.+ |+|+.++|+||||+...
T Consensus 268 -------~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 268 -------F-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred -------C-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 0 011247889999999999866544 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=382.12 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=211.9
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
+.||+|+||.||++++..+|+.||+|+++.... .......+.+|+.+++.++||||++++++|.... .+||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-EEEEEEeCCCC
Confidence 369999999999999999999999999975432 3344566788999999999999999999998765 79999999998
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ........||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 158 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccCC
Confidence 766655555567999999999999999999999999999999999999999999999999998754222 1223446799
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 159 ~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------- 212 (323)
T cd05595 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------- 212 (323)
T ss_pred cCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence 99999999876 5789999999999999999999999988877666665532100
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||.+||.+|+ ++.++|+|+||...
T Consensus 213 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 213 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 01235789999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=388.34 Aligned_cols=262 Identities=29% Similarity=0.419 Sum_probs=216.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+++.||||+++.... ..+....+.+|+.++..++||||+++++.+.+.. .+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-NLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEEEE
Confidence 469999999999999999999999999999999975432 3345667889999999999999999999998765 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--- 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--- 313 (665)
|||+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999766655554555799999999999999999999999999999999999999999999999999875432110
Q ss_pred -------------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC
Q 006004 314 -------------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362 (665)
Q Consensus 314 -------------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g 362 (665)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCC
Confidence 01124579999999999986 6789999999999999999999999999
Q ss_pred CChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc---CHHHHHh
Q 006004 363 RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG---SAASALR 439 (665)
Q Consensus 363 ~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp---Ta~eaL~ 439 (665)
.+..+.+.++...... ..++ ....+++++++||.+|+. ||.+|+ ++.++++
T Consensus 239 ~~~~~~~~~i~~~~~~--------------~~~p-----------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQETYRKVMNWKET--------------LVFP-----------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHHHHHHHHcCCCc--------------eecC-----------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 8887777666431000 0000 012478899999999874 999998 4899999
Q ss_pred CcCCCCCC
Q 006004 440 SEFFKTEP 447 (665)
Q Consensus 440 Hp~f~~~~ 447 (665)
||||....
T Consensus 293 hp~f~~~~ 300 (360)
T cd05627 293 HPFFEGVD 300 (360)
T ss_pred CCCCCCCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=386.26 Aligned_cols=258 Identities=26% Similarity=0.504 Sum_probs=234.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.-|.+.+.||+|.|++|.+|++.-||..||||+|.+..++.-....+..|+..|+.+.|||||+||+++..+. .+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-KlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-KLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-eEEEEE
Confidence 3599999999999999999999999999999999988887777778899999999999999999999988765 799999
Q ss_pred Eeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE-cCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI-NNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl-d~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|+-++ ++.+++.+....+.|+.+++|+.||+.|+.|||+..||||||||+|+.+ ..-|.+||.|||++..+.++..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 99986 7888888877789999999999999999999999999999999999766 4679999999999999887655
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
+++.||++.|.|||+++|..+..+++||||||||||.|++|++||+..++.+.+..|+....+
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt----------------- 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT----------------- 237 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-----------------
Confidence 788999999999999999777778999999999999999999999999999999999764222
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.+.+++.++++||..||..||.+|.+.+++..|+|++...
T Consensus 238 ------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 238 ------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred ------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 2247899999999999999999999999999999998653
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.59 Aligned_cols=281 Identities=41% Similarity=0.752 Sum_probs=230.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||.|+||.||+|++..+|+.||||+++...........+.+|++++++++||||+++++++.... .+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-cEEEEee
Confidence 489999999999999999999999999999998765443344456789999999999999999999987654 7899999
Q ss_pred eccccchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|+.+++...+.. ....+++.++..++.||+.||+|||+.|++|+||+|+|||++.++.+||+|||++..+.... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 158 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccc
Confidence 998876665543 34568999999999999999999999999999999999999999999999999988664322 1223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc--cCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA--TSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~--~~~ 395 (665)
...+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.++.+.+.++.+..+.+....|........ ..+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 346789999999987756678899999999999999999999999999999999999888888777754321110 001
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.. ............+++++++||.+||..||.+|||+.++|.||||
T Consensus 239 ~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PK--WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cc--ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 00111223345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=378.80 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=212.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHH---HhCCCCCcceeeeeeeccCCcEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHIL---RKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
|++++.||+|+||.||+|++..+++.||||+++.... .....+.+.+|+.++ +.++||||+++++++.... .+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-HVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-EEEE
Confidence 7889999999999999999999999999999975432 233455667777665 4668999999999998755 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+...... ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DR 157 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-Cc
Confidence 9999998766555543 369999999999999999999999999999999999999999999999999987543222 22
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------------ 218 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 345679999999999876 5789999999999999999999999999887777766543110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||.+|| ++.++++||||+..
T Consensus 219 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 -----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 01135788999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=371.49 Aligned_cols=287 Identities=46% Similarity=0.830 Sum_probs=234.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC------
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS------ 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 230 (665)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 45899999999999999999999999999999998755433222344678999999999999999999875443
Q ss_pred -CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 231 -GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 231 -~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
..+|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||+++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 2479999999998888777666689999999999999999999999999999999999999999999999999998654
Q ss_pred CCCC----------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 006004 310 PSQN----------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 310 ~~~~----------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3221 112344678999999998765668999999999999999999999999999999999999999888
Q ss_pred ChhHHhhhccccccCC-CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 380 SEDYWRKSKSAHATSF-KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+..|........... .........+...+..+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 7776654322211110 001111222334456677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=392.50 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=223.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
..|+.++.||+|+||.||+|.+..+++.||+|++..... ...+..+++|+.+|.+++++||.++|+.|.... .++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHH
Confidence 368899999999999999999999999999999987654 345677899999999999999999999998765 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||.|+....++..+..+.|.++..++++++.||.|||..+.+|||||+.||||..+|.+||+|||++..+....... .
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 999998887777777777999999999999999999999999999999999999999999999999999886655444 7
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
+++|||.|||||++.+ ..|+.++||||||++.|||++|.||+....+.-.+-.|-+ ..+|
T Consensus 170 tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------------~~PP 229 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------------SAPP 229 (467)
T ss_pred cccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------------------CCCC
Confidence 7899999999999995 7899999999999999999999999988765222111111 1111
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.+-..+++.+++||..||++||+.||+|.++|+|+|++.
T Consensus 230 ---------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 ---------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 112378999999999999999999999999999999987
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=382.89 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=210.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.... .+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-EEEEEEeCCCC
Confidence 369999999999999999999999999975432 2334556778999999999999999999988765 79999999998
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
+.+.........+++.+++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 158 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccC
Confidence 7666655555679999999999999999999997 799999999999999999999999999987643221 22344579
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.+..+....+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~------------------------- 212 (325)
T cd05594 159 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------- 212 (325)
T ss_pred CcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence 999999999976 578999999999999999999999999887666555543210
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......+++++.+||.+||.+||.+|+ ++.++|+||||...
T Consensus 213 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 213 ----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 001135788999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.70 Aligned_cols=290 Identities=42% Similarity=0.732 Sum_probs=236.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
+|++++.||+|+||.||+|.+..+|+.||||.++..... ......+..|++++++++|+||+++++++... ..+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-SNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-CEEEE
Confidence 488999999999999999999999999999999765433 23345567899999999999999999999875 47999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+++...+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-K 158 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-c
Confidence 999996666666554434799999999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....+++.|+|||.+.+...++.++|+|||||++|+|++|.++|.+.++.+.+.++...++.+....|..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV- 237 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc-
Confidence 3334668899999998765678999999999999999999999999999999999998888888777775432221110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCD 451 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~ 451 (665)
.............+...+..+.+||.+||.+||.+|||+.++|.|+||.+.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00011111123344567899999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.86 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=215.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||++++..+++.||||++.... ......+.+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-NLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-eEEEE
Confidence 47999999999999999999999999999999997532 23334566888999999999999999999998764 89999
Q ss_pred EEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+ ..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999986544 4444445579999999999999999999999999999999999999999999999999998765433322
Q ss_pred cccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 316 LTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+.++.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF------------ 227 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc------------
Confidence 333578999999999863 2457889999999999999999999999888777766664321100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~ 446 (665)
. +......++..+++||.+||..++.+ |+++.++|+||||...
T Consensus 228 --~----------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 228 --Q----------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred --c----------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0 00112348899999999999765544 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.09 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=214.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCC-CcceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHP-NVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIV~l~~~~~~~~~~l~lV 236 (665)
+|++++.||+|+||.||+|++..+++.||||+++.... .....+.+..|+.++..+.|+ +|+++++++...+ .+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-EEEEE
Confidence 48999999999999999999999999999999976432 234456678899999999765 5788888887654 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 158 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTT 158 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cce
Confidence 9999976665555555579999999999999999999999999999999999999999999999999987542221 123
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------- 218 (324)
T cd05587 159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------- 218 (324)
T ss_pred eeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 44579999999999986 5689999999999999999999999999888777776643210
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH-----HHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA-----ASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa-----~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||.+||.+|+++ .++++||||...
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 219 ----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 1113578899999999999999999986 899999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=363.70 Aligned_cols=280 Identities=36% Similarity=0.638 Sum_probs=228.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeecc-CCcEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSR-SGSLYLVF 237 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~l~lV~ 237 (665)
|++++.||+|+||.||++.+..+++.||+|+++......... ...+|+.+++++. |+||+++++++.+. .+.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987543332222 3457999999985 99999999998875 24799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.++..++.||+.||.|||+.||+|+||||+|||++. +.+||+|||++..+.... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 99999888877765567999999999999999999999999999999999999999 999999999998764322 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45689999999987655667899999999999999999999999999999999999988888876543322221111111
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......+......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111112223344679999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.30 Aligned_cols=276 Identities=35% Similarity=0.647 Sum_probs=214.7
Q ss_pred EEeeccCceEEEEEEECC--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDLE--TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~Ey~ 240 (665)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++... ...+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 589999999999999654 568899999875432 23467899999999999999999988643 45789999999
Q ss_pred cccchhhhcC--------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE----cCCCcEEEEecccceec
Q 006004 241 EHDLAGLATT--------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTY 308 (665)
Q Consensus 241 ~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl----d~~g~lKL~DFGlA~~~ 308 (665)
.+++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9987765532 12358999999999999999999999999999999999999 56679999999999876
Q ss_pred CCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 006004 309 DPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKLCG 377 (665)
Q Consensus 309 ~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~kI~~~~g 377 (665)
..... ......++|+.|+|||++.+...++.++|||||||++|+|++|++||.+..+ ..++..+...+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43321 1234557899999999998766789999999999999999999999976542 456778888899
Q ss_pred CCChhHHhhhccccc-cC----CCC----CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 378 SPSEDYWRKSKSAHA-TS----FKP----QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~-~~----~~~----~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+..+.|........ .. +.. ...............+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888876432110 00 000 0000000111112356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.23 Aligned_cols=284 Identities=25% Similarity=0.328 Sum_probs=217.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||++++..+|..||+|++.... .......+.+|+++|+.++||||+++++++.... .+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEEE
Confidence 468999999999999999999999999999999997543 3455667899999999999999999999988754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 99999876665555555799999999999999999999986 69999999999999999999999999998664322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc-ccccc-
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK-SAHAT- 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~-~~~~~- 393 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........+.... .....
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 244578999999999986 568999999999999999999999998877654333221111000000000000 00000
Q ss_pred -----CCCCCCcch-------hhhh-----hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 -----SFKPQQPYK-------RKVL-----ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 -----~~~~~~p~~-------~~~~-----~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+.. .... .....+++++++||.+||.+||++|||+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000000 0000 0012478899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=378.67 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=210.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|+++.+++.||||+++.... .......+..|+.++..+ +||||+++++++.... .+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-RLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-EEEEEEcCCC
Confidence 369999999999999999999999999975432 233456677899999876 7999999999998765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 158 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCG 158 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccccc
Confidence 86665555555679999999999999999999999999999999999999999999999999987643221 22345579
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (320)
T cd05590 159 TPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------------------------ 213 (320)
T ss_pred CccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 999999999876 6789999999999999999999999999888777776643110
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH------HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA------ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa------~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||..||.+|+++ .++++||||...
T Consensus 214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 0112478899999999999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.76 Aligned_cols=285 Identities=31% Similarity=0.529 Sum_probs=231.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 232 (665)
++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.++++++||||++++++|.... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 5799999999999999999999999999999998654434455566778999999999999999999886432 25
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+.. .+++.++..++.||+.||.|||.+||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 96 VYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 799999999887776543 28999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++...++.+..+++........
T Consensus 173 --~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 173 --MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred --CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 2334568999999999986 6789999999999999999999999999999999999999999998877654321111
Q ss_pred cCCCCC-----Ccchhh---------hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 TSFKPQ-----QPYKRK---------VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~~~~-----~p~~~~---------~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
...... .++... ........++.+++||.+||..||.+|||+.++|.||||+.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 100000 000000 00012235677899999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=367.65 Aligned_cols=286 Identities=45% Similarity=0.783 Sum_probs=234.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~l 235 (665)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.++++++||||+++++++... ...+||
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 3579999999999999999999999999999999976544433344567899999999999999999988765 258999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987777666555579999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~ 394 (665)
.....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++...++.+....|........ ..
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 33456789999999987655678999999999999999999999999999999999999999998888875432111 10
Q ss_pred CCCCCcchhhhhhhccC--CcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRN--FPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~--~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..........+...++. +++.+.+||.+||..||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00001111112233333 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=361.22 Aligned_cols=283 Identities=35% Similarity=0.627 Sum_probs=226.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-KLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-EEEEEE
Confidence 4699999999999999999999999999999998754333333455788999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++++..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+..... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 9999988887766666799999999999999999999999999999999999999999999999999987654321 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh---HHhhhccccccC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED---YWRKSKSAHATS 394 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~---~~~~~~~~~~~~ 394 (665)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+..... .|..........
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 45678999999998765678899999999999999999999999998888777776655543321 111100000000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
... ..........+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPE-PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCC-cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 000111223345789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=364.48 Aligned_cols=284 Identities=37% Similarity=0.712 Sum_probs=229.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|.++.+++.||||.+...... .....+.+|++++++++|+||+++++++.... ..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKK-TLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCC-eEEEE
Confidence 35799999999999999999999999999999998754322 12234568999999999999999999988754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TY 160 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cc
Confidence 99999988777666555789999999999999999999999999999999999999999999999999876432211 12
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhHHhhhccccccC-
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT-EVEQMHKIFKLCGSPSEDYWRKSKSAHATS- 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~- 394 (665)
....++..|+|||++.+...++.++||||+||++|+|++|++||.+.+ ..+++..+.+..+.+..+.|..........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 233568899999998765668899999999999999999999998776 677888888999998888886543221110
Q ss_pred CCCCCcchhhhhhhccCCc--HHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFP--QSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s--~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..........+......++ .++.+||.+||..||.+|||+.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000000111223333455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=362.59 Aligned_cols=280 Identities=39% Similarity=0.778 Sum_probs=233.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||.|++|.||+|++..+|+.||||+++..... .....+.+|+.++++++||||+++++++.... .+|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEe
Confidence 489999999999999999999999999999999765432 23445678999999999999999999998764 7899999
Q ss_pred eccccchhhhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAGLATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.+++...+.... ..+++.++..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++........ ..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 99998777665433 4689999999999999999999999999999999999999999999999999986543222 12
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.++......+....|........ +.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 235 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE--YK 235 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch--hc
Confidence 3346789999999987756678999999999999999999999999999999999999999998888876542211 11
Q ss_pred CCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
...+. ..........+++.+.++|.+||+.||.+|||+.++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11111 112233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=367.00 Aligned_cols=288 Identities=48% Similarity=0.876 Sum_probs=238.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----- 230 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----- 230 (665)
..++|++.+.||+|+||.||+|.++.+|+.||+|+++...........+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 346899999999999999999999999999999999765433333445678999999999999999999886533
Q ss_pred ----CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 231 ----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 231 ----~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
+.+|+||||++++++..+......+++.+++.++.||+.||.|||+.||+|+||||+|||+++++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 3689999999998887777655579999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.+............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 76544333333445688899999887655678999999999999999999999999999999999999999888877764
Q ss_pred hccccc-cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 387 SKSAHA-TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 387 ~~~~~~-~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
...... ..........+.+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 322111 111111222233444556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=383.32 Aligned_cols=264 Identities=27% Similarity=0.378 Sum_probs=216.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.... .+|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-EEEE
Confidence 4689999999999999999999999999999999975332 2334456788999999999999999999998754 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+..+.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 99999876555444433 58999999999999999999999999999999999999999999999999998765433323
Q ss_pred cccccccccccCcccccCC---cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 316 LTSRVVTLWYRAPELLLGA---TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~---~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||.+.+......+|.......
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 266 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------------- 266 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-------------
Confidence 3456899999999998753 247899999999999999999999999988877777665421100
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTEP 447 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~~ 447 (665)
. ......++..+++||..||..++.+ |+++.++++|+||+...
T Consensus 267 -~-----------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 267 -T-----------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -c-----------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0 0112368999999999999844433 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=375.68 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=210.9
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||||+++.... .......+..|+.++..+ +||||+++++++.... .+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-RLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-eEEEEEeCCC
Confidence 369999999999999999999999999976432 234455677899999876 8999999999998765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 158 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCG 158 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccccc
Confidence 86665555455579999999999999999999999999999999999999999999999999998643222 22345579
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....-
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (321)
T cd05591 159 TPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV------------------------ 213 (321)
T ss_pred CccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 999999999876 6789999999999999999999999999988877777644110
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCc-------CHHHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRG-------SAASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-------Ta~eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||.+||.+|+ ++.++++||||...
T Consensus 214 -----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 214 -----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 01124688999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=418.02 Aligned_cols=277 Identities=27% Similarity=0.394 Sum_probs=238.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.|.+++++.+++.||+|++.+-.+ .......|+.|..||...+.+.|+.|+..|++.. ++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~-~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER-YLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-ceE
Confidence 45789999999999999999999999999999999976433 3445567899999999999999999999999976 899
Q ss_pred EEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+|||||.| |++.++..-+ +++|..+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.+..++.+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999986 6777777666 899999999999999999999999999999999999999999999999999999987777
Q ss_pred CCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 314 LPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
......+|||.|++||++.. .+.|+..+|+|||||++||||.|..||...+-.+++-+|...-.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~------------ 298 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE------------ 298 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh------------
Confidence 77777899999999999862 25799999999999999999999999999999999999976310
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC---HHHHHhCcCCCCCCCCCCCCCCCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS---AASALRSEFFKTEPLPCDPSNLPKYPP 460 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT---a~eaL~Hp~f~~~~~~~~p~~~p~~~~ 460 (665)
.-.|+ ....+|..+++||+++|. +|+.|.. +.++.+||||.+..|..-....|++.|
T Consensus 299 --~l~FP-----------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 299 --SLSFP-----------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred --hcCCC-----------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 00111 012599999999999995 7888988 999999999999887544444455444
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=361.14 Aligned_cols=284 Identities=58% Similarity=1.014 Sum_probs=239.6
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVFE 238 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~E 238 (665)
|++++.||.|+||.||+|++..+++.||+|.+............+.+|+.+++.++|+||+++++++... .+.+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7889999999999999999999999999999986543344456678999999999999999999998876 258999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.+++...+......+++.+++.++.||+.||.|||+.|++|+||||+|||+++++.+||+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99998887777665689999999999999999999999999999999999999999999999999998775543323344
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc-cccCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA-HATSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~-~~~~~~~ 397 (665)
..++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+...++.+....|...... ....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 567889999998876567899999999999999999999999999999999999999998888777654322 1122222
Q ss_pred CCcchhhhhhhccCC-cHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 398 QQPYKRKVLETFRNF-PQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~-s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..+....+...+... ++.+.+||.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333333444445554 9999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=373.85 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=214.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+|++++.||+|+||.||+|++..+++.||||+++.... .......+..|+.++..+ .|++|+++++++...+ .+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-RLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-EEEEE
Confidence 48999999999999999999999999999999975432 233445567788888887 5899999999988755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~ 158 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTT 158 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Ccc
Confidence 9999876555444445579999999999999999999999999999999999999999999999999997643221 123
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------------- 218 (323)
T cd05616 159 KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------- 218 (323)
T ss_pred ccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence 45679999999999986 6789999999999999999999999999888777766654210
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||.+||.+|++ ..++++||||...
T Consensus 219 ----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 219 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 011357889999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=365.52 Aligned_cols=287 Identities=47% Similarity=0.744 Sum_probs=229.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC------
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS------ 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~------ 230 (665)
.++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34799999999999999999999999999999998754333233344568999999999999999999876532
Q ss_pred -CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 231 -GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 231 -~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
...|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 3469999999998888777666679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 310 PSQN---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 310 ~~~~---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...+|..+.+.|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3322 1223456789999999987755678999999999999999999999999998888888889898888776654
Q ss_pred hccccccC-CCCCCcchhhhhhh--ccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 387 SKSAHATS-FKPQQPYKRKVLET--FRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 387 ~~~~~~~~-~~~~~p~~~~~~~~--~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
........ .............. ....++.+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 32111100 00000000011111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=386.98 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=231.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+.|+.++.+|+|+||.+++++++.+++.||+|+|+.........+....|+.+++++.|||||.+.+.|...+..++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35799999999999999999999999999999999998877666667889999999999999999999999877569999
Q ss_pred EEeccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+||+|+.+. .+.. ++..|+|+.+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+.+.. .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-S 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-h
Confidence 9999986554 3433 34679999999999999999999999999999999999999999999999999999987654 2
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...+.+||+.||+||++.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|.+.+..|-+
T Consensus 162 ~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------- 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------- 227 (426)
T ss_pred hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------------
Confidence 4567899999999999987 78999999999999999999999999999999999999886544422
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
..++.+++.||+.||..+|..||+|.++|.+|...
T Consensus 228 ---------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ---------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 35788999999999999999999999999997765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=375.30 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=215.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+++++.+++.||+|++..... .......+.+|+.++..++|+||+++++++.+.. .+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-NLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-EEEEE
Confidence 379999999999999999999999999999999864322 2333455788999999999999999999998765 79999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++ |...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999865 444554445579999999999999999999999999999999999999999999999999998654333322
Q ss_pred cccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 316 LTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
....+||+.|+|||++.. ...++.++|||||||+||+|++|+.||.+.+..+.+.++.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------ 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc------------
Confidence 334579999999999862 3468899999999999999999999999988777777664321000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~ 446 (665)
........+++++++||.+||..++.+ |+++.++++||||...
T Consensus 228 ------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 228 ------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 001112357899999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=374.10 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=209.7
Q ss_pred EEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 163 IDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.++||||++++++|.... .+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-KLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-eEEEEE
Confidence 368999999999999864 5788999999975432 2233455778999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cccc
Confidence 999986665555555678999999999999999999999999999999999999999999999999987543222 1233
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+....+..+....
T Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------- 216 (323)
T cd05584 159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------- 216 (323)
T ss_pred ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence 4578999999999876 567899999999999999999999999988776666654311
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||.+||++|+ ++.++++||||...
T Consensus 217 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 --------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 011235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=365.62 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=205.4
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||+|+||+||++.+..+++.||+|++...... ......+..|+.+++.++||||+++.+++.... .+|+||||+.++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-DLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-eEEEEEeCCCCCC
Confidence 79999999999999999999999999754332 223456778999999999999999999888754 7999999999765
Q ss_pred hhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccc
Q 006004 245 AGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 245 l~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
+.... .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 158 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYA 158 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccC
Confidence 54332 2345699999999999999999999999999999999999999999999999999987644322 233457
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 159 g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------- 216 (280)
T cd05608 159 GTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--------------------- 216 (280)
T ss_pred CCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc---------------------
Confidence 8999999999986 578999999999999999999999998765432222221110000
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.......+++.+.+||.+||+.||++|+ |++++++||||+...
T Consensus 217 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 217 ----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 0011235889999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=373.28 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=207.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-HLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 369999999999999999999999999975432 223344556677777754 8999999999988755 7999999998
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
|+.+..+......+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~g 158 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccC
Confidence 87665555555679999999999999999999999999999999999999999999999999998653322 22345579
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~---------------------- 213 (316)
T cd05592 159 TPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P---------------------- 213 (316)
T ss_pred CccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C----------------------
Confidence 999999999986 568999999999999999999999999988776666653210 0
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH-HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA-ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa-~eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||..||.+|+++ .++++||||...
T Consensus 214 -----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 -----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0113478899999999999999999986 588899999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=363.15 Aligned_cols=285 Identities=41% Similarity=0.738 Sum_probs=229.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCC----c
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSG----S 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~----~ 232 (665)
++|++.+.||+|+||.||+|++..+++.||||+++...........+.+|+.+++.+. ||||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999999999999999998765433333456778999999995 6999999998876542 3
Q ss_pred EEEEEEeccccchhhhcCC----CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEeccccee
Q 006004 233 LYLVFEYMEHDLAGLATTP----GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATT 307 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~ 307 (665)
+|+||||+.+++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999999877765542 245899999999999999999999999999999999999998 89999999999986
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
+..... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+.+++...+.+....|...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 643221 2233467899999999876566899999999999999999999999999999999999888888877766432
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.........+... ...+....+.+++.+.+||.+||.+||.+|||+.++|.||||+
T Consensus 240 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWK-PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCccc-chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2111110001100 0112233456899999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=363.91 Aligned_cols=286 Identities=41% Similarity=0.757 Sum_probs=232.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|++|.||+|.+..+|+.||||+++...........+.+|++++++++||||+++++++.... .+|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-RLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-eEEEEE
Confidence 4799999999999999999999999999999998765443344456788999999999999999999998755 799999
Q ss_pred EeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+++++...+.... ..+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++....... ..
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RT 159 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cc
Confidence 999988777665433 34688899999999999999999999999999999999985 5579999999997654321 12
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~ 394 (665)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|........ ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 23456789999999987656688999999999999999999999999999999999999999998888864321111 00
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+ ........+.+++.+.+||.+||+.||++||++.++|.||||.+.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 240 AFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 001000 011222345688999999999999999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=377.07 Aligned_cols=333 Identities=23% Similarity=0.314 Sum_probs=269.2
Q ss_pred cCCCcccccccccccCCCCCCcceeeeeccCCCcccceeecCCCCCCcccccc---------CCc------cccccccc-
Q 006004 84 ERPKRNRHQRCATMDMGMGTGTETTIVAVGLQPQMSRIVCLPVGPEGDEVVAG---------WPS------WLTSVAGE- 147 (665)
Q Consensus 84 ~~~~~~~~~~~~~~~~~~g~~~~~s~~~~~~~p~~~r~~~~p~~~~g~~~~~~---------~p~------~~~~~~g~- 147 (665)
||++||++|++++|+++.....++..+..-+.......+++|+.+...+-... .+. ........
T Consensus 257 DrTsRNDFMGslSFgisEl~K~p~~GWyKlLsqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~ 336 (683)
T KOG0696|consen 257 DRTSRNDFMGSLSFGISELQKAPVDGWYKLLSQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSK 336 (683)
T ss_pred cccccccccceecccHHHHhhcchhhHHHHhhhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCccc
Confidence 89999999999999999988888888888888888888888887665332110 000 00000000
Q ss_pred --cccCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceee
Q 006004 148 --AIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLE 223 (665)
Q Consensus 148 --~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~ 223 (665)
........+..+|..+..||+|+||.|.++..+.+.+.||||++++..+ ..+.++.-+.|-.+|... +-|.+++|+
T Consensus 337 ~~~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlH 416 (683)
T KOG0696|consen 337 FHNSSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLH 416 (683)
T ss_pred CCCCCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHH
Confidence 0000112345679999999999999999999999999999999987643 334455556788888776 678999999
Q ss_pred eeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 224 ~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.+|+.-+ .+|+||||+.|+.+.+.+++-++|.|+.+..|+.+|+-||-+||++|||+||||.+|||||.+|++||+|||
T Consensus 417 ScFQTmD-RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 417 SCFQTMD-RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred HHhhhhh-heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 9999865 899999999987666666666689999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
++..--. ......+++|||.|+|||++. ..+|+.++|+||+||+|||||.|++||.|.++.+....|......
T Consensus 496 mcKEni~-~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 496 MCKENIF-DGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS----- 568 (683)
T ss_pred ccccccc-CCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-----
Confidence 9975322 223456789999999999887 478999999999999999999999999999999999998763221
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEPL 448 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~~ 448 (665)
.++.+|.++.++++.+|.+.|.+|.. -.++-.||||+...+
T Consensus 569 ------------------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 569 ------------------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred ------------------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 23578999999999999999999965 367889999986543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.58 Aligned_cols=284 Identities=35% Similarity=0.646 Sum_probs=229.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++.... .+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-RLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-eEEEEE
Confidence 3699999999999999999999999999999998654433334556788999999999999999999997654 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++..+.... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 999998877666555569999999999999999999999999999999999999999999999999998764432 2234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc-c-cccCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS-A-HATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~-~-~~~~~ 395 (665)
...++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+............ . .....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 457899999999987656678899999999999999999999999888888888877666543322111000 0 00011
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+...........++.++..+.+||.+||..||.+|||+.++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 111122222333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.32 Aligned_cols=283 Identities=35% Similarity=0.642 Sum_probs=233.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||+|.+..+++.||+|+++...........+.+|++++++++|+||+++++++...+ .+|+|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-RLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-EEEEEEe
Confidence 699999999999999999999999999999998765444455567889999999999999999999998754 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++++..+......+++.++..++.||+.||.|||..||+|+||+|+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99998887776666679999999999999999999999999999999999999999999999999998876544334455
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc---CC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT---SF 395 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~---~~ 395 (665)
..++.+|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+..+...++......+......... .+
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 678999999999987547899999999999999999999999999888888888887777766554332211000 00
Q ss_pred CCCCcchhhhhhhc-cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETF-RNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~-~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.... ....+...+ ..++..+++||.+||..||++|||+.++++||||
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPS-QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCC-CcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 001111122 2358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=363.97 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=212.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++.+.||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...+ .+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-eEEEEE
Confidence 489999999999999999999999999999999754332 223345678999999999999999999988765 799999
Q ss_pred Eeccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++.+. .+.. ....+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++....... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--T 157 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--c
Confidence 999876554 3322 23469999999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+........
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--------------- 221 (285)
T ss_pred cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------------
Confidence 234578999999999976 5689999999999999999999999998766544444322110000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+|+ ++.++++||||...
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 222 ----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 011235788999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=373.49 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=207.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHH-HHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIH-ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||+||+|++..+|+.||||++..... .......+..|+. +++.++||||+++++++.... .+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-KLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-EEEEEEcCCC
Confidence 369999999999999999999999999975432 2223344555555 567899999999999988755 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 158 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCG 158 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccccC
Confidence 8766655555668999999999999999999999999999999999999999999999999998754222 122345579
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (323)
T cd05575 159 TPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------- 212 (323)
T ss_pred ChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 999999999876 678999999999999999999999999988776666654310
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|+++ .++++||||...
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 213 ----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 01123578999999999999999999998 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=377.80 Aligned_cols=276 Identities=26% Similarity=0.337 Sum_probs=213.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
..|++++.||+|+||.||+|++..+++.||+|+..... ...|+.+|++++||||+++++++.... ..|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence 36999999999999999999999999999999754322 246999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~ 214 (357)
T PHA03209 137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFL 214 (357)
T ss_pred EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccc
Confidence 999999888887767789999999999999999999999999999999999999999999999999997543221 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhcCCCChhHHhhh
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRT---------EVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~---------~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
...||+.|+|||++.+ ..++.++|||||||++|||+++. ++|.... ...++..+...++..+..+....
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4578999999999986 56899999999999999999855 5554322 12344555555554444332110
Q ss_pred cccccc-----CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 388 KSAHAT-----SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 388 ~~~~~~-----~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...... ......++..........++.++.+||.+||+.||.+||||.|+|+||||+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000000 0001111111111122367888999999999999999999999999999975
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=376.10 Aligned_cols=259 Identities=29% Similarity=0.408 Sum_probs=207.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|+++++||+|+||.||+|++..+++.||||++.... .......+.+|+++|+.++|+||+++++++.... .+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-EIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-eEEEE
Confidence 457999999999999999999999999999999986443 3344567889999999999999999999987654 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 225 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPC 225 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccc
Confidence 999998765322 246788899999999999999999999999999999999999999999999998764322 123
Q ss_pred ccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 317 TSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+||..|+|||++.. ...++.++|||||||+||+|++|+.||......+....+.......
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------- 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-------------
Confidence 45579999999998743 1344678999999999999999999997433222211111110000
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.......++.++++||.+||..||++|||+.|+|+||||....
T Consensus 293 ------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 ------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011235788999999999999999999999999999998754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=372.95 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=214.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++++...+ .+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-YLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-EEEEE
Confidence 47999999999999999999999999999999987532 22334456788999999999999999999998765 79999
Q ss_pred EEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.|+.+. .+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999875544 444435579999999999999999999999999999999999999999999999999998765433222
Q ss_pred cccccccccccCcccccCC----cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 316 LTSRVVTLWYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~----~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.++......+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF------------ 227 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc------------
Confidence 2345799999999998642 357889999999999999999999999888777766664311000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~ 446 (665)
+ +......++..+++||.+||..++.+ |+++.++++||||...
T Consensus 228 --------~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 228 --------Q----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred --------c----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 0 01112357899999999999976655 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.62 Aligned_cols=289 Identities=37% Similarity=0.626 Sum_probs=236.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~ 234 (665)
++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+|++++||||+++++++... ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 579999999999999999999999999999999876543334556678899999999999999999987642 24689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~- 313 (665)
+||||+.+++...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999998776666544 4699999999999999999999999999999999999999999999999999977543221
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......+++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....|.++...+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 122345789999999998765568999999999999999999999999999999999999999999887765432211
Q ss_pred ccC----CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 392 ATS----FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 392 ~~~----~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
... +....+ ......++.++.++.+||.+||+.||.+|||+.++|.||||...+.+
T Consensus 244 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 244 VRKYIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred HHHHHhhcccCCC--CCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 111 111111 11223345689999999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=371.61 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=206.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|+++.+|+.||+|+++.... .......+..|+.++..+ +||||+++++++...+ .+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-HLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-EEEEEECCCC
Confidence 469999999999999999999999999975432 123345567788888765 8999999999998765 8999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCC
Confidence 76655444455679999999999999999999999999999999999999999999999999987542221 22345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~---------------------- 213 (316)
T cd05620 159 TPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP---------------------- 213 (316)
T ss_pred CcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----------------------
Confidence 999999999986 57899999999999999999999999988876665554321 00
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH-HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA-ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa-~eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||..||.+|+++ +++++||||...
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 -----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0112478899999999999999999998 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=364.38 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=228.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|..++.||+|+||.|-+|+.+.+|+.||||++++..+ ..+.+..-..|-.+|+.++||.+..|...|+..+ .+|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eEE
Confidence 45689999999999999999999999999999999987754 5667777889999999999999999999998866 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||..|+-+...+.+...|+|+.++.|-..|+.||.|||+++||+||||.+|+|||.+|++||+||||+..-- ....
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~ 323 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGD 323 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-cccc
Confidence 999999998888777777789999999999999999999999999999999999999999999999999997532 2223
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...++||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+.......|...-
T Consensus 324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------------ 384 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------------ 384 (516)
T ss_pred eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------------
Confidence 4678899999999999986 789999999999999999999999999988766666654321
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEP 447 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~ 447 (665)
...+..++++++.|+..+|.+||.+|.. |.++.+|+||....
T Consensus 385 -----------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 385 -----------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 1123479999999999999999999964 89999999999754
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=372.67 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=204.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||||+++.... ..+....+.+|+.+++.+ +||||+++++++.... .+||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-RLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-EEEEEEeCCC
Confidence 369999999999999999999999999986533 234456788999999998 7999999999998765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 158 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccccC
Confidence 8666555545568999999999999999999999999999999999999999999999999998753221 122345689
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--------VEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--------~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
|+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..... .+.+.+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------ 219 (329)
T cd05588 159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------------------ 219 (329)
T ss_pred CccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc------------------
Confidence 999999999986 6789999999999999999999999963211 1111111100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC------HHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS------AASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT------a~eaL~Hp~f~~~ 446 (665)
........++..+.+||.+||..||.+|+| +.++++||||...
T Consensus 220 ----------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 220 ----------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 000112357889999999999999999987 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=384.31 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=221.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|+++..||.|+||.||+|..++++-..|.|+|... ..+.+..+.-||+||..|+||+||+|++.|..++ .+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEE
Confidence 3588999999999999999999999998999988643 3567788889999999999999999999877654 899999
Q ss_pred Eeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||.|+-.+ .++.-+..|++.++..+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+..... .....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 999987665 3444566899999999999999999999999999999999999999999999999999875432 22345
Q ss_pred ccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 317 TSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.+++|||+|||||++.+ ..+|++++|||||||+|.||..+.||-...+....+.+|.+- -++..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTL--------- 255 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTL--------- 255 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcc---------
Confidence 67899999999999863 468999999999999999999999999888888777777651 11111
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..++..+.||+.+||.+||..||+++++|+||||.+.
T Consensus 256 --------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 --------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 1223678889999999999999999999999999999975
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=355.12 Aligned_cols=260 Identities=32% Similarity=0.489 Sum_probs=212.7
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|++++.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++.... .+++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-YLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-EEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-cccccccc
Confidence 88999999999999999999999999999999876544444444567999999999999999999998754 78999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
+.++.+..+......+++.++..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++.... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~ 158 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPF 158 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9995444444344579999999999999999999999999999999999999999999999999998652 222334556
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
.+|..|+|||++.....++.++||||||+++|+|++|..||......+....+.+.........+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 223 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--------------- 223 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------------
Confidence 78999999999873467899999999999999999999999988544444444333211111100
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......+..+.+||.+||+.||.+|||+.++++||||
T Consensus 224 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 -------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001234789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=381.28 Aligned_cols=281 Identities=25% Similarity=0.340 Sum_probs=219.0
Q ss_pred CCeeEEEEeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.+|++++.||+|+||.||+|... .+++.||+|.+.... ...+|+.+|++|+|||||++++++.... .+|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~-~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKS-TVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCC-EEEE
Confidence 37999999999999999999764 356789999876421 2457999999999999999999988754 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC-
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL- 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~- 314 (665)
|||++.+++...+ .....+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 164 v~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 9999998888777 34457999999999999999999999999999999999999999999999999999876543221
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT---EVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.. ...++..+.+.++..+.++........
T Consensus 243 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 2234579999999999876 568999999999999999999999997754 456777777777665544322110000
Q ss_pred -----ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 392 -----ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 -----~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
........++.......-..++.++.+||.+||.+||++|||+.++|+||||...+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 000000111110000011246788999999999999999999999999999987543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.92 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=209.8
Q ss_pred EEeeccCceEEEEEEE---CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARD---LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
+.||+|+||.||++++ ..+|+.||+|++............+.+|+++|++++||||+++++++.... .+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-EEEEEEcCC
Confidence 6799999999999986 357899999999865433334455778999999999999999999998754 799999999
Q ss_pred cccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccc
Q 006004 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 241 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 159 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFC 159 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceeccc
Confidence 875554444445579999999999999999999999999999999999999999999999999998654322 2234567
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 160 g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~----------------------- 215 (318)
T cd05582 160 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL----------------------- 215 (318)
T ss_pred CChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 8999999999876 5678999999999999999999999999887777766543110
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||+.||.+||| +.+++.||||...
T Consensus 216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 111357889999999999999999999 7889999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=370.42 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=210.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+++.+ +||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-RLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 369999999999999999999999999986432 233456677899999988 7999999999988765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCG 158 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccceec
Confidence 87666555555689999999999999999999999999999999999999999999999999987532221 22334578
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------------------~---- 213 (318)
T cd05570 159 TPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------------------V---- 213 (318)
T ss_pred CccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------------------C----
Confidence 999999999986 678999999999999999999999999887766655553210 0
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH-----HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA-----ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa-----~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+|||+ .+++.||||+..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 214 -----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0113578899999999999999999999 999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=368.21 Aligned_cols=288 Identities=37% Similarity=0.599 Sum_probs=232.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l 233 (665)
++|++.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 579999999999999999999999999999999864322 234455778999999999999999998876432 357
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99999999887766543 3699999999999999999999999999999999999999999999999999987543221
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....+.+..+.|.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 122345789999999988765678999999999999999999999999999888899898888888777665432221
Q ss_pred ccCCCCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
...+....+. ..........+++.+.+||.+||+.||.+|||+.++|+||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1111100010 11122233467889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.99 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=213.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV 236 (665)
+|+..+.||+|+||.||+|+++.+|+.||||+++.... .....+.+..|+.+++.+. |++|+++++++.... .+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-RLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-EEEEE
Confidence 48899999999999999999999999999999975432 2334556778999998886 577888999887754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~ 158 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTT 158 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-ccc
Confidence 9999976665555555579999999999999999999999999999999999999999999999999987643221 122
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.....
T Consensus 159 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------- 218 (323)
T cd05615 159 RTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------- 218 (323)
T ss_pred cCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence 34578999999999876 5689999999999999999999999999887776666644210
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||.+||.+|++ ..++++||||...
T Consensus 219 ----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 219 ----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 111357889999999999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.97 Aligned_cols=281 Identities=42% Similarity=0.794 Sum_probs=229.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|++++.||.|++|.||+|.+..+|..||+|++............+.+|+++++.++||||+++++++.... ..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-KLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-eEEEEEec
Confidence 67889999999999999999999999999999765443333455778999999999999999999988754 78999999
Q ss_pred ccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 240 MEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 240 ~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
+++.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+..... ....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~ 158 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTH 158 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCc
Confidence 9877666554432 3689999999999999999999999999999999999999999999999999976543221 1233
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~~~~ 397 (665)
..++..|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+.++.+..+.+....|........ ....+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 46689999999887655678999999999999999999999999999888888988888888877754322110 00000
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..+ ..........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 239 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 011223345788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=357.31 Aligned_cols=281 Identities=37% Similarity=0.652 Sum_probs=224.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|.+..+|..||||.+...... .....+.+|+.+++.++|+||+++++++.... ..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKE-TLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-eEEEEE
Confidence 5799999999999999999999999999999998654322 22234578999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 161 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYS 161 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCC
Confidence 999988887766555568899999999999999999999999999999999999999999999999997643322 1223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhHHhhhcccccc---
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT-EVEQMHKIFKLCGSPSEDYWRKSKSAHAT--- 393 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~~~~~~~~~~~--- 393 (665)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++....+.|....|.........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 44679999999998765568889999999999999999999997654 45677778888888877776554321111
Q ss_pred CCCCCCcchhhhhhhcc--CCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 394 SFKPQQPYKRKVLETFR--NFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~--~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+.... .......+. ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCK--PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccC--CcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000 011111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=367.63 Aligned_cols=295 Identities=43% Similarity=0.780 Sum_probs=238.6
Q ss_pred CCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHH------------HHHHHHHHHHHHhCCCCCcceeee
Q 006004 158 DAFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES------------VRFMAREIHILRKLDHPNVMKLEG 224 (665)
Q Consensus 158 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------~~~~~~Ei~iL~~L~HpnIV~l~~ 224 (665)
++|..+ +.||.|+||.||+|++..+++.||||+++........ ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 467654 6799999999999999999999999998754322100 124678999999999999999999
Q ss_pred eeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 225 LVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 225 ~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
++.... .+|+||||+.+++...+.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||+
T Consensus 88 ~~~~~~-~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 88 VYVEGD-FINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEecCC-cEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 988755 7899999999887776654 44699999999999999999999999999999999999999999999999999
Q ss_pred ceecCCC-------------CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 006004 305 ATTYDPS-------------QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHK 371 (665)
Q Consensus 305 A~~~~~~-------------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~k 371 (665)
+..+... .........+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.++.+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9876411 111223345788999999998756679999999999999999999999999999999999
Q ss_pred HHHhcCCCChhHHhhhcccc-ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 372 IFKLCGSPSEDYWRKSKSAH-ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
+...++.+....|....... ...+.... .......+...+..+.+||.+||..||.+|||++++|.||||...+.++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCC--cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 99999988877665432111 01111111 1223334556789999999999999999999999999999999998888
Q ss_pred CCCCCC
Q 006004 451 DPSNLP 456 (665)
Q Consensus 451 ~p~~~p 456 (665)
++..+|
T Consensus 324 ~~~~~~ 329 (335)
T PTZ00024 324 DPSQLP 329 (335)
T ss_pred CcccCC
Confidence 777655
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.64 Aligned_cols=269 Identities=29% Similarity=0.437 Sum_probs=224.0
Q ss_pred CccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH-HHHHHHHHHHHHHhCCCCCcceeeeeeeccC
Q 006004 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE-SVRFMAREIHILRKLDHPNVMKLEGLVTSRS 230 (665)
Q Consensus 152 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~ 230 (665)
++|...+.|+.-+.||+|+||.||-|+-..||+.||+|++.+..+... -....++|..||.+++.++||.+-..|++.+
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 356677889999999999999999999999999999999865544222 2234568999999999999999999999876
Q ss_pred CcEEEEEEeccccchhhhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 231 GSLYLVFEYMEHDLAGLATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
.+||||..|+|+.+...+... ..|+|..+++|+.+|+.||++||+.+||+|||||+|||||+.|+++|+|+|||..+
T Consensus 259 -~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 259 -ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred -ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 899999999986665544433 36999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... +...++||.+|||||++.+ ..|+..+|+|||||+||||+.|+.||....+..-...+-+..-.-+.
T Consensus 338 ~~g~--~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~------- 407 (591)
T KOG0986|consen 338 PEGK--PIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE------- 407 (591)
T ss_pred CCCC--ccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-------
Confidence 6543 4677799999999999987 45999999999999999999999999876544333332221111111
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEPLP 449 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~~~ 449 (665)
+....||+++++|.+.+|.+||.+|. +++++.+||||++..+.
T Consensus 408 ------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 408 ------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred ------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 22347999999999999999999995 57899999999987654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=374.35 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=206.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC---CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL---DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
||+|+||+||+|++..+++.||||++..... .......+..|..++..+ .||||+++++++.... .+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-DLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-eEEEEEcCCC
Confidence 7999999999999999999999999975432 223344456677887765 6999999999998765 7999999998
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~g 158 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCG 158 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccC
Confidence 76655555555679999999999999999999999999999999999999999999999999987643222 22345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+...++.++|||||||+||+|++|..||.+.+..+.+..+...... .+
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------~~- 217 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--------------------FP- 217 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--------------------CC-
Confidence 999999999986566899999999999999999999999988776666555321000 00
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCc----CHHHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRG----SAASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp----Ta~eaL~Hp~f~~~ 446 (665)
...+++++.+||.+||..||.+|+ ++.++++||||...
T Consensus 218 -------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 218 -------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 014788999999999999999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=373.15 Aligned_cols=251 Identities=30% Similarity=0.432 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcE-EEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+.+.+.||.|+||+||++.+. |.. ||+|++.......+..+.|.+|+.+|.+|+|||||++++++......++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 4566677999999999999984 455 9999998766655557889999999999999999999999987654689999
Q ss_pred EeccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCC-ccccCCCcccEEEcCCC-cEEEEecccceecCCCCC
Q 006004 238 EYMEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRG-ILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~g-IiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~ 313 (665)
|||.++.+..+... ...|+...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99998776655544 678999999999999999999999999 99999999999999998 99999999998865432
Q ss_pred CCcccccccccccCcccccC-CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLG-ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~-~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+...||+.|||||++.+ ...|+.++|||||||+||||+||..||.+....+....+....-.|
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------------- 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------------- 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------------
Confidence 33455789999999999985 3689999999999999999999999999998855555543321111
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++.+..||.+|+..||.+||+..+++.
T Consensus 266 --------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 --------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 111237889999999999999999999998874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=367.78 Aligned_cols=291 Identities=37% Similarity=0.615 Sum_probs=234.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l 233 (665)
.+|.+++.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++|+||+++++++.... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 3799999999999999999999999999999998754333334456678999999999999999999876432 358
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+.+++...+... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 85 YIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 999999998877666544 479999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.......++..|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.|.........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22345578999999999876556899999999999999999999999999988888888888888877655321111110
Q ss_pred CCCCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 394 SFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 394 ~~~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
.+....+. .......++.+++.+.+||.+||..||.+|||+.++|+||||.....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 00000000 0111233457899999999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=369.55 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=204.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.++.++ +||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-EEEEEEeCCC
Confidence 369999999999999999999999999986532 334556678899998887 8999999999998765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 158 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccC
Confidence 87665555555679999999999999999999999999999999999999999999999999987542221 22345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--------VEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--------~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+.+.+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------------------ 219 (329)
T cd05618 159 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------------------ 219 (329)
T ss_pred CccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------------------
Confidence 999999999986 5789999999999999999999999953211 1111111000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC------HHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS------AASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT------a~eaL~Hp~f~~~ 446 (665)
.....+..++..+.+||.+||..||.+|+| +.++++||||+..
T Consensus 220 ----------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 220 ----------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 000122357889999999999999999998 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=366.25 Aligned_cols=289 Identities=38% Similarity=0.634 Sum_probs=239.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l~ 234 (665)
+|++.+.||.|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 489999999999999999999999999999998754433455667889999999999999999999887653 3689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~- 313 (665)
+||||+.+++...+.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999987766665444 899999999999999999999999999999999999999999999999999988754321
Q ss_pred -CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 -LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 -~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......+|++|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+..+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2234557899999999998754789999999999999999999999999999999999999999988877654322222
Q ss_pred cCCCCC--CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 TSFKPQ--QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~~~~--~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
..+... ......+...+..++..+.+||.+||++||.+|||+.++|+||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 111110 01112233445668999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.42 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=206.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHH-HHHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREI-HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++.... .+|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-eEEEEEeCCC
Confidence 369999999999999999999999999975432 112223344444 4568899999999999988765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 158 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcccccC
Confidence 8766655555567999999999999999999999999999999999999999999999999999754322 222345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (325)
T cd05602 159 TPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------- 212 (325)
T ss_pred CccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-------------------------
Confidence 999999999986 678999999999999999999999999988777766664310
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH----HHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSAA----SALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~----eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|+++. ++++|+||...
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 213 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 011236889999999999999999999876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=350.82 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=212.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.... .+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence 4699999999999999999999999999999998754332 223456889999999999999999999998765 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+.........+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999987666554444457899999999999999999999999999999999999999999999999999866432221
Q ss_pred Cc--ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 315 PL--TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 315 ~~--~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+.....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------------- 224 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--------------- 224 (263)
T ss_pred cccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---------------
Confidence 11 34567899999999987 5589999999999999999999999987665554444322100
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 225 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 ------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.12 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=206.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHh-CCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRK-LDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||||+++.... ..........|+.++.. ++||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-NLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-EEEEEEeCCC
Confidence 469999999999999999999999999976432 12234456678888876 49999999999998765 7999999998
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecC
Confidence 76555555445579999999999999999999999999999999999999999999999999987643221 12345578
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~---------------------- 213 (316)
T cd05619 159 TPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P---------------------- 213 (316)
T ss_pred CccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C----------------------
Confidence 999999999876 578999999999999999999999999887766655543210 0
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH-HHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSAA-SALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~-eaL~Hp~f~~~ 446 (665)
.....++.++.+||.+||..||.+|+++. ++++||||...
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 214 -----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 00124678899999999999999999996 89999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.65 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=206.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHH-HHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIH-ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||+||+|++..+|+.||||++..... .......+..|.. +++.++||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-KLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-EEEEEEcCCC
Confidence 369999999999999999999999999975422 2233344555655 567799999999999988755 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g 158 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCG 158 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccC
Confidence 87665555556689999999999999999999999999999999999999999999999999987542221 22345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------- 212 (325)
T cd05604 159 TPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------- 212 (325)
T ss_pred ChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 999999999876 568999999999999999999999999888776666553310
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+||++ .+++.||||...
T Consensus 213 ----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 213 ----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 01113578889999999999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=384.40 Aligned_cols=277 Identities=24% Similarity=0.327 Sum_probs=212.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|+++|++|+|+|||++++++.... ..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGG-LTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEE
Confidence 3479999999999999999999999999999996432 22468999999999999999999887654 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC-C
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL-P 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~-~ 315 (665)
||++.++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999999888887766567999999999999999999999999999999999999999999999999999876433221 1
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhcCCCChhH-----
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPGRT------EVEQMHKIFKLCGSPSEDY----- 383 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~------~~e~l~kI~~~~g~p~~~~----- 383 (665)
....+||+.|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++.+++...+....++
T Consensus 319 ~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 224579999999999986 5689999999999999999998754 43321 1234555554433322111
Q ss_pred ---HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 384 ---WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 384 ---~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
............ ...+.......+..++.++.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNR--RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhccc--CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000000 000111111222356788999999999999999999999999999974
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=367.75 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=205.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHH-HHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIH-ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+. +++.++||||+++++++.... .+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-KLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-EEEEEEcCCC
Confidence 369999999999999999999999999975432 2223344555554 678899999999999988755 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCG 158 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccC
Confidence 87666555555679999999999999999999999999999999999999999999999999987532221 12344578
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+... +
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~---------------------- 212 (321)
T cd05603 159 TPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P---------------------- 212 (321)
T ss_pred CcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C----------------------
Confidence 999999999876 56899999999999999999999999988766655554321 0
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f~~~ 446 (665)
.......+..+.+||.+||+.||.+|+++ .++++|+||...
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 213 ----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 01123567889999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=359.50 Aligned_cols=285 Identities=38% Similarity=0.637 Sum_probs=224.6
Q ss_pred CeeEEEEeeccCceEEEEEEECC--CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLE--TGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
+|++++.||+|+||.||+|.+.. +++.||||.+..... .......+.+|+.+++.++||||+++++++... ...+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 899999999876331 122335567899999999999999999999876 24799
Q ss_pred EEEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC----CCcEEEEecccce
Q 006004 235 LVFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN----AGVLKIGDFGLAT 306 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~----~g~lKL~DFGlA~ 306 (665)
+||||+++++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999887765532 1236899999999999999999999999999999999999999 9999999999998
Q ss_pred ecCCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHh
Q 006004 307 TYDPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMHKIFKL 375 (665)
Q Consensus 307 ~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~kI~~~ 375 (665)
.+..... .......+|+.|+|||++.+...++.++|||||||+||+|++|++||.+.+. ...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 1223446799999999988766789999999999999999999999987654 2467778888
Q ss_pred cCCCChhHHhhhccccc-cC---CCCCCcch----hhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 376 CGSPSEDYWRKSKSAHA-TS---FKPQQPYK----RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~-~~---~~~~~p~~----~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
++.+....|........ .. .....++. ....+.....+..+.+||.+||..||.+|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 88887776643221100 00 00001111 11122223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.96 Aligned_cols=287 Identities=35% Similarity=0.621 Sum_probs=231.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||.||++.+..+|..||||++............+.+|+.+|+.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 35799999999999999999999999999999998654333344556789999999999999999999887542 2
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+||||+.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4689999997666555443 36999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.+....+.++.+..+.++.+++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2344679999999998765568899999999999999999999999999888899988888887777665543221
Q ss_pred ccCCCCCCc-c-hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 392 ATSFKPQQP-Y-KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 392 ~~~~~~~~p-~-~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
...+....+ . ...+......+++.+.+||.+||..||.+|||+.++|.||||......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 111100000 0 011223345788999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=353.45 Aligned_cols=282 Identities=44% Similarity=0.781 Sum_probs=235.0
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+|++++|+||+++++++.... .+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-DLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-CEEEEEec
Confidence 67889999999999999999999999999998765544445567889999999999999999999988764 78999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
+.+++...+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||.+....... ......
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 158 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHY 158 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCc
Confidence 9998888777665689999999999999999999999999999999999999999999999999998775443 223345
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC-CCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS-FKPQ 398 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~-~~~~ 398 (665)
.++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+.+.++...++.+....|.......... +...
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 688999999998875578999999999999999999999999999999999999988888877776543211000 0000
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.............++..+.+||.+||..||.+||++.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000111123345688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=345.64 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=213.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|++++.||+|++|.||++++..+++.||+|++..........+.+.+|++++++++|+||+++++.+...+..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48999999999999999999999999999999976555555566788999999999999999999988755557899999
Q ss_pred eccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.++.+. .+.. ....+++.+++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||++..+.... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Ccc
Confidence 99875444 4433 23468999999999999999999999999999999999999999999999999998764322 223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.... .
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------------- 219 (257)
T cd08223 160 STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L----------------- 219 (257)
T ss_pred ccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C-----------------
Confidence 44578999999999876 568899999999999999999999998877655544443210 0
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00113578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=366.76 Aligned_cols=288 Identities=36% Similarity=0.632 Sum_probs=236.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-----
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG----- 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~----- 231 (665)
.++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 357999999999999999999999999999999986543334455667889999999999999999998765432
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+|+||+.+++...+.. ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998777666554 36999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++.+|.+.....
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3445789999999998765578899999999999999999999999999999999999999988888776543322
Q ss_pred ccCCCCCCcc--hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 392 ATSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 392 ~~~~~~~~p~--~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
...+....+. .......+..+++.+.+||.+||..||.+|||+.++|+||||.....+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 2111110010 0112233456789999999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=366.90 Aligned_cols=284 Identities=26% Similarity=0.367 Sum_probs=213.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.++||+|+||.||++++..++..+|+|++.... .......+.+|+++|+.++||||++++++|.... .+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-EEEEE
Confidence 358999999999999999999999999999999987543 3445567889999999999999999999998754 89999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 99998766655544455789999999999999999999975 79999999999999999999999999997653321
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCChhHHhhhcccccc-
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK-LCGSPSEDYWRKSKSAHAT- 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~-~~g~p~~~~~~~~~~~~~~- 393 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+..............
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 234578999999999976 5689999999999999999999999987655333221110 0111111000000000000
Q ss_pred --CCCC-CCcch---hh----hh-----hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 --SFKP-QQPYK---RK----VL-----ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 --~~~~-~~p~~---~~----~~-----~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+.+ ..|.. .. .. .....++.++++||.+||.+||.+|||+.++|.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 00000 00 00 0011367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.83 Aligned_cols=283 Identities=34% Similarity=0.609 Sum_probs=230.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 232 (665)
++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4799999999999999999999999999999998754333333456789999999999999999999886532 24
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+..++.... +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 6999999987654433 236899999999999999999999999999999999999999999999999998765322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+...+++.......
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 23457799999999987655689999999999999999999999999998889999999888888877665432221
Q ss_pred cCCCCCCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 393 TSFKPQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 393 ~~~~~~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
..+....+ ....+...++.+++.+.+||.+||+.||.+|||+.++|.||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 11110000 01122333456788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.01 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=208.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+.+++.+...+ .+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-EEEEEE
Confidence 488899999999999999999999999999998754332 233455678999999999999999999988765 799999
Q ss_pred Eeccccchhhhc-C-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAGLAT-T-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~~~~-~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++.+.... . ....+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 157 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 157 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--c
Confidence 999875554333 2 23468999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+........
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--------------- 221 (285)
T ss_pred ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------------
Confidence 234578999999999976 5689999999999999999999999987543211111111100000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
......+++++.+||.+||+.||.+|+| +.++++||||+..
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 ----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0112357889999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.80 Aligned_cols=282 Identities=43% Similarity=0.760 Sum_probs=235.1
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.++++++|+||+++++++.... .+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER-KLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC-ceEEEecC
Confidence 67788999999999999999999999999999865433344456778999999999999999999988764 79999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
+.+++...+......+++.++..++.||+.||.|||++||+|+||+|+||++++++.+||+|||++........ .....
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 158 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHE 158 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCcc
Confidence 99887777766545799999999999999999999999999999999999999999999999999987643322 23344
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
.++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++...++.+.+..|...............
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 56889999999876557899999999999999999999999999999999999999999998888765433211110001
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.........++.++..+.+||.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11112234455678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=364.82 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=205.3
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|++..+++.||+|+++.... ..+....+.+|+.++.++ .||||+++++++.... .+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-RLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-EEEEEEeCCC
Confidence 369999999999999999999999999986533 334566788999999998 6999999999988765 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCG 158 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccC
Confidence 86665555455579999999999999999999999999999999999999999999999999987532211 22345679
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE------VEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~------~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
|+.|+|||++.+ ..++.++|||||||+||+|++|..||..... .+.+..+... .
T Consensus 159 t~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~----------------- 218 (327)
T cd05617 159 TPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K----------------- 218 (327)
T ss_pred CcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C-----------------
Confidence 999999999986 6789999999999999999999999964321 1112211110 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC------HHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS------AASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT------a~eaL~Hp~f~~~ 446 (665)
.......++..+.+||.+||.+||.+|++ ..++++||||...
T Consensus 219 ---------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 219 ---------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 00112357889999999999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=383.94 Aligned_cols=259 Identities=25% Similarity=0.338 Sum_probs=217.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS------- 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~------- 230 (665)
++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|..++|+||++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4799999999999999999999999999999999877666666777889999999999999999988775432
Q ss_pred CcEEEEEEeccccch-hhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 231 GSLYLVFEYMEHDLA-GLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll-~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
..+++||||+.++.+ ..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 137899999986544 43332 23469999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 307 TYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 307 ~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
.+..... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+.++......
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~------- 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD------- 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-------
Confidence 7643221 12345679999999999986 56899999999999999999999999988876666665431100
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++++.+||.+||..||.+||++.++|+|||++.
T Consensus 264 ---------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 ---------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 112367899999999999999999999999999999874
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=353.00 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=213.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|+..+.||+|+||+||++.+..+++.||+|.+...... ......+.+|+.+|+.++|+||+.+++++...+ .+|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-ALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-EEEEEE
Confidence 378899999999999999999999999999998765432 223445778999999999999999999888765 789999
Q ss_pred Eeccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+..+. .+.. ....+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||++....... .
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--S 157 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--c
Confidence 999976554 3332 23469999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.........
T Consensus 158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-------------- 222 (285)
T ss_pred ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--------------
Confidence 244578999999999976 56899999999999999999999999987765555544332111100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+||| +.+++.|+||...
T Consensus 223 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 223 -----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 112357888999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=365.21 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=218.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
-|.++.+||+|+||.||+|.++++|..+|||.+... ..++.+..||.||++++.|++|++|+.|.... .+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehh
Confidence 488899999999999999999999999999999754 34677889999999999999999999877655 7999999
Q ss_pred eccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||.. ...+.+..++++|+|.++..+++..+.||+|||...-||||||..||||+.+|..||+|||.|-.+..... ...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRN 187 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhC
Confidence 9985 45556666788999999999999999999999999999999999999999999999999999987654322 235
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
+.+|||.|||||++.. ..|+..+||||||++..||..|+|||...-+ +..|+-+-..|++.|
T Consensus 188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF-------------- 249 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTF-------------- 249 (502)
T ss_pred ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCC--------------
Confidence 6799999999999986 6799999999999999999999999976433 344444333333322
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
......+.++.|||++||.+.|++|-||.++++|||.++.+
T Consensus 250 ---------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 ---------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ---------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11235788999999999999999999999999999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.30 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=201.3
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||+|+||.||+++++.+|+.||+|.+....... .....+..|++++++++||||+++++++.... .+|+||||+.|+.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-HLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-eEEEEEecCCCCC
Confidence 799999999999999999999999987543321 22334567999999999999999999988754 7999999998765
Q ss_pred hh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 245 AG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 245 l~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
+. .+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.... ......||
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~ 157 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGT 157 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCC
Confidence 54 3322 23358999999999999999999999999999999999999999999999999998764322 22345789
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....-. .
T Consensus 158 ~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------~--------- 213 (277)
T cd05607 158 NGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE--------------D--------- 213 (277)
T ss_pred CCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc--------------c---------
Confidence 99999999986 45899999999999999999999999765432211111110000 0
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCCCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFFKTEPL 448 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f~~~~~ 448 (665)
........+++++.+||.+||++||.+||++ .+++.||||+...+
T Consensus 214 -~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 214 -EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred -ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 0000113578999999999999999999999 77889999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=379.52 Aligned_cols=257 Identities=26% Similarity=0.380 Sum_probs=214.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++.... .+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-KLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-EEEE
Confidence 34599999999999999999998887 788999977543 2344456788999999999999999999998764 8999
Q ss_pred EEEeccccchhh-hc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 236 VFEYMEHDLAGL-AT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~ll~~-~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
||||+.++.+.. +. ....++++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999998755433 22 23457999999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 312 QN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 312 ~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------ 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------------ 289 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 22 12345579999999999876 67899999999999999999999999988877766665431100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++++.+||.+||..||.+|||+.++|.|+|++.
T Consensus 290 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 ----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 011257889999999999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=355.69 Aligned_cols=263 Identities=30% Similarity=0.402 Sum_probs=217.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++.+.||+|+||.||+|.+..+++.||||.+....... ...+.+.+|+++++.++||||+++++++.... .+|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-YLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-EEEEEE
Confidence 6999999999999999999999999999999997654432 35567889999999999999999999987754 789999
Q ss_pred EeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC--
Q 006004 238 EYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-- 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-- 313 (665)
||+.++.+..+.. .+..+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9998755544433 235799999999999999999999999999999999999999999999999999876532211
Q ss_pred --------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHH
Q 006004 314 --------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE 367 (665)
Q Consensus 314 --------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e 367 (665)
......+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468999999999986 567999999999999999999999999888776
Q ss_pred HHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC----HHHHHhCcCC
Q 006004 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS----AASALRSEFF 443 (665)
Q Consensus 368 ~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT----a~eaL~Hp~f 443 (665)
.+..+...... . .....+++.+.+||.+||..||++||| +.++|+||||
T Consensus 240 ~~~~~~~~~~~--------------------~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 240 TFSNILKKEVT--------------------F-------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHhcCCcc--------------------C-------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 66655321000 0 001137889999999999999999999 9999999999
Q ss_pred CCCCCCC
Q 006004 444 KTEPLPC 450 (665)
Q Consensus 444 ~~~~~~~ 450 (665)
+...++.
T Consensus 293 ~~~~~~~ 299 (316)
T cd05574 293 RGVNWAL 299 (316)
T ss_pred hcCChhh
Confidence 9876654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.85 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=199.9
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|+.+ +||||+++++++....+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 57999999999999999999852 445789999987432 334456788999999999 89999999998876666
Q ss_pred cEEEEEEeccccchh-hhcCC-----------------------------------------------------------
Q 006004 232 SLYLVFEYMEHDLAG-LATTP----------------------------------------------------------- 251 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~-~~~~~----------------------------------------------------------- 251 (665)
.+|+||||+.++.+. .+...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 789999999975443 33211
Q ss_pred --CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CCcccccccccccCc
Q 006004 252 --GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAP 328 (665)
Q Consensus 252 --~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~AP 328 (665)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... .......+++.|+||
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 12478889999999999999999999999999999999999999999999999986533221 112233457889999
Q ss_pred ccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhh
Q 006004 329 ELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLE 407 (665)
Q Consensus 329 E~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 407 (665)
|++.+ ..++.++|||||||+||||++ |.+||.+....+.+...... +.. ..
T Consensus 246 E~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~--------------------------~~ 297 (338)
T cd05102 246 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR--------------------------MR 297 (338)
T ss_pred HHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------CC
Confidence 99976 568999999999999999997 99999886644433332221 000 00
Q ss_pred hccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 408 TFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 408 ~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++.+.+||.+||..||.+|||+.++++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11356888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=377.84 Aligned_cols=255 Identities=29% Similarity=0.501 Sum_probs=224.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|.-++.||.|+||-||-|++..+.+.||||++..... ..+.++.+..|+.+|++|+|||+|.+.+||..+. ..||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-TAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-hHHHHH
Confidence 47778999999999999999999999999999987654 5677889999999999999999999999998765 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||-|+-.+++....++|-+.+|..|+.+.+.||.|||+.+.||||||..||||++.|.|||+|||.|....+ ..
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----An 180 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----AN 180 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----hh
Confidence 9999977776666667899999999999999999999999999999999999999999999999999987654 46
Q ss_pred cccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
+++|||.|||||+|+ ..+.|+-++|||||||+..||...+||+-..+..-.+.-|... .+|.-
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtL-------------- 245 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTL-------------- 245 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCC--------------
Confidence 789999999999997 3468999999999999999999999999888877776666541 11100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.-..++..++.||..||.+-|.+|||++++|.|+|....
T Consensus 246 ------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 246 ------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 013578889999999999999999999999999998754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.22 Aligned_cols=285 Identities=35% Similarity=0.602 Sum_probs=228.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
++|++++.||+|+||.||++.+..+++.||+|++..........+.+.+|+.++++++||||+++++++... ...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 589999999999999999999999999999999875433334455678899999999999999999988643 134
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|++++++.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 97 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 789999987766554433 35899999999999999999999999999999999999999999999999998865322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+....+........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 174 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred ---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 23457899999999987656789999999999999999999999999888888888888888877766544321111
Q ss_pred cCCC---CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 393 TSFK---PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 393 ~~~~---~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
..+. +..+ .......+...++.+.+||.+||..||.+|+|+.++|.||||.....+
T Consensus 251 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 251 RNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HHHHHHhcccC-CcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0000 0000 001112223568899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=357.12 Aligned_cols=288 Identities=36% Similarity=0.585 Sum_probs=231.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCC--CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec---cCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLET--GKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS---RSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~---~~~~ 232 (665)
+|++.+.||+|+||.||++++..+ +..||||++..........+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999888 89999999875432333455678899999999 59999999986432 2235
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|++|||+.++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 799999999887766654 4479999999999999999999999999999999999999999999999999998764322
Q ss_pred C---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 N---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.+..+.+.+...
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1223457899999999887656789999999999999999999999999999999999999999888776655432
Q ss_pred ccccCCC---CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 390 AHATSFK---PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 390 ~~~~~~~---~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.....+. ...+ ...+.......+..+.+||.+||..||.+|||+.++|.||||..+..
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 240 PKAQNYIRSLPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhHHHHHHhccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 2111000 0000 01122233456889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.37 Aligned_cols=289 Identities=37% Similarity=0.627 Sum_probs=233.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc-CCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-~~~l 233 (665)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++++ +||||+++++++... ...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 34579999999999999999999999999999998864433334455677899999999 999999999988654 3368
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+.+++...+... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999998776665443 689999999999999999999999999999999999999999999999999987643322
Q ss_pred ----CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 314 ----LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 314 ----~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.....+.||+.|+|||++.+...++.++|+|||||++|+|++|++||.+....+.+.++....+.+..+.|.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1234457899999999987666788999999999999999999999999999999999988888877766554322
Q ss_pred ccccCCCC--CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKP--QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~--~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....+.. ............+.++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 11111100 0011112233445689999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=358.57 Aligned_cols=286 Identities=36% Similarity=0.600 Sum_probs=221.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS------- 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~------- 230 (665)
.+|++.+.||.|+||.||+|++..+|+.||+|++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 479999999999999999999999999999999875543 34566788999999999999999998766432
Q ss_pred ------CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecc
Q 006004 231 ------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFG 303 (665)
Q Consensus 231 ------~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFG 303 (665)
..+|+||||+.+++...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 25789999999876655532 36899999999999999999999999999999999999984 5678999999
Q ss_pred cceecCCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 006004 304 LATTYDPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 304 lA~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~ 381 (665)
++..+..... .......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9986533211 11123367899999998876567889999999999999999999999999888887777665443333
Q ss_pred hHHhhhccccccCCC-CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 382 DYWRKSKSAHATSFK-PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+.+............ ...............++.++++||.+||..||.+|||+.++|.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 222211000000000 011111122233457889999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=353.76 Aligned_cols=280 Identities=26% Similarity=0.340 Sum_probs=213.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||++++..++..||+|.+.... .......+.+|++++++++||||+++++++.... .+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-EISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-EEEEEe
Confidence 36999999999999999999999999999999987532 3445566889999999999999999999998754 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++....... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 155 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 155 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence 999986666555555679999999999999999999997 599999999999999999999999999987653321 2
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...++++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.... ..++........ +............
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~ 231 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGE--AKESHRPVSGHPP 231 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCcccccc--ccCCcccccCCCC
Confidence 44578999999999876 5688999999999999999999999987664332 222221110000 0000000000000
Q ss_pred C---CCcchh----h-----hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 397 P---QQPYKR----K-----VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 397 ~---~~p~~~----~-----~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ..+... . .......++.++.+||.+||..||++|||+.++|+||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0 000000 0 000012367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=394.91 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=214.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
..++|++++.||+|+||+||+|++..++..||+|++............+..|+.+|++|+|||||+++++|... ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 34589999999999999999999999999999999987666666677789999999999999999999988654 45789
Q ss_pred EEEEeccccch-hhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhC-------CccccCCCcccEEEcC----------
Q 006004 235 LVFEYMEHDLA-GLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSR-------GILHRDIKGSNLLINN---------- 293 (665)
Q Consensus 235 lV~Ey~~g~ll-~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~-------gIiHrDLKPeNILld~---------- 293 (665)
|||||+.++.+ ..+.. ....|++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999997544 44432 234799999999999999999999985 4999999999999964
Q ss_pred -------CCcEEEEecccceecCCCCCCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCCh
Q 006004 294 -------AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTE 365 (665)
Q Consensus 294 -------~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~ 365 (665)
.+.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|++|..||...+.
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999998764322 23445799999999998643 4588999999999999999999999987766
Q ss_pred HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 366 VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 366 ~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..++..+.... + .. ....++.++.+||..||.+||.+|||+.|+|.|+||+.
T Consensus 249 ~~qli~~lk~~--p------------------~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRG--P------------------DL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcC--C------------------CC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 65554433210 0 00 11246889999999999999999999999999999986
Q ss_pred CC
Q 006004 446 EP 447 (665)
Q Consensus 446 ~~ 447 (665)
..
T Consensus 301 i~ 302 (1021)
T PTZ00266 301 VG 302 (1021)
T ss_pred cC
Confidence 53
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.89 Aligned_cols=286 Identities=37% Similarity=0.609 Sum_probs=232.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|++++.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||++++++|......+|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 34689999999999999999999999999999999865433334456678899999999999999999998765557899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+++...+.. ..+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++......
T Consensus 88 v~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 88 VTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred EeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 999998776655543 35889999999999999999999999999999999999999999999999998865322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+.+|.++.+.+..........+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23456789999999887656789999999999999999999999999988888888888899988877654322111111
Q ss_pred CCCCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 396 KPQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 396 ~~~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
....+ ...........+++.+.+||.+||..||++|||+.++|.||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00000 01112233456889999999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.93 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=214.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... .+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-KLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-EEEEEEE
Confidence 488999999999999999999999999999999876555666777889999999999999999999988754 7999999
Q ss_pred eccccchhh-hcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAGL-ATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~~-~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.+..+.. +... ...+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+..... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~ 158 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA 158 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence 998755443 3332 45789999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+...++......
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 219 (256)
T cd08529 159 NTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP------------------ 219 (256)
T ss_pred hccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 34468999999999886 56889999999999999999999999888766655554331100
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....++..+.++|.+||+.+|++||++.++++|||+
T Consensus 220 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 ----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0112478889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.43 Aligned_cols=255 Identities=30% Similarity=0.447 Sum_probs=214.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++|++++||||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-NLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-eEEEE
Confidence 369999999999999999999999999999999875432 3345567889999999999999999999988754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 999976555544444468999999999999999999999999999999999999999999999999999876443 2
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+... .+
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------------- 215 (290)
T cd05580 156 YTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV----------------- 215 (290)
T ss_pred CCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc-----------------
Confidence 34468999999999876 46789999999999999999999999887765555554321 00
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.....++..+.+||.+||..||.+|+ +++++++||||....
T Consensus 216 ----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 ----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred ----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 01134688999999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.36 Aligned_cols=279 Identities=43% Similarity=0.716 Sum_probs=223.9
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeeeeccCC----c
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL---DHPNVMKLEGLVTSRSG----S 232 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~----~ 232 (665)
|++.+.||+|+||.||+|++..+++.||+|.++...........+.+|+.+++++ +||||+++++++..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999975443333344566788887776 59999999999886542 3
Q ss_pred EEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|++|||+.+++...+.... ..+++.+++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999987766554432 36899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.. .....++..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+.++....+.+....|.......
T Consensus 161 ~~--~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 MA--LTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cc--cccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22 234457899999999986 568999999999999999999999999999999999998877766655554322111
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
...+.... ..........+++.+.+||.+||..||.+||++.++|+||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYT--PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhccccc--ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111111 111233334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=358.00 Aligned_cols=281 Identities=24% Similarity=0.342 Sum_probs=208.0
Q ss_pred EEEEeecc--CceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 162 KIDKIGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 162 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
+++.||+| +|++||+++++.+|+.||||++............+.+|+.+++.++||||+++++++...+ .+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-EEEEEEec
Confidence 56789999 7889999999999999999999876555566677889999999999999999999998765 78999999
Q ss_pred ccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-C--
Q 006004 240 MEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-L-- 314 (665)
Q Consensus 240 ~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~-- 314 (665)
++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 997655444322 34589999999999999999999999999999999999999999999999987654321110 0
Q ss_pred ---CcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC----------
Q 006004 315 ---PLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS---------- 380 (665)
Q Consensus 315 ---~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~---------- 380 (665)
......++..|+|||++.+. ..|+.++|||||||++|+|++|+.||.............. +..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchhh
Confidence 01223567889999998753 4689999999999999999999999987655443333222 1111
Q ss_pred hhHHhhhccccc-----cCCC--CCCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 381 EDYWRKSKSAHA-----TSFK--PQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 381 ~~~~~~~~~~~~-----~~~~--~~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
++...+...... .... ...+ ...........+++.+.+||.+||.+||++|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000000000 0000 0000 000111123356889999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=347.59 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=211.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||++++..+++.||+|.++.. ........+.+|+.++++++||||+++++++.... .+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-AVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-eEEEEE
Confidence 3699999999999999999999999999999998754 23444567889999999999999999999888754 899999
Q ss_pred EeccccchhhhcCC---CCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 238 EYMEHDLAGLATTP---GIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||+.+..+..+... ...+++..+..++.||+.||.|||. .||+|+||||+|||++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99998666555443 2368999999999999999999997 599999999999999999999999999997653221
Q ss_pred CCcccccccccccCcccccCC-----cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 314 LPLTSRVVTLWYRAPELLLGA-----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~-----~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.....+++.|+|||++.+. ..++.++|+|||||++|+|++|+.||...+.......+.........
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 228 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------- 228 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-------
Confidence 2334678899999988542 23588999999999999999999999776544433333222111100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.....++.++.+||.+||..||.+||++.++++||||....
T Consensus 229 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 229 ------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 11235789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.19 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=207.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||+|+||.||+|++..+++.||+|.+.... ..+....+.+|+.++++++||||+++++++.... ..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-RISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-EEEEEEe
Confidence 6899999999999999999999999999999987543 3445567889999999999999999999998765 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ...
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKT 152 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccC
Confidence 9998776544 257899999999999999999999999999999999999999999999999998764332 244
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCChhHHhhhccccccCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ---MHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~---l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.++|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+. ...+....... .
T Consensus 153 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~ 216 (279)
T cd06619 153 YVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE---------------D 216 (279)
T ss_pred CCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc---------------C
Confidence 578999999999986 5689999999999999999999999975332110 00111100000 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+. .....+++++.+||.+||..||.+||++.++|+||||...
T Consensus 217 ~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000 0112467889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=348.60 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=215.0
Q ss_pred eeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEE
Q 006004 160 FEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 160 y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
|++. +.||+|+|+.|--|....+|..||||+|.+. ......++.||++++.++ .|+||++|+++|+++. .+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~-~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT-RFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc-eEEEEE
Confidence 4433 5789999999999999999999999999765 334566788999999999 5999999999999876 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEecccceecCCC---
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPS--- 311 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~~~~~--- 311 (665)
|-|.|+.+-..++..+.|+|.++..+++.|+.||+|||.+||.||||||+|||..... -+|||||.|+.-+...
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999865544444556899999999999999999999999999999999999997654 4899999998654221
Q ss_pred ---CCCCcccccccccccCccccc----CCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---------------HHHH
Q 006004 312 ---QNLPLTSRVVTLWYRAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------------VEQM 369 (665)
Q Consensus 312 ---~~~~~~~~~gT~~Y~APE~l~----~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---------------~e~l 369 (665)
..-.+.+.+|+..|||||++. ....|+.+.|.||||||||.||+|++||.|.-. ....
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 122356679999999999874 346799999999999999999999999987522 2334
Q ss_pred HHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 370 HKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 370 ~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+.|......+++..| .++|.+++|||..||..|+..|.+|.++|+|||+....
T Consensus 316 esIQEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHhccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 455555455555544 47999999999999999999999999999999998643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=345.51 Aligned_cols=256 Identities=26% Similarity=0.337 Sum_probs=211.2
Q ss_pred CCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc---CC
Q 006004 157 ADAFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR---SG 231 (665)
Q Consensus 157 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~---~~ 231 (665)
.++|.+- ++||-|-.|.|..|.++.||+.+|+|++... ....+|+++.-.. .|||||.++++|+.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3567665 5789999999999999999999999998632 2246788887666 699999999998753 33
Q ss_pred cEEEEEEeccccchh-hhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccce
Q 006004 232 SLYLVFEYMEHDLAG-LATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLAT 306 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~-~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~ 306 (665)
.+.+|||+|+|+.+. .+..++ ..|+|.++..+++||+.|+.|||+.+|.||||||+|+|+.. +..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 688999999986554 444333 45999999999999999999999999999999999999975 4579999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE----VEQMHKIFKLCGSPSED 382 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~----~e~l~kI~~~~g~p~~~ 382 (665)
.... ...+.+.+.||.|.|||++-. ..|+...|+||+||++|.||+|.|||..... ...-.+|...-..++.+
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 7543 345677789999999998865 6799999999999999999999999987653 23445565544445554
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
-| ..+|.+++|||+.||..+|.+|.|+.+++.|||+...+
T Consensus 290 EW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 290 EW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 44 36899999999999999999999999999999998653
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.21 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=214.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.... .+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-ELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-EEEEEE
Confidence 46999999999999999999999999999999987654433 5677899999999999999999999887754 789999
Q ss_pred EeccccchhhhcCC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99987655544432 246899999999999999999999999999999999999999999999999999876543322
Q ss_pred ---CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 ---PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ---~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....+++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++... .+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~--------- 226 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS--------- 226 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC---------
Confidence 1233468999999999876447899999999999999999999999877665555544331 0000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
+. ....+..+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 227 ---~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 ---LE--------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---cC--------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 001134678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=378.62 Aligned_cols=284 Identities=24% Similarity=0.340 Sum_probs=208.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCC-cEEEEEEEe---------------cCCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETG-KIVALKKVR---------------FANMDPESVRFMAREIHILRKLDHPNVM 220 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~---------------~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 220 (665)
.++|++++.||+|+||+||+|..+... ..+++|.+. ...........+.+|+.+|++|+|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 357999999999999999998865432 222222111 0111223445678999999999999999
Q ss_pred eeeeeeeccCCcEEEEEEeccccchhhhcCCC----CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 221 KLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 221 ~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
++++++.... ..|+|||++.++++..+.... ......+++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 227 ~l~~~~~~~~-~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEA-NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECC-eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999998765 789999999988777654322 23456778899999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCC--CChHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPG--RTEVEQMHKIF 373 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g--~~~~e~l~kI~ 373 (665)
+||+|||++..+...........+||+.|+|||++.+ ..|+.++|||||||+||||++|..+ |.+ .....++.+++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998875443333345689999999999986 5789999999999999999998854 432 34556666666
Q ss_pred HhcCCCChhH-------HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 374 KLCGSPSEDY-------WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 374 ~~~g~p~~~~-------~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..++.+..++ |+........... .....+. ....++.++.+||.+||.+||.+|||+.|+|.||||...
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~---~~~~~~~-~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAG---HSVPPLI-RNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCc---cchhhHH-HhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 6655443332 1111100000000 0000011 112478889999999999999999999999999999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.24 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=205.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHH-HHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI-LRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||++++..+|+.||||.++......... .+..|+.+ ++.++||||+++++++.... .+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG-DVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEE
Confidence 36999999999999999999999999999999997654333333 34556665 66679999999999987654 79999
Q ss_pred EEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+++++...+. .....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999987655443 2345799999999999999999999997 99999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCC---cccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGA---TKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~---~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
..+...++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... +..+.+..+.... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------- 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S--------- 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C---------
Confidence 12334688999999988642 34688999999999999999999999653 3334443332210 0
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+ ...+|.++.+||.+||..||.+|||+.+++.||||...
T Consensus 226 --------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 --------PQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000 12478899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.78 Aligned_cols=259 Identities=29% Similarity=0.429 Sum_probs=213.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|+++++||+|+||.||++++..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-KLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-eEEEEE
Confidence 4699999999999999999999999999999998643 3455677889999999999999999999987754 799999
Q ss_pred Eeccccchhhh-cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLA-TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++.+..+ ......+++..+..++.||+.+|.|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 167 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR 167 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence 99998766543 344457999999999999999999999999999999999999999999999999998764322 1223
Q ss_pred ccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 317 TSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+++.|+|||++.+ ...++.++|+|||||++|+|++|.+||...+....+.++.... + .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~-~----------- 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--P-P----------- 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--C-c-----------
Confidence 44568899999999853 2457889999999999999999999998876555444442210 0 0
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.......++.++.+||.+||..||++||++.++|+||||...
T Consensus 234 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 234 ------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred ------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001123577889999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=356.51 Aligned_cols=279 Identities=27% Similarity=0.466 Sum_probs=221.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--C----CcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--P----NVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--p----nIV~l~~~~~~~~~ 231 (665)
.+|++++.||+|+||.|-.|.+.+++..||||+++... ...+..+-||++|+++.+ | -+|++.++|.-+ +
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-g 164 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-G 164 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-C
Confidence 47999999999999999999999999999999997432 223344569999999932 2 367787877764 4
Q ss_pred cEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-----------------
Q 006004 232 SLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN----------------- 293 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~----------------- 293 (665)
+.|||+|.++-++.+.+...+ .+|+..+++.+.+||++++++||+++++|-||||||||+.+
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 899999999888887777643 67999999999999999999999999999999999999943
Q ss_pred ---CCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH
Q 006004 294 ---AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370 (665)
Q Consensus 294 ---~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 370 (665)
+-.++|+|||.|++.... ..+.+.|..|+|||++++ -.++..+||||+||||+||.+|..+|++.++.|+++
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred cCCCcceEEEecCCcceeccC----cceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 225899999999975433 356688999999999998 789999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhHHhhh---------cccccc---------CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc
Q 006004 371 KIFKLCGSPSEDYWRKS---------KSAHAT---------SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~---------~~~~~~---------~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp 432 (665)
.+..++|.++.....+. ++.... .+.+-.|....... -..-...+.|||++||.+||.+|+
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHHHHHHHccCccccc
Confidence 99999998776554332 111111 11111111111100 001123478999999999999999
Q ss_pred CHHHHHhCcCCCCC
Q 006004 433 SAASALRSEFFKTE 446 (665)
Q Consensus 433 Ta~eaL~Hp~f~~~ 446 (665)
|+.|||.||||+..
T Consensus 399 Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 TLREALSHPFFARL 412 (415)
T ss_pred cHHHHhcCHHhhcC
Confidence 99999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.81 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=207.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++.... .+|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-KLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-EEEEEE
Confidence 479999999999999999999999999999999875432 23456788999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+..... ...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 9999866655444455799999999999999999999999999999999999999999999999999987643221 123
Q ss_pred cccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...+++.|+|||.+.. ...++.++|+|||||++|+|++|++||...+..+....+... .+
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------------~~ 226 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------------NF 226 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------------CC
Confidence 4568899999998852 345788999999999999999999999765543332222110 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
.+. .......++..+.+||.+||..||++|||++++|+|+|
T Consensus 227 ~~~------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 227 QPP------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 00011257889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.52 Aligned_cols=262 Identities=29% Similarity=0.378 Sum_probs=213.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||++++..+++.||+|.+..... .......+.+|+++++.++||||+++++.+.... .+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-HLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-EEEEE
Confidence 369999999999999999999999999999999875533 2334566789999999999999999999988754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--- 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--- 313 (665)
|||+.|+.+..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999866665555555799999999999999999999999999999999999999999999999999864211100
Q ss_pred -----------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 314 -----------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 314 -----------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
.......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 235 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW--- 235 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC---
Confidence 01122457889999999876 568999999999999999999999999887666555543311000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC---HHHHHhCcCCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS---AASALRSEFFKTEP 447 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT---a~eaL~Hp~f~~~~ 447 (665)
+ .....++.++.+||.+||+.||++||+ +.++|+||||....
T Consensus 236 -----------------~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 236 -----------------P------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred -----------------C------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0 001247888999999999999999998 89999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.37 Aligned_cols=279 Identities=38% Similarity=0.702 Sum_probs=228.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
|++.+.||+|+||+||+|++..+++.||||.+.......+ .....+|+..+++++ ||||+++++++... ...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFREN-DELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcC-CcEEEEEe
Confidence 6788999999999999999998999999999865432222 223457999999999 99999999998874 47899999
Q ss_pred eccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|+.+++...+.... ..+++.++..++.||+.+|.|||++||+|+||+|+|||++.++.++|+|||++....... ...
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~ 156 (283)
T cd07830 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PYT 156 (283)
T ss_pred cCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--CcC
Confidence 99888777666543 478999999999999999999999999999999999999999999999999998764322 234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...++..|+|||++.....++.++|+||||+++|+|++|++||++.+..+.+.++....+.+..+.|......... ...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK-LGF 235 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc-ccc
Confidence 4578999999999876566899999999999999999999999999999999999999999887777653221111 100
Q ss_pred CCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 398 QQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 398 ~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..+ ....+...+...+..+.+||.+||..||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 001 0111223334557899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.99 Aligned_cols=255 Identities=30% Similarity=0.552 Sum_probs=209.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-------HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-------PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
+|.+...||+|+||.||+|.+..+++.||+|.+...... .+..+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 367788999999999999999999999999988654321 123456889999999999999999999987754
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+++||||+.+..+..+......+++..+..++.||+.||.|||++|++|+||+|+|||+++++.+||+|||++..+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 78999999988666655555567999999999999999999999999999999999999999999999999999876422
Q ss_pred CC-----CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 312 QN-----LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 312 ~~-----~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---------- 228 (267)
T ss_pred cccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC----------
Confidence 11 11123457899999999876 567899999999999999999999998876655444432210
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+ .....++..+.+||.+||+.||.+||++.++|+||||
T Consensus 229 ---------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ---------SP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------CC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 1113578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=346.01 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=214.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||.|+||.||++.+..++..||+|.+... .......+.+|++++++++||||+++++++.... .+|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-KLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-eEEEEe
Confidence 5799999999999999999999999999999998754 3445667889999999999999999999988754 789999
Q ss_pred Eeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||++++.+..+. .....+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 160 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKR 160 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-ccc
Confidence 999986665444 444579999999999999999999999999999999999999999999999999987653322 122
Q ss_pred ccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 317 TSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+|+.|+|||++.. ...++.++|+|||||++|+|++|++||.+.+....+.++... .++
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------------ 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP------------ 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC------------
Confidence 34568999999999852 245788999999999999999999999887766555554321 000
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.......++.++.+||.+||..||.+||++.++|+||||...
T Consensus 227 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 ------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 001113578889999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.13 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=213.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
-|++++.||+|+||.||++++..++..+|+|.+... .......+.+|+++++.++||||+++++++.... ..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-EEEEEEE
Confidence 378899999999999999999999999999998643 2445667889999999999999999999988755 7899999
Q ss_pred eccccchhhh-cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHDLAGLA-TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|+.++.+..+ ......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9998766543 3344579999999999999999999999999999999999999999999999999987653221 1233
Q ss_pred cccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 318 SRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
...+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+.+..+...... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~------------ 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--T------------ 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--C------------
Confidence 4578999999999842 245788999999999999999999999988776665555331100 0
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 228 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 ------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00112478899999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=343.10 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=207.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-KLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-EEEEEE
Confidence 36999999999999999999999999999999987543 233455788999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++.+..+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ....
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK 164 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence 999976555544445579999999999999999999999999999999999999999999999999987664322 2233
Q ss_pred cccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...|++.|+|||++. ....++.++|+|||||++|+|++|.+||........+..+.... ...
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--~~~-------------- 228 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--FQP-------------- 228 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC--CCC--------------
Confidence 457899999999874 23457899999999999999999999997665444333321110 000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
+. ......++..+.+||.+||..||++|||+.++|+|||
T Consensus 229 -~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 229 -PK-------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -Cc-------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00 0001246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.69 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=213.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||.|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++.... .+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-KLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-eEEEEE
Confidence 36899999999999999999999999999999987654 2344566789999999999999999999988764 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+.... ++++..++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++..+..... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999986555554444 799999999999999999999999999999999999999999999999999988754321 233
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.... .+
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~~ 216 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------------PP 216 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------CC
Confidence 4578899999999986 458999999999999999999999998776554444332210 00
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+ ...++.++.+||.+||..||++|||+.++++||||...
T Consensus 217 ~~~--------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 SLE--------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CCc--------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 000 01278889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.51 Aligned_cols=257 Identities=29% Similarity=0.498 Sum_probs=207.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
+|+..+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.++++++||||+++++++... ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68999999999999999999999999999999875432 223456788999999999999999999988754 35789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~- 313 (665)
++|||+.++.+.........+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 9999998765555444445789999999999999999999999999999999999999999999999999986542211
Q ss_pred -CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 -LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 -~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+....+..+... +.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~------------ 226 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT------------ 226 (266)
T ss_pred CCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC------------
Confidence 11223457899999999876 56889999999999999999999999876655444433211 00
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.+ .....+++.+.+|| +||..||++|||+.++|+||||.
T Consensus 227 ---~~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ---NP---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---CC---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 11124677889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=334.24 Aligned_cols=279 Identities=31% Similarity=0.584 Sum_probs=229.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeecc-CCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~l~ 234 (665)
.++|++++++|+|-|+.||.|++..+.+.++||+++. -..+.+.||+.||+.|. ||||++|++++.+. +....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4689999999999999999999999999999999874 34567899999999996 99999999998876 55678
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~~~~~~ 313 (665)
||+||+++.....+- ..|+..+++.|+.||+.||+|||++||+|||+||.|++||.. -.++|+|+|||.++.+...
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999999974443333 258899999999999999999999999999999999999954 5799999999999876543
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCh-hHHhhhcccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSE-DYWRKSKSAH 391 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~kI~~~~g~p~~-~~~~~~~~~~ 391 (665)
..-++.+..|--||++.....|+.+.|+|||||+|..|+..+ |.|.|.++.+|+-+|.+++|+..- .|..+.....
T Consensus 189 --YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred --eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 455678999999999998889999999999999999998877 556899999999999999997532 3444433222
Q ss_pred ccCCC------CCCcchhhhhhhccC-CcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 392 ATSFK------PQQPYKRKVLETFRN-FPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 392 ~~~~~------~~~p~~~~~~~~~~~-~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...+. ...++.+.+.....+ ++++++|||.++|.+|-++|+||.|++.||||..
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 22111 122233333222233 5699999999999999999999999999999974
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.46 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=211.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|++++++++||||+++++++.... .+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-KLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-EEEEEE
Confidence 47999999999999999999999999999999997543 235567889999999999999999999987755 799999
Q ss_pred EeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++.+..+... ...+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+..... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 99998766655443 36899999999999999999999999999999999999999999999999999987643221 12
Q ss_pred ccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 317 TSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
....++..|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+.......+....-.+ .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~------------- 224 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-P------------- 224 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-c-------------
Confidence 345788999999998753 267889999999999999999999998877665554433210000 0
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
.......++.++.+||.+||..||..|||+.++|.|+|
T Consensus 225 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ----------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=333.36 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=216.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|+.++.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++.... .++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-TLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-eEEEEEE
Confidence 489999999999999999999999999999999876656666777889999999999999999999998754 7999999
Q ss_pred ecccc-chhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHD-LAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~-ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.++ +...+... ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 99875 44444433 35689999999999999999999999999999999999999999999999999987644331 23
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+... .+.
T Consensus 159 ~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------------- 219 (256)
T cd08221 159 ETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------------- 219 (256)
T ss_pred cccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC----------------
Confidence 44578999999999876 45789999999999999999999999988777766665431 110
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....++.++.+||.+||..||.+||++.++|+|+|+
T Consensus 220 ----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 ----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0013578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=340.15 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=205.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc-----CC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR-----SG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-----~~ 231 (665)
+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+||+++++++... ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 369999999999999999999999999999999875432 234577899999998 799999999998753 23
Q ss_pred cEEEEEEeccccchhh-hcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 232 SLYLVFEYMEHDLAGL-ATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~-~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+|+||||+.++.+.. +.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 5899999998755444 333 23468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
... .......|++.|+|||++.+ ...|+.++|||||||++|+|++|..||...........+... +
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~------ 232 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------ 232 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C------
Confidence 322 12344578999999999863 235788999999999999999999999765543333222110 0
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
. .......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 233 ----------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ----------A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------C--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 000112467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=337.38 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=209.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC----CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+++|++++|+||+++++++... ..+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence 478889999999999999986 5788999999875432 223446688999999999999999999998875 4899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC---
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS--- 311 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~--- 311 (665)
+||||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999998766655555557999999999999999999999999999999999999999999999999998765321
Q ss_pred --CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 --QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 --~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM---------- 227 (265)
T ss_pred ccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----------
Confidence 1112234568999999999876 568899999999999999999999998776554443332211100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 228 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 ----------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 01123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.51 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=211.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+|++++||||+++++.+.... .+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-ALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-EEEEEEe
Confidence 489999999999999999999999999999999876665566778899999999999999999999887654 7999999
Q ss_pred eccccchh-hhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceecCCCCCCC
Q 006004 239 YMEHDLAG-LATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 239 y~~g~ll~-~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|+.++.+. .+... +..+++..+..++.||+.+|.|||++||+|+||||+|||++.+ +.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99875444 44332 3458999999999999999999999999999999999999865 4689999999987653322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------------ 218 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------------ 218 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC------------------
Confidence 233568999999999876 5678999999999999999999999988776655554432100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 219 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00112478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=345.14 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=212.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++++.||+|+||.||++++..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+.... .+|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-EEEEee
Confidence 3799999999999999999999999999999998765432 3456789999999999999999999988754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+... ..+++.++..++.||+.||.|||..||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~ 174 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence 99997666555443 3689999999999999999999999999999999999999999999999999886543221 123
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+... +.+.
T Consensus 175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~----------------- 235 (296)
T cd06654 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE----------------- 235 (296)
T ss_pred cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC-----------------
Confidence 4478999999998876 56789999999999999999999999887765444332211 0000
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||++|||+.++|+||||...
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01123577889999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.56 Aligned_cols=260 Identities=30% Similarity=0.545 Sum_probs=209.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC----CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+|+..+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.++++++|+||+++++++.... .++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence 37888999999999999999999999999999875432 1234567889999999999999999999988755 789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.+..+..+.....++++..+..++.||+.||.|||++||+|+||+|+||+++.++ .+||+|||++..+.....
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999877665555556799999999999999999999999999999999999998776 699999999987643211
Q ss_pred ---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 ---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.......+|..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....-.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 226 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------------ 226 (268)
T ss_pred cCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc------------
Confidence 11123467899999999876 56889999999999999999999999765543333333221100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
... ......+++++.+||.+||..||.+|||+.++|+||||+
T Consensus 227 ---~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ---TTA---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---CCC---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 011235788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=333.39 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=212.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++++.||+|+||.||++++..+|+.||+|.+............+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-NLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-eEEEEEe
Confidence 489999999999999999999999999999999765544555667889999999999999999999987754 8999999
Q ss_pred ecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.+. +...+.. ....+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+..... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 158 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LA 158 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hh
Confidence 99864 4444433 234689999999999999999999999999999999999999999999999999987643221 12
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+... ..+
T Consensus 159 ~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------------- 219 (256)
T cd08218 159 RTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP---------------- 219 (256)
T ss_pred hhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC----------------
Confidence 23467899999999876 56789999999999999999999999887766666555331 110
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....++.++.+||.+||..||.+||++.++|+||||
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 ----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=343.98 Aligned_cols=257 Identities=28% Similarity=0.506 Sum_probs=215.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++++.||.|+||.||++++..+++.||||.+..... .....+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGD-ELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCc-eEEEEE
Confidence 369999999999999999999999999999999875433 23456789999999999999999999988754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+.... .+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCC
Confidence 999987776655443 689999999999999999999999999999999999999999999999999886543322 123
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+... +.+.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------------- 234 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------------- 234 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------------
Confidence 3468999999998876 56789999999999999999999999988776655544321 1100
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 235 --------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 --------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred --------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123578899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.76 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=212.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~ 237 (665)
+|++++.||.|+||.||++.+..++..||+|.+..........+.+..|+++++.++||||+++++++... ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999987666666677788999999999999999999987653 44689999
Q ss_pred Eeccccchh-hhcC---CCCCCChhHHHHHHHHHHHHHHHHH-----hCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 238 EYMEHDLAG-LATT---PGIKFTEPQIKCYMQQLLRGLEHCH-----SRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 238 Ey~~g~ll~-~~~~---~~~~lse~~i~~i~~QIl~aL~~LH-----~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
||+.++.+. .+.. ...++++.+++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999875444 3322 2457999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+....+... ..
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KF--------- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CC---------
Confidence 54322 1234578999999999876 56889999999999999999999999887754444333221 00
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......++..+.+||.+||..||.+|||+.++|+|||+
T Consensus 228 -----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 -----------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 01113577899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=365.46 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=227.4
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.....|.+++.||+|.|+.|.++++..++..||||++.+...+....+.+.+|++||+.|+|||||+++.+..... .+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-TLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-eeE
Confidence 3445799999999999999999999999999999999988888888788999999999999999999999998865 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+..++...+.+.+..++.++.|++.|++|||+++|+|||||++||||+.+.++||+|||++.++... .
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--c
Confidence 99999987666666666668888999999999999999999999999999999999999999999999999998743 3
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.+.+++|++.|.|||++.+..+.++.+|+||+|++||.|+.|..||.|.+-.+.-.+....
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g------------------- 270 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG------------------- 270 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-------------------
Confidence 4678899999999999999888899999999999999999999999987644333222110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....-.++.++.+||+++|.++|.+|++.++++.|.|....
T Consensus 271 ----------k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 271 ----------KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ----------eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 111122478899999999999999999999999999998643
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.96 Aligned_cols=259 Identities=33% Similarity=0.566 Sum_probs=212.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||++.+..+++.||+|.++.........+.+.+|++++++++|+||+++++++...+ .+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-KVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-EEEEEEe
Confidence 489999999999999999999999999999999876555567788999999999999999999999877654 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC---
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--- 315 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~--- 315 (665)
|+.+..+..+...+..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99987776666665678999999999999999999999999999999999999999999999999998765433221
Q ss_pred cccccccccccCcccccCCc--ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 316 LTSRVVTLWYRAPELLLGAT--KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~--~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|+.||.+............. +.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------------- 223 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH--------------- 223 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC---------------
Confidence 11346788999999987532 3789999999999999999999999765433222221111 10
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.+..| ....+++.+.+||.+||..||.+|||+.+++.|||+
T Consensus 224 --~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 224 --KPPIP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --CCCCC-------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00011 112458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=342.69 Aligned_cols=286 Identities=36% Similarity=0.600 Sum_probs=239.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSLYL 235 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l~l 235 (665)
.+--+.||-|.||.||.+.|..+|+.||+|++......-...+.+.+|+.+|..++|.|++..++..+... ..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44457899999999999999999999999998644333445567889999999999999999988765432 24789
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
++|+|..+|...+..+. .|+.+.++-+++||+.||.|||+.||+||||||.|+|++.+..+||||||+|+..+.+....
T Consensus 135 ~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 99999999988887765 79999999999999999999999999999999999999999999999999999988877777
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc---cccc
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK---SAHA 392 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~---~~~~ 392 (665)
++..+.|..|+|||++.|...|+.++||||+|||+.|||..+-+|+..+..+++..|..++|+|+.+-.+... ..+.
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 8888999999999999999999999999999999999999999999999999999999999999988766421 1111
Q ss_pred cCCCCCCcchhhhhhhc--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETF--RNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.......|....+.... .+-..++.+++..||..||.+|.+.++++.|+|....
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11122222111111111 1344578999999999999999999999999998644
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=344.61 Aligned_cols=257 Identities=28% Similarity=0.499 Sum_probs=212.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++++.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++.... .+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-EEEEee
Confidence 4799999999999999999999999999999999754432 3355788999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~ 173 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcC
Confidence 99998766655543 3589999999999999999999999999999999999999999999999999987644322 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~----------------- 234 (297)
T cd06656 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE----------------- 234 (297)
T ss_pred cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC-----------------
Confidence 4578999999999876 5678999999999999999999999987665443322211 01110
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+||++.++|+||||...
T Consensus 235 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 --------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred --------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 01123577889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.76 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=209.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
.+|++.+.||+|+||.||++++..+|+.||||.+..... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999865322 234567788999999999999999999988764 3468
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999998765555544445689999999999999999999999999999999999999999999999999986532111
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+.++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 11233468999999999876 5689999999999999999999999987655544433321 1100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
+ .....++..+.++|.+||. +|.+||+++++++|||+.
T Consensus 228 -----~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 -----P---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----C---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 0123567889999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.34 Aligned_cols=282 Identities=33% Similarity=0.554 Sum_probs=235.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 232 (665)
.+|..+..+|.|.- .|..|-|...++.||+|++..........++..+|..++..+.|+||++++.+|.... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36899999999999 8999999999999999998654333445566789999999999999999999997542 35
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+|||||.+++...+. -.+....+..+++|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..+..
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 89999999999888776 35788899999999999999999999999999999999999999999999999986654
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
..++.++.|+.|+|||++.+ ..|...+||||+||++.||++|+..|+|.+..++..+|...+|+|.+.|.++....-+
T Consensus 172 -~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred -cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 45788999999999999998 4599999999999999999999999999999999999999999999999877543222
Q ss_pred cCCC-----------CCCcchhh--hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFK-----------PQQPYKRK--VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~-----------~~~p~~~~--~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.... ...|.... ..+..+.-+..+++|+.+||..||++|.++.+||+||||+-+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 2111 11110000 011111223568999999999999999999999999999833
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.09 Aligned_cols=255 Identities=32% Similarity=0.510 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
+|+..+.||+|+||.||+|.+..+++.||+|.+..... ..+..+.+.+|+.+++.++|+||+++++++.... .+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-NLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-eEEE
Confidence 47778999999999999999998999999999875432 2445677889999999999999999999887654 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+..+..+......+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 99999986665555555579999999999999999999999999999999999999999999999999988764332 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....++..|+|||.+.....++.++|+|||||++|+|++|++||......+...++.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------ 219 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE------------------ 219 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc------------------
Confidence 34456899999999987633489999999999999999999999987665444443322100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......+++++.+||.+||..||.+|||+.++|.|||+
T Consensus 220 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.09 Aligned_cols=261 Identities=31% Similarity=0.545 Sum_probs=208.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--------CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--------DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS 230 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~ 230 (665)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 48889999999999999999999999999998864321 1122456788999999999999999999887754
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+++||||+.++.+..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 -YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred -ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 7899999998866655555546899999999999999999999999999999999999999999999999999976542
Q ss_pred CCC-CCcccccccccccCcccccCCc-ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 311 SQN-LPLTSRVVTLWYRAPELLLGAT-KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 311 ~~~-~~~~~~~gT~~Y~APE~l~~~~-~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
... .......++..|+|||++.... .++.++|+|||||++|+|++|..||...+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 229 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS----------- 229 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-----------
Confidence 211 1123346789999999987543 478999999999999999999999976655444433221100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
...+. ......++..+.+||.+||.+||.+|||+.++|+||||
T Consensus 230 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 ---APPIP---------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---CCcCC---------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00000 01223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=335.82 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++.+.||.|+||.||+|++..+++.||+|++..... .....+.+.+|++++++++||||+++++++.... .+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-NMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-eEEEEE
Confidence 48999999999999999999999999999999976543 3355678899999999999999999999987654 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.+..+.........+++.++..++.||+.||.|||++||+|+||+|+|||+++++.++|+|||++....... ...
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 157 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTT 157 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--ccc
Confidence 999987666555544689999999999999999999999999999999999999999999999999988764432 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--VEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~---------------- 217 (258)
T cd05578 158 STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A---------------- 217 (258)
T ss_pred ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c----------------
Confidence 4567889999999876 5589999999999999999999999987764 2222221110 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH--HHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA--ASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa--~eaL~Hp~f 443 (665)
.......++..+.+||.+||..||.+|+++ .++++||||
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ---------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001113467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.49 Aligned_cols=255 Identities=29% Similarity=0.501 Sum_probs=214.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++++.||+|+||.||++.+..+++.||+|++..... ..+..+.+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 94 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWLVM 94 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEEEH
Confidence 59999999999999999999999999999999875432 4455567889999999999999999999988755 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.|.+...+......+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...... .
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~ 169 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----N 169 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----C
Confidence 99999887777655567999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~---------------- 231 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---------------- 231 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC----------------
Confidence 3567889999998852 356889999999999999999999999887765544433210 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+.. ....++..+.+||.+||..||.+||++.+++.||||...
T Consensus 232 -~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 -PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 000 011367789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.42 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=208.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC----
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS---- 230 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~---- 230 (665)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34689999999999999999999999999999999875432 345678999999999 7999999999987532
Q ss_pred -CcEEEEEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 231 -GSLYLVFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 231 -~~l~lV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
..+|+||||+.+..+..+.. .+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 35899999999865543332 2357999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~ 381 (665)
........ ......+++.|+|||++.. ...++.++|||||||+||+|++|++||........+..+... +..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~ 236 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPP 236 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCC
Confidence 87643222 2234568999999998753 235778999999999999999999999876655544443221 000
Q ss_pred hHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
. ......++..+.+||.+||..||.+|||+.++++|||+
T Consensus 237 ~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T-----------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 00112467889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.16 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=207.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~----~ 231 (665)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++...+ +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 457999999999999999999999999999999986432 2234567899999999 8999999999886432 3
Q ss_pred cEEEEEEeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 232 SLYLVFEYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.+|+||||+.++.+..+. ..+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 589999999876554332 2345789999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCcccccccccccCcccccCCc----ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGAT----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~----~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
+..... ......++..|+|||++.... .++.++|||||||++|+|++|++||...+....+..+.+. +...
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~- 252 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPT- 252 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCC-
Confidence 543221 122346889999999886422 3688999999999999999999999887765555444221 0000
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
......++..+.+||.+||..||++||++.++|+||||+
T Consensus 253 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ----------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ----------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000124567899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=359.92 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=212.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
..|+++++||.||.+.||++.. .+...||+|++.....+...+.-+..||..|.+| .|.+||+|++|-.. ++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 4599999999999999999986 4456789998887777888889999999999999 59999999997555 5699999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~~ 315 (665)
|||-+.||-..+.+...-++.-.++.|.+|||.|+.++|..||||.||||.|+|+-. |.+||+|||+|..+..+. +..
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 999999999988887766666699999999999999999999999999999999986 899999999999886543 334
Q ss_pred cccccccccccCcccccCC----------cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 316 LTSRVVTLWYRAPELLLGA----------TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~----------~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
..+.+||+.||+||.+... -..+.++||||||||||+|+.|++||.... .++.++..+.. |..
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~-P~~---- 590 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD-PNH---- 590 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC-CCc----
Confidence 5667999999999998631 236789999999999999999999996532 13333333211 111
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCc--HHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFP--QSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s--~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
. ..|+.+| .+++++++.||..||.+|+|+.++|+|||+...+.
T Consensus 591 ----------~----------Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 591 ----------E----------IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred ----------c----------ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 0 0111222 23899999999999999999999999999986443
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.09 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=213.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+.... ..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-ELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-eEEEEEe
Confidence 4666788999999999999999999999999986432 334556889999999999999999999988754 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+.... .+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ....
T Consensus 100 ~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 100 FLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred CCCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 99987766655443 689999999999999999999999999999999999999999999999999876543221 2234
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+...... .
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~ 237 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-------------------R 237 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------------c
Confidence 578999999999875 56889999999999999999999999887766655544321100 0
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
. .....++..+.+||.+||..||.+|||+.++|+||||.....|
T Consensus 238 ~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 238 V-------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred c-------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 0112467889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.80 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=205.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc-----CC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR-----SG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-----~~ 231 (665)
+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 47999999999999999999999999999999986432 3345578899999998 799999999988532 34
Q ss_pred cEEEEEEeccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 232 SLYLVFEYMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+|++|||+.++.+. .+.. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 689999999875444 3332 23458899999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
.... ......|++.|+|||++.. ...++.++|+|||||++|+|++|.+||........+..+... ..
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 243 (282)
T cd06636 173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----- 243 (282)
T ss_pred cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----
Confidence 3221 2334578999999998863 245788999999999999999999999776554443332110 00
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......++.++.+||.+||..||.+|||+.++|+||||
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000113578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.55 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=217.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD 243 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ 243 (665)
+.||+|-||+||-++++.+|+.||||+|.+..........+..|+.||+.+.||.||.|...|+..+ .+++|||-+.|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-rvFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-RVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-eEEEEehhhcch
Confidence 6899999999999999999999999999887776666678899999999999999999999999876 899999999999
Q ss_pred chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC---CcEEEEecccceecCCCCCCCcccc
Q 006004 244 LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 244 ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~---g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
.+..++. ..++|++...++++.||+.||.|||.++|+|+||||+||||.+. -.+||||||+|+.+.+... ..+.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--RrsV 726 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RRSV 726 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hhhh
Confidence 9887765 45689999999999999999999999999999999999999754 4799999999999875443 4677
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
+|||.|+|||++.. ..|+...|+||+|||+|.-|+|..||... +-.+|++.. .-..+..
T Consensus 727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---aFMyPp~---------------- 786 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---AFMYPPN---------------- 786 (888)
T ss_pred cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcc---ccccCCC----------------
Confidence 99999999999987 67999999999999999999999999654 333444432 1111222
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.|..+++.++|||..+|++.=.+|.+++..|.|||+++.
T Consensus 787 ---------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 787 ---------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ---------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 235799999999999999999999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=332.86 Aligned_cols=253 Identities=31% Similarity=0.501 Sum_probs=209.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||++++..+++.||+|.+.... ....+.+|+.+++.++||||+++++++.... .+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNT-DLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-cEEEEE
Confidence 57999999999999999999999889999999986432 2567889999999999999999999988764 799999
Q ss_pred Eeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.+..+..+. .....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999976555443 3456789999999999999999999999999999999999999999999999999987654321 22
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+... ...
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~--------------- 217 (256)
T cd06612 157 NTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPP--------------- 217 (256)
T ss_pred ccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCC---------------
Confidence 33457899999999876 57899999999999999999999999876654433322110 000
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 218 --------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 --------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 001113467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=329.22 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=221.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++.+.+..||.|+.|+||+++.+.+|...|||.++... +.+..+++++.+.++... ++|+||+.+++|.... .++
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHH
Confidence 3456788889999999999999999999999999998655 455667778888876655 6999999999998865 688
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|.||.|......++..-.++++|..+-++...++.||.||.++ ||||||+||+|||||..|++||||||++-.+..+..
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999877666666667899999999999999999999975 999999999999999999999999999988755433
Q ss_pred CCcccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 LPLTSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPG-RTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.+...|.+.|||||-+.- ...|+.++||||||++|+||.||+.||.+ .++.+.+.+|...
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--------------- 310 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--------------- 310 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc---------------
Confidence 455689999999999863 36799999999999999999999999997 5678888888651
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+|..| .-..||+++.+|+..||.+|+.+||...++|+|||+...
T Consensus 311 ----ePP~L~-------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 311 ----EPPLLP-------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ----CCCCCC-------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111111 113499999999999999999999999999999999854
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.26 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=203.6
Q ss_pred CCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++.... .+|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-TMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-CcE
Confidence 46999999999999999999865 456789999987543 2344566889999999999999999999988754 799
Q ss_pred EEEEeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+..+. .....+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999987666444 3345799999999999999999999999999999999999999999999999998765432211
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 227 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-------------- 227 (266)
T ss_pred hcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--------------
Confidence 11112234678999999876 678999999999999999775 99999988877766655331100
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 228 --------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 --------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.45 Aligned_cols=261 Identities=30% Similarity=0.485 Sum_probs=206.9
Q ss_pred ccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec---
Q 006004 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS--- 228 (665)
Q Consensus 153 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~--- 228 (665)
.+...++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 33445689999999999999999999999999999998764321 224567899999999 79999999998742
Q ss_pred -cCCcEEEEEEeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 229 -RSGSLYLVFEYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 229 -~~~~l~lV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
....+|+||||++++.+..+. .....+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 234689999999876554332 234568999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
++..+.... .......|++.|+|||++.. ...++.++|||||||++|+|++|+.||........+.++... .+
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~ 246 (286)
T cd06638 170 VSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP 246 (286)
T ss_pred ceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC
Confidence 998764322 12234478999999998853 245788999999999999999999999876654444332110 00
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
+. ......++..+.+||.+||..||++|||+.++|+|+||
T Consensus 247 -----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -----------------PT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------Cc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 00112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.96 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=206.8
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||.|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. .+|+||||+.++.
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-YIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-ccEEEEecCCCCc
Confidence 6899999999999999999999999976543 3345567899999999999999999999988765 7899999998766
Q ss_pred hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccccc
Q 006004 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW 324 (665)
Q Consensus 245 l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~ 324 (665)
+..+......+++.++..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......+++.
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~ 157 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPE 157 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcC
Confidence 65555555579999999999999999999999999999999999999999999999999998765432 1234478999
Q ss_pred ccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT--EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 325 Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~--~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
|+|||.+.+ ..++.++|+|||||++|+|++|..||...+ ..+.+.++...... .
T Consensus 158 ~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~----- 213 (262)
T cd05572 158 YVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK------------------L----- 213 (262)
T ss_pred ccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC------------------C-----
Confidence 999999875 568999999999999999999999998776 44444443310000 0
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
......++++.+||.+||..||.+|+| +.|+++||||+..
T Consensus 214 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 214 ----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 011234788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=356.44 Aligned_cols=291 Identities=32% Similarity=0.541 Sum_probs=237.4
Q ss_pred cccccccccccCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC----
Q 006004 140 WLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---- 215 (665)
Q Consensus 140 ~~~~~~g~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---- 215 (665)
++....|+.++. +|.+....|+|-||+|..|.+..-|..||||+|+.... ..+.=++|++||++|.
T Consensus 421 YYrv~igE~LD~-------RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 421 YYRVRIGELLDS-------RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADP 490 (752)
T ss_pred eEEEehhhhhcc-------eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCc
Confidence 555666777765 89999999999999999999999999999999986432 2333468999999994
Q ss_pred --CCCcceeeeeeeccCCcEEEEEEeccccchhhhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE
Q 006004 216 --HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291 (665)
Q Consensus 216 --HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl 291 (665)
--++++|+..|...+ ++|||||-+.-+|...+..-+ ..|....++.|++||+.||.+|...||+|.||||+||||
T Consensus 491 Edk~Hclrl~r~F~hkn-HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKHKN-HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV 569 (752)
T ss_pred hhhhHHHHHHHHhhhcc-eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe
Confidence 358899999888765 899999999988887776543 458889999999999999999999999999999999999
Q ss_pred cCC-CcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH
Q 006004 292 NNA-GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370 (665)
Q Consensus 292 d~~-g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 370 (665)
+.. ..+||||||.|....... .+.+..+..|+|||+++| ..|+...|+||+||+||||.||+.+|+|.++.+++.
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 965 569999999999875543 578888999999999998 789999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhHHhhhccc--c--------------------ccCCCCCCcchhhhhhhcc--CCc-------HHHHHH
Q 006004 371 KIFKLCGSPSEDYWRKSKSA--H--------------------ATSFKPQQPYKRKVLETFR--NFP-------QSALAL 419 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~--~--------------------~~~~~~~~p~~~~~~~~~~--~~s-------~~a~dL 419 (665)
....+.|.++.....+.... | ........|.+-...++.. .++ ..+++|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 99999999988776653211 0 0011112222211111111 122 357899
Q ss_pred HHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 420 VDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 420 I~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
|.+||..||++|.|..|||.||||+.
T Consensus 726 Ldkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCCcccC
Confidence 99999999999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.83 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=197.9
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH-HHHHHHHHHHHHH---hCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE-SVRFMAREIHILR---KLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~Ei~iL~---~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
.||+|+||.||++.+..+++.||+|.+........ ......+|..+++ ..+||||+.+++++...+ .+|+||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-KLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-eEEEEEecC
Confidence 48999999999999999999999999875443211 1222344544443 347999999999988754 789999999
Q ss_pred cccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccc
Q 006004 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 241 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
.++.+..+......+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .....
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 156 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcC
Confidence 987666555555579999999999999999999999999999999999999999999999999997654322 23347
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV--EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~--e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
||+.|+|||.+.+...++.++|+||+||++|+|++|..||.+.... ..+..... ..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~------------------- 214 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV------------------- 214 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC-------------------
Confidence 8999999999875466899999999999999999999999765321 11111110 00
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.......+++++.+||.+||..||.+|+ |+.++++||||+...
T Consensus 215 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 215 ------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0011235788999999999999999999 699999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=334.87 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=208.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|++++++++||||+++++++.... .+|+|||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-DISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-EEEEEEE
Confidence 68889999999999999999999999999999876543 345567889999999999999999999988764 7999999
Q ss_pred eccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.+..+..+. .....+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 99965444444 333689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT-----EVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~-----~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+ ..+.+..+... ..
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~----------- 221 (265)
T cd06605 157 KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PP----------- 221 (265)
T ss_pred hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CC-----------
Confidence 12578899999999876 578999999999999999999999997642 22222222110 00
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+ ...++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 222 -----~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -----PRLP--------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----CCCC--------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0000 01278889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.24 Aligned_cols=261 Identities=21% Similarity=0.334 Sum_probs=207.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|+.++.||+|+||.||++++..+++.||||.+...... .....+.+|+.++.++. |+||+++++++.... ..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-DCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-cEEEE
Confidence 4678889999999999999999999999999998755433 44566789999999995 999999999887654 78999
Q ss_pred EEeccccchhhh----cCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLA----TTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~----~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
|||+...+..+. ......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 999987544322 12335799999999999999999999975 9999999999999999999999999999765432
Q ss_pred CCCCcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .....|++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+.........
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~------ 231 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL------ 231 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC------
Confidence 21 2334678999999999764 3689999999999999999999999976542 2222222111110000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+ ......++..+.+||.+||..||.+|||+.+++.||||..
T Consensus 232 ----------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 232 ----------S-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ----------C-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0 0111357889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.43 Aligned_cols=257 Identities=28% Similarity=0.501 Sum_probs=211.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l~l 235 (665)
.|++++.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. ||||+++++++.... .+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-RLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-EEEE
Confidence 4888999999999999999999999999999987543 2344566789999999996 999999999987654 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+..+...+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K 157 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence 99999886665555444 799999999999999999999999999999999999999999999999999987754332 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------------------~ 218 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-------------------K 218 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------C
Confidence 334578999999999876566789999999999999999999999876544333221110 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+ ...++.++.+||.+||..||.+|||+.+++.|+||+..
T Consensus 219 ~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 219 PPRLE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCCCC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 00000 11377889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.38 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=203.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||+|+||+||+|.+..+|+.||+|++...... ......+.+|+++|++++||||+++++++.... .+|+||||++++.
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-DLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-eEEEEEecCCCCc
Confidence 68999999999999999999999998754332 223445678999999999999999999988754 7899999999765
Q ss_pred hhhhcCC-C-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 245 AGLATTP-G-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 245 l~~~~~~-~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
+...... . ..+++.++..++.||+.||.|||+.||+|+||+|+|||+++++.+||+|||++...... .......++
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 157 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGT 157 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCC
Confidence 5443322 2 36999999999999999999999999999999999999999999999999998765432 222345678
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+....-.
T Consensus 158 ~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 212 (277)
T cd05577 158 PGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------------ 212 (277)
T ss_pred CCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------------
Confidence 89999999876 45899999999999999999999999876542222222111000
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCCC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEPL 448 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~~ 448 (665)
........+++.+.+||.+||..||.+|| ++.++++||||+...+
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 00112235789999999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.76 Aligned_cols=243 Identities=19% Similarity=0.202 Sum_probs=201.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeec--c-CCcEEEEEEe
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTS--R-SGSLYLVFEY 239 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~-~~~l~lV~Ey 239 (665)
..||+|+++.||+|.. +|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.+ . ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999987 7899999999765432 3335678899999999999999999998876 2 3468999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
+.++.+..+......+++.....++.|++.||.|||.. +++||||||+|||++.++.+||+|||++..+.... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 99876666655556799999999999999999999984 99999999999999999999999999998654321 23
Q ss_pred ccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 319 RVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
.++|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 4689999999998652 5789999999999999999999999998887766666543211110
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++.+.+||.+||+.||.+|||+.++|+
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246888999999999999999999999986
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.56 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=211.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++.... .+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-NICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-EEEEE
Confidence 357999999999999999999999999999999987543 2344567889999999999999999999998764 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+..+......+++..+..++.||+.||.|||+ .|++|+||||+|||+++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999987776665555679999999999999999999997 599999999999999999999999999987653221
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCCChhHHhhhcccc
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ----MHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~----l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||......+. ...+.. .+.....
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~-- 227 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD--------LLQQIVQ-- 227 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH--------HHHHHhh--
Confidence 123578999999999876 5788999999999999999999999986554211 111110 0000000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...+..+ ...++..+.+||.+||.+||.+|||+.++++|+||...
T Consensus 228 --~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 228 --EPPPRLP--------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --ccCCCCC--------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000000 01367889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.26 Aligned_cols=254 Identities=30% Similarity=0.523 Sum_probs=208.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||++.+..+|..||+|.+..........+.+.+|+++++.++|+||+++++.+.... .+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-RLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-eEEEEEe
Confidence 489999999999999999999999999999999765444444566789999999999999999999887754 7999999
Q ss_pred eccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCCCC
Q 006004 239 YMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 239 y~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~~~ 315 (665)
|+.+..+. .+.. .+..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .+||+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 99875444 3333 233589999999999999999999999999999999999999886 469999999987643322 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 218 (257)
T cd08225 159 AYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------- 218 (257)
T ss_pred ccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------------
Confidence 233468999999998876 568899999999999999999999998876655544432210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.......++.++.++|.+||..+|++|||+.++|+||||
T Consensus 219 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ---------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 001123578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.12 Aligned_cols=255 Identities=33% Similarity=0.518 Sum_probs=212.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~l 235 (665)
++|++.+.||+|+||.||++++..+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.... .+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE-NLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-eEEE
Confidence 369999999999999999999999999999999876433 2344566889999999998 999999999887654 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC--
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-- 313 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-- 313 (665)
||||+.++.+..+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999996654444444445799999999999999999999999999999999999999999999999999987643321
Q ss_pred -----------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 006004 314 -----------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 314 -----------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~ 376 (665)
.......++..|+|||++.. ..++.++|+|||||++++|++|+.||...+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 12233467899999998876 568899999999999999999999999887665555543211
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCC
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFF 443 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f 443 (665)
. .....+++.+.+||.+||..||.+|||+ .++|+||||
T Consensus 239 ~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 Y-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 0 1113468889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.93 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=213.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
-|.....||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.... .+|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-ELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCC-eEEEEEe
Confidence 36666789999999999999999999999999875432 23455789999999999999999999988754 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... .....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 9998766655543 368999999999999999999999999999999999999999999999999987654322 12234
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+... +..
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~----------------- 235 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP----------------- 235 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC-----------------
Confidence 578999999999876 56899999999999999999999999887766665544221 000
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
.......++..+.+||.+||..||.+||++.++++||||.....+
T Consensus 236 ------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 236 ------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred ------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 001123577889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=323.99 Aligned_cols=254 Identities=34% Similarity=0.521 Sum_probs=213.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|||++++++.+... ..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 48999999999999999999999999999999987665556677788999999999999999999998876 48999999
Q ss_pred eccccchh-hhcCC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 239 YMEHDLAG-LATTP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 239 y~~g~ll~-~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+++..+. .+... +..+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 99975444 44332 3679999999999999999999999999999999999999999999999999998765432 1
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 220 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----------------- 220 (258)
T ss_pred eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-----------------
Confidence 2234578999999998876 5688999999999999999999999987765544444322100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......++..+.++|.+||..||.+|||+.++|+||||
T Consensus 221 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 -----------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00112578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=333.94 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=199.0
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-HHHHHHHHH---HHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMARE---IHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~E---i~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
.||+|+||.||+|++..+++.||+|.+....... .....+..| +.+++.+.||||+++++++.... .+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-EEEEEEecC
Confidence 3899999999999999999999999987654321 111122333 34455568999999999988765 789999999
Q ss_pred cccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccc
Q 006004 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 241 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
.|+.+..+......+++.+++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+.... ....+
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~ 156 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 156 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcC
Confidence 987666555555679999999999999999999999999999999999999999999999999987654322 23457
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
|+..|+|||++.+...++.++||||+||++|+|++|+.||.+............... .
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------------------- 214 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-M--------------------- 214 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-c---------------------
Confidence 899999999997655689999999999999999999999987632211111000000 0
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.......++..+.+||.+||..||.+|+ ++.++++||||+...
T Consensus 215 ----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 215 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0011234688999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=334.13 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=205.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.+|++++.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.++++++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ-P 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-c
Confidence 46999999999999999999976655 689999987443 3445567889999999999999999999987654 7
Q ss_pred EEEEEEeccccchh-hhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 233 LYLVFEYMEHDLAG-LATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 233 l~lV~Ey~~g~ll~-~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
.|++|||+.++.+. .+.... ..+++.++..++.||+.||.|||++||+|+||||+|||+++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 89999999875443 332211 45888999999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999986533221 12234466889999999876 568999999999999999998 9999998877666555433
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
... ......+++++.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 110 01123678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.65 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=214.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|..+++||+|+||.||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+.. ..|+||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-TAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEEE
Confidence 47788899999999999999999999999999875433 3345567889999999999999999999998765 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... ..
T Consensus 101 e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 9999988877776666799999999999999999999999999999999999999999999999999865322 23
Q ss_pred cccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+.... .+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------------- 238 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP---------------- 238 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC----------------
Confidence 4578999999999852 3567889999999999999999999998887666665543210 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. .....++..+.+||.+||+++|.+||++.++|.||||...
T Consensus 239 --~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 --T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred --C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 0112467789999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=337.11 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=198.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECC----------------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE----------------TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~ 221 (665)
++|++.++||+|+||.||+|++.. ++..||+|+++... .......+.+|+.+|.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 479999999999999999998532 34579999987543 3445567889999999999999999
Q ss_pred eeeeeeccCCcEEEEEEeccccchhhhcCC-------------------CCCCChhHHHHHHHHHHHHHHHHHhCCcccc
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTP-------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~-------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHr 282 (665)
+++++.... .+|+||||+.++.+..+... ...+++.++..++.||+.||.|||+.||+||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 84 LLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999988754 78999999987544332211 1246788899999999999999999999999
Q ss_pred CCCcccEEEcCCCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh--CCCC
Q 006004 283 DIKGSNLLINNAGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA--GKPI 359 (665)
Q Consensus 283 DLKPeNILld~~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt--G~~p 359 (665)
||||+|||++.++.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999876433221 1123345788999999876 568999999999999999986 5678
Q ss_pred CCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 360 MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 360 F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
|.+.+..+.+..+......... ..+ .......+..+.+||.+||..||.+|||+.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGR-----------QVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccc-----------ccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8877666555544321100000 000 0011356788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.76 Aligned_cols=255 Identities=34% Similarity=0.494 Sum_probs=212.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|++|.||+|++..+++.||+|++...... .....+.+|+.++.+++|+||+++++++... ..+|+|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEE
Confidence 699999999999999999999999999999998765432 4566788999999999999999999998875 47999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|+.++.+..+......+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++..+..... ...
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~ 158 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCN 158 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-ccc
Confidence 99976666555544679999999999999999999999 9999999999999999999999999999987654332 123
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT---EVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+ ..+....+.. ...
T Consensus 159 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~-------------- 220 (264)
T cd06623 159 TFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP-------------- 220 (264)
T ss_pred ceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC--------------
Confidence 4568899999999876 578899999999999999999999998774 2222222211 000
Q ss_pred CCCCCcchhhhhhhccC-CcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRN-FPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~-~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...... ++..+.+||.+||..+|.+|||+.++|+||||+.
T Consensus 221 -----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 221 -----------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -----------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 001123 7889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.32 Aligned_cols=254 Identities=30% Similarity=0.519 Sum_probs=214.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|++|.||++++..+++.||+|.+............+.+|++++++++||||+++++++... ..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence 48899999999999999999999999999999987665556677889999999999999999999998775 47899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.+..+..+......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......... ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~ 158 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DAS 158 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccc
Confidence 9998666655555568999999999999999999999999999999999999999999999999999887543321 234
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+....+.++... . .
T Consensus 159 ~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------~----~--- 216 (254)
T cd06627 159 VVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------D----H--- 216 (254)
T ss_pred cccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------C----C---
Confidence 467999999998876 45889999999999999999999999877654444433210 0 0
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......++..+.+||.+||..||++|||+.++|.||||
T Consensus 217 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 -------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 01123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.71 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=211.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|+.++.||.|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++++.+.. .+|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-KLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEEEEEe
Confidence 58889999999999999999999999999999875432 344567889999999999999999999988754 8999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+... .++++.++..++.||+.||.|||+.+++|+||+|+|||++.++.++|+|||++..+.... .....
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccccc
Confidence 9998665555444 368999999999999999999999999999999999999999999999999998764322 12234
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+... . .+
T Consensus 161 ~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~-----------------~~- 219 (277)
T cd06640 161 FVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N-----------------PP- 219 (277)
T ss_pred ccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C-----------------CC-
Confidence 467899999999876 56899999999999999999999999877655444332110 0 00
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+||++.++|+|+||...
T Consensus 220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 220 --------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred --------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 1122467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.81 Aligned_cols=250 Identities=25% Similarity=0.446 Sum_probs=207.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||.|+||.||++++..+++.||+|.++.... ....+.+.+|+.+++.++|+||+++++++.... .+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-HLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEe
Confidence 48999999999999999999999999999999875432 345567789999999999999999999998754 8999999
Q ss_pred ecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.++ +...+.. .+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-ccc
Confidence 99864 5444433 34468999999999999999999999999999999999999999999999999998764322 122
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+....+..+......
T Consensus 158 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 218 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------------ 218 (255)
T ss_pred ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------------
Confidence 34578999999999876 56899999999999999999999999887765555544321100
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....++..+.+||.+||+.||++|||+.++|.-
T Consensus 219 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.96 Aligned_cols=257 Identities=27% Similarity=0.485 Sum_probs=212.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|...+.||+|++|.||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-ELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-eEEEEEe
Confidence 4666789999999999999999999999999986432 233456789999999999999999999887654 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.+..+..+... .++++.++..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9988666555544 4789999999999999999999999999999999999999999999999998876543221 1234
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+.+..+.... .+
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------------- 233 (285)
T cd06648 175 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------------- 233 (285)
T ss_pred ccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC-------------------
Confidence 568999999999876 568999999999999999999999998877766666553310 00
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.......++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 234 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 234 ------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0001123778899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.55 Aligned_cols=251 Identities=31% Similarity=0.432 Sum_probs=202.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHH-HhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHIL-RKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|.+..+|+.||+|+++..... ......+..|..++ ..++|+||+++++++...+ .+|+||||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-YLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-eEEEEEeccC
Confidence 5799999999999999999999999998754332 22233445565554 4458999999999998754 7999999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
++.+..+......+++.++..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..... .....+
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVG 155 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCC
Confidence 876666655555799999999999999999999999999999999999999999999999999876532 123467
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+...... +..
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~---- 214 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN----------------WPE---- 214 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------------CCC----
Confidence 899999999886 45899999999999999999999999887766555544321100 000
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcC---HHHHHhCcCCCCC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGS---AASALRSEFFKTE 446 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT---a~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||++||| +.|+|.||||+..
T Consensus 215 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 215 -----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 111257899999999999999999995 5899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.44 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=207.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV 236 (665)
++|+.++.||.|++|.||+|.+..+++.||+|.+..... ......+.+|++++++++||||++++++|... .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 469999999999999999999999999999999875432 24456688999999999999999999988654 3468999
Q ss_pred EEeccccchhhh----cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLA----TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~----~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||++++.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999987544322 2334568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCChhHHhhh
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-----VEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-----~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+... ....
T Consensus 160 ~---~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~----- 227 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPE----- 227 (287)
T ss_pred c---ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchh-----
Confidence 1 23457889999998876 5789999999999999999999999986522 2222221110 0000
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. +.. ...-..+++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 228 -------~-~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 228 -------L-KDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -------h-ccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0 000 00001356789999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.08 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=214.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|+.++.||+|+||.||++++..++..||+|++..... ..+....+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence 48899999999999999999999999999999875432 3445567889999999999999999999988755 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.|+++..+.....++++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...... .
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 99999887777665667999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
...+++.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+....+..+......+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 243 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------------- 243 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC----------------
Confidence 3468899999999752 3467899999999999999999999998876666555554311000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||.+|||+.++++|+|+...
T Consensus 244 -----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0012467789999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.28 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=209.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC---CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN---MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.+. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36999999999999999999999999999999986432 1334566788999999999999999999988764 3468
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ- 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~- 312 (665)
++||||+.+..+.........+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999876555444444468999999999999999999999999999999999999999999999999998654211
Q ss_pred -CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 -NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 -~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........++..|+|||++.+ ..++.++|+|||||++|+|++|++||......+.+.++.. .+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCCC---------
Confidence 112234568999999999876 5678999999999999999999999987765554444321 11100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....+++.+.++|.+||. +|.+|||+.++|.|||.
T Consensus 229 ---------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 ---------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1123688899999999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.30 Aligned_cols=252 Identities=33% Similarity=0.474 Sum_probs=206.1
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||.|+||.||++++..+|+.||+|.+..... .......+.+|++++++++||||+++++.+.... .+|+||||+.++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-NLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-EEEEEEecCCCCc
Confidence 6899999999999999999999999875433 2345567889999999999999999999887654 7899999998755
Q ss_pred hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-------CCcc
Q 006004 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-------LPLT 317 (665)
Q Consensus 245 l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-------~~~~ 317 (665)
+..+......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........ ....
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 544444434799999999999999999999999999999999999999999999999999876533211 1223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+..+....+... ...
T Consensus 160 ~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----------------- 219 (265)
T cd05579 160 RIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE----------------- 219 (265)
T ss_pred CcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC-----------------
Confidence 3467889999999876 45789999999999999999999999888766655554331 000
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH---HHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA---ASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa---~eaL~Hp~f~~~ 446 (665)
.+ ....++..+.+||.+||+.||.+|||+ .++|+||||+..
T Consensus 220 -~~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 220 -WP-------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -CC-------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00 001258899999999999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.16 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=201.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++.. +++.||+|+++... .....+.+.+|+.+++++ +|+||+++++++.....
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 479999999999999999997543 45789999987443 334456678899999999 89999999998876666
Q ss_pred cEEEEEEeccccchhhhcCC------------------------------------------------------------
Q 006004 232 SLYLVFEYMEHDLAGLATTP------------------------------------------------------------ 251 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~------------------------------------------------------------ 251 (665)
.+|++|||+.++.+..++..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 89999999997555433211
Q ss_pred -CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CCcccccccccccCcc
Q 006004 252 -GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPE 329 (665)
Q Consensus 252 -~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE 329 (665)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .......++..|+|||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 12688999999999999999999999999999999999999999999999999987643221 1223345577899999
Q ss_pred cccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhh
Q 006004 330 LLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLET 408 (665)
Q Consensus 330 ~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 408 (665)
++.+ ..++.++|||||||+||+|++ |..||.+....+.+....... .. . ..
T Consensus 246 ~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-----------------~---------~~ 297 (337)
T cd05054 246 SIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TR-----------------M---------RA 297 (337)
T ss_pred HhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-CC-----------------C---------CC
Confidence 9886 678999999999999999998 999998765444433332210 00 0 01
Q ss_pred ccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 409 FRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 409 ~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
....++++.+|+.+||+.+|++||++.++++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.21 Aligned_cols=282 Identities=25% Similarity=0.328 Sum_probs=205.5
Q ss_pred EEeecc--CceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
..||.| +||+||++++..+|+.||+|++.......+..+.+.+|+.+++.++||||++++++|.... .+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEeccc
Confidence 356666 9999999999999999999999876655666788899999999999999999999998765 7899999999
Q ss_pred ccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC---C-
Q 006004 242 HDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL---P- 315 (665)
Q Consensus 242 g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~---~- 315 (665)
++.+..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+......... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 7554444332 235899999999999999999999999999999999999999999999999865433211100 0
Q ss_pred --cccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh--HHhhhccc
Q 006004 316 --LTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED--YWRKSKSA 390 (665)
Q Consensus 316 --~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~--~~~~~~~~ 390 (665)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+....+.+..+.......+.+ .+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112346679999998753 357899999999999999999999998877665554443321111100 00000000
Q ss_pred ----------------cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 391 ----------------HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 391 ----------------~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....................+++.+++||.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00000000000000011123467889999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.27 Aligned_cols=255 Identities=28% Similarity=0.468 Sum_probs=210.3
Q ss_pred ccCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 006004 149 IKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS 228 (665)
Q Consensus 149 ~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~ 228 (665)
.+.|...+ ..+++++.||+|-||.||+|.+..+ ..||+|.++...+..+ .|.+|++||++|+|+|||++++++..
T Consensus 198 ~d~wei~r-~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~---~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPR-EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPE---AFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecH-HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChh---HHHHHHHHHHhCcccCeEEEEEEEec
Confidence 44554443 2488899999999999999998543 3699999987655433 36799999999999999999999987
Q ss_pred cCCcEEEEEEeccc-cchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 229 RSGSLYLVFEYMEH-DLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
+. .+|||||||.. .|+..+.. .+..+...+...|+.||++|++||+++++|||||-..||||+++..+||+|||||+
T Consensus 273 ~~-piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 273 QE-PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred CC-ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 54 79999999985 56666665 46679999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
....+........--...|.|||.+.- ..++.++|||||||+||||+| |+.|+++.+..+.+..+.+...-|
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp------ 424 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP------ 424 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC------
Confidence 654443222222222456999999975 679999999999999999987 889999999999999986642222
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
.+...|+.+.+|+..|+..+|++|||.+.+.
T Consensus 425 ----------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ----------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2246899999999999999999999998554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.52 Aligned_cols=149 Identities=30% Similarity=0.439 Sum_probs=131.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|+++++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+++.++||||+++++++.... .+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-NVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-EEEE
Confidence 3579999999999999999999999999999999976443 4455677889999999999999999999887654 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
||||+.|+.+..++.....+++..++.|+.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999876555454444578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.92 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=202.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.... .+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-CcEEEEE
Confidence 5999999999999999999999999999999986432 23456789999999999999999999887654 7899999
Q ss_pred eccccchh-hhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHDLAG-LATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~ll~-~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|+.++.+. .+.. ....+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99865444 4433 234589999999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+....
T Consensus 163 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------------- 222 (263)
T cd05052 163 AGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------------- 222 (263)
T ss_pred CCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------------
Confidence 22234678999998876 578899999999999999998 999999877655544442210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+ .....++..+.+||.+||..||++|||+.++++.
T Consensus 223 ~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 RM---------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 00 1123578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.47 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=213.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
..|..++.||+|+||.||++++..++..||+|.+..... .......+.+|+++++.++|+||+++++++.... ..|+|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-eeEEE
Confidence 358889999999999999999999999999999875432 3344566789999999999999999999988754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+.+...+......+++.++..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 999998877776655667999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 317 TSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+.... .+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~--------------- 232 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP--------------- 232 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC---------------
Confidence 23467899999999852 2457889999999999999999999998766555444432210 00
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 233 -----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -----------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00012577889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.00 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=201.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||++++. ++..+|+|.+...... ...+.+|+.+|++++||||+++++++.... .+|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-PLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCC-CEEEEE
Confidence 46999999999999999999875 4567999988654433 245778999999999999999999987754 789999
Q ss_pred Eecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999865 4444444344689999999999999999999999999999999999999999999999999986543222222
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||++.+ ..++.++|+|||||++|+|++ |++||...+..+.+..+......
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------------- 220 (256)
T ss_pred CCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------------
Confidence 22345668999999875 568999999999999999999 99999988877777766432100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+..+.+||.+||..||.+||++.++++
T Consensus 221 -----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=319.30 Aligned_cols=258 Identities=33% Similarity=0.552 Sum_probs=212.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-CcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-GSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~l~lV~ 237 (665)
+|++.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++||||+++++.+.... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 488899999999999999999999999999999866554566778899999999999999999999887651 4789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC-Cc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL-PL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~-~~ 316 (665)
||+.+..+..+......+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99977666555544448999999999999999999999999999999999999999999999999999887554321 12
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ....+......
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~------------------ 219 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSS------------------ 219 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcccc------------------
Confidence 34467899999998876 4589999999999999999999999987662 11222111100
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.........++..+.+||.+||..||.+||++.++|+||||
T Consensus 220 ------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00011223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.12 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=202.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|+++++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.... .+|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-PIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CcEEE
Confidence 357999999999999999999964 56779999876433 23456889999999999999999999887654 78999
Q ss_pred EEecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++ +...+.. ....+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999864 4444433 3456899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM--------------- 223 (261)
T ss_pred ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2233345778999999876 568899999999999999998 99999988776666555331100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++.++.+||.+||..||++|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.95 Aligned_cols=255 Identities=29% Similarity=0.416 Sum_probs=201.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++...+ .+|+|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-FFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-EEEEEEe
Confidence 4455578999999999999999999999999886543 334567889999999999999999999988754 7899999
Q ss_pred eccccchhh-hcCCCCCC--ChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCCCCCC
Q 006004 239 YMEHDLAGL-ATTPGIKF--TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 239 y~~g~ll~~-~~~~~~~l--se~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+.+..+.. +......+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++..+.... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~ 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-P 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-C
Confidence 998755544 43333445 88899999999999999999999999999999999986 6799999999998654322 2
Q ss_pred CcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||................
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 227 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF----------------- 227 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----------------
Confidence 22334679999999998653 347899999999999999999999997543221111000000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
+........+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 228 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ---------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=349.31 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=198.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-----KIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++..+| ..||||+++... .......+.+|+.+++.+ +|+|||++++++....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 47999999999999999999965444 579999997543 234456788999999999 8999999999987754
Q ss_pred cEEEEEEeccccchhhhc-C------------------------------------------------------------
Q 006004 232 SLYLVFEYMEHDLAGLAT-T------------------------------------------------------------ 250 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~-~------------------------------------------------------------ 250 (665)
.+|+||||+.++.+..+. .
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 789999999865443222 1
Q ss_pred ---------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC-ccccc
Q 006004 251 ---------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP-LTSRV 320 (665)
Q Consensus 251 ---------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~-~~~~~ 320 (665)
...++++.++..++.||+.||.|||++||+||||||+|||+++++.+||+|||++..+....... .....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 11247889999999999999999999999999999999999999999999999998764332211 11223
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||........+..+..... ...
T Consensus 276 ~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~------------------~~~- 335 (374)
T cd05106 276 LPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY------------------QMS- 335 (374)
T ss_pred CccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc------------------Ccc-
Confidence 4678999999876 578999999999999999997 9999987654443333322100 000
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 336 --------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 --------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01236889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=354.57 Aligned_cols=260 Identities=32% Similarity=0.494 Sum_probs=217.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
-|..++.||-|+||+|.+++...|...||+|.+++... ....+..++.|..||..-+.+.||+||..|++.+ .+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEE
Confidence 38899999999999999999999999999999987643 5566778889999999999999999999999976 799999
Q ss_pred Eeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC-------
Q 006004 238 EYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD------- 309 (665)
Q Consensus 238 Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~------- 309 (665)
+|+.| |++.++++-+ -|.|+.+++|+.+|.+|+++.|.+|+|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99986 5666666655 69999999999999999999999999999999999999999999999999996441
Q ss_pred --CCCCC--------------------------------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh
Q 006004 310 --PSQNL--------------------------------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355 (665)
Q Consensus 310 --~~~~~--------------------------------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt 355 (665)
.+... ...+.+||+.|+|||+|.. ..|+..+|+||.|||||||+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhh
Confidence 10000 0124589999999999987 679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC--
Q 006004 356 GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-- 433 (665)
Q Consensus 356 G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-- 433 (665)
|++||...+..+.-.+|.. |.+.. . +....++++++.+||.+|. -+++.|..
T Consensus 867 g~~pf~~~tp~~tq~kv~n---------w~~~l-----~-----------~~~~~~ls~e~~~li~kLc-~sad~RLGkn 920 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVIN---------WRNFL-----H-----------IPYQGNLSKEALDLIQKLC-CSADSRLGKN 920 (1034)
T ss_pred CCCCccCCCCCcceeeeee---------hhhcc-----c-----------cccccccCHHHHHHHHHHh-cChhhhhccc
Confidence 9999998887776666543 33211 0 1122478999999999876 46777864
Q ss_pred -HHHHHhCcCCCCCC
Q 006004 434 -AASALRSEFFKTEP 447 (665)
Q Consensus 434 -a~eaL~Hp~f~~~~ 447 (665)
++++..||||++..
T Consensus 921 g~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 921 GADQVKAHPFFKGID 935 (1034)
T ss_pred chhhhhcCccccccc
Confidence 78899999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.90 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=229.0
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
....+++++..||-|+||.|-++........+|+|++++..+ +..+.+.+..|..||..++.|+||+||..|.+.. .+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-yv 495 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-YV 495 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-hh
Confidence 334578999999999999999998776666799999987654 5566778899999999999999999999998755 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|++||-|-|+-+-.++...+.|.+..+++|+..+++|++|||++|||+|||||+|+||+.+|.+||.|||+|+.+..+..
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999987654444445555899999999999999999999999999999999999999999999999999999876544
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
..++||||.|.|||++++ ...+.++|.||||+++||||+|.|||.+.++..++..|.+.+. .
T Consensus 576 --TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----~---------- 637 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----K---------- 637 (732)
T ss_pred --eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----h----------
Confidence 578999999999999997 5679999999999999999999999999999999999987531 1
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEPL 448 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~~ 448 (665)
.+.++.++..+.+||+++...+|.+|.. +.++-.|-||.+..+
T Consensus 638 ------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 638 ------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred ------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 1223578999999999999999999976 899999999976544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.83 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=211.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
-|++++.||.|+||.||++.+..++..||||.+..... ......+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-eEEEEEE
Confidence 48889999999999999999999999999999865433 344567889999999999999999999988754 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.... .....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcc
Confidence 9998666555543 368999999999999999999999999999999999999999999999999987764322 12233
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... .+ +
T Consensus 161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----------------~- 219 (277)
T cd06641 161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP-----------------P- 219 (277)
T ss_pred ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----------------C-
Confidence 467899999998875 56788999999999999999999999876654444433210 00 0
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....++.++.++|.+||..||.+||++.++++||||...
T Consensus 220 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 --------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0113468889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.08 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=209.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|+.++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-KLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-ceEEEEE
Confidence 58888999999999999999999999999999875432 344567889999999999999999999988754 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNT 160 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhc
Confidence 9998666555543 468999999999999999999999999999999999999999999999999998764322 12233
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
..++..|+|||++.+ ..++.++|+|||||++|+|++|++||...........+... ..+
T Consensus 161 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------------~~~- 219 (277)
T cd06642 161 FVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------------------SPP- 219 (277)
T ss_pred ccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------------------CCC-
Confidence 467899999999876 56889999999999999999999999765544333222110 000
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....++..+.+||.+||..+|.+|||+.++|+||||..
T Consensus 220 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 220 --------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred --------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 011246788999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.59 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=211.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||++++..+++.||+|.+............+.+|+.+++.++|+||+++++++... ...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence 48999999999999999999999999999999987655555566778999999999999999999998875 47999999
Q ss_pred eccccchhhhcCC----CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 239 YMEHDLAGLATTP----GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 239 y~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+.+..+..+... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9987555433322 356899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.... .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------- 218 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--Y--------------- 218 (256)
T ss_pred CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--C---------------
Confidence 1233467899999999876 668899999999999999999999998887655444432210 0
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
. .....++.+++++|.+||..+|.+|||+.++|+||+.
T Consensus 219 -~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 -P----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -C----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0 0112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.14 Aligned_cols=252 Identities=31% Similarity=0.516 Sum_probs=206.3
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
.||+|+||+||.|+|..|....|||.|.... ...++-+..||.+.++|+|.|||++++.+.. ++.+-|+||-++|+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCc
Confidence 6999999999999999999999999986432 3456668899999999999999999998654 668899999999876
Q ss_pred hh-hhcCCCCCC--ChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-CCCcEEEEecccceecCCCCCCCccccc
Q 006004 245 AG-LATTPGIKF--TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 245 l~-~~~~~~~~l--se~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
+. ++...-++| .|..+.+|.+||++||.|||++.|||||||.+|+||+ -.|.+||.|||.++.+..- +-...++.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 65 444455678 8889999999999999999999999999999999997 4799999999999876432 22345778
Q ss_pred ccccccCccccc-CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 321 VTLWYRAPELLL-GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 321 gT~~Y~APE~l~-~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
||+.|||||++. |...|+.++|||||||++.||.||+|||....... +.++++ | .|+...
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-G----------------myKvHP 798 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-G----------------MYKVHP 798 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-c----------------ceecCC
Confidence 999999999996 45789999999999999999999999996543221 112221 0 111111
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.++..++.+++.||.+|+.+||..||+|.++|+.||++..
T Consensus 799 -------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 799 -------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1234578899999999999999999999999999999865
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.10 Aligned_cols=274 Identities=22% Similarity=0.287 Sum_probs=202.4
Q ss_pred CceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccchhhhc
Q 006004 170 TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLAT 249 (665)
Q Consensus 170 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~ 249 (665)
+++.||.+++..+++.||||+++......+....+.+|+.+++.++|+||+++++++.... .+|++|||+.++.+..+.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-eEEEEEeccCCCCHHHHH
Confidence 4566777777779999999999876555667788999999999999999999999988755 789999999976555444
Q ss_pred CC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC------CCcccccc
Q 006004 250 TP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN------LPLTSRVV 321 (665)
Q Consensus 250 ~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~------~~~~~~~g 321 (665)
.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+..+..... .......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 32 34689999999999999999999999999999999999999999999999999876532211 11233456
Q ss_pred cccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh----HHhhhcccccc---
Q 006004 322 TLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED----YWRKSKSAHAT--- 393 (665)
Q Consensus 322 T~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~----~~~~~~~~~~~--- 393 (665)
+..|+|||++.+. ..|+.++|+|||||++|+|++|..||........+.... .+..... .+.........
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCccccccCchhhhcCCcCcccc
Confidence 8899999998753 358899999999999999999999998766544332221 2221110 00000000000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+................++.++.+||.+||.+||++|||+.++|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000000111112223467889999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.21 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=195.1
Q ss_pred CeeEEEEe--eccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKI--GQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.|++.+.+ |+|+||.||+++++.++..+|+|.+....... .|+.+...+ +||||+++++.|...+ .+|+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~-~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK-GHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC-eeEE
Confidence 56666665 99999999999999999999999987543221 122223222 7999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~~ 314 (665)
||||+.++.+..+......+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999998755544444444899999999999999999999999999999999999999998 9999999999876432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ-MHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~-l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||......+. ...+.... ..
T Consensus 164 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-------------- 225 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-------------- 225 (267)
T ss_pred --ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc--------------
Confidence 23467999999999976 5689999999999999999999999986544321 11111100 00
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-HHHHHhCcCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-AASALRSEFFKT 445 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-a~eaL~Hp~f~~ 445 (665)
.....+.+++.+.+||.+||+.||.+|++ ++++|+||||+.
T Consensus 226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112368899999999999999999996 599999999973
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=316.76 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=208.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|+..+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.... ..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-ELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEe
Confidence 48899999999999999999998999999999975442 35567889999999999999999999988754 7899999
Q ss_pred eccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|+.+..+..+. .....+++..+..++.||+.||.+||.+|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99965555444 3335799999999999999999999999999999999999999999999999999987754332 23
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+.... .+ .
T Consensus 156 ~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-~---------------- 216 (253)
T cd05122 156 TMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PP-G---------------- 216 (253)
T ss_pred ceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CC-C----------------
Confidence 4578899999999876 458899999999999999999999998876555444432210 00 0
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
.+ ....++..+.+||.+||..||.+|||+.++|.|||
T Consensus 217 -~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 -LR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -cC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.57 Aligned_cols=257 Identities=29% Similarity=0.507 Sum_probs=211.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEE
Confidence 479999999999999999999999999999999864432 23456789999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~ 173 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence 999976665554433 588999999999999999999999999999999999999999999999999876644322 223
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...+..+.+..+... +.+
T Consensus 174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~------------------ 233 (293)
T cd06647 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP------------------ 233 (293)
T ss_pred cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC------------------
Confidence 4468899999999876 56789999999999999999999999887665443332110 000
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ......++..+.+||.+||..||++||++.+++.|+||+..
T Consensus 234 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 234 E-------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 0 01122467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.07 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=203.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||+|++..+++.||||.++... ........+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEEE
Confidence 47999999999999999999999999999999886533 34455667889999999999999999999988754 78999
Q ss_pred EEeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+.++.+..+. .....+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999975444322 233458999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ...+.......+.++.
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL---------- 228 (267)
T ss_pred H-HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC----------
Confidence 1 1233468899999999876 5678999999999999999999999865432 1222222221111100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
....++..+.+||.+||..||++||++.++|+.
T Consensus 229 ----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 ----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.83 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=201.2
Q ss_pred eeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 160 FEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
|++.+.||+|+||.||+|....+ +..||||+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999997654 478999999866555556677899999999999999999999876533 1
Q ss_pred cEEEEEEeccccchhhhc-C-----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 232 SLYLVFEYMEHDLAGLAT-T-----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~-~-----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
..++||||+.++.+..+. . ....+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 379999999875443332 1 2236899999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 306 TTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 306 ~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
+........ ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~---- 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R---- 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C----
Confidence 876433211 1112234678999998865 678999999999999999999 899998877666555443210 0
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++..+.+||.+||+.||.+|||+.+++.+
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.15 Aligned_cols=262 Identities=24% Similarity=0.420 Sum_probs=207.9
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
.|++.+.||.|+||.||+|++. .+|+.||+|+++.... .....+.+.+|+.+++++ +|+||+++++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-K 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC-e
Confidence 4889999999999999999975 4789999999875432 122345678899999999 6999999999988754 7
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+..+.........+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..+....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 89999999976555544445579999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+....-..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------------ 227 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------------
Confidence 3333455789999999998753 356889999999999999999999997543322222222211000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.. .....+++.+.+||.+||..||.+|+ ++.+++.||||...
T Consensus 228 ------~~-------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 ------EP-------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ------CC-------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 00 01134788899999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.70 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=203.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|.+.+.||+|+||.||+|.+.. +++.||+|+++... ..+....+.+|+++|+.++|+||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-P 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC-C
Confidence 469999999999999999998753 46789999987543 3334567889999999999999999999988764 7
Q ss_pred EEEEEEeccccchhhhcCC--------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEE
Q 006004 233 LYLVFEYMEHDLAGLATTP--------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLK 298 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~--------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lK 298 (665)
+|+||||+.++.+..+... ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 9999999987655443321 23588999999999999999999999999999999999999999999
Q ss_pred EEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 006004 299 IGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 299 L~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~ 376 (665)
|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986532221 11223345788999999876 568999999999999999998 999998877766555543210
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. ......++..+.+||.+||..||.+|||+.|+++
T Consensus 242 --~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 --L--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred --c--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 0111357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.15 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=202.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeee-eeecc---C--C
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEG-LVTSR---S--G 231 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~-~~~~~---~--~ 231 (665)
++++.+.|.+|||+.||+|++...|..||+|++-.. ++...+.+.+||++|+.|+ |+|||.+++ ..... . .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 689999999999999999999988899999998644 6778889999999999997 999999999 33222 1 2
Q ss_pred cEEEEEEecc-ccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 232 SLYLVFEYME-HDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 232 ~l~lV~Ey~~-g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.++|+||||. |+|.+.+.++ ...|+|.+|.+||+++++|+.+||... |||||||-|||||+.+|..||||||.|..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 4789999999 5777766642 234999999999999999999999998 99999999999999999999999999975
Q ss_pred cCCCCCCCc--------ccccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 006004 308 YDPSQNLPL--------TSRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCG 377 (665)
Q Consensus 308 ~~~~~~~~~--------~~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g 377 (665)
.-....... -...-|+.|+|||+|. ....++.++|||+|||+||-|+....||.+.....++..-+.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~--- 272 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS--- 272 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc---
Confidence 422211000 0123499999999985 336789999999999999999999999987644332222111
Q ss_pred CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
| ..++.++..+++||..||+.||.+||++.|++.+-+
T Consensus 273 -----------------~-----------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 273 -----------------F-----------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -----------------C-----------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 1 112467889999999999999999999999998655
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.40 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=198.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++ ..++..||||+++.... ....+.+.+|+.+|+.+ +||||+++++++....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 4699999999999999999974 34677899999875432 23456688999999999 8999999999988765
Q ss_pred cEEEEEEecccc-chhhhcCC-----------------------------------------------------------
Q 006004 232 SLYLVFEYMEHD-LAGLATTP----------------------------------------------------------- 251 (665)
Q Consensus 232 ~l~lV~Ey~~g~-ll~~~~~~----------------------------------------------------------- 251 (665)
..|+|||||.++ |...+...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 789999999864 43333221
Q ss_pred ---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC-
Q 006004 252 ---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP- 315 (665)
Q Consensus 252 ---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~- 315 (665)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 1247888999999999999999999999999999999999999999999999998764332211
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+.++....
T Consensus 273 ~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------------ 333 (375)
T cd05104 273 KGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG------------------ 333 (375)
T ss_pred cCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC------------------
Confidence 122334677999999976 578999999999999999998 889998765444333332210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
..+ ......+.++.+||.+||..||.+|||+.++++.
T Consensus 334 ~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 YRM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ccC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000 0112357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.54 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=195.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD 243 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ 243 (665)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+++++.++||||+++++++.... .+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCC
Confidence 3699999999999999999999999987643 24455667889999999999999999999987755 789999999875
Q ss_pred chh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC-cccccc
Q 006004 244 LAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP-LTSRVV 321 (665)
Q Consensus 244 ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~-~~~~~g 321 (665)
.+. .+...+..+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... ......
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 554 444445568999999999999999999999999999999999999999999999999987654221110 011122
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..... .
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-------------------~--- 215 (252)
T cd05084 159 PVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------------------L--- 215 (252)
T ss_pred ceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------------C---
Confidence 456999999876 568999999999999999997 8899977665544443322100 0
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..||++|||+.++++
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 ------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.69 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=202.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD----LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++.+.||+|+||.||+|.+ ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-PV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-ce
Confidence 5799999999999999999985 3456789999987433 3445567889999999999999999999988765 78
Q ss_pred EEEEEeccccch-hhhcCC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 234 YLVFEYMEHDLA-GLATTP----------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 234 ~lV~Ey~~g~ll-~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
|+||||+.++.+ ..+... ...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 999999986544 333211 124788999999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987543221 11233455778999999876 568999999999999999998 9999988776555555432
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.. . ......+++.+.+||.+||+.||.+||++.+++++
T Consensus 242 ~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 10 0 01123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.92 Aligned_cols=259 Identities=19% Similarity=0.290 Sum_probs=203.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 3579999999999999999997652 355899998864432 233445778999999999999999999987655
Q ss_pred cEEEEEEeccccchhhhcCC----------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEe
Q 006004 232 SLYLVFEYMEHDLAGLATTP----------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~D 301 (665)
..|+||||+.++.+..+... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 78999999986544433321 12346678899999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||+++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+.+..+... +.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~ 240 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYL 240 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 9999865332211 1122345678999999876 568999999999999999998 78999887766555444321 000
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh------CcCCCCC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR------SEFFKTE 446 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~------Hp~f~~~ 446 (665)
......++.+.+||.+||+.||.+|||+.++++ ||||...
T Consensus 241 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 241 ---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 011245788999999999999999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.11 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=201.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKI----VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
..+|++++.||+|+||.||+|++..++.. ||+|+++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--C
Confidence 35799999999999999999998777664 8999986432 344556788999999999999999999988753 4
Q ss_pred EEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.++|+||+.++ +...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999864 55555554556899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.. .+......+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---------- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL---------- 230 (316)
T ss_pred CcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC----------
Confidence 221 1122234678999999876 678999999999999999997 99999876654433 222210000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+.++.+||.+||..||.+|||+.+++.+
T Consensus 231 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=331.15 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=211.6
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|....+||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++|+||+++++++...+ ..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-EEEEEEec
Confidence 445578999999999999999999999999986432 234556889999999999999999999988755 78999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
+.++.+..+.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9987666655443 689999999999999999999999999999999999999999999999999876643221 22345
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
.+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+.... + .
T Consensus 177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-~------------------ 234 (292)
T cd06657 177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P-P------------------ 234 (292)
T ss_pred ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--C-c------------------
Confidence 68999999998875 567899999999999999999999999877666555443211 0 0
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.......++..+.+||.+||..||.+||++.++|.||||.....
T Consensus 235 -----~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 235 -----KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -----ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00011346888999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.63 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=200.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|.+. +++.||+|.++..... .+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-PIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCC-Ceeeee
Confidence 46999999999999999999975 4578999998754432 345788999999999999999999887654 789999
Q ss_pred Eecccc-chhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHD-LAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~-ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+. +...+... +..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999654 44444332 3468999999999999999999999999999999999999999999999999998775322111
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......+..|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+......
T Consensus 161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------- 223 (261)
T cd05068 161 REGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---------------- 223 (261)
T ss_pred cCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 111223457999998876 568999999999999999999 99999988776666555321000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+..+.+||.+||..||.+||++.++++
T Consensus 224 ------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.07 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++++||+|+||.||+|.+. ++..||+|.++...... ..+.+|+.++++++|+||+++++++.. ...|++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEE
Confidence 47999999999999999999875 56679999987654432 347899999999999999999998753 3579999
Q ss_pred Eeccccch-hhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLA-GLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll-~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++.+ ..+.. ....+++.++..++.||+.||.|||++||+|+||||+|||+++++.++|+|||++..+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99987544 44433 23468999999999999999999999999999999999999999999999999998764432222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 160 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------- 221 (260)
T cd05070 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----------------- 221 (260)
T ss_pred ccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 222345678999998875 568999999999999999999 8999998877666665532100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. ......+..+.+||.+||.+||.+|||+.+++.
T Consensus 222 --~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 --M---------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --C---------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 012357788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=321.68 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=203.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|++.+.||+|+||.||+|++..+ ...||||.++... .......+.+|+.+++.++||||+++++++.... .+|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-PVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-ceE
Confidence 4799999999999999999998654 4579999887543 3444566889999999999999999999887654 789
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+. .+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999875554 4444445799999999999999999999999999999999999999999999999999998752211
Q ss_pred C-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 L-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 ~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------------- 227 (266)
T ss_pred ceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1 1112234678999998876 568999999999999999998 99999877766555554321000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+..+.+||.+||..||++||++.+++++
T Consensus 228 ---------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ---------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0012567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=325.53 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=199.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 357999999999999999999864 245689999986433 2233456789999999999999999999987654
Q ss_pred cEEEEEEeccccchhhhcCC-C---------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEe
Q 006004 232 SLYLVFEYMEHDLAGLATTP-G---------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~-~---------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~D 301 (665)
..++||||+.++.+..+... . ..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence 78999999997555443322 1 2357788999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+... +.+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~ 240 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLL 240 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC
Confidence 9998765332211 1122345788999999876 568999999999999999999 78999887766555443321 000
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++.+.+||.+||..||.+|||+.+++++
T Consensus 241 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 ---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=374.87 Aligned_cols=261 Identities=32% Similarity=0.480 Sum_probs=207.4
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeee--------
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLV-------- 226 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-------- 226 (665)
+...+|+.++.||+|+||.||+|+++-+|+.||||+|.... .......+.+|+.+|.+|+|||||+++..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35567999999999999999999999999999999998765 556677899999999999999999976544
Q ss_pred -------------------------------------------------e--c-------------------c-------
Q 006004 227 -------------------------------------------------T--S-------------------R------- 229 (665)
Q Consensus 227 -------------------------------------------------~--~-------------------~------- 229 (665)
. + .
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0 0 0
Q ss_pred -------------------------C--------CcEEEEEEeccccchhhhcCCCCCC-ChhHHHHHHHHHHHHHHHHH
Q 006004 230 -------------------------S--------GSLYLVFEYMEHDLAGLATTPGIKF-TEPQIKCYMQQLLRGLEHCH 275 (665)
Q Consensus 230 -------------------------~--------~~l~lV~Ey~~g~ll~~~~~~~~~l-se~~i~~i~~QIl~aL~~LH 275 (665)
+ ..+||-||||+..++..+...+... ....++.+++||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1479999999999999988887554 46789999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCcEEEEecccceecC-----------------CCCCCCcccccccccccCcccccCCc--c
Q 006004 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-----------------PSQNLPLTSRVVTLWYRAPELLLGAT--K 336 (665)
Q Consensus 276 ~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~-----------------~~~~~~~~~~~gT~~Y~APE~l~~~~--~ 336 (665)
++|||||||||.||+|+.++.|||+|||+|.... .......++.+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 01112567889999999999998755 6
Q ss_pred cCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHH
Q 006004 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC-GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQS 415 (665)
Q Consensus 337 ~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~-g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~ 415 (665)
|+.++|||||||||+||+. ||.. ..|....+..+- |..+.+ ...+.+--+.
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-----------------------~~f~~~~~~~ 846 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-----------------------ADFFDPEHPE 846 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-----------------------cccccccchH
Confidence 9999999999999999994 3643 333333332221 111110 0001122334
Q ss_pred HHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 416 ALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 416 a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
...+|..||+.||.+||||.|+|++.||.
T Consensus 847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 56799999999999999999999999986
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.87 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=198.7
Q ss_pred eEEEEeeccCceEEEEEEECCCCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCcE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGK--IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGSL 233 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~l 233 (665)
.+.+.||+|+||.||+|++..++. .||+|.++...........+.+|+.+++.++||||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999887775 689999876554556677888999999999999999999876422 1246
Q ss_pred EEEEEeccccchh-hhc-----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 234 YLVFEYMEHDLAG-LAT-----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 234 ~lV~Ey~~g~ll~-~~~-----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
++||||+.++.+. .+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999865443 322 1223589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 308 YDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 308 ~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~------ 232 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--NR------ 232 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CC------
Confidence 6432211 1122245778999998876 578999999999999999999 89999887765554444221 00
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++..+.+||.+||..||++|||+.+++++
T Consensus 233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00113577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.06 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=198.8
Q ss_pred EeeccCceEEEEEEE--CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 165 KIGQGTYSSVYKARD--LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
.||+|+||.||+|.+ ..++..||+|+++.........+.+.+|+.+++.++||||+++++++... ..++||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE--SWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CcEEEEecCCC
Confidence 589999999999964 46788999999876655556677789999999999999999999987543 57999999997
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC--ccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSRV 320 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~--~~~~~ 320 (665)
+.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+....... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 6555544444579999999999999999999999999999999999999999999999999998764332211 11223
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
+++.|+|||.+.. ..++.++|+|||||++|||++ |.+||.+.+..+....+..... +
T Consensus 160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-------------------~-- 217 (257)
T cd05116 160 WPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-------------------M-- 217 (257)
T ss_pred CCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------------------C--
Confidence 4678999998865 568899999999999999998 9999998877666665532110 0
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++++.+||.+||+.||.+||++.++..
T Consensus 218 -------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 -------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=322.28 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=199.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++.++||+|+||.||+|++..++ .||+|+++..... ...+.+|++++++++||||+++++++.. ...|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEE
Confidence 36999999999999999999986654 5999998754432 2457889999999999999999998753 3579999
Q ss_pred Eecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++ +...+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999874 4444433 23458999999999999999999999999999999999999999999999999998765433222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 160 ~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------------- 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------- 222 (262)
T ss_pred ccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------------
Confidence 223345778999998875 568999999999999999999 88999888766665554321000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..||++|||+.++++
T Consensus 223 ------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011257888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.93 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=199.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+|++.+.||+|+||.||++++. ++..+|+|++...... ...+.+|+.+++.++||||+++++++.... ..|+|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-PIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-ceEEEEe
Confidence 6899999999999999999885 4668999998654332 234678999999999999999999887654 7899999
Q ss_pred ecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 239 YMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 239 y~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|++++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99875 44444444447899999999999999999999999999999999999999999999999999865432211111
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+.....
T Consensus 160 ~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 219 (256)
T cd05059 160 GTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------------- 219 (256)
T ss_pred CCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------------
Confidence 1223457999999876 568999999999999999998 8999988776665555432110
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
. ......+..+.+||.+||..+|++|||+.++++.
T Consensus 220 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 L---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 1112478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=328.17 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=208.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++.+.||+|+||.||+|.+..+++.||||.++..... .....+.+|+.++..+ .||||+++++++.... .+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-DVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC-eEE
Confidence 456899999999999999999999989999999999765432 2344566788777666 5999999999998755 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.+.+..++......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+.....
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999999887666665545579999999999999999999997 5999999999999999999999999999876643222
Q ss_pred CCcccccccccccCcccccCC---cccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhHHhhhcc
Q 006004 314 LPLTSRVVTLWYRAPELLLGA---TKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~---~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.....+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+.....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 236 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP------------ 236 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC------------
Confidence 2233578899999998753 3478899999999999999999999976432 333333322100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+ ....++.++.+||.+||..||.+|||+.++++||||...
T Consensus 237 -------~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 -------PSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -------CCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0000 011467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.59 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=200.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||++.+.. +..||+|.+...... ...+.+|+.++++++||||+++++++.... .+|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEEE
Confidence 469999999999999999998754 446999998754332 345788999999999999999999987654 689999
Q ss_pred Eeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++.+ ..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99987544 44444344789999999999999999999999999999999999999999999999999886543322111
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------------- 220 (256)
T ss_pred CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------------
Confidence 22235678999999876 568999999999999999998 99999887766655555331100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+..+.+||.+||..||.+|||+.+++.+
T Consensus 221 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=326.99 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=201.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-P 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-c
Confidence 4699999999999999999985 234567999988643 2345567889999999999999999999988754 7
Q ss_pred EEEEEEeccccchhhhcC-C------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEE
Q 006004 233 LYLVFEYMEHDLAGLATT-P------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKI 299 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~-~------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL 299 (665)
+|+||||+.++.+..+.. . ...+++.++..++.||+.||+|||++||+||||||+|||+++++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 899999998755443332 1 124899999999999999999999999999999999999999999999
Q ss_pred EecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 006004 300 GDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCG 377 (665)
Q Consensus 300 ~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g 377 (665)
+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~- 239 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR- 239 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999986543221 11122345778999999876 578999999999999999998 999998887766666654311
Q ss_pred CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. ......++.++.+||.+||+.||.+|||+.+++.
T Consensus 240 -~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 -V--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0011357788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=353.63 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=207.0
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
...+.|++...||.|+|+.|..|.+..+++.+++|++.... ....+|+.++... +||||+++++++.+.. .+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK-EI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCc-ee
Confidence 35678999999999999999999999999999999997552 1234678777666 8999999999998764 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE-cCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI-NNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl-d~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+|||++.|+.+...+.....+. .++..|++||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.+......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999876655444443344 7888999999999999999999999999999999 58999999999999887544
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
..+.+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +.+.+| +.+...
T Consensus 470 ---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s--------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS--------- 532 (612)
T ss_pred ---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc---------
Confidence 345577999999999984 78999999999999999999999999876555 333333 222111
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+|..|++||..||+.||.+|+++.+++.||||...
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 3689999999999999999999999999999999443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.14 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=202.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET-----GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.+|++++.||+|+||.||+|.+..+ ++.||||+++... .......+.+|+.++..++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-P 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-c
Confidence 3688899999999999999987543 5789999987543 3344566889999999999999999999988765 6
Q ss_pred EEEEEEeccccchhhhcC----------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 233 LYLVFEYMEHDLAGLATT----------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~----------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
+++++||+.+..+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||+++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 899999998654433321 1235888899999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||+++....... .......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999886543221 11233356789999999876 568999999999999999998 8899988877766666543
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.... .....++..+.+||.+||+.||.+||++.++++.
T Consensus 242 ~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2100 0113578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=329.62 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=197.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcE--EEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++.... .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-Cc
Confidence 45799999999999999999999888865 466665432 2344556788999999999 8999999999987754 79
Q ss_pred EEEEEecccc-chhhhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcE
Q 006004 234 YLVFEYMEHD-LAGLATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~l 297 (665)
|+||||+.++ +...+... ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999865 44433221 2358899999999999999999999999999999999999999999
Q ss_pred EEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 006004 298 KIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 298 KL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~ 376 (665)
||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 239 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 239 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-
Confidence 9999999864321111 111234667999998865 568999999999999999998 99999887765544433110
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.. .....+++.+.+||.+||..||.+||++.++|++
T Consensus 240 ------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ------------------YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------------------CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0112467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.70 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=202.4
Q ss_pred EEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
+.||+|+||.||+|.+... +..||+|.++...... ..+.+.+|+.+++.++|+||+++++++... ..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-EPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-CceEEEEEec
Confidence 3689999999999999866 8899999997654332 467788999999999999999999998874 4799999999
Q ss_pred cccchh-hhcCC--------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 241 EHDLAG-LATTP--------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 241 ~g~ll~-~~~~~--------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.++.+. .+... ...+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 765444 44433 367999999999999999999999999999999999999999999999999999877543
Q ss_pred CC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .......+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~----------- 224 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y----------- 224 (262)
T ss_pred cccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C-----------
Confidence 21 11233457889999998876 478999999999999999999 69999988766655554321 0
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.......+++++.+||.+||..||.+|||+.+++++
T Consensus 225 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ---------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ---------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.96 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=201.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-----KIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG- 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-
Confidence 47999999999999999999976443 789999987543 334456688999999999 8999999999887654
Q ss_pred cEEEEEEeccccchhhhc----------------CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC
Q 006004 232 SLYLVFEYMEHDLAGLAT----------------TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG 295 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~----------------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g 295 (665)
.+|++|||+.++.+..+. .....+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 799999999875444333 2235689999999999999999999999999999999999999999
Q ss_pred cEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 006004 296 VLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIF 373 (665)
Q Consensus 296 ~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~ 373 (665)
.+||+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876432211 1122234677999998875 678999999999999999997 999998877655544432
Q ss_pred HhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 374 KLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 374 ~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
... .. ......+..+.+||.+||..||.+|||+.++|++
T Consensus 249 ~~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGY-------------------RM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCC-------------------cC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 210 00 0112467889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=326.20 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=203.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC----------------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG----------------KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~ 221 (665)
.+|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 47999999999999999999876644 568999987543 3355677889999999999999999
Q ss_pred eeeeeeccCCcEEEEEEeccccchhhhcCCCC-----------CCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEE
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGI-----------KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLL 290 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~-----------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNIL 290 (665)
+++++... ..+++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+|+||||+|||
T Consensus 84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99998875 47899999998755544433322 6899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh--CCCCCCCCChHH
Q 006004 291 INNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA--GKPIMPGRTEVE 367 (665)
Q Consensus 291 ld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~e 367 (665)
++.++.++|+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ +..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999986533221 11233456788999999876 568999999999999999998 678887776666
Q ss_pred HHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 368 ~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+..+......... . ........++.++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~--------------~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 242 VIENAGHFFRDDGR--------------Q-------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHhccccccc--------------c-------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 55554332110000 0 000112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.11 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
+.|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-P 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-C
Confidence 469999999999999999999987 77889999886433 2334456788999999999999999999887654 6
Q ss_pred EEEEEEeccccchh-hhcCCC------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEec
Q 006004 233 LYLVFEYMEHDLAG-LATTPG------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDF 302 (665)
Q Consensus 233 l~lV~Ey~~g~ll~-~~~~~~------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DF 302 (665)
.|+||||+.++.+. .+.... ..+++.++..++.||+.||.|||++|++|+||||+|||++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 79999999865444 433221 2589999999999999999999999999999999999998765 5999999
Q ss_pred ccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 006004 303 GLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPS 380 (665)
Q Consensus 303 GlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~ 380 (665)
|++..+..... ........+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~-- 239 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R-- 239 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c--
Confidence 99987632211 11112233567999999976 568999999999999999997 999999887666554432210 0
Q ss_pred hhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
. .....++..+.+||.+||..||++|||+.++|+|
T Consensus 240 ----------------~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 ----------------L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ----------------C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.08 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=201.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-----GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC-
Confidence 35799999999999999999998644 3789999986443 2334456789999999999999999999988754
Q ss_pred cEEEEEEeccccchhhhc-CC---------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEe
Q 006004 232 SLYLVFEYMEHDLAGLAT-TP---------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~-~~---------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~D 301 (665)
.+|+||||+.++.+..+. .. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 789999999865444333 21 22478889999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||+++.+..... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.. +..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~ 239 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGH 239 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCC
Confidence 999986543321 12233456889999999875 568999999999999999998 9999988776655544421 100
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++..+.+||.+||..+|.+|||+.++++
T Consensus 240 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 --------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.34 Aligned_cols=258 Identities=31% Similarity=0.551 Sum_probs=212.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+.|+....||+|+||.||++.+..++..||+|++..... ....+.+|+++++.++|+||+++++++.... .+|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGD-ELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-EEEEE
Confidence 3469999999999999999999998999999999975442 4556788999999999999999999988764 79999
Q ss_pred EEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.+..+..+.... ..+++.++..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++........ .
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 9999965554444433 3799999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+... +.+.
T Consensus 173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------------- 235 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------------- 235 (286)
T ss_pred hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------------
Confidence 233457889999998876 56899999999999999999999999887666555443221 0000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||+.||.+|||+.++|.|+||+..
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 ----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 01112477889999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.90 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=200.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK----IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||+||+|++..+|. .||+|+++... .......+.+|+.+++.+.||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--C
Confidence 4579999999999999999999887776 48999987543 344456788999999999999999999988653 5
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+++|||+++ ++...+......+++.++..++.||+.||.|||++||+||||||+|||+++++.+||+|||++..+...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999985 555555444557999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||......+....+.. ...+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~---------- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL---------- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC----------
Confidence 221 1112234678999999876 568999999999999999998 8999977655443332221 1000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+.++.+||.+||..||++||++.+++.
T Consensus 231 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -----------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=321.49 Aligned_cols=252 Identities=31% Similarity=0.472 Sum_probs=202.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||.|+||.||++++..+++.||||.+..... .......+.+|+.+++.++||||+++++++.... .++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEE
Confidence 469999999999999999999999999999998865432 3444567889999999999999999999988754 78999
Q ss_pred EEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999754443322 34568999999999999999999999999999999999999999999999999988764332
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV--EQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~--e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.... +....+... .
T Consensus 161 ~-~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 224 (267)
T cd08229 161 T-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D------------- 224 (267)
T ss_pred c-ccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-C-------------
Confidence 1 2234578999999999876 56789999999999999999999999765432 111221110 0
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.+ .....++..+.+||.+||..||.+|||+.++++
T Consensus 225 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ----YPP---------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----CCC---------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 011247889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.15 Aligned_cols=247 Identities=24% Similarity=0.426 Sum_probs=200.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ..+|++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~ 79 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIIT 79 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEE
Confidence 5799999999999999999986 45788999998755433 3457889999999999999999998754 3689999
Q ss_pred Eecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++ +...+.. .+..+++.++..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999864 4444433 34578999999999999999999999999999999999999999999999999998765332222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 160 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------------- 222 (260)
T ss_pred ccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------------
Confidence 233345778999998875 568899999999999999998 99999988766655554221100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..||++|||+.+++.
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.75 Aligned_cols=252 Identities=33% Similarity=0.513 Sum_probs=202.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|++++++++|+||+++++++.... ..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-ELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEEE
Confidence 479999999999999999999999999999999875332 3444667889999999999999999999998754 78999
Q ss_pred EEeccccchh-hhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAG-LAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+.++.+. .+. .....+++.++..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999975443 332 234568999999999999999999999999999999999999999999999999988764322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--VEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+....+...
T Consensus 161 ~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 223 (267)
T cd08224 161 T-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--------------- 223 (267)
T ss_pred c-ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC---------------
Confidence 1 2234568999999999876 5689999999999999999999999965431 1112221110
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+. ..+ ...++..+.+||.+||..+|.+|||+.++++
T Consensus 224 ---~~~-~~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---DYP-PLP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---CCC-CCC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 000 1256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.29 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=197.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK--IVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|++.+.||+|+||.||+|++..++. .+++|.++... .....+.+.+|+.++.++ +||||+++++++.... .+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-YLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-cce
Confidence 479999999999999999999887775 46888776322 334456688999999999 7999999999987654 789
Q ss_pred EEEEeccccch-hhhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEE
Q 006004 235 LVFEYMEHDLA-GLATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLK 298 (665)
Q Consensus 235 lV~Ey~~g~ll-~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lK 298 (665)
+||||+.++.+ ..+... ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999986544 333221 12588999999999999999999999999999999999999999999
Q ss_pred EEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 006004 299 IGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCG 377 (665)
Q Consensus 299 L~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g 377 (665)
|+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+...++.....
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999864322111 111123557999998876 568999999999999999997 9999988876665554422100
Q ss_pred CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++..+.+||.+||..||.+|||++++++.
T Consensus 237 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 ----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01113578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=320.64 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=204.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
..+|++++.||.|+||.||+|++.. +..+|+|++.... ......+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEE
Confidence 3479999999999999999999977 8899999987543 223456889999999999999999999887755 78999
Q ss_pred EEeccccch-hhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLA-GLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++.+ ..+.. .+..+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999987544 44433 3456899999999999999999999999999999999999999999999999999876432221
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 161 -~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 223 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--------------- 223 (261)
T ss_pred -ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------------
Confidence 123345778999999876 568899999999999999998 89999888776666665431100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++.+.++|.+||..||.+|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.03 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=205.4
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
+|++.+.||+|+||.||++++. .+++.||||.++.... .......+.+|+.++.++ +||||+++++.+.... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-K 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC-E
Confidence 4889999999999999999864 4678999999875432 122345678899999999 6999999999887754 7
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.++.+.........+++..++.++.||+.||.|||+.|++|+||||.|||++.++.++|+|||++..+....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 89999999875555444444579999999999999999999999999999999999999999999999999988764433
Q ss_pred CCCcccccccccccCcccccCCc-ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGAT-KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~-~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........|+..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+.......+.+.. ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~~------ 226 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI-------LK------ 226 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH-------Hc------
Confidence 22223346899999999987532 36889999999999999999999996543222222221110 00
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC---HHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS---AASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT---a~eaL~Hp~f~~~~~ 448 (665)
. .......++..+.+||.+||+.||++||| +.++|+||||+...+
T Consensus 227 --~----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 227 --S----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --c----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 0 00112347788999999999999999998 567799999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.92 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=202.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|.+. ++..||||.+...... ...+.+|+.++++++|+||+++++++.... .+|+|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-PIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCC-ceEEE
Confidence 357999999999999999999975 4578999998755433 345788999999999999999999987654 78999
Q ss_pred EEeccccch-hhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLA-GLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++.+ ..+... +..+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999987544 444332 246899999999999999999999999999999999999999999999999999876532211
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+.++......+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 224 (261)
T cd05034 160 AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-------------- 224 (261)
T ss_pred hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 1122234678999999876 568999999999999999998 999999888777666654321100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+..+.++|.+||..||.+||++.++++
T Consensus 225 --------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 --------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=350.28 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=215.5
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYLVF 237 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~lV~ 237 (665)
+.-..||+|+|-+||+|.|..+|..||.-.++...+ .++..++|..|+.+|+.|+|||||++|++|.+. +..+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 344689999999999999999999999776655433 566778999999999999999999999999876 44588999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcC-CCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|++..+.+..+..+.+.+....++.|++||+.||.|||++. |||||||.+||+|+. .|.|||+|+|||.......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99998888888887778999999999999999999999994 999999999999984 5999999999999876543
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG-RTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
..+.+|||.|||||++. ..|+..+||||||++++||+|+..||.. .+..++++++.. |..+..+.
T Consensus 201 -aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~--------- 266 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS--------- 266 (632)
T ss_pred -cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh---------
Confidence 35579999999999997 5799999999999999999999999974 455555666544 33333221
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+--.+++++||.+||.. ...|+|+.|+|.||||...
T Consensus 267 ----------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 ----------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12367899999999999 9999999999999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.65 Aligned_cols=246 Identities=31% Similarity=0.483 Sum_probs=204.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
||.|+||.||++.+..+++.||+|.++.... .......+.+|+.++++++||||+++++.+.... .+|+||||+.++.
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-eeEEEEecCCCCc
Confidence 6899999999999998999999999876543 2335667889999999999999999999987754 7899999996654
Q ss_pred hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccccc
Q 006004 245 AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW 324 (665)
Q Consensus 245 l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~ 324 (665)
+.........+++.++..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~ 158 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPE 158 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCcc
Confidence 44444444479999999999999999999999999999999999999999999999999998764432 12334567899
Q ss_pred ccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhh
Q 006004 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRK 404 (665)
Q Consensus 325 Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~ 404 (665)
|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+... ..
T Consensus 159 ~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------------- 210 (250)
T cd05123 159 YLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PL------------------------- 210 (250)
T ss_pred ccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CC-------------------------
Confidence 999999876 45788999999999999999999999877764444444320 00
Q ss_pred hhhhccCCcHHHHHHHHHhcccCcCCCcCH---HHHHhCcCC
Q 006004 405 VLETFRNFPQSALALVDKLLTIEPENRGSA---ASALRSEFF 443 (665)
Q Consensus 405 ~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa---~eaL~Hp~f 443 (665)
.....++..+.+||.+||..||++|||+ .++++||||
T Consensus 211 --~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 --RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1112458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.87 Aligned_cols=283 Identities=27% Similarity=0.437 Sum_probs=219.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-----C---CCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-----H---PNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIV~l~~~~~~~ 229 (665)
.+|.+.++||.|.|++||+|.|..+.+.||+|+++-+. ...+....||.+|+++. | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 48999999999999999999999999999999998543 34455678999999983 3 4699999999754
Q ss_pred ---CCcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCC---------
Q 006004 230 ---SGSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAG--------- 295 (665)
Q Consensus 230 ---~~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g--------- 295 (665)
..++|+|+|++..+|+.++.... ..++...++.|++|||.||+|||.. ||||-||||+|||+..+.
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 45799999999999999888754 4599999999999999999999976 999999999999992110
Q ss_pred --------------------------------------------------------------------------------
Q 006004 296 -------------------------------------------------------------------------------- 295 (665)
Q Consensus 296 -------------------------------------------------------------------------------- 295 (665)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred -----------------------------------------------------------------------------cEE
Q 006004 296 -----------------------------------------------------------------------------VLK 298 (665)
Q Consensus 296 -----------------------------------------------------------------------------~lK 298 (665)
.+|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 134
Q ss_pred EEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC------ChHHHHHHH
Q 006004 299 IGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR------TEVEQMHKI 372 (665)
Q Consensus 299 L~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~------~~~e~l~kI 372 (665)
|+|||-|+-+.. .++.-+-|..|+|||++++ ..|++.+||||++|++|||+||..+|... .+.+.++.|
T Consensus 395 IaDlGNACW~~k----hFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVHK----HFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhhh----hhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 555555543321 1233455899999999998 57999999999999999999999999643 357889999
Q ss_pred HHhcCCCChhH----------Hhhh-ccccccCCCCCCcchhhhhhhcc---CCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 373 FKLCGSPSEDY----------WRKS-KSAHATSFKPQQPYKRKVLETFR---NFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 373 ~~~~g~p~~~~----------~~~~-~~~~~~~~~~~~p~~~~~~~~~~---~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
+.++|..+..+ |++. .+.+...++ ..|....+.+.+. .-..++.+||.-||+.+|++|+||.++|
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK-~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLK-PWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccC-CCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 99998876543 3321 122222222 2344444444442 1234578899999999999999999999
Q ss_pred hCcCCCCCCCC
Q 006004 439 RSEFFKTEPLP 449 (665)
Q Consensus 439 ~Hp~f~~~~~~ 449 (665)
+|||+...+.+
T Consensus 549 ~hPwLn~~~~~ 559 (590)
T KOG1290|consen 549 KHPWLNPVAGP 559 (590)
T ss_pred cCccccCCCCC
Confidence 99999977655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=349.92 Aligned_cols=277 Identities=23% Similarity=0.319 Sum_probs=190.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCC----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeee----e
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLET----GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLV----T 227 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~----~ 227 (665)
..++|++.+.||+|+||.||+|++..+ +..||||++..... .+.+..| .++...+.+++.+...+ .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 567899999999999999999999988 99999998764321 1111111 12222233333222221 1
Q ss_pred -ccCCcEEEEEEeccccchhhhcC-CCC-------------------CCChhHHHHHHHHHHHHHHHHHhCCccccCCCc
Q 006004 228 -SRSGSLYLVFEYMEHDLAGLATT-PGI-------------------KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKG 286 (665)
Q Consensus 228 -~~~~~l~lV~Ey~~g~ll~~~~~-~~~-------------------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP 286 (665)
.....++|||||+.++.+..+.. ... ...+..+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 23447899999998765443332 211 122345778999999999999999999999999
Q ss_pred ccEEEcC-CCcEEEEecccceecCCCCCCCcccccccccccCcccccCCc---------------------ccCcccchh
Q 006004 287 SNLLINN-AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT---------------------KYGAAIDMW 344 (665)
Q Consensus 287 eNILld~-~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~---------------------~~~~~sDIW 344 (665)
+||||+. ++.+||+|||+|..+..........+++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 589999999999876544444445678999999999764321 234567999
Q ss_pred hhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhc
Q 006004 345 SAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLL 424 (665)
Q Consensus 345 SLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL 424 (665)
|||||||||+++. |+..+...++.+++..++.... .|.+..... ..+......+.+......+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999854 5556666666666665554333 333221110 011111112223334556789999999
Q ss_pred ccCcCCCcCHHHHHhCcCCCCCC
Q 006004 425 TIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 425 ~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.+||.+|||+.++|+||||....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999998753
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.71 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=199.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+...... .+.+.+|+.++++++||||+++++++.. ...|+||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEE
Confidence 4699999999999999999997655 45999988654322 3457789999999999999999998754 3579999
Q ss_pred Eeccc-cchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+ ++...+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99987 45555543 23458899999999999999999999999999999999999999999999999998764332222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~---------------- 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R---------------- 221 (260)
T ss_pred cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C----------------
Confidence 223345778999998875 568999999999999999999 999999887766665543210 0
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. .....++..+.+||.+||.+||.+||++.++++
T Consensus 222 --~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 --M---------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --C---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 011357888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=362.89 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=201.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|+++++||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.++++++||||+++++++.... ..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-PVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-EEEEE
Confidence 479999999999999999999999999999999975432 3344567889999999999999999999987754 78999
Q ss_pred EEeccccchhhhcCC-----------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 237 FEYMEHDLAGLATTP-----------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~-----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
|||++|+.+..+... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999998655433321 124566788999999999999999999999999999999999999999999999
Q ss_pred eecCCCC-----------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH
Q 006004 306 TTYDPSQ-----------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368 (665)
Q Consensus 306 ~~~~~~~-----------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~ 368 (665)
....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 8762110 001123579999999999886 5689999999999999999999999987554332
Q ss_pred HHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 369 l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.... ....+ . ....+..+++.+.+++.+||..||.+|++..++|.+
T Consensus 240 ~~~~--~i~~P-~-----------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRD--VILSP-I-----------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhh--hccCh-h-----------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 00000 0 001123678899999999999999999988777765
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=377.70 Aligned_cols=259 Identities=31% Similarity=0.538 Sum_probs=220.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
+++...+||.|.||.||-|.+..+|...|+|.++...........+.+|+.+|..|+|||||+++++-..++ .+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHHHHHH
Confidence 355667899999999999999999999999999876555556677899999999999999999999766654 7899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---CC
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LP 315 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~---~~ 315 (665)
||.++.+..+...+.-++|...+-|..|++.||.|||+.|||||||||+||||+.+|.+|++|||.|..+..... ..
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999998888887888999999999999999999999999999999999999999999999999998865421 23
Q ss_pred cccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 316 LTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
+...+||+.|||||++.+. ...+-++||||||||+.||+||+.||...+. +.++.+...
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------------ 1456 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------------ 1456 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------------
Confidence 4567899999999999864 3456789999999999999999999976554 444443322
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...|+.| ..++++.++||++||..||.+|.++.|+|.|.|-+..
T Consensus 1457 -gh~Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1457 -GHKPQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -cCCCCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 2233333 2489999999999999999999999999999997754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.03 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=202.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.+|++.+.||+|+||.||+|++..++. .+|+|.++... .......+.+|+.++++++||||+++++++.... .+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-PVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-ccE
Confidence 479999999999999999999875543 79999886543 3345667889999999999999999999987654 789
Q ss_pred EEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+ ..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 99999987544 44444445789999999999999999999999999999999999999999999999999987654322
Q ss_pred CCc--ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 LPL--TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ~~~--~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+......
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------ 228 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------------ 228 (267)
T ss_pred eeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------------
Confidence 111 11223568999999976 568999999999999999886 99999887766655554321100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||+.+|.+||++.++++
T Consensus 229 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ----------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011246888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.51 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=203.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|+..+.||+|+||.||+|++..++. .+|+|.++... .....+.+..|+.++++++||||+++++++.... ..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-CcE
Confidence 468999999999999999999877665 79999886543 2344566889999999999999999999988754 789
Q ss_pred EEEEeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+..+. .....+++.++..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999976555444 3445789999999999999999999999999999999999999999999999999987643322
Q ss_pred CCccc--ccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 LPLTS--RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ~~~~~--~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
..... ...++.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......+
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 230 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP----------- 230 (268)
T ss_pred cceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-----------
Confidence 21111 122457999999876 568999999999999999997 999998877766666654321100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+..+.+||.+||..||.+||++.++++
T Consensus 231 -----------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -----------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.52 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=195.5
Q ss_pred EEeeccCceEEEEEEECCCC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
++||+|+||.||+|++..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.. ..+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeC
Confidence 46999999999999876655 78999998765443 345668899999999999999999998764 3589999999
Q ss_pred cccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc--
Q 006004 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS-- 318 (665)
Q Consensus 241 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~-- 318 (665)
.++.+..+......+++..+..++.||+.||.|||..||+|+||||+|||++.++.+||+|||++..+..........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 875555444444479999999999999999999999999999999999999999999999999998764433211111
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.... +
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 216 (257)
T cd05060 158 GRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R------------------ 216 (257)
T ss_pred ccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c------------------
Confidence 123467999998876 568999999999999999998 999998877655544442210 0
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++..+.+||.+||..||.+||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 --------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.32 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=197.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++.....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5799999999999999999985 3567899999997543 234456788999999999 68999999998876666
Q ss_pred cEEEEEEeccccchhhhcCC------------------------------------------------------------
Q 006004 232 SLYLVFEYMEHDLAGLATTP------------------------------------------------------------ 251 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~------------------------------------------------------------ 251 (665)
.+++||||+.++.+..+...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 78999999997554433211
Q ss_pred -------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CCcccccccc
Q 006004 252 -------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTL 323 (665)
Q Consensus 252 -------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~ 323 (665)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .......++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 12367888999999999999999999999999999999999999999999999987532221 1112234567
Q ss_pred cccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 324 ~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+...... +. ..
T Consensus 246 ~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~-----------------~~----- 301 (343)
T cd05103 246 KWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT-----------------RM----- 301 (343)
T ss_pred ceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cC-----------------CC-----
Confidence 8999999876 568999999999999999997 99999876443332222110 00 00
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++.+.+++..||..||.+|||+.++++|
T Consensus 302 ----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.75 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|++++++++||||+++++++.... ..|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERS-PICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-ceEEEE
Confidence 46999999999999999999885 4678999998754433 234678999999999999999999987755 789999
Q ss_pred Eeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++.+..+. .....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999976655444 3345689999999999999999999999999999999999999999999999999986543221111
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.....
T Consensus 159 ~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 219 (256)
T cd05112 159 TGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------------ 219 (256)
T ss_pred CCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------------
Confidence 22234678999998876 568899999999999999998 9999988776665555432100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
. ......+..+.+|+.+||..||++|||+.+++++
T Consensus 220 -~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 -L---------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -C---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0 0012357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=314.94 Aligned_cols=243 Identities=22% Similarity=0.402 Sum_probs=197.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+||+++++++......+|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4799999999999999999976 47789999986432 24567899999999999999999998765555789999
Q ss_pred Eeccc-cchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+ .+...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99986 4444444333 348899999999999999999999999999999999999999999999999988654322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 157 -~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------ 216 (256)
T cd05082 157 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------------ 216 (256)
T ss_pred -CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------------
Confidence 22344678999998876 568899999999999999997 999998776555544442210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+ .....+++.+.+||.+||..||.+|||+.++++
T Consensus 217 -~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 -KM---------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -CC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 111357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.87 Aligned_cols=251 Identities=18% Similarity=0.284 Sum_probs=198.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKI----VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||+||+|++..++.. |++|.+.... .......+..|+.++.+++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC--Cc
Confidence 35799999999999999999999887764 6777764322 23344567889999999999999999998753 35
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+++++||+.+ ++...+......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999985 555555555567999999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+ .....+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~---------- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERL---------- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC----------
Confidence 221 1233456778999999876 568999999999999999998 99999887654433222 110000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+.++.++|.+|+..||.+|||+.++++
T Consensus 231 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 -----------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001134667899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.48 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=208.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.+.+...||+|.||+||+|++..+ ||||++......++..+.|++|+.+|++-+|.||+-+.+++.... +.||+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--~AIiT 466 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--LAIIT 466 (678)
T ss_pred HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc--eeeee
Confidence 4578889999999999999999653 999999998888899999999999999999999999999998654 59999
Q ss_pred Eecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC-CCCCC
Q 006004 238 EYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLP 315 (665)
Q Consensus 238 Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~-~~~~~ 315 (665)
-+|+|. |+..+.....+|.....+.|++||+.|+.|||.++|||||||..||||.+++.|||+||||+..-.. .....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 999995 5556666667899999999999999999999999999999999999999999999999999975321 12223
Q ss_pred cccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 316 LTSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
+....|...|||||++.. ..+|++.+||||||||+|||++|..||...+...++-.+-+..+.|.
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------------- 613 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------------- 613 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-------------
Confidence 444567889999999963 46899999999999999999999999984433322222211111110
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.....+-++++++|+..|+.+++++||+..++|.
T Consensus 614 -----------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -----------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11223356789999999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.39 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=200.3
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||++.+. .++..||+|+++... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 47999999999999999999863 345689999887543 234456788999999999 7999999999987754
Q ss_pred cEEEEEEeccccch-hhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 232 SLYLVFEYMEHDLA-GLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+|+||||+.++.+ ..+... ...+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 78999999986544 444332 2348999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 310 PSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 310 ~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+...++....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 260 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG----------- 260 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-----------
Confidence 32211 1122345788999999876 568999999999999999998 999998876655444432210
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.. .....+++.+.+||.+||..||++|||+.++++
T Consensus 261 -------~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 -------YRM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------CcC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.72 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=199.9
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-P 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-c
Confidence 36999999999999999999854 345678999876432 344466889999999999999999999988754 7
Q ss_pred EEEEEEeccccchhhhcCC----------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 233 LYLVFEYMEHDLAGLATTP----------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
+++||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 8999999987555443321 234899999999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 99999999976543221 11223456888999999876 568999999999999999998 9999988776665544322
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.. . ......++..+.+||.+||..||.+|||+.++++
T Consensus 241 ~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 241 GR--V--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CC--C--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 10 0 0011246788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.31 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=202.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCC----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETG----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
+++.+.||.|+||.||++++..++ ..||+|.++.... ......+..|+.+++.++|+||+++++++.... ..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-PLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-eeEE
Confidence 456789999999999999998776 8999999975543 235667889999999999999999999988754 7899
Q ss_pred EEEeccccchhhhc-CCCCC-CChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 236 VFEYMEHDLAGLAT-TPGIK-FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 236 V~Ey~~g~ll~~~~-~~~~~-lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+|||+.++.+..+. ..... +++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999875554443 33323 99999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------------- 222 (258)
T ss_pred cccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 11112236789999998864 678999999999999999998 8899988776666655533110
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++..+.++|.+||..||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011237889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=318.71 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=196.8
Q ss_pred Ce-eEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCc
Q 006004 159 AF-EKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGS 232 (665)
Q Consensus 159 ~y-~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 232 (665)
+| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+++|+.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 45 999999999999998865 34578899999987543 233455678999999999999999999987654 345
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999987665554433 59999999999999999999999999999999999999999999999999998764332
Q ss_pred CC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCChhHHhhhcc
Q 006004 313 NL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL-CGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~-~g~p~~~~~~~~~~ 389 (665)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+... .+......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~-- 236 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL-- 236 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh--
Confidence 21 0122245677999998876 56899999999999999999999998654321 1111110 000000000000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..... .......++..+.+||.+||..||.+|||+.++++
T Consensus 237 -~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 -LERGM---------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -hhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.96 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-----GKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|++... +..||||+++... .....+.+.+|+.+|++|. |||||++++++....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35799999999999999999987543 3479999987543 3344567889999999996 999999999987654
Q ss_pred CcEEEEEEeccccchh-hhcCC----------------------------------------------------------
Q 006004 231 GSLYLVFEYMEHDLAG-LATTP---------------------------------------------------------- 251 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~-~~~~~---------------------------------------------------------- 251 (665)
.+|||||||.++.+. .+...
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 115 -PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred -ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 799999999865433 22211
Q ss_pred -------------------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC
Q 006004 252 -------------------------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294 (665)
Q Consensus 252 -------------------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~ 294 (665)
...+++.++..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 1247888899999999999999999999999999999999999
Q ss_pred CcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006004 295 GVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372 (665)
Q Consensus 295 g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI 372 (665)
+.+||+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......+.+...
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999987643221 11223356788999999876 568999999999999999997 99999876543333222
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.... ... .....++..+.+||.+||..||++|||+.++.+
T Consensus 353 ~~~~------------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSG------------------YRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcC------------------CCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2210 000 011357889999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.95 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=203.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC---CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN---MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
+|.+.+.||+|+||.||++++..++..+++|+++... ........+.+|+.+++.++||||+++++++.... ..++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence 4899999999999999999998887777777765422 22233445678999999999999999999987765 6899
Q ss_pred EEEeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 236 VFEYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
||||+.+..+..+. .....+++.+++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++..+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999975554332 23457999999999999999999999999999999999999975 67999999999876432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+... .++
T Consensus 159 ~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~----------- 223 (260)
T cd08222 159 CD-LATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP----------- 223 (260)
T ss_pred cc-cccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC-----------
Confidence 22 1233467899999998865 56788999999999999999999999877665555544321 000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....++.++.+||.+||..||++||++.++|+||||
T Consensus 224 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ---------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0113567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.60 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=200.2
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-P 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-c
Confidence 46899999999999999999743 35678999987643 3345567889999999999999999999887754 7
Q ss_pred EEEEEEeccccchhhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcE
Q 006004 233 LYLVFEYMEHDLAGLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~l 297 (665)
.|+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 89999999875544333221 248899999999999999999999999999999999999999999
Q ss_pred EEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 006004 298 KIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKL 375 (665)
Q Consensus 298 KL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~ 375 (665)
||+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999865432211 1122345788999999876 568999999999999999998 99999887776665554321
Q ss_pred cCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. + ......+++.+.+||.+||..||.+||++.+++.
T Consensus 241 ~--~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 241 R--E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred c--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0 0111357888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.79 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC--------------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG--------------KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~ 223 (665)
++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 47999999999999999999875432 358999987542 344556788999999999999999999
Q ss_pred eeeeccCCcEEEEEEeccccchhhhcCCC------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE
Q 006004 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPG------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291 (665)
Q Consensus 224 ~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl 291 (665)
+++.... .+|+||||+.+..+..+.... ..+++.++..++.||+.||.|||++|++|+||||+|||+
T Consensus 84 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVCVSDD-PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEcCCC-ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 9987754 789999999875444333211 236888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh--CCCCCCCCChHHH
Q 006004 292 NNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA--GKPIMPGRTEVEQ 368 (665)
Q Consensus 292 d~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~e~ 368 (665)
+.++.+||+|||++..+..... .......+++.|+|||++.+ ..++.++|+|||||++|+|++ +..||...+..+.
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999986533221 11223345778999998876 568999999999999999988 6688888776665
Q ss_pred HHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 369 l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+..+.... .... ... .......+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~--------~~~~---~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFF--------RNQG---RQI----------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhh--------hhcc---ccc----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55543311 1000 000 00112346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.75 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=196.1
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD 243 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ 243 (665)
+.||+|+||.||++.. .++..||+|+++... .......+.+|+++++.++||||+++++++.... ..++||||+.++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCC
Confidence 3689999999999986 468899999886543 3344456889999999999999999999987755 789999999865
Q ss_pred ch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccccc
Q 006004 244 LA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322 (665)
Q Consensus 244 ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT 322 (665)
.+ ..+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...............++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 44 44444445689999999999999999999999999999999999999999999999999976543222111222346
Q ss_pred ccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcc
Q 006004 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPY 401 (665)
Q Consensus 323 ~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~ 401 (665)
..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.... ..
T Consensus 158 ~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-------------------~~---- 213 (250)
T cd05085 158 IKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-------------------RM---- 213 (250)
T ss_pred ccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------------------CC----
Confidence 77999999875 568899999999999999998 999998877665554442210 00
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 402 KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 402 ~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....++..+.+||.+||..||++||++.++++.
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 214 -----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 1113578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.00 Aligned_cols=253 Identities=21% Similarity=0.375 Sum_probs=201.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|++++.||+|+||.||+|+.+. +.+.||+|.+.... .......+.+|+.++++++|+||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE-P 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC-c
Confidence 479999999999999999999754 34679999876432 2335567889999999999999999999887654 7
Q ss_pred EEEEEEeccccchhhhcCCCC---------CCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 233 LYLVFEYMEHDLAGLATTPGI---------KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~---------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.|+||||+.++.+..+..... .+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 899999999655544333222 68999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
++...............++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~-- 237 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLE-- 237 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcC--
Confidence 987653332223344466888999998876 457899999999999999998 78899776655544443210 000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
| .....++..+.+||.+||..||.+|||+.+++.+
T Consensus 238 -~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 -L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0112578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.88 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=198.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-------TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
++|.+.+.||+|+||.||++++.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 579999999999999999998643 23579999987543 334456688899999999 799999999998876
Q ss_pred CCcEEEEEEecccc-chhhhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHD-LAGLATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~-ll~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+|+||||+.++ |...+... ...+++.++..++.||+.||+|||++|++||||||+|||++.
T Consensus 97 ~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 G-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 5 789999999864 44444322 124888999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCCCC-cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQNLP-LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||++..+....... .....+++.|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 9999999999987654321111 111234578999999876 568999999999999999998 8899987665444433
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+... .. ......++.++.+||.+||..+|.+|||+.+++.+
T Consensus 255 ~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 255 LKEG--HR--------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHcC--CC--------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 3210 00 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.90 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=202.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.+|++.+.||+|+||.||+|.+..+++ .||||.+... ........+..|+.+++.++||||+++++++.... .++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-PVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-ceE
Confidence 369999999999999999999887765 5999998643 24455677899999999999999999999987654 789
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+. .+......+++.++..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999976554 4444445789999999999999999999999999999999999999999999999999876543221
Q ss_pred C-Cccccc---ccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 314 L-PLTSRV---VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 314 ~-~~~~~~---gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. ...... .+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~---------- 230 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL---------- 230 (269)
T ss_pred ccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC----------
Confidence 1 111111 2457999999875 568999999999999999886 99999887766655554321000
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..+|.+||++.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 ------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011256788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=320.06 Aligned_cols=262 Identities=24% Similarity=0.430 Sum_probs=216.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
...+|.+++.||+|+|++|.+++.+.|.+.||+|++++.-. +.+.+.-...|-.+..+- +||.+|-|+.+|+.++ .+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes-rl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES-RL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-eE
Confidence 45679999999999999999999999999999999987644 345566677888888886 7999999999999987 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
++|.||++|+.+....++..+|+|+.++.|-.+|+.||.|||++|||+||||.+|+|||..|++||.|+|+++.--. ..
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~-~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-CC
Confidence 99999999866655556666899999999999999999999999999999999999999999999999999875322 22
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCC--CCCh-----HHHHHHHHHhcCCCChhHHhh
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTE-----VEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~--g~~~-----~e~l~kI~~~~g~p~~~~~~~ 386 (665)
....+++|||.|+|||++.+ ..|+..+|+|+||++++||+.|+.||. |.++ .+.+-+++-
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil------------ 472 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL------------ 472 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh------------
Confidence 23567899999999999987 789999999999999999999999995 2222 222222111
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC------HHHHHhCcCCCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS------AASALRSEFFKTEPL 448 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT------a~eaL~Hp~f~~~~~ 448 (665)
.....+++.++-.+..+++..|++||.+|.. ..++..|+||+...+
T Consensus 473 ----------------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 473 ----------------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ----------------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 0112234567778889999999999999954 789999999986543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=319.65 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=197.2
Q ss_pred CeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-Cc
Confidence 47889999999999999998753 23578888886443 3344567889999999999999999999887654 78
Q ss_pred EEEEEeccccchhhhcC------------------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccE
Q 006004 234 YLVFEYMEHDLAGLATT------------------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNL 289 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~------------------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNI 289 (665)
|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999755543321 113588999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHH
Q 006004 290 LINNAGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVE 367 (665)
Q Consensus 290 Lld~~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e 367 (665)
|+++++.+||+|||++..+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999865332211 1122245678999998876 568999999999999999998 999998876554
Q ss_pred HHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 368 ~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+.... .. .....++.++.+||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGY-------------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCC-------------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 443322110 00 011357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.07 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=201.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+. ..|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--PVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--CcE
Confidence 4699999999999999999997654 3468999886433 344566788999999999999999999988753 578
Q ss_pred EEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++ +...+......+++.++..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999865 4444444444689999999999999999999999999999999999999999999999999987644322
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 227 (270)
T cd05056 163 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-------------- 227 (270)
T ss_pred eecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------------
Confidence 11222234568999998875 568999999999999999986 99999988876666554321000
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....++..+.+||.+||..+|.+|||+.+++..
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 --------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=321.89 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=201.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-------ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~ 228 (665)
.++|++.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 357999999999999999999753 234579999886432 344566788999999999 89999999999887
Q ss_pred cCCcEEEEEEeccccchh-hhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc
Q 006004 229 RSGSLYLVFEYMEHDLAG-LATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN 292 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~-~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld 292 (665)
.. .+|+||||+.++.+. .+... ...++..++..++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 DG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred CC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 54 789999999875443 33321 23578889999999999999999999999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 006004 293 NAGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMH 370 (665)
Q Consensus 293 ~~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 370 (665)
.++.+||+|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999876432221 1122345678999999876 568999999999999999998 889998877666555
Q ss_pred HHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+.... . .......+..+.+||.+||..+|.+|||+.++|+.
T Consensus 251 ~~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 251 LLKEGH--R--------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 442210 0 00113578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.04 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+++++.++|+||+++++++.. ...|++|
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~ 79 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIIT 79 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEE
Confidence 57999999999999999999864 45669999886432 335567889999999999999999998876 4689999
Q ss_pred Eeccc-cchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+ ++...+.. .+..+++.++..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++..+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99986 45555443 34468889999999999999999999999999999999999999999999999998764332222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....++..|+|||++.. ..++.++|+|||||++|+|++ |++||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------- 221 (260)
T cd05073 160 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------------- 221 (260)
T ss_pred ccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------------
Confidence 223345678999999876 568999999999999999998 9999998776665554422100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++..+.+||.+||..||++||++.+++.
T Consensus 222 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0111357889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=311.04 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=196.2
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecccc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD 243 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ 243 (665)
++||+|+||.||++.+.. ++.||+|++...... .....+.+|++++++++|+||+++++++.... ..|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCC
Confidence 369999999999999877 999999998765433 45567889999999999999999999988755 789999999865
Q ss_pred ch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc-ccccc
Q 006004 244 LA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL-TSRVV 321 (665)
Q Consensus 244 ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~-~~~~g 321 (665)
.+ ..+......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........... .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 44 44444445789999999999999999999999999999999999999999999999999986542211111 12233
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+.......+......
T Consensus 158 ~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~---------------------- 214 (251)
T cd05041 158 PIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM---------------------- 214 (251)
T ss_pred eeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC----------------------
Confidence 567999999876 568999999999999999999 88999887755444443221000
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..+|.+|||+.++|+
T Consensus 215 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 ------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=322.86 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=198.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-------TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
++|.+.+.||+|+||.||+|++.. ....||+|.++... .......+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 479999999999999999998642 34579999887433 344566788999999999 699999999988765
Q ss_pred CCcEEEEEEeccccchhhhc-CC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHDLAGLAT-TP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~-~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+|+||||+.++.+..+. .. ...+++.++..++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~-~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 91 G-PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 4 789999999875444333 21 235889999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876432211 1111234567999999876 578999999999999999999 8999988776665554
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.... . ......++.++.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~--~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 249 LREGH--R--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHcCC--C--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 43210 0 0111356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=316.51 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=201.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECC----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLE----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3579999999999999999999876 3578999987633 3455567788999999999999999999987765557
Q ss_pred EEEEEEeccccchhhhc-CCC-------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 233 LYLVFEYMEHDLAGLAT-TPG-------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~-~~~-------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
.++++||+.++.+..+. ... ..+++.++..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999865444333 211 4589999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 305 ATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 305 A~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
++.+...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------ 236 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY------ 236 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC------
Confidence 9865433211 1122345678999999876 568999999999999999998 999998876655443332210
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.. .....+++.+.++|.+||..||++|||+.++++
T Consensus 237 -------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -------------RL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------CC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 001246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.70 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=200.0
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++++++||||+++++++.... .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-P 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-c
Confidence 57999999999999999999974 367889999987433 3444566889999999999999999999888754 7
Q ss_pred EEEEEEeccccch-hhhcCC---------------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEE
Q 006004 233 LYLVFEYMEHDLA-GLATTP---------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLL 290 (665)
Q Consensus 233 l~lV~Ey~~g~ll-~~~~~~---------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNIL 290 (665)
+|+||||+.++.+ ..+... ...+++.++..++.||+.||.|||++|++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 8999999997544 333211 124788899999999999999999999999999999999
Q ss_pred EcCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHH
Q 006004 291 INNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQ 368 (665)
Q Consensus 291 ld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~ 368 (665)
++.++.+||+|||++..+..... ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999876532211 11122234677999998876 568999999999999999997 8889988776665
Q ss_pred HHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 369 l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+..+..... ......++..+.+||.+||..||.+|||+.|+++
T Consensus 242 ~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 242 IYYVRDGNV----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 554432100 0011256788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.18 Aligned_cols=243 Identities=24% Similarity=0.402 Sum_probs=198.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||.|+||.||+|.+ .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++... ...|+||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-NPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-CCeEEEE
Confidence 4799999999999999999987 478999999975432 456688999999999999999999998874 4789999
Q ss_pred Eeccccch-hhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLA-GLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll-~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+..+ ..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 99996444 4443322 268999999999999999999999999999999999999999999999999998763222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+...
T Consensus 157 -~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------------- 215 (256)
T cd05039 157 -DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG------------------- 215 (256)
T ss_pred -ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 12234667999999875 568899999999999999997 99999877655544433210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.. .....+++.+.+||.+||..+|++|||+.+++.
T Consensus 216 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 YRM---------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCC---------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 111356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=311.86 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=199.0
Q ss_pred EEeeccCceEEEEEEECC-CCc--EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDLE-TGK--IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
+.||+|+||.||+|.+.. .++ .||||.++..... ...+.+.+|+.++++++||||+++++++.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEec
Confidence 368999999999999865 333 6999999866543 566778999999999999999999999887 4789999999
Q ss_pred ccc-chhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC--Cc
Q 006004 241 EHD-LAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL--PL 316 (665)
Q Consensus 241 ~g~-ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~--~~ 316 (665)
.++ +...+.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 864 444444433 46899999999999999999999999999999999999999999999999999876442211 11
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+...... +
T Consensus 158 ~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~----------- 220 (257)
T cd05040 158 EHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----L----------- 220 (257)
T ss_pred cCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----C-----------
Confidence 23456788999998875 568999999999999999998 99999888777766665431000 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..+|.+|||+.++++
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 -----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.73 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=194.1
Q ss_pred EeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 165 KIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+++||||+.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCC
Confidence 4899999999999765 445679999986543 34445678899999999999999999998754 368999999987
Q ss_pred cchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC--cccc
Q 006004 243 DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSR 319 (665)
Q Consensus 243 ~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~--~~~~ 319 (665)
+.+. .+......+++.++..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+....... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 5554 443345579999999999999999999999999999999999999999999999999998664332211 1112
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
.+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+..+.... .
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------------- 216 (257)
T cd05115 159 KWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R------------------- 216 (257)
T ss_pred CCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C-------------------
Confidence 23578999998875 568999999999999999996 999998887766555443210 0
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.......++++.+||.+||..||++||++.++++
T Consensus 217 -------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 -------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.69 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=196.2
Q ss_pred eEEEEeeccCceEEEEEEEC----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDL----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++.+.||.|.||.||+|... ..+..|+||.++. ....+..+.+.+|++++++++||||+++++++.... .+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-PLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-SEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccc-ccccc
Confidence 46789999999999999987 3467899999954 334555778899999999999999999999998544 69999
Q ss_pred EEecccc-chhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-
Q 006004 237 FEYMEHD-LAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~- 313 (665)
|||+.++ |...+... ...+++.++..++.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999865 44445444 46799999999999999999999999999999999999999999999999999988732211
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...........|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+.+.++....-
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---------------
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccc---------------
Confidence 11223356788999999876 458999999999999999999 7899998887777777633110
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++..+.+||..||..||.+|||+.++++
T Consensus 224 -------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 -------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112357889999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.85 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=199.1
Q ss_pred CeeEEEEeeccCceEEEEEEE----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARD----LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
.|++++.||+|+||.||+|+. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 479999999999999999984 4578899999986543 344456789999999999999999999988765 3468
Q ss_pred EEEEEeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
++||||+.|+.+..+. .....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999876555444 333468999999999999999999999999999999999999999999999999998764332
Q ss_pred CC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH-Hhhhcc
Q 006004 313 NL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY-WRKSKS 389 (665)
Q Consensus 313 ~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~-~~~~~~ 389 (665)
.. ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+..... . +.+..+....+. +.....
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcccccccccHHHHHH
Confidence 21 1123456778999999876 5688999999999999999998866533211 1 111111111110 000000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
..... ........++..+.+||.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000 0011123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.33 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=192.0
Q ss_pred EEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEec
Q 006004 164 DKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
+.||+|+||.||+|.+.. +...||||.+... ........+.+|+.+++.++||||+++++++...++..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998654 3457999987532 234456678899999999999999999997765555789999999
Q ss_pred cccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---CCc
Q 006004 241 EHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LPL 316 (665)
Q Consensus 241 ~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~---~~~ 316 (665)
.++.+ ..+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 86544 44444344577888899999999999999999999999999999999999999999999986533211 111
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+... .+
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~---------------- 220 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR---------------- 220 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC----------------
Confidence 22345778999998876 568999999999999999999 56788877665544443221 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+ .....+++.+.+||.+||..||++||++.+++..
T Consensus 221 -~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 -L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0012467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.86 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=196.4
Q ss_pred CCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 232 (665)
.+|++++.||+|+||.||++. +..++..||+|.+... .....+.+.+|+++|+.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999998 4567889999998643 344566788999999999999999999976543 346
Q ss_pred EEEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 8999999986544 444444456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCC--cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNLP--LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~~--~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..++..... .....+.... ...........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~ 237 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDK--QGQMIVYHLIE 237 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccc--ccccchHHHHH
Confidence 2211 111123456999999876 5689999999999999999999876644321 1111110000 00000000000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
...... .......++..+.+||.+||..||++|||+.++++
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000 00112467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.63 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=199.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET-------GKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
.+|++.+.||+|+||.||+|++... +..||+|.++.. ......+.+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3699999999999999999986432 236899987643 2344567788999999999 899999999998765
Q ss_pred CCcEEEEEEeccccchh-hhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHDLAG-LATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~-~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+|++|||+.++.+. .+... ...++..++..++.||+.||.|||.+||+||||||+|||++.
T Consensus 91 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 91 G-PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 4 789999999875444 33221 224778889999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||+++........ ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999876432211 1122234567999999876 568999999999999999998 8899988876665554
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.... . .......+..+.+||.+||..+|.+|||+.++|.+
T Consensus 249 ~~~~~-------------------~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 249 LKEGH-------------------R---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHcCC-------------------C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 42210 0 01112567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.09 Aligned_cols=239 Identities=19% Similarity=0.259 Sum_probs=187.7
Q ss_pred EEeeccCceEEEEEEECCC------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 164 DKIGQGTYSSVYKARDLET------------GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
+.||+|+||.||+++...+ ...+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 3689999999999985322 2358888875432 233456788999999999999999999987654
Q ss_pred cEEEEEEeccccchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc-------EEEEecc
Q 006004 232 SLYLVFEYMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-------LKIGDFG 303 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~-------lKL~DFG 303 (665)
..++||||++++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 6799999999876665543 3457999999999999999999999999999999999999987664 8999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
++...... ....++..|+|||++.....++.++|||||||++|+|+ +|..||......+.. .+....
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~------ 225 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ------ 225 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC------
Confidence 98765321 23467889999998875567899999999999999997 588888776543322 111100
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+ ......++++.+||.+||..||.+||++.++|++
T Consensus 226 ------------~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ------------C-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------c-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0011345778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.64 Aligned_cols=258 Identities=19% Similarity=0.302 Sum_probs=197.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECC----------------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcce
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE----------------TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~ 221 (665)
++|++.+.||+|+||.||++.+.. ++..||+|+++... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 369999999999999999986532 34579999987542 3444567889999999999999999
Q ss_pred eeeeeeccCCcEEEEEEeccccch-hhhcCC----------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEE
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHDLA-GLATTP----------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLL 290 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ll-~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNIL 290 (665)
+++++.... .+|+||||+.++.+ ..+... ...+++.++..++.||+.||.|||+.||+|+||||+|||
T Consensus 84 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 84 LLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999987755 78999999986444 333321 124778899999999999999999999999999999999
Q ss_pred EcCCCcEEEEecccceecCCCCCCC-cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh--CCCCCCCCChHH
Q 006004 291 INNAGVLKIGDFGLATTYDPSQNLP-LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA--GKPIMPGRTEVE 367 (665)
Q Consensus 291 ld~~g~lKL~DFGlA~~~~~~~~~~-~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~e 367 (665)
++.++.++|+|||++..+....... .....+++.|+|||++.+ ..++.++|+|||||++|||++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999998654322111 122344678999998876 568999999999999999998 778898776655
Q ss_pred HHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 368 ~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+..... ++.... .... ......+++.+.+||..||..||.+|||+.++++
T Consensus 242 ~~~~~~~--------~~~~~~---~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGE--------FFRDQG---RQVY----------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHH--------HHhhcc---cccc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5543321 111000 0000 0112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.37 Aligned_cols=239 Identities=19% Similarity=0.252 Sum_probs=188.4
Q ss_pred EEeeccCceEEEEEEECCCCcE-------EEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKI-------VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+..|+.+++.++||||+++++++.... ..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEE
Confidence 3689999999999998765543 8888775322 334556788999999999999999999988754 68999
Q ss_pred EEeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc--------EEEEeccccee
Q 006004 237 FEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV--------LKIGDFGLATT 307 (665)
Q Consensus 237 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~--------lKL~DFGlA~~ 307 (665)
|||+.++.+..+. ..+..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999976554444 44556899999999999999999999999999999999999987765 69999999876
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.... ....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+........ ...
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~---------- 221 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR---------- 221 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc----------
Confidence 5322 23467889999999987566899999999999999999995 666655544332211 100
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.......+.++.+||.+||+.||++|||+.++++.
T Consensus 222 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 -------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00112345778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.28 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK----IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++++.||+|+||.||+|.++.+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cce
Confidence 579999999999999999999877765 58999876543 24455678899999999999999999998876 478
Q ss_pred EEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
++||||+.++ +...+......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999864 555555545579999999999999999999999999999999999999999999999999998765332
Q ss_pred CCC-cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 NLP-LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~~~-~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....+... ..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~----------- 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG--ER----------- 229 (279)
T ss_pred cceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--CC-----------
Confidence 211 111223567999998865 568899999999999999998 99999887765544444321 00
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.......+.++.++|.+||..||.+|||+.++++
T Consensus 230 ---------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ---------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.79 Aligned_cols=242 Identities=28% Similarity=0.404 Sum_probs=190.0
Q ss_pred EeeccCceEEEEEEECCCCcE--EEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 165 KIGQGTYSSVYKARDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
.||+|+||.||+|++..++.. +|+|.++.. ........+.+|+.+++++ +||||+++++++.... .+|+||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCC
Confidence 689999999999999888764 588877632 2344556788999999999 8999999999988754 7899999998
Q ss_pred cc-chhhhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 242 HD-LAGLATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 242 g~-ll~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
++ |...+... ...+++.+++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 64 44443321 124789999999999999999999999999999999999999999999999998
Q ss_pred eecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
........ ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~--------- 227 (270)
T cd05047 160 RGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--------- 227 (270)
T ss_pred cccchhhh--ccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC---------
Confidence 64321111 111223567999998865 668999999999999999997 99999887655544443210
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
... .....++.++.+||.+||..||.+|||+.++++
T Consensus 228 ----------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ----------YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ----------CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.22 Aligned_cols=238 Identities=24% Similarity=0.297 Sum_probs=187.0
Q ss_pred EeeccCceEEEEEEECCC------------------------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 006004 165 KIGQGTYSSVYKARDLET------------------------GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 220 (665)
.||+|+||.||++....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999975322 2358888886432 23345678899999999999999
Q ss_pred eeeeeeeccCCcEEEEEEeccccchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----
Q 006004 221 KLEGLVTSRSGSLYLVFEYMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---- 295 (665)
Q Consensus 221 ~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---- 295 (665)
++++++.... ..|+||||++++.+..+.. ....+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 80 FVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eEEEEEEeCC-ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999987754 7899999999877665553 355789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHH-HhCCCCCCCCChHHHHHH
Q 006004 296 ---VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAEL-FAGKPIMPGRTEVEQMHK 371 (665)
Q Consensus 296 ---~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeL-ltG~~pF~g~~~~e~l~k 371 (665)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++||| ++|++||.+.+..+....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999998654221 2235788899999987656789999999999999998 579999987665443221
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.... ......++.+.+||.+||..||.+|||+.++|++
T Consensus 234 ~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKH------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhcc------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11100 0011245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.68 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=199.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
..-++-||.|+.|-||+++. .++.||||+++.- -..+|+-|++|+||||+.+.+++... ..+||||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-PcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-PCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-ceeEEeeec
Confidence 45567899999999999986 5678999988621 13588899999999999999998764 478999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~ 319 (665)
|..+-+..+++.+..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+... ...-++
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 998777777777778999999999999999999999999999999999999999999999999999876543 345678
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~ 399 (665)
+||..|||||+|.+ .+.+.++|||||||||||||||..||..-+. .+.|+- .|+..-.
T Consensus 272 aGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAIIwG-VGsNsL~----------------- 329 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAIIWG-VGSNSLH----------------- 329 (904)
T ss_pred hhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccch---heeEEe-ccCCccc-----------------
Confidence 99999999999987 7899999999999999999999999976543 333322 1221110
Q ss_pred cchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCc
Q 006004 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441 (665)
Q Consensus 400 p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp 441 (665)
.......|+.++-||+.|+.-.|..||+..++|.|-
T Consensus 330 ------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 ------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 011235678899999999999999999999999983
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.93 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=202.4
Q ss_pred CeeEEEEeeccCceEEEEEEECC-CCcEEEEEEEecCC--------CCHHHHHHHHHHHHHHHh-CCCCCcceeeeeeec
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLE-TGKIVALKKVRFAN--------MDPESVRFMAREIHILRK-LDHPNVMKLEGLVTS 228 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~ 228 (665)
.|++.+.||+|+||.||++++.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999988 67899999886432 123345567789998875 799999999999877
Q ss_pred cCCcEEEEEEeccccchhhh----cCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecc
Q 006004 229 RSGSLYLVFEYMEHDLAGLA----TTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~----~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.. .+|+||||+.+..+..+ ......+++..++.++.||+.||.|||+ .||+|+||+|+|||++.++.+||+|||
T Consensus 81 ~~-~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 ND-RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CC-eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 54 89999999987544332 2344579999999999999999999996 789999999999999999999999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
++....... ......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+.......+......+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 232 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP---- 232 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc----
Confidence 998765432 3345578999999999986 568999999999999999999999998776655554443311100
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||++||++.|+..+
T Consensus 233 -----------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 -----------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0012467889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.33 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=199.0
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~ 231 (665)
++|.+.++||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|.++. |||||++++++....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 36889999999999999999964 345689999997543 2334456889999999997 999999999988754
Q ss_pred cEEEEEEeccccch-hhhcCC-----------------------------------------------------------
Q 006004 232 SLYLVFEYMEHDLA-GLATTP----------------------------------------------------------- 251 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~----------------------------------------------------------- 251 (665)
.+||||||+.++.+ ..+...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 78999999986443 333211
Q ss_pred --------------------------------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 252 --------------------------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 252 --------------------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
...+++.++..|+.||+.||.|||+.||+||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 123677888999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||++..+..... .......+++.|+|||++.+ ..++.++|||||||++|||++ |..||......+.+..
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 99999999999987533221 11223456889999999876 568999999999999999998 8899987665554443
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.... +. .+ .....++..+.+||.+||..||.+||++.++|+.
T Consensus 354 ~~~~-~~-----------------~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AIKR-GY-----------------RM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHc-CC-----------------CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3221 00 00 0123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.85 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=189.0
Q ss_pred EEeeccCceEEEEEEECC--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLE--TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.... .+|+||||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCC
Confidence 368999999999996533 34578888776433 3344556788999999999999999999887654 7899999998
Q ss_pred ccchhhhc-CCC----CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CC
Q 006004 242 HDLAGLAT-TPG----IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LP 315 (665)
Q Consensus 242 g~ll~~~~-~~~----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~ 315 (665)
++.+..+. ... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 75554433 221 2356788899999999999999999999999999999999999999999999875432211 11
Q ss_pred cccccccccccCcccccC------CcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 316 LTSRVVTLWYRAPELLLG------ATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~------~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.....+++.|+|||++.. ...++.++|||||||++|+|++ |.+||....+.+.+..+.........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~------- 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP------- 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC-------
Confidence 123345778999998742 2356889999999999999999 78899888776666655432111000
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+ .....+++...+++..|+ .||++|||+++++.
T Consensus 232 ----------~~------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 ----------KP------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------CC------cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 112357788889999988 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.80 Aligned_cols=229 Identities=26% Similarity=0.346 Sum_probs=183.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccchhhh
Q 006004 169 GTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLA 248 (665)
Q Consensus 169 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~ 248 (665)
|.|+.||+|++..+++.||+|.++... ...+|...+....||||+++++++.... .+|+||||+.++.+..+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSED-SVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCC-eEEEEEecCCCCCHHHH
Confidence 899999999999999999999997542 1234555556667999999999988754 78999999997655444
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCc
Q 006004 249 TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328 (665)
Q Consensus 249 ~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~AP 328 (665)
......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+... .....++..|+||
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP 151 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP 151 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence 434446999999999999999999999999999999999999999999999999988765432 2234567889999
Q ss_pred ccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhh
Q 006004 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLET 408 (665)
Q Consensus 329 E~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 408 (665)
|.+.+ ..++.++|+||+||++|+|++|..||...... + .. . . ....
T Consensus 152 E~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~----~-~-----------~~~~ 197 (237)
T cd05576 152 EVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT----H-T-----------TLNI 197 (237)
T ss_pred cccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc----c-c-----------ccCC
Confidence 98865 56789999999999999999999877432110 0 00 0 0 0011
Q ss_pred ccCCcHHHHHHHHHhcccCcCCCcCH-----HHHHhCcCC
Q 006004 409 FRNFPQSALALVDKLLTIEPENRGSA-----ASALRSEFF 443 (665)
Q Consensus 409 ~~~~s~~a~dLI~~lL~~DP~~RpTa-----~eaL~Hp~f 443 (665)
...+++.+.+||.+||+.||.+|+|+ .++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 23578899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=303.60 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=198.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc----CCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR----SGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----~~~ 232 (665)
..+|++.+.||+|||+-||+++...++..||+|++.... .+..+..++|++..++++||||++++++.... ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 358999999999999999999999999999999998655 45667788999999999999999998865432 345
Q ss_pred EEEEEEecccc-chhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEecccce
Q 006004 233 LYLVFEYMEHD-LAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 233 l~lV~Ey~~g~-ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
.||+++|...+ +++.+. ..+..++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999998754 555443 24457999999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCC--C------CCcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 006004 307 TYDPSQ--N------LPLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 307 ~~~~~~--~------~~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~ 376 (665)
...-.- + +....-..|..|+|||++.-. ...+.++|||||||+||.|+.|..||.- ++..-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcC
Confidence 653110 0 011122458999999988632 3568999999999999999999999842 22211
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
|+-.-..- ....+++.. ..+|..+.+||+.||..||.+||++.++|.+
T Consensus 249 gSlaLAv~-----n~q~s~P~~-----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQ-----NAQISIPNS-----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeee-----ccccccCCC-----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11100000 000011111 1378899999999999999999999999864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.11 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK----IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
..+|+.++.||+|+||.||++++..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--C
Confidence 4579999999999999999999988876 46888876433 234444678999999999999999999988653 4
Q ss_pred EEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.++++||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 67999999864 55555544556899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.. .+......+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~---------- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL---------- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC----------
Confidence 221 1223345778999999876 668999999999999999997 89999876543332 222210000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+.++.+||.+|+..||++||++.++++.
T Consensus 231 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 -----------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.49 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred eeEEEEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 160 FEKIDKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
|++.+.||+|+||.||+|.+.. +++.||||++..........+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998653 5789999999765555566677889999999999999999999876432 1
Q ss_pred cEEEEEEeccccchh-hhcC-----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 232 SLYLVFEYMEHDLAG-LATT-----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~-~~~~-----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
..++++||+.++.+. .+.. ....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999865443 3221 1125789999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 306 TTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 306 ~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~---- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--R---- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC--c----
Confidence 876432211 1123345678999998875 567899999999999999999 899998877655444443210 0
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++..+.+|+.+||..+|.+||++.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=336.59 Aligned_cols=264 Identities=28% Similarity=0.493 Sum_probs=219.8
Q ss_pred ccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc--
Q 006004 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR-- 229 (665)
Q Consensus 153 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-- 229 (665)
.|...+.|++++.||.|.+|.||+++++.+++..|+|++.......+ .+.-|.+||+.+ .|||++.++++|.-.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 45667789999999999999999999999999999999976654333 355689999988 699999999988632
Q ss_pred --CCcEEEEEEeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 230 --SGSLYLVFEYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 230 --~~~l~lV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
.+.+|||||||.|+....+.+ .+.++.|+.+.+|++.++.||.|||.+.++|||||-.|||++.+|.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 457999999999876655443 2568999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccCC----cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~ 381 (665)
..++.... ...+.+|||.|||||++... ..|+..+|+||||++..||.-|.||+-..-+.- .++.+...|++
T Consensus 171 aQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNPPP 246 (953)
T KOG0587|consen 171 AQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNPPP 246 (953)
T ss_pred eeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCCCc
Confidence 98865443 34567999999999999753 457889999999999999999999997765443 33443334433
Q ss_pred hHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.. ..+...+..+.+||..||.+|-++||+..++|+|||++..
T Consensus 247 kL-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 KL-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cc-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 32 1234578889999999999999999999999999999843
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.89 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=193.7
Q ss_pred EEeeccCceEEEEEEECCCC------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 164 DKIGQGTYSSVYKARDLETG------KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.||+|+||.||+|++.... +.||||.+.... .......+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEE
Confidence 36899999999999986544 689999886432 2234556788999999999999999999987654 789999
Q ss_pred Eeccccch-hhhcC------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-----cEEEEecccc
Q 006004 238 EYMEHDLA-GLATT------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-----VLKIGDFGLA 305 (665)
Q Consensus 238 Ey~~g~ll-~~~~~------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-----~lKL~DFGlA 305 (665)
||+.++.+ ..+.. ....+++.++..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99986444 43332 223478899999999999999999999999999999999999887 8999999999
Q ss_pred eecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 306 TTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 306 ~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-------
Confidence 76532211 11123345788999999876 568999999999999999998 999998877666555442210
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.......+|..+.+||.+||..+|.+||++.++++
T Consensus 231 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ---------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112357888999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.93 Aligned_cols=250 Identities=21% Similarity=0.257 Sum_probs=187.8
Q ss_pred EEeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
+.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.++++++||||+++++++.... .+|+||||+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCC
Confidence 36899999999999864 3456799998875543 233446788999999999999999999887654 6899999999
Q ss_pred ccchh-hhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CC
Q 006004 242 HDLAG-LATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LP 315 (665)
Q Consensus 242 g~ll~-~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~ 315 (665)
++.+. .+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ ..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 65544 3332 123456778889999999999999999999999999999999999999999999875432211 11
Q ss_pred cccccccccccCcccccCC------cccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 316 LTSRVVTLWYRAPELLLGA------TKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~------~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.....+++.|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL---------- 228 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC----------
Confidence 1234568889999988642 135789999999999999996 99999877665544332211000
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....| .....+++.+.+||..|+ .||++|||+.+++.
T Consensus 229 -------~~~~~------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -------KLPKP------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------CCCCC------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000 011246778899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.11 Aligned_cols=241 Identities=26% Similarity=0.426 Sum_probs=195.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++||||+++++++... .+|+||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEE
Confidence 4699999999999999999864 78889999986432 234678899999999999999999988653 479999
Q ss_pred Eeccc-cchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.+ ++...+... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99986 444444433 2358999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+.+..
T Consensus 155 -~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------ 214 (254)
T cd05083 155 -DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY------------------ 214 (254)
T ss_pred -CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC------------------
Confidence 22234677999998875 568999999999999999997 999998877655444432210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.. .....++..+.+||.+||..+|.+||++.+++.
T Consensus 215 -~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 -RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.45 Aligned_cols=236 Identities=22% Similarity=0.276 Sum_probs=186.5
Q ss_pred EEeeccCceEEEEEEECCCC----------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 164 DKIGQGTYSSVYKARDLETG----------KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
+.||+|+||.||++.+..++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR--DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec--CCc
Confidence 36899999999999998777 3578887654321 15667899999999999999999998876 367
Q ss_pred EEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-------cEEEEecccc
Q 006004 234 YLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-------VLKIGDFGLA 305 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-------~lKL~DFGlA 305 (665)
|+||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999987666555433 3789999999999999999999999999999999999999888 7999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+....... .
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~------- 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-Q------- 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-C-------
Confidence 87543 1234567789999998764 378999999999999999999 5777766553322221110 0
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.. .+ ......+.+||.+||..||.+|||+.++|+
T Consensus 223 ----------~~---~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----------HR---LP---------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------CC---CC---------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00 011267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.40 Aligned_cols=259 Identities=17% Similarity=0.174 Sum_probs=189.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCH--HHH-------HHHHHHHHHHHhCCCCCcceeeee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDP--ESV-------RFMAREIHILRKLDHPNVMKLEGL 225 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~--~~~-------~~~~~Ei~iL~~L~HpnIV~l~~~ 225 (665)
.+|++.+.||+|+||.||+|++..+ +..+|+|+........ +.. .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998887 6778888654332211 100 111233445566789999999987
Q ss_pred eeccCC---cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEec
Q 006004 226 VTSRSG---SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302 (665)
Q Consensus 226 ~~~~~~---~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DF 302 (665)
...... ..+++||++...+...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 654432 2367788776655544433 234688899999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 006004 303 GLATTYDPSQN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 303 GlA~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~ 376 (665)
|+|+.+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+......+....+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~-- 247 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK-- 247 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH--
Confidence 99987643211 11233468999999999876 6789999999999999999999999988743322222111
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+++...... ...+...++.+.++++.|+..+|++||+..++++
T Consensus 248 ----~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 ----CDFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----HHHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0111111000 0012356788999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.55 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=193.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|..-..||+|+||.||+|.- .+|..||||++....... .+.|.+|+.+|.+++|||+|+|++||.+.+...+||
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 35788889999999999999986 455899999876544321 344899999999999999999999998765358999
Q ss_pred EEeccccch-hhhcCCCC-CCChhHHHHHHHHHHHHHHHHHhCC---ccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 237 FEYMEHDLA-GLATTPGI-KFTEPQIKCYMQQLLRGLEHCHSRG---ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~-~lse~~i~~i~~QIl~aL~~LH~~g---IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|||..+.+ ..+..... .|+|....+|+.+++.||+|||... |||||||++|||||.+.+.||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999996554 44444444 8999999999999999999999864 999999999999999999999999999765431
Q ss_pred CCCCcccc-cccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhHHhhhc
Q 006004 312 QNLPLTSR-VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--VEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 312 ~~~~~~~~-~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
....... .||.+|+|||++.. +..+.++|||||||+|.||++|+.+...... ...+..... ..|.+.
T Consensus 231 -~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~-------~~~~~~- 300 (361)
T KOG1187|consen 231 -DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK-------PLLEEG- 300 (361)
T ss_pred -ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH-------HHHHCc-
Confidence 1112222 79999999999975 6789999999999999999999987764321 111111100 011110
Q ss_pred cccccCCCCCCcchhhhhhhccCCc-----HHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFP-----QSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s-----~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......++.... ..++ ..+..+..+|+..+|.+||++.|+++
T Consensus 301 -~~~eiiD~~l~~--------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 -KLREIVDPRLKE--------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -chhheeCCCccC--------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 011111111100 0111 22667888999999999999999765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.16 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=197.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECC----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 232 (665)
++|++++.||+|+||.||+++... +++.||||.+...... .....+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 468999999999999999998643 4789999999765433 4566789999999999999999999988763 336
Q ss_pred EEEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 8999999986544 444443446999999999999999999999999999999999999999999999999999877532
Q ss_pred CCCC--cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC----hhHHh
Q 006004 312 QNLP--LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS----EDYWR 385 (665)
Q Consensus 312 ~~~~--~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~----~~~~~ 385 (665)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ . ..+... ..-+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~---~~~~~~~~~~~~~~~ 236 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--R---MIGIAQGQMIVTRLL 236 (284)
T ss_pred CcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhc--c---ccccccccccHHHHH
Confidence 2111 112234567999998876 5688999999999999999999998865432110 0 000000 00000
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..... .. . .......+..+.+||.+||..||.+|||+.+++.
T Consensus 237 ~~~~~-~~----~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKE-GE----R-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHc-CC----c-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00 0 0011245688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.80 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=216.7
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-----HHHHHHHHHHHHHHhCCCCCcceeeeeeecc
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-----ESVRFMAREIHILRKLDHPNVMKLEGLVTSR 229 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~ 229 (665)
.-.++|-++..||+|+|+.||+|.|....++||+|+-....... ...+...+|..|.+.|+||.||++|++|.-.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34567999999999999999999999999999999876544322 2345677999999999999999999999987
Q ss_pred CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC--CccccCCCcccEEEcC---CCcEEEEeccc
Q 006004 230 SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR--GILHRDIKGSNLLINN---AGVLKIGDFGL 304 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--gIiHrDLKPeNILld~---~g~lKL~DFGl 304 (665)
...+|-|+|||+|+.++.++.....++|.+++.|+.||+.||.||... -|||-||||.||||-+ -|.+||.||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 778999999999998888888888899999999999999999999987 5999999999999964 47899999999
Q ss_pred ceecCCCCCC-----Cc-ccccccccccCcccccC---CcccCcccchhhhHHHHHHHHhCCCCCCCCChHH-HHH--HH
Q 006004 305 ATTYDPSQNL-----PL-TSRVVTLWYRAPELLLG---ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMH--KI 372 (665)
Q Consensus 305 A~~~~~~~~~-----~~-~~~~gT~~Y~APE~l~~---~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~--kI 372 (665)
+..++.+... .+ ....||.||++||.+.- ...++.++||||+|||+|..|.|+.||....... ++. .|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9988654321 22 23478999999998852 2467899999999999999999999997643322 221 12
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
++. ....|++ -+.+++++++||++||++--+.|....++..||||.-
T Consensus 700 lkA---------------tEVqFP~-----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 700 LKA---------------TEVQFPP-----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hcc---------------eeccCCC-----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 110 1111211 1358999999999999999999999999999999963
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.48 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=187.1
Q ss_pred EeeccCceEEEEEEECCCC--cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 165 KIGQGTYSSVYKARDLETG--KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
.||+|+||.||++....++ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.... .+|+||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCCC
Confidence 6999999999999754332 346677665433 2334567889999999999999999999988754 78999999997
Q ss_pred cch-hhhcCC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CCCcc
Q 006004 243 DLA-GLATTP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NLPLT 317 (665)
Q Consensus 243 ~ll-~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~~~~ 317 (665)
+.+ ..+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 544 444322 2346777889999999999999999999999999999999999999999999986432111 11123
Q ss_pred cccccccccCcccccCC------cccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 318 SRVVTLWYRAPELLLGA------TKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~------~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
..+++..|+|||++... ..++.++|||||||++|+|++ |.+||...++.+.+..+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------------ 227 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------------ 227 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc------------
Confidence 45678999999987531 245789999999999999997 57888887777766665432110
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..+.+ .....+++.+.+||..|+ .||.+|||+.++++
T Consensus 228 --~~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 --KLFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred --ccCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00001 011246788999999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.53 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=212.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHH-HhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL-RKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++.+-+..||.|+||+|++.+++.+|+..|||.|+..+... ..++++.|.+.. +.-++||||++|+....+ +..|
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~E-GdcW 139 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-GDCW 139 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-Ccee
Confidence 3456777889999999999999999999999999999877644 445567787765 445899999999987764 4789
Q ss_pred EEEEeccccchhhhc----CCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 235 LVFEYMEHDLAGLAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
|.||+|+-++..++. .....++|..+-.+...++.||+||... .||||||||+||||+..|.+||||||++-.+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999976544332 2334699999999999999999999865 89999999999999999999999999987765
Q ss_pred CCCCCCcccccccccccCcccccCCc-ccCcccchhhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhHHhhh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGAT-KYGAAIDMWSAGCILAELFAGKPIMPGRT-EVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~-~~~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
.+-. .+.-+|...|||||-+.... .|+.++|+||||++|||+.||+.|+.+-+ ..+|+..+.. |.|+.-..+
T Consensus 220 ~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~~-- 293 (361)
T KOG1006|consen 220 DSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLFD-- 293 (361)
T ss_pred HHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecCc--
Confidence 4322 34447889999999997544 49999999999999999999999998754 3456655543 333321110
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...-+++..++.||..||.+|-..||...+++.+||++..
T Consensus 294 -------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 -------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 1112688999999999999999999999999999999753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.63 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=208.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCc---E-EEEEEEecC-CCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGK---I-VALKKVRFA-NMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS 230 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~ 230 (665)
..++-.+.++||+|.||.||+|+.+..+. . ||+|..+.. ....+.+..+.+|.++|+.|+|||||+++|+...+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34567778999999999999999766432 3 899998863 357788889999999999999999999999887765
Q ss_pred CcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+|||||+|.|+.+..+++.. ..++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+||||++.-.
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 799999999986665555544 469999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... .....--...|+|||.+.. ..|+.++||||+||++||+++ |..||++.+..+...+|.......
T Consensus 314 ~~~~-~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~--------- 382 (474)
T KOG0194|consen 314 QYVM-KKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM--------- 382 (474)
T ss_pred ceee-ccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC---------
Confidence 1111 0111123567999999986 589999999999999999988 889999999999888885421110
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....-|..+..++.+|+..||+.|+|+.++.+
T Consensus 383 ------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 ------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011246778889999999999999999998865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=329.61 Aligned_cols=201 Identities=32% Similarity=0.517 Sum_probs=170.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----CcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~l 233 (665)
.+..-+.||+|+||.||+++++++|+.||||.++... ....++.+.+|++||++|+|+|||+++++-+... ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4667789999999999999999999999999987644 2334566889999999999999999998654332 235
Q ss_pred EEEEEeccccchh-hhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC--CC--cEEEEecccce
Q 006004 234 YLVFEYMEHDLAG-LATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN--AG--VLKIGDFGLAT 306 (665)
Q Consensus 234 ~lV~Ey~~g~ll~-~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~--~g--~lKL~DFGlA~ 306 (665)
.+|||||.|+.+. .+.++ ...|+|.++..++..+..||.|||++||+||||||.||++-. +| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 7999999976554 44443 245999999999999999999999999999999999999853 23 47999999999
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g 362 (665)
.++.+. ..++.+||+.|.+||++.....|+..+|.|||||++|+.+||..||-.
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 886544 688999999999999998557899999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=283.19 Aligned_cols=244 Identities=39% Similarity=0.615 Sum_probs=196.8
Q ss_pred CceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccchhhhc
Q 006004 170 TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLAT 249 (665)
Q Consensus 170 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~ 249 (665)
+||.||+|.+..+|+.+|+|++........ .+.+.+|++++++++|+||+++++++.... ..+++|||+.++.+..+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDED-KLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCC-EEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999876543221 567889999999999999999999887754 789999999984444444
Q ss_pred CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcc
Q 006004 250 TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329 (665)
Q Consensus 250 ~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE 329 (665)
.....+++..+..++.+|+.+|.+||+.||+|+||+|.||+++.++.++|+|||++....... ......++..|++||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE 156 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPE 156 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHH
Confidence 333348999999999999999999999999999999999999999999999999998875432 234457889999999
Q ss_pred cccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhc
Q 006004 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETF 409 (665)
Q Consensus 330 ~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 409 (665)
.+.+ ..++.++|+||||+++|+|++|..||......+.+........... ....
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~ 210 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPPE 210 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------cccc
Confidence 8875 5678899999999999999999999987443333333222100000 0001
Q ss_pred cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 410 RNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 410 ~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
..++..+.++|.+||..||.+||++.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 1277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=319.82 Aligned_cols=274 Identities=27% Similarity=0.368 Sum_probs=188.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC----------------CCCcEEEEEEEecCCCCH--H----------HHHHHHHH
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDL----------------ETGKIVALKKVRFANMDP--E----------SVRFMARE 207 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~--~----------~~~~~~~E 207 (665)
..++|++.++||+|+||.||+|... ..++.||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 345689999986432110 0 11123457
Q ss_pred HHHHHhCCCCCc-----ceeeeeeecc-------CCcEEEEEEeccccchhhhcCC------------------------
Q 006004 208 IHILRKLDHPNV-----MKLEGLVTSR-------SGSLYLVFEYMEHDLAGLATTP------------------------ 251 (665)
Q Consensus 208 i~iL~~L~HpnI-----V~l~~~~~~~-------~~~l~lV~Ey~~g~ll~~~~~~------------------------ 251 (665)
+.++.+++|.++ ++++++|... .+..||||||+.++.+..+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 5666666431 2468999999997554433221
Q ss_pred CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccc
Q 006004 252 GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331 (665)
Q Consensus 252 ~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l 331 (665)
...+++..++.++.||+.+|.|||..+|+||||||+|||++.++.+||+|||++...............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 11245678899999999999999999999999999999999999999999999976543322222222458999999988
Q ss_pred cCCcc-------------------cC--cccchhhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 332 LGATK-------------------YG--AAIDMWSAGCILAELFAGKP-IMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 332 ~~~~~-------------------~~--~~sDIWSLG~iLyeLltG~~-pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
..... |+ ...||||+|||||+|++|.. ||.+........+. . ......|...+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---Y-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---c-cchHHHHHhhcc
Confidence 63211 22 24799999999999999874 66543221111110 0 011122332211
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCc---CCCcCHHHHHhCcCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP---ENRGSAASALRSEFFKT 445 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP---~~RpTa~eaL~Hp~f~~ 445 (665)
.. + ....+...++.++|||.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~---------~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK---------Y---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC---------C---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 10 0 112245678999999999999876 68999999999999964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=307.58 Aligned_cols=282 Identities=34% Similarity=0.532 Sum_probs=215.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
....|..+++||+|+|++||++.+.. ..+.||+|.+.... ....+..|+++|..+ -+.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd- 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND- 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCC-
Confidence 34569999999999999999999988 78899999987544 234478999999999 5999999999988765
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~ 310 (665)
.+.+||||++++....+.. .++..+++.|++.++.||.++|.+|||||||||.|+|++. .+.-.|+|||||...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 7999999999976665553 4778999999999999999999999999999999999984 56789999999972210
Q ss_pred CC-------------------------------------------CCCcccccccccccCcccccCCcccCcccchhhhH
Q 006004 311 SQ-------------------------------------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAG 347 (665)
Q Consensus 311 ~~-------------------------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG 347 (665)
.. ......+.||++|+|||++......+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00012357899999999999888889999999999
Q ss_pred HHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChh----------HHhhhcc------------ccccCCCCCCcchhh
Q 006004 348 CILAELFAGKPIM-PGRTEVEQMHKIFKLCGSPSED----------YWRKSKS------------AHATSFKPQQPYKRK 404 (665)
Q Consensus 348 ~iLyeLltG~~pF-~g~~~~e~l~kI~~~~g~p~~~----------~~~~~~~------------~~~~~~~~~~p~~~~ 404 (665)
||+..+++++.|| ...++.+.+..|..+.|.-.-. +|.+..- .+.........+...
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999665 5667777777776666643211 3332110 000000000000001
Q ss_pred hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 405 VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 405 ~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.......++..+.+|+++||..||.+|.||+++|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 11112245668999999999999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=332.63 Aligned_cols=252 Identities=24% Similarity=0.433 Sum_probs=208.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-C----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-G----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.+..++.+.||+|.||.||.|....- | ..||||.++... +...+..|.+|..+|+.++|||||++++++.+ .+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CC
Confidence 45688999999999999999986543 3 248999887543 45667788999999999999999999999888 55
Q ss_pred cEEEEEEeccc-cchhhhcCC------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 232 SLYLVFEYMEH-DLAGLATTP------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
..+|++|||+| ||+..+... ...|+..+...++.+|+.|+.||+++++|||||-..|+||+....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 78999999986 666666655 45689999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCcccc-cccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 305 ATTYDPSQNLPLTSR-VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 305 A~~~~~~~~~~~~~~-~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
|+.+-.......... .-...|||||.+.. ..++.++|||||||+|||++| |..||++.++.+.+.-....-
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg------ 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG------ 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC------
Confidence 995432222111111 22467999999986 789999999999999999987 789999999988887654421
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+...|..+.+|+..|+..+|++||+...+++
T Consensus 922 ----------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ----------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11223467888999999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.47 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=206.1
Q ss_pred CeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
+.+..+.||+|.||+||+|+-.. +...||||.++... +....+.|.||+++|..|+|||||+|++++...+ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGD-PL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-ee
Confidence 57788999999999999998532 34679999997544 3446678999999999999999999999998765 79
Q ss_pred EEEEEeccc-cchhhhcCC---------CC----CCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEE
Q 006004 234 YLVFEYMEH-DLAGLATTP---------GI----KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKI 299 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~---------~~----~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL 299 (665)
|+|||||.+ ||...+... +. +|+..+...++.||+.|+.||-++.+|||||-..|+||.++-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 999999985 554444321 12 3889999999999999999999999999999999999999999999
Q ss_pred EecccceecCCCCCCCcc-cccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 006004 300 GDFGLATTYDPSQNLPLT-SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCG 377 (665)
Q Consensus 300 ~DFGlA~~~~~~~~~~~~-~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g 377 (665)
+||||++.+-........ ...-...|||||.|+- +.|+.++||||+||+|||+++ |.-|+.|.++.|.++.|.+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-- 721 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-- 721 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC--
Confidence 999999875332221111 2234678999999985 789999999999999999986 88999999999999988652
Q ss_pred CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
.+.....+-|.++.+|+..|++.+|.+||+++|+=
T Consensus 722 --------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 --------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred --------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 12334457899999999999999999999998863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.84 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=216.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++.++|.|+||.||+++++.+++..|+|+++.... ....-+..||-+++.++|||||.+++.+..+. .+||+|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEE
Confidence 579999999999999999999999999999999987643 23455778999999999999999999888765 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||+|+.++.+..-.++++|.++...++..+.||+|||.+|=+|||||..|||+++.|.+||+|||.+..+...- ....
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Krk 170 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRK 170 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hhhh
Confidence 999998888877777799999999999999999999999999999999999999999999999999998775432 2346
Q ss_pred cccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
+++||+.|||||+.. ....|...+|||++|++..|+-.-++|....-....+..+.+-...|+.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-------------- 236 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-------------- 236 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--------------
Confidence 789999999999863 3467999999999999999999999886554444333333221111110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.+.-...++.+.+|++.+|.++|.+|||++.+|+|||..
T Consensus 237 ----------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 237 ----------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred ----------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 111124677889999999999999999999999999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.18 Aligned_cols=257 Identities=24% Similarity=0.322 Sum_probs=203.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+...+.++||+|-||.|.+|.- ..+..||+|+++.... ......|.+||++|.+|+|||||.|++++..++ .+++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHH
Confidence 4578899999999999999985 4468999999986543 344577899999999999999999999988755 799999
Q ss_pred Eeccc-cchhhhcCCCCC-CChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEH-DLAGLATTPGIK-FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g-~ll~~~~~~~~~-lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+. +|-+.+.....+ +.-.....++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-......
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99985 555555443322 3455677799999999999999999999999999999999999999999999653333222
Q ss_pred -cccccccccccCcccccCCcccCcccchhhhHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 316 -LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 316 -~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLl--tG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+-...|||+|.++. ++++.++|+|++|++|||++ +...||...++.+.+...-..+......
T Consensus 695 vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---------- 763 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---------- 763 (807)
T ss_pred eecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----------
Confidence 223355788999999986 67999999999999999974 5778998888777766654433222111
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++-.+..+.+||.+|+..|-.+||+.+++-.
T Consensus 764 -----------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 -----------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -----------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 011223457888999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=308.29 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=215.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
...+.+.||.|-||.||+++.+..|+ .||||.++.. ..+.....|+.|..||-+++||||++|.+++.... -+.|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-PVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-eeEE
Confidence 35788899999999999999887774 6999999754 45667778999999999999999999999987654 7899
Q ss_pred EEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+|||+.+.++ .+....+.|+..|+..+++.|+.|+.||-++|+|||||-..||||+.+-.+|++||||++.+.++...
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999966554 55556678999999999999999999999999999999999999999999999999999988665544
Q ss_pred Ccccccc--cccccCcccccCCcccCcccchhhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 PLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ~~~~~~g--T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
..++.-| ...|.|||.|.- .+++.++||||+||+|||.+ .|..||...++.+.+..|.+...-|++
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---------- 856 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---------- 856 (996)
T ss_pred cccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC----------
Confidence 4444333 467999999975 78999999999999999965 599999999999999999775544433
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+.|..+..|+..|+++|-.+||+..|++.+
T Consensus 857 ------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 ------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3678889999999999999999999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=311.51 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=193.0
Q ss_pred eeEEEEeeccCceE-EEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEE
Q 006004 160 FEKIDKIGQGTYSS-VYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 160 y~~~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
|.--+.+|.|+-|+ ||+|.. .|+.||||.+- .+......+||..|+.- +|||||++++.-.+ .+.+||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEe
Confidence 33445689999985 799987 67899999764 35566778999999998 69999999997655 45899999
Q ss_pred EeccccchhhhcCCCC--CC-ChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CC--cEEEEecccceecC
Q 006004 238 EYMEHDLAGLATTPGI--KF-TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AG--VLKIGDFGLATTYD 309 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~--~l-se~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g--~lKL~DFGlA~~~~ 309 (665)
|+|...|.+++..... .. .....+..+.|+++||+|||+.+||||||||.||||+. ++ .++|+|||+++.+.
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9999988888776421 11 11456889999999999999999999999999999986 34 68999999999987
Q ss_pred CCCCC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 310 PSQNL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 310 ~~~~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.+... ......||-+|+|||++... .-..++||||||||+|+.++| ..||...- +.-..|... ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~--~~------- 730 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTG--NY------- 730 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcC--cc-------
Confidence 65432 24456789999999999864 346799999999999999887 78986542 222333221 10
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+...-.....+|.+||.+||++||..||+|.++|.||||.+.
T Consensus 731 -----------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 731 -----------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -----------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 0111111122289999999999999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=266.18 Aligned_cols=214 Identities=27% Similarity=0.427 Sum_probs=181.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++...+..||+|+||.|-+.++..+|...|+|.++..- +....+++++|+.+..+. .+|++|.+|+.+..+ +.+||
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-gdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-GDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-ccEEE
Confidence 356777889999999999999999999999999997543 344556678899987776 899999999977664 57999
Q ss_pred EEEeccccchh---hhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 236 VFEYMEHDLAG---LATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~ll~---~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.||.|..++.. .....+..++|..+-+++..++.||.|||++ .|||||+||+||||+.+|++|+||||.+-.+..+
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99999976544 4445778899999999999999999999986 8999999999999999999999999999877544
Q ss_pred CCCCcccccccccccCcccccC---CcccCcccchhhhHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 006004 312 QNLPLTSRVVTLWYRAPELLLG---ATKYGAAIDMWSAGCILAELFAGKPIMP-GRTEVEQMHKIFK 374 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~---~~~~~~~sDIWSLG~iLyeLltG~~pF~-g~~~~e~l~kI~~ 374 (665)
-. .+.-.|...|||||.+.. ...|+.++||||||++++||.+++.||. ..++.+++.++..
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 32 233467889999999853 3479999999999999999999999986 5788899998876
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=296.66 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=202.3
Q ss_pred eEEEEeeccCceEEEEEEECCC--C--cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLET--G--KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~--g--~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+-+.||.|-||.||+|....- | --||||..+.+. +++..+.|+.|..+|+.++|||||+|++++... ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeEE
Confidence 3446799999999999986432 3 358899887544 456678899999999999999999999999864 58999
Q ss_pred EEecc-ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~-g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||++. |.|..++.+....|+......|++||+.||.|||+...|||||-..|||+....-+||+||||++.+.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 99998 55666666667789999999999999999999999999999999999999999999999999999886554322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.+...-..-|||||.+. ...++.++|||-|||++||+|. |..||.|-.+.+.+-.|.+.-.
T Consensus 549 aS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR----------------- 610 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER----------------- 610 (974)
T ss_pred ccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-----------------
Confidence 22222255699999886 4778999999999999999875 8899999887776666543211
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
...+++.|+.+..|+.+|+++||.+||+..++..
T Consensus 611 -----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 611 -----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 1123478899999999999999999999988753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=293.27 Aligned_cols=256 Identities=22% Similarity=0.370 Sum_probs=209.0
Q ss_pred cCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc
Q 006004 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR 229 (665)
Q Consensus 150 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~ 229 (665)
+.|...+.+ ...-.+||-|-||.||.+.|+.....||||.++.+.+ .+..|+.|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtd-ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchh-eeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 567666653 7778899999999999999999999999999986554 366789999999999999999999999876
Q ss_pred CCcEEEEEEecc-ccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 230 SGSLYLVFEYME-HDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 230 ~~~l~lV~Ey~~-g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
. .+|||+|||. |+|++++...+ ..++.-.+..++.||..|++||..+++|||||-..|+|+..+..+||+||||+++
T Consensus 336 p-PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 336 P-PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred C-CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 5 7899999997 67777766544 3466667788889999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
+..+.........-..-|.|||-+. ...++.++|||+|||+|||+.| |..||+|.+-...+..+.+..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---------- 483 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---------- 483 (1157)
T ss_pred hcCCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc----------
Confidence 8665432222222356699999886 3678999999999999999976 889999987655544443210
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..+.....|+.+..|+..|+++.|..||+.+++-+
T Consensus 484 ------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 ------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 11223478999999999999999999999887643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=323.34 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=184.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|...+.||+|+||.||+|++..++..||||++...... ...|+.++++++|||||++++++.... ..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEe
Confidence 356677899999999999999999999999998643211 134688999999999999999998765 6899999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH---hCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH---SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH---~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|++++.+..+.. .+++.++..++.||+.||+||| ..+|+||||||+|||++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 999766655543 4889999999999999999999 6699999999999999998888875 6665443211
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCC-CChhHHhhhcccccc
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGS-PSEDYWRKSKSAHAT 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~-p~~~~~~~~~~~~~~ 393 (665)
....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... ...+....+.... .....|
T Consensus 836 -~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 904 (968)
T PLN00113 836 -TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--------- 904 (968)
T ss_pred -CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe---------
Confidence 23368999999999876 6789999999999999999999999853221 1111111111000 000000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
..+... ...........++.+|+.+|++.||++|||+.|+++.
T Consensus 905 -~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 -IDPSIR---GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -eCcccc---CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000 0000001122357789999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=295.90 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=207.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCC-Cc--EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLET-GK--IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~-g~--~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
+..+.++||+|.||+|+++.|... |+ .||||.++...... ....|.+|+.+|.+|+|||+|+||+++.+. .+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q--p~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ--PAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc--hhhH
Confidence 566778999999999999998753 33 68999998766544 567789999999999999999999999873 5789
Q ss_pred EEEeccc-cchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 236 VFEYMEH-DLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 236 V~Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||++.. .|++.+.+ ....|.......|+.||+.||.||..+++|||||-..||||.....|||+||||.+.+.....
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999985 55555554 455788999999999999999999999999999999999999999999999999998865543
Q ss_pred CC--cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 LP--LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ~~--~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.. .........|.|||.|.. ..++.++|+|++||+||||++ |..||.|....+++++|-+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------------- 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------------- 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------------
Confidence 22 111223556999999986 789999999999999999987 67999999999999887431
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+..+.++.+++..|+..+|++|||...+..
T Consensus 332 -------------erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 -------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 112233567899999999999999999999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=291.03 Aligned_cols=204 Identities=28% Similarity=0.450 Sum_probs=175.8
Q ss_pred cCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHH------HHHHHHHHHHHHhCC---CCCcceeee
Q 006004 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES------VRFMAREIHILRKLD---HPNVMKLEG 224 (665)
Q Consensus 154 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------~~~~~~Ei~iL~~L~---HpnIV~l~~ 224 (665)
+....+|..++.||+|+||.|++|.++++...|+||.|.+..+-.+. +-.+-.||+||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 34455799999999999999999999999999999999766532111 223557999999997 999999999
Q ss_pred eeeccCCcEEEEEEeccc--cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEec
Q 006004 225 LVTSRSGSLYLVFEYMEH--DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302 (665)
Q Consensus 225 ~~~~~~~~l~lV~Ey~~g--~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DF 302 (665)
+|++.+ .+||+||-... +|.+. +.....++|.+++.+++|+..|+++||+.||||||||-+|++++.+|-+||+||
T Consensus 637 fFEddd-~yyl~te~hg~gIDLFd~-IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFEDDD-YYYLETEVHGEGIDLFDF-IEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeecCC-eeEEEecCCCCCcchhhh-hhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 999865 89999998764 34444 445568999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC
Q 006004 303 GLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362 (665)
Q Consensus 303 GlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g 362 (665)
|.|... .+.+...++||..|.|||++.|..+.+..-|||+||++||.++....||..
T Consensus 715 gsaa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999875 345678899999999999999888889999999999999999988888753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=241.70 Aligned_cols=213 Identities=40% Similarity=0.628 Sum_probs=180.0
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccch
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLA 245 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll 245 (665)
||+|.+|.||++++..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++... ...+++|||+.+..+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 356688999999999999999999998875 478999999995444
Q ss_pred h-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCCCCCCCcccccccc
Q 006004 246 G-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323 (665)
Q Consensus 246 ~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~ 323 (665)
. .+......+++.++..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~ 157 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTP 157 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCC
Confidence 4 44333246899999999999999999999999999999999999999 89999999999987654321 123346788
Q ss_pred cccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchh
Q 006004 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKR 403 (665)
Q Consensus 324 ~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~ 403 (665)
.|++||.+.....++.+.|+|+||+++++|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------- 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------- 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------
Confidence 899999887633778999999999999998
Q ss_pred hhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCc
Q 006004 404 KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441 (665)
Q Consensus 404 ~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp 441 (665)
..+.++|..||..||.+||++.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2356789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=271.33 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=187.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh--CCCCCcceeeeeeeccC---Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK--LDHPNVMKLEGLVTSRS---GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~ 232 (665)
+..++++.||+|.||.||+|+. +++.||||++.. +..+.+..|-+|... ++|+||++++++-.... -.
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4577888999999999999985 568999999863 456778888888876 48999999998644321 25
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC---------CccccCCCcccEEEcCCCcEEEEecc
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR---------GILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---------gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
++||+||.+.+.+..++..+ .+++.+..+++..|+.||+|||+- .|+|||||..||||.++++.-|+|||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 89999999866555555444 589999999999999999999963 59999999999999999999999999
Q ss_pred cceecCCCCC-CCcccccccccccCcccccCCcccC-----cccchhhhHHHHHHHHhCCCCCC-CCChHHHHHHHHHhc
Q 006004 304 LATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYG-----AAIDMWSAGCILAELFAGKPIMP-GRTEVEQMHKIFKLC 376 (665)
Q Consensus 304 lA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~-----~~sDIWSLG~iLyeLltG~~pF~-g~~~~e~l~kI~~~~ 376 (665)
||..+.+... ......+||..|||||++.+...+. .+.||||+|.|||||++.-.-+. +..+.=++.--..+-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 9999876543 2344479999999999998755444 46899999999999999765442 222111111111111
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhcc--CCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR--NFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
..|.-+-.... ...+...|. +...+. .....+++.|+.|++.||+.|.||.
T Consensus 442 ~hPt~e~mq~~-----VV~kK~RP~---~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 442 NHPTLEEMQEL-----VVRKKQRPK---IPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCCCHHHHHHH-----HHhhccCCC---ChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 12221111100 000000110 111111 2335578999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=244.48 Aligned_cols=212 Identities=37% Similarity=0.561 Sum_probs=175.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|++.+++++|+||+++++++.... ..++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPE-PLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCC-ceEEEEec
Confidence 56789999999999999999988999999999765432 25667889999999999999999999887654 78999999
Q ss_pred ccccchhhhcCCCCC-CChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 240 MEHDLAGLATTPGIK-FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~-lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
+.+..+..+...... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++..+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 998444444433334 8999999999999999999999999999999999999999999999999998875432112344
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG-RTEV-EQMHKIF 373 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g-~~~~-e~l~kI~ 373 (665)
..++..|++||.+.+...++.++|+|+||+++|+|++|++||.. .+.. +....|.
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 57788999999884446678899999999999999999999988 4444 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=284.54 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=196.7
Q ss_pred eeEEEEeeccCceEEEEEEEC----C---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 160 FEKIDKIGQGTYSSVYKARDL----E---TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~----~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
..+.+.||+|.||.|++|.-. . ....||||.++..... ...+.+..|+++|+.+ +|+||+.+++++.. .+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-CC
Confidence 466679999999999998733 1 1457999998765444 6677899999999998 69999999999887 56
Q ss_pred cEEEEEEeccc-cchhhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG 295 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g 295 (665)
.+++|+||+.. +|+..+.... ..|+..+...++.||+.|++||++..+|||||-..||||..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 89999999985 5555554443 2489999999999999999999999999999999999999999
Q ss_pred cEEEEecccceecCCCCCCCcccccc--cccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCC-hHHHHHH
Q 006004 296 VLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRT-EVEQMHK 371 (665)
Q Consensus 296 ~lKL~DFGlA~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~-~~e~l~k 371 (665)
.+||+|||+|+..............+ ...|||||.+.. ..|+.++||||+||+||||++ |..|+++.. ..+.+..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999999654333222121222 234999999987 789999999999999999987 679998854 3333333
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.... ..+.+...++++.+|++.|++.+|++||+..++..
T Consensus 535 l~~G~----------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGN----------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCC----------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 32210 11222356889999999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=304.52 Aligned_cols=204 Identities=20% Similarity=0.243 Sum_probs=147.7
Q ss_pred HhCCC-CCcceeeeeeec------cCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCC
Q 006004 212 RKLDH-PNVMKLEGLVTS------RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284 (665)
Q Consensus 212 ~~L~H-pnIV~l~~~~~~------~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL 284 (665)
+.++| .||+.++++|.. ....++++|||++++|...+......+++.+++.|++||+.||+|||++||+||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 34455 577778777621 12357888999999888887666667999999999999999999999999999999
Q ss_pred CcccEEEcCCC-------------------cEEEEecccceecCCCCC---------------CCcccccccccccCccc
Q 006004 285 KGSNLLINNAG-------------------VLKIGDFGLATTYDPSQN---------------LPLTSRVVTLWYRAPEL 330 (665)
Q Consensus 285 KPeNILld~~g-------------------~lKL~DFGlA~~~~~~~~---------------~~~~~~~gT~~Y~APE~ 330 (665)
||+||||+..| .+||+|||+++....... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 455666666543211000 00112468999999999
Q ss_pred ccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhcc
Q 006004 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR 410 (665)
Q Consensus 331 l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 410 (665)
+.+ ..|+.++|||||||+||||++|.+||.... ..+..+.... .+.. +.
T Consensus 187 ~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~~ 235 (793)
T PLN00181 187 DNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ--------------------------IL 235 (793)
T ss_pred hcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh--------------------------hh
Confidence 886 568999999999999999999988875422 1122221100 0000 00
Q ss_pred CCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 411 NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 411 ~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.-.+.+.+++.+||.+||.+|||+.|+|+||||...
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 113446789999999999999999999999999753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=260.84 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=186.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh--CCCCCcceeeeeeeccC---Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK--LDHPNVMKLEGLVTSRS---GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~ 232 (665)
.+..+++.||+|.||.||+|++ .|+.||||++... + .+.+.||.+|.+. |+|+||+.+++.-...+ ..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr--d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR--D---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEeccc--c---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3789999999999999999998 5789999998632 2 2346678888876 59999999988654332 25
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC--------CccccCCCcccEEEcCCCcEEEEeccc
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR--------GILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
+|||++|.+.+.+.+++.+. .++.....+++..++.||+|||.. .|.|||||..||||.++|..-|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 89999999977776666664 799999999999999999999963 499999999999999999999999999
Q ss_pred ceecCCCCC---CCcccccccccccCcccccCCccc-----CcccchhhhHHHHHHHHhC----------CCCCCCCC--
Q 006004 305 ATTYDPSQN---LPLTSRVVTLWYRAPELLLGATKY-----GAAIDMWSAGCILAELFAG----------KPIMPGRT-- 364 (665)
Q Consensus 305 A~~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~~~-----~~~sDIWSLG~iLyeLltG----------~~pF~g~~-- 364 (665)
|.......+ .....++||..|||||+|...... -..+||||||.|+||++.. ++||.+-.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 998765432 345678999999999998643211 2368999999999999763 36665432
Q ss_pred --hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCc--HHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 365 --EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFP--QSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 365 --~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s--~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
..+.+.+++-. ..+.|..| ..+...+ ..+-.|++.|+..||.-|.||-.+.
T Consensus 443 DPs~eeMrkVVCv-----------------~~~RP~ip------nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 443 DPSFEEMRKVVCV-----------------QKLRPNIP------NRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCHHHHhcceee-----------------cccCCCCC------cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 23344433211 00011111 1111111 2355789999999999999987654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=272.03 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=200.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK----IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
...+..++||+|+||+||++.+...|+ +||||++.... ..+....+++|+-+|.+|+|||+++|++++... .+
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TL 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hH
Confidence 346677899999999999999987775 68899886543 344556688999999999999999999998764 47
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
-||++||++ .|++.+...+..+-......|..||++||.|||.++++||||-..|+||..-..+||.|||+|+.+..+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 899999995 5666666666678889999999999999999999999999999999999999999999999999887665
Q ss_pred CCCcccc-cccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 NLPLTSR-VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~~~~~~~-~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
....... ...+-|||=|.+.. ..|+.++||||+||++||++| |..|+.+....++-. +++.-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~g-------------- 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKG-------------- 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhcc--------------
Confidence 4332221 22556888898875 789999999999999999987 888888876544332 22210
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. ....++.-+-++.-++-+|+..|+..||+++++..
T Consensus 917 e-------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 E-------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred c-------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 0 01122356778899999999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=242.56 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=186.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.|.|.+.+.||+|.||.+.+|+++.+...+|+|.+.... ...+.|.+|..---.| .|.||+.-|++-....+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 467999999999999999999999999999999987543 3356688888766666 589999888764444557889
Q ss_pred EEEecc-ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC--CCcEEEEecccceecCCCC
Q 006004 236 VFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 236 V~Ey~~-g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~~~~~~ 312 (665)
+|||++ |+|...+...+ +-|.-.+.++.|+++||.|||+.++||||||.+||||-+ ...+||||||+.+..+...
T Consensus 100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 999998 55655555443 789999999999999999999999999999999999953 3489999999988754322
Q ss_pred CCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 NLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. ..--+..|.+||++.. .-...+.+|+|.||||+|.+|+|.+||+..... ...||.-.+
T Consensus 178 ~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-------------d~~Y~~~~~ 240 (378)
T KOG1345|consen 178 K----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-------------DKPYWEWEQ 240 (378)
T ss_pred h----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-------------CchHHHHHH
Confidence 1 1123667999998752 234578899999999999999999999743211 122333221
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R 431 (665)
...... ..+...|..+++.+..+.++-|..+|.+|
T Consensus 241 w~~rk~--------~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 241 WLKRKN--------PALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred HhcccC--------ccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 111110 12345667899999999999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=228.42 Aligned_cols=263 Identities=35% Similarity=0.515 Sum_probs=206.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-HHHHHHHHHHHHHHhCCCC-CcceeeeeeeccCCcEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLDHP-NVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~Ei~iL~~L~Hp-nIV~l~~~~~~~~~~l~lV~ 237 (665)
|.+...||.|+|+.||++.+. ..+|+|.+....... .....+.+|+.++..+.|+ +|+++++++.... ..++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-SLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-EEEEEE
Confidence 788999999999999999987 789999987654433 2567788999999999988 7999999995543 579999
Q ss_pred EeccccchhhhcCCCC---CCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCC
Q 006004 238 EYMEHDLAGLATTPGI---KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~ 313 (665)
+|+.+..+..+..... .+++..+..++.|++.+|.|+|..|++||||||+|||++..+ .++++|||++..+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999866664444432 699999999999999999999999999999999999999988 799999999986644332
Q ss_pred C-----CcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-Chh
Q 006004 314 L-----PLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSP-SED 382 (665)
Q Consensus 314 ~-----~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~kI~~~~g~p-~~~ 382 (665)
. .....+||..|+|||.+.+. ..+....|+||+|++++++++|..||..... .............+ ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1 34667899999999999864 4789999999999999999999999888764 33333333322221 000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...+... ......+.+++..++..+|..|.+..+...++|....
T Consensus 238 --------------~~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 238 --------------PLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred --------------ccCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000 1234678899999999999999999999999776643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=272.52 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=202.7
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEec----CCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRF----ANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~----~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.....+|.|.+|.|+.+......+.++.|..+. ..........+..|+-+-..|.||||+.....+..... .+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 456789999999999999888888788876552 22222223337778888899999999888777766543 3444
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC---
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--- 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--- 313 (665)
||||.+||...+... ..++..++.++++||+.||+|||..||.|||||++|||++.+|.+||+|||.+..+.....
T Consensus 400 mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999999666666554 4799999999999999999999999999999999999999999999999999988754332
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+|+..|+|||++.+...-...+||||.|++++.|++|+.||.-....+....-.. ...
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----------------~~~ 542 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----------------YSD 542 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------------ccc
Confidence 3456678999999999998855555679999999999999999999975443322110000 000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+. ........+..++...+.+|.+||++||.+|.|+++||+.+||+..
T Consensus 543 ~~~----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 543 QRN----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ccc----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 011 1111223345688899999999999999999999999999999865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=224.75 Aligned_cols=166 Identities=23% Similarity=0.291 Sum_probs=127.6
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
|+|...+...+..|++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCC
Confidence 3455555555667999999999999999999999998 999999999999999 99998764422 268
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
|+.|||||++.+ ..|+.++|||||||++|||++|++||....... .+..+....... .+
T Consensus 67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~ 126 (176)
T smart00750 67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-------------------DP 126 (176)
T ss_pred cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-------------------Cc
Confidence 999999999986 678999999999999999999999997655432 223322211000 00
Q ss_pred chhhhhhhccCCcH--HHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 401 YKRKVLETFRNFPQ--SALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 401 ~~~~~~~~~~~~s~--~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
..+. ....++. .+.+||.+||..||.+|||+.+++.|+|+.
T Consensus 127 ~~~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRS---NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccc---cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000 0112333 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=239.55 Aligned_cols=165 Identities=23% Similarity=0.248 Sum_probs=131.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECC-CCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHhCCCCCcce-eeeeeeccC
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLE-TGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHPNVMK-LEGLVTSRS 230 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~-l~~~~~~~~ 230 (665)
..+.|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+.+|++|+|+||+. +++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 34579999999999999999999876 678889998753311 2334567899999999999999985 4432
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCC-CcccEEEcCCCcEEEEecccceecC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI-KGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL-KPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
+..|||||||.|..+..... .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 25799999999876653321 11 2578899999999999999999999 9999999999999999999999775
Q ss_pred CCCC-------CCcccccccccccCccccc
Q 006004 310 PSQN-------LPLTSRVVTLWYRAPELLL 332 (665)
Q Consensus 310 ~~~~-------~~~~~~~gT~~Y~APE~l~ 332 (665)
.... ...+..++++.|+|||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 4321 1124567889999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=252.13 Aligned_cols=243 Identities=28% Similarity=0.416 Sum_probs=201.6
Q ss_pred EeeccCceEEEEEEE---CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEEEec
Q 006004 165 KIGQGTYSSVYKARD---LETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
.+|+|+||.|++++. ...|..||+|++++.............|..++..++ ||.+|+++..|+.+. .+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-KLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-chhHhhhhc
Confidence 379999999998763 345778999998766542222224567889999986 999999999999865 799999999
Q ss_pred cccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccccc
Q 006004 241 EHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320 (665)
Q Consensus 241 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~ 320 (665)
.|+.+.........+.+..++.|...++.+++++|..||+|||+|++||+++.+|++++.|||+.+..-.... .|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~c 154 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----AC 154 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----cc
Confidence 9876666666666799999999999999999999999999999999999999999999999999987654332 28
Q ss_pred ccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc
Q 006004 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP 400 (665)
Q Consensus 321 gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p 400 (665)
||..|||||++. ....++|+||+|+++|+|++|..||.+ +.+..|.+..-.
T Consensus 155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~---------------------- 205 (612)
T KOG0603|consen 155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE---------------------- 205 (612)
T ss_pred cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC----------------------
Confidence 999999999987 368899999999999999999999988 667777653211
Q ss_pred chhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCCCC
Q 006004 401 YKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEPLP 449 (665)
Q Consensus 401 ~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~~~ 449 (665)
....++..+.+++..|+..+|.+|.. +.++++|+||....+.
T Consensus 206 -------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 -------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 12346778999999999999999975 5899999999876543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=225.94 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=198.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++++....+-+|+||.||.|.+.+.. +.|-+|.++.. ..+-++..+..|--+|..+.|||+..+.++.......
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46888889999999999999776543 34566666532 2345567788999999999999999999987766557
Q ss_pred EEEEEEeccccchhhhcC------C--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 233 LYLVFEYMEHDLAGLATT------P--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~------~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
.++++.+++-+.+..+++ . ...++..++..++.||+.|++|||..||||.||-..|.+||+.-.+||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 788899988444333322 1 13477889999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCcc-cccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 305 ATTYDPSQNLPLT-SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 305 A~~~~~~~~~~~~-~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
++.+-+....-+. .......||+||.+.+ ..|+.++|+||||++||||+| |+.|+...++.|..+-+.+..
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy------ 515 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY------ 515 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc------
Confidence 9876544322111 1122567999999987 789999999999999999976 889999988888777664421
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.-.+| -+.|+++..++..|+..+|++||+.+|+..
T Consensus 516 -------------RlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -------------RLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -------------eecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11122 368999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=215.97 Aligned_cols=210 Identities=27% Similarity=0.315 Sum_probs=168.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC----CCcceeeeeeeccCCcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAREIHILRKLDH----PNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIV~l~~~~~~~~~~l 233 (665)
+|.+.++||+|+||.||+|.+..++ ..+|+|........... .+..|+.+|..+.. +++..+++........-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 6999999999999999999998775 67899987654321111 46779999998863 68889988874233467
Q ss_pred EEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-----CcEEEEecccce-
Q 006004 234 YLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-----GVLKIGDFGLAT- 306 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-----g~lKL~DFGlA~- 306 (665)
||||+++..+|.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+|+
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999999888877544 3789999999999999999999999999999999999999865 469999999999
Q ss_pred -ecCCCCC---C---C-cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 006004 307 -TYDPSQN---L---P-LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHK 371 (665)
Q Consensus 307 -~~~~~~~---~---~-~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~k 371 (665)
.+..... . . ...+.||..|.++.+..+ ...+.+.|+||++-++.+|+.|..||.+........+
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~ 248 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK 248 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence 3322211 1 1 123569999999998887 6679999999999999999999999977664443333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=244.43 Aligned_cols=226 Identities=32% Similarity=0.436 Sum_probs=172.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
...+|+.++.|-.|+||-||+++|+.+.+.+|+| +++.++ +.|- ||.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee---------------
Confidence 3467999999999999999999999999999994 443321 1111 34434444444
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC--
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-- 313 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-- 313 (665)
||-..++...+ +++.+. +.+++|||..||+|||+||+|+||+.-|++|+.|||+.........
T Consensus 136 ------gDc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333333322 454433 7899999999999999999999999999999999999865321110
Q ss_pred ------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 006004 314 ------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 314 ------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~ 381 (665)
..-...+|||.|+|||+++. ..|+..+|+|++|+|+||+|.|..||.|++..+.+...+......++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 01123489999999999987 67999999999999999999999999999999988887664332222
Q ss_pred hHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC---cCHHHHHhCcCCCCCCC
Q 006004 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR---GSAASALRSEFFKTEPL 448 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R---pTa~eaL~Hp~f~~~~~ 448 (665)
. -..+++++++||.+||..+|..| +.+.++.+|+||+...+
T Consensus 280 ~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 280 E--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred c--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 1 23588999999999999999999 45888999999986544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=200.53 Aligned_cols=141 Identities=20% Similarity=0.240 Sum_probs=109.7
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES------------------------VRFMAREIHILRKLDHPN 218 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------------------~~~~~~Ei~iL~~L~Hpn 218 (665)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|.+|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999986 8999999999764321110 122345999999998887
Q ss_pred cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHH-HhCCccccCCCcccEEEcCCCcE
Q 006004 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC-HSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 219 IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L-H~~gIiHrDLKPeNILld~~g~l 297 (665)
+.....+.. .. .+|||||++|+.+.........+++.++..++.||+.+|.+| |+.||+||||||+|||++ ++.+
T Consensus 81 v~~p~~~~~-~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPILL-KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEEe-cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 744333222 22 389999999865543322335799999999999999999999 799999999999999998 4789
Q ss_pred EEEecccceec
Q 006004 298 KIGDFGLATTY 308 (665)
Q Consensus 298 KL~DFGlA~~~ 308 (665)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=199.98 Aligned_cols=172 Identities=14% Similarity=0.124 Sum_probs=132.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHH------HHHHHHHHHhCCCCCcceeeeeeecc-
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRF------MAREIHILRKLDHPNVMKLEGLVTSR- 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~------~~~Ei~iL~~L~HpnIV~l~~~~~~~- 229 (665)
++|++++.||.|+||.||++.+ ++..+|||+++..... +..... +.+|+..+.+|.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4899999999999999999755 4668999999755432 222233 57899999999999999999886643
Q ss_pred ------CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 230 ------SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 230 ------~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.+..+|||||++|..+..+. .+++ ..+.+|+.+|..||+.||+|+||||+|||++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 23579999999997665442 2333 3466999999999999999999999999999999 9999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHH
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF 354 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLl 354 (665)
............ .+++ ...|+.++|+||||+++..+.
T Consensus 180 ~~~~~~e~~a~d-------------~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKD-------------RIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHH-------------HHHH-HhHhcccccccceeEeehHHH
Confidence 887653222110 0233 356788999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=192.57 Aligned_cols=208 Identities=24% Similarity=0.305 Sum_probs=166.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC-CCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~l~l 235 (665)
...|.++++||.|+||.+|++....+|+.||||+-+..... ..+..|..+.+.|.+ ..|..+..+...+. .-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~-ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKD-YNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccc-ccee
Confidence 45899999999999999999999999999999986533222 235678899998864 56666666665544 6689
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC---CcEEEEecccceecCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~---g~lKL~DFGlA~~~~~~~ 312 (665)
||+++...|.+++.--...|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.-. ..+.|+|||||..+....
T Consensus 89 VMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 89 VMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred eeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 99999988777766656679999999999999999999999999999999999998643 469999999998874432
Q ss_pred CC------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH
Q 006004 313 NL------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370 (665)
Q Consensus 313 ~~------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 370 (665)
.. .-....||..|.+--...+ ...+...|+=|+|-+|..+..|..||+|.......+
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 21 1234578999988776665 445788999999999999999999999876544433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=193.30 Aligned_cols=141 Identities=22% Similarity=0.319 Sum_probs=112.5
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC----------------------HH--HHHHHHHHHHHHHhCCCCC
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD----------------------PE--SVRFMAREIHILRKLDHPN 218 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------------------~~--~~~~~~~Ei~iL~~L~Hpn 218 (665)
.+.||+|+||.||+|++. +|+.||||+++..... .. ....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999864211 00 0123468999999999998
Q ss_pred cceeeeeeeccCCcEEEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCc
Q 006004 219 VMKLEGLVTSRSGSLYLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 219 IV~l~~~~~~~~~~l~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~ 296 (665)
|.....+... ..||||||++|..+ ..... ...+++.++..++.|++.+|.+||. .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK---KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec---CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 8655544332 24899999998633 22222 3468889999999999999999999 9999999999999999 799
Q ss_pred EEEEecccceecC
Q 006004 297 LKIGDFGLATTYD 309 (665)
Q Consensus 297 lKL~DFGlA~~~~ 309 (665)
++|+|||+|....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=203.15 Aligned_cols=236 Identities=22% Similarity=0.322 Sum_probs=151.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCC----------CCcceeeeeee
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH----------PNVMKLEGLVT 227 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H----------pnIV~l~~~~~ 227 (665)
.+...+.||.|+++.||.++|.+||+.+|||+...... ....++.+.+|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 47788899999999999999999999999999866543 23356677777655544322 12222222111
Q ss_pred ---------ccC--C-----cEEEEEEeccccchhhhc---C-CCC--CCChhHHHHHHHHHHHHHHHHHhCCccccCCC
Q 006004 228 ---------SRS--G-----SLYLVFEYMEHDLAGLAT---T-PGI--KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIK 285 (665)
Q Consensus 228 ---------~~~--~-----~l~lV~Ey~~g~ll~~~~---~-~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK 285 (665)
... . +.+++|+-+.++|...+. . ... .+.......+..|++..+++||..||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 110 0 347788888887765433 1 111 12222334455899999999999999999999
Q ss_pred cccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCC-------cccCcccchhhhHHHHHHHHhCCC
Q 006004 286 GSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA-------TKYGAAIDMWSAGCILAELFAGKP 358 (665)
Q Consensus 286 PeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-------~~~~~~sDIWSLG~iLyeLltG~~ 358 (665)
|+|+|++.+|.++|+||+.....+... .....+..|.+||+.... ..++.+.|.|+||+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999887654321 113446789999976431 357889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC
Q 006004 359 IMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431 (665)
Q Consensus 359 pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R 431 (665)
||......... .. ......++|+.++.||..||..||.+|
T Consensus 249 Pf~~~~~~~~~----------------------------~~-----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP----------------------------EW-----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS----------------------------GG-----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc----------------------------cc-----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99765321000 00 112223789999999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=199.83 Aligned_cols=208 Identities=22% Similarity=0.306 Sum_probs=171.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++.++||+|+||+++.+.+.-+++.||||.=.... ..-.+..|....+.| ..+.|..+|.+-.... +-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-YNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccc-hhhhhh
Confidence 6999999999999999999999999999999754322 233466788888888 5788888877544432 457999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-----CcEEEEecccceecCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-----GVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-----g~lKL~DFGlA~~~~~~~ 312 (665)
|++..+|.+++.--+..|+...+.-++.|++.-++|+|++.+|+|||||+|+||... ..+.|+|||+|+.+....
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 999988877777677789999999999999999999999999999999999999754 469999999999875433
Q ss_pred CC------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 006004 313 NL------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR---TEVEQMHKI 372 (665)
Q Consensus 313 ~~------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~---~~~e~l~kI 372 (665)
.. ...+..||..||+=-..+| ...+..-|+=|||-+++++|.|..||+|. +..+.+++|
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 22 2345579999999888887 56789999999999999999999999875 445555555
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-22 Score=227.71 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=180.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecC--CCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFA--NMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~--~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.|...+.||.+.|=+|.+|++.+ |. |+||++-+. .+.-....+...|++ ...++|||++.+.-+..... ..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k-AAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK-AAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH-HHHHH
Confidence 58889999999999999999754 54 899987433 233333334445666 66679999999877655433 56899
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec--CCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~--~~~~~~ 314 (665)
-+|+.++|.+.+..+- .|.+-+-+.|+.||+.||.-||..||+|+|||.+||||+.-+.+.|+||..-+.. ..++..
T Consensus 100 RqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 9999999988776543 5888899999999999999999999999999999999999999999999876432 222222
Q ss_pred Ccccccc----cccccCcccccCCc----------ccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 315 PLTSRVV----TLWYRAPELLLGAT----------KYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 315 ~~~~~~g----T~~Y~APE~l~~~~----------~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
..+-+.. -..|+|||-+.... ..+++.||||+||+++||++ |+|||.- -|+-+..... ..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~-~~ 253 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN-AD 253 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-cc
Confidence 2222222 34599999885311 25788999999999999965 7899832 1221111100 00
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.. ..+.+... +...+.||..|++.||.+|.+|++.|+-
T Consensus 254 ~~---------------------e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DP---------------------EQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CH---------------------HHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 11112222 2368999999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=186.91 Aligned_cols=190 Identities=17% Similarity=0.148 Sum_probs=141.5
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH--HHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE--SVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.+...|++|+||+||.+.. .+..++.+.+........ ....+.+|+++|++|. |++|++++++ + ..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEEE
Confidence 4567899999999998765 677888777764433111 2235789999999995 5889999885 2 469999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCC-CcccEEEcCCCcEEEEecccceecCCCCCC--
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI-KGSNLLINNAGVLKIGDFGLATTYDPSQNL-- 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL-KPeNILld~~g~lKL~DFGlA~~~~~~~~~-- 314 (665)
||+.|..+..... .. ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9999977643321 11 2457899999999999999999999 799999999999999999999865433210
Q ss_pred --C--------cccccccccccCcccccCCcccC-cccchhhhHHHHHHHHhCCCCCCCCC
Q 006004 315 --P--------LTSRVVTLWYRAPELLLGATKYG-AAIDMWSAGCILAELFAGKPIMPGRT 364 (665)
Q Consensus 315 --~--------~~~~~gT~~Y~APE~l~~~~~~~-~~sDIWSLG~iLyeLltG~~pF~g~~ 364 (665)
. ..-...++.|+.|+.-.--...+ ...++++.|+-+|.++|+..++.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00113478888888653222233 66788899999999999998876654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-21 Score=198.50 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=174.7
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCC-----------------------------------cEEEEEEEec-C--CC
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETG-----------------------------------KIVALKKVRF-A--NM 196 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-----------------------------------~~vAiK~i~~-~--~~ 196 (665)
.+.++|++...||+|.-+.||.|+...+| -+.|||.+-. + ..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 34678999999999999999998754321 1356665421 1 11
Q ss_pred CHHHHHHHHHHHH------H--------HHh--------CCCCCcceeeeeeecc-------------------------
Q 006004 197 DPESVRFMAREIH------I--------LRK--------LDHPNVMKLEGLVTSR------------------------- 229 (665)
Q Consensus 197 ~~~~~~~~~~Ei~------i--------L~~--------L~HpnIV~l~~~~~~~------------------------- 229 (665)
....++.+.+|.- . .+. -+|||||++..+|.+.
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 2223344444431 0 111 2599999998877432
Q ss_pred -CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc--CCC--cEEEEeccc
Q 006004 230 -SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN--NAG--VLKIGDFGL 304 (665)
Q Consensus 230 -~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld--~~g--~lKL~DFGl 304 (665)
...+|+||.-....|..++-.+. .+.....-++.|+++|+.|||.+||.|||||.+||||. +++ .+.|+|||.
T Consensus 314 ~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 23589999988888777665543 56777888999999999999999999999999999984 333 689999997
Q ss_pred ceecCCC-CCCC----cccccccccccCcccccCCcc-----cCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 006004 305 ATTYDPS-QNLP----LTSRVVTLWYRAPELLLGATK-----YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 305 A~~~~~~-~~~~----~~~~~gT~~Y~APE~l~~~~~-----~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~ 374 (665)
+-.-+.. -..+ ....-|.-..||||+...-.. --.++|.|+.|.+.||+++...||.+..+...-..-++
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 6542210 0111 223346777899998753211 12478999999999999999999988543221111111
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH---HHHHh
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA---ASALR 439 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa---~eaL~ 439 (665)
.. .+......+++.+++||..+|..||.+|+++ +.+|+
T Consensus 472 -----------e~----------------qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 -----------ES----------------QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -----------hh----------------hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 00 1122334689999999999999999999984 44554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=212.09 Aligned_cols=176 Identities=30% Similarity=0.486 Sum_probs=131.6
Q ss_pred EEEEEEeccccchhhhcCC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 233 LYLVFEYMEHDLAGLATTP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
+||.|++|.-+.+..++.+ ....+......++.|+..|++| +|.+|||+||.||++..+..+||+|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 6777777776656555532 2345667888999999999999 999999999999999999999999999998775
Q ss_pred CCC-----CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCChhH
Q 006004 310 PSQ-----NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL-CGSPSEDY 383 (665)
Q Consensus 310 ~~~-----~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~-~g~p~~~~ 383 (665)
... ....+..+||++||+||.|.+ ..|+.++||||||+|||||+.- | .+..+.+.....+ -|..++++
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~---f--~T~~er~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQ---F--STQFERIATLTDIRDGIIPPEF 481 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHH---h--ccHHHHHHhhhhhhcCCCChHH
Confidence 444 234667799999999999997 7899999999999999999971 1 1222222222111 12233333
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
|. + .+...+|+..||.+.|.+||++.+.-.|+|.
T Consensus 482 ~~-------------------------d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQ-------------------------D-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hh-------------------------c-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22 1 2345689999999999999988887777764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=184.09 Aligned_cols=145 Identities=22% Similarity=0.242 Sum_probs=113.9
Q ss_pred CeeEEEEeeccCceEEEEEE-ECCCCcEEEEEEEecCCCC--------------------HH--HHHHHHHHHHHHHhCC
Q 006004 159 AFEKIDKIGQGTYSSVYKAR-DLETGKIVALKKVRFANMD--------------------PE--SVRFMAREIHILRKLD 215 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~--------------------~~--~~~~~~~Ei~iL~~L~ 215 (665)
-|.+.+.||+|+||.||+|. +..+|+.||||+++..... .. ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 7789999999999754311 00 1124578999999997
Q ss_pred CCC--cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC-ccccCCCcccEEEc
Q 006004 216 HPN--VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG-ILHRDIKGSNLLIN 292 (665)
Q Consensus 216 Hpn--IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g-IiHrDLKPeNILld 292 (665)
+.. +.+++. .. ..||||||++|+.+.........+.+.++..++.||+.+|.+||..| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~---~~--~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIA---WR--RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeE---ec--CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 533 333443 22 34899999999765444333345777788899999999999999999 99999999999999
Q ss_pred CCCcEEEEecccceecC
Q 006004 293 NAGVLKIGDFGLATTYD 309 (665)
Q Consensus 293 ~~g~lKL~DFGlA~~~~ 309 (665)
++.++|+|||+|....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=178.06 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=105.0
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-----CCCCcceeeeeeeccC--CcE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-----DHPNVMKLEGLVTSRS--GSL 233 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~~~~~~~--~~l 233 (665)
.-.+.||+|+|+.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++++++++.. +.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 3457899999999995 7777765 7999876432 2345688999999999 6799999999998864 343
Q ss_pred E-EEEEecc--ccchhhhcCCCCCCChhHHHHHHHHHHHHH-HHHHhCCccccCCCcccEEEcCC----CcEEEEecccc
Q 006004 234 Y-LVFEYME--HDLAGLATTPGIKFTEPQIKCYMQQLLRGL-EHCHSRGILHRDIKGSNLLINNA----GVLKIGDFGLA 305 (665)
Q Consensus 234 ~-lV~Ey~~--g~ll~~~~~~~~~lse~~i~~i~~QIl~aL-~~LH~~gIiHrDLKPeNILld~~----g~lKL~DFGlA 305 (665)
+ +||||+. ++.+..+.... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899944 54444444443 46666 46788888888 99999999999999999999743 37999995443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-20 Score=212.96 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=206.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLET-GKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV 236 (665)
.|.+.+.||+|+|+.|-++....+ ...+|+|.+............+..|..+-+.+. |+|++.+++...... ..+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-ccccc
Confidence 688899999999999999886443 346777777654434455566777999999997 999999999877654 67899
Q ss_pred EEeccccchhhhc-CCCC-CCChhHHHHHHHHHHHHHHHHH-hCCccccCCCcccEEEcCCC-cEEEEecccceecCC--
Q 006004 237 FEYMEHDLAGLAT-TPGI-KFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDP-- 310 (665)
Q Consensus 237 ~Ey~~g~ll~~~~-~~~~-~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~-- 310 (665)
++|..|+.+.... .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9998875554444 4443 6788899999999999999999 99999999999999999999 999999999998765
Q ss_pred CCCCCcccccc-cccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 311 SQNLPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 311 ~~~~~~~~~~g-T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
+........+| ++.|+|||...+....+...|+||+|+++..|++|..|+......+... ..|...+
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~~- 247 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSNK- 247 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeecccc-
Confidence 33334455688 9999999999876677899999999999999999998876544322100 0111110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...-...+..++..+.+++.++|..+|..|.+..++-.++|+..
T Consensus 248 ------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 ------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00012334578899999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=168.59 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=109.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE------SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.||+|++|.||+|++ +|..+++|+......... ....+.+|+.++..+.|++|.....++.... ..++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEE
Confidence 5799999999999987 677899998654332111 1235778999999999999877666655443 578999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
||++|..+..+.... .. +...++.+|+.+|.+||..|++|+|++|.|||++ ++.++|+|||++...
T Consensus 79 e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 79 EYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999986665554332 12 7889999999999999999999999999999999 789999999998763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=199.68 Aligned_cols=194 Identities=25% Similarity=0.323 Sum_probs=151.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l 233 (665)
.+.|.|-+.||+|+||+||+|.+.. |+.||||+=+..+..+-.+ =.+++.+|+ -+-|+.+..++.-.+ .-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~-~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQN-AS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCC-cc
Confidence 4569999999999999999999876 9999999877655332111 124455555 234455555444434 34
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-------CCcEEEEecccce
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-------AGVLKIGDFGLAT 306 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-------~g~lKL~DFGlA~ 306 (665)
+||+||.+.+.+..+....+-+++..+..+..|||..|++||..+|||+||||+|+||.. .--++|+|||-+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 799999996655555556678999999999999999999999999999999999999953 3359999999987
Q ss_pred ecCCC-CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCC
Q 006004 307 TYDPS-QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358 (665)
Q Consensus 307 ~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~ 358 (665)
.+..- ........++|-.+-.+|+..| ..+++.+|.|.|+.+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 65322 2234667788999999998887 789999999999999999999973
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=173.96 Aligned_cols=248 Identities=17% Similarity=0.215 Sum_probs=188.7
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
....+..++-+|.+...|..|++++.. ..+++|++..........+.|..|.-.|+-+.||||+.+++.+.... ++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-Cce
Confidence 334456677889999999999999854 45788888766666666677889999999999999999999998764 789
Q ss_pred EEEEeccc-cchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 235 LVFEYMEH-DLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 235 lV~Ey~~g-~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
++..||+- +|+..+... +.-....++..++..|+.|+.|||+.. |.---|....++||++-+.+|. .+-+++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs-- 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-- 340 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee--
Confidence 99999995 555555433 334677899999999999999999974 4444688889999998876663 2222211
Q ss_pred CCCCCcccccccccccCcccccCCcc--cCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGATK--YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~~--~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.....+.-.|.||+||.+..... --.++|+|||+++||||.|...||..-.+.+.-.+|.-.
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------- 404 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------- 404 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-------------
Confidence 01123345889999999975432 235799999999999999999999998888766665321
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
.....+++.++.....|+.-|+..||.+||....++
T Consensus 405 --------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 --------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 112234467889999999999999999999877653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=165.67 Aligned_cols=140 Identities=24% Similarity=0.230 Sum_probs=109.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH--------------------HHHHHHHHHHHHHHhCCCCC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP--------------------ESVRFMAREIHILRKLDHPN 218 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hpn 218 (665)
.|.+.+.||+|+||.||++... +|+.||||+++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3788899999999999999874 79999999987543110 01123567999999998874
Q ss_pred --cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 219 --VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 219 --IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
+..+++. +..++||||+.|..+..+.. ......++.+|+.++.++|..||+|+||||+||||+.++.
T Consensus 95 i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPIDW-----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceeec-----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4444431 24589999999876554332 1456788999999999999999999999999999999999
Q ss_pred EEEEecccceecCC
Q 006004 297 LKIGDFGLATTYDP 310 (665)
Q Consensus 297 lKL~DFGlA~~~~~ 310 (665)
++|+|||++.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999976644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.4e-17 Score=160.09 Aligned_cols=133 Identities=20% Similarity=0.240 Sum_probs=101.8
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEEecCCCC-H-----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMD-P-----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.||+|+||.||++.+ +|..|++|........ . .....+.+|+++++.+.|+++.....++.... ..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-NKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-CCEEEEE
Confidence 379999999999984 6788999986433211 1 12355778999999998887554443333333 5689999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
|++|..+..+...... .++.||+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9998665544332211 7899999999999999999999999999999 799999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=156.02 Aligned_cols=138 Identities=25% Similarity=0.267 Sum_probs=99.9
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF----------------------MAREIHILRKLDHPN-- 218 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hpn-- 218 (665)
.+.||+|+||.||+|.+. +|+.||||+++........... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 8999999998754322111111 135666777764433
Q ss_pred cceeeeeeeccCCcEEEEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCc
Q 006004 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 219 IV~l~~~~~~~~~~l~lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~ 296 (665)
+.+++++ ...++||||+.++... ...... ... .++..++.+++.++.++|. .||+|+||||+|||++ ++.
T Consensus 81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec-----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4444442 1358999999983221 111111 111 6788999999999999999 9999999999999999 899
Q ss_pred EEEEecccceecC
Q 006004 297 LKIGDFGLATTYD 309 (665)
Q Consensus 297 lKL~DFGlA~~~~ 309 (665)
++|+|||++....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=178.23 Aligned_cols=138 Identities=17% Similarity=0.136 Sum_probs=106.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-C-----HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-D-----PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~-----~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.|...+.||+|+||+||++.+... .+++|+...... . ......+.+|+++++.++|++|+....++.... .
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-E 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-C
Confidence 345678999999999999987443 455554322111 1 112346789999999999999988776665543 5
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
.++||||++|..+..... ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 689999999866554332 457899999999999999999999999999999 6789999999999764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-15 Score=154.75 Aligned_cols=137 Identities=16% Similarity=0.197 Sum_probs=102.3
Q ss_pred EEee-ccCceEEEEEEECCCCcEEEEEEEecCCC-----------CHHHHHHHHHHHHHHHhCCCCCc--ceeeeeeecc
Q 006004 164 DKIG-QGTYSSVYKARDLETGKIVALKKVRFANM-----------DPESVRFMAREIHILRKLDHPNV--MKLEGLVTSR 229 (665)
Q Consensus 164 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--V~l~~~~~~~ 229 (665)
..|| .|+.|+||.+.. .+..+|||.+..... .......+.+|+.++.+|.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 889999999876 367899998753221 11223457889999999998775 6666654433
Q ss_pred CCcE---EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 230 SGSL---YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 230 ~~~l---~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
.+.. +|||||++| ..+..+.... .+++. .+.||+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 3223 599999997 3444333332 45554 3678999999999999999999999999999999999999988
Q ss_pred ee
Q 006004 306 TT 307 (665)
Q Consensus 306 ~~ 307 (665)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 75
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=168.56 Aligned_cols=206 Identities=28% Similarity=0.400 Sum_probs=153.3
Q ss_pred HHhCCCCCcceeeeeeeccCCcEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCc-cccCCCccc
Q 006004 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI-LHRDIKGSN 288 (665)
Q Consensus 211 L~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gI-iHrDLKPeN 288 (665)
|+.+.|.|+.++++...+. ..+++|.+||.- .+.+.+......++.-....+++.|+.||.|||.--| .|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4678999999999998887 478999999985 5555555556788888999999999999999998865 999999999
Q ss_pred EEEcCCCcEEEEecccceecCCC-CCCCcccccccccccCcccccCCc------ccCcccchhhhHHHHHHHHhCCCCCC
Q 006004 289 LLINNAGVLKIGDFGLATTYDPS-QNLPLTSRVVTLWYRAPELLLGAT------KYGAAIDMWSAGCILAELFAGKPIMP 361 (665)
Q Consensus 289 ILld~~g~lKL~DFGlA~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~------~~~~~sDIWSLG~iLyeLltG~~pF~ 361 (665)
.++|....+||.|||+....... .........-..-|.|||++.+.. ..+.+.|+||+|++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998876421 111112222356699999987631 14677999999999999999999998
Q ss_pred CCCh----HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHH
Q 006004 362 GRTE----VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA 437 (665)
Q Consensus 362 g~~~----~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea 437 (665)
.... .+.+..+.+ .+. .+++..+.. ...+++++..++..|+..+|..||+++++
T Consensus 160 ~~~~~~~~~eii~~~~~-~~~--------------------~~~rP~i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKK-GGS--------------------NPFRPSIEL-LNELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred cccccCChHHHHHHHHh-cCC--------------------CCcCcchhh-hhhcchHHHHHHHHhcccChhhCccHHHH
Confidence 6432 233333322 011 011111111 11466689999999999999999999987
Q ss_pred Hh
Q 006004 438 LR 439 (665)
Q Consensus 438 L~ 439 (665)
-.
T Consensus 218 ~~ 219 (484)
T KOG1023|consen 218 RS 219 (484)
T ss_pred Hh
Confidence 54
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=136.94 Aligned_cols=133 Identities=24% Similarity=0.232 Sum_probs=109.6
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeeeeccCCcEEEEEEe
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
+++.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| .++++++.++... +..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEe
Confidence 45789999999999999744 6799998865432 3457889999999976 5888988877654 468999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC---CccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR---GILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
+.|..+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++|+|||++...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 998655432 5566778899999999999985 7999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-15 Score=169.00 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=199.4
Q ss_pred CCeeEEEEeec--cCceEEEEEEE--CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQ--GTYSSVYKARD--LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
..|.+...+|. |.+|.||.++. ..++..+|+|.-+.....+..-..=.+|+.-.+.+ .|+|.++.+..++... .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-I 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC-c
Confidence 35778889999 99999999998 89999999997332211112222234677777777 5999999888887754 8
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHH----HHHHHHhCCccccCCCcccEEEcCC-CcEEEEeccccee
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLR----GLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATT 307 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~----aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~ 307 (665)
+|+-+|++...+..........+++..++.++.+... ||.++|..+|+|-|+||+||++..+ ...+++|||+...
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 8999999999999998888877999999999999999 9999999999999999999999999 8899999999998
Q ss_pred cCCCCCCCc----ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCCh
Q 006004 308 YDPSQNLPL----TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR--TEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 308 ~~~~~~~~~----~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~--~~~e~l~kI~~~~g~p~~ 381 (665)
+........ ...-|..-|++||++.+ -++...|+|+||.++.+-.++..++... +.+.++..++
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------- 342 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------- 342 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--------
Confidence 865432111 11146778999998875 6899999999999999988887655443 3333332221
Q ss_pred hHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...+.....+..+..++..||+.||..|+++..+++|++...
T Consensus 343 ----------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ----------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ----------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 112233356666677999999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-15 Score=175.63 Aligned_cols=265 Identities=26% Similarity=0.302 Sum_probs=199.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..+.+.+++.+-+|.++.++.+.-..+|-..++|+...... .....+.+..+-.++-...+|.++....-+.... .++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-P~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-PLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-Ccc
Confidence 45678899999999999999999888887778877654432 2223344445555555556777776655544444 689
Q ss_pred EEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC--
Q 006004 235 LVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS-- 311 (665)
Q Consensus 235 lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~-- 311 (665)
|+++|+.++ +...+... ...+++-++.++..+..++++||...+.|+|++|.|+|+..+|..++.|||+.......
T Consensus 881 L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999864 44444433 36788888999999999999999999999999999999999999999999844322100
Q ss_pred -------------------C---------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC
Q 006004 312 -------------------Q---------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR 363 (665)
Q Consensus 312 -------------------~---------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~ 363 (665)
. .......++|+.|.+||.+++ ...+..+|+|++|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 001223468999999999987 56789999999999999999999999998
Q ss_pred ChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH---HHHhC
Q 006004 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA---SALRS 440 (665)
Q Consensus 364 ~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~---eaL~H 440 (665)
+.......|....- -| ..-....++.+.+++.++|..+|.+|..+. ++-.|
T Consensus 1039 tpq~~f~ni~~~~~-----~~---------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI-----PW---------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred chhhhhhccccCCC-----CC---------------------CCCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 88776665543210 01 111235788999999999999999999887 99999
Q ss_pred cCCCCCCCC
Q 006004 441 EFFKTEPLP 449 (665)
Q Consensus 441 p~f~~~~~~ 449 (665)
+||+...+.
T Consensus 1093 ~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1093 PFFQDVDWE 1101 (1205)
T ss_pred CccCCCCcc
Confidence 999976554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=144.37 Aligned_cols=143 Identities=20% Similarity=0.225 Sum_probs=96.1
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----------------------------H----HHH------HHH
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----------------------------E----SVR------FMA 205 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------------------~----~~~------~~~ 205 (665)
+.||.|++|.||+|+. .+|+.||||+.+...... + ... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 579999999987532100 0 000 133
Q ss_pred HHHHHHHhC----CCCCcceeeeeeeccCCcEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHH-HHHHHHhCCc
Q 006004 206 REIHILRKL----DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLR-GLEHCHSRGI 279 (665)
Q Consensus 206 ~Ei~iL~~L----~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~-aL~~LH~~gI 279 (665)
+|...+.++ .|.+-+.+-.++.......+|||||++|..+..+... ...+ ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 455555544 2333344434443333356899999998655433221 1112 23455666665 4788999999
Q ss_pred cccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 280 iHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
+|+|+||.|||++.+|.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=149.70 Aligned_cols=257 Identities=23% Similarity=0.227 Sum_probs=190.0
Q ss_pred CCccCCCCCeeEEEEeeccCceEEEEEEEC-CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 006004 151 GWQPRRADAFEKIDKIGQGTYSSVYKARDL-ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS 228 (665)
Q Consensus 151 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~ 228 (665)
.|......+|..+..||.|.|+.|+.+... .++..|++|.+.........-.+-..|+.+...| .|.+++..+..|..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 344555678999999999999999998765 6788999998765443333333345677777777 59999988877765
Q ss_pred cCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEeccccee
Q 006004 229 RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATT 307 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~ 307 (665)
-. ..||-.|||++....+...-...+.+...+.+..|++.++.++|...++|+|+||+||++..+ +..++.|||.+..
T Consensus 338 ~r-~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 338 LR-QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cc-cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 44 568999999987666555444468889999999999999999999999999999999999986 7889999999875
Q ss_pred cCCCCCCCccccccccccc-CcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 308 YDPSQNLPLTSRVVTLWYR-APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~-APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
+... ......+-++. ..|++.....+..++|++|||..+++.+++.+.-...+... .|..
T Consensus 417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~------------ 477 (524)
T KOG0601|consen 417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRS------------ 477 (524)
T ss_pred ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeec------------
Confidence 3221 12223445555 36666666788999999999999999999986443322111 1100
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
........+...+..+.+.++..|+..|+.+.++..|.=|-
T Consensus 478 -----------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 -----------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -----------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01111123447788899999999999999999998886554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-13 Score=152.13 Aligned_cols=144 Identities=18% Similarity=0.285 Sum_probs=99.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---------------------------CH-----HHHHHH--
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---------------------------DP-----ESVRFM-- 204 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---------------------------~~-----~~~~~~-- 204 (665)
.|+. +.||.|++|+||+|+.+.+|+.||||+++.... .. +..+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 799999999999999988899999999975310 00 111222
Q ss_pred ----HHHHHHHHhC----CCCCcceeeeeeeccCCcEEEEEEeccccchhhh---cCCCC---CCChhHHHHHHHHHHHH
Q 006004 205 ----AREIHILRKL----DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLA---TTPGI---KFTEPQIKCYMQQLLRG 270 (665)
Q Consensus 205 ----~~Ei~iL~~L----~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~---~~~~~---~lse~~i~~i~~QIl~a 270 (665)
.+|...+.++ .+.+.+.+-.+|.+-....+|||||+.|.-+..+ ...+. .+.+..+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 3344444443 2444455444444433456899999998654432 22221 355666666777765
Q ss_pred HHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceecCC
Q 006004 271 LEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTYDP 310 (665)
Q Consensus 271 L~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~~~ 310 (665)
..|++|+|+||.|||++.+| .++++|||++..++.
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 48999999999999999988 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-12 Score=127.14 Aligned_cols=140 Identities=18% Similarity=0.215 Sum_probs=101.1
Q ss_pred EEeeccCceEEEEEEECC------CCcEEEEEEEecCCC-----------C---------HHHHHHH----HHHHHHHHh
Q 006004 164 DKIGQGTYSSVYKARDLE------TGKIVALKKVRFANM-----------D---------PESVRFM----AREIHILRK 213 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~-----------~---------~~~~~~~----~~Ei~iL~~ 213 (665)
..||.|--+.||.|.... .+..+|||+.+.... + ......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 357899998863210 0 0111222 279999999
Q ss_pred CC--CCCcceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHH-HhCCccccCCCcccEE
Q 006004 214 LD--HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC-HSRGILHRDIKGSNLL 290 (665)
Q Consensus 214 L~--HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L-H~~gIiHrDLKPeNIL 290 (665)
|. .-++.+++++ . .-+|||||++++.+....-....+++.++..++.+++.+|..| |..||+|+||++.|||
T Consensus 83 l~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 83 MQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 84 3456666654 2 2489999998753321111222466677788899999999998 8999999999999999
Q ss_pred EcCCCcEEEEecccceecC
Q 006004 291 INNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 291 ld~~g~lKL~DFGlA~~~~ 309 (665)
++ ++.+.|+|||.+...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4789999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.2e-12 Score=122.67 Aligned_cols=128 Identities=16% Similarity=0.135 Sum_probs=95.0
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcc-eeeeeeeccCCcEEEEEEecc
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM-KLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. . .-++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--E-TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--C-CCeEEEEecC
Confidence 467899999999999863 77899998754321 122356899999998655544 4554332 2 3479999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCc-----cccCCCcccEEEcCCCcEEEEeccccee
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI-----LHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gI-----iHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
|..+... ......++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8654322 11123567899999999999985 9999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.3e-11 Score=133.58 Aligned_cols=184 Identities=20% Similarity=0.341 Sum_probs=134.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|.+ ...+-++.+..-.+..+.++.+|.|..++...- +......+-++-|+.|+||||+++++.++... .+|||+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeec
Confidence 444 333334443322456677888999998876543 44555778889999999999999999988754 89999999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH-hCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
+..= -..+. .+....+..-+.||+.||.||| +.+++|++|.-+-|+|+..|..||++|.++........ +...
T Consensus 91 V~Pl-~~~lk----~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~ 164 (690)
T KOG1243|consen 91 VRPL-ETVLK----ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKS 164 (690)
T ss_pred cccH-HHHHH----HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cccc
Confidence 8641 11111 2346778888999999999998 56899999999999999999999999999876543221 1122
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG 356 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG 356 (665)
..---.|..|+.+... ....|.|-|||++++++.|
T Consensus 165 ~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 2223447777765431 2567999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-12 Score=134.81 Aligned_cols=238 Identities=22% Similarity=0.238 Sum_probs=155.2
Q ss_pred EEEEEEECCCCcEEEEEEEecCCC-CHH-HHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcEEEEEEeccccchh
Q 006004 173 SVYKARDLETGKIVALKKVRFANM-DPE-SVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSLYLVFEYMEHDLAG 246 (665)
Q Consensus 173 ~Vy~a~~~~~g~~vAiK~i~~~~~-~~~-~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l~lV~Ey~~g~ll~ 246 (665)
.||++-+.+.|-.|+.-.+++... +.. .-.....-..-|-++.|-|||+++.|+.+.. ....++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 478888888887766655543221 111 1111222234456678999999999987642 2578999999965444
Q ss_pred hhc----CCCCCCChhHHHHHHHHHHHHHHHHHhC--CccccCCCcccEEEcCCCcEEEEecccceecCCCCCC----Cc
Q 006004 247 LAT----TPGIKFTEPQIKCYMQQLLRGLEHCHSR--GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL----PL 316 (665)
Q Consensus 247 ~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~--gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~----~~ 316 (665)
..+ .....+.....++|+.||+.||.|||+. -|+|+++..+-|++..+|-+||+--- -..+....+. ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhh
Confidence 333 2345688999999999999999999998 49999999999999999988874221 1111111110 01
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.--.+-++|.+||.=.. ...+.++|||++|....+|..+..- -.+....+.-..|....
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 11135688999996543 4567889999999999999887632 22222111111111110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
+..-..--+++|.+||+-.|..||++.++|.||.+-
T Consensus 300 -------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 300 -------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred -------------eeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 000011134689999999999999999999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.8e-10 Score=113.50 Aligned_cols=141 Identities=23% Similarity=0.287 Sum_probs=106.0
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeeeeccC--CcEEEEEEe
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKLEGLVTSRS--GSLYLVFEY 239 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~--~~l~lV~Ey 239 (665)
+.|+.|.++.||++... +|+.|++|+....... .....+.+|+.+++.+.+ .++.+++.+..... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 67899999999999864 3678999987643321 123457889999999965 44566776654321 356899999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS------------------------------------------- 276 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~------------------------------------------- 276 (665)
++|..+...... ..+++.+...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999766544321 357778888888888888888884
Q ss_pred -------------CCccccCCCcccEEEcC--CCcEEEEeccccee
Q 006004 277 -------------RGILHRDIKGSNLLINN--AGVLKIGDFGLATT 307 (665)
Q Consensus 277 -------------~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~ 307 (665)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 67789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-09 Score=118.82 Aligned_cols=214 Identities=20% Similarity=0.239 Sum_probs=155.1
Q ss_pred ceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEEEEEEeccc--cch
Q 006004 171 YSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLYLVFEYMEH--DLA 245 (665)
Q Consensus 171 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~lV~Ey~~g--~ll 245 (665)
-.+.|+|....+|..|++|.++-.... .......-+++++++.|+|||++.++|... +..+++|++|.++ .|+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 357899999999999999999433221 111223457889999999999999988743 4478999999885 344
Q ss_pred hhhcC--------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 246 GLATT--------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 246 ~~~~~--------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+++.. .+...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..++|..-|....+..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43332 2335789999999999999999999999999999999999999888888777766655443
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.. |.+.. -.+-|.=-||.+++.|.+|..--.-.+ ..+-..
T Consensus 447 ~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d-~~~~s~-------------------- 486 (655)
T KOG3741|consen 447 PT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTD-STQSSH-------------------- 486 (655)
T ss_pred CC---------------cchhH----HhhhhHHHHHHHHHHHhhccccccccc-chHHHH--------------------
Confidence 21 11222 245688899999999999963211111 111110
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+......++.+++++|.-+...++++ -++.++|.|
T Consensus 487 -------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 -------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11222467889999999999999987 788888876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-09 Score=103.90 Aligned_cols=143 Identities=17% Similarity=0.245 Sum_probs=101.4
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHH-----HHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPE-----SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~-----~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.+..|-+|+-+.|+++.+ .|+.+.||.-..... .+. ..++..+|+.+|.++.--.|.-..-+|.+.. .-.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-GGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-CCeE
Confidence 567888999999999986 688888886422221 111 2346788999999986444433333344433 3479
Q ss_pred EEEeccc--cchhhhcCCCCCCChhH-HHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEeccccee
Q 006004 236 VFEYMEH--DLAGLATTPGIKFTEPQ-IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATT 307 (665)
Q Consensus 236 V~Ey~~g--~ll~~~~~~~~~lse~~-i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~ 307 (665)
+|||++| .+.+.+......-.+++ ...++++|-+.|.-||.++|+|+||..+||||..+| .+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999998 44444443322223333 378999999999999999999999999999998765 358999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-09 Score=105.07 Aligned_cols=131 Identities=25% Similarity=0.294 Sum_probs=94.3
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHH-----HHHHHHHHHHHHhCCCC--CcceeeeeeeccCCcEEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPES-----VRFMAREIHILRKLDHP--NVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~-----~~~~~~Ei~iL~~L~Hp--nIV~l~~~~~~~~~~l~l 235 (665)
..+.+|+-+.+|.+.+ -|..+++|.-..... .++. .....+|..++..+.-- +...++++.. . .-.|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~-~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--D-NGLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--C-CCEE
Confidence 3578899999999965 344577775422221 2221 23567899999988543 3344454432 2 4579
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
+|||++|.++....... .-.++..+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998887555433 246777888888999999999999999999998765 99999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.4e-09 Score=102.51 Aligned_cols=128 Identities=25% Similarity=0.307 Sum_probs=85.6
Q ss_pred EEEEEEECCCCcEEEEEEEecCCC-----------------------CHH-HHHHHHHHHHHHHhCCCC--Ccceeeeee
Q 006004 173 SVYKARDLETGKIVALKKVRFANM-----------------------DPE-SVRFMAREIHILRKLDHP--NVMKLEGLV 226 (665)
Q Consensus 173 ~Vy~a~~~~~g~~vAiK~i~~~~~-----------------------~~~-~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~ 226 (665)
.||.|.. .+|..+|||+.+.... ... ......+|..+|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 5678999998863210 001 123467899999999755 566666542
Q ss_pred eccCCcEEEEEEecc--ccchhhhcCCCCCCChhHHHHHHHHHHHHHHH-HHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 227 TSRSGSLYLVFEYME--HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH-CHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 227 ~~~~~~l~lV~Ey~~--g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~-LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
+ -+|||||++ |..+..+... .++..+...++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus 80 --~---~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 --R---NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp --T---TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred --C---CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2 279999999 6555444332 23356778888999986655 579999999999999999987 89999999
Q ss_pred cceecC
Q 006004 304 LATTYD 309 (665)
Q Consensus 304 lA~~~~ 309 (665)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.1e-10 Score=126.23 Aligned_cols=158 Identities=23% Similarity=0.360 Sum_probs=118.5
Q ss_pred HHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc--------ccccccccCcccccCCc
Q 006004 265 QQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS--------RVVTLWYRAPELLLGAT 335 (665)
Q Consensus 265 ~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~--------~~gT~~Y~APE~l~~~~ 335 (665)
.+...||.|+|.. ++||+.|.|++|.++..|..||+.|+++.........+... ..-...|.|||++.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3444999999976 99999999999999999999999999987654422211111 123667999999987 6
Q ss_pred ccCcccchhhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcH
Q 006004 336 KYGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQ 414 (665)
Q Consensus 336 ~~~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~ 414 (665)
..+.++|+|||||++|.+. .|+..|.+.........-....+. .......++|+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------------------~~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------------------GAFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------------------ccccccccCcH
Confidence 7799999999999999998 777777665443333322111110 01112257999
Q ss_pred HHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 415 SALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 415 ~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
++++=|.++|..|+..||++.+++..|||.+...
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 9999999999999999999999999999987543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.6e-08 Score=102.24 Aligned_cols=131 Identities=17% Similarity=0.102 Sum_probs=89.3
Q ss_pred EEEEEECCCCcEEEEEEEecCCCCHHHHH----------HHHHHHHHHHhCCCCCc--ceeeeeeecc----CCcEEEEE
Q 006004 174 VYKARDLETGKIVALKKVRFANMDPESVR----------FMAREIHILRKLDHPNV--MKLEGLVTSR----SGSLYLVF 237 (665)
Q Consensus 174 Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~----------~~~~Ei~iL~~L~HpnI--V~l~~~~~~~----~~~l~lV~ 237 (665)
|+++.. .|+.|.||....... .+..+ .+.+|...+.+|..-+| ..+..+.+.. ...-+|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~-~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGW-GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcH-HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 555543 577899996632221 11111 36789888888843333 3344444332 12468999
Q ss_pred Eecccc-chhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-------CCcEEEEeccccee
Q 006004 238 EYMEHD-LAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-------AGVLKIGDFGLATT 307 (665)
Q Consensus 238 Ey~~g~-ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-------~g~lKL~DFGlA~~ 307 (665)
|++++. .+..+... ....++.....++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999984 33333221 234566778899999999999999999999999999999985 46899999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.5e-08 Score=98.16 Aligned_cols=138 Identities=26% Similarity=0.268 Sum_probs=103.0
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC--------------------HHHHHHHHHHHHHHHhCCCC--
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD--------------------PESVRFMAREIHILRKLDHP-- 217 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------~~~~~~~~~Ei~iL~~L~Hp-- 217 (665)
+.+...||-|--|.||.|.+. .|..+|||.-+..... .-......+|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999975 6889999976532110 01123457899999999644
Q ss_pred CcceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcE
Q 006004 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 218 nIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~l 297 (665)
.|.+.++. + .-.+||||++|-.+.... ++...+..++..|++-+..+-..||||+|+.+=|||++++|.+
T Consensus 172 ~VP~P~~~----n-RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 172 KVPKPIAW----N-RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCCcccc----c-cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 67776663 2 458999999995554322 2455566677777777777778999999999999999999999
Q ss_pred EEEecccceec
Q 006004 298 KIGDFGLATTY 308 (665)
Q Consensus 298 KL~DFGlA~~~ 308 (665)
.|+||--+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=7e-07 Score=96.04 Aligned_cols=245 Identities=14% Similarity=0.119 Sum_probs=152.8
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcce--------eeeeeeccCCcEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMK--------LEGLVTSRSGSLY 234 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~--------l~~~~~~~~~~l~ 234 (665)
+.||+|+-+.+|-.-.-. -.+.|++...... ... .-+..|... .||-+-. |++- ++...+-
T Consensus 17 r~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa-~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iG 86 (637)
T COG4248 17 RPLGQGGEADLYTLGEVR---DQVAKIYHAPPPA-AQA----QKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIG 86 (637)
T ss_pred ccccCCccceeeecchhh---chhheeecCCCch-HHH----HHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeE
Confidence 679999999999764322 2567877643211 111 122333333 5664432 2221 2222377
Q ss_pred EEEEecccc--chhhhc-----CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 235 LVFEYMEHD--LAGLAT-----TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 235 lV~Ey~~g~--ll~~~~-----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
++|..+.|. ...++. +.-..+.++.+....+.|+.+...||..|.+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 889988873 111111 1122367788999999999999999999999999999999999999999998765444
Q ss_pred cCCCCCCCcccccccccccCccccc-C---CcccCcccchhhhHHHHHHHHhC-CCCCCCCC-------hHHHHHHHHHh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLL-G---ATKYGAAIDMWSAGCILAELFAG-KPIMPGRT-------EVEQMHKIFKL 375 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~-~---~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~-------~~e~l~kI~~~ 375 (665)
... .......+|...|.+||.-. + .-.-+...|.|.||+++++||.| +.||.|.. ..|. .|...
T Consensus 167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g 242 (637)
T COG4248 167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHG 242 (637)
T ss_pred ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcc
Confidence 322 22344568999999999653 1 12346789999999999999877 89998742 1110 11111
Q ss_pred cCCCChhHHhhhccccccCCCCCCcchhh-hhhhccCCcHHHHHHHHHhccc--CcCCCcCHHH
Q 006004 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRK-VLETFRNFPQSALALVDKLLTI--EPENRGSAAS 436 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~s~~a~dLI~~lL~~--DP~~RpTa~e 436 (665)
.... ..+...+++.. ....+.-+++++..|..+|+.. ++.-|||++-
T Consensus 243 ~f~y--------------a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAY--------------ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeee--------------chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0000 00001111111 1122345789999999999874 3668999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.6e-09 Score=115.68 Aligned_cols=246 Identities=19% Similarity=0.146 Sum_probs=168.1
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeeeeccCCcEEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN-VMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~~l~lV~E 238 (665)
|.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++. +...+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhh
Confidence 556677899999999999987766555 6766532 22345899999999999 5554444443 337889999
Q ss_pred ecccc--chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 239 YMEHD--LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 239 y~~g~--ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
++.++ ...........|.+-+.....+.-+.+|++||+.-=+|+| |||..+ +..|+.||+.+..+.... ..
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 99875 2222222333456666777778888999999988778998 887766 778999999988775443 24
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
.+..+|+.++|||++.. ..+....|.|++|+--.+|.-|-+|-...- .... ..|..+.. ++.+
T Consensus 388 ~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p~s-------~~L~--- 450 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGPNS-------PMLT--- 450 (829)
T ss_pred ccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCCCc-------cccc---
Confidence 56689999999998876 678999999999988778877777654310 0000 00111000 0000
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
-+..+ -+..-.++...||..-|..|++...++.|.+|..-++
T Consensus 451 ----~~~aw------~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 451 ----DKSAW------SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ----hhhhc------CcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 00000 0011115778899999999999999999999987554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.8e-07 Score=92.61 Aligned_cols=106 Identities=19% Similarity=0.160 Sum_probs=79.6
Q ss_pred HHHHHHHHHHhCCCC--CcceeeeeeeccC---CcEEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh
Q 006004 203 FMAREIHILRKLDHP--NVMKLEGLVTSRS---GSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276 (665)
Q Consensus 203 ~~~~Ei~iL~~L~Hp--nIV~l~~~~~~~~---~~l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~ 276 (665)
...+|...+..|..- .+.+.+.+..... ...+||+|++++. .+..+......++......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 467888888887433 3344555544432 2358999999973 344444332236777889999999999999999
Q ss_pred CCccccCCCcccEEEcCCC---cEEEEecccceec
Q 006004 277 RGILHRDIKGSNLLINNAG---VLKIGDFGLATTY 308 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~~ 308 (665)
.||+|+|+++.|||++.++ .+.|+||+.+...
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.9e-06 Score=85.64 Aligned_cols=140 Identities=20% Similarity=0.269 Sum_probs=98.9
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC--------------------HHHHH--HHHHHHHHHHhCC--CCC
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD--------------------PESVR--FMAREIHILRKLD--HPN 218 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------~~~~~--~~~~Ei~iL~~L~--Hpn 218 (665)
...|..|--+.||+|.. .++..+|+|+++..... ..... -..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777888999999985 56889999998743211 11111 1235777788873 445
Q ss_pred cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcE
Q 006004 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 219 IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~l 297 (665)
+.+-+.+.. -.|||||++.+..-.-.-....+...++..+..+++..+.-|-. .|+||+||..=|||+. ++.+
T Consensus 132 vP~Pi~~~~-----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN-----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC-----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 555565432 37999999865221111122234455788889999999988877 8999999999999999 7899
Q ss_pred EEEecccceecC
Q 006004 298 KIGDFGLATTYD 309 (665)
Q Consensus 298 KL~DFGlA~~~~ 309 (665)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=6e-06 Score=82.51 Aligned_cols=139 Identities=23% Similarity=0.304 Sum_probs=80.7
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCC--Ccceeeeeeecc--CCcEEEEEE
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP--NVMKLEGLVTSR--SGSLYLVFE 238 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~~~~--~~~l~lV~E 238 (665)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|... .+.+++.+.... ....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999999754 48999987532 3455677899998888433 345666533222 345799999
Q ss_pred eccccchhh--------------------hcCC---CCCCChhH---------HHHH------------HHHHHH-HHHH
Q 006004 239 YMEHDLAGL--------------------ATTP---GIKFTEPQ---------IKCY------------MQQLLR-GLEH 273 (665)
Q Consensus 239 y~~g~ll~~--------------------~~~~---~~~lse~~---------i~~i------------~~QIl~-aL~~ 273 (665)
+++|..+.. +.+. ...+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999853333 0011 01110000 0000 111222 2333
Q ss_pred HH-------hCCccccCCCcccEEEc-CCCcEEEEeccccee
Q 006004 274 CH-------SRGILHRDIKGSNLLIN-NAGVLKIGDFGLATT 307 (665)
Q Consensus 274 LH-------~~gIiHrDLKPeNILld-~~g~lKL~DFGlA~~ 307 (665)
++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33 24699999999999999 667678999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.8e-06 Score=83.06 Aligned_cols=138 Identities=15% Similarity=0.185 Sum_probs=96.4
Q ss_pred eccCceEEEEEEECCCCcEEEEEEEecC---CCC-HHHHHHHHHHHHHHHhCCCC--Ccceeeeeeecc----CCcEEEE
Q 006004 167 GQGTYSSVYKARDLETGKIVALKKVRFA---NMD-PESVRFMAREIHILRKLDHP--NVMKLEGLVTSR----SGSLYLV 236 (665)
Q Consensus 167 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~-~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~~~~----~~~l~lV 236 (665)
|.||-|.|+.... .|+.|-+|.-... ... +--...+.+|+..|++|..- .+.++. ++... .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4588888998764 3446888865311 110 22234588999999998532 244444 22211 1235799
Q ss_pred EEeccc--cchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc--EEEEeccccee
Q 006004 237 FEYMEH--DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV--LKIGDFGLATT 307 (665)
Q Consensus 237 ~Ey~~g--~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~--lKL~DFGlA~~ 307 (665)
+|-++| +|...+.... .+.++.+...++.+|+..|.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999985 4544443321 24677778899999999999999999999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.2e-06 Score=82.37 Aligned_cols=139 Identities=21% Similarity=0.243 Sum_probs=89.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH-HHHH------HHHHHHHHHhCC---CCCcceeeeeee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE-SVRF------MAREIHILRKLD---HPNVMKLEGLVT 227 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~------~~~Ei~iL~~L~---HpnIV~l~~~~~ 227 (665)
.+|.+++.+-......|.+..- +|+.+++|..+......+ .... ..+++..+.++. .-.+..++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3799999998888888887764 678899998764332111 1111 234444444442 222233222222
Q ss_pred cc----CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 228 SR----SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 228 ~~----~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.. ....+|||||++|--+..+.. +++ .+...|.++|.-||..|++|+|++|.|+++++++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 11 123568999999965443321 232 2445677889999999999999999999999655 9999998
Q ss_pred ccee
Q 006004 304 LATT 307 (665)
Q Consensus 304 lA~~ 307 (665)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 6553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.1e-06 Score=95.79 Aligned_cols=143 Identities=18% Similarity=0.248 Sum_probs=86.7
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCC---------------------------CCHH-HH----HH------HH
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFAN---------------------------MDPE-SV----RF------MA 205 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---------------------------~~~~-~~----~~------~~ 205 (665)
..|+.++-|+||+|+. .+|+.||||+.+..- .... .+ +. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5899999999999996 459999999987321 1100 01 11 23
Q ss_pred HHHHHHHhC----CCCCcceeeeeeeccCCcEEEEEEeccccchhh---hcCCCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 006004 206 REIHILRKL----DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278 (665)
Q Consensus 206 ~Ei~iL~~L----~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~---~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g 278 (665)
+|..-+.++ ....-+.+=.+|.+-.+.-.|+|||++|--+.. +... .++...+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhcC
Confidence 344444443 222222333333333335589999999833222 2222 234323222222221 22233479
Q ss_pred ccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 279 IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
++|.|.+|.||+++.+|.+.+.|||+...+++.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.5e-05 Score=78.00 Aligned_cols=128 Identities=26% Similarity=0.346 Sum_probs=91.4
Q ss_pred CCeeEEEEeeccCc-eEEEEEEECCCCcEEEEEEEec---CC-------CCH---------HHHHHHHHHHHHHHhCC--
Q 006004 158 DAFEKIDKIGQGTY-SSVYKARDLETGKIVALKKVRF---AN-------MDP---------ESVRFMAREIHILRKLD-- 215 (665)
Q Consensus 158 ~~y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~~-------~~~---------~~~~~~~~Ei~iL~~L~-- 215 (665)
.+++.++.||.|.- |.||+++. +|+.||||+.+. .. ... ....-|..|..+.-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999986 788999999432 10 000 11234667888877774
Q ss_pred -CCCc--ceeeeeeecc-----------------CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH
Q 006004 216 -HPNV--MKLEGLVTSR-----------------SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275 (665)
Q Consensus 216 -HpnI--V~l~~~~~~~-----------------~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH 275 (665)
+.++ |++++++.-. .....||.||+.... .++. .-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8888877311 112467888876543 2232 33567788889999
Q ss_pred hCCccccCCCcccEEEcCCCcEEEEecccc
Q 006004 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 276 ~~gIiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
..||+-+|+++.|.. .=||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 3489999964
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.5e-05 Score=81.31 Aligned_cols=133 Identities=19% Similarity=0.139 Sum_probs=79.6
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC--cceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN--VMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
..||+|..+.||+. .|..+++|..+... . ...+.+|.++++.+..-. +.+.+.+.... +..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDG-GRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecC-CeeeeeeeecC
Confidence 57899999999984 24468889876422 2 233578999999985433 35566655443 35789999999
Q ss_pred ccc-hhh----------------------hcC---CCCCCChhHHHHHHHHH----------HH-HHHHHH----hCCcc
Q 006004 242 HDL-AGL----------------------ATT---PGIKFTEPQIKCYMQQL----------LR-GLEHCH----SRGIL 280 (665)
Q Consensus 242 g~l-l~~----------------------~~~---~~~~lse~~i~~i~~QI----------l~-aL~~LH----~~gIi 280 (665)
|.. ... +.. ....++. ....+..+| .. ...+|. ...++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 851 110 111 0001110 000110000 01 111222 12478
Q ss_pred ccCCCcccEEEcCCCcEEEEeccccee
Q 006004 281 HRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 281 HrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
|+|+.|.||+++.++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.3e-06 Score=79.59 Aligned_cols=132 Identities=23% Similarity=0.220 Sum_probs=93.0
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
.+..+.|++|++|.||++.+ .|..+|+|+-+.+. ....+..|.++|..+.--++..=+..+. ...+.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence 45678899999999999997 45689999876433 3456788999999998777754333222 23566999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCC-cccEEEcCCCcEEEEecccceec
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIK-GSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK-PeNILld~~g~lKL~DFGlA~~~ 308 (665)
+.|-.+..+.... . ++-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|+.-
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9984443332211 1 2334556666556778899999998 66555666669999999999854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=91.05 Aligned_cols=143 Identities=17% Similarity=0.166 Sum_probs=89.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-----------------------------HHHHHH------HHHHH
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-----------------------------PESVRF------MAREI 208 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----------------------------~~~~~~------~~~Ei 208 (665)
+.||.-+.|.||+|+-+. |+.||||+-+..-.. .+..+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999655 999999987632100 011111 22232
Q ss_pred H----HHHhCCCCC---cceeeeeeeccCCcEEEEEEecccc---chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 006004 209 H----ILRKLDHPN---VMKLEGLVTSRSGSLYLVFEYMEHD---LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278 (665)
Q Consensus 209 ~----iL~~L~Hpn---IV~l~~~~~~~~~~l~lV~Ey~~g~---ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g 278 (665)
+ +.+.+.|-+ -|.+=.+|.+-...-.|+||||+|. .+..+...+ ++...+...+.++..-+ |-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHHHH--HHhcC
Confidence 2 223334555 2223334444334568999999983 333444443 55555555444443322 33458
Q ss_pred ccccCCCcccEEEcC----CCcEEEEecccceecCCC
Q 006004 279 ILHRDIKGSNLLINN----AGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 279 IiHrDLKPeNILld~----~g~lKL~DFGlA~~~~~~ 311 (665)
++|.|-+|.|||++. ++.+.|.|||+...+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999994 568999999998876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.8e-05 Score=91.71 Aligned_cols=146 Identities=25% Similarity=0.386 Sum_probs=91.5
Q ss_pred EEEEeeccCceEEEEEEECCCC--cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCc--ceeeeeeecc--CCcEE
Q 006004 162 KIDKIGQGTYSSVYKARDLETG--KIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNV--MKLEGLVTSR--SGSLY 234 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--V~l~~~~~~~--~~~l~ 234 (665)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+. .+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3678899999999998764432 46888876543221 12345789999999995 6665 6777766543 24678
Q ss_pred EEEEeccccchhh------------------------hcCCC----------CC--CChhHHHHHHHH------------
Q 006004 235 LVFEYMEHDLAGL------------------------ATTPG----------IK--FTEPQIKCYMQQ------------ 266 (665)
Q Consensus 235 lV~Ey~~g~ll~~------------------------~~~~~----------~~--lse~~i~~i~~Q------------ 266 (665)
+||||++|..+.. +..-. .+ +...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999853210 11100 00 111233332222
Q ss_pred ---HHHHHHHHHh-----------CCccccCCCcccEEEcCC-C-cEEEEecccceec
Q 006004 267 ---LLRGLEHCHS-----------RGILHRDIKGSNLLINNA-G-VLKIGDFGLATTY 308 (665)
Q Consensus 267 ---Il~aL~~LH~-----------~gIiHrDLKPeNILld~~-g-~lKL~DFGlA~~~ 308 (665)
+...+.+|.. ..+||+|+++.|||++.+ + .+-|+||+++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556632 249999999999999853 3 4679999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=5e-05 Score=77.76 Aligned_cols=135 Identities=15% Similarity=0.115 Sum_probs=78.9
Q ss_pred EeeccCc-eEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 165 KIGQGTY-SSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 165 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
.|-.|.. +.||++... +..+.||+..... ...+.+|+.+++.|. +--+.+++.+.... +..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCC
Confidence 3444444 789999753 3678888765332 234567999988883 44455677766543 357899999998
Q ss_pred cchhhhc--------------------CC---CCCCChh------HHHHHHH----------------HHHHHHHHH---
Q 006004 243 DLAGLAT--------------------TP---GIKFTEP------QIKCYMQ----------------QLLRGLEHC--- 274 (665)
Q Consensus 243 ~ll~~~~--------------------~~---~~~lse~------~i~~i~~----------------QIl~aL~~L--- 274 (665)
..+.... .. ..++... .....+. .+...+..|
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 5333111 00 0011100 0000000 011111222
Q ss_pred ----HhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 275 ----HSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 275 ----H~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999988888999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.5e-05 Score=93.22 Aligned_cols=204 Identities=21% Similarity=0.201 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeeeeccC--C-cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC
Q 006004 201 VRFMAREIHILRKLDHPNVMKLEGLVTSRS--G-SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277 (665)
Q Consensus 201 ~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--~-~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~ 277 (665)
+....-|+..+..+.|+|++.++.|-..+. + .+.+..+++....+....+.-...+...++.+..++++||.|+|..
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334445777788889999999988755432 2 2334557777765555666666789999999999999999999999
Q ss_pred CccccCCCcc---cEEEcCCCcEEEE--ecccceecCCCCCCCcccccccccccCcccccCCcccCc--ccchhhhHHHH
Q 006004 278 GILHRDIKGS---NLLINNAGVLKIG--DFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA--AIDMWSAGCIL 350 (665)
Q Consensus 278 gIiHrDLKPe---NILld~~g~lKL~--DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~--~sDIWSLG~iL 350 (665)
...|.-|... +-.++.++.+.+. ||+....+..... .....-+..|.++|.... ..+.. ..|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence 6666555444 4444556667766 8888776643322 122234566788887764 33333 46999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccC-CcHHHHHHHHHhcccCcC
Q 006004 351 AELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRN-FPQSALALVDKLLTIEPE 429 (665)
Q Consensus 351 yeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~s~~a~dLI~~lL~~DP~ 429 (665)
..+..|..+-.- ...+ ...... ......+++.+|+.-|++
T Consensus 383 ~~~~~~~~i~~~------~~~~---------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 383 LQLSQGEDISEK------SAVP---------------------------------VSLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhcCccccc------ccch---------------------------------hhhhccccchhhhhhhhhhcchhhh
Confidence 999887642100 0000 000111 122677899999999999
Q ss_pred CCcCHHHHHhCcCCCCC
Q 006004 430 NRGSAASALRSEFFKTE 446 (665)
Q Consensus 430 ~RpTa~eaL~Hp~f~~~ 446 (665)
+|+.+.++|.|+|.+..
T Consensus 424 ~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFP 440 (1351)
T ss_pred hccchhhhhhchhcccc
Confidence 99999999999998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00014 Score=74.29 Aligned_cols=31 Identities=26% Similarity=0.395 Sum_probs=26.3
Q ss_pred CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999999776667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=4.4e-06 Score=101.10 Aligned_cols=257 Identities=13% Similarity=0.012 Sum_probs=162.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEE---ecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CC
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKV---RFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i---~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~ 231 (665)
+...|++.=-++-|.++..-.-+.+.++ +-+|+. .+.++.+...+.+..|...++...|+++...+.-.... +.
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 3445666666666665544333333333 334433 34444445555666777777778999988766544433 44
Q ss_pred cEEEEEEeccccch-hhhcCC---CCCCChhHHHHHHHHHHHHHHHHHhC-----CccccCCCcccEEEcCCCcEEEEec
Q 006004 232 SLYLVFEYMEHDLA-GLATTP---GIKFTEPQIKCYMQQLLRGLEHCHSR-----GILHRDIKGSNLLINNAGVLKIGDF 302 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~-----gIiHrDLKPeNILld~~g~lKL~DF 302 (665)
..|++++|+.++.+ ..+.+. ...+.+.-+.+...+.+.+..-+|.. -.+|++||+-|.+|..+..+|++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 57899999986544 444432 22355555666666667888887764 2899999999999999999999999
Q ss_pred ccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 303 GLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 303 GlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
|+.+...+ ........++++.|+.|++... ..++.++|+|..|+.+|++..|.++| ...+..+.+..- ...
T Consensus 1385 gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f-----i~flq~~Lkgii--dn~ 1455 (2724)
T KOG1826|consen 1385 GLDKIKNP-VLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF-----IFFLQPALKGII--DNH 1455 (2724)
T ss_pred ccccccCc-hHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH-----HHHHHHHHcCcc--ccc
Confidence 99983322 2223455577899999997654 66788899999999999999998776 223333322110 000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
+ ......-.|.++-.+...+|-+.-..||.-...+.-+.|.
T Consensus 1456 ----------t-----------f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1456 ----------T-----------FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ----------c-----------cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 0 0011112244444555556666667788888888777764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.001 Score=66.66 Aligned_cols=131 Identities=21% Similarity=0.226 Sum_probs=88.6
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCC--------------CCHHHHHHHHHHHHHHHhCC------CCCccee
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFAN--------------MDPESVRFMAREIHILRKLD------HPNVMKL 222 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIV~l 222 (665)
...||+|+.=.||.-- .....+||+++... ......+...+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3578999999999843 34457899987655 11112344566776666665 8899999
Q ss_pred eeeeeccCCcEEEEEEeccc------cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-
Q 006004 223 EGLVTSRSGSLYLVFEYMEH------DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG- 295 (665)
Q Consensus 223 ~~~~~~~~~~l~lV~Ey~~g------~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g- 295 (665)
++++++.- -+-+|+|.+.. -++..+...+ .+++ .+.. .|-+-..||-+.+|+.+||+|.||++....
T Consensus 83 ~G~veT~~-G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNL-GLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCC-ceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99998865 47899999763 1333333333 3555 3333 344455678889999999999999997432
Q ss_pred ---cEEEEec
Q 006004 296 ---VLKIGDF 302 (665)
Q Consensus 296 ---~lKL~DF 302 (665)
.+.|+|-
T Consensus 157 ~~~~lvlIDG 166 (199)
T PF10707_consen 157 GEFRLVLIDG 166 (199)
T ss_pred CceEEEEEeC
Confidence 4777773
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00091 Score=71.13 Aligned_cols=142 Identities=20% Similarity=0.232 Sum_probs=82.0
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC--cceeeee-----eeccCCc
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN--VMKLEGL-----VTSRSGS 232 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~-----~~~~~~~ 232 (665)
...++.|+.|....+|++.. .+| .+++|+.+... . ...+..|++++..|.... +.+++.. +..-.+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 44567788888889999864 344 58899875421 1 223456777777774222 3343331 1112346
Q ss_pred EEEEEEeccccchh---------------hhcCCCCCCCh--------h---H--HH----------HHHHHHHHHHHHH
Q 006004 233 LYLVFEYMEHDLAG---------------LATTPGIKFTE--------P---Q--IK----------CYMQQLLRGLEHC 274 (665)
Q Consensus 233 l~lV~Ey~~g~ll~---------------~~~~~~~~lse--------~---~--i~----------~i~~QIl~aL~~L 274 (665)
.+++|+|++|.... .+......++. . . .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999873210 11110001100 0 0 00 0111233345555
Q ss_pred Hh-------CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 275 HS-------RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 275 H~-------~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 32 5899999999999999988778999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.001 Score=67.53 Aligned_cols=73 Identities=16% Similarity=0.201 Sum_probs=46.4
Q ss_pred EEEeeccCceEEEEEEECC-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeeeeccCCcEEEEEEec
Q 006004 163 IDKIGQGTYSSVYKARDLE-TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN-VMKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~~l~lV~Ey~ 240 (665)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+.... ..+++..+. . .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ--N---GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C---cEEEEee
Confidence 4677788888999997543 356799997653211 1112347888999885333 445544322 2 4799999
Q ss_pred ccc
Q 006004 241 EHD 243 (665)
Q Consensus 241 ~g~ 243 (665)
+|.
T Consensus 75 ~G~ 77 (235)
T cd05157 75 PGR 77 (235)
T ss_pred CCC
Confidence 874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00067 Score=70.14 Aligned_cols=132 Identities=23% Similarity=0.302 Sum_probs=75.2
Q ss_pred eeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEEEEEEeccccc
Q 006004 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLYLVFEYMEHDL 244 (665)
Q Consensus 166 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~lV~Ey~~g~l 244 (665)
+..|-...+|+.. .+++.+++|......... .+ ...+|..+++.+....+ .+++... . -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~---~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN--E---HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe--C---CEEEEEeccCcc
Confidence 4557778899887 356678898754321110 01 24678999998854333 3333322 1 268999999843
Q ss_pred hhh------------------hcCC---CCCCCh-hHHHHHHHHH---------HHHHHHHHh--------CCccccCCC
Q 006004 245 AGL------------------ATTP---GIKFTE-PQIKCYMQQL---------LRGLEHCHS--------RGILHRDIK 285 (665)
Q Consensus 245 l~~------------------~~~~---~~~lse-~~i~~i~~QI---------l~aL~~LH~--------~gIiHrDLK 285 (665)
+.. +... +.+++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 221 1111 111111 1222332222 111222211 258999999
Q ss_pred cccEEEcCCCcEEEEeccccee
Q 006004 286 GSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 286 PeNILld~~g~lKL~DFGlA~~ 307 (665)
|.|||++.++ +.|+||..|..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0024 Score=67.83 Aligned_cols=78 Identities=17% Similarity=0.215 Sum_probs=54.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC---CCcceeeeeeecc--CCcEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH---PNVMKLEGLVTSR--SGSLY 234 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~~~~~--~~~l~ 234 (665)
-.-.+.||.|..+.||.... .++ .+++|..+. .. ....+..|...|+.|.- -.+.++++++... .+..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD-SQG-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEc-CCC-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567899999999999864 233 477777432 11 12357889999998843 3577777766543 34679
Q ss_pred EEEEecccc
Q 006004 235 LVFEYMEHD 243 (665)
Q Consensus 235 lV~Ey~~g~ 243 (665)
||||+++|.
T Consensus 90 LVmE~i~G~ 98 (297)
T PRK10593 90 LLLERLRGV 98 (297)
T ss_pred EEEeccCCE
Confidence 999999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0033 Score=67.08 Aligned_cols=31 Identities=29% Similarity=0.475 Sum_probs=26.7
Q ss_pred CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.|++|+|++|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999999766668999998753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.001 Score=66.10 Aligned_cols=100 Identities=25% Similarity=0.206 Sum_probs=77.8
Q ss_pred HHHHHHHHhCCC-CCcceeeeeeeccCCcEEEEEEecccc-chhhh--cCCCCCCChhHHHHHHHHHHHHHHHHHh---C
Q 006004 205 AREIHILRKLDH-PNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLA--TTPGIKFTEPQIKCYMQQLLRGLEHCHS---R 277 (665)
Q Consensus 205 ~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~l~lV~Ey~~g~-ll~~~--~~~~~~lse~~i~~i~~QIl~aL~~LH~---~ 277 (665)
..|.-+|+.+.+ +++.+++|++- . ++|.||+... ++... ...-...++..+..++.+++..+++|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999966 69999999762 3 5789999853 32211 1111246889999999999999999998 3
Q ss_pred CccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 278 gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+.-.|++++|+-|+++|.+|++|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 47779999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00028 Score=74.64 Aligned_cols=137 Identities=18% Similarity=0.206 Sum_probs=95.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHH--------------------HHHHHHHHHHHHhCC-CC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES--------------------VRFMAREIHILRKLD-HP 217 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--------------------~~~~~~Ei~iL~~L~-Hp 217 (665)
-+.+...||-|--+.||.+-+ ..|+.+++|+-++....-.. .-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 366788999999999999986 56889999976543211100 112457888888883 33
Q ss_pred C-cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 218 N-VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 218 n-IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
. +.+.+++ +.-++|||++.|-.+..... ...+..+...|..-+--|-.+|+||+|..-=||+|++++.
T Consensus 172 fpVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 172 FPVPKPIDH-----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCcccc-----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2 3344442 24589999999854433321 1123445556666677788999999999999999999999
Q ss_pred EEEEeccccee
Q 006004 297 LKIGDFGLATT 307 (665)
Q Consensus 297 lKL~DFGlA~~ 307 (665)
++++||--...
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999975543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0035 Score=67.50 Aligned_cols=143 Identities=22% Similarity=0.303 Sum_probs=98.8
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC----------------------CCHH-HHHH-HHHHHHHHHhCCC
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN----------------------MDPE-SVRF-MAREIHILRKLDH 216 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~----------------------~~~~-~~~~-~~~Ei~iL~~L~H 216 (665)
++-..|..|--+.||.|.. .+|..+|||+++..- .++. -++- ...|+.-|++|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3446788899999999985 678889999886211 0111 1221 2357778888865
Q ss_pred CCcceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH-hCCccccCCCcccEEEcCCC
Q 006004 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNAG 295 (665)
Q Consensus 217 pnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKPeNILld~~g 295 (665)
..|.-..-... . .-.|||+|+..+-+..-.-....++...+..+-.|++.-+.-|- ..++||.||.-=|+|+-+ |
T Consensus 226 aGIP~PePIlL-k--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 226 AGIPCPEPILL-K--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G 301 (520)
T ss_pred cCCCCCCceee-e--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence 44432222221 1 23799999997555443334457888888888888888777764 569999999999999876 7
Q ss_pred cEEEEecccceec
Q 006004 296 VLKIGDFGLATTY 308 (665)
Q Consensus 296 ~lKL~DFGlA~~~ 308 (665)
.+.|+|-+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999998876543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0042 Score=65.37 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=81.6
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC--cceeeee-----eeccCCcE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN--VMKLEGL-----VTSRSGSL 233 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~-----~~~~~~~l 233 (665)
.-++.|..|....+|++.. ++..+++|+... .. ...+..|+.++..|.+.. +.+++.. +..-.+..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3466788888889999864 334689998753 11 234567888888874322 4444331 11113456
Q ss_pred EEEEEeccccchhh---------------hcCCCCCCCh--------hHH------------HHHHHHHHHHHHHHHh--
Q 006004 234 YLVFEYMEHDLAGL---------------ATTPGIKFTE--------PQI------------KCYMQQLLRGLEHCHS-- 276 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~---------------~~~~~~~lse--------~~i------------~~i~~QIl~aL~~LH~-- 276 (665)
++||+|++|..... +......+.. ... ......+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999843211 1100000000 000 0011112233444443
Q ss_pred -----CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 -----RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 -----~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987789999997753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0047 Score=68.24 Aligned_cols=78 Identities=22% Similarity=0.175 Sum_probs=53.1
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecC-C---C-CHHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcE
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFA-N---M-DPESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~---~-~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l 233 (665)
..+.||.|.+..||++.+...++.|+||.-... . . .+-...+...|.+.|+.+. -.++.+++.+.. . ..
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~-~~ 106 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E-LA 106 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C-CC
Confidence 357899999999999998544368999975311 0 0 0123455677888888862 345777777532 2 45
Q ss_pred EEEEEeccc
Q 006004 234 YLVFEYMEH 242 (665)
Q Consensus 234 ~lV~Ey~~g 242 (665)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0013 Score=73.29 Aligned_cols=172 Identities=23% Similarity=0.319 Sum_probs=114.6
Q ss_pred HHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccC
Q 006004 204 MAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283 (665)
Q Consensus 204 ~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrD 283 (665)
+.--.++++.+.|+|....+++.........+|||+++.++.+...... +-... ++ .+|+.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s-------~~-------~~~~~~~- 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDES-------LL-------AHGVLHL- 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhh-------hc-------cccccee-
Confidence 5567789999999999999998776655788999999987776655433 21111 11 2233332
Q ss_pred CCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC
Q 006004 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR 363 (665)
Q Consensus 284 LKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~ 363 (665)
|| ++++| ..... | | ...++++||||+|.++.++..|...++..
T Consensus 92 ----~~-------~~~td----~~~t~--------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 92 ----NI-------IYITD----HFLTK--------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ----hh-------hhccc----ccccc--------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 22 23333 00000 0 1 11225999999999999999999999988
Q ss_pred ChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 364 ~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
+..+++..|.+..-.+....-- .+.-......+.....+..+|+...|..||...+++.++-|
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~ 197 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLST-----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSF 197 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHH-----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccH
Confidence 8888888887754333221100 00001122466778899999999999999999999999999
Q ss_pred CCC
Q 006004 444 KTE 446 (665)
Q Consensus 444 ~~~ 446 (665)
.+.
T Consensus 198 ~ev 200 (725)
T KOG1093|consen 198 TEV 200 (725)
T ss_pred HHH
Confidence 754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0029 Score=66.92 Aligned_cols=73 Identities=23% Similarity=0.289 Sum_probs=45.4
Q ss_pred EEEeeccCceEEEEEEECC------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEEE
Q 006004 163 IDKIGQGTYSSVYKARDLE------TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLYL 235 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~l 235 (665)
++.|..|--..||++.... +++.|++|+..... .......+|..+++.+....+ .+++.++. . .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP--N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cc
Confidence 4556667777899987533 25789999865432 122234678888888853333 34555442 2 35
Q ss_pred EEEecccc
Q 006004 236 VFEYMEHD 243 (665)
Q Consensus 236 V~Ey~~g~ 243 (665)
|+||++|.
T Consensus 75 v~e~i~G~ 82 (302)
T cd05156 75 IEEFIPSR 82 (302)
T ss_pred hhheeCCC
Confidence 89998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0068 Score=64.91 Aligned_cols=148 Identities=22% Similarity=0.288 Sum_probs=85.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeeeeccC-CcEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKLEGLVTSRS-GSLYLV 236 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~-~~l~lV 236 (665)
..++..+-.|.--.+|...+. ++.++|. ...............+|..+++.+.- .-+...++++.... +..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 444555533333445665543 7788888 43222334556677889999988732 23334455555544 567999
Q ss_pred EEeccccchhhhcCC-------------------------C-------CCCChhHHHHHHHHH--------------HHH
Q 006004 237 FEYMEHDLAGLATTP-------------------------G-------IKFTEPQIKCYMQQL--------------LRG 270 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~-------------------------~-------~~lse~~i~~i~~QI--------------l~a 270 (665)
|+|++|......... + ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998311100000 0 001111222222222 112
Q ss_pred HHHHHhC--------CccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 271 LEHCHSR--------GILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 271 L~~LH~~--------gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
..||+.+ .++|+|+.+.||||+..+-+=|+||+++..-++
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2333332 489999999999999999999999999886543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.022 Score=59.94 Aligned_cols=31 Identities=19% Similarity=0.274 Sum_probs=25.9
Q ss_pred CccccCCCcccEEEcCCCc-EEEEecccceec
Q 006004 278 GILHRDIKGSNLLINNAGV-LKIGDFGLATTY 308 (665)
Q Consensus 278 gIiHrDLKPeNILld~~g~-lKL~DFGlA~~~ 308 (665)
.++|+|++|.|||+++++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.03 Score=60.84 Aligned_cols=140 Identities=13% Similarity=0.152 Sum_probs=81.4
Q ss_pred eeEEEEeeccCceEEEEEEECC----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLE----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLY 234 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~ 234 (665)
...+..|-.|-.-.+|++.... .++.|++|+..... ...+.+ .+|+.+++.+..-++ .++++.+. .+
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~--~g--- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFP--NG--- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEEC--Cc---
Confidence 3344566558888999987432 24679999775432 122222 579999998854444 35555543 22
Q ss_pred EEEEeccccchhh------------------hcCCC---C--CCChhHHHHHHHHHH-----------------HHHHHH
Q 006004 235 LVFEYMEHDLAGL------------------ATTPG---I--KFTEPQIKCYMQQLL-----------------RGLEHC 274 (665)
Q Consensus 235 lV~Ey~~g~ll~~------------------~~~~~---~--~lse~~i~~i~~QIl-----------------~aL~~L 274 (665)
.|++|+++..+.. +.+.. . .....++..++.++. ..+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 5799988743221 11111 0 111233434432221 111111
Q ss_pred ----H----hCCccccCCCcccEEEcC-CCcEEEEeccccee
Q 006004 275 ----H----SRGILHRDIKGSNLLINN-AGVLKIGDFGLATT 307 (665)
Q Consensus 275 ----H----~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~ 307 (665)
. ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 236899999999999986 47899999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.022 Score=60.19 Aligned_cols=29 Identities=31% Similarity=0.526 Sum_probs=25.7
Q ss_pred CCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 277 RGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999998 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.031 Score=60.38 Aligned_cols=149 Identities=19% Similarity=0.241 Sum_probs=82.3
Q ss_pred cCCccCCCCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeee
Q 006004 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGL 225 (665)
Q Consensus 150 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~ 225 (665)
.+|.-...+..++. .|-.|-.-.+|++..... +..|++|+..... ...+. -.+|+.+++.+..-++ .+++++
T Consensus 7 ~~w~~~~~~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~~~Id-R~~E~~il~~l~~~gl~P~~l~~ 82 (330)
T PLN02421 7 KGWSDLDDSDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--DYVID-RERELQAIKYLSAAGFGAKLLGV 82 (330)
T ss_pred CccccCCcCceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc--CeEec-hHHHHHHHHHHHhcCCCCceeEE
Confidence 34443333445554 454477778999875432 3478899775322 11122 2578899999865444 455555
Q ss_pred eeccCCcEEEEEEeccccchh------------------hhcCCCCC----C-ChhHHHHHHHHHH--------------
Q 006004 226 VTSRSGSLYLVFEYMEHDLAG------------------LATTPGIK----F-TEPQIKCYMQQLL-------------- 268 (665)
Q Consensus 226 ~~~~~~~l~lV~Ey~~g~ll~------------------~~~~~~~~----l-se~~i~~i~~QIl-------------- 268 (665)
+. ++ +|.+|++|..+. .+.....+ + ....+..|+.++-
T Consensus 83 ~~--~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~ 157 (330)
T PLN02421 83 FG--NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYE 157 (330)
T ss_pred eC--Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhc
Confidence 42 32 588998874321 11111100 1 1223333333321
Q ss_pred --------HHHHHHH----hC----CccccCCCcccEEEcC-CCcEEEEeccccee
Q 006004 269 --------RGLEHCH----SR----GILHRDIKGSNLLINN-AGVLKIGDFGLATT 307 (665)
Q Consensus 269 --------~aL~~LH----~~----gIiHrDLKPeNILld~-~g~lKL~DFGlA~~ 307 (665)
.-+..+. .. -++|.||.+.|||+++ ++.++|+||..|..
T Consensus 158 ~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 158 TISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111111 11 2799999999999975 57899999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.059 Score=59.73 Aligned_cols=76 Identities=18% Similarity=0.182 Sum_probs=50.6
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--C---HHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcE
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--D---PESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~---~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l 233 (665)
..+.||.|....||++.+. +..|+||.-..... . +-...+...|...|+.+. -.++.+++.+..+ .-
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CC
Confidence 4678999999999999873 45689997541111 0 113344455677777663 2477788887653 34
Q ss_pred EEEEEeccc
Q 006004 234 YLVFEYMEH 242 (665)
Q Consensus 234 ~lV~Ey~~g 242 (665)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.065 Score=57.11 Aligned_cols=30 Identities=17% Similarity=0.129 Sum_probs=28.0
Q ss_pred CccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 278 GILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 278 gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
+++|+|+.+.|||++.++.+-|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.032 Score=60.77 Aligned_cols=75 Identities=19% Similarity=0.238 Sum_probs=47.7
Q ss_pred EeeccCceEEEEEEECCCCcEEEEEEEe----c-CCCCHHHHHHHHHHHHHHHhCC--CC-CcceeeeeeeccCCcEEEE
Q 006004 165 KIGQGTYSSVYKARDLETGKIVALKKVR----F-ANMDPESVRFMAREIHILRKLD--HP-NVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 165 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~----~-~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~~~~~~~~l~lV 236 (665)
.||.|....||++.+...++.|+||.-. . ....+-...+..-|..+|+.+. .| .+.+++.+ .. . ...+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~-e-~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DT-E-MAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-cc-c-cceeh
Confidence 5799999999999975444689999642 1 1111223445567888887763 34 45556554 22 2 45699
Q ss_pred EEeccc
Q 006004 237 FEYMEH 242 (665)
Q Consensus 237 ~Ey~~g 242 (665)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.039 Score=60.81 Aligned_cols=77 Identities=22% Similarity=0.229 Sum_probs=50.7
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEE----ecCCCCHHHHHHHHHHHHHHHhCC--CC-CcceeeeeeeccCCcEEE
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKV----RFANMDPESVRFMAREIHILRKLD--HP-NVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i----~~~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~~~~~~~~l~l 235 (665)
++.||.|.-.-||++.+...++.|+||.- +.....+-...+..-|.++|+.+. .| .+.+++.+ .. . ...+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~-e-~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DS-V-MNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-Cc-H-HhhH
Confidence 67899999999999998444567999953 211111223455667888888773 34 45556654 22 2 4578
Q ss_pred EEEeccc
Q 006004 236 VFEYMEH 242 (665)
Q Consensus 236 V~Ey~~g 242 (665)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.12 Score=54.77 Aligned_cols=76 Identities=17% Similarity=0.237 Sum_probs=45.8
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l~lV 236 (665)
.+..+.|+.|....+|+.. .+++.+.||+-... ....+..|..-|+.|. --.+.+++.+....+ .-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-DAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-CCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-CceEE
Confidence 4566789999999999987 57788999987622 2334667888787773 345667777665544 44899
Q ss_pred EEecccc
Q 006004 237 FEYMEHD 243 (665)
Q Consensus 237 ~Ey~~g~ 243 (665)
|||++..
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998743
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.046 Score=54.71 Aligned_cols=30 Identities=37% Similarity=0.521 Sum_probs=21.7
Q ss_pred CccccCCCcccEEE-cCCCcEEEEeccccee
Q 006004 278 GILHRDIKGSNLLI-NNAGVLKIGDFGLATT 307 (665)
Q Consensus 278 gIiHrDLKPeNILl-d~~g~lKL~DFGlA~~ 307 (665)
-+.|.||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.23 Score=61.52 Aligned_cols=31 Identities=26% Similarity=0.479 Sum_probs=26.5
Q ss_pred CCccccCCCcccEEEcCCC--cEE-EEeccccee
Q 006004 277 RGILHRDIKGSNLLINNAG--VLK-IGDFGLATT 307 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g--~lK-L~DFGlA~~ 307 (665)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.05 Score=58.84 Aligned_cols=85 Identities=18% Similarity=0.210 Sum_probs=60.2
Q ss_pred CCcceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCC
Q 006004 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAG 295 (665)
Q Consensus 217 pnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g 295 (665)
++..+++-+-.++...+|++|++-.+.+...- .-..+++..++.+.+..|+-+... ..-|||+.-.||||+ +|
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 44444333322344466778887766544321 124567888888888777777655 689999999999999 89
Q ss_pred cEEEEeccccee
Q 006004 296 VLKIGDFGLATT 307 (665)
Q Consensus 296 ~lKL~DFGlA~~ 307 (665)
++.|+||-+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.17 Score=55.86 Aligned_cols=77 Identities=19% Similarity=0.285 Sum_probs=43.6
Q ss_pred EEEEeeccCceEEEEEEECCC-CcEEEEEEE--ec-CCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEEEE
Q 006004 162 KIDKIGQGTYSSVYKARDLET-GKIVALKKV--RF-ANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i--~~-~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~lV 236 (665)
.++.|..|-...+|++..... +..+.+|.+ +. .....-.+. -.+|+.+++.|...++ .++++.+. -++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~-----~g~l 127 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFG-----DFTI 127 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEec-cHHHHHHHHHHHhCCCCCeEEEecC-----CEEE
Confidence 345665588889999975432 223333321 11 111111122 2569999999965555 55666553 2699
Q ss_pred EEeccccc
Q 006004 237 FEYMEHDL 244 (665)
Q Consensus 237 ~Ey~~g~l 244 (665)
.||++|..
T Consensus 128 ~efIeGr~ 135 (383)
T PTZ00384 128 QEWVEGNT 135 (383)
T ss_pred EEEecccc
Confidence 99999843
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.36 Score=54.36 Aligned_cols=84 Identities=13% Similarity=0.184 Sum_probs=49.9
Q ss_pred CCccCCCCCeeEEEEeeccCceEEEEEEECCC--------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcc-e
Q 006004 151 GWQPRRADAFEKIDKIGQGTYSSVYKARDLET--------GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM-K 221 (665)
Q Consensus 151 ~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV-~ 221 (665)
+|.....++. .++.|-.|-.-.+|++..... ++.|.+++.-... ...+ .-..|..+++.+..-.|- +
T Consensus 99 ~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~~ls~~gi~P~ 174 (442)
T PTZ00296 99 EWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYKTMSKYRIAPQ 174 (442)
T ss_pred ccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHHHHHHCCCCCc
Confidence 4443233345 566776677778999875421 4678888764321 1112 234688888888644443 4
Q ss_pred eeeeeeccCCcEEEEEEecccc
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHD 243 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ 243 (665)
+++.+. . +.|.||++|.
T Consensus 175 l~~~f~--g---g~I~efi~g~ 191 (442)
T PTZ00296 175 LLNTFS--G---GRIEEWLYGD 191 (442)
T ss_pred eEEEeC--C---CEEEEeeCCc
Confidence 555542 2 4678999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.6 Score=50.25 Aligned_cols=70 Identities=21% Similarity=0.187 Sum_probs=41.1
Q ss_pred cCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCccee---ee--eeeccCCcEEEEEEecc
Q 006004 169 GTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKL---EG--LVTSRSGSLYLVFEYME 241 (665)
Q Consensus 169 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l---~~--~~~~~~~~l~lV~Ey~~ 241 (665)
+.-..||++.. .+|..|++|+.+..... ...+..|+.++..|.. -.++.. -+ ++. -++..+.|+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~-~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE-HQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE-ECCEEEEEEeeeC
Confidence 45567999874 45677999987644322 3345567777777631 112221 11 111 1346788999988
Q ss_pred cc
Q 006004 242 HD 243 (665)
Q Consensus 242 g~ 243 (665)
|.
T Consensus 111 G~ 112 (325)
T PRK11768 111 GR 112 (325)
T ss_pred CC
Confidence 73
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.55 Score=50.82 Aligned_cols=136 Identities=21% Similarity=0.268 Sum_probs=77.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC------cceeeeeeecc-CC--cEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN------VMKLEGLVTSR-SG--SLY 234 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~~~~~~~-~~--~l~ 234 (665)
..|.+ .--.||++.. .+|+ +++|+.+.. ... ..+..|+..|+.|.-.. |..+-+-.... .+ ..+
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGR-YILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEe-cCCC-eEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 5567899875 3444 499988765 333 33566888888873211 22222211111 23 678
Q ss_pred EEEEeccccchhh----------------hcC--CCCC---------CChh----H---------HHHHHHHHHHHHHHH
Q 006004 235 LVFEYMEHDLAGL----------------ATT--PGIK---------FTEP----Q---------IKCYMQQLLRGLEHC 274 (665)
Q Consensus 235 lV~Ey~~g~ll~~----------------~~~--~~~~---------lse~----~---------i~~i~~QIl~aL~~L 274 (665)
-|++|++|..+.. +.. ++.+ ..+. . -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999854431 000 0101 1111 0 011233444445544
Q ss_pred Hh--------CC--ccccCCCcccEEEcCCCc-EEEEecccce
Q 006004 275 HS--------RG--ILHRDIKGSNLLINNAGV-LKIGDFGLAT 306 (665)
Q Consensus 275 H~--------~g--IiHrDLKPeNILld~~g~-lKL~DFGlA~ 306 (665)
.+ .+ |||+|+.|.|||++.+.. +.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 43 24 999999999999998874 8999999765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.39 Score=48.95 Aligned_cols=115 Identities=17% Similarity=0.219 Sum_probs=71.9
Q ss_pred cCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEeccccchhhh
Q 006004 169 GTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLA 248 (665)
Q Consensus 169 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~ 248 (665)
++-++.-.+...- | ...+|+++.-...-. ...+..+..++.++. .|++|.. +....+-+++|+|-.-
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~----- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKI----- 139 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCc-----
Confidence 4555555554333 4 356676653322211 223567888888863 5777763 2334577899998521
Q ss_pred cCCCCCCChhHHHHHHHHHHHHHHHHHh--CCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 249 TTPGIKFTEPQIKCYMQQLLRGLEHCHS--RGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 249 ~~~~~~lse~~i~~i~~QIl~aL~~LH~--~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
.. + ...++..=+.+|.-.|+ .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 140 ---~i-~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 140 ---KI-N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---cc-c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 00 0 11222222466777884 3799999999999999999999999874
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.16 E-value=0.49 Score=52.17 Aligned_cols=61 Identities=20% Similarity=0.071 Sum_probs=37.4
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH-hCCccccCCCcccEEEcCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKGSNLLINNA 294 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKPeNILld~~ 294 (665)
..|+-+|+.|-........ ...+|...+.++.-...||.-|- -.+.+|.|++|.|||+.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4566677776433333322 23456556666655555554433 4579999999999999643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 665 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-63 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-62 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-62 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-62 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-58 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-58 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-58 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-58 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-57 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-57 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-57 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-57 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-57 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-57 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-57 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-57 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-57 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-57 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-57 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-57 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-57 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-57 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-57 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-57 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-57 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-57 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-57 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-57 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-57 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-57 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-57 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-57 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-57 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-57 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-57 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-57 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-57 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-57 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-57 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-57 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-56 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-55 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-53 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-53 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-52 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-52 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-52 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-52 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-52 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-52 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-52 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-52 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-50 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-49 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-49 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-49 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-46 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-45 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-44 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-44 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-44 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-44 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-44 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-44 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-44 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-44 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-44 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-44 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-44 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-44 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-44 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-44 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-44 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-44 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-44 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-44 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-44 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-44 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-44 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-44 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-44 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-44 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-44 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-44 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-44 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-44 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-44 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-44 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-44 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-44 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-43 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-43 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-43 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-43 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-43 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-43 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-42 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-42 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-42 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-42 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-41 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-41 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-41 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-41 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-41 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-41 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-41 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-41 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-41 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-41 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-41 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-41 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-41 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-41 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-41 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-41 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-41 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-41 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-41 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-41 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-41 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-41 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-41 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-41 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-41 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-41 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-41 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-41 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-41 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-41 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-41 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-41 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-41 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-41 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-41 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-41 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-41 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-41 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-41 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-41 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-41 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-41 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-40 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-40 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-40 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-40 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-40 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-40 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-40 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-40 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-40 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-40 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-40 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-40 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-40 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-39 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-39 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-39 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-39 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-38 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-35 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-35 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-34 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-33 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-33 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-33 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-32 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-32 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-32 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-32 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-32 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-32 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-26 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-26 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-26 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-26 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-26 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-26 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-26 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-26 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-26 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-26 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-26 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-26 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-26 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-25 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-25 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-25 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-25 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-24 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-24 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-24 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-24 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-22 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-22 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-19 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-17 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-17 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-08 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 137/345 (39%), Positives = 193/345 (55%), Gaps = 15/345 (4%)
Query: 147 EAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA- 205
++++ +EK+ KIGQGT+ V+KAR +TG+ VALKKV N + E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 206 REIHILRKLDHPNVMKLEGLVTSRS-------GSLYLVFEYMEHDLAGLATTPGIKFTEP 258
REI IL+ L H NV+ L + +++ GS+YLVF++ EHDLAGL + +KFT
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP---SQNLP 315
+IK MQ LL GL + H ILHRD+K +N+LI GVLK+ DFGLA + SQ
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
T+RVVTLWYR PELLLG YG ID+W AGCI+AE++ PIM G TE Q+ I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 376 CGSPSEDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQS--ALALVDKLLTIEPENRG 432
CGS + + W + + KRKV + + + + AL L+DKLL ++P R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 433 SAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQE 477
+ AL +FF ++P+P D + + + +
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHHH 349
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 487 bits (1257), Expect = e-170
Identities = 122/340 (35%), Positives = 186/340 (54%), Gaps = 12/340 (3%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD--PESVRFMA-REIHI 210
RA +EK+D +G+G +++VYKARD T +IVA+KK++ + + + A REI +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
L++L HPN++ L +S ++ LVF++ME DL + + T IK YM L+G
Sbjct: 66 LQELSHPNIIGLLDAFGHKS-NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPE 329
LE+ H ILHRD+K +NLL++ GVLK+ DFGLA ++ P++ T +VVT WYRAPE
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPE 182
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SK 388
LL GA YG +DMW+ GCILAEL P +PG ++++Q+ +IF+ G+P+E+ W
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
+FK F L L+ L P R +A AL+ ++F P
Sbjct: 243 LPDYVTFKSFPGIPLH--HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300
Query: 449 PCDPSNLPKYPPSKELDAKLRDQEA--RKQEAEAVRGRGP 486
P LP+ E + + +++ EA+ G
Sbjct: 301 PTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGL 340
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 414 bits (1066), Expect = e-141
Identities = 114/321 (35%), Positives = 172/321 (53%), Gaps = 8/321 (2%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + K+DK+G+GTY++VYK + T +VALK++R + + + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
N++ L ++ + SL LVFEY++ DL G +K ++ QLLRGL +CH +
Sbjct: 61 NIVTLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPELLLGATK 336
+LHRD+K NLLIN G LK+ DFGLA P++ + VVTLWYR P++LLG+T
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTD 177
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATSF 395
Y IDMW GCI E+ G+P+ PG T EQ+H IF++ G+P+E+ W + ++
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
+ +L L+ KLL E NR SA A++ FF + L
Sbjct: 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--L 295
Query: 456 PKYPPSKELDAKLRDQEARKQ 476
P L +EA +
Sbjct: 296 PDTTSIFALKEIQLQKEASLR 316
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 415 bits (1068), Expect = e-140
Identities = 119/393 (30%), Positives = 186/393 (47%), Gaps = 45/393 (11%)
Query: 151 GWQPRRADAFEKID-KIGQGTYSSVYKARDLE--TGKIVALKKVRFANMDPESVRFMARE 207
+ R D FE K+G+GTY VYKA+ + K ALK++ + + R E
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----E 68
Query: 208 IHILRKLDHPNVMKLEGLVTSRS-GSLYLVFEYMEHDLAGL--------ATTPGIKFTEP 258
I +LR+L HPNV+ L+ + S + ++L+F+Y EHDL + A ++
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTY-DPSQN 313
+K + Q+L G+ + H+ +LHRD+K +N+L+ G +KI D G A + P +
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 314 LP-LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV------ 366
L L VVT WYRAPELLLGA Y AID+W+ GCI AEL +PI R E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 367 ---EQMHKIFKLCGSPSEDYWRK-SKSAHATSFKP---QQPYKRKVLET-----FRNFPQ 414
+Q+ +IF + G P++ W K ++ + Y L
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 415 SALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP---KYPPSKELDAKLRDQ 471
A L+ KLLT++P R ++ A++ +F +PLP YP + L + D
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDD 368
Query: 472 EARKQEAEAVRGRGPE--SVRRGSRDFSAVRTP 502
+ K+ + +G + G++D S + P
Sbjct: 369 KGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGP 401
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-139
Identities = 117/306 (38%), Positives = 163/306 (53%), Gaps = 16/306 (5%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF---MAREIHIL 211
+E + +IG G Y +VYKARD +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 212 RKL---DHPNVMKLEGLVTSRS----GSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCY 263
R+L +HPNV++L + + + LVFE+++ DL L P IK
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
M+Q LRGL+ H+ I+HRD+K N+L+ + G +K+ DFGLA Y + LT VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVVTL 183
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383
WYRAPE+LL +T Y +DMWS GCI AE+F KP+ G +E +Q+ KIF L G P ED
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
W + S +F P+ P R V +S L+ ++LT P R SA AL+ +
Sbjct: 243 WPRDVSLPRGAFPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300
Query: 444 KTEPLP 449
+
Sbjct: 301 HKDEGN 306
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-139
Identities = 115/321 (35%), Positives = 174/321 (54%), Gaps = 19/321 (5%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-VRFMA-REIHILRK 213
+ F++++K+G GTY++VYK + TG VALK+V+ +D E A REI ++++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKE 59
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK-----FTEPQIKCYMQQLL 268
L H N+++L ++ + + L LVFE+M++DL + + +K + QLL
Sbjct: 60 LKHENIVRLYDVIHTEN-KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRA 327
+GL CH ILHRD+K NLLIN G LK+GDFGLA + P +S VVTLWYRA
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRA 176
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK- 386
P++L+G+ Y +ID+WS GCILAE+ GKP+ PG + EQ+ IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 387 SKSAHATSFKPQQPYK--RKVL--ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
+K Q+P + R+VL T + + + LL + P+ R SA AL +
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 443 FKTEPLPCDPSNLPKYPPSKE 463
F +
Sbjct: 297 FAEYYHHASMGGSRSHHHHHH 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 404 bits (1042), Expect = e-138
Identities = 119/296 (40%), Positives = 173/296 (58%), Gaps = 9/296 (3%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
+EK++KIG+GTY +V+KA++ ET +IVALK+VR + D E V A REI +L++L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N+++L ++ S L LVFE+ + DL + +K ++ QLL+GL CHS
Sbjct: 61 KNIVRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPELLLGAT 335
R +LHRD+K NLLIN G LK+ +FGLA + P + ++ VVTLWYR P++L GA
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAK 177
Query: 336 KYGAAIDMWSAGCILAELF-AGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHAT 393
Y +IDMWSAGCI AEL AG+P+ PG +Q+ +IF+L G+P+E+ W +K
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
+ P P ++ + L+ LL P R SA AL+ +F P
Sbjct: 238 PY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 405 bits (1044), Expect = e-138
Identities = 103/309 (33%), Positives = 161/309 (52%), Gaps = 6/309 (1%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
+ +EKI KIG+G+Y V+K R+ +TG+IVA+KK + D ++ +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
PN++ L V R L+LVFEY +H + E +K Q L+ + CH
Sbjct: 62 PNLVNLLE-VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+HRD+K N+LI V+K+ DFG A + V T WYR+PELL+G T+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATSF 395
YG +D+W+ GC+ AEL +G P+ PG+++V+Q++ I K G + + S + + +
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 396 KPQQPYKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
K P + LE F N AL L+ L ++P R + L +F+ D +
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAK 299
Query: 455 LPKYPPSKE 463
P
Sbjct: 300 EHDKPAENL 308
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-137
Identities = 97/321 (30%), Positives = 169/321 (52%), Gaps = 10/321 (3%)
Query: 148 AIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-R 206
+ + + +E + +G+G+Y V K R+ +TG+IVA+KK ++ D + V+ +A R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMR 73
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
EI +L++L H N++ L V + YLVFE+++H + ++ Y+ Q
Sbjct: 74 EIKLLKQLRHENLVNLLE-VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWY 325
++ G+ CHS I+HRDIK N+L++ +GV+K+ DFG A T P + V T WY
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWY 190
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW- 384
RAPELL+G KYG A+D+W+ GC++ E+F G+P+ PG ++++Q++ I G+ +
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 385 --RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
K+ P+ + + + + + L K L I+P+ R A L +F
Sbjct: 251 LFNKNPVFAGVRL-PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 443 FKTEPLPCDPSNLPKYPPSKE 463
F+ + S + K+
Sbjct: 310 FQMDGFAERFSQELQLKVQKD 330
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-137
Identities = 119/299 (39%), Positives = 175/299 (58%), Gaps = 8/299 (2%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
+ + ++K++K+G+GTY VYKA+D G+IVALK++R + + E + A REI +
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRL-DAEDEGIPSTAIREISL 72
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
L++L HPN++ L ++ S L LVFE+ME DL + + QIK Y+ QLLRG
Sbjct: 73 LKELHHPNIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPE 329
+ HCH ILHRD+K NLLIN+ G LK+ DFGLA + P + T VVTLWYRAP+
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPD 189
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SK 388
+L+G+ KY ++D+WS GCI AE+ GKP+ PG T+ +Q+ KIF + G+P+ W + +
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447
Q K+ F Q + L+ +L +P R SA A+ +FK
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-136
Identities = 120/329 (36%), Positives = 177/329 (53%), Gaps = 18/329 (5%)
Query: 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDL-ETGKIVALKKVRFANMDPESVRFMA-RE 207
K R +E + +IG+G Y V+KARDL G+ VALK+VR E + RE
Sbjct: 3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIRE 61
Query: 208 IHILRKL---DHPNVMKLEGLVTSRS----GSLYLVFEYMEHDLAG-LATTPGIKFTEPQ 259
+ +LR L +HPNV++L + T L LVFE+++ DL L P
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 260 IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319
IK M QLLRGL+ HS ++HRD+K N+L+ ++G +K+ DFGLA Y + LTS
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSV 179
Query: 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379
VVTLWYRAPE+LL ++ Y +D+WS GCI AE+F KP+ G ++V+Q+ KI + G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
E+ W + + +F + + + + + + L+ K LT P R SA SAL
Sbjct: 239 GEEDWPRDVALPRQAF-HSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
Query: 440 SEFFKTEPLPCD--PSNLPKYPPSKELDA 466
+F+ + S+LP + EL+
Sbjct: 297 HPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 395 bits (1016), Expect = e-134
Identities = 105/306 (34%), Positives = 162/306 (52%), Gaps = 13/306 (4%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHI 210
D + +I K+G+GTY VYKA D T + VA+K++R + + E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
L++L H N+++L+ ++ L+L+FEY E+DL + IK ++ QL+ G
Sbjct: 87 LKELQHRNIIELKSVIHHNH-RLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLING 144
Query: 271 LEHCHSRGILHRDIKGSNLLIN-----NAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLW 324
+ CHSR LHRD+K NLL++ VLKIGDFGLA + P + T ++TLW
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLW 202
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384
YR PE+LLG+ Y ++D+WS CI AE+ P+ PG +E++Q+ KIF++ G P + W
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 385 RK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ P+ K L L+ +L ++P R SA +AL +F
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 444 KTEPLP 449
Sbjct: 323 SHNDFD 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-133
Identities = 107/290 (36%), Positives = 164/290 (56%), Gaps = 9/290 (3%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDH 216
+ + ++KIG+GTY VYKA++ G+ ALKK+R + E + REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++KL ++ ++ L LVFE+++ DL L K ++ QLL G+ +CH
Sbjct: 60 SNIVKLYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAPELLLGAT 335
R +LHRD+K NLLIN G LKI DFGLA + P + T +VTLWYRAP++L+G+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSK 176
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHATS 394
KY ID+WS GCI AE+ G P+ PG +E +Q+ +IF++ G+P+ W ++
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ +S + L+ K+L ++P R +A AL +FK
Sbjct: 237 NFTVYE-PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 349 bits (896), Expect = e-114
Identities = 124/396 (31%), Positives = 184/396 (46%), Gaps = 32/396 (8%)
Query: 138 PSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD 197
S +T+V +G + ++ IG G++ VY+A+ ++G++VA+KKV D
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QD 90
Query: 198 PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS-----LYLVFEYMEHDLAGLA---T 249
RF RE+ I+RKLDH N+++L S L LV +Y+ + +A +
Sbjct: 91 K---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 147
Query: 250 TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTY 308
+K YM QL R L + HS GI HRDIK NLL++ + VLK+ DFG A
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368
+ P S + + +YRAPEL+ GAT Y ++ID+WSAGC+LAEL G+PI PG + V+Q
Sbjct: 208 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265
Query: 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFR-NFPQSALALVDKLLTIE 427
+ +I K+ G+P+ + R+ + T FK Q + FR P A+AL +LL
Sbjct: 266 LVEIIKVLGTPTREQIREMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 428 PENRGSAASALRSEFFKTEPLP-CDPSNLPKYPP-----------SKELDAKLRDQEARK 475
P R + A FF P N P + L L AR
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI 384
Query: 476 QEAEAVRGRGPESVRRGSRDF-SAVRTPEFIPSGQS 510
Q A + + + D S +
Sbjct: 385 QAAASTPTNATAASDANTGDRGQTNNAASASASNST 420
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-105
Identities = 113/349 (32%), Positives = 169/349 (48%), Gaps = 38/349 (10%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
+R A+ IG G++ V++A+ +E+ + VA+KKV D RF RE+ I+R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL---QDK---RFKNRELQIMRIV 89
Query: 215 DHPNVMKLEGLVTSRSGS-----LYLVFEYMEHDLAGLA---TTPGIKFTEPQIKCYMQQ 266
HPNV+ L+ S L LV EY+ + + IK YM Q
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
LLR L + HS GI HRDIK NLL++ +GVLK+ DFG A + P S + + +Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYY 207
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
RAPEL+ GAT Y ID+WS GC++AEL G+P+ PG + ++Q+ +I K+ G+PS + +
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 386 KSKSAHATSFKPQQPYKRKVLET-FR-NFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ PQ + FR P A+ L+ +LL P R +A AL FF
Sbjct: 268 TMNPNYMEHKFPQ--IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 444 KTEPLPCDPSNLPKYPP--------------SKELDAKLRDQEARKQEA 478
+ L + +P +L ++L Q A +
Sbjct: 326 --DELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELL 372
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-100
Identities = 103/343 (30%), Positives = 155/343 (45%), Gaps = 28/343 (8%)
Query: 136 GWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN 195
G S ++ A A + D F+ GQGT+ +V ++ TG VA+KKV
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--- 57
Query: 196 MDPESVRFMAREIHILRKL---DHPNVMKLEGLVTSRSGS------LYLVFEYMEHDLAG 246
+ RF RE+ I++ L HPN+++L+ + L +V EY+ L
Sbjct: 58 ---QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114
Query: 247 LA---TTPGIKFTEPQIKCYMQQLLRGLE--HCHSRGILHRDIKGSNLLINNA-GVLKIG 300
+ IK ++ QL+R + H S + HRDIK N+L+N A G LK+
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 301 DFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIM 360
DFG A PS+ P + + + +YRAPEL+ G Y A+D+WS GCI AE+ G+PI
Sbjct: 175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 361 PGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ---QPYKRKVLETFRNFPQSAL 417
G Q+H+I ++ G PS + RK +H P+ + + A
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 418 ALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPP 460
L+ LL PE R AL +F + L + LP
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYF--DELHDPATKLPNNKD 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = 1e-98
Identities = 97/360 (26%), Positives = 157/360 (43%), Gaps = 54/360 (15%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILR 212
+ + +G G++ V + D+E+GK ALKKV DP R+ RE+ I++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---QDP---RYKNRELDIMK 55
Query: 213 KLDHPNVMKLEGLVTSRSGS-------------------------------------LYL 235
LDH N++KL + L +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 236 VFEYMEHDLAGLA---TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN 292
+ EY+ L + G I Y+ QL R + HS GI HRDIK NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 293 -NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILA 351
LK+ DFG A PS+ P + + + +YRAPEL+LGAT+Y +ID+WS GC+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 352 ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRN 411
EL GKP+ G T ++Q+ +I ++ G+P+++ + + P + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPE 292
Query: 412 F-PQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRD 470
P A+ L++++L EP+ R + A+ FF + L + S ++
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 8e-94
Identities = 95/301 (31%), Positives = 153/301 (50%), Gaps = 24/301 (7%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DH 216
D ++ + K+G+G YS V++A ++ + V +K ++ P + + REI IL L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 90
Query: 217 PNVMKLEGLVTSR-SGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
PN++ L +V S + LVFE+ D L T T+ I+ YM ++L+ L++C
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 146
Query: 275 HSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
HS GI+HRD+K N++I++ L++ D+GLA Y P Q RV + +++ PELL+
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVD 204
Query: 334 ATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPS-EDYWRKSKSAH 391
Y ++DMWS GC+LA + K P G +Q+ +I K+ G+ DY K
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 392 ATSFKPQQP-YKRKVLETF------RNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
F + RK E F AL +DKLL + ++R +A A+ +F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 445 T 445
T
Sbjct: 325 T 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 5e-92
Identities = 97/292 (33%), Positives = 153/292 (52%), Gaps = 14/292 (4%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ +G G Y SV A D +G+ VA+KK+ + RE+ +L+ + H NV
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 220 MKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T S YLV +M+ DL + F+E +I+ + Q+L+GL++
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYI 142
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS G++HRD+K NL +N LKI DFGLA D +T VVT WYRAPE++L
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSW 198
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+AE+ GK + G+ ++Q+ +I K+ G P ++ +K A S
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258
Query: 395 FKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ P + + F A L++K+L ++ + R +AA AL FF+
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 9e-92
Identities = 111/366 (30%), Positives = 158/366 (43%), Gaps = 70/366 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+E IG G+Y V +A D ++VA+KK+ D + + REI IL +L+H +V
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 220 MKLEGLVTSRSGS----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+K+ +V + LY+V E + D L TP + TE IK + LL G+++ H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH 173
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP-------------------- 315
S GILHRD+K +N L+N +K+ DFGLA T D +N
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 316 ------LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF-----------AGKP 358
LT VVT WYRAPEL+L Y AID+WS GCI AEL P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 359 IMPG--------------------RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+ PG R +Q++ IF + G+PSE+ + A +
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353
Query: 399 QPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT------EPLPC 450
P + E F A+ L+ ++L P R + L FFK E
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT 413
Query: 451 DPSNLP 456
+ LP
Sbjct: 414 EKVRLP 419
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-91
Identities = 96/334 (28%), Positives = 143/334 (42%), Gaps = 23/334 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR-FMA--------REIHI 210
+ I G+Y +V D G VA+K+V D +V REI +
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 211 LRKLDHPNVMKLEGLVTSRSGS----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
L HPN++ L + LYLV E M DLA + I + I+ +M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
+L GL H G++HRD+ N+L+ + + I DF LA N T V WYR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYR 200
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
APEL++ + +DMWSAGC++AE+F K + G T Q++KI ++ G+P +
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 387 SKSAHATSF-KPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
S A + + AL L+ K+L P+ R S ALR +F
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
Query: 444 KTEPLPCDPSNLPKYPPSK-ELDAKLRDQEARKQ 476
E L DP +L + + D + D +
Sbjct: 321 --ESL-FDPLDLTEGLSERFHFDESVTDVYDMHK 351
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 6e-91
Identities = 110/310 (35%), Positives = 162/310 (52%), Gaps = 16/310 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILRKLDHPN 218
+ + IG+G Y V A D VA+KK+ F + + REI IL + H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 219 VMKLEGLVTSRSGS----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
++ + ++ + + +Y+V + ME DL L T + I ++ Q+LRGL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 144
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSRVVTLWYRAPELLL 332
HS +LHRD+K SNLL+N LKI DFGLA DP + LT V T WYRAPE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
+ Y +ID+WS GCILAE+ + +PI PG+ ++Q++ I + GSPS++ + A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 393 TSFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
++ P+K KV F N AL L+DK+LT P R AL + E
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL--EQY-Y 321
Query: 451 DPSNLPKYPP 460
DPS+ P
Sbjct: 322 DPSDEPIAEA 331
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-90
Identities = 106/305 (34%), Positives = 156/305 (51%), Gaps = 27/305 (8%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +G G V+ A D + K VA+KK+ + P+SV+ REI I+R+LDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 220 MKLEGLVTSRSGS-------------LYLVFEYMEHDLAGLATTPGIK---FTEPQIKCY 263
+K+ ++ +Y+V EYME DLA + ++ E + +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV-----LEQGPLLEEHARLF 125
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDP--SQNLPLTSRV 320
M QLLRGL++ HS +LHRD+K +NL IN VLKIGDFGLA DP S L+ +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS 380
VT WYR+P LLL Y AIDMW+AGCI AE+ GK + G E+EQM I +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 381 EDYWRKSKSAHATSFKPQQPYKRKVLET-FRNFPQSALALVDKLLTIEPENRGSAASALR 439
E+ ++ S + K L + A+ ++++LT P +R +A AL
Sbjct: 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
Query: 440 SEFFK 444
+
Sbjct: 306 HPYMS 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 5e-90
Identities = 100/311 (32%), Positives = 157/311 (50%), Gaps = 22/311 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +G G Y +V A D TG VA+KK+ + RE+ +L+ + H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 220 MKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIK---FTEPQIKCYMQQLLRGL 271
+ L + T YLV +M DL L +K E +I+ + Q+L+GL
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-----MKHEKLGEDRIQFLVYQMLKGL 141
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
+ H+ GI+HRD+K NL +N LKI DFGLA D +T VVT WYRAPE++
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVI 197
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
L +Y +D+WS GCI+AE+ GK + G ++Q+ +I K+ G+P ++ ++ +S
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257
Query: 392 ATSFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
A ++ P K N A+ L++K+L ++ E R +A AL +F E L
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--ESL- 314
Query: 450 CDPSNLPKYPP 460
D + P+
Sbjct: 315 HDTEDEPQVQK 325
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 3e-89
Identities = 103/332 (31%), Positives = 157/332 (47%), Gaps = 34/332 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-FANMDPESVRFMAREIHILRKLDHPN 218
F+ +G+G Y V A TG+IVA+KK+ F P REI IL+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 219 VMKLEGLVTSRSGS----LYLVFEYMEHDLAGLATTPGIK---FTEPQIKCYMQQLLRGL 271
++ + + S +Y++ E M+ DL + I ++ I+ ++ Q LR +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-----ISTQMLSDDHIQYFIYQTLRAV 125
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP---------LTSRVVT 322
+ H ++HRD+K SNLLIN+ LK+ DFGLA D S + V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP-SE 381
WYRAPE++L + KY A+D+WS GCILAELF +PI PGR Q+ IF + G+P S+
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 382 DYWRKSKSAHATSFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ R +S A + P + F + L+ ++L +P R +A AL
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 440 SEFFKT------EPLPCDPSNLPKYPPSKELD 465
+ +T EP +P + +
Sbjct: 306 HPYLQTYHDPNDEP-EGEPIPPSFFEFDHYKE 336
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 1e-88
Identities = 100/308 (32%), Positives = 154/308 (50%), Gaps = 16/308 (5%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + +G G Y SV A D +TG VA+KK+ + RE+ +L+ + H NV
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 220 MKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T +YLV M DL + K T+ ++ + Q+LRGL++
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI 148
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS I+HRD+K SNL +N LKI DFGLA +T V T WYRAPE++L
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNW 204
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+AEL G+ + PG ++Q+ I +L G+P + +K S A +
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 395 FKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDP 452
+ K+ F A+ L++K+L ++ + R +AA AL +F DP
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--AQY-HDP 321
Query: 453 SNLPKYPP 460
+ P P
Sbjct: 322 DDEPVADP 329
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-85
Identities = 104/358 (29%), Positives = 154/358 (43%), Gaps = 62/358 (17%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ IG+G+Y VY A D T K VA+KKV D + + REI IL +L +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 220 MKLEGLVTSRSGS----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
++L L+ LY+V E + DL L TP I TE IK + LL G H
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH 146
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP-------------------- 315
GI+HRD+K +N L+N +K+ DFGLA T + ++
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 316 -LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-----------KPIMPG- 362
LTS VVT WYRAPEL+L Y +ID+WS GCI AEL P+ PG
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 363 ----------------RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKV- 405
++ +Q++ IF + G+P+ED + + P+++ +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 406 -LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT------EPLPCDPSNLP 456
+ + + + L++ +L P R + AL + K E LP
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILP 384
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-84
Identities = 108/350 (30%), Positives = 168/350 (48%), Gaps = 43/350 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPN 218
+E + K+G+G Y V+K+ D TG++VA+KK+ A + + REI IL +L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 219 VMKLEGLVTSRSGS-LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
++ L ++ + + +YLVF+YME DL + + + QL++ +++ HS
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--------------------LT 317
G+LHRD+K SN+L+N +K+ DFGL+ ++ + + LT
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCG 377
V T WYRAPE+LLG+TKY IDMWS GCIL E+ GKPI PG + + Q+ +I +
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248
Query: 378 SPSEDYWRKSKSAHATSFKPQQPYKRKV----------------LETFRNFPQSALA--L 419
PS + +S A + K ++ L+ + A L
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308
Query: 420 VDKLLTIEPENRGSAASALRSEFFKTEPLPCD-PSNLPKYPPSKELDAKL 468
+DKLL P R SA AL+ F P + P+ + K
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 4e-82
Identities = 88/322 (27%), Positives = 151/322 (46%), Gaps = 29/322 (9%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG G V A D + VA+KK+ + + RE+ +++ ++H N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 220 MKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +Y+V E M+ +L + ++ + Q+L G++H
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHL 143
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T S + T VVT +YRAPE++LG
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILG- 200
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+ E+ G + PG ++Q +K+ + G+P ++ +K + +
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRT 259
Query: 395 FKPQQPYKRKV--------------LETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
+ +P E + A L+ K+L I+ R S AL+
Sbjct: 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319
Query: 441 EFFKTEPLPCDPSNLPKYPPSK 462
+ DPS PP
Sbjct: 320 PYI--NVW-YDPSEAEAPPPKI 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 264 bits (675), Expect = 3e-81
Identities = 105/416 (25%), Positives = 183/416 (43%), Gaps = 42/416 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG G V A D + VA+KK+ + + RE+ +++ ++H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 220 MKLEGLVTSRSGS-----LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +YLV E M+ +L + ++ + Q+L G++H
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHL 180
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T S + T VVT +YRAPE++LG
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILG- 237
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K + +
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TVRN 296
Query: 395 FKPQQPYKRKVLETFRN-FPQS---------------ALALVDKLLTIEPENRGSAASAL 438
+ +P + TF FP S A L+ K+L I+P R S AL
Sbjct: 297 YVENRPKYAGL--TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 439 RSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSA 498
+ + DP+ + PP + R+ E + E + + +
Sbjct: 355 QHPYI--NVW-YDPAEVEAPPPQIYDK----QLDEREHTIEEWK----ELIYKEVMNSEE 403
Query: 499 VRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVGRQNVNSHSSTAVHPSAS 554
+ GQ P+ + S Q + S + +++ SA
Sbjct: 404 KTKNGVVK-GQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAG 458
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-71
Identities = 78/316 (24%), Positives = 126/316 (39%), Gaps = 56/316 (17%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
R A FE+I +GQG + V KAR+ + A+KK+R ++ E+ +L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 215 DHPNVMKL------------EGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIK 261
+H V++ + +L++ EY E L L + + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP------ 315
+Q+L L + HS+GI+HRD+K N+ I+ + +KIGDFGLA S ++
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 316 -------LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368
LTS + T Y A E+L G Y IDM+S G I E+ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 369 MHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP 428
+ K+ + D+ N + ++ L+ +P
Sbjct: 238 LKKLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDP 272
Query: 429 ENRGSAASALRSEFFK 444
R A + L S +
Sbjct: 273 NKRPGARTLLNSGWLP 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-69
Identities = 68/310 (21%), Positives = 123/310 (39%), Gaps = 43/310 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN- 218
+ + +IG G S V++ + E +I A+K V D +++ EI L KL +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 219 -VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++L + +Y+V E DL + K Y + +L + H
Sbjct: 89 KIIRLYDYEIT-DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH 146
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGA-- 334
GI+H D+K +N LI + G+LK+ DFG+A P + ++ S+V T+ Y PE +
Sbjct: 147 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 335 --------TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
+K D+WS GCIL + GK P + + Q+ K+ +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDP-------- 255
Query: 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
+ + + P + ++ L +P+ R S L + + +
Sbjct: 256 -------NHEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
Query: 447 PLPCDPSNLP 456
P +
Sbjct: 300 THPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-68
Identities = 76/357 (21%), Positives = 135/357 (37%), Gaps = 43/357 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN- 218
+ + +IG G S V++ + E +I A+K V D +++ EI L KL +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 219 -VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++L + +Y+V E DL + K Y + +L + H
Sbjct: 70 KIIRLYDYEIT-DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH 127
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLG--- 333
GI+H D+K +N LI + G+LK+ DFG+A P + ++ S+V T+ Y PE +
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 334 -------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
+K D+WS GCIL + GK P + + Q+ K+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA-----------I 233
Query: 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
H F + ++ L +P+ R S L + + +
Sbjct: 234 IDPNHEIEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
Query: 447 PLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPE 503
P + K + +L + +A + S + S+ +T E
Sbjct: 281 THPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 337
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 9e-67
Identities = 78/301 (25%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
P RA+ +E + IG G+Y K R GKI+ K++ + +M + + E+++LR+
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 214 LDHPNVMKL-EGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLL 268
L HPN+++ + ++ + +LY+V EY E DLA + T E + M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 269 RGLEHCHSRG-----ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
L+ CH R +LHRD+K +N+ ++ +K+GDFGLA + + + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383
+Y +PE + Y D+WS GC+L EL A P ++ E KI + G
Sbjct: 181 YYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRI- 236
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
P + + ++ ++L ++ +R S L +
Sbjct: 237 -------------PYR------------YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
Query: 444 K 444
Sbjct: 272 L 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-66
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 36/293 (12%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILR 212
+ +F+++ ++G G+Y V+K R E G++ A+K+ P+ E+
Sbjct: 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111
Query: 213 KL-DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
K+ HP ++LE G LYL E L G E Q+ Y++ L L
Sbjct: 112 KVGQHPCCVRLEQAWEEG-GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
H HS+G++H D+K +N+ + G K+GDFGL + + Y APELL
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELL 228
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
G YG A D++S G + E+ +P E ++ +
Sbjct: 229 QG--SYGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG---------------- 267
Query: 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
P+ +++ +L +P+ R +A + L +
Sbjct: 268 --YLPPEFT---------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-66
Identities = 75/357 (21%), Positives = 134/357 (37%), Gaps = 43/357 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN- 218
+ + +IG G S V++ + E +I A+K V D +++ EI L KL +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 219 -VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++L + +Y+V E DL + K Y + +L + H
Sbjct: 117 KIIRLYDYEIT-DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH 174
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGA-- 334
GI+H D+K +N LI + G+LK+ DFG+A P + ++ S+V + Y PE +
Sbjct: 175 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 335 --------TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
+K D+WS GCIL + GK P + + Q+ K+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA-----------I 280
Query: 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
H F + ++ L +P+ R S L + + +
Sbjct: 281 IDPNHEIEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
Query: 447 PLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPE 503
P + K + +L + +A + S + S+ +T E
Sbjct: 328 THPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-65
Identities = 82/368 (22%), Positives = 149/368 (40%), Gaps = 44/368 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + ++ KIG+G++ + E G+ +K++ + M + RE+ +L + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
N+++ GSLY+V +Y E DL + G+ F E QI + Q+ L+H H
Sbjct: 84 NIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
R ILHRDIK N+ + G +++GDFG+A + + L + + T +Y +PE+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICEN-K 200
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y D+W+ GC+L EL K + + KI SF
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS------------------GSF 242
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
P ++ +LV +L P +R S S L F +
Sbjct: 243 PPVSL----------HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA--------KRI 284
Query: 456 PKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSI 515
K+ + + + + K ++ + + P S G S + + +
Sbjct: 285 EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPAS---GQNSISVMPAQKITKPAAKYGIPL 341
Query: 516 SHKFHNQE 523
++K + +
Sbjct: 342 AYKKYGDK 349
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 59/308 (19%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
R F++I+ IG G + V+KA+ GK +K+V++ N RE+ L K
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 214 LDHPNVMKL---------------EGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFT 256
LDH N++ + S++ L++ E+ + L + G K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316
+ +Q+ +G+++ HS+ +++RD+K SN+ + + +KIGDFGL T+
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376
T TL Y +PE + YG +D+++ G ILAEL + +
Sbjct: 179 TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD--TAFETSKFFTDLRD-- 233
Query: 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS 436
G S+ + K L+ KLL+ +PE+R + +
Sbjct: 234 GIISDIF---DKKEK--------------------------TLLQKLLSKKPEDRPNTSE 264
Query: 437 ALRSEFFK 444
LR+
Sbjct: 265 ILRTLTVW 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-63
Identities = 71/320 (22%), Positives = 124/320 (38%), Gaps = 57/320 (17%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
R FE I +G+G + V++A++ A+K++R N + + M RE+ L KL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 215 DHPNVMK-----------LEGLVTSRSGSLYLVFEYMEH-DLAGL--ATTPGIKFTEPQI 260
+HP +++ + +S LY+ + +L +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL------ 314
Q+ +E HS+G++HRD+K SN+ V+K+GDFGL T D +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 315 -----PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM 369
T +V T Y +PE + G Y +D++S G IL EL + P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFEL-----LYPFSTQMERV 234
Query: 370 HKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPE 429
+ + K F +V +L+ P
Sbjct: 235 RTLTDVR-------------------------NLKFPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 430 NRGSAASALRSEFFKTEPLP 449
R A + + + F+ P
Sbjct: 270 ERPEAINIIENAVFEDLDFP 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-61
Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 35/288 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDH 216
F KIG+G +S VY+A L G VALKKV+ + MD ++ +EI +L++L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLE 272
PNV+K L +V E + DL+ + E + Y QL LE
Sbjct: 92 PNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
H HSR ++HRDIK +N+ I GV+K+GD GL + S V T +Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIH 209
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF-KLCGSPSEDYWRKSKSAH 391
Y D+WS GC+L E+ A + P + ++ + K+ DY
Sbjct: 210 E-NGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKKIE---QCDY-------- 255
Query: 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
P P + + LV+ + +PE R
Sbjct: 256 -----PPLPSDH--------YSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ D +GQG ++V++ R +TG + A+K + M RE +L+KL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 218 NVMKL-EGLVTSRSGSLYLVFEYMEH-DLAGLATTPG--IKFTEPQIKCYMQQLLRGLEH 273
N++KL + + L+ E+ L + P E + ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 274 CHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
GI+HR+IK N++ + V K+ DFG A + + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPD 185
Query: 330 LLLGAT-------KYGAAIDMWSAGCILAELFAGKP----IMPGRTEVEQMHKIFKLCGS 378
+ A KYGA +D+WS G G R E M+KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 379 PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
+ +K+++ + P + + ++ +L + E
Sbjct: 246 GAISGVQKAEN-GPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGF---- 297
Query: 439 RSEFFK 444
+FF
Sbjct: 298 -DQFFA 302
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 8e-58
Identities = 70/311 (22%), Positives = 113/311 (36%), Gaps = 20/311 (6%)
Query: 146 GEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA 205
G + +E +++G G + V + +TG+ VA+K+ R + P++
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWC 60
Query: 206 REIHILRKLDHPNVMKL-----EGLVTSRSGSLYLVFEYMEH-DLAGLATTPG--IKFTE 257
EI I++KL+HPNV+ + + L EY E DL E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 258 PQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNL 314
I+ + + L + H I+HRD+K N+++ + KI D G A D +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL- 179
Query: 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
T V TL Y APELL KY +D WS G + E G + Q H +
Sbjct: 180 -CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
+ + A S P + + + +L RG+
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER-----WLQCMLMWHQRQRGTD 292
Query: 435 ASALRSEFFKT 445
F+
Sbjct: 293 PQNPNVGCFQA 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ D +GQG ++V++ R +TG + A+K + M RE +L+KL+H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHK 67
Query: 218 NVMKL-EGLVTSRSGSLYLVFEYMEH-DLAGLATTPG--IKFTEPQIKCYMQQLLRGLEH 273
N++KL + + L+ E+ L + P E + ++ ++ G+ H
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 274 CHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
GI+HR+IK N++ + V K+ DFG A + + S T Y P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPD 185
Query: 330 LLLGAT-------KYGAAIDMWSAGCILAELFAGKP----IMPGRTEVEQMHKIFKLCGS 378
+ A KYGA +D+WS G G R E M+KI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 379 PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
+ +K+++ + P + + LA +L + E
Sbjct: 246 GAISGVQKAEN-GPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKCWGF---- 297
Query: 439 RSEFFK 444
+FF
Sbjct: 298 -DQFFA 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-57
Identities = 63/309 (20%), Positives = 110/309 (35%), Gaps = 61/309 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPN 218
F +++KIG G + SV+K G I A+K+ + + RE++ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLEHC 274
V++ + + EY LA F E ++K + Q+ RGL +
Sbjct: 73 VVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 275 HSRGILHRDIKGSNLLINNAGVL-------------------KIGDFGLATTYDPSQNLP 315
HS ++H DIK SN+ I+ + KIGD G T Q
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--- 188
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
+ A E+L + D+++ + +P +P +Q H+I +
Sbjct: 189 --VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEIRQ- 242
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435
G P+ P + Q L+ ++ +PE R SA
Sbjct: 243 -GRL-----------------PRIP---------QVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 436 SALRSEFFK 444
+ ++
Sbjct: 276 ALVKHSVLL 284
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 84/335 (25%), Positives = 133/335 (39%), Gaps = 42/335 (12%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF-MAREIHILR 212
PR + + +G+G ++ ++ D +T ++ A K V + + R M+ EI I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H +V+ G +++V E L L TEP+ + Y++Q++ G
Sbjct: 97 SLAHQHVVGFHGFFEDND-FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 154
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
++ H ++HRD+K NL +N +KIGDFGLAT + T Y APE+L
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVL 213
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
+ +D+WS GCI+ L GKP P E
Sbjct: 214 SK-KGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET-----SCLK 247
Query: 392 ATSFKPQQPYKRKVLETFR---NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
T Y R + + A +L+ K+L +P R + L EFF + +
Sbjct: 248 ET-------YLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
Query: 449 PCD-PSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
P P PP + D RK +
Sbjct: 301 PARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 335
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-56
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 39/293 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ ++++ K+G G Y V RD T A+K +R ++ S + E+ +L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N+MKL + + YLV E + +L KF E ++Q+L G+ + H
Sbjct: 97 NIMKLYDFFEDKR-NYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHK 154
Query: 277 RGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
I+HRD+K NLL+ + ++KI DFGL+ ++ + + R+ T +Y APE+L
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRK 212
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--EDYWRKSKSAH 391
KY D+WS G IL L AG P G+T+ E + K+ K G + W
Sbjct: 213 --KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDSPEW------- 261
Query: 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+N + A L+ ++L + + R SA AL + K
Sbjct: 262 ------------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 66/307 (21%), Positives = 110/307 (35%), Gaps = 45/307 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ I K+G+G +S V L G ALK++ + RE + R +HPN+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNI 88
Query: 220 MKLEGLVTSRSGS---LYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRGLE 272
++L G+ +L+ + + L G TE QI + + RGLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--------TLW 324
H++G HRD+K +N+L+ + G + D G + + T+
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 325 YRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382
YRAPEL D+WS GC+L + G+ P + + +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGDS 255
Query: 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
PQ P + L++ ++T++P R L
Sbjct: 256 VALA---VQNQLSIPQSP----------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
Query: 443 FKTEPLP 449
P P
Sbjct: 303 ALQPPAP 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-56
Identities = 82/327 (25%), Positives = 140/327 (42%), Gaps = 59/327 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + + +G+G++ V K +D T + A+K + A+ + + RE+ +L+KLDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQL 267
N+MKL ++ S S Y+V E G I +F+E ++Q+
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLW 324
G+ + H I+HRD+K N+L+ + +KI DFGL+T + + + R+ T +
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--ED 382
Y APE+L G Y D+WSAG IL L +G P G+ E + + ++ G +
Sbjct: 189 YIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLP 244
Query: 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
W R A L+ K+LT P R +A L +
Sbjct: 245 QW-------------------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279
Query: 443 FKTEPLPCDPSNLPKYPPSKELDAKLR 469
+ + + P + +R
Sbjct: 280 IQKY--SSETPTISDLPSLESAMTNIR 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-56
Identities = 66/298 (22%), Positives = 110/298 (36%), Gaps = 44/298 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPN 218
F D +G G ++ R + + VA+K+ + PE F RE+ +LR+ D HPN
Sbjct: 26 FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKR-----ILPECFSFADREVQLLRESDEHPN 79
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
V++ R Y+ E L + +QQ GL H HS
Sbjct: 80 VIRYFCTEKDRQ-FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 279 ILHRDIKGSNLLINNAG-----VLKIGDFGLATTYDPSQNL--PLTSRVVTLWYRAPELL 331
I+HRD+K N+LI+ I DFGL ++ + T + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 332 LGATK--YGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
K +D++SAGC+ + + G + + + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
A L++K++ ++P+ R SA L+ FF +
Sbjct: 259 IAR--------------------------ELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 81/313 (25%), Positives = 128/313 (40%), Gaps = 42/313 (13%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF-MAREIHILR 212
PR + + +G+G ++ ++ D +T ++ A K V + + R M+ EI I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H +V+ G +++V E L L TEP+ + Y++Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDND-FVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 128
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
++ H ++HRD+K NL +N +KIGDFGLAT + T Y APE+L
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVL 187
Query: 332 LGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391
+ +D+WS GCI+ L GKP P E
Sbjct: 188 SK-KGHSFEVDVWSIGCIMYTLLVGKP--------------------PFET-----SCLK 221
Query: 392 ATSFKPQQPYKRKVLETFR---NFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
T Y R + + A +L+ K+L +P R + L EFF + +
Sbjct: 222 ET-------YLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274
Query: 449 PCD-PSNLPKYPP 460
P P PP
Sbjct: 275 PARLPITCLTIPP 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-56
Identities = 88/340 (25%), Positives = 142/340 (41%), Gaps = 64/340 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D ++ +G+G++ V +D TG+ A+K + + + RE+ +L++LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQ 266
PN+MKL + YLV E G I +F+E ++Q
Sbjct: 86 PNIMKLYEFFEDKG-YFYLVGEVYT----------GGELFDEIISRKRFSEVDAARIIRQ 134
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTL 323
+L G+ + H I+HRD+K NLL+ + ++I DFGL+T ++ S+ + ++ T
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTA 192
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--E 381
+Y APE+L G Y D+WS G IL L +G P G E + + K+ K G +
Sbjct: 193 YYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFEL 248
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441
W+ +SA L+ K+LT P R SA AL E
Sbjct: 249 PQWK-------------------------KVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 442 FFKTEPLPCDPSNLPKYPPSKELDAKLRDQEAR---KQEA 478
+ +T P +R + Q A
Sbjct: 284 WIQTY---TKEQISVDVPSLDNAILNIRQFQGTQKLAQAA 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-55
Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 42/296 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++G+G++ V++ +D +TG A+KKVR E E+ L P +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+ L G V + + E +E L L G E + Y+ Q L GLE+ H+R
Sbjct: 113 VPLYGAVREGP-WVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRR 170
Query: 279 ILHRDIKGSNLLINNAGVL-KIGDFGLATTYDPSQNLPLTSRVVTL----WYRAPELLLG 333
ILH D+K N+L+++ G + DFG A P + + APE+++G
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
A +D+WS+ C++ + G P T+ + K+ A+
Sbjct: 231 -KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKI----------------AS 270
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
P + + + L EP +R SA R + +
Sbjct: 271 EPPPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVGKALQEVG 319
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 80/302 (26%), Positives = 136/302 (45%), Gaps = 57/302 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + + +G+G++ V K +D T + A+K + A+ + + RE+ +L+KLDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQL 267
N+MKL ++ S S Y+V E G I +F+E ++Q+
Sbjct: 82 NIMKLFEILEDSS-SFYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLW 324
G+ + H I+HRD+K N+L+ + +KI DFGL+T + + + R+ T +
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--ED 382
Y APE+L G Y D+WSAG IL L +G P G+ E + + ++ G +
Sbjct: 189 YIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLP 244
Query: 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
W ++ S A L+ K+LT P R +A L +
Sbjct: 245 QW-RTIS------------------------DDAKDLIRKMLTFHPSLRITATQCLEHPW 279
Query: 443 FK 444
+
Sbjct: 280 IQ 281
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-55
Identities = 92/338 (27%), Positives = 148/338 (43%), Gaps = 57/338 (16%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAR----EIHILRKL- 214
+E + IG+G++ V KA D + + VALK VR + + R EI IL L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLR 151
Query: 215 -----DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLL 268
+ NV+ + T R + + FE + +L + F+ P ++ + +L
Sbjct: 152 KQDKDNTMNVIHMLENFTFR-NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAG--VLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
+ L+ H I+H D+K N+L+ G +K+ DFG + ++ + + + + +YR
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRFYR 266
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386
APE++LGA +YG IDMWS GCILAEL G P++PG E +Q+ + +L G PS+
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 387 SKSAHA----------------TSFKPQQPYKRKVLETFRNFPQSA-------------- 416
SK A + R R P+S
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 417 LALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
L + + L +P R + ALR + LP P+
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWL-RRRLPKPPTG 422
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-55
Identities = 91/357 (25%), Positives = 143/357 (40%), Gaps = 81/357 (22%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANM------DPESVRFMAREI 208
D + +G G V A + +T K VA+K K +FA +V EI
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEI 66
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEP 258
IL+KL+HP ++K++ + Y+V E ME G + + E
Sbjct: 67 EILKKLNHPCIIKIKNFFDAED--YYIVLELME----------GGELFDKVVGNKRLKEA 114
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLP 315
K Y Q+L +++ H GI+HRD+K N+L+++ ++KI DFG + +
Sbjct: 115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--L 172
Query: 316 LTSRVVTLWYRAPELLLGATK--YGAAIDMWSAGCILAELFAGKPIMP---GRTEVEQMH 370
+ + T Y APE+L+ Y A+D WS G IL +G P P RT+V
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKD 230
Query: 371 KIFKLCGS---PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
+I G E W + AL LV KLL ++
Sbjct: 231 QI--TSGKYNFIPE-VW-------------------------AEVSEKALDLVKKLLVVD 262
Query: 428 PENRGSAASALRSEFFKTEPLPCDPSNLPK----YPPSKELDAKLRDQEARKQEAEA 480
P+ R + ALR + + E + +L ++ A+ R +E EA
Sbjct: 263 PKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEA 319
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-55
Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 48/305 (15%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVRFANMDPESVRFMAREI 208
+ + F+ + +G+G+++ VY+A + TG VA+K + A M + V+ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV-QRVQ---NEV 62
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQL 267
I +L HP++++L + +YLV E + ++ F+E + + +M Q+
Sbjct: 63 KIHCQLKHPSILELYNYFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRA 327
+ G+ + HS GILHRD+ SNLL+ +KI DFGLAT T T Y +
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYIS 180
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
PE+ + +G D+WS GC+ L G+P P +
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRP--------------------PFDT----- 214
Query: 388 KSAHATSFKPQQPYKRKVLETFR---NFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ T + VL + A L+ +LL P +R S +S L F
Sbjct: 215 DTVKNT-------LNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
Query: 445 TEPLP 449
Sbjct: 268 RNSST 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 39/290 (13%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+IG+G++ +VYK D ET VA +++ + + E +L+ L HPN+++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 224 G---LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG- 278
+ LV E M L ++ + +Q+L+GL+ H+R
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 279 -ILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
I+HRD+K N+ I G +KIGD GLAT S + + T + APE + K
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPE--MYEEK 205
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y ++D+++ G + E+ + P +E + +I++ S K
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV---------------K 247
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446
P K + E + ++ + + R S L FF+ E
Sbjct: 248 PASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-54
Identities = 76/320 (23%), Positives = 127/320 (39%), Gaps = 66/320 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKL 214
D ++ +++G+G +S V + TG A K + + D + + RE I RKL
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKL 62
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYM 264
HPN+++L + YLVF+ + G I ++E +
Sbjct: 63 QHPNIVRLHDSIQEE-SFHYLVFDLVT----------GGELFEDIVAREFYSEADASHCI 111
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVV 321
QQ+L + +CHS GI+HR++K NLL+ + +K+ DFGLA + S+
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAG 169
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSP 379
T Y +PE+L Y +D+W+ G IL L G P P + +I G+
Sbjct: 170 TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAY 224
Query: 380 S--EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA 437
W + A +L+D +LT+ P+ R +A A
Sbjct: 225 DYPSPEWDT------VT-------------------PEAKSLIDSMLTVNPKKRITADQA 259
Query: 438 LRSEFFKTEPLPCDPSNLPK 457
L+ + +
Sbjct: 260 LKVPWICNRERVASAIHRQD 279
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 77/359 (21%), Positives = 134/359 (37%), Gaps = 75/359 (20%)
Query: 151 GWQPRRADAFEKI----DKIGQGTYSSVYKARDLETGKIVALK-------KVRFANMDPE 199
G +P + E +++G G ++ V K R+ TG A K + + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 200 SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I 253
+ RE+ ILR++ H NV+ L + +R+ + L+ E + G +
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVYENRT-DVVLILELVS----------GGELFDFL 106
Query: 254 ----KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLA 305
+E + +++Q+L G+ + H++ I H D+K N+++ +K+ DFGLA
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
Query: 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GR 363
+ + T + APE++ G DMWS G I L +G P G
Sbjct: 167 HEIEDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGD 221
Query: 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKL 423
T+ E + I + E+++ TS + A + KL
Sbjct: 222 TKQETLANITSVSYDFDEEFFSH------TS-------------------ELAKDFIRKL 256
Query: 424 LTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
L E R + ALR + D S R Q R++ +
Sbjct: 257 LVKETRKRLTIQEALRHPWITPV----DNQQAMVRRESVVNLENFRKQYVRRRWKLSFS 311
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-54
Identities = 87/353 (24%), Positives = 137/353 (38%), Gaps = 74/353 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR-----------FANMDPESVRFMAR 206
+++ K+ K+G G Y V ++ A+K ++ + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFT 256
EI +L+ LDHPN++KL + + YLV E+ E G I KF
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKK-YFYLVTEFYE----------GGELFEQIINRHKFD 144
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQN 313
E M+Q+L G+ + H I+HRDIK N+L+ N +KI DFGL++ +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY- 203
Query: 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
L R+ T +Y APE+L KY D+WS G I+ L G P G+ + + + K+
Sbjct: 204 -KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 374 KLCGSPS--EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
K G + W +N A L+ +LT + R
Sbjct: 261 K--GKYYFDFNDW-------------------------KNISDEAKELIKLMLTYDYNKR 293
Query: 432 GSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEAR---KQEAEAV 481
+A AL S + K + N + +R E Q A
Sbjct: 294 CTAEEALNSRWIKKY---ANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 39/305 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + + +G+G + V++ + + K K V+ D V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 218 NVMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ L S L ++FE++ D+ T + E +I Y+ Q+ L+ HS
Sbjct: 62 NILHLHESFESME-ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 277 RGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
I H DI+ N++ + +KI +FG A P Y APE+
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQH- 177
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
A DMWS G ++ L +G P T + + I + E+ +++
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE------ 229
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDP 452
S A+ VD+LL E ++R +A+ AL+ + K +
Sbjct: 230 IS-------------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
Query: 453 SNLPK 457
+
Sbjct: 271 KVIRT 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-53
Identities = 88/349 (25%), Positives = 138/349 (39%), Gaps = 57/349 (16%)
Query: 129 EGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKI----DKIGQGTYSSVYKARDLETGK 184
E+ V + Q A +G G V A + +T K
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCK 161
Query: 185 IVALK---------KVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235
VA++ +V EI IL+KL+HP ++K++ + Y+
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVE---TEIEILKKLNHPCIIKIKNFFDAED--YYI 216
Query: 236 VFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294
V E ME +L + E K Y Q+L +++ H GI+HRD+K N+L+++
Sbjct: 217 VLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 295 G---VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK--YGAAIDMWSAGCI 349
++KI DFG + + + + T Y APE+L+ Y A+D WS G I
Sbjct: 276 EEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 350 LAELFAGKPIMP---GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVL 406
L +G P P RT+V +I G Y +F P +V
Sbjct: 334 LFICLSGYP--PFSEHRTQVSLKDQI--TSG----KY----------NFIP--EVWAEVS 373
Query: 407 ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
E AL LV KLL ++P+ R + ALR + + E + +L
Sbjct: 374 E-------KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 80/345 (23%), Positives = 135/345 (39%), Gaps = 69/345 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D ++ +++G+G +S V + TG A K + + + + RE I RKL HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQL 267
N+++L + YLVF+ + G I ++E +QQ+
Sbjct: 89 NIVRLHDSIQEE-SFHYLVFDLVT----------GGELFEDIVAREFYSEADASHCIQQI 137
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLW 324
L + +CHS GI+HR++K NLL+ + +K+ DFGLA + S+ T
Sbjct: 138 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPG 195
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSPS-- 380
Y +PE+L Y +D+W+ G IL L G P P + +I G+
Sbjct: 196 YLSPEVLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYP 250
Query: 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W + A +L+D +LT+ P+ R +A AL+
Sbjct: 251 SPEWDT------VT-------------------PEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 441 EFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEAR---KQEAEAVR 482
+ C+ + ++ L+ AR K
Sbjct: 286 PWI------CNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM 324
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-52
Identities = 72/357 (20%), Positives = 123/357 (34%), Gaps = 69/357 (19%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-H 216
+ +G G+ +V G+ VA+K+ M + EI +L + D H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEIKLLTESDDH 68
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLA------GLATTPGIKFTEPQIKCYMQQLLRG 270
PNV++ T+ LY+ E +L ++ E ++Q+ G
Sbjct: 69 PNVIRYYCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGV-------------LKIGDFGLATTYDPSQ---NL 314
+ H HS I+HRD+K N+L++ + + I DFGL D Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 315 PLTSRVVTLWYRAPELLLGAT------KYGAAIDMWSAGCILAE-LFAGKPIMPGRTEVE 367
L + T +RAPELL + + +ID++S GC+ L GK P +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKYS 245
Query: 368 QMHKIFK--LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLT 425
+ I + + +S A L+ +++
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLI------------------------AEATDLISQMID 281
Query: 426 IEPENRGSAASALRSEFFKTE----PLPCDPSNLPKYPPSKELDAKLRDQEARKQEA 478
+P R +A LR F + S+ + A L +A
Sbjct: 282 HDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFV 338
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 84/315 (26%), Positives = 133/315 (42%), Gaps = 64/315 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
+ + IG+G++ V A T A KK+ + D + + +EI I++ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDH 65
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQ 266
PN+++L + +YLV E G + F E M+
Sbjct: 66 PNIIRLYETFEDNT-DIYLVMELCT----------GGELFERVVHKRVFRESDAARIMKD 114
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTL 323
+L + +CH + HRD+K N L LK+ DFGLA + P + + ++V T
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTP 172
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--E 381
+Y +P++L G YG D WSAG ++ L G P T+ E M KI G+ + E
Sbjct: 173 YYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPE 228
Query: 382 DYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
W S A + +L+ +LLT P+ R ++ AL
Sbjct: 229 KDWLNVSPQA-----E---------------------SLIRRLLTKSPKQRITSLQALEH 262
Query: 441 EFFKTEPLPCDPSNL 455
E+F+ + L P NL
Sbjct: 263 EWFEKQ-LSSSPRNL 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 71/338 (21%), Positives = 121/338 (35%), Gaps = 79/338 (23%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKL 214
+ IGQG+Y V A + +T I A+K K + ++P+ V + E+ +++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYME--------------------------------- 241
HPN+ +L + + LV E
Sbjct: 86 HHPNIARLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 242 -------HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294
+ G + E I M+Q+ L + H++GI HRDIK N L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 295 G--VLKIGDFGLATTY---DPSQNLPLTSRVVTLWYRAPELLLGATK-YGAAIDMWSAGC 348
+K+ DFGL+ + + + +T++ T ++ APE+L + YG D WSAG
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 349 ILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--EDYWRKSKSAHATSFKPQQPYKRKVL 406
+L L G PG + + + ++ +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNY---------------------- 300
Query: 407 ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
A L+ LL + R A AL+ +
Sbjct: 301 ---NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-52
Identities = 45/323 (13%), Positives = 82/323 (25%), Gaps = 57/323 (17%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRF-ANMDPESVRFMAREIHILRK 213
+ + ++ + G S V+ RD+E + ALK A + + +
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 214 LDHPNVMKL-------------------------EGLVTSRSGSLYLVFEYMEHDLAGL- 247
L + + G + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 248 -----ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302
+ QL+R + S+G++H NL I G L +GD
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 303 GLATTYDPSQNLPLTSRVVTLWYRAPELLLG-ATKYGAAIDMWSAGCILAELFAGKPIMP 361
+ V + Y E L + A++ W G + ++
Sbjct: 239 SALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 362 GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVD 421
T + P D + P L+
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLA--------------------FGSCTPLPDFVKTLIG 334
Query: 422 KLLTIEPENRGSAASALRSEFFK 444
+ L + R A+ + F
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFL 357
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-52
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKV--RFANMDPESVRFMAREIHILRKLD 215
D F K+G G + V+ + +G +K + + + E + EI +L+ LD
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLD 78
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYME-----HDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
HPN++K+ + ++Y+V E E + +E + M+Q++
Sbjct: 79 HPNIIKIFEVFEDYH-NMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNA 136
Query: 271 LEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRA 327
L + HS+ ++H+D+K N+L + +KI DFGLA + + T+ T Y A
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMA 194
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--EDYWR 385
PE+ D+WSAG ++ L G G + E K P+ +
Sbjct: 195 PEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP 250
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ A L+ ++LT +PE R SAA L E+FK
Sbjct: 251 LTPQA-----V---------------------DLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-52
Identities = 80/385 (20%), Positives = 157/385 (40%), Gaps = 56/385 (14%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D ++ ++++G G + V++ + TG++ K + D +V+ EI I+ +L H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ L + + L+ E++ +L K +E ++ YM+Q GL+H H
Sbjct: 108 PKLINLHDAFEDKY-EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 276 SRGILHRDIKGSNLLINNAG--VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
I+H DIK N++ +KI DFGLAT +P + + T + APE++
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDR 224
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHA 392
G DMW+ G + L +G G ++E + + + ED + S A
Sbjct: 225 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA-- 281
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE-PLPCD 451
++F + LL EP R + AL + K +
Sbjct: 282 -----------------KDF-------IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 317
Query: 452 PSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSK 511
+Y ++ K++++ A + GR +FS++R + +
Sbjct: 318 RIPSSRY---NKIRQKIKEKYADWPAPQPAIGR--------IANFSSLR------KHRPQ 360
Query: 512 PTSISHKFHNQEDSCSGFRIEPPTV 536
I + +++++ F++ P +
Sbjct: 361 EYQIYDSYFDRKEAVPRFKLRPSLI 385
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-52
Identities = 75/303 (24%), Positives = 126/303 (41%), Gaps = 67/303 (22%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKL 214
+ ++ +++G+G +S V + + G+ A + + D + + RE I R L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLL 67
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYM 264
HPN+++L ++ G YL+F+ + G I ++E +
Sbjct: 68 KHPNIVRLHDSISEE-GHHYLIFDLVT----------GGELFEDIVAREYYSEADASHCI 116
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVV 321
QQ+L + HCH G++HR++K NLL+ + +K+ DFGLA + Q
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFAG 175
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSP 379
T Y +PE+L YG +D+W+ G IL L G P P + +I G+
Sbjct: 176 TPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAY 230
Query: 380 S--EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS 436
W + A K L++K+LTI P R +AA
Sbjct: 231 DFPSPEWDTVTPEA-----K---------------------DLINKMLTINPSKRITAAE 264
Query: 437 ALR 439
AL+
Sbjct: 265 ALK 267
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-52
Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK 221
+G+GTY VY RDL +A+K++ D + + EI + + L H N+++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 222 LEGLVTSRSGSLYLVFEYME----HDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHS 276
G + + + E + L L + G +K E I Y +Q+L GL++ H
Sbjct: 84 YLGSFSENG-FIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 277 RGILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGA 334
I+HRDIKG N+LIN GVLKI DFG + T TL Y APE++
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198
Query: 335 TK-YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
+ YG A D+WS GC + E+ GKP P E +FK+ K
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKV---------GMFKVH--- 244
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445
P+ P + + F + K +P+ R A L EF K
Sbjct: 245 ---PEIP--ESMSAEAKAF-------ILKCFEPDPDKRACANDLLVDEFLKV 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-52
Identities = 99/378 (26%), Positives = 157/378 (41%), Gaps = 71/378 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKL 214
D +E + IG+G +S V + + ETG+ A+K +F + S + RE I L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYME-----HDLAGLATTPGIKFTEPQIKCYMQQLLR 269
HP++++L +S G LY+VFE+M+ ++ A G ++E YM+Q+L
Sbjct: 84 KHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILE 141
Query: 270 GLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
L +CH I+HRD+K +L+ N+ +K+G FG+A S + RV T +
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRVGTPHFM 200
Query: 327 APELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFK--LCGSPS-- 380
APE++ YG +D+W G IL L +G P G E ++F+ + G
Sbjct: 201 APEVVKR-EPYGKPVDVWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMN 252
Query: 381 EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
W S+SA K LV ++L ++P R + AL
Sbjct: 253 PRQWSHISESA-----K---------------------DLVRRMLMLDPAERITVYEALN 286
Query: 440 SEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEAR---KQEAEAVRGRGPESVRRGSRDF 496
+ K + E +LR AR K A S + + +
Sbjct: 287 HPWLK------ERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAV-----SSHKFNSFY 335
Query: 497 SAVRTPEFIPSGQSKPTS 514
PE +P PTS
Sbjct: 336 GD--PPEELPDFSEDPTS 351
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-52
Identities = 77/298 (25%), Positives = 119/298 (39%), Gaps = 61/298 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
F ++ +G G +S V+ + TGK+ ALK ++ + S+ EI +L+K+ H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKH 65
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQ 266
N++ LE + S + YLV + + G I +TE +QQ
Sbjct: 66 ENIVTLEDIYESTT-HYYLVMQLVS----------GGELFDRILERGVYTEKDASLVIQQ 114
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTL 323
+L +++ H GI+HRD+K NLL + I DFGL+ +++ T
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTP 171
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--E 381
Y APE+L Y A+D WS G I L G P TE + KI + G
Sbjct: 172 GYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFES 228
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+W S +SA + LL +P R + AL
Sbjct: 229 PFWDD------IS-------------------ESAKDFICHLLEKDPNERYTCEKALS 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-52
Identities = 79/340 (23%), Positives = 137/340 (40%), Gaps = 50/340 (14%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-------- 214
+ K+G G +S+V+ A+D+ VA+K VR + E+ EI +L+++
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 215 ---DHPNVMKLEGLVTSRSGS---LYLVFEYMEHDLAGLA-TTPGIKFTEPQIKCYMQQL 267
+++KL + + + +VFE + +L L +K +QL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 268 LRGLEHCHSR-GILHRDIKGSNLLIN------NAGVLKIGDFGLATTYDPSQNLPLTSRV 320
L GL++ H R GI+H DIK N+L+ N +KI D G A + T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNSI 196
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT------EVEQMHKIFK 374
T YR+PE+LLGA +G D+WS C++ EL G + + + + +I +
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 375 LCGSPSEDYWRKSKSAHA-----TSFKPQQPYKRKVL-----ETFRNFPQSALALVD--- 421
L G R K + K L E ++ A + D
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 422 KLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPS 461
+L ++P R A + + + L + +P
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRELY 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 75/314 (23%), Positives = 129/314 (41%), Gaps = 65/314 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVR----FMAREIHI 210
+ +E + +G+G S V + T K A+K + E V+ +E+ I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 211 LRKLD-HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQ 259
LRK+ HPN+++L+ + + +LVF+ M+ + +E +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNT-FFFLVFDLMK----------KGELFDYLTEKVTLSEKE 125
Query: 260 IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR 319
+ M+ LL + H I+HRD+K N+L+++ +K+ DFG + DP + L
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREV 183
Query: 320 VVTLWYRAPELLLGA-----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
T Y APE++ + YG +DMWS G I+ L AG P R ++ + I
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-- 241
Query: 375 LCGSPS--EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
+ G+ W S + LV + L ++P+ R
Sbjct: 242 MSGNYQFGSPEWDD------YS-------------------DTVKDLVSRFLVVQPQKRY 276
Query: 433 SAASALRSEFFKTE 446
+A AL FF+
Sbjct: 277 TAEEALAHPFFQQY 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 2e-51
Identities = 75/356 (21%), Positives = 127/356 (35%), Gaps = 50/356 (14%)
Query: 157 ADAFEKIDKIGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
+E + IG+G +V AR TG+ V ++++ E V F+ E+H+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
+HPN++ + + L++V +M DL + T E I +Q +L+
Sbjct: 84 NHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKA 140
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ------NLPLTSRVVTLW 324
L++ H G +HR +K S++LI+ G + + + + V L
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 325 YRAPELLL-GATKYGAAIDMWSAGCILAELFAGKP------------------------I 359
+ +PE+L Y A D++S G EL G
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 360 MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALAL 419
E M + S D S + P PY R F +F
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF------- 313
Query: 420 VDKLLTIEPENRGSAASALRSEFFK-TEPLPCD--PSNLPKYPPSKELDAKLRDQE 472
V++ L P+ R SA++ L FFK + + P L P +
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDH 369
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVRFANMDPESVRFMAREIHILRKL 214
FE +G+G + +VY AR+ ++ I+ALK ++ A ++ +R RE+ I L
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLR---REVEIQSHL 66
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
HPN+++L G + +YL+ EY + KF E + Y+ +L L +
Sbjct: 67 RHPNILRLYGYFHDAT-RVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 124
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
CHS+ ++HRDIK NLL+ +AG LKI DFG + + + T TL Y PE++ G
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
+ +D+WS G + E GKP T E +I ++ ++
Sbjct: 182 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF---------- 224
Query: 394 SFKPQQPYKRKVLETF-RNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
TF + A L+ +LL P R L +
Sbjct: 225 --------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 74/348 (21%), Positives = 134/348 (38%), Gaps = 71/348 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK-------KVRFANMDPESVRFMAREIHI 210
D ++ +++G G ++ V K R+ TG A K + + E + RE+ I
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSI 68
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQI 260
LR++ HPN++ L + +R+ + L+ E + G + +E +
Sbjct: 69 LRQVLHPNIITLHDVYENRT-DVVLILELVS----------GGELFDFLAQKESLSEEEA 117
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYDPSQNLPL 316
+++Q+L G+ + H++ I H D+K N+++ +K+ DFGLA +
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EF 175
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFK 374
+ T + APE++ G DMWS G I L +G P G T+ E + I
Sbjct: 176 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITA 232
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
+ E+++ + TS + A + KLL E R +
Sbjct: 233 VSYDFDEEFFSQ------TS-------------------ELAKDFIRKLLVKETRKRLTI 267
Query: 435 ASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
ALR + D S + Q R++ +
Sbjct: 268 QEALRHPWITPV----DTQQAMVRRESVVNLENFKKQYVRRRWKLSFS 311
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 82/343 (23%), Positives = 136/343 (39%), Gaps = 73/343 (21%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAR----EIHILR 212
D +E IG+G++ V KA D + VA+K ++ + + E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 213 KL------DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK------FTEPQI 260
+ ++ L+ R L LVFE + ++L L ++ +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFR-NHLCLVFEMLSYNLYDL-----LRNTNFRGVSLNLT 159
Query: 261 KCYMQQLLRGLEHCHSR--GILHRDIKGSNLLINNAG--VLKIGDFGLATTYDPSQNLPL 316
+ + QQ+ L + I+H D+K N+L+ N +KI DFG + +
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRI 215
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376
+ + +YR+PE+LLG Y AIDMWS GCIL E+ G+P+ G EV+QM+KI ++
Sbjct: 216 YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274
Query: 377 GSPSEDYWRKSKSAH--------------------ATSFKPQQPYKRKVLETFRNFPQSA 416
G P ++ A P +L P
Sbjct: 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334
Query: 417 LA---------------LVDKLLTIEPENRGSAASALRSEFFK 444
A L+ ++L +P+ R AL+ FFK
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 91/401 (22%), Positives = 150/401 (37%), Gaps = 77/401 (19%)
Query: 75 GENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGLQPQMSRIVCLPVGPEGDEVV 134
G + + R R + ++ I ++ P S + D
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLN---REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 135 AGWPSWLTSVAGEAIKGWQPRRADAFEKI----DKIGQGTYSSVYKARDLETGKIVALK- 189
G + G + A F + D IG+G S V + TG A+K
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 190 ----KVRFANMDPESVRFM-AREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEHD 243
R + E VR RE HILR++ HP+++ L S S ++LVF+ M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS-FMFLVFDLMR-- 183
Query: 244 LAGLATTPG------I----KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293
+ +E + + M+ LL + H+ I+HRD+K N+L+++
Sbjct: 184 --------KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 294 AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA-----TKYGAAIDMWSAGC 348
+++ DFG + +P + L T Y APE+L + YG +D+W+ G
Sbjct: 236 NMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 349 ILAELFAGKPIMP--GRTEVEQMHKIFKLCGSPS--EDYWRK-SKSAHATSFKPQQPYKR 403
IL L AG P P R ++ + I + G W S
Sbjct: 294 ILFTLLAGSP--PFWHRRQILMLRMI--MEGQYQFSSPEWDDRS---------------- 333
Query: 404 KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ L+ +LL ++PE R +A AL+ FF+
Sbjct: 334 ----------STVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-50
Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 67/305 (21%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK-------KVRFANMDPESVRFMAREIHI 210
D +E +++G G ++ V K R TGK A K + E + RE++I
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REVNI 61
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQI 260
LR++ HPN++ L + +++ + L+ E + G + TE +
Sbjct: 62 LREIRHPNIITLHDIFENKT-DVVLILELVS----------GGELFDFLAEKESLTEDEA 110
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV----LKIGDFGLATTYDPSQNLPL 316
+++Q+L G+ + HS+ I H D+K N+++ + V +K+ DFG+A +
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EF 168
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFK 374
+ T + APE++ G DMWS G I L +G P G T+ E + I
Sbjct: 169 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISA 225
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
+ E+Y+ TS + A + +LL +P+ R +
Sbjct: 226 VNYDFDEEYFSN------TS-------------------ELAKDFIRRLLVKDPKRRMTI 260
Query: 435 ASALR 439
A +L
Sbjct: 261 AQSLE 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-50
Identities = 62/329 (18%), Positives = 117/329 (35%), Gaps = 49/329 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMA----------- 205
+ I + QG ++ + + K ALK K +
Sbjct: 33 YRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 206 -REIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME--------HDLAGLATTPGIKFT 256
E+ I+ + + + EG++T+ +Y+++EYME L
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 257 EPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315
IKC ++ +L + H+ + I HRD+K SN+L++ G +K+ DFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY---MVDKK 206
Query: 316 LTSRVVTLWYRAPELLLGATKY-GAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMH-K 371
+ T + PE + Y GA +D+WS G L +F P + + ++
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV--PFSLKISLVELFNN 264
Query: 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
I ++ + + +K + + + L P R
Sbjct: 265 IRT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 432 GSAASALRSEFFK---TEPLPCDPSNLPK 457
++ AL+ E+ E L L K
Sbjct: 315 ITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 72/330 (21%), Positives = 131/330 (39%), Gaps = 67/330 (20%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALK-------KVRFANMDPESVRFMAREIHI 210
D ++ +++G G ++ V K R+ TG A K K + E + RE+ I
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE---REVSI 67
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQI 260
L+++ HPNV+ L + +++ + L+ E + G + TE +
Sbjct: 68 LKEIQHPNVITLHEVYENKT-DVILILELVA----------GGELFDFLAEKESLTEEEA 116
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN----AGVLKIGDFGLATTYDPSQNLPL 316
+++Q+L G+ + HS I H D+K N+++ + +KI DFGLA D
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EF 174
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFK 374
+ T + APE++ G DMWS G I L +G P G T+ E + +
Sbjct: 175 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSA 231
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
+ ++Y+ TS A + +LL +P+ R +
Sbjct: 232 VNYEFEDEYFSN------TS-------------------ALAKDFIRRLLVKDPKKRMTI 266
Query: 435 ASALRSEFFKTEPLPCDPSNLPKYPPSKEL 464
+L+ + K + S ++
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEKF 296
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-50
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 36/293 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPN 218
K + +G G + V+K + TG +A K ++ M D E V+ EI ++ +LDH N
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHAN 147
Query: 219 VMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
+++L S++ + LV EY++ +L TE +M+Q+ G+ H H
Sbjct: 148 LIQLYDAFESKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 278 GILHRDIKGSNLLINNAG--VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
ILH D+K N+L N +KI DFGLA Y P + L T + APE++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNY-D 263
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
DMWS G I L +G G + E ++ I ++ + + S A F
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF-QDISEEAKEF 322
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
+ KLL E R SA+ AL+ + L
Sbjct: 323 ------------------------ISKLLIKEKSWRISASEALKHPWLSDHKL 351
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-50
Identities = 80/328 (24%), Positives = 133/328 (40%), Gaps = 53/328 (16%)
Query: 142 TSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVRFANM 196
T++A + + D F+ +G+G + +VY AR+ + I+ALK ++ +
Sbjct: 1 TALAEMPKRKF---TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV 57
Query: 197 DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKF 255
+ +R REI I L HPN++++ R +YL+ E+ +L G +F
Sbjct: 58 E-HQLR---REIEIQSHLRHPNILRMYNYFHDRK-RIYLMLEFAPRGELYKELQKHG-RF 111
Query: 256 TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315
E + +M++L L +CH R ++HRDIK NLL+ G LKI DFG + + +L
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLR 168
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
+ TL Y PE++ G + +D+W AG + E G P + E +I +
Sbjct: 169 RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETF-RNFPQSALALVDKLLTIEPENRGSA 434
D F + L+ KLL P R
Sbjct: 228 ------DL------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPL 257
Query: 435 ASALRSEFFKTEPLPCDPSNLPKYPPSK 462
+ + K P P Y ++
Sbjct: 258 KGVMEHPWVKANSRRVLP---PVYQSTQ 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 83/331 (25%), Positives = 144/331 (43%), Gaps = 52/331 (15%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKLD 215
F + +IG G++ +VY ARD+ ++VA+KK+ ++ E + + +E+ L+KL
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 216 HPNVMKLEGLVTS--RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
HPN ++ G R + +LV EY + L E +I L+GL +
Sbjct: 113 HPNTIQYRG---CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR---VVTLWYRAPEL 330
HS ++HRD+K N+L++ G++K+GDFG A+ + V T ++ APE+
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI--------MAPANSFVGTPYWMAPEV 221
Query: 331 LLGATK--YGAAIDMWSAGCILA-ELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
+L + Y +D+WS G I EL KP P + M ++ + +
Sbjct: 222 ILAMDEGQYDGKVDVWSLG-ITCIELAERKP--P-LFNMNAMSALYHIAQNE-------- 269
Query: 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447
E FRNF VD L P++R ++ L+ F
Sbjct: 270 ---------SPALQSGHWSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR-- 311
Query: 448 LPCDPSNL-PKYPPSKELDAKLRDQEARKQE 477
P+ + +K+ +L + + RK +
Sbjct: 312 -ERPPTVIMDLIQRTKDAVRELDNLQYRKMK 341
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-49
Identities = 72/354 (20%), Positives = 124/354 (35%), Gaps = 70/354 (19%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGK-IVALKKVRFANMDPESVRFMAR----EIHILRKL 214
+E + +G+GT+ V + D GK VALK +R +V EI++L+K+
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKI 73
Query: 215 ------DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK------FTEPQIKC 262
+ + + G + + FE + + +K + P ++
Sbjct: 74 KEKDKENKFLCVLMSDWFNFH-GHMCIAFELLGKNTFEF-----LKENNFQPYPLPHVRH 127
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-------------------LKIGDFG 303
QL L H + H D+K N+L N+ +++ DFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR 363
AT T+ V T YR PE++L + D+WS GCIL E + G +
Sbjct: 188 SATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAH---------------ATSFKPQQPYKRKVLET 408
E + + K+ G +++ K + +
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302
Query: 409 FRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSK 462
L+ ++L +P R + A AL FF P + S PS+
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF-AGLTPEERSFHTSRNPSR 355
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 72/342 (21%), Positives = 135/342 (39%), Gaps = 75/342 (21%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAR----EIHILRKL- 214
F I K+G GT+ V + ++ K A+K VR +++ R E IL+K+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQ 89
Query: 215 ----DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK------FTEPQIKCYM 264
++ N++K G + L+FE + L + I F IK Y
Sbjct: 90 NDDINNNNIVKYHGKFMYY-DHMCLIFEPLGPSLYEI-----ITRNNYNGFHIEDIKLYC 143
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-------------------------LKI 299
++L+ L + + H D+K N+L+++ +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 300 GDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI 359
DFG AT + + S + T YRAPE++L + + DMWS GC+LAEL+ G +
Sbjct: 204 IDFGCAT-FK---SDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLL 258
Query: 360 MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF------KPQQPYKRKVLETFRNFP 413
+E + + + ++ ++ + + + K P + + ++
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 414 QSA-----------LALVDKLLTIEPENRGSAASALRSEFFK 444
+ + +L I+P R S A L+ +F +
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-49
Identities = 76/367 (20%), Positives = 132/367 (35%), Gaps = 43/367 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D ++ +++G G + V++ + TG A K V + D E+VR +EI + L H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRH 213
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ L + + +++E+M +L K +E + YM+Q+ +GL H H
Sbjct: 214 PTLVNLHDAFEDDN-EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 276 SRGILHRDIKGSNLLINNAGV--LKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
+H D+K N++ LK+ DFGL DP Q + T + APE+ G
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEG 330
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-SKSAHA 392
G DMWS G + L +G G + E + + + + + S+
Sbjct: 331 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG-- 387
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDP 452
++F + KLL +P R + AL +
Sbjct: 388 -----------------KDF-------IRKLLLADPNTRMTIHQALEHPWLTP-----GN 418
Query: 453 SNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKP 512
+ K+RD K +A + S I
Sbjct: 419 APGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDR 478
Query: 513 TSISHKF 519
+ +F
Sbjct: 479 SEAQPRF 485
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 69/324 (21%), Positives = 119/324 (36%), Gaps = 43/324 (13%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PNVMKLE 223
++G+G ++ V + TG+ A K ++ + + EI +L P V+ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 224 GLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ + S + L+ EY L +E + ++Q+L G+ + H I
Sbjct: 96 EVYENTS-EIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 280 LHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+H D+K N+L+++ G +KI DFG++ + L + T Y APE+L
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY-DP 209
Query: 337 YGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
A DMW+ G I L P G E I ++ SE+ + S
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS------VS 261
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
Q A + LL PE R +A L + +
Sbjct: 262 -------------------QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302
Query: 455 LPKYPPSKELDAKLRDQEARKQEA 478
S+ D +R E + ++
Sbjct: 303 EETSSSSQTQDHSVRSSEDKTSKS 326
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 31/223 (13%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMA-------------- 205
D+IG+G+Y V A + A+K K + R
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 206 -------REIHILRKLDHPNVMKL-EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFT 256
+EI IL+KLDHPNV+KL E L LY+VFE + + + T +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLS 135
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316
E Q + Y Q L++G+E+ H + I+HRDIK SNLL+ G +KI DFG++ + S L L
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL-L 194
Query: 317 TSRVVTLWYRAPELLLGATK-Y-GAAIDMWSAGCILAELFAGK 357
++ V T + APE L K + G A+D+W+ G L G+
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 84/340 (24%), Positives = 133/340 (39%), Gaps = 77/340 (22%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLE 223
IG G+YS + T A+K + + DP EI IL + HPN++ L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITLK 82
Query: 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQLLRGLEH 273
+ +Y+V E M+ G I F+E + + + + +E+
Sbjct: 83 DVYDDGK-YVYVVTELMK----------GGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 274 CHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
H++G++HRD+K SN+L N ++I DFG A +N L + T + APE
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTANFVAPE 190
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKP---IMPGRTEVEQMHKIFKLCGS---PSEDY 383
+L Y AA D+WS G +L + G P T E + +I G Y
Sbjct: 191 VLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--GSGKFSLSGG-Y 246
Query: 384 WRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
W S +A LV K+L ++P R +AA LR +
Sbjct: 247 WNSVS--------------------------DTAKDLVSKMLHVDPHQRLTAALVLRHPW 280
Query: 443 FKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVR 482
LP+Y +++ DA + A A+
Sbjct: 281 I------VHWDQLPQYQLNRQ-DAPHLVKGAMAATYSALN 313
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 77/332 (23%), Positives = 117/332 (35%), Gaps = 76/332 (22%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMK 221
D +G+G ++ V +L T + A+K + V RE+ +L + H NV++
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLE 75
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQLLRGL 271
L YLVFE M G I F E + +Q + L
Sbjct: 76 LIEFFEEED-RFYLVFEKMR----------GGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 272 EHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQ------NLPLTSRVVT 322
+ H++GI HRD+K N+L + +KI DF L + + L + +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 323 LWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS 378
Y APE++ A+ Y D+WS G IL I+ L G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL--------------LSGY 223
Query: 379 P---SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFP--------QSALALVDKLLTIE 427
P Q + E FP +A L+ KLL +
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283
Query: 428 PENRGSAASALRSEFFKTE----PLPCDPSNL 455
+ R SAA L+ + + LP P L
Sbjct: 284 AKQRLSAAQVLQHPWVQGCAPENTLP-TPMVL 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 35/304 (11%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
D +E + IG G + V A + VA+K++ + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYME---------HDLAGLATTPGIKFTEPQIKCYM 264
HPN++ + L+LV + + H +A G+ E I +
Sbjct: 70 CHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATIL 127
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG----LATTYDPSQNLPLTSRV 320
+++L GLE+ H G +HRD+K N+L+ G ++I DFG LAT D ++N + V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS 380
T + APE++ Y D+WS G EL G P + M +
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-YHKYPPMKVLMLT----- 239
Query: 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
+ P + E + + +S ++ L +PE R +AA LR
Sbjct: 240 -----------LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 441 EFFK 444
+FF+
Sbjct: 289 KFFQ 292
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-48
Identities = 70/341 (20%), Positives = 126/341 (36%), Gaps = 69/341 (20%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAR----EIHILRKL 214
+E +D +G+G + V + D + G + VA+K V+ +V EI +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHL 68
Query: 215 ------DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIK------FTEPQIKC 262
+++ G + +VFE + IK F I+
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHH-GHICIVFELLGLSTYDF-----IKENGFLPFRLDHIRK 122
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-------------------LKIGDFG 303
Q+ + + HS + H D+K N+L + +K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR 363
AT YD ++ ++ V T YRAPE++L + D+WS GCIL E + G + P
Sbjct: 183 SAT-YD-DEHH--STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 364 TEVEQMHKIFKLCGSPSEDYWRKSKSAH---------------ATSFKPQQPYKRKVLET 408
E + + ++ G + +K++ ++ + +
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297
Query: 409 FRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
+ L+ K+L +P R + AL+ FF
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 70/312 (22%), Positives = 115/312 (36%), Gaps = 63/312 (20%)
Query: 150 KGWQPRRADAFE--KIDK--IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA 205
+G +P++ + ++ K +G G V + TG+ ALK + D R
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR--- 69
Query: 206 REIHILRKL-DHPNVMKLEGL---VTSRSGSLYLVFEYMEHDLAG------LATTPGIKF 255
+E+ + P+++ + + + L ++ E ME G + F
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAF 125
Query: 256 TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQ 312
TE + M+ + ++ HS I HRD+K NLL + VLK+ DFG A +
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN- 184
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
L + T +Y APE+L G KY + DMWS G I+ L G P T +
Sbjct: 185 --ALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 373 FK--LCGSPS--EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
+ G W + S + A L+ LL +
Sbjct: 242 KRRIRLGQYGFPNPEWSEVS--------------------------EDAKQLIRLLLKTD 275
Query: 428 PENRGSAASALR 439
P R + +
Sbjct: 276 PTERLTITQFMN 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 82/308 (26%), Positives = 127/308 (41%), Gaps = 69/308 (22%)
Query: 154 PRRADAFEKI----DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIH 209
DA ++G+G S VY+ + T K ALK ++ +D + VR EI
Sbjct: 45 GSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIG 100
Query: 210 ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQ 259
+L +L HPN++KL+ + + + + LV E + G I ++E
Sbjct: 101 VLLRLSHPNIIKLKEIFETPT-EISLVLELVT----------GGELFDRIVEKGYYSERD 149
Query: 260 IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPL 316
++Q+L + + H GI+HRD+K NLL LKI DFGL+ + +
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM 207
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK-- 374
+ T Y APE+L G YG +DMWS G I L G P E +F+
Sbjct: 208 KTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRI 263
Query: 375 LCGSPS--EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
L +W + S +A K LV KL+ ++P+ R
Sbjct: 264 LNCEYYFISPWWDEVSLNA-----------KD---------------LVRKLIVLDPKKR 297
Query: 432 GSAASALR 439
+ AL+
Sbjct: 298 LTTFQALQ 305
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 82/315 (26%), Positives = 130/315 (41%), Gaps = 47/315 (14%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK-----KVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+G+G+Y V + D ET A+K K+R +V+ +EI +LR+L H NV+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 221 KL-EGLVTSRSGSLYLVFEYMEHDLAGL-ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+L + L +Y+V EY + + + P +F Q Y QL+ GLE+ HS+G
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGATKY 337
I+H+DIK NLL+ G LKI G+A P + + + + ++ PE+ G +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 338 -GAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
G +D+WSAG L + G P G + I K Y
Sbjct: 190 SGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----------- 230
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
P + L+ +L EP R S + +F+ + P
Sbjct: 231 ---AIP---------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP--AEA 276
Query: 455 LPKYPPSKELDAKLR 469
PPS + + R
Sbjct: 277 PVPIPPSPDTKDRWR 291
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 48/336 (14%), Positives = 101/336 (30%), Gaps = 82/336 (24%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDP-ESVRFMAREIHILRKL---------- 214
+GQ + +A D ETG+ + F P +++ M E+ LR L
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 215 ---------------DHPNVMKL-EGLVTSRSGSLYLVFEYMEHDLAGL------ATTPG 252
++++ S + ++ M+ +L ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
Q++R L H G++H ++ +++++ G + + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--- 257
Query: 313 NLPLTSRVVTLWYRAPELL----------LGATKYGAAIDMWSAGCILAELFAGKPIMPG 362
V+ + PEL T + D W+ G ++ ++ +
Sbjct: 258 --ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 363 RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDK 422
+ IF+ C +N PQ AL++
Sbjct: 316 DAALGGSEWIFRSC---------------------------------KNIPQPVRALLEG 342
Query: 423 LLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKY 458
L E+R A+ + ++ + LP Y
Sbjct: 343 FLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-47
Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 41/296 (13%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES---VRFMAREIHILRK 213
+ +E + ++G G + VYKA++ ETG + A K ++ +S + EI IL
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-----IETKSEEELEDYIVEIEILAT 72
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
DHP ++KL G G L+++ E+ + + TEPQI+ +Q+L L
Sbjct: 73 CDHPYIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
HS+ I+HRD+K N+L+ G +++ DFG++ + S + T ++ APE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-KRDSFIGTPYWMAPEVVM 190
Query: 333 GATK----YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
T Y D+WS G L E+ +P P E+ M + K+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKI------------- 234
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
A S P K FR+F + L PE R SAA L F
Sbjct: 235 ---AKSDPPTLLTPSKWSVEFRDF-------LKIALDKNPETRPSAAQLLEHPFVS 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 83/322 (25%), Positives = 144/322 (44%), Gaps = 51/322 (15%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +VY A D+ TG+ VA++++ + + + EI ++R+ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNI 79
Query: 220 MKLEGLVTS--RSGSLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHC 274
+ S L++V EY+ G T T E QI ++ L+ LE
Sbjct: 80 VNYLD---SYLVGDELWVVMEYLA---GGSLTDVVTET-CMDEGQIAAVCRECLQALEFL 132
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS ++HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR- 190
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
YG +D+WS G + E+ G+P P + ++ + AT+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP--P-YLNENPLRALYLI----------------ATN 231
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
P+ K+ FR+F +++ L ++ E RGSA L+ +F K S+
Sbjct: 232 GTPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKELLQHQFLKI---AKPLSS 281
Query: 455 LPKYPPSKELDAKLRDQEARKQ 476
L L A ++
Sbjct: 282 L------TPLIAAAKEATKNNH 297
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 81/331 (24%), Positives = 132/331 (39%), Gaps = 71/331 (21%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKL 222
+G+G++S K ++ + A+K + + + + +EI L+ + HPN++KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPG------I----KFTEPQIKCYMQQLLRGLE 272
+ + +LV E + G I F+E + M++L+ +
Sbjct: 72 HEVFHDQL-HTFLVMELLN----------GGELFERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 273 HCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
H H G++HRD+K NLL + +KI DFG A P N PL + TL Y APE
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPE 179
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKP-------IMPGRTEVEQMHKIFKLCGSPS-- 380
LL Y + D+WS G IL + +G+ + + VE M KI G S
Sbjct: 180 LL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--KKGDFSFE 236
Query: 381 EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ W+ S+ A K L+ LLT++P R +
Sbjct: 237 GEAWKNVSQEA-------------K-------------DLIQGLLTVDPNKRLKMSGLRY 270
Query: 440 SEFFKT-EPLPCDPSNLPKYPPSKELDAKLR 469
+E+ + L +P P S
Sbjct: 271 NEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 89/323 (27%), Positives = 152/323 (47%), Gaps = 43/323 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ F+ ++K+G+G+Y SVYKA ETG+IVA+K+V + D + + +EI I+++ D P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSP 84
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+V+K G ++ L++V EY ++ + TE +I +Q L+GLE+ H
Sbjct: 85 HVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+HRDIK N+L+N G K+ DFG+A + + + T ++ APE++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIG- 201
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y D+WS G E+ GKP P ++ M IF + T+
Sbjct: 202 YNCVADIWSLGITAIEMAEGKP--P-YADIHPMRAIFMI----------------PTNPP 242
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456
P + F +F V + L PE R +A L+ F ++ S L
Sbjct: 243 PTFRKPELWSDNFTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKGVSIL- 291
Query: 457 KYPPSKELDAKLRDQEARKQEAE 479
++L + D + ++QE++
Sbjct: 292 -----RDLINEAMDVKLKRQESQ 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 87/330 (26%), Positives = 150/330 (45%), Gaps = 53/330 (16%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
+ F K++KIG+G++ V+K D T K+VA+K + + E + + +EI +L + D
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEH 273
P V K G + L+++ EY+ G A PG E QI ++++L+GL++
Sbjct: 80 PYVTKYYGSYL-KDTKLWIIMEYLG---GGSALDLLEPG-PLDETQIATILREILKGLDY 134
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
HS +HRDIK +N+L++ G +K+ DFG+A +Q + V T ++ APE++
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQ 193
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS---EDYWRKSKSA 390
+ Y + D+WS G EL G+P P +E+ M +F + + E + SK
Sbjct: 194 SA-YDSKADIWSLGITAIELARGEP--P-HSELHPMKVLFLIPKNNPPTLEGNY--SKP- 246
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
+ F V+ L EP R +A L+ +F
Sbjct: 247 ------------------LKEF-------VEACLNKEPSFRPTAKELLKHKFILRNAKK- 280
Query: 451 DPSNLPKYPPSKELDAKLRDQEARKQEAEA 480
S L EL + + +A + ++
Sbjct: 281 -TSYL------TELIDRYKRWKAEQSHDDS 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 78/346 (22%), Positives = 142/346 (41%), Gaps = 67/346 (19%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-D 215
A FE ++ +G GTY VYK R ++TG++ A+K + ++ + + +EI++L+K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 216 HPNVMK-----LEGLVTSRSGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQ 266
H N+ ++ L+LV E+ DL + T G E I ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
+LRGL H H ++HRDIKG N+L+ +K+ DFG++ D + + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWM 196
Query: 327 APELLLGATK----YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP--- 379
APE++ Y D+WS G E+ G P P ++ M +F + +P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--P-LCDMHPMRALFLIPRNPAPR 253
Query: 380 -SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
W SK F++F ++ L R + +
Sbjct: 254 LKSKKW--SKK-------------------FQSF-------IESCLVKNHSQRPATEQLM 285
Query: 439 RSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGR 484
+ F + P +++ +L+D R ++ +
Sbjct: 286 KHPFIR------------DQPNERQVRIQLKDHIDRTKKKRGEKDE 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-45
Identities = 81/305 (26%), Positives = 126/305 (41%), Gaps = 53/305 (17%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+G+G Y V A + T + VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 223 EGLVTSRSGSLYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
G + YL EY D P I EP + + QL+ G+ + H G
Sbjct: 71 YGHRREGN-IQYLFLEYCSGGELFDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGATKY 337
I HRDIK NLL++ LKI DFGLAT + ++ L TL Y APELL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
+D+WS G +L + AG+ +P + ++Y + +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKEKKT---YLN 229
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPK 457
++ + LAL+ K+L P R + + ++ L K
Sbjct: 230 P----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK--------PLKK 271
Query: 458 Y--PP 460
P
Sbjct: 272 GAKRP 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 58/294 (19%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKL 222
+G G V + + T + ALK ++ D R RE+ + + P+++++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRI 120
Query: 223 EGL---VTSRSGSLYLVFEYMEHDLAG------LATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ + + L +V E ++ G + FTE + M+ + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 274 CHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPEL 330
HS I HRD+K NLL + +LK+ DFG A LT+ T +Y APE+
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEV 234
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK--LCGSPS--EDYWRK 386
L G KY + DMWS G I+ L G P + + G W +
Sbjct: 235 L-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 387 -SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
S+ K L+ LL EP R + +
Sbjct: 294 VSEEV-------------K-------------MLIRNLLKTEPTQRMTITEFMN 321
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 45/301 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ KIG+G+ V AR+ +G+ VA+K + + + E+ I+R H NV
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNV 104
Query: 220 MKLEGLVTS--RSGSLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHC 274
+++ S L+++ E+++ G T + + E QI + +L+ L +
Sbjct: 105 VEMYK---SYLVGEELWVLMEFLQ---GGALTDIVSQV-RLNEEQIATVCEAVLQALAYL 157
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
H++G++HRDIK ++L+ G +K+ DFG S V T ++ APE++
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISR- 215
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
+ Y +D+WS G ++ E+ G+P P + + +L S
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP--P-YFSDSPVQAMKRL----------------RDS 256
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
P+ KV R+F ++++L +P+ R +A L F P
Sbjct: 257 PPPKLKNSHKVSPVLRDF-------LERMLVRDPQERATAQELLDHPFLLQ---TGLPEC 306
Query: 455 L 455
L
Sbjct: 307 L 307
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-45
Identities = 75/366 (20%), Positives = 133/366 (36%), Gaps = 63/366 (17%)
Query: 142 TSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVRFANM 196
+V E + + + + + +G G + V+ A D E K V +K KV
Sbjct: 8 KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 197 -DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG------LAT 249
+ + + EI IL +++H N++K+ + ++ LV ME +G +
Sbjct: 68 IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG-FFQLV---MEKHGSGLDLFAFIDR 123
Query: 250 TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309
P + EP +QL+ + + + I+HRDIK N++I +K+ DFG A +
Sbjct: 124 HP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM 369
+ + T+ Y APE+L+G G ++MWS G L L
Sbjct: 182 RGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL---------------- 223
Query: 370 HKIFKLCGS-PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP 428
+ P + ++ A P PY + ++LV LL P
Sbjct: 224 -----VFEENPFCEL-EETVEAA---IHP--PYL---------VSKELMSLVSGLLQPVP 263
Query: 429 ENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPES 488
E R + + + P NL Y + + + + R
Sbjct: 264 ERRTTLEKLVTDPWVTQ------PVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD 317
Query: 489 VRRGSR 494
V +
Sbjct: 318 VAQAQE 323
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 84/349 (24%), Positives = 134/349 (38%), Gaps = 51/349 (14%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+G+G Y V A + T + VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 223 EGLVTSRSGSLYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
G + YL EY D P I EP + + QL+ G+ + H G
Sbjct: 71 YGHRREGN-IQYLFLEYCSGGELFDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGATKY 337
I HRDIK NLL++ LKI DFGLAT + ++ L TL Y APELL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
+D+WS G +L + AG+ +P + ++Y + +
Sbjct: 186 AEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKEKKT---YLN 229
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPK 457
++ + LAL+ K+L P R + + ++ L K
Sbjct: 230 P----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK--------PLKK 271
Query: 458 YPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIP 506
+ + + V SR + + E
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHH 320
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 75/309 (24%), Positives = 137/309 (44%), Gaps = 42/309 (13%)
Query: 166 IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL-EG 224
IG+G ++ V AR + TG+ VA+K + ++P S++ + RE+ I++ L+HPN++KL E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 225 LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
+ T ++ LYL+ EY ++ G + E + + +Q++ +++CH + I+HRD
Sbjct: 83 IETEKT--LYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDM 343
+K NLL++ +KI DFG + + L + Y APEL G G +D+
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDV 197
Query: 344 WSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKR 403
WS G IL L +G G+ E ++ + G ++
Sbjct: 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY------------------- 236
Query: 404 KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKE 463
L+ + L + P RG+ ++ + + P E
Sbjct: 237 --------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE------DELKPFVE 282
Query: 464 LDAKLRDQE 472
+ + DQ+
Sbjct: 283 PELDISDQK 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 77/347 (22%), Positives = 126/347 (36%), Gaps = 65/347 (18%)
Query: 138 PSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVR 192
P+ + + + +G+G + +V+ L VA+K +V
Sbjct: 11 PAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVL 70
Query: 193 FANMDPESVRFMAREIHILRKLD----HPNVMKLEGLVTSRSGSLYLVFEYMEH--DLAG 246
+ +SV E+ +L K+ HP V++L LV E DL
Sbjct: 71 GWSPLSDSVT-CPLEVALLWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFD 128
Query: 247 LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLA 305
T G E +C+ Q++ ++HCHSRG++HRDIK N+LI+ G K+ DFG
Sbjct: 129 YITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
Query: 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE 365
P T T Y PE + + +WS G +L ++
Sbjct: 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM------------ 232
Query: 366 VEQMHKIFKLCGS-PSEDYWRKSKSAHATSFKPQQPYKRKVLE-TFR---NFPQSALALV 420
+CG P E +++LE + AL+
Sbjct: 233 ---------VCGDIPFERD-------------------QEILEAELHFPAHVSPDCCALI 264
Query: 421 DKLLTIEPENRGSAASALRSEFFKT--EPLPCDPSNLPKYPPSKELD 465
+ L +P +R S L + +T E +P +PS P + L
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 38/313 (12%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ D FEKI ++G G V+K +G ++A K + + P + RE+ +L + +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
P ++ G G + + E+M+ L + G + E + +++GL +
Sbjct: 90 SPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL 147
Query: 275 HSRG-ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
+ I+HRD+K SN+L+N+ G +K+ DFG++ S S V T Y +PE L G
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 204
Query: 334 ATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
T Y D+WS G L E+ G+ PI P + ++ ++ G +E R
Sbjct: 205 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 393 TSFKPQQPYKRKVL---------------------ETFRNFPQSALALVDKLLTIEPENR 431
+ + F++F V+K L P R
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLIKNPAER 316
Query: 432 GSAASALRSEFFK 444
+ F K
Sbjct: 317 ADLKQLMVHAFIK 329
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPN 218
+ +G ++ VY+A+D+ +G+ ALK++ + E R + +E+ ++KL HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 219 VMKL-------EGLVTSRSGSLYLVFEYMEHDLAGL--ATTPGIKFTEPQIKCYMQQLLR 269
+++ + + L+ E + L + + Q R
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 270 GLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS--------- 318
++H H + I+HRD+K NLL++N G +K+ DFG ATT + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 319 --RVVTLWYRAPEL--LLGATKYGAAIDMWSAGCILAELFAGKP 358
R T YR PE+ L G D+W+ GCIL L +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 50/309 (16%), Positives = 96/309 (31%), Gaps = 59/309 (19%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILR 212
+G+G ++ VY+A D + + LK + AN P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEHD-----LAGLATTPGIKFTEPQIKCYMQQL 267
MK ++GS LV E + + TP + + + ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNA-----------GVLKIGDFGLATTYDP-SQNLP 315
L +E H I+H DIK N ++ N L + D G + +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
T++ T ++ E+L + ID + + + L
Sbjct: 242 FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCM---------------------L 279
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435
G+ + + KP+ ++R +L I + +
Sbjct: 280 FGTYMKVKNEGGE------CKPEGLFRR------LPHLDMWNEFFHVMLNIPDCHHLPSL 327
Query: 436 SALRSEFFK 444
LR + K
Sbjct: 328 DLLRQKLKK 336
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 7e-43
Identities = 53/352 (15%), Positives = 105/352 (29%), Gaps = 73/352 (20%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-VRFMAREIHILRK 213
R + +GQ + +A D ETG+ + F P + ++ M E+ LR
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 214 L-------------------------DHPNVMKL-EGLVTSRSGSLYLVFEYMEHDLAGL 247
L ++++ S + ++ M+ +L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 248 ------ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301
++ Q++R L H G++H ++ +++++ G + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 302 FGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGK 357
F S P+ A +L T A D W+ G + ++
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 358 PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSAL 417
+ IF+ C +N PQ
Sbjct: 315 LPNTDDAALGGSEWIFRSC---------------------------------KNIPQPVR 341
Query: 418 ALVDKLLTIEPENRGSAASALRSEFFK---TEPLPCDPSNLPKYPPSKELDA 466
AL++ L E+R A+ + ++ TE P P++E A
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGA 393
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 60/312 (19%), Positives = 103/312 (33%), Gaps = 83/312 (26%)
Query: 150 KGWQPRRADAFEKID----KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA 205
G Q ++ + +G G V + + T + ALK ++ D R
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR--- 58
Query: 206 REIHILRKL-DHPNVMKLEGL---VTSRSGSLYLVFEYMEHDLAG------LATTPGIKF 255
RE+ + + P+++++ + + + L +V E ++ G + F
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAF 114
Query: 256 TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQ 312
TE + M+ + +++ HS I HRD+K NLL + +LK+ DFG
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
A E KY + DMWS G I+ L G P + +
Sbjct: 167 --------------AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210
Query: 373 FK--LCGSPS--EDYWRK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
G W + S+ K L+ LL E
Sbjct: 211 KTRIRMGQYEFPNPEWSEVSEEV-----K---------------------MLIRNLLKTE 244
Query: 428 PENRGSAASALR 439
P R + +
Sbjct: 245 PTQRMTITEFMN 256
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
+G+G + K ETG+++ +K++ D E+ R +E+ ++R L+HPNV+K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 225 LVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283
++ + L + EY++ L G+ + ++ Q + + + G+ + HS I+HRD
Sbjct: 75 VLY-KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 284 IKGSNLLINNAGVLKIGDFGLA-------------TTYDPSQNLPLTSRVVTLWYRAPEL 330
+ N L+ + + DFGLA + + V ++ APE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPG 362
+ G Y +D++S G +L E+ P
Sbjct: 194 ING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 71/322 (22%), Positives = 118/322 (36%), Gaps = 65/322 (20%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK-----KVRFANMDPESVRFMAREIHILRKL 214
++ +G G + SVY + VA+K ++ P R + E+ +L+K+
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKV 103
Query: 215 DH--PNVMKLEGLVTSRSGSLYLVFEYMEH--DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
V++L R S L+ E E DL T G E + + Q+L
Sbjct: 104 SSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEA 161
Query: 271 LEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
+ HCH+ G+LHRDIK N+LI+ N G LK+ DFG + T T Y PE
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 218
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS-PSEDYWRKSK 388
+ +G + +WS G +L ++ +CG P E
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDM---------------------VCGDIPFEH------ 251
Query: 389 SAHATSFKPQQPYKRKVLETFRNFP----QSALALVDKLLTIEPENRGSAASALRSEFFK 444
+++ F L+ L + P +R + + +
Sbjct: 252 -------------DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 445 TEPLPCDPSNLPKYP----PSK 462
LP + + + + PSK
Sbjct: 299 DVLLPQETAEIHLHSLSPGPSK 320
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 64/360 (17%), Positives = 108/360 (30%), Gaps = 102/360 (28%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGK----------------------IVALKKVR 192
R FE I +G+G + V++A++ + AL K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 193 FAN----------------------------------MDPESVRFMAREIHILRKLDHPN 218
P + + +I + N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEH-DLAGL--ATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+ +S LY+ + +L Q+ +E H
Sbjct: 123 TVGQLQ-PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD-----------PSQNLPLTSRVVTLW 324
S+G++HRD+K SN+ V+K+GDFGL T D T +V T
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384
Y +PE + G Y +D++S G IL EL T++E++ I +
Sbjct: 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDVR-------- 287
Query: 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
K F +V +L+ P R A + + F+
Sbjct: 288 -----------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 38/304 (12%)
Query: 149 IKGWQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMARE 207
I G + + E + ++G GT V+K R +TG ++A+K++R + + E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMD 73
Query: 208 IHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
+ ++ K D P +++ G + +++ E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFI-TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 267 LLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
+++ L + G++HRD+K SN+L++ G +K+ DFG++ Y
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAGCAAY 190
Query: 326 RAPE----LLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPS 380
APE Y D+WS G L EL G+ P +T+ E + K+ + P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP- 247
Query: 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
P P F++F V LT + R L
Sbjct: 248 ----------------PLLPGHMGFSGDFQSF-------VKDCLTKDHRKRPKYNKLLEH 284
Query: 441 EFFK 444
F K
Sbjct: 285 SFIK 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 83/347 (23%), Positives = 133/347 (38%), Gaps = 46/347 (13%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
+D ++ + IG G + RD T ++VA+K + E+V+ REI R L
Sbjct: 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSL 73
Query: 215 DHPNVMKL-EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
HPN+++ E ++T L ++ EY +L G +F+E + + + QQLL G+
Sbjct: 74 RHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVS 130
Query: 273 HCHSRGILHRDIKGSNLLI--NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPEL 330
+CHS I HRD+K N L+ + A LKI DFG + + S V T Y APE+
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEV 188
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
LL G D+WS G L + G E K ++ S
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI-----------QRILSV 237
Query: 391 HATSFK-PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
+ P L+ ++ +P R S +F
Sbjct: 238 K---YSIPDDIR----------ISPECCHLISRIFVADPATRISIPEIKTHSWFLK---- 280
Query: 450 CDPSNLPKY-PPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRD 495
NLP ++ ++ E Q + + E+ R+
Sbjct: 281 ----NLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 74/319 (23%), Positives = 126/319 (39%), Gaps = 61/319 (19%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMD-PESVRFMAREIHILRKLDHPNVMK 221
+G+G++ V A +T + VALK + D V REI L+ L HP+++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIK 73
Query: 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
L ++T+ + + +V EY +L + TE + + + QQ++ +E+CH I+H
Sbjct: 74 LYDVITTPT-DIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVH 131
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL------PLTSRVVTLWYRAPELLLGAT 335
RD+K NLL+++ +KI DFGL+ L P Y APE++ G
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------YAAPEVINGKL 183
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
G +D+WS G +L + G+ K+ +
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDF----------- 230
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455
A +L+ +++ +P R + R +F NL
Sbjct: 231 ----------------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--------NL 266
Query: 456 PKY-PPSKELDAKLRDQEA 473
P Y P +E+ D
Sbjct: 267 PDYLRPMEEVQGSYADSRI 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 48/304 (15%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL- 214
A+ + + +IG+G Y SV K +G+I+A+K++R + +D + + + ++ ++ +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSS 78
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYM----EHDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
D P +++ G R G ++ E M + + + E + ++
Sbjct: 79 DCPYIVQFYG-ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 271 LEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
L H I+HRDIK SN+L++ +G +K+ DFG++ S + T Y APE
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPE 195
Query: 330 LLLGATK---YGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFK-----LCGSPS 380
+ + Y D+WS G L EL G+ P + +Q+ ++ K L S
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
++ S S F NF V+ LT + R L+
Sbjct: 256 REF---SPS-------------------FINF-------VNLCLTKDESKRPKYKELLKH 286
Query: 441 EFFK 444
F
Sbjct: 287 PFIL 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-40
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 46/301 (15%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI-LRKL 214
+AD E I ++G+G Y V K R + +G+I+A+K++R A ++ + + + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTV 63
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYME---HDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
D P + G R G +++ E M+ G E + +++ L
Sbjct: 64 DCPFTVTFYG-ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 272 EHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPEL 330
EH HS ++HRD+K SN+LIN G +K+ DFG++ + Y APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPER 180
Query: 331 LLG---ATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSP---SEDY 383
+ Y D+WS G + EL + P T +Q+ ++ + D
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADK 238
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ S F +F + L + R + ++ FF
Sbjct: 239 F--SAE-------------------FVDF-------TSQCLKKNSKERPTYPELMQHPFF 270
Query: 444 K 444
Sbjct: 271 T 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 166 IGQGTYSSVYKARDLETGKIVALK---KVRFANMD-PESVRFMAREIHILRKLDHPNVMK 221
+G GT+ V TG VA+K + + ++D ++ REI L+ HP+++K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIK 75
Query: 222 LEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
L ++++ + ++V EY+ +L G + E + + QQ+L +++CH ++
Sbjct: 76 LYQVISTPT-DFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL------PLTSRVVTLWYRAPELLLGA 334
HRD+K N+L++ KI DFGL+ + L P Y APE++ G
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVISGR 185
Query: 335 TKYGAAIDMWSAGCILAELFAGK 357
G +D+WS G IL L G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGT 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 164 DKIGQGTYSSVYKAR---DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+IG G++ +VYK + D VA+K + P+ ++ E+ +LRK H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
G T+ L +V ++ E L KF ++ +Q RG+++ H++ I
Sbjct: 84 LFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLAT-TYDPSQNLPLTSRVVTLWYRAPELLLG--ATK 336
+HRD+K +N+ ++ +KIGDFGLAT S + ++ + APE++ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 337 YGAAIDMWSAGCILAELFAGK 357
Y D+++ G +L EL G+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 160 FEKID---KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
FE+++ IG+G + VY R VA++ + + + ++ RE+ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
NV+ G L ++ + L + I + + Q++++G+ + H
Sbjct: 89 ENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLAT----TYDPSQNLPLTSRVVTLWYRAPELL 331
++GILH+D+K N+ +N G + I DFGL + + L + L + APE++
Sbjct: 148 AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 332 LGATK--------YGAAIDMWSAGCILAELFAGK 357
+ + D+++ G I EL A +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-----VRFMAREIHILRKL 214
E +IG+G + V+K R ++ +VA+K + + + E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+HPN++KL GL+ + +V E++ DL M + G+E+
Sbjct: 81 NHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 274 CHSRG--ILHRDIKGSNLLINNAG-----VLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
++ I+HRD++ N+ + + K+ DFGL+ ++ + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWM 193
Query: 327 APELLLGATK-YGAAIDMWSAGCILAELFAGK 357
APE + + Y D +S IL + G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 160 FEKID---KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
+ ++ KIG G++ +V++A G VA+K + + E V RE+ I+++L H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGL--ATTPGIKFTEPQIKCYMQQLLRGLEH 273
PN++ G VT + +L +V EY+ L L + + E + + +G+ +
Sbjct: 94 PNIVLFMGAVT-QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 274 CHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
H+R I+HR++K NLL++ +K+ DFGL+ S L S T + APE+L
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVL 211
Query: 332 LGATKYGAAIDMWSAGCILAELFAGK 357
D++S G IL EL +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-37
Identities = 82/339 (24%), Positives = 140/339 (41%), Gaps = 67/339 (19%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMD-PESVRFMAREI 208
+ + D +G GT+ V + TG VA+K + + ++D +R REI
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REI 67
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQL 267
L+ HP+++KL ++++ S +++V EY+ +L G + E + + QQ+
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPS-DIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQI 125
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL------PLTSRVV 321
L G+++CH ++HRD+K N+L++ KI DFGL+ + L P
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----- 180
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMP--GRTEVEQMHKIFKLCGSP 379
Y APE++ G G +D+WS+G IL L G +P KI G
Sbjct: 181 ---YAAPEVISGRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD--GIF 233
Query: 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ S ++L+ +L ++P R +
Sbjct: 234 YTPQY---------------------------LNPSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 440 SEFFKTEPLPCDPSNLPKY--PPSKELDAKLRDQEARKQ 476
E+FK +LPKY P + + D EA K+
Sbjct: 267 HEWFKQ--------DLPKYLFPEDPSYSSTMIDDEALKE 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 37/202 (18%), Positives = 73/202 (36%), Gaps = 19/202 (9%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224
K+ + ++K R G + +K ++ + R E LR HPNV+ + G
Sbjct: 17 KLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 225 LVTSR-SGSLYLVFEYME----HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG- 278
S + L+ +M +++ L + Q + + RG+ H+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 279 -ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG--AT 335
I + +++I+ +I + ++ R+ + APE L
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 336 KYGAAIDMWSAGCILAELFAGK 357
+ DMWS +L EL +
Sbjct: 187 TNRRSADMWSFAVLLWELVTRE 208
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 45/301 (14%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILR 212
R + F+ +G+G++S+V AR+L T + A+K K + V ++ RE ++
Sbjct: 28 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMS 85
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
+LDHP +KL LY Y ++ +L G F E + Y +++ L
Sbjct: 86 RLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSAL 143
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPEL 330
E+ H +GI+HRD+K N+L+N ++I DFG A P + V T Y +PEL
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
L + D+W+ GCI+ +L AG P E KI KL
Sbjct: 204 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA----ASALRS-EFFK 444
+ P F A LV+KLL ++ R G L++ FF+
Sbjct: 248 -----EYDFP---------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 445 T 445
+
Sbjct: 294 S 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
E + +G+G + V KA+ K VA+K++ + E+ L +++HPN+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNI 63
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGL--ATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+KL G + + LV EY E L + P +T + Q +G+ + HS
Sbjct: 64 VKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 277 R---GILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
++HRD+K NLL+ G VLKI DFG A +T+ + + APE+
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFE 176
Query: 333 GATKYGAAIDMWSAGCILAELFAGK 357
G + Y D++S G IL E+ +
Sbjct: 177 G-SNYSEKCDVFSWGIILWEVITRR 200
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 80/366 (21%), Positives = 138/366 (37%), Gaps = 93/366 (25%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-----DHP 217
I K+G G +S+V+ + D++ K VA+K V+ A E+ EI +L+ + + P
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDP 98
Query: 218 N---VMKLEG--LVTSRSGS-LYLVFEYMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRG 270
N V++L ++ +G+ + +VFE + H L P +K +QQ+L+G
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 271 LEHCHSR-GILHRDIKGSNLLIN------------------------------------- 292
L++ H++ I+H DIK N+L++
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 293 ------------NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
+KI D G A T + T YR+ E+L+G+ Y
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLEVLIGS-GYNTP 273
Query: 341 IDMWSAGCILAELFAGKPIMPGRT------EVEQMHKIFKLCGSPSEDYWRKSKSA---- 390
D+WS C+ EL G + + + + + I +L G K +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 391 -------HATSFKPQQPYKRKVLETFRNFP----QSALALVDKLLTIEPENRGSAASALR 439
H T KP +VL + + +L + PE R +AA LR
Sbjct: 334 TKKGDLKHITKLKP--WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
Query: 440 SEFFKT 445
+ +
Sbjct: 392 HPWLNS 397
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 75/310 (24%), Positives = 120/310 (38%), Gaps = 42/310 (13%)
Query: 149 IKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAR 206
+K + +R D FE + IG+G +S V + +TG++ A+K + +M E F
Sbjct: 53 LKEVRLQRDD-FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE- 110
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQ 265
E +L D + +L + LYLV EY DL L + G + + Y+
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
+++ ++ H G +HRDIK N+L++ G +++ DFG + V T Y
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 326 RAPELLLG------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379
+PE+L YG D W+ G E+F G+ + E KI
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH----- 284
Query: 380 SEDYWRKSKSAHATSFK-PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA-AS 436
+ P P+ A + +LL PE R G A
Sbjct: 285 -----------YKEHLSLPLVD---------EGVPEEARDFIQRLLC-PPETRLGRGGAG 323
Query: 437 ALRS-EFFKT 445
R+ FF
Sbjct: 324 DFRTHPFFFG 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-33
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 10/231 (4%)
Query: 149 IKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAR 206
+K + R D FE + IG+G + V + K+ A+K + M E+ F
Sbjct: 66 VKQMRLHRED-FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE- 123
Query: 207 EIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQ 265
E +L D + L +LYLV +Y DL L + + E + Y+
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
+++ ++ H +HRDIK N+L++ G +++ DFG + + V T Y
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 326 RAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
+PE+L G +YG D WS G + E+ G+ + VE KI
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 27/231 (11%)
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+ IG+G + V++ + G+ VA+K F++ + S F EI+ L H N++
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 221 KLEGLVTSRSGS---LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+G+ L+LV +Y EH L T + GL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHM 157
Query: 277 R--------GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LPLTSRVVTLWY 325
I HRD+K N+L+ G I D GLA +D + + + RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 326 RAPELLLGAT-----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHK 371
APE+L + + D+++ G + E+ I + + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 27/228 (11%)
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+ + +IG+G Y V+ + G+ VA+K F + S F EI+ + H N++
Sbjct: 40 QMVKQIGKGRYGEVWMGK--WRGEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENIL 94
Query: 221 KLEGLVTSRSGS---LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+GS LYL+ +Y E+ L + + + GL H H+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 277 R--------GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LPLTSRVVTLWY 325
I HRD+K N+L+ G I D GLA + N +P +RV T Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 326 RAPELLLGAT-----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ 368
PE+L + + DM+S G IL E+ E +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK--KVRFANMDPESV-RFMAREIHILRKLDH 216
++ +DK+G G S+VY A D VA+K + E++ RF RE+H +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-KEETLKRF-EREVHNSSQLSH 70
Query: 217 PNVMKL-----EGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
N++ + E YLV EY+E L+ + G + + Q+L G
Sbjct: 71 QNIVSMIDVDEED------DCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDG 123
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPE 329
++H H I+HRDIK N+LI++ LKI DFG+A +L T+ V+ T+ Y +PE
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPE 182
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
G D++S G +L E+ G+P G T V K
Sbjct: 183 QAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK------------------ 223
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441
H P + ++ PQS ++ + + NR ++ +
Sbjct: 224 -HIQDSVPNVTTDVR-----KDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 160 FEKID---KIGQGTYSSVYKA--RDLETGKIVALKKVRFANMDPESVRFM--AREIHILR 212
F ++ IG G + VY+A G VA+K R + S +E +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L HPN++ L G+ + +L LV E+ L + + + + + Q+ RG+
Sbjct: 62 MLKHPNIIALRGVCL-KEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGM 118
Query: 272 EHCHSRG---ILHRDIKGSNLLINNAG--------VLKIGDFGLATTYDPSQNLPLTSRV 320
+ H I+HRD+K SN+LI +LKI DFGLA + + S
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAA 175
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK 357
+ APE++ + + D+WS G +L EL G+
Sbjct: 176 GAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGE 211
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 32/253 (12%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
++ + ++ +G + V+KA+ + VA+K F D +S + E++ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 216 HPNVMKLEGLVTSRSGS---LYLVFEYMEH----DLAGLATTPGIKFTEPQIKCYMQQLL 268
H N+++ G + L+L+ + E D L + ++ + +
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF--LKANV---VSWNELCHIAETMA 131
Query: 269 RGLEHCHSR----------GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
RGL + H I HRDIK N+L+ N I DFGLA ++ ++ T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 319 RVV-TLWYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIF 373
V T Y APE+L GA IDM++ G +L EL + G + +
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 374 KLCGSPSEDYWRK 386
++ PS + ++
Sbjct: 252 EIGQHPSLEDMQE 264
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 27/216 (12%)
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
++ +G+G Y V++ G+ VA+K F++ D +S F E++ L H N++
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKI--FSSRDEKSW-FRETELYNTVMLRHENIL 65
Query: 221 KLEGLVTSRSGS---LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+ S L+L+ Y E L + + GL H H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHI 123
Query: 277 R--------GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LPLTSRVVTLWY 325
I HRD+K N+L+ G I D GLA + S N + RV T Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 326 RAPELLLGAT-----KYGAAIDMWSAGCILAELFAG 356
APE+L +D+W+ G +L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 10/223 (4%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRK 213
+A+ +E + IG+G + V R T K+ A+K + M +S F E I+
Sbjct: 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMAF 125
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
+ P V++L LY+V EYM DL L + E + Y +++ L+
Sbjct: 126 ANSPWVVQLFYAFQDDR-YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALD 182
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
HS G +HRD+K N+L++ +G LK+ DFG + + + V T Y +PE+L
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 333 ---GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
G YG D WS G L E+ G + V KI
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 53/309 (17%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHIL 211
QP + F + +G+G + V + TGK+ A KK+ + E IL
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYME------HDLAGLATTPGIKFTEPQIKCYMQ 265
K++ V+ L ++ +L LV M H + F E + Y
Sbjct: 239 EKVNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAA 293
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
++ GLE H I++RD+K N+L+++ G ++I D GLA + + RV T+ Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGY 351
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
APE++ +Y + D W+ GC+L E+ AG+ R + + ++
Sbjct: 352 MAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 398
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQS----ALALVDKLLTIEPENR----GSAASA 437
R V E + + A +L +LL +P R G +A
Sbjct: 399 -----------------RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441
Query: 438 LRS-EFFKT 445
++ FK
Sbjct: 442 VKEHPLFKK 450
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 64/305 (20%), Positives = 119/305 (39%), Gaps = 59/305 (19%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDH 216
D FE + IG+G++ V + +T K+ A+K + ++ VR + +E+ I++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCYMQQ 266
P ++ L +++V + + G + F E +K ++ +
Sbjct: 75 PFLVNLWYSFQDEE-DMFMVVDLL----------LGGDLRYHLQQNVHFKEETVKLFICE 123
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYR 326
L+ L++ ++ I+HRD+K N+L++ G + I DF +A +T+ T Y
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYM 181
Query: 327 APELLL--GATKYGAAIDMWSAGCILAELFAGKP---IMPGRTEVEQMHKIFKLCGSPSE 381
APE+ Y A+D WS G EL G+ I + E +H
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------ 235
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSAASALRS 440
P + Q ++L+ KLL P+ R +
Sbjct: 236 --------------VVTYP---------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272
Query: 441 EFFKT 445
+
Sbjct: 273 PYMND 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALK--KVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+G+G VY+A D +IVALK ++ DP M RE +L P+V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHV- 96
Query: 221 KLEGLVT-----SRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
V G LY+ + DLA + G P+ ++Q+ L+
Sbjct: 97 -----VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA 150
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLG 333
H+ G HRD+K N+L++ + DFG+A+ + L V TL+Y APE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 334 ATKYGAAIDMWSAGCILAELFAGKP 358
+ D+++ C+L E G P
Sbjct: 210 SHA-TYRADIYALTCVLYECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALK--KVRFANMDPESV-RFMAREIHILRKLDH 216
+E + +G G S V+ ARDL + VA+K + A DP RF RE L+H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRF-RREAQNAAALNH 71
Query: 217 PNVMKL--EGLVTSRSGSL-YLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
P ++ + G + +G L Y+V EY++ L + T G T + + + L
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALN 130
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVV-TLWYRAPEL 330
H GI+HRD+K +N++I+ +K+ DFG+A S N + T+ V+ T Y +PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKP 358
G + A D++S GC+L E+ G+P
Sbjct: 191 ARGDSV-DARSDVYSLGCVLYEVLTGEP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 50/309 (16%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHIL 211
QP D F +G+G + V+ + TGK+ A KK+ + + E IL
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYME------HDLAGLATTPGIKFTEPQIKCYMQ 265
K+ ++ L +++ L LV M H + + F EP+ Y
Sbjct: 240 AKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTA 296
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
Q++ GLEH H R I++RD+K N+L+++ G ++I D GLA + T +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGF 355
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
APELLLG +Y ++D ++ G L E+ A + R E + ++
Sbjct: 356 MAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------ 402
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQS----ALALVDKLLTIEPENR----GSAASA 437
++VLE +P + + LL +PE R +
Sbjct: 403 -----------------QRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445
Query: 438 LRS-EFFKT 445
LR+ F+
Sbjct: 446 LRTHPLFRD 454
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 20/215 (9%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLE-TGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
A +E I G +Y A D G+ V LK + + D E+ E L ++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV 137
Query: 216 HPNVMKL----EGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRG 270
HP+++++ E Y+V EY+ L + Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPE 329
L + HS G+++ D+K N+++ + K+ D G + + + T ++APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGYLYGTPGFQAPE 247
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT 364
++ A D+++ G LA L P GR
Sbjct: 248 IVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 21/231 (9%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W D ++IG+G + V+ R +VA+K R +F+ +E IL
Sbjct: 109 WVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARIL 166
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
++ HPN+++L G+ T + +Y+V E ++ D T G + + + G
Sbjct: 167 KQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA--------TTYDPSQNLPLTSRVVT 322
+E+ S+ +HRD+ N L+ VLKI DFG++ + +P+
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----- 280
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE L +Y + D+WS G +L E F+ G P + + +
Sbjct: 281 -WT-APEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 38/239 (15%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA-REIHILRKLDHPN 218
+ ++ IG+G Y +VYK L+ + VA+K F+ + ++ F+ + I+ + ++H N
Sbjct: 15 LKLLELIGRGRYGAVYKGS-LD-ERPVAVKV--FSFANRQN--FINEKNIYRVPLMEHDN 68
Query: 219 VMKLEGLVTSRSGS----LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYM-QQLLRGLE 272
+ + + LV EY + L + + C + + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS---SCRLAHSVTRGLA 125
Query: 273 HCHS---------RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS-------QNLPL 316
+ H+ I HRD+ N+L+ N G I DFGL+ + ++
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 317 TSRVVTLWYRAPELLLGA------TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM 369
S V T+ Y APE+L GA +DM++ G I E+F + V +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
+ + ++G+G + SV R TG++VA+KK++ + + F REI IL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKS 67
Query: 214 LDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H N++K +G+ S +L L+ EY+ + L + ++ Y Q+ +G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
E+ ++ +HRD+ N+L+ N +KIGDFGL + + P+
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----- 182
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
WY APE L +K+ A D+WS G +L ELF
Sbjct: 183 -WY-APESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
++I +G+G + V R TG+ VA+K ++ + +EI ILR
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRN 79
Query: 214 LDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H N++K +G+ T G + L+ E++ L K Q Y Q+ +G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
++ SR +HRD+ N+L+ + +KIGDFGL Y + P+
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----- 194
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
WY APE L+ +K+ A D+WS G L EL
Sbjct: 195 -WY-APECLM-QSKFYIASDVWSFGVTLHELL 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (295), Expect = 3e-29
Identities = 41/340 (12%), Positives = 90/340 (26%), Gaps = 79/340 (23%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD------PESVRFMAREIHIL 211
+ ++ +KIG+G + V++ VA+K + D ++ + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 212 RKL---------DHPNVMKL-----------------------------EGLVTSRSGSL 233
++L + L + + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLIN 292
++V E E L + K + QL L + HRD+ N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 293 NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAE 352
+ K+ + +P V++ Y + + +
Sbjct: 197 KTSLKKLHYTLNGKSST----IPSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 353 LFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH---------ATSFKPQQPYKR 403
+ + + G + + I++L + + W + K +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 404 KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
+ + +L SA L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
+ + ++G+G + SV R TG++VA+KK++ + + F REI IL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFE-REIEILKS 98
Query: 214 LDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H N++K +G+ S +L L+ EY+ + L + ++ Y Q+ +G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
E+ ++ +HRD+ N+L+ N +KIGDFGL Y + P+
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----- 213
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
WY APE L +K+ A D+WS G +L ELF
Sbjct: 214 -WY-APESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 19/247 (7%)
Query: 134 VAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRF 193
W+ R D K+G G Y VY+ + VA+K ++
Sbjct: 197 APKRNKPTIYGVSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 255
Query: 194 ANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTP 251
M+ E F+ E +++++ HPN+++L G+ T R Y++ E+M + +L L
Sbjct: 256 DTMEVEE--FLK-EAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECN 311
Query: 252 GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----T 306
+ + + Q+ +E+ + +HR++ N L+ ++K+ DFGL+
Sbjct: 312 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTE 365
TY + W APE L K+ D+W+ G +L E+ G PG
Sbjct: 372 TYTAHAGAKFPIK----WT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
Query: 366 VEQMHKI 372
+ +
Sbjct: 426 SQVYELL 432
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-28
Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKL-- 214
+ F IG+G + VY R +TGK+ A+K + + E +L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 215 -DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
D P ++ + + L + + M DL + G F+E ++ Y +++ GLE
Sbjct: 249 GDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLE 306
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
H H+R +++RD+K +N+L++ G ++I D GLA + + + V T Y APE+L
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQ 363
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
Y ++ D +S GC+L +L G P F K+K H
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHS--P-----------F---------RQHKTKDKHE 401
Query: 393 TSFKPQQPYKRKVLETFRNFPQS----ALALVDKLLTIEPENR----GSAASALRS-EFF 443
R L P S +L++ LL + R G A ++ FF
Sbjct: 402 I--------DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 444 KT 445
++
Sbjct: 454 RS 455
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 28/238 (11%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKI---VALKKVRFANMDPESVRFMAREI 208
+ + IG+G + VY L+ A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQL 267
I++ HPNV+ L G+ GS +V YM+H DL T + + Q+
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN-----LPLT 317
+G+++ S+ +HRD+ N +++ +K+ DFGLA Y N LP+
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 318 SRVVTLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
W A E L K+ D+WS G +L EL P P + +
Sbjct: 198 ------WM-ALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 245
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
+ I ++G+G + SV R TG +VA+K+++ + P+ R REI IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQILKA 80
Query: 214 LDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L ++K G+ SL LV EY+ L + ++ Y Q+ +G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
E+ SR +HRD+ N+L+ + +KI DFGLA Y + P+
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----- 195
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
WY APE L + D+WS G +L ELF
Sbjct: 196 -WY-APESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
+ IG+G + V G VA+K ++ F+ E ++ +L H N+++L
Sbjct: 26 LQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQL 79
Query: 223 EGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
G++ G LY+V EYM L L + + + + +E+ +
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQN--LPLTSRVVTLWYRAPELLLGATKY 337
HRD+ N+L++ V K+ DFGL LP+ W APE L K+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT-APEALR-EKKF 191
Query: 338 GAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
D+WS G +L E+++ G+ P + + ++
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 163 IDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
IG G V R G+ VA+K ++ + + F+ E I+ + DHPN+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++LEG+VT R +V EYME+ L T +FT Q+ ++ + G+ + G
Sbjct: 113 IRLEGVVT-RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVTLWYRAPE 329
+HRD+ N+L+++ V K+ DFGL+ + +P+ W APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI------RWT-APE 224
Query: 330 LLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
+ + +A D+WS G ++ E+ A G+ T + + +
Sbjct: 225 AIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W ++ + +IG G + V+ L K VA+K +R M E F+ E ++
Sbjct: 3 WVIDPSE-LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEVM 57
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
KL HP +++L G+ + LV E+MEH L+ T F + + G
Sbjct: 58 MKLSHPKLVQLYGVCL-EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVVTL 323
+ + ++HRD+ N L+ V+K+ DFG+ Y S P+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------ 170
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W +PE+ ++Y + D+WS G ++ E+F+ GK R+ E + I
Sbjct: 171 WA-SPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R D K+G G Y VY+ + VA+K ++ M+ E F+ +E ++
Sbjct: 8 WEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVM 63
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLR 269
+++ HPN+++L G+ T R Y++ E+M + +L L + + + Q+
Sbjct: 64 KEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVVT 322
+E+ + +HRD+ N L+ ++K+ DFGL+ TY P+
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----- 177
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE L K+ D+W+ G +L E+ G PG + +
Sbjct: 178 -WT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 31/237 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
+KI +G+G + V + TG++VA+K ++ A+ P+ +EI ILR
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRT 89
Query: 214 LDHPNVMKLEGLVTSRSG-SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L H +++K +G SL LV EY+ L P Q+ + QQ+ G+
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
+ H++ +HRD+ N+L++N ++KIGDFGLA Y ++ P+
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----- 202
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379
WY APE L K+ A D+WS G L EL + K +L G
Sbjct: 203 -WY-APECLK-EYKFYYASDVWSFGVTLYELL-----THCDSSQSPPTKFLELIGIA 251
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 24/224 (10%)
Query: 163 IDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+G G + V R K VA+K ++ + + F+ E I+ + DHPN+
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNI 108
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++LEG+VT +S + +V EYME+ L +FT Q+ ++ + G+++ G
Sbjct: 109 IRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLA--------TTYDPSQ-NLPLTSRVVTLWYRAPE 329
+HRD+ N+LIN+ V K+ DFGL Y +P+ W +PE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI------RWT-SPE 220
Query: 330 LLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
+ K+ +A D+WS G +L E+ + G+ + + + +
Sbjct: 221 AIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 21/237 (8%)
Query: 142 TSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESV 201
+ GW + + + IG+G + V G VA+K ++ + ++
Sbjct: 178 AAQDEFYRSGWALNMKE-LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQA- 232
Query: 202 RFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQ 259
F+ E ++ +L H N+++L G++ G LY+V EYM L L +
Sbjct: 233 -FL-AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290
Query: 260 IKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQN--LPL 316
+ + + +E+ +HRD+ N+L++ V K+ DFGL LP+
Sbjct: 291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE L K+ D+WS G +L E+++ G+ P + + ++
Sbjct: 351 K------WT-APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 23/230 (10%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
+ +R + + ++G G + V + VA+K ++ +M + F +E +
Sbjct: 3 MELKREE-ITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTM 57
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
KL HP ++K G+ + + +Y+V EY+ + L + G Q+ + G
Sbjct: 58 MKLSHPKLVKFYGVCS-KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVVTL 323
+ S +HRD+ N L++ +K+ DFG+ Y S P+
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------ 170
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE+ KY + D+W+ G ++ E+F+ GK T E + K+
Sbjct: 171 WS-APEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 143 SVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR 202
S AG W+ D + ++G G + V + VA+K ++ +M +
Sbjct: 10 STAGLGYGSWEIDPKD-LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE-- 65
Query: 203 FMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIK 261
F+ E ++ L H +++L G+ T + ++++ EYM + L +F Q+
Sbjct: 66 FI-EEAKVMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--L 314
+ + +E+ S+ LHRD+ N L+N+ GV+K+ DFGL+ Y S
Sbjct: 124 EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 183
Query: 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
P+ W PE+L+ +K+ + D+W+ G ++ E+++ GK T E I
Sbjct: 184 PVR------WS-PPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/241 (23%), Positives = 108/241 (44%), Gaps = 26/241 (10%)
Query: 145 AGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKI---VALKKVRFANMDPESV 201
G + + ++ +R E IG+G + V++ + VA+K + D
Sbjct: 3 MGSSTRDYEIQRER-IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE 61
Query: 202 RFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQI 260
+F+ +E +R+ DHP+++KL G++T ++++ E +L +
Sbjct: 62 KFL-QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASL 118
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN-- 313
Y QL L + S+ +HRDI N+L+++ +K+GDFGL+ +TY +
Sbjct: 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHK 371
LP+ W APE + ++ +A D+W G + E+ KP G + + +
Sbjct: 179 LPI------KWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGR 229
Query: 372 I 372
I
Sbjct: 230 I 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 25/229 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR---DLETGKI-VALKKVRFANMDPESVRFMAREIHILRK 213
F+KI +G G + +VYK + E KI VA+K++R A + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
+D+P+V +L G+ + + + L+ + M L + + Q+ +G+
Sbjct: 74 VDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--------LPLTSRVVTLW 324
+ R ++HRD+ N+L+ +KI DFGLA + +P+ W
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------W 185
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
A E +L Y D+WS G + EL G G E +
Sbjct: 186 M-ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 25/232 (10%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKAR-DLETGKI-VALKKVRFANMDPESVRFMAREIHIL 211
R I ++G G + SV + + +I VA+K ++ ++ M RE I+
Sbjct: 7 KRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIM 64
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRG 270
+LD+P +++L G+ + + L LV E L + + + Q+ G
Sbjct: 65 HQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 271 LEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVV 321
+++ + +HRD+ N+L+ N KI DFGL+ + Y PL
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL----- 177
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
WY APE + K+ + D+WS G + E + G+ E M I
Sbjct: 178 -KWY-APECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 78/296 (26%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVA---LKKVRFANMDPESVRFMAREIHILRKL 214
F+ + +G G++ V+ R G+ A LKK + V E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIV 63
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCYM 264
HP ++++ G + ++++ +Y+ G +F P K Y
Sbjct: 64 THPFIIRMWGTFQD-AQQIFMIMDYI----------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSR 319
++ LE+ HS+ I++RD+K N+L++ G +KI DFG A TY
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----------- 161
Query: 320 VVTLW----YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375
TL Y APE++ Y +ID WS G ++ E+ AG ++ KI L
Sbjct: 162 --TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--L 216
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
+ + P F + L+ +L+T + R
Sbjct: 217 NA------------------ELRFP---------PFFNEDVKDLLSRLITRDLSQR 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 25/230 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRK 213
+ IG G + VYK + VA+K ++ + + V F+ E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 102
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
H N+++LEG+++ + + ++ EYME+ L +F+ Q+ ++ + G++
Sbjct: 103 FSHHNIIRLEGVIS-KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA--------TTYDPS-QNLPLTSRVVTL 323
+ + +HRD+ N+L+N+ V K+ DFGL+ TY S +P+
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI------R 215
Query: 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE + K+ +A D+WS G ++ E+ G+ + E M I
Sbjct: 216 WT-APEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 27/232 (11%)
Query: 152 WQ-PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
W+ PR + + ++++G G + V+ K VA+K ++ +M P++ F+A E ++
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANL 61
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLL 268
+++L H +++L +VT +Y++ EYME+ L L T GIK T ++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVV 321
G+ R +HRD++ +N+L+++ KI DFGLA Y + P+
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---- 175
Query: 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE + + D+WS G +L E+ G+ PG T E + +
Sbjct: 176 --WT-APEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKI---VALKKVRFANMDPESVRFMAREI 208
+ + IG+G + VY L+ A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQL 267
I++ HPNV+ L G+ GS +V YM+H DL T + + Q+
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-TTYDPSQNLPLTSRVVTL--- 323
+G++ S+ +HRD+ N +++ +K+ DFGLA YD + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 324 WYRAPE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
W A E L K+ D+WS G +L EL P P + +
Sbjct: 262 WM-ALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++ K+GQG + V+ T + VA+K ++ M PE F+ +E +++KL H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 239
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+++L +V+ +Y+V EYM L L G PQ+ Q+ G+ +
Sbjct: 240 KLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPEL 330
+HRD++ +N+L+ V K+ DFGLA Y Q + W APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WT-APEA 352
Query: 331 LLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
L ++ D+WS G +L EL G+ PG E + ++
Sbjct: 353 AL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 28/236 (11%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKA--RDLETGKI-VALKKVRFANMDPESVRFMAREIHI 210
P IG+G + VY D +I A+K + + F+ RE +
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLL 75
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLR 269
+R L+HPNV+ L G++ G +++ YM H DL +P T + + Q+ R
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN-----LPLTSR 319
G+E+ + +HRD+ N +++ + +K+ DFGLA Y Q LP+
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK-- 193
Query: 320 VVTLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
W A E L ++ D+WS G +L EL P + H +
Sbjct: 194 ----WT-ALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFL 241
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDH 216
D F++I +G G++ V + E+G A+K + + + + E IL+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCYMQQ 266
P ++KLE S +LY+V EY+ G +F+EP + Y Q
Sbjct: 101 PFLVKLEFSFKDNS-NLYMVMEYV----------AGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL--- 323
++ E+ HS +++RD+K NLLI+ G +++ DFG A R TL
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------GRTWTLCGT 201
Query: 324 -WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358
APE++L Y A+D W+ G ++ E+ AG P
Sbjct: 202 PEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 63/329 (19%), Positives = 116/329 (35%), Gaps = 28/329 (8%)
Query: 57 QQQQQPGLKANVTVPFDEGENPRTTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGLQP 116
+ + GL + + P H T +
Sbjct: 239 LKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298
Query: 117 QMSRIVCLPVGPEGDEVVAGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYK 176
S P+ + + S + K +R + ++G G + SV +
Sbjct: 299 ITSPDKPRPMPMDTS----VFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQ 354
Query: 177 AR-DLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234
+ +I VA+K ++ ++ M RE I+ +LD+P +++L G+ + + L
Sbjct: 355 GVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLIGVCQAEA--LM 411
Query: 235 LVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293
LV E L + + + Q+ G+++ + +HR++ N+L+ N
Sbjct: 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 294 AGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMW 344
KI DFGL+ + Y PL WY APE + K+ + D+W
Sbjct: 472 RHYAKISDFGLSKALGADDSYYTARSAGKWPL------KWY-APECIN-FRKFSSRSDVW 523
Query: 345 SAGCILAELFA-GKPIMPGRTEVEQMHKI 372
S G + E + G+ E M I
Sbjct: 524 SYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 49/222 (22%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 163 IDKIGQGTYSSVYKA--RDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+G+G + VY+ + + KI VA+K + +FM E I++ LDHP++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHI 75
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+KL G++ +++ E + +L + Y Q+ + + + S
Sbjct: 76 VKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVVTLWYRAPELL 331
+HRDI N+L+ + +K+GDFGL+ Y + LP+ W +PE +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WM-SPESI 186
Query: 332 LGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
++ A D+W + E+ + GK + + +
Sbjct: 187 N-FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 26/244 (10%)
Query: 144 VAGEAI--KGWQPRRADAFEKIDKIGQGTYSSVYKAR-DLETGKI-VALKKVRFANMDPE 199
+A E I K R + ++G G + +V K ++ VA+K ++ DP
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 200 SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEP 258
+ E +++++LD+P ++++ G+ + S LV E E L +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNR-HVKDK 117
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPS 311
I + Q+ G+++ +HRD+ N+L+ KI DFGL+ Y
Sbjct: 118 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 312 QN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQ 368
+ P+ WY APE + K+ + D+WS G ++ E F+ G+ G E
Sbjct: 178 THGKWPVK------WY-APECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
Query: 369 MHKI 372
+
Sbjct: 230 TAML 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 27/231 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKA--RDLETGKI-VALKKVRFANMDPESVR--FMAREIHILR 212
++K+G G++ V + + VA+K ++ + F+ RE++ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMH 76
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
LDH N+++L G+V + + +V E L F + Y Q+ G+
Sbjct: 77 SLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-------TTYDPSQN--LPLTSRVVT 322
+ S+ +HRD+ NLL+ ++KIGDFGL Y ++ +P
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----- 189
Query: 323 LWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE L + A D W G L E+F G+ G + +HKI
Sbjct: 190 -WC-APESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 60/305 (19%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDH 216
+ F+ + +G+GT+ V R+ TG+ A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLR 269
P + L+ + L V EY +L FTE + + Y +++
Sbjct: 65 PFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVS 116
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL----WY 325
LE+ HSR +++RDIK NL+++ G +KI DFGL + + + + T Y
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTFCGTPEY 171
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
APE+L YG A+D W G ++ E+ G+ + I
Sbjct: 172 LAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------- 220
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA---ASALRS- 440
+ + P R A +L+ LL +P+ R G A +
Sbjct: 221 ----------EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 441 EFFKT 445
FF +
Sbjct: 262 RFFLS 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 78/364 (21%), Positives = 139/364 (38%), Gaps = 65/364 (17%)
Query: 80 TTIVERPKRNRHQRCATMDMGMGTGTETTIVAVGLQPQMSRIVCLPVGPEGDEVVAGWPS 139
TT++ER T + T VA GL+ Q + + G D S
Sbjct: 81 TTVIER-----TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDN------S 129
Query: 140 WLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDP 198
+ K + FE + +G+GT+ V ++ TG+ A+K ++ +
Sbjct: 130 GAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK 189
Query: 199 ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY------MEHDLAGLATTPG 252
+ V E +L+ HP + L+ + L V EY H L+
Sbjct: 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFH----LSRER- 243
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311
F+E + + Y +++ L++ HS + +++RD+K NL+++ G +KI DFGL
Sbjct: 244 -VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----K 297
Query: 312 QNLPLTSRVVTLW----YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE 367
+ + + + T Y APE+L YG A+D W G ++ E+ G+ + +
Sbjct: 298 EGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356
Query: 368 QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIE 427
I + + P R A +L+ LL +
Sbjct: 357 LFELILME--------------------EIRFP---------RTLGPEAKSLLSGLLKKD 387
Query: 428 PENR 431
P+ R
Sbjct: 388 PKQR 391
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 74/326 (22%), Positives = 134/326 (41%), Gaps = 70/326 (21%)
Query: 143 SVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKAR---DLETGKIVALKKVRFAN-MDP 198
++ +G + FE + +GQG++ V+ + + ++ A+K ++ A
Sbjct: 9 AITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR 68
Query: 199 ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG------ 252
+ VR E IL +++HP ++KL + G LYL+ +++ G
Sbjct: 69 DRVRTKM-ERDILVEVNHPFIVKLHYAFQT-EGKLYLILDFL----------RGGDLFTR 116
Query: 253 ----IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308
+ FTE +K Y+ +L L+H HS GI++RD+K N+L++ G +K+ DFGL+
Sbjct: 117 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--- 173
Query: 309 DPSQNLPLTSRVVTL----WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT 364
+++ + + Y APE++ + + D WS G ++ E+ G G+
Sbjct: 174 --KESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 365 EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLL 424
E M I K K P + A +L+ L
Sbjct: 231 RKETMTMILKA--------------------KLGMP---------QFLSPEAQSLLRMLF 261
Query: 425 TIEPENR-GSA---ASALRS-EFFKT 445
P NR G+ ++ FF T
Sbjct: 262 KRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 76/312 (24%), Positives = 132/312 (42%), Gaps = 70/312 (22%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILR 212
+ FE + +G+G Y V++ R + TGKI A+K ++ A + + + E +IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKC 262
++ HP ++ L + G LYL+ EY+ G F E
Sbjct: 77 EVKHPFIVDLIYAFQT-GGKLYLILEYL----------SGGELFMQLEREGIFMEDTACF 125
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVT 322
Y+ ++ L H H +GI++RD+K N+++N+ G +K+ DFGL +++ + T
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTHT 180
Query: 323 LW----YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS 378
Y APE+L+ + + A+D WS G ++ ++ G P G + + KI K
Sbjct: 181 FCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--- 236
Query: 379 PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA--- 434
K P Q A L+ KLL +R G+
Sbjct: 237 -----------------KLNLP---------PYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 435 ASALRS-EFFKT 445
A +++ FF+
Sbjct: 271 AGEVQAHPFFRH 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 25/233 (10%)
Query: 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIH 209
W+ R + K+G G + V+ A + K VA+K ++ +M E+ F+ E +
Sbjct: 181 DAWEIPRES-LKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEAN 235
Query: 210 ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQL 267
+++ L H ++KL +VT +Y++ E+M L L + G K P++ + Q+
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQ--NLPLTSRV 320
G+ R +HRD++ +N+L++ + V KI DFGLA Y + P+
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--- 350
Query: 321 VTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
W APE + + D+WS G +L E+ G+ PG + E + +
Sbjct: 351 ---WT-APEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++ K+GQG + V+ T + VA+K ++ M PE F+ +E +++KL H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHE 322
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+++L +V+ +Y+V EYM L L G PQ+ Q+ G+ +
Sbjct: 323 KLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQNLPLTSRVVTLWYRAPEL 330
+HRD++ +N+L+ V K+ DFGLA Y Q + W APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WT-APEA 435
Query: 331 LLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
L ++ D+WS G +L EL G+ PG E + ++
Sbjct: 436 AL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 163 IDKIGQGTYSSVYKARDLETGKI---VALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
IG+G + V++ + VA+K + D +F+ +E +R+ DHP++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHI 453
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
+KL G++T ++++ E +L + Y QL L + S+
Sbjct: 454 VKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLA-----TTYDPSQN--LPLTSRVVTLWYRAPELL 331
+HRDI N+L+++ +K+GDFGL+ +TY + LP+ W APE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI------KWM-APESI 564
Query: 332 LGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
++ +A D+W G + E+ KP G + + +I
Sbjct: 565 N-FRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 25/229 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR---DLETGKI-VALKKVRFANMDPESVRFMAREIHILRK 213
F+KI +G G + +VYK + E KI VA+K++R A + + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMAS 73
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
+D+P+V +L G+ + + + L+ + M L + + Q+ +G+
Sbjct: 74 VDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--------LPLTSRVVTLW 324
+ R ++HRD+ N+L+ +KI DFGLA + +P+ W
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------W 185
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
A E +L Y D+WS G + EL G G E +
Sbjct: 186 M-ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/242 (21%), Positives = 102/242 (42%), Gaps = 50/242 (20%)
Query: 163 IDKIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++GQG++ VY+ A+ + + VA+K V A E + F+ E ++++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCH 88
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL---------AGLATTPGIKFTEPQIKCYMQQL 267
+V++L G+V+ + ++ E M DL A + ++ ++
Sbjct: 89 HVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWY 325
G+ + ++ +HRD+ N ++ +KIGDFG+ R + T +Y
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDIYETDYY 194
Query: 326 R------------APE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMH 370
R +PE L G + D+WS G +L E+ A +P G + + +
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLR 251
Query: 371 KI 372
+
Sbjct: 252 FV 253
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 51/301 (16%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR----FANMDPESVRFMAREIHIL 211
+ + F +G+G++ V+ A +T + A+K ++ + D E E +L
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM---VEKRVL 71
Query: 212 -RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLR 269
+HP + + ++ +L+ V EY+ DL + KF + Y +++
Sbjct: 72 SLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIIL 129
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL----WY 325
GL+ HS+GI++RD+K N+L++ G +KI DFG+ +N+ ++ T Y
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-----KENMLGDAKTNTFCGTPDY 184
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
APE+LLG KY ++D WS G +L E+ G+ G+ E E H I
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------- 233
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSAASALRSEFFK 444
P P R + A L+ KL EPE R G + F+
Sbjct: 234 ----------NPFYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
Query: 445 T 445
Sbjct: 275 E 275
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 35/235 (14%)
Query: 163 IDKIGQGTYSSVYKA--RDLETGKI-VALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+G+G + SV +A + + + VA+K ++ + + RE +++ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 220 MKLEGLVT-----SRSGSLYLVFEYMEH-DL-----AGLATTPGIKFTEPQIKCYMQQLL 268
KL G+ R ++ +M+H DL A + +M +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQN--LPLTSRV 320
G+E+ SR +HRD+ N ++ + + DFGL+ Y LP+
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK--- 204
Query: 321 VTLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
W A E L Y D+W+ G + E+ P G E + +
Sbjct: 205 ---WL-ALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYL 252
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++++G+ + VYK E + VA+K ++ P F E + +L HP
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHP 72
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEPQIK 261
NV+ L G+VT + L ++F Y H DL T P
Sbjct: 73 NVVCLLGVVT-KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 262 CYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQN-- 313
+ Q+ G+E+ S ++H+D+ N+L+ + +KI D GL Y N
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 314 LPLTSRVVTLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF 354
LP+ R W APE ++ G K+ D+WS G +L E+F
Sbjct: 192 LPI--R----WM-APEAIMYG--KFSIDSDIWSYGVVLWEVF 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 31/214 (14%), Positives = 63/214 (29%), Gaps = 35/214 (16%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFA-NMDPESVRFMAREIHILRKLDHPNVMK 221
+ G ++A D + VAL V + + ++ L ++D P V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 222 LEGLVTSRSGSLYLVFEYME-HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGIL 280
+ +V +R +V E++ L +A T + MQ L + H G+
Sbjct: 96 VLDVVHTR-AGGLVVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 281 HRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAA 340
S + ++ G + + +P
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPDANPQD---------------------------- 183
Query: 341 IDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFK 374
D+ G L L + +P + +
Sbjct: 184 -DIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 48/234 (20%), Positives = 89/234 (38%), Gaps = 34/234 (14%)
Query: 163 IDKIGQGTYSSVYKAR---DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+G+G + SV + + T VA+K ++ N + E ++ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 220 MKLEGLVT----SRSGSLYLVFEYMEH-DL-----AGLATTPGIKFTEPQIKCYMQQLLR 269
++L G+ ++ +M++ DL T + +M +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQN--LPLTSRVV 321
G+E+ +R LHRD+ N ++ + + + DFGL+ Y + +P+
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---- 214
Query: 322 TLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
W A E L Y + D+W+ G + E+ P PG E +
Sbjct: 215 --WI-AIESLADR--VYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYL 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 25/229 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKAR---DLETGKI-VALKKVRFANMDPESVRFMAREIHILRK 213
K+ +G G + +V+K + E+ KI V +K + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGS 71
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
LDH ++++L GL S L LV +Y+ L + + Q+ +G+
Sbjct: 72 LDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQN--LPLTSRVVTLW 324
+ G++HR++ N+L+ + +++ DFG+A P+ W
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI------KW 183
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
A E + KY D+WS G + EL G G E +
Sbjct: 184 M-ALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 70/315 (22%), Positives = 115/315 (36%), Gaps = 74/315 (23%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR----FANMDPESVRFMAREIHIL 211
D FE I +G+G++ V AR ETG + A+K ++ + D E E IL
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRIL 77
Query: 212 RK-LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQI 260
+HP + +L + L+ V E++ G +F E +
Sbjct: 78 SLARNHPFLTQLFCCFQTPD-RLFFVMEFV----------NGGDLMFHIQKSRRFDEARA 126
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320
+ Y +++ L H +GI++RD+K N+L+++ G K+ DFG+ + +
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTT 181
Query: 321 VTL----WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC 376
T Y APE+L YG A+D W+ G +L E+ G E + I
Sbjct: 182 ATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND- 239
Query: 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSAA 435
+ P + A ++ +T P R GS
Sbjct: 240 -------------------EVVYP---------TWLHEDATGILKSFMTKNPTMRLGSLT 271
Query: 436 SALRSE-----FFKT 445
FFK
Sbjct: 272 QGGEHAILRHPFFKE 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 45/238 (18%), Positives = 83/238 (34%), Gaps = 26/238 (10%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKI-------VALKKVRFANMDPESVRFM 204
+ R D + +GQGT++ ++K E G V LK + A+ + F
Sbjct: 3 HKIRNED-LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF 60
Query: 205 AREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCY 263
++ KL H +++ G+ LV E+++ L
Sbjct: 61 -EAASMMSKLSHKHLVLNYGVCV-CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLIN--------NAGVLKIGDFGLATTYDPSQNLP 315
+QL + ++H ++ N+L+ N +K+ D G++ T P L
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL- 177
Query: 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372
+ W PE + A D WS G L E+ + G + ++
Sbjct: 178 ---QERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 61/308 (19%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKL 214
+ F + +G+G++ V + T ++ A+K ++ + + V E +L
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 215 D-HPNVMKLEGLVTSRSGSLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQ 266
P + +L + LY V EY+ DL G +F EP Y +
Sbjct: 78 GKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVG-------RFKEPHAVFYAAE 129
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW-- 324
+ GL S+GI++RD+K N+++++ G +KI DFG+ +N+ T
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGT 184
Query: 325 --YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382
Y APE++ YG ++D W+ G +L E+ AG+ G E E I +
Sbjct: 185 PDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------- 236
Query: 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA---ASAL 438
P ++ + A+A+ L+T P R G +
Sbjct: 237 -------------NVAYP---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 274
Query: 439 RS-EFFKT 445
+ FF+
Sbjct: 275 KEHAFFRY 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 70/310 (22%), Positives = 110/310 (35%), Gaps = 70/310 (22%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVA---LKKVRFANMDPESVRFMAREIHIL-RK 213
F + IG+G++ V AR A L+K E M+ E ++L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKHIMS-ERNVLLKN 95
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCY 263
+ HP ++ L + LY V +Y+ G F EP+ + Y
Sbjct: 96 VKHPFLVGLHFSFQTAD-KLYFVLDYI----------NGGELFYHLQRERCFLEPRARFY 144
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL 323
++ L + HS I++RD+K N+L+++ G + + DFGL +N+ S T
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-----KENIEHNSTTSTF 199
Query: 324 ----WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379
Y APE+L Y +D W G +L E+ G P R E I
Sbjct: 200 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---- 254
Query: 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSAASAL 438
Q N SA L++ LL + R G+ +
Sbjct: 255 ----------------PLQLK---------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 289
Query: 439 ---RSEFFKT 445
FF
Sbjct: 290 EIKSHVFFSL 299
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/236 (27%), Positives = 98/236 (41%), Gaps = 37/236 (15%)
Query: 163 IDKIGQGTYSSVYKAR--DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNV 219
D IG+G + V KAR A+K+++ + F E+ +L KL HPN+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNI 88
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEPQIKCY 263
+ L G G LYL EY H +L +A + + Q+ +
Sbjct: 89 INLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 264 MQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA---TTYDPSQN--LPLTS 318
+ RG+++ + +HRD+ N+L+ V KI DFGL+ Y LP+
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-- 205
Query: 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMHKI 372
R W A E L + Y D+WS G +L E+ G P G T E K+
Sbjct: 206 R----WM-AIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKL 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 49/302 (16%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHIL-RK 213
+ F + +G+G++ V + T ++ A+K ++ + + V E +L
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
P + +L + LY V EY+ DL G +F EP Y ++ GL
Sbjct: 399 GKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLF 456
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLW----YRAP 328
S+GI++RD+K N+++++ G +KI DFG+ +N+ T Y AP
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPDYIAP 511
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
E++ YG ++D W+ G +L E+ AG+ G E E I +
Sbjct: 512 EIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------- 557
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA---ASALRS-EFF 443
P ++ + A+A+ L+T P R G ++ FF
Sbjct: 558 -------NVAYP---------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
Query: 444 KT 445
+
Sbjct: 602 RY 603
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 60/248 (24%), Positives = 94/248 (37%), Gaps = 57/248 (22%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-H 216
+G+G + V +A T + VA+K ++ E M E+ IL + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHH 90
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEPQI 260
NV+ L G T G L ++ E+ + +L T +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320
CY Q+ +G+E SR +HRD+ N+L++ V+KI DFGLA R
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------------RD 197
Query: 321 V--TLWYR------------APE-LLLGATKYGAAIDMWSAGCILAELFA-GK---PIMP 361
+ Y APE + Y D+WS G +L E+F+ G P +
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 362 GRTEVEQM 369
E +
Sbjct: 256 IDEEFCRR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 71/315 (22%), Positives = 127/315 (40%), Gaps = 68/315 (21%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDL---ETGKIVA---LKKVRFANMDPESVRFMAREIHIL 211
+ FE + +G G Y V+ R + +TGK+ A LKK + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVL 112
Query: 212 RKLDH-PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQI 260
+ P ++ L + L+L+ +Y+ G +FTE ++
Sbjct: 113 EHIRQSPFLVTLHYAFQT-ETKLHLILDYI----------NGGELFTHLSQRERFTEHEV 161
Query: 261 KCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRV 320
+ Y+ +++ LEH H GI++RDIK N+L+++ G + + DFGL+ + +
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 321 VTLWYRAPELLLGATK-YGAAIDMWSAGCILAELFAGKP----IMPGRTEVEQMHKIFKL 375
T+ Y AP+++ G + A+D WS G ++ EL G ++ E +I K
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-GSA 434
+P P + A L+ +LL +P+ R G
Sbjct: 282 --------------------EPPYP---------QEMSALAKDLIQRLLMKDPKKRLGCG 312
Query: 435 ---ASALRS-EFFKT 445
A ++ FF+
Sbjct: 313 PRDADEIKEHLFFQK 327
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 50/242 (20%)
Query: 163 IDKIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
I +G G + VY+ + VA+K + + + + F+ E I+ K +H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 93
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLRG 270
N+++ G+ +S +++ E M DL + + + + G
Sbjct: 94 NIVRCIGVSL-QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 271 LEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVV--TLWY 325
++ +HRDI N L+ G V KIGDFG+A R + +Y
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRASYY 199
Query: 326 R------------APE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMH 370
R PE + G + + D WS G +L E+F P P ++ E +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLE 256
Query: 371 KI 372
+
Sbjct: 257 FV 258
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 73/314 (23%), Positives = 130/314 (41%), Gaps = 67/314 (21%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRK-LD 215
F+ + IG+G+Y+ V R +T +I A+K V+ D E + ++ E H+ + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCYMQ 265
HP ++ L + S L+ V EY+ G K E + Y
Sbjct: 69 HPFLVGLHSCFQTES-RLFFVIEYV----------NGGDLMFHMQRQRKLPEEHARFYSA 117
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL-- 323
++ L + H RGI++RD+K N+L+++ G +K+ D+G+ + L T
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCG 172
Query: 324 --WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
Y APE+L G YG ++D W+ G ++ E+ AG+ P F + GS
Sbjct: 173 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDN 218
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQS----ALALVDKLLTIEPENR-GSAAS 436
+ + +LE P+S A +++ L +P+ R G
Sbjct: 219 PDQNT-----------EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ 267
Query: 437 ALRSE-----FFKT 445
++ FF+
Sbjct: 268 TGFADIQGHPFFRN 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 38/172 (22%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+G+G + V KA VA+K ++ E + E ++L++++HP
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHP 86
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL-----------------------AGLATTPGI 253
+V+KL G + + G L L+ EY ++ L + L
Sbjct: 87 HVIKLYGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
T + + Q+ +G+++ ++HRD+ N+L+ +KI DFGL+
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 56/237 (23%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREI 208
RR ++ ++G+G + V+ +L K +VA+K ++ + F RE
Sbjct: 13 KRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQ-REA 68
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPG 252
+L L H +++K G+ L +VFEYM+H DL G
Sbjct: 69 ELLTNLQHEHIVKFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
+ Q+ Q+ G+ + S+ +HRD+ N L+ ++KIGDFG++
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------- 180
Query: 313 NLPLTSRVVTL--WYR------------APE-LLLGATKYGAAIDMWSAGCILAELF 354
R V +YR PE ++ K+ D+WS G IL E+F
Sbjct: 181 ------RDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIF 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 165 KIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++G+G + V+ +L + +VA+K ++ A+ F RE +L L H ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQ-REAELLTMLQHQHI 105
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DL--------------AGLATTPGIKFTEPQIKCYM 264
++ G+ T L +VFEYM H DL AG Q+
Sbjct: 106 VRFFGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 265 QQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQNLPLTS 318
Q+ G+ + +HRD+ N L+ V+KIGDFG++ Y L
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 319 RVVTLWYRAPE-LLLGATKYGAAIDMWSAGCILAELF 354
R W PE +L K+ D+WS G +L E+F
Sbjct: 225 R----WM-PPESILYR--KFTTESDVWSFGVVLWEIF 254
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 72/314 (22%), Positives = 130/314 (41%), Gaps = 67/314 (21%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRK-LD 215
F+ + IG+G+Y+ V R +T +I A++ V+ D E + ++ E H+ + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG----------IKFTEPQIKCYMQ 265
HP ++ L + S L+ V EY+ G K E + Y
Sbjct: 112 HPFLVGLHSCFQTES-RLFFVIEYV----------NGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTL-- 323
++ L + H RGI++RD+K N+L+++ G +K+ D+G+ + L T
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCG 215
Query: 324 --WYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381
Y APE+L G YG ++D W+ G ++ E+ AG+ P F + GS
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDN 261
Query: 382 DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQS----ALALVDKLLTIEPENR-GSAAS 436
+ + +LE P+S A +++ L +P+ R G
Sbjct: 262 PDQNT-----------EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ 310
Query: 437 ALRSE-----FFKT 445
++ FF+
Sbjct: 311 TGFADIQGHPFFRN 324
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 50/242 (20%)
Query: 163 IDKIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
I +G G + VY+ + VA+K + + + + F+ E I+ K +H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQ 134
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL------AGLATTPGIKFTEPQIKCYMQQLLRG 270
N+++ G+ +S +++ E M DL + + + + G
Sbjct: 135 NIVRCIGVSL-QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 271 LEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNLPLTSRVV--TLWY 325
++ +HRDI N L+ G V KIGDFG+A R + +Y
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRAGYY 240
Query: 326 R------------APE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMPGRTEVEQMH 370
R PE + G + + D WS G +L E+F P P ++ E +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLE 297
Query: 371 KI 372
+
Sbjct: 298 FV 299
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 59/251 (23%)
Query: 163 IDKIGQGTYSSVYKAR-------DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL- 214
+G+G + V A + VA+K ++ + + + E+ +++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 98
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEP 258
H N++ L G T + G LY++ EY +L + P + T
Sbjct: 99 KHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
+ QL RG+E+ S+ +HRD+ N+L+ V+KI DFGLA
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------------- 204
Query: 319 RVV--TLWYR------------APE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMP 361
R + +Y+ APE L Y D+WS G ++ E+F G P P
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSP-YP 261
Query: 362 GRTEVEQMHKI 372
G E +
Sbjct: 262 GIPVEELFKLL 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 31/172 (18%)
Query: 163 IDKIGQGTYSSVYK--ARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ IG+G + V++ A L + +VA+K ++ F RE ++ + D+P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNP 110
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DL-----------------------AGLATTPGI 253
N++KL G+ + L+FEYM + DL A +++
Sbjct: 111 NIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA 305
+ + C +Q+ G+ + R +HRD+ N L+ V+KI DFGL+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 163 IDKIGQGTYSSVYKAR-------DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL- 214
+G+G + V A VA+K ++ + + + E+ +++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIG 132
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEP 258
H N++ L G T + G LY++ EY +L + P + +
Sbjct: 133 KHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
+ Q+ RG+E+ S+ +HRD+ N+L+ V+KI DFGLA
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------------- 238
Query: 319 RVV--TLWYR------------APE-LLLGATKYGAAIDMWSAGCILAELF 354
R + +Y+ APE L Y D+WS G +L E+F
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIF 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 59/251 (23%)
Query: 163 IDKIGQGTYSSVYKAR-------DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL- 214
+G+G + V A + VA+K ++ + + + E+ +++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG 144
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DL---------------AGLATTPGIKFTEP 258
H N++ L G T + G LY++ EY +L + P + T
Sbjct: 145 KHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
+ QL RG+E+ S+ +HRD+ N+L+ V+KI DFGLA
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------------- 250
Query: 319 RVV--TLWYR------------APE-LLLGATKYGAAIDMWSAGCILAELF--AGKPIMP 361
R + +Y+ APE L Y D+WS G ++ E+F G P P
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSP-YP 307
Query: 362 GRTEVEQMHKI 372
G E +
Sbjct: 308 GIPVEELFKLL 318
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 56/249 (22%), Positives = 93/249 (37%), Gaps = 58/249 (23%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DH 216
+G G + V +A + VA+K ++ + E M E+ +L L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNH 86
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DL-----------------AGLATTPGIKFTEP 258
N++ L G T G ++ EY + DL + +
Sbjct: 87 MNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
+ + Q+ +G+ S+ +HRD+ N+L+ + + KI DFGLA
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------------- 192
Query: 319 RVV--TLWYR------------APELLLGATKYGAAIDMWSAGCILAELFA-GK---PIM 360
R + Y APE + Y D+WS G L ELF+ G P M
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 361 PGRTEVEQM 369
P ++ +M
Sbjct: 252 PVDSKFYKM 260
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 163 IDKIGQGTYSSVYKA-----RDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-H 216
+G G + V +A + VA+K ++ E M E+ I+ L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQH 109
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DL-------------AGLATTPGIKFTEPQIKC 262
N++ L G T G + ++ EY + DL + +
Sbjct: 110 ENIVNLLGACT-HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 263 YMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------TTYDPSQNLPL 316
+ Q+ +G+ S+ +HRD+ N+L+ N V KIGDFGLA + Y N L
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELF 354
+ W APE + Y D+WS G +L E+F
Sbjct: 229 PVK----WM-APESIFDC-VYTVQSDVWSYGILLWEIF 260
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 55/268 (20%)
Query: 127 GPEGDEVVAGWPSWLTSVAGEAIKGWQPRRA-DAFEKIDKIGQGTYSSVYKARDLETGKI 185
E EV G + + + A D F + +G+G + VYK R L G +
Sbjct: 6 AEEDPEVHLGQLKRFSLR--------ELQVASDNFSNKNILGRGGFGKVYKGR-LADGTL 56
Query: 186 VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYM----- 240
VA+K+++ ++F E+ ++ H N+++L G + + L LV+ YM
Sbjct: 57 VAVKRLKEERTQGGELQFQT-EVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSV 114
Query: 241 EHDLAGLATTPGIKFTEPQIKCYMQQLL-------------RGL----EHCHSRGILHRD 283
L + Q L RGL +HC + I+HRD
Sbjct: 115 ASCLRERPES--------------QPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRD 159
Query: 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPE-LLLGATKYGAAI 341
+K +N+L++ +GDFGLA D +T+ V T+ + APE L G +
Sbjct: 160 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKT-- 216
Query: 342 DMWSAGCILAELFAG-KPIMPGRTEVEQ 368
D++ G +L EL G + R +
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 44/234 (18%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR----FMAREIHI 210
+K+G+G + VYK + VA+KK+ A +D + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY-VN-NTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYM-----EHDLAGLATTP------------GI 253
+ K H N+++L G + LV+ YM L+ L TP G
Sbjct: 84 MAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313
G+ H +HRDIK +N+L++ A KI DFGLA +
Sbjct: 143 A--------------NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 314 LPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTE 365
+TSR+V T Y APE L G + D++S G +L E+ G + R
Sbjct: 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 60/256 (23%), Positives = 95/256 (37%), Gaps = 63/256 (24%)
Query: 163 IDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DH 216
+G G + V A VA+K ++ E M E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSH 108
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DL----------------------AGLATTPGI 253
N++ L G T SG +YL+FEY + DL
Sbjct: 109 ENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313
T + C+ Q+ +G+E + +HRD+ N+L+ + V+KI DFGLA
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-------- 219
Query: 314 LPLTSRVV--TLWYR------------APELLLGATKYGAAIDMWSAGCILAELFA-GK- 357
R + Y APE L Y D+WS G +L E+F+ G
Sbjct: 220 -----RDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVN 273
Query: 358 --PIMPGRTEVEQMHK 371
P +P ++ +
Sbjct: 274 PYPGIPVDANFYKLIQ 289
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 43/231 (18%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVR----FMAREIHILRKLD 215
F+ IG G + VYK L G VALK+ PES + F EI L
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSFCR 93
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHD-----LAGLATTPGIKFTEPQIKCYMQQLL-- 268
HP+++ L G R+ + L+++YME+ L G + P + + Q ++ +
Sbjct: 94 HPHLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYG-SDLPTMSMSWEQ---RLEICIGA 148
Query: 269 -RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYR 326
RGL + H+R I+HRD+K N+L++ V KI DFG++ L++ V TL Y
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 327 APELLLGATKYGAAI--------DMWSAGCILAELFAGK-PIMPGRTEVEQ 368
PE Y I D++S G +L E+ + I+
Sbjct: 209 DPE-------Y--FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 51/253 (20%)
Query: 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PNVMK 221
KIG G++ +Y D+ G+ VA+K P+ + E I + + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPT 69
Query: 222 L-----EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+ EG +V E + L L KF+ + Q++ +E+ HS
Sbjct: 70 IRWCGAEGDYN------VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 277 RGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
+ +HRD+K N L+ ++ I DFGLA Y ++ T + + YR + L G
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR----THQHIP--YRENKNLTG 177
Query: 334 ATKYGAAI------------DMWSAGCILAELFAGK---PIMPGRTEVEQMHKIFK---- 374
+Y A+I D+ S G +L G + T+ ++ +I +
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236
Query: 375 -----LC-GSPSE 381
LC G PSE
Sbjct: 237 TPIEVLCKGYPSE 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 53/268 (19%), Positives = 102/268 (38%), Gaps = 55/268 (20%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PN 218
++ +IG+G++ +++ +L + VA+K + P+ + E + L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 67
Query: 219 VMKLEGLVTSRSGSL----YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ + G LV + + L L G KF+ + +Q+L ++
Sbjct: 68 IPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 275 HSRGILHRDIKGSNLLI-----NNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRAP 328
H + +++RDIK N LI NA ++ + DFG+ Y DP + YR
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREK 175
Query: 329 ELLLGATKYGAAI------------DMWSAGCILAELFAGK---PIMPGRTEVEQMHKIF 373
+ L G +Y +I D+ + G + G + T ++ +I
Sbjct: 176 KNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
Query: 374 K---------LC-GSPSE--DYWRKSKS 389
+ LC G P E Y +++
Sbjct: 235 EKKQSTPLRELCAGFPEEFYKYMHYARN 262
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 3e-17
Identities = 104/499 (20%), Positives = 176/499 (35%), Gaps = 60/499 (12%)
Query: 153 QPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILR 212
+PR + F KIG G++ +Y +++T + VA+K P+ + E I R
Sbjct: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYR 57
Query: 213 KL-DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
L + + LV + + L L K + + Q++ +
Sbjct: 58 ILQGGTGIPNVRWFGVEG-DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 272 EHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTLWYRA 327
E HS+ LHRDIK N L+ A + I DFGLA Y D S + + YR
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-------YRE 169
Query: 328 PELLLGATKYGAAI------------DMWSAGCILAELFAGK---PIMPGRTEVEQMHKI 372
+ L G +Y A++ D+ S G +L G + T+ ++ KI
Sbjct: 170 NKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
Query: 373 FK---------LC-GSPSE--DYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALV 420
+ LC G P+E Y+ +S KP Y +++ FR+
Sbjct: 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDD-KPDYSYLKRL---FRDLFIREGFQF 284
Query: 421 DKLL--TIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEA 478
D + TI + ASA + PS L PP+ + D + E R
Sbjct: 285 DYVFDWTILKYQQSQIASAPP----RAVGHGAGPSGLA--PPALQNDRQSGVDEGRTSGW 338
Query: 479 EAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTSISHKFHNQEDSCSGFRIEPPTVGR 538
++ R + + P + SK IS S S R + R
Sbjct: 339 SSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSS-SR 397
Query: 539 QNVNSHSSTAVHPSASWNKSTVSTRNNSELRTQR--SHLPQTAADFSNNNNRMNDRVFIR 596
+ +S A+ R + ++ S P+ ++ +++N N ++
Sbjct: 398 DVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALK 457
Query: 597 DSNMGYVPKKNRIHYSGPL 615
R+ Y+ L
Sbjct: 458 GIEGLNFDGDERVQYAAAL 476
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 48/225 (21%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRF--MAREIHILRKLDH- 216
F KIG G + + ++L T + VA+K ++P R + E ++L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 217 PNVMKLEGLVTSRSGSL----YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
+ ++ G +V E + L L F+ + QL+ +E
Sbjct: 65 DGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 273 HCHSRGILHRDIKGSNLLI-----NNAGVLKIGDFGLATTY-DPS--QNLPLTSRVVTLW 324
+ HS+ +++RD+K N LI V+ I DF LA Y DP +++P
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP--------- 170
Query: 325 YRAPELLLGATKYGAAI------------DMWSAGCILAELFAGK 357
YR + L G +Y +I D+ + G + G
Sbjct: 171 YREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 40/226 (17%), Positives = 79/226 (34%), Gaps = 45/226 (19%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE- 223
KIG G + +Y A + A V+ + + + E+ +++ + +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKV---EYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 224 ----------------GLVTSRSGSL-YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
GL + S ++V E + DL ++ G F + + +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLI--NNAGVLKIGDFGLATTY-DPSQNLPLTSRVVTL 323
+L LE+ H +H DIK +NLL+ N + + D+GL+ Y +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 324 WYRAPELLLGATKYGAAI------------DMWSAGCILAELFAGK 357
+ G ++ ++ D+ G + GK
Sbjct: 214 -ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 21/168 (12%)
Query: 165 KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE- 223
IGQG + +Y A + + V ++P + E+ ++ P ++
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 224 ----------------GLVTSRSGSL-YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQ 266
GL S +++ + DL + +F+ + +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 267 LLRGLEHCHSRGILHRDIKGSNLLIN--NAGVLKIGDFGLATTYDPSQ 312
+L LE+ H +H DIK SNLL+N N + + D+GLA Y P
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 2e-13
Identities = 97/621 (15%), Positives = 183/621 (29%), Gaps = 154/621 (24%)
Query: 82 IVERPKR-NRHQRCATMDMGMGTGTETTIVAVG--LQPQ----MSRIVCLPVGPEGDEVV 134
I+ + R + E V L+ MS I P +
Sbjct: 54 IIMSKDAVSGTLR--LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 135 -AGWPSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLE---------TGK 184
L + K R + K+ Q + + R + +GK
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRL----QPYLKLRQA----LLELRPAKNVLIDGVLGSGK 163
Query: 185 -IVALKKVRFANMDPESVRFMAREIH-I-LRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241
VAL + M +I + L+ + P + LE L L +
Sbjct: 164 TWVALDVCL----SYKVQCKMDFKIFWLNLKNCNSPETV-LEMLQK-----LLYQIDPNW 213
Query: 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301
+ + IK I+ +++LL+ + + +L +++ NA +
Sbjct: 214 TSRS--DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQ-------NAKAWNAFN 263
Query: 302 FG---LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAE---LFA 355
L TT VT + L AT ++D S E L
Sbjct: 264 LSCKILLTTRFKQ---------VT------DFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 356 ---GKPI--MPGRTEVEQMHKIF----KLCGS-----PSE-DYWR-----KSKSAHATSF 395
+P ++ + + D W+ K + +S
Sbjct: 309 KYLDCRPQDLP-----REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 396 KPQQPYK-RKVLETFRNFPQSA------LALV-DKLLTIEPENRGSAASALRSEFFKTEP 447
+P + RK+ + FP SA L+L+ ++ + + ++ K
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV-------VVNKLHKYSL 416
Query: 448 LPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRG--SRDFSAVRTPEFI 505
+ P PS L+ K++ + V ++ + S D ++
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY---NIPKTFDSDDLIPPYLDQYF 473
Query: 506 PSGQSKPTSISHKFH----NQEDSCSGFR--------IEPPTVGRQNVNSHSSTAVHPSA 553
S I H H + + FR +E Q + H STA
Sbjct: 474 YS------HIGH--HLKNIEHPERMTLFRMVFLDFRFLE------QKIR-HDSTA----- 513
Query: 554 SWNKSTVSTRNNSELRTQRSHLPQTAADFSNNNNRMNDRVFIRDSNMGYVPKKNRIHYSG 613
WN S +L+ + ++ + N + D + + N+ + + +
Sbjct: 514 -WNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIA- 571
Query: 614 PLMPPGGNMEDILKEHERQIQ 634
LM E I +E +Q+Q
Sbjct: 572 -LMAED---EAIFEEAHKQVQ 588
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 24/171 (14%), Positives = 48/171 (28%), Gaps = 20/171 (11%)
Query: 165 KIGQGTYSSVYKARDLETGKI--------VALKKVRFANMDPESVRFMAREI-------- 208
+ +Y+A T +LK F R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGL-ATTPGIKFTEPQIKCYMQQL 267
L + G + +LV + L +P +E + +L
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 268 LRGLEHCHSRGILHRDIKGSNLLI--NNAGVLKIGDFGLATTY-DPSQNLP 315
L LE H +H ++ N+ + + + + +G A Y +++
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 16/189 (8%)
Query: 193 FANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG 252
+ + I L ++ SG + +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLA------T 306
T + CY Q+ +G+E SR +HRD+ N+L++ V+KI DFGLA
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GK---PIMPG 362
Y + L + W APE + Y D+WS G +L E+F+ G P +
Sbjct: 248 DYVRKGDARLPLK----WM-APETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
Query: 363 RTEVEQMHK 371
E + K
Sbjct: 302 DEEFCRRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREI 208
PR D + +G+G + V +A T + VA+K ++ R + E+
Sbjct: 20 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSEL 76
Query: 209 HILRKLD-HPNVMKLEGLVTSRSGSLYLVFEYMEH 242
IL + H NV+ L G T G L ++ E+ +
Sbjct: 77 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.88 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.57 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=523.09 Aligned_cols=289 Identities=37% Similarity=0.608 Sum_probs=245.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|++|+|||||++++++... .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999987666666677889999999999999999999987643 257
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC-
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS- 311 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~- 311 (665)
+|||||||+|+|...+... ..|++.+++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 134 ~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 9999999999887777654 48999999999999999999999999999999999999999999999999999876432
Q ss_pred --CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 --QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 --~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
......+.+||++|||||++.+...|+.++||||||||||||++|++||.+.+..+++..|....|.|+...|.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 223456789999999999998877889999999999999999999999999999999999999999999887765322
Q ss_pred cccc----CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 390 AHAT----SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 390 ~~~~----~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
.... .+++..+ ..+...++.+++++++||.+||.+||.+|+||.|||+||||+....|
T Consensus 293 ~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 293 ERVRAYIQSLPPRQP--VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp -CHHHHHHSSCCCCC--CCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhcCCCcCC--CCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 2111 1111111 12344567899999999999999999999999999999999976544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-61 Score=506.14 Aligned_cols=263 Identities=29% Similarity=0.433 Sum_probs=227.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+|||||+++++|++.+ .+|
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~y 108 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLY 108 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEE
Confidence 34689999999999999999999999999999999976432 2234567899999999999999999999999865 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-C
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-N 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~ 313 (665)
||||||+|+.+..++...+.|+|.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999975555444445589999999999999999999999999999999999999999999999999999875433 3
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.+...
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------- 251 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---------------- 251 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------------
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 34567899999999999987 6789999999999999999999999999999988888866311
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHH------HHhCcCCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS------ALRSEFFKTEPLP 449 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~e------aL~Hp~f~~~~~~ 449 (665)
.....+++++++||.+||.+||.+|+|+.| +++||||++..+.
T Consensus 252 -------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 252 -------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp -------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 011358899999999999999999999987 5899999976543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=493.10 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=209.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|++|+|||||+++++|.+.+ .+||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-EIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EEEE
Confidence 45899999999999999999999999999999999866542 344567899999999999999999999998865 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||+|+|+..+...+ +|++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...... .
T Consensus 91 vmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~ 167 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F 167 (275)
T ss_dssp EEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence 99999988888776654 79999999999999999999999999999999999999999999999999998765332 3
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
..+.+||+.|||||++.+...++.++|||||||+||+|++|++||.+.+..+.+..|.... +
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~---------------- 229 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y---------------- 229 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C----------------
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C----------------
Confidence 4567999999999999886556789999999999999999999999988887777775421 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 230 -----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 -----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 012358999999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=505.68 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=224.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
..|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++|+|||||+++++|.+.+ .+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 3699999999999999999999999999999999865432 2345789999999999999999999998865 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||+|+.+..+...+ .|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ....
T Consensus 151 Ey~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccc
Confidence 999987666555443 69999999999999999999999999999999999999999999999999999875432 2356
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
+.+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~----------------- 289 (346)
T 4fih_A 229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR----------------- 289 (346)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-----------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC-----------------
Confidence 7799999999999876 6799999999999999999999999999999888888765211 10
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
...+..+|+++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 290 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 012246899999999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-60 Score=505.91 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=221.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|++|+|||||+++++|.+.. .+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-SLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEE
Confidence 35899999999999999999999999999999999987777777888999999999999999999999998764 89999
Q ss_pred EEecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||+|+ |...+.. .+..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999974 5555543 34568999999999999999999999999999999999999999999999999998764321 1
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
..++.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+|......
T Consensus 181 ~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------- 243 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---------------- 243 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----------------
T ss_pred cccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence 2345689999999999987 67999999999999999999999999999999988888663110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 244 ------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 ------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 012368999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=507.23 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=225.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
..|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+.+ .+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGD-ELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECC-EEEEEE
Confidence 4699999999999999999999999999999999865432 2345789999999999999999999999865 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||+|+.+..+...+ .|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ....
T Consensus 228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBC
T ss_pred eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cccc
Confidence 999987666555543 69999999999999999999999999999999999999999999999999999875432 2356
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|.... .+.
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~----------------- 366 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPR----------------- 366 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC-----------------
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCC-----------------
Confidence 7799999999999876 679999999999999999999999999999998888876521 110
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
...+..+|+++++||.+||.+||.+|+|+.|+|+||||+...
T Consensus 367 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 367 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp --------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 012246899999999999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-58 Score=479.61 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=217.0
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLYLV 236 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~lV 236 (665)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+.+|++|+|||||+++++|.+. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999999999999999987777777778899999999999999999999998752 3468999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcC-CCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||+|+.+..++.....+++.+++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999998766655555568999999999999999999999998 999999999999984 79999999999986433
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+.+....+.+.... +..+.
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~------------ 249 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA------------ 249 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG------------
T ss_pred CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC------------
Confidence 23466799999999998864 5999999999999999999999999887766555443321 11111
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++++++||.+||.+||.+|||+.|+|+||||+.
T Consensus 250 -------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112357889999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=489.56 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=214.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||+++++|.+.. .+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT-EE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-EE
Confidence 357999999999999999999984 46889999999765433233345778999999999999999999998865 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||||||+|+.+..++.....|++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999976555444445589999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|.+..-
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------- 243 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL---------------- 243 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence 23456799999999999986 6799999999999999999999999999999998888865210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
..+..+|+++++||.+||++||.+||| ++|+|+||||++.
T Consensus 244 -------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 244 -------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 012358999999999999999999998 5899999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=483.28 Aligned_cols=284 Identities=30% Similarity=0.433 Sum_probs=223.4
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
...++|+++++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||+++++|.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 34468999999999999999999875 467899999986543 234577899999998 6999999999998765
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceecC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTYD 309 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~~ 309 (665)
.+|||||||+|+.+..+.. .+++.+++.|++||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+...
T Consensus 94 -~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 94 -HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp -EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred -EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 8999999999755544442 59999999999999999999999999999999999999876 899999999998654
Q ss_pred CCC---------------------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCC-C
Q 006004 310 PSQ---------------------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIM-P 361 (665)
Q Consensus 310 ~~~---------------------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF-~ 361 (665)
... ....++.+||++|||||++.+...|+.++||||+|||||||++|++|| .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 321 122456689999999999988677999999999999999999999887 6
Q ss_pred CCChHHHHHHHHHhcCCCChhHHhhhccccc--cCCCCC----------------Cc-------chhhhhhhccCCcHHH
Q 006004 362 GRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA--TSFKPQ----------------QP-------YKRKVLETFRNFPQSA 416 (665)
Q Consensus 362 g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~--~~~~~~----------------~p-------~~~~~~~~~~~~s~~a 416 (665)
+.++.+++..|...+|++....+........ ....+. .| ......+.+..+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 7788999999999999765443332110000 000000 00 0011123456789999
Q ss_pred HHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 417 LALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 417 ~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+|||.+||.+||.+|+||+|||+||||++.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=481.26 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=215.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|++.++||+|+||+||+|+++.+|+.||||+++..... .+|+.+|++|+|||||+++++|.+.. .+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~-~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGP-WVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 4699999999999999999999999999999999865432 46999999999999999999998765 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCCC--
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNL-- 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~~-- 314 (665)
|||+|+.+..++.....|++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999765555555555899999999999999999999999999999999999999988 6999999999987543211
Q ss_pred --CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 315 --PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 315 --~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+|... .+
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~------------- 273 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PP------------- 273 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CC-------------
T ss_pred eecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CC-------------
Confidence 1234589999999999987 67999999999999999999999999998877777776542 11
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHH-------------HhCcCCCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA-------------LRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea-------------L~Hp~f~~~~~ 448 (665)
.....+..+++.+.+||.+||++||.+|||+.|+ |+|||+.....
T Consensus 274 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 274 -----------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp -----------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred -----------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 0112335789999999999999999999999997 57999986543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=460.97 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=197.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG------ 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~------ 231 (665)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||+++++|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999998654 34455678999999999999999999999875432
Q ss_pred -----cEEEEEEeccccchhhhcCCCCCC---ChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 232 -----SLYLVFEYMEHDLAGLATTPGIKF---TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 232 -----~l~lV~Ey~~g~ll~~~~~~~~~l---se~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.+|||||||.|+.+..+......+ ++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 379999999976665554443344 345688999999999999999999999999999999999999999999
Q ss_pred cceecCCCCC-----------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006004 304 LATTYDPSQN-----------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372 (665)
Q Consensus 304 lA~~~~~~~~-----------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI 372 (665)
+|+.+..... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||.+. .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 9988754321 12345689999999999987 679999999999999999996 67543 3333333
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
........+. .+...++.+.+||.+||++||.+|||+.|+|+||||++..+
T Consensus 238 ~~~~~~~~p~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 238 TDVRNLKFPP-------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTTCCCH-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHhcCCCCC-------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 3221111111 11235677889999999999999999999999999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=494.58 Aligned_cols=268 Identities=24% Similarity=0.412 Sum_probs=233.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+.. .+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-EMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-EEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEE
Confidence 468999999999999999999999999999999997643 344567889999999999999999999998865 89999
Q ss_pred EEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC--CcEEEEecccceecCCCCC
Q 006004 237 FEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA--GVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~--g~lKL~DFGlA~~~~~~~~ 313 (665)
||||.| +|...+......|++.+++.|++||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999986 5556665566689999999999999999999999999999999999999854 899999999999876433
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+||+.|||||++.+ ..|+.++||||||||||+||+|++||.+.+..+++..|......++...
T Consensus 312 -~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------- 379 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 379 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG----------
T ss_pred -ceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc----------
Confidence 3566799999999999987 6799999999999999999999999999999999998876543333322
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNL 455 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~ 455 (665)
+..+|+++++||.+||.+||.+|||+.|+|+||||+....+.....+
T Consensus 380 ---------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~ 426 (573)
T 3uto_A 380 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426 (573)
T ss_dssp ---------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred ---------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence 34689999999999999999999999999999999987665544433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=485.77 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=216.7
Q ss_pred cCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC----CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc
Q 006004 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR 229 (665)
Q Consensus 154 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~ 229 (665)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+..+ ..........++.+++.++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 5567899999999999999999999999999999999975432 222223334456777788999999999999986
Q ss_pred CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 230 SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
+ .+|||||||.|+.+..++.....|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 265 ~-~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 D-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp S-EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred C-EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 5 899999999976555555455689999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhHHhh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV---EQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~---e~l~kI~~~~g~p~~~~~~~ 386 (665)
... ..+.+||+.|||||++.+...|+.++||||||||||||++|++||.+.+.. +....+....
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~---------- 410 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------- 410 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC----------
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC----------
Confidence 432 356799999999999976567999999999999999999999999875432 2233332210
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTEP 447 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~~ 447 (665)
...+..+|+++++||.+||.+||.+|++ +.|+++||||++..
T Consensus 411 -------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 411 -------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 0112468999999999999999999998 89999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=432.25 Aligned_cols=287 Identities=39% Similarity=0.686 Sum_probs=247.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.++++++||||+++++++.+.. .+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-EEEEEE
Confidence 4799999999999999999999999999999999876655556677889999999999999999999998754 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ....
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 159 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence 999999988888777789999999999999999999999999999999999999999999999999998765332 2344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
..+||+.|+|||++.+...++.++|||||||++|+|++|. ++|.+.+..+.+..+....+.+....|............
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 5688999999999987666899999999999999999776 457888889999999999999998888765432222222
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+...........+++.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 22233333445556789999999999999999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=444.58 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=208.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.++||+|+||+||+|++.. .||||+++......+..+.|.+|+.+|++|+|||||++++++.. +.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEE
Confidence 3579999999999999999998643 59999998776677778889999999999999999999998754 368999
Q ss_pred EEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CC
Q 006004 237 FEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NL 314 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~ 314 (665)
||||+|+.+ ..+.....++++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999997554 5555555689999999999999999999999999999999999999999999999999998764322 23
Q ss_pred CcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+..+.+..+......++.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----------- 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD----------- 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC-----------
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC-----------
Confidence 34567899999999999742 46899999999999999999999999998877766665442111100
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.....++|+.+.+||.+||+.||.+|||+.|++++
T Consensus 259 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 259 ------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112234688999999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=459.16 Aligned_cols=292 Identities=37% Similarity=0.593 Sum_probs=230.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc----CCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR----SGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----~~~l 233 (665)
++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|++|+|||||++++++... ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 579999999999999999999999999999999976555666677889999999999999999999998543 2469
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+++++...+... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 999999999888777654 4799999999999999999999999999999999999999999999999999987643221
Q ss_pred --------------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-----------C
Q 006004 314 --------------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-----------G 356 (665)
Q Consensus 314 --------------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-----------G 356 (665)
...+..+||++|+|||++.....|+.++||||||||||||++ |
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 134567899999999988766789999999999999999999 8
Q ss_pred CCCCCCCC--------------------hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCc--chhhhhhhccCCcH
Q 006004 357 KPIMPGRT--------------------EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQP--YKRKVLETFRNFPQ 414 (665)
Q Consensus 357 ~~pF~g~~--------------------~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~~~s~ 414 (665)
+++|++.+ ..+++..|+..+|.|+.+.|..........+....+ ....+...++.+++
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 89998865 368899999999999998876543322211111111 11234556678899
Q ss_pred HHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 415 SALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 415 ~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
++++||.+||.+||.+|||+.|||+||||+....+.
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 999999999999999999999999999999775543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=462.11 Aligned_cols=285 Identities=30% Similarity=0.522 Sum_probs=232.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++|||||++++++.... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 35799999999999999999999999999999999866555666778899999999999999999999987542 3
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+||||||++++++..+.. .+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 5899999999998877653 4899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
...+..+||++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++.+|.+.+|.|..++|.+.....
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 23566789999999999987 579999999999999999999999999999999999999999999999886543111
Q ss_pred ccCCC-----CCCcchhhhh--------hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 392 ATSFK-----PQQPYKRKVL--------ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 392 ~~~~~-----~~~p~~~~~~--------~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
..... ....+..... +.....++++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 10000 0000000000 00011267899999999999999999999999999998543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=438.36 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=209.7
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+++|++|+|||||++++++.+.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-P 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-E
Confidence 57999999999999999999875 36889999999743 3556678999999999999999999999998754 7
Q ss_pred EEEEEEeccccchh-hhcC------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEE
Q 006004 233 LYLVFEYMEHDLAG-LATT------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKI 299 (665)
Q Consensus 233 l~lV~Ey~~g~ll~-~~~~------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL 299 (665)
+|||||||+++.+. .+.. ....|++.++..|+.||+.||.|||+++||||||||+||||+.++.+||
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence 99999999975554 4432 2246999999999999999999999999999999999999999999999
Q ss_pred EecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 006004 300 GDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCG 377 (665)
Q Consensus 300 ~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g 377 (665)
+|||+|+........ .....+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876443221 1233478999999999986 679999999999999999998 8999999998888877755210
Q ss_pred CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
. ..+..+|+++.+||.+||+.||.+|||+.+++ +|+.
T Consensus 249 ~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 249 L----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred C----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 0 11236889999999999999999999999984 4543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=431.69 Aligned_cols=287 Identities=41% Similarity=0.733 Sum_probs=238.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|++. +|+.||||+++...........+.+|+.+|++++||||+++++++.+.. .+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-CLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-CEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-EEEEE
Confidence 358999999999999999999985 5899999999765544445567889999999999999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 176 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSY 176 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C--
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-ccc
Confidence 9999999988888777789999999999999999999999999999999999999999999999999998865332 223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc-CC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT-SF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~-~~ 395 (665)
...+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|......... ..
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 45578999999999987677899999999999999999999999999999999999999999988777653221100 00
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
................+++++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 000111122344456789999999999999999999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=438.88 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=204.0
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|.+.++||+|+||+||+|++. .+++.||||+++.. .....+.|.+|+.+|++|+|||||++++++.+.. .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-P 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-E
Confidence 47999999999999999999865 46889999999743 4556678999999999999999999999998754 7
Q ss_pred EEEEEEeccccchhhhc-CC--------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcE
Q 006004 233 LYLVFEYMEHDLAGLAT-TP--------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~-~~--------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~l 297 (665)
+|||||||+++.+..++ .. ..+|++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999976554433 21 2469999999999999999999999999999999999999999999
Q ss_pred EEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 006004 298 KIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKL 375 (665)
Q Consensus 298 KL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~ 375 (665)
||+|||+|+.+..... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987644332 22345679999999999986 679999999999999999999 89999999988888777552
Q ss_pred cCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 376 CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
. . + ..+..+|+++.+||.+||+.||++|||+.|++++
T Consensus 277 ~--~-----------------~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 277 R--E-----------------L---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp C--C-----------------C---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred C--C-----------------C---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1 0 0 1123688999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=448.43 Aligned_cols=292 Identities=35% Similarity=0.571 Sum_probs=240.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----Cc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~ 232 (665)
.++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|++|+||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 35899999999999999999999999999999999865555666778899999999999999999999987653 47
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+||||||++++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 9999999999887777654 479999999999999999999999999999999999999999999999999999865432
Q ss_pred C---------------------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-----------CCCCC
Q 006004 313 N---------------------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-----------GKPIM 360 (665)
Q Consensus 313 ~---------------------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-----------G~~pF 360 (665)
. ...+..+||++|+|||++.....|+.++||||||||||||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124677999999999998766789999999999999999998 67788
Q ss_pred CCCC-----------------hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCC--cchhhhhhhccCCcHHHHHHHH
Q 006004 361 PGRT-----------------EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ--PYKRKVLETFRNFPQSALALVD 421 (665)
Q Consensus 361 ~g~~-----------------~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~~~~s~~a~dLI~ 421 (665)
++.+ ..+++..|+..+|.|+.+.|..........+.... .....+...++.+++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7765 47899999999999999887654332211110000 0112234456789999999999
Q ss_pred HhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 422 KLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 422 ~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
+||.+||.+|||+.|||+||||+....+
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999976544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=423.53 Aligned_cols=283 Identities=38% Similarity=0.715 Sum_probs=234.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++ .+|+.||||+++...........+.+|+.++++++||||+++++++.... .+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-eEEEEE
Confidence 4799999999999999999998 67899999999765433333456789999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYT 158 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cccc
Confidence 999998888777766689999999999999999999999999999999999999999999999999998764322 2234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....|........ +.+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK--YDP 236 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--CCT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc--ccc
Confidence 557899999999998766789999999999999999999999999999999999999999988877764322111 111
Q ss_pred CCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 398 QQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 398 ~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+ ...........+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 100 011122344578999999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=443.83 Aligned_cols=288 Identities=36% Similarity=0.604 Sum_probs=229.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeecc-CCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSR-SGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~l~l 235 (665)
++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.+. ||||+++++++... ...+||
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4799999999999999999999999999999999765556666777889999999997 99999999999754 346899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC----
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS---- 311 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~---- 311 (665)
|||||++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 89 v~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 999999988777654 36999999999999999999999999999999999999999999999999999876321
Q ss_pred ----------------CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 006004 312 ----------------QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKL 375 (665)
Q Consensus 312 ----------------~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~ 375 (665)
.....+.++||++|+|||++.+...|+.++||||||||||+|++|++||++.+..+++..|...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1122455789999999999987678999999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccccC---------------CCCCCc-chhhh--hhhccCCcHHHHHHHHHhcccCcCCCcCHHHH
Q 006004 376 CGSPSEDYWRKSKSAHATS---------------FKPQQP-YKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASA 437 (665)
Q Consensus 376 ~g~p~~~~~~~~~~~~~~~---------------~~~~~p-~~~~~--~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea 437 (665)
++.|..+.+.....+.... +....+ +.... ......+++++++||.+||.+||.+|||+.|+
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 9999988765432221100 000000 00000 01122678999999999999999999999999
Q ss_pred HhCcCCCCCC
Q 006004 438 LRSEFFKTEP 447 (665)
Q Consensus 438 L~Hp~f~~~~ 447 (665)
|+||||+...
T Consensus 327 l~Hp~~~~~~ 336 (388)
T 3oz6_A 327 LKHPFVSIFH 336 (388)
T ss_dssp TTSTTTTTTC
T ss_pred hCCHHHHHhc
Confidence 9999997643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=433.26 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=209.4
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++++++++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.... .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-P 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-E
Confidence 46999999999999999999853 467899999997543 2344567899999999999999999999998754 7
Q ss_pred EEEEEEeccccch-hhhcCC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 233 LYLVFEYMEHDLA-GLATTP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 233 l~lV~Ey~~g~ll-~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
+|||||||+++.+ ..+... ...|++.++..|+.||+.||.|||+++||||||||+||||+++++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 8999999997554 444322 235899999999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||+|+.+..... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..|..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987643322 23455689999999999986 679999999999999999998 8999999998887777654
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.... ..+.+.|+.+.+||.+||+.||.+|||+.|++++
T Consensus 263 ~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 263 RQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2110 1123678999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=426.47 Aligned_cols=259 Identities=26% Similarity=0.470 Sum_probs=225.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... .+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-TLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-EEEEE
Confidence 45899999999999999999999999999999999877767777788999999999999999999999998754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cc
Confidence 9999875554444344579999999999999999999999999999999999999999999999999998765432 34
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+...++......
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------ 232 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR------------------ 232 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence 66789999999999987555568999999999999999999999999888877777552110
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
....+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 233 -----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 233 -----------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp -----------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred -----------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 1124789999999999999999999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=435.92 Aligned_cols=288 Identities=33% Similarity=0.581 Sum_probs=236.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----G 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~ 231 (665)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35799999999999999999999999999999999765555666778899999999999999999999987642 3
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+|+||||+.++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 4699999997666666554 36999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.+..++|++|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.++.+++.......
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 3566899999999999876789999999999999999999999999999999999999999999998876543221
Q ss_pred ccCCCCCCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 392 ATSFKPQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 392 ~~~~~~~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
...+....+ ....+...+..+++.+++||.+||..||.+|||+.++|+||||+....+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 111000000 01123345567899999999999999999999999999999998765443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=425.81 Aligned_cols=287 Identities=37% Similarity=0.688 Sum_probs=224.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+|+.||||+++.... ......+.+|+.+|++|+||||+++++++.... .+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTEN-KLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-EEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-eEEEEE
Confidence 479999999999999999999999999999999976542 223355778999999999999999999998754 799999
Q ss_pred EeccccchhhhcCC-----CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 238 EYMEHDLAGLATTP-----GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~-----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 99999877665432 2358999999999999999999999999999999999999999999999999998875332
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
. .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|........
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 2 234568899999999998766789999999999999999999999999999999999999999999888876432211
Q ss_pred cC--CCC--CCcchhh-hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 393 TS--FKP--QQPYKRK-VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 393 ~~--~~~--~~p~~~~-~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.. +.. ....... .......+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 10 000 0011111 1122336889999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=427.52 Aligned_cols=294 Identities=45% Similarity=0.734 Sum_probs=243.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-------
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR------- 229 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~------- 229 (665)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3579999999999999999999999999999999876554444445677999999999999999999998764
Q ss_pred CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 230 SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+.+||||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 23689999999999988888777789999999999999999999999999999999999999999999999999998765
Q ss_pred CCC---CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 310 PSQ---NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 310 ~~~---~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..+...++.++.+.|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 322 22345568899999999998767789999999999999999999999999999999999999999998888765
Q ss_pred hcccccc-CCCCCCcchhhhhhhc--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 387 SKSAHAT-SFKPQQPYKRKVLETF--RNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 387 ~~~~~~~-~~~~~~p~~~~~~~~~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
....... ...........+...+ ...++.+.+||.+||.+||.+|||+.|+|+||||+..+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 4321111 1110001011111111 12478899999999999999999999999999999876654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=436.61 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=209.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC-CCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET-----GKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||+||+|++..+ ++.||||+++... .....+.+.+|+.+|.+|+| ||||++++++.....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 5799999999999999999997654 3689999997543 34556778999999999976 899999999876655
Q ss_pred cEEEEEEeccccchhhhc-CC---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC
Q 006004 232 SLYLVFEYMEHDLAGLAT-TP---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG 295 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~-~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g 295 (665)
.+|||||||+++.+..++ .. ...|++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 789999999975554333 21 23589999999999999999999999999999999999999999
Q ss_pred cEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 006004 296 VLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIF 373 (665)
Q Consensus 296 ~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~ 373 (665)
.+||+|||+|+.+...... ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+.++.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976543322 2345678999999999987 679999999999999999998 999999876555444443
Q ss_pred HhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 374 KLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 374 ~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+ ..+...++++.+||.+||+.||.+|||+.++++|
T Consensus 302 ~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 311000 1123578999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=427.78 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=227.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.+.|++.+.||+|+||.||+|+++.+|+.||||+++...... ...+.+.+|+.+|++|+||||++++++|.+.. .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-D 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-E
Confidence 357999999999999999999999999999999998654321 13466889999999999999999999998754 7
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceec
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTY 308 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~ 308 (665)
+||||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999998766655555566899999999999999999999999999999999999998877 7999999999987
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......++..+|
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 242 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF---- 242 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH----
T ss_pred CCCC--ccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc----
Confidence 5432 2456689999999999876 67899999999999999999999999999999988888775554444444
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+++.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 243 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 ---------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ---------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3688999999999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=417.96 Aligned_cols=284 Identities=40% Similarity=0.697 Sum_probs=234.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC---HHHHHHHHHHHHHHHhC---CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---PESVRFMAREIHILRKL---DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~ 231 (665)
++|++++.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4899999999999999999999999999999999754321 11123456777777776 49999999999876532
Q ss_pred ----cEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 232 ----SLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 232 ----~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
.+++||||+.+++...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 489999999998877766544 349999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++...++.++...|..
T Consensus 169 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 169 IYSYQM--ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TSTTCC--CSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred ccCCCc--ccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 764332 3456789999999999986 5689999999999999999999999999999999999999999999888765
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
........+.+..+ +.+......+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLPRGAFPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCGGGSCCCCC--CCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccccccCCCCC--CcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 43322222222221 23344556899999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=426.82 Aligned_cols=287 Identities=38% Similarity=0.689 Sum_probs=233.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+++.||||+++..... .....+.+|+.+|++++||||+++++++.... .+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-SLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-EEEEEe
Confidence 5799999999999999999999999999999999754321 11223457999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+++++...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 158 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYD 158 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccc
Confidence 999999888888777789999999999999999999999999999999999999999999999999998654322 2234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc-cCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA-TSFK 396 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~-~~~~ 396 (665)
..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.+....|........ ..+.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 557899999999998767789999999999999999999999999999999999999999999888765322110 0000
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
........+......+++++.+||.+||.+||.+|||+.|+|+||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 001111223444567899999999999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=423.98 Aligned_cols=297 Identities=39% Similarity=0.693 Sum_probs=241.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH---HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP---ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++++.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.... .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-ce
Confidence 457999999999999999999999999999999987543211 12345789999999999999999999998754 78
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|+||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 9999999998888877777789999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..++...+.+..+.|.........
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 23455689999999999987667899999999999999999999999999999999999999999988877654221111
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p 456 (665)
......+ ...+...+..+++++++||.+||..||.+|||+.|+|+||||+..+.+.....+|
T Consensus 247 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 247 VTFKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp CCCCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred ccccccC-CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccCC
Confidence 1000001 1123344567899999999999999999999999999999999877665444333
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=423.25 Aligned_cols=288 Identities=35% Similarity=0.648 Sum_probs=228.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|++++||||+++++++.... .+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-RLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-EEEEE
Confidence 35799999999999999999999999999999999766554455566789999999999999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-----CCCcEEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-----NAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-----~~g~lKL~DFGlA~~~~~~ 311 (665)
|||+++++...+.... .+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 112 ~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9999998777766544 699999999999999999999999999999999999994 4556999999999876533
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|.......
T Consensus 191 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 191 I-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 2 223455789999999999876678999999999999999999999999999999999999999999887776432211
Q ss_pred c-cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 392 A-TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 392 ~-~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
. ....+..............+++++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1 0000111111111112234789999999999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=431.21 Aligned_cols=286 Identities=35% Similarity=0.591 Sum_probs=226.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.|+||||+++++++... ...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 479999999999999999999999999999999976555556677788999999999999999999998653 246
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.++|...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 899999998777666544 46999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.+..+||++|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.|........
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 262 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred ---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 35568999999999998767899999999999999999999999999999999999999999999988776433221
Q ss_pred cCCC---CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 393 TSFK---PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 393 ~~~~---~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
..+. +..+ ...+...+..+++.+++||.+||.+||.+|||+.++|+||||.....+.
T Consensus 263 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 263 RNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHHTSCCCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHHHhccCCCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 1110 0011 1123344567899999999999999999999999999999999765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=409.57 Aligned_cols=288 Identities=33% Similarity=0.578 Sum_probs=236.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-RLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-eEEEEE
Confidence 5799999999999999999999999999999999776666666777889999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++++..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 160 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence 9999988877776666899999999999999999999999999999999999999999999999999988653322 234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc-C-C
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT-S-F 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~-~-~ 395 (665)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++......+......... . .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 5688999999999987677899999999999999999999999999999999999888888776543322111110 0 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.+...........+..+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0111111223344567999999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=430.38 Aligned_cols=285 Identities=29% Similarity=0.523 Sum_probs=225.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 232 (665)
++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5799999999999999999999999999999999866556666778899999999999999999999987643 26
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+.. .+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 899999999988777653 58999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++.++...++.+..++|........
T Consensus 182 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred --ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 2455689999999999987 5789999999999999999999999999999999999999999999888765321110
Q ss_pred cCC--CCC---Ccchhhh--------hhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 TSF--KPQ---QPYKRKV--------LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~--~~~---~p~~~~~--------~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
... .+. ..+.... .......++.+++||.+||.+||.+|||+.|+|+||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 000 000 0000000 0001123678999999999999999999999999999986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=421.63 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=225.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+|+.|+||||+++++++.+.. .+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 4799999999999999999999999999999999877767777788999999999999999999999998755 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.|+.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+....
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 9999865544444455799999999999999999999999999999999999998654 59999999998765332
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------- 253 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE----------- 253 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG-----------
T ss_pred ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc-----------
Confidence 2445689999999999876 5789999999999999999999999999988888877765432222222
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+..+++++.+||.+||.+||.+|||+.++|+||||..
T Consensus 254 --------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 --------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 2468899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=429.69 Aligned_cols=282 Identities=37% Similarity=0.576 Sum_probs=231.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
.+|++++.||+|+||.||+|++..+|+.||||++..... ...+|+++|+.|+|||||+++++|... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 369999999999999999999999999999999875421 134799999999999999999988542 123
Q ss_pred EEEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-CcEEEEecccceec
Q 006004 233 LYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-GVLKIGDFGLATTY 308 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-g~lKL~DFGlA~~~ 308 (665)
+++||||+.+++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 77999999987665543 345579999999999999999999999999999999999999955 67899999999976
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... .....+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.+|++.+|.|..+.|....
T Consensus 208 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 208 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred ccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5432 23456899999999999876689999999999999999999999999999999999999999999998887643
Q ss_pred cccccCCCCCCcchhhhhh-hccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLE-TFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~-~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
........+... ...+.. ....+++++++||.+||.+||.+|||+.|+|+||||.....
T Consensus 286 ~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 286 PNYTEFKFPQIK-AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp SCCCCCCCCCCC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhhccCccC-CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 221111111100 011111 22467899999999999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=420.04 Aligned_cols=288 Identities=35% Similarity=0.570 Sum_probs=241.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----Cc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~ 232 (665)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 358999999999999999999999999999999997533 3455677889999999999999999999987542 46
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 8999999999887776543 59999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 N--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
. ......+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.|......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 2 12355689999999999877667899999999999999999999999999999999999999999998877543211
Q ss_pred cccCCC--CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 391 HATSFK--PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 391 ~~~~~~--~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
....+. ...+........+..+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 111000 001111223445567899999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=422.99 Aligned_cols=281 Identities=33% Similarity=0.552 Sum_probs=232.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-------
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR------- 229 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~------- 229 (665)
.++|++++.||+|+||.||+|++..+|+.||||++...... ..+|+.+|+.|+|||||+++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 35799999999999999999999999999999998754321 23799999999999999999998542
Q ss_pred ------------------------------CCcEEEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHh
Q 006004 230 ------------------------------SGSLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHS 276 (665)
Q Consensus 230 ------------------------------~~~l~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~ 276 (665)
...+++||||+++++...+. ..+..+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 22489999999987554443 455689999999999999999999999
Q ss_pred CCccccCCCcccEEEc-CCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh
Q 006004 277 RGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355 (665)
Q Consensus 277 ~gIiHrDLKPeNILld-~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt 355 (665)
+||+||||||+||||+ .++.+||+|||+|..+.... .....++|+.|+|||++.+...|+.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 68999999999999775433 24556889999999999876679999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 356 GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 356 G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
|++||.+.+..+++..|.+.+|.|..+.|............+..............+++++.+||.+||.+||.+|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999999999999999999999999887664332221111111111112223346899999999999999999999999
Q ss_pred HHHhCcCCCC
Q 006004 436 SALRSEFFKT 445 (665)
Q Consensus 436 eaL~Hp~f~~ 445 (665)
|+|+||||+.
T Consensus 318 e~l~hp~f~~ 327 (383)
T 3eb0_A 318 EAMAHPFFDH 327 (383)
T ss_dssp HHHTSGGGHH
T ss_pred HHhcCHHHHH
Confidence 9999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=413.94 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=225.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.. .+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESME-ELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-EEEEE
Confidence 358999999999999999999999999999999987432 34556889999999999999999999998765 79999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC--CCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.|+ |...+......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999874 55555555557999999999999999999999999999999999999997 7899999999999875432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 226 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA---------- 226 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH----------
T ss_pred -ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh----------
Confidence 2455689999999999986 5689999999999999999999999999999888888877544443333
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+..+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 227 ---------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 ---------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ---------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ---------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 246899999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=424.72 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=217.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.+ +||||+++++++.+.. .+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-EEE
Confidence 4689999999999999999999999999999999975422 223456678999999998 7999999999998765 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|...... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~ 179 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GV 179 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-Cc
Confidence 99999998666555544557999999999999999999999999999999999999999999999999999864322 22
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|......
T Consensus 180 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 242 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---------------- 242 (353)
T ss_dssp ------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred cccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3456689999999999986 67899999999999999999999999999998888888652110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH------HHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA------ASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa------~eaL~Hp~f~~~ 446 (665)
....+++++.+||.+||.+||.+|+++ .++++||||+..
T Consensus 243 -------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 243 -------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 112478999999999999999999999 999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=411.07 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=224.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
+.|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|++|+||||+++++++.... .+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-DV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EE
Confidence 46999999999999999999999999999999997654321 13566889999999999999999999998754 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceecC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTYD 309 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~~ 309 (665)
|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999998766655555566899999999999999999999999999999999999999887 89999999999875
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..........+
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 240 (326)
T 2y0a_A 170 FGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------ 240 (326)
T ss_dssp TTS--CCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred CCC--ccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc------
Confidence 432 2345689999999999875 6789999999999999999999999999998888888766543333332
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 -------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 -------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 24688999999999999999999999999999999853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=433.04 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=223.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.+|+.|+|||||++++++.+.. .+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-HHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-EEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-EEEEEE
Confidence 4799999999999999999999999999999999877666666778899999999999999999999998754 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc---CCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN---NAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld---~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.|+.+.........+++.++..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.... .
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-Q 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-C
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-c
Confidence 9999755544433445799999999999999999999999999999999999998 46789999999998765432 2
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+..+......++...
T Consensus 169 ~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------- 236 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE----------- 236 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT-----------
T ss_pred eeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc-----------
Confidence 3355689999999999876 5789999999999999999999999999998888888766433322222
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+..+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 --------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 --------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp --------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred --------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 2468999999999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=421.98 Aligned_cols=282 Identities=36% Similarity=0.572 Sum_probs=230.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-----c
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG-----S 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 232 (665)
.+|++++.||+|+||.||+|++..+++ ||+|++..... ...+|+.+|+.++||||++++++|..... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 379999999999999999999987776 88888764321 12379999999999999999999865432 3
Q ss_pred EEEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-CCCcEEEEecccceec
Q 006004 233 LYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTY 308 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-~~g~lKL~DFGlA~~~ 308 (665)
+|+||||+.++++..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|..+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999998765443 2345799999999999999999999999999999999999999 7999999999999887
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... .....+||++|+|||++.+...|+.++|||||||+||+|++|++||.+.+..+++..|.+.+|.|..+.|....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 4433 24566889999999999876779999999999999999999999999999999999999999999998876543
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
........+..............+++++++||.+||.+||.+|||+.|+|+||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 222111111111111111122358999999999999999999999999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=417.37 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=221.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.... .+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-EEEE
Confidence 4579999999999999999999999999999999975421 1223556789999999999999999999998765 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 161 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Cc
Confidence 99999986665555445579999999999999999999999999999999999999999999999999998643222 23
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|....-
T Consensus 162 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------ 222 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------ 222 (337)
T ss_dssp BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred ccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 456789999999999976 6789999999999999999999999999888777777654210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||..||.+|+ ++.++++||||...
T Consensus 223 -----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 01135889999999999999999999 99999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=417.02 Aligned_cols=284 Identities=34% Similarity=0.593 Sum_probs=236.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-----c
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG-----S 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 232 (665)
++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 47999999999999999999999999999999998765566667788999999999999999999999976542 2
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 122 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 197 (371)
T ss_dssp CEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-
Confidence 39999999988776653 35999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+++........
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 34568899999999998767899999999999999999999999999999999999999999999888765322111
Q ss_pred cCCC--CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 TSFK--PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~~--~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
..+. ............+..+++.+.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 1000 0001112233445678999999999999999999999999999999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=409.52 Aligned_cols=287 Identities=32% Similarity=0.607 Sum_probs=237.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-RWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-EEEEE
Confidence 45799999999999999999999999999999999876666666777889999999999999999999998754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ...
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 181 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 181 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-ccc
Confidence 9999998888776666679999999999999999999999999999999999999999999999999998764332 223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc--ccC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH--ATS 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~--~~~ 394 (665)
...+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+...+..+....... ...
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 455789999999999876678999999999999999999999999999999999999988887765433221111 011
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+...........+..+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 111111222334455678999999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=433.20 Aligned_cols=268 Identities=22% Similarity=0.354 Sum_probs=224.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+|..++||||++++++|.+.. .+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-NLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-EEEE
Confidence 4689999999999999999999999999999999975321 1112233788999999999999999999998765 7999
Q ss_pred EEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||.|+ |...+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999765 44555444568999999999999999999999999999999999999999999999999999877554443
Q ss_pred CcccccccccccCccccc----CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 315 PLTSRVVTLWYRAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~----~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.....+||+.|+|||++. +...|+.++|||||||+||||++|++||.+.+..+.+.+|.......
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 300 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 300 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----------
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-----------
Confidence 445568999999999987 23578999999999999999999999999999998888886421100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~~~~ 449 (665)
.+ ......+++++++||++||..+|.+ |+++.|+++||||+...+.
T Consensus 301 ---~~----------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 301 ---QF----------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp ---CC----------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred ---cC----------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 00 0112368999999999999999988 9999999999999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=410.77 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=221.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+.. .+|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-EEEE
Confidence 4579999999999999999999999999999999975421 1123556789999999999999999999998755 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 9999997655555544557999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|.....
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------ 220 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------ 220 (318)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------
T ss_pred cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 245689999999999886 6789999999999999999999999999988888877765210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.....+++++.+||.+||..||.+|+ ++.++++||||+...
T Consensus 221 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 221 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 01135789999999999999999999 999999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=410.25 Aligned_cols=289 Identities=32% Similarity=0.507 Sum_probs=227.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-----
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG----- 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~----- 231 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+|+..+..++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 45799999999999999999999999999999998654321 2235678888899999999999999865321
Q ss_pred -cEEEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHH--hCCccccCCCcccEEEcC-CCcEEEEeccc
Q 006004 232 -SLYLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCH--SRGILHRDIKGSNLLINN-AGVLKIGDFGL 304 (665)
Q Consensus 232 -~l~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH--~~gIiHrDLKPeNILld~-~g~lKL~DFGl 304 (665)
.+|+||||+.+++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 278999999998765443 35567999999999999999999999 999999999999999996 89999999999
Q ss_pred ceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 305 ATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 305 A~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
+..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++.+.|
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98765433 2345678999999999987667899999999999999999999999999999999999999999999988
Q ss_pred hhhccccccC---CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 385 RKSKSAHATS---FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 385 ~~~~~~~~~~---~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
.......... .....++...........++.+.+||.+||++||.+|||+.|+|+||||+....+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 7654322111 01112222223333345788999999999999999999999999999998765443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=402.73 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=219.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEE
Confidence 4799999999999999999999999999999999765432 2355789999999999999999999998755 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ...
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence 999876665554433 599999999999999999999999999999999999999999999999999988754332 344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+..... +.
T Consensus 175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~----------------- 235 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE----------------- 235 (297)
T ss_dssp CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC-----------------
T ss_pred CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-----------------
Confidence 5689999999999986 5789999999999999999999999999888777766654211 10
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 --------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp --------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 01123578899999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=427.45 Aligned_cols=279 Identities=26% Similarity=0.420 Sum_probs=227.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|..++||||++++++|.+.. .+|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-YLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS-EEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-EEE
Confidence 34689999999999999999999999999999999975322 1223345788999999999999999999998765 899
Q ss_pred EEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||||+.|+ |...+...+..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999764 4455544445799999999999999999999999999999999999999999999999999988765443
Q ss_pred CCcccccccccccCcccccC------CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 314 LPLTSRVVTLWYRAPELLLG------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~------~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
......+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+.+|.......
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL-------- 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc--------
Confidence 33345689999999999973 3568999999999999999999999999999888888876421000
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCC---cCHHHHHhCcCCCCCCCCCCCCCCCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR---GSAASALRSEFFKTEPLPCDPSNLPKYPP 460 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~R---pTa~eaL~Hp~f~~~~~~~~p~~~p~~~~ 460 (665)
.+ | .....+|+++++||.+||. ||.+| ++++++++||||+...+..-....|.+.|
T Consensus 290 ------~~----p------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 290 ------SL----P------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp ------CC----C----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred ------CC----C------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 00 0 1123689999999999999 99998 59999999999998766543333444443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=405.51 Aligned_cols=263 Identities=29% Similarity=0.424 Sum_probs=215.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.... .+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEEE
Confidence 34689999999999999999999999999999999975432 223356789999999999999999999988754 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NL 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~ 314 (665)
||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999986666566666689999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..............
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 226 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT----------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc----------------
Confidence 2345689999999999987555688999999999999999999999876654322222111000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
....+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 001124688999999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=400.27 Aligned_cols=259 Identities=29% Similarity=0.418 Sum_probs=212.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH------------------------HHHHHHHHHHHHHH
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP------------------------ESVRFMAREIHILR 212 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------------------------~~~~~~~~Ei~iL~ 212 (665)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999999999999999997653211 12356889999999
Q ss_pred hCCCCCcceeeeeeecc-CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE
Q 006004 213 KLDHPNVMKLEGLVTSR-SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI 291 (665)
Q Consensus 213 ~L~HpnIV~l~~~~~~~-~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl 291 (665)
+|+||||+++++++... ...+|+||||++++.+..+... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999999999863 4578999999998766655443 479999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcc--cCcccchhhhHHHHHHHHhCCCCCCCCChHHHH
Q 006004 292 NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK--YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM 369 (665)
Q Consensus 292 d~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~--~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l 369 (665)
+.++.+||+|||++..+..... .....+||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+.....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 9999999999999988654322 2345689999999999976432 578899999999999999999999988776665
Q ss_pred HHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 370 HKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 370 ~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
..+....... .....+++.+.+||.+||..||.+|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 5554311000 01136889999999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=428.99 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=222.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.+|+.++|||||+++++|.+.. .+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEE
Confidence 35689999999999999999999999999999999975221 1111234778999999999999999999998755 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||||.|+.+..+... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 99999987555444433 36999999999999999999999999999999999999999999999999999887554333
Q ss_pred CcccccccccccCcccccCCc---ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 PLTSRVVTLWYRAPELLLGAT---KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~---~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
...+.+||+.|+|||++.+.. .|+.++|||||||+||||++|++||.+.+..+.+.+|.......
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 292 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------------ 292 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------------
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------------
Confidence 345678999999999997532 28899999999999999999999999999988888886521000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCC--CcCHHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPEN--RGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~--RpTa~eaL~Hp~f~~~~~ 448 (665)
. ......+++++++||.+||..+|.+ |+++.|+++||||+...+
T Consensus 293 --~-----------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 293 --T-----------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp --C-----------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred --c-----------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 0 0112368999999999999999988 999999999999997644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=410.29 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=216.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.+|+++ +||||+++++++.+.. .+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RL 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-EE
Confidence 45689999999999999999999999999999999986644 455677788999999998 8999999999998765 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 9999999876555544444579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCChhHH
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT---------EVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~---------~~e~l~kI~~~~g~p~~~~~ 384 (665)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.... .......+...
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 234 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 234 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------
Confidence 23456689999999999986 678999999999999999999999997532 11122222210
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH------HHHHhCcCCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA------ASALRSEFFKTEP 447 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa------~eaL~Hp~f~~~~ 447 (665)
.......+++.+.+||.+||.+||.+|+++ .++++||||+...
T Consensus 235 --------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 235 --------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 001123688999999999999999999995 8999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=408.33 Aligned_cols=278 Identities=26% Similarity=0.386 Sum_probs=228.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-----CCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-----HPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l~~~~~~~~~~ 232 (665)
++|+++++||+|+||.||+|++..+++.||||+++. .......+.+|+.+++.+. ||||+++++++.... .
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~-~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-H 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-E
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-e
Confidence 489999999999999999999999999999999963 2344566788999999996 999999999998765 7
Q ss_pred EEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC------------------
Q 006004 233 LYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN------------------ 293 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~------------------ 293 (665)
+||||||+.++|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99999999777777666543 35999999999999999999999999999999999999975
Q ss_pred -------CCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH
Q 006004 294 -------AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV 366 (665)
Q Consensus 294 -------~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~ 366 (665)
++.+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 789999999999875432 245688999999999987 57899999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCC----------CCCCcch-------hhhhhhccCCcHHHHHHHHHhcccCcC
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSF----------KPQQPYK-------RKVLETFRNFPQSALALVDKLLTIEPE 429 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~----------~~~~p~~-------~~~~~~~~~~s~~a~dLI~~lL~~DP~ 429 (665)
+.+..+....+.++...+..........+ +...... ..........++.+.+||.+||++||.
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 99999999999888877654322111100 0000000 000111123457888999999999999
Q ss_pred CCcCHHHHHhCcCCC
Q 006004 430 NRGSAASALRSEFFK 444 (665)
Q Consensus 430 ~RpTa~eaL~Hp~f~ 444 (665)
+|||+.|+|+||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=418.92 Aligned_cols=289 Identities=36% Similarity=0.646 Sum_probs=217.4
Q ss_pred CCeeEE-EEeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 158 DAFEKI-DKIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 158 ~~y~~~-~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
+.|++. ++||+|+||.||+|+++ .+++.||||++...... ..+.+|+.+|++|+|||||++++++... ...+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 357764 47999999999999966 57889999999755433 2467899999999999999999998653 4579
Q ss_pred EEEEEeccccchhhhcC--------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE----cCCCcEEEEe
Q 006004 234 YLVFEYMEHDLAGLATT--------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGD 301 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl----d~~g~lKL~D 301 (665)
||||||+.++++..+.. ....+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999988776542 12359999999999999999999999999999999999999 6778999999
Q ss_pred cccceecCCCCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 006004 302 FGLATTYDPSQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---------VEQMH 370 (665)
Q Consensus 302 FGlA~~~~~~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~ 370 (665)
||+|..+..... ......+||++|+|||++.+...|+.++||||||||||+|++|++||.+.+. .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 2345568999999999998766799999999999999999999999987765 58999
Q ss_pred HHHHhcCCCChhHHhhhcccccc-----CCC----CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCc
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHAT-----SFK----PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~-----~~~----~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp 441 (665)
.|+..+|.|....|......... .+. ........+.......++.+.+||.+||.+||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 99999999998888654221100 000 000001111111223478899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 006004 442 FFKTEPLPC 450 (665)
Q Consensus 442 ~f~~~~~~~ 450 (665)
||+..+.+.
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999887664
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=419.96 Aligned_cols=280 Identities=31% Similarity=0.508 Sum_probs=231.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC------CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL------DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIV~l~~~~~~~~~ 231 (665)
++|++++.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~- 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN- 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT-
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC-
Confidence 4799999999999999999999999999999999743 34455677899988887 5779999999998764
Q ss_pred cEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc--EEEEecccceec
Q 006004 232 SLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV--LKIGDFGLATTY 308 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~--lKL~DFGlA~~~ 308 (665)
.+||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 899999999998887776543 45999999999999999999999999999999999999999987 999999999875
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
... ....+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++..+...++.++..++....
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred CCc----ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 432 345689999999999987 568999999999999999999999999999999999999999999998776432
Q ss_pred ccccc----CCCC-------------------------CCcchhhh-hhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH
Q 006004 389 SAHAT----SFKP-------------------------QQPYKRKV-LETFRNFPQSALALVDKLLTIEPENRGSAASAL 438 (665)
Q Consensus 389 ~~~~~----~~~~-------------------------~~p~~~~~-~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL 438 (665)
..... .++. ..+....+ .......++.+++||.+||.+||.+|||+.|||
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 11100 0000 00000011 111224578899999999999999999999999
Q ss_pred hCcCCCCC
Q 006004 439 RSEFFKTE 446 (665)
Q Consensus 439 ~Hp~f~~~ 446 (665)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=415.80 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=220.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|..+ +||||+++++++.+.. .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-~~ 93 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NL 93 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-EE
Confidence 34689999999999999999999999999999999975421 112345677899999886 9999999999998765 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999876555555444579999999999999999999999999999999999999999999999999998653222
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|.... +
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~-------------- 235 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P-------------- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C--------------
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--C--------------
Confidence 22456789999999999986 578999999999999999999999999999888877775421 0
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH-HHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA-SALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~-eaL~Hp~f~~~~ 447 (665)
.....+++++.+||.+||..||.+||++. ++++||||+...
T Consensus 236 -------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 236 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 01135789999999999999999999998 999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=407.72 Aligned_cols=283 Identities=35% Similarity=0.622 Sum_probs=234.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC-----c
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG-----S 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-----~ 232 (665)
++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 47999999999999999999999999999999997665556667788999999999999999999999876532 3
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 59999999987766553 25999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..|.++.+++........
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 34567899999999998766789999999999999999999999999999999999999999999887765322111
Q ss_pred cCC---CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 TSF---KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ~~~---~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
..+ .+..+ ...+...+..+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 257 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 257 KSYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHTSCBCS-SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHhCcCCC-CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 000 00000 11122344578999999999999999999999999999999986543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=413.87 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=221.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+.. .+|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-EEE
Confidence 45689999999999999999999999999999999975432 1123566889999999999999999999998755 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999987555444444457999999999999999999999999999999999999999999999999999976432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.+|.....
T Consensus 195 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------- 255 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------------- 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred -cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 245689999999999986 5789999999999999999999999999988888877765210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||..||.+|++ +.++++||||+..
T Consensus 256 ------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 ------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 011357899999999999999999998 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=419.47 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=213.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
.++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.+|+++ +|||||+++++|.+.. .+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC-EEE
Confidence 4579999999999999999999999999999999986543 233455678899999887 8999999999998765 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 208 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-CC
Confidence 99999998666555544557999999999999999999999999999999999999999999999999999863322 22
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH---------HHHHHHHHhcCCCChhHHh
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV---------EQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~---------e~l~kI~~~~g~p~~~~~~ 385 (665)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.... .....|...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------- 277 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------- 277 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----------
T ss_pred ccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----------
Confidence 3456789999999999987 67899999999999999999999999754221 122222210
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH------HHHHhCcCCCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA------ASALRSEFFKTEP 447 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa------~eaL~Hp~f~~~~ 447 (665)
.......+++++++||.+||.+||.+|+++ .|+++||||+...
T Consensus 278 -------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 278 -------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp -------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred -------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 001123689999999999999999999985 8999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=392.40 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=224.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.... ..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-EEEEE
Confidence 46899999999999999999999999999999999877767777788999999999999999999999998754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc---EEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV---LKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~---lKL~DFGlA~~~~~~~~ 313 (665)
|||+.++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 999987655433333457999999999999999999999999999999999999987655 9999999998765432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 228 (284)
T 3kk8_A 163 -AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------ 228 (284)
T ss_dssp -BCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------
T ss_pred -cccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc------------
Confidence 2345679999999999986 57899999999999999999999999999888877777553322211
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 229 -------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred -------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 1124688999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=401.30 Aligned_cols=290 Identities=34% Similarity=0.569 Sum_probs=233.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc----CCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR----SGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----~~~ 232 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 358999999999999999999999999999999996433 345566788999999999999999999987653 257
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+||||+.+++...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999887776654 369999999999999999999999999999999999999999999999999998765322
Q ss_pred CC---------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 313 NL---------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 313 ~~---------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123457899999999987667789999999999999999999999999999999999999888876322
Q ss_pred Hhh-hccccccC---CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 384 WRK-SKSAHATS---FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 384 ~~~-~~~~~~~~---~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
... ........ ..+..+ ...+...+..+++.+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYP-AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cccccccchhhHHhhcccCCC-CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 110 00000000 000000 1112334567899999999999999999999999999999999765544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=412.63 Aligned_cols=291 Identities=22% Similarity=0.327 Sum_probs=219.0
Q ss_pred CCCCeeEEEEeecc--CceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQG--TYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+| +||.||+|++..+|+.||||+++......+..+.+.+|+.+|+.++|||||++++++.... .+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-EL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-EE
Confidence 34689999999999 9999999999999999999999887766777788999999999999999999999998755 89
Q ss_pred EEEEEeccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 234 YLVFEYMEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
|||||||.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999997655544332 256999999999999999999999999999999999999999999999999998754221
Q ss_pred C------CCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC------
Q 006004 312 Q------NLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS------ 378 (665)
Q Consensus 312 ~------~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~------ 378 (665)
. .......+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+....-.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1 1112334789999999999864 56899999999999999999999999988776665544321110
Q ss_pred --CChhHHhhhccc-c----ccCCC--CCCc--chhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 379 --PSEDYWRKSKSA-H----ATSFK--PQQP--YKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 379 --p~~~~~~~~~~~-~----~~~~~--~~~p--~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
+...++...... . ..... ...+ ...........+++.+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000000000000 0 00000 0000 00011223456899999999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=410.28 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=214.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+.|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.|+||||+++++++.... .+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-MLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEE
Confidence 479999999999999999999999999999999964321 1113456889999999999999999999998754 899
Q ss_pred EEEEeccccch-hhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc---EEEEeccccee
Q 006004 235 LVFEYMEHDLA-GLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV---LKIGDFGLATT 307 (665)
Q Consensus 235 lV~Ey~~g~ll-~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~---lKL~DFGlA~~ 307 (665)
||||||.|+.+ ..+.. .+..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999996544 33332 3346899999999999999999999999999999999999987654 99999999988
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
+.... ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+ .+.+..+...........
T Consensus 183 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~---- 255 (351)
T 3c0i_A 183 LGESG-LVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ---- 255 (351)
T ss_dssp CCTTS-CBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH----
T ss_pred ecCCC-eeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc----
Confidence 75432 22345689999999999986 578999999999999999999999998853 344555544322222222
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 256 ---------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 ---------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ---------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ---------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 24689999999999999999999999999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=406.44 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=190.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC---cEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG---SLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~---~l~ 234 (665)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+.++.+|+|||||++++++..... .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 3699999999999999999987 68999999996432 112223356666678999999999999876532 589
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC--------CccccCCCcccEEEcCCCcEEEEecccce
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR--------GILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
||||||+++.+..++... .+++.++..++.|++.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999976655554433 699999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCCCC---CCcccccccccccCcccccCC-----cccCcccchhhhHHHHHHHHhCCCCCCCCCh-------------
Q 006004 307 TYDPSQN---LPLTSRVVTLWYRAPELLLGA-----TKYGAAIDMWSAGCILAELFAGKPIMPGRTE------------- 365 (665)
Q Consensus 307 ~~~~~~~---~~~~~~~gT~~Y~APE~l~~~-----~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~------------- 365 (665)
....... ......+||++|||||++.+. ..|+.++||||||||||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7754332 123346899999999999753 2478899999999999999999887754321
Q ss_pred -HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 366 -VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 366 -~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+.+.+.... ....|..|... .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~-----------------~~~rp~~p~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCE-----------------QKLRPNIPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTT-----------------SCCCCCCCGGG----GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhc-----------------ccCCCCCCccc----cchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111111110 01111111100 00123456889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=412.79 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=220.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|..+ .||||+++++++.+.. .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS-EE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC-EE
Confidence 34689999999999999999999999999999999975421 112345678899999988 8999999999998765 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 9999999876555444444579999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.+|....-
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 238 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------------- 238 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 23456689999999999986 6789999999999999999999999999998888887765210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~~ 447 (665)
.....+++++.+||.+||..||.+|+ ++.++++||||+...
T Consensus 239 -------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 239 -------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 01135889999999999999999999 479999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=404.14 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=200.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|+.+|++|+||||+++++++.... .+|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-EISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-eEEEE
Confidence 357999999999999999999999999999999997542 2345778999999999999999999998754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999987655555555567999999999999999999999999999999999999975 8899999999998764322
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+..+.........
T Consensus 206 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~----------- 272 (349)
T 2w4o_A 206 -LMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS----------- 272 (349)
T ss_dssp --------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT-----------
T ss_pred -ccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC-----------
Confidence 2345679999999999986 568999999999999999999999998776554 44444332111111
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 273 --------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 273 --------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp --------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred --------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 1224688999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=407.75 Aligned_cols=288 Identities=31% Similarity=0.481 Sum_probs=230.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---------CHHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---------DPESVRFMAREIHILRKLDHPNVMKLEGLVTS 228 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~ 228 (665)
++|++++.||+|+||.||+|++.. |+.||||++..... .....+.+.+|+.+|++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 579999999999999999999855 89999999864322 23345778999999999999999999998854
Q ss_pred c----CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 229 R----SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 229 ~----~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
. ...+|+||||+.++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 2 236899999999999998887777899999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 305 ATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 305 A~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
+....... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+
T Consensus 181 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 181 AREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 98654332 2345678999999999987667899999999999999999999999999999999999999999887654
Q ss_pred hhhccccccCCC---CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 385 RKSKSAHATSFK---PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 385 ~~~~~~~~~~~~---~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
..........+. ...............+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 432211110000 0000112233445678999999999999999999999999999999997643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=414.59 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=217.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|+.++|||||+++++|.+.. .+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEE
Confidence 4589999999999999999999999999999999975421 1233567889999999999999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+... ..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 170 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQ 170 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cc
Confidence 9999988777666666668999999999999999999999999999999999999999999999999999987543 23
Q ss_pred cccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhHHhhhccc
Q 006004 316 LTSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
....+||+.|+|||++.+ ...|+.++|||||||++|+|++|++||.+.+. .+.+..+...
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------- 235 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------------- 235 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------------
Confidence 466789999999999874 24589999999999999999999999986433 2222222211
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-HHHHHhCcCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-AASALRSEFFKTE 446 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-a~eaL~Hp~f~~~ 446 (665)
.......+++.+.+||.+||..||.+||+ +.++++||||+..
T Consensus 236 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 236 --------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred --------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 00112357899999999999999999998 9999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.75 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=215.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.... .+|
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-DIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEE
Confidence 456899999999999999999999999999999999743211 112346789999999999999999999998765 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.|+++..+...+ .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 86 lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 86 MVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999999888887776543 79999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+...++
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------------- 220 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------------- 220 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------------
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------------
Confidence 2455689999999999987555589999999999999999999999765422111100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..........+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 221 -------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 -------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000111224589999999999999999999999999999999854
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=410.23 Aligned_cols=259 Identities=25% Similarity=0.455 Sum_probs=221.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+|+.|+||||+++++++.... .+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-EEEEE
Confidence 357999999999999999999999999999999997543 334456889999999999999999999998754 79999
Q ss_pred EEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC--CCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.++.+ ..+......+++.+++.++.||+.||.|||++||+||||||+||||+. .+.+||+|||++..+....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 999987544 555555557999999999999999999999999999999999999974 4789999999999875432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 206 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 271 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 271 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------
T ss_pred -ceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence 2345579999999999986 67899999999999999999999999999988888777553211111
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 272 -------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 272 -------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1234689999999999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=399.38 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=209.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|+++++||+|+||+||+|++..+|+.||||++...............|+..+.++ .||||+++++++.... .+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-ILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-EEEEE
Confidence 479999999999999999999999999999999876554445555555666666555 9999999999998754 89999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.+++...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 213 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AG 213 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CC
Confidence 9999998888877766679999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+. +.. +..+.
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~--------------- 271 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP--------------- 271 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH---------------
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc---------------
Confidence 45579999999999875 689999999999999999999877765433222 111 11111
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 272 ----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 ----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 122468999999999999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=398.15 Aligned_cols=260 Identities=26% Similarity=0.376 Sum_probs=223.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|++++||||+++++++.... .+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-DV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-EE
Confidence 47999999999999999999999999999999997654321 13566889999999999999999999998754 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceecC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTYD 309 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~~ 309 (665)
|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999998765555555556799999999999999999999999999999999999999888 79999999998875
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..+
T Consensus 171 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 241 (321)
T 2a2a_A 171 DGV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF------ 241 (321)
T ss_dssp TTC--CCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH------
T ss_pred ccc--cccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh------
Confidence 432 2345679999999999876 6789999999999999999999999999998888887765433332222
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 242 -------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 242 -------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp -------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred -------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 24688999999999999999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=425.97 Aligned_cols=259 Identities=31% Similarity=0.484 Sum_probs=223.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|++|+||||+++++++.... .+|+|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-YFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-EEEEE
Confidence 4799999999999999999999999999999999765432 334567889999999999999999999998754 89999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence 9999876554444445579999999999999999999999999999999999999 467899999999998775433
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 184 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 249 (484)
T 3nyv_A 184 -KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP----------- 249 (484)
T ss_dssp -SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-----------
T ss_pred -ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-----------
Confidence 3456689999999999875 58999999999999999999999999999998888886643322222
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+++.+++||.+||.+||.+|||+.++|+||||+..
T Consensus 250 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 250 --------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp --------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred --------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 224689999999999999999999999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=401.72 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=209.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 458999999999999999999985 6899999999976533 2234456788999999999999999999998754
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+||||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 79999999987655544444457999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.++.....
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------- 238 (327)
T 3a62_A 175 G-TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------- 238 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------------
T ss_pred C-ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 2 12345689999999999976 5689999999999999999999999999998888877765211
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||.+|| ++.++|+||||+..
T Consensus 239 ---------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 239 ---------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ---------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 01135789999999999999999999 89999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=413.64 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=213.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHH-HHhCCCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHI-LRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|..+ ++.++||||++++++|.+.. .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~-~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS-EE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC-EE
Confidence 34689999999999999999999999999999999986543 23344556778777 56789999999999998765 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-C
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-C
Confidence 999999998666555544557999999999999999999999999999999999999999999999999999864322 2
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|....-
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 256 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------------- 256 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC----------------
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 23456789999999999986 6789999999999999999999999999998888887765210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH----HHHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA----ASALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa----~eaL~Hp~f~~~~ 447 (665)
.....+++.+.+||.+||.+||.+|+++ .++++||||+...
T Consensus 257 -------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 257 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp -------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 1123688999999999999999999986 6999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=395.59 Aligned_cols=284 Identities=38% Similarity=0.632 Sum_probs=226.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec---------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS--------- 228 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--------- 228 (665)
++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4899999999999999999999999999999998754 35567778999999999999999999998742
Q ss_pred ----cCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-CCCcEEEEecc
Q 006004 229 ----RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFG 303 (665)
Q Consensus 229 ----~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-~~g~lKL~DFG 303 (665)
....+|+||||+.+++...+.. ..+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 2347899999999877766643 4699999999999999999999999999999999999997 56799999999
Q ss_pred cceecCCCC--CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 006004 304 LATTYDPSQ--NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSE 381 (665)
Q Consensus 304 lA~~~~~~~--~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~ 381 (665)
++....... ........+|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 998764321 122344577999999999876677899999999999999999999999999999999999887777666
Q ss_pred hHHhhhccccc-----cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 382 DYWRKSKSAHA-----TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 382 ~~~~~~~~~~~-----~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
+.+........ ....+. ..+......+++.+.+||.+||..||.+|||+.++|+||||+....|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPH----KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCC----CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhcCcccccccccCCC----CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 65543221100 000011 11233445789999999999999999999999999999999976554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=425.13 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=216.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..++..||||+++...........+.+|+.+|+.|+|||||++++++.... .+||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-NYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-EEEEEE
Confidence 4699999999999999999999999999999999866544444566889999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC---CcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~---g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999875554333334579999999999999999999999999999999999999764 559999999998875432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----------- 260 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE----------- 260 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG-----------
T ss_pred cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh-----------
Confidence 3456689999999998864 689999999999999999999999999999888888876443332222
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+..+++.+++||.+||.+||.+|||+.++|+||||+.
T Consensus 261 --------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 --------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 2468999999999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=421.47 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=222.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|.+.+.||+|+||.||+|++..+|+.||||++...... .+....+.+|+.+|+.++||||+++++++.... .+||
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEE
Confidence 45899999999999999999999999999999999754221 123456889999999999999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~ 171 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 171 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--c
Confidence 99999876665555556689999999999999999999999999999999999999999999999999999875432 3
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+.+|.....
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------ 233 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------------------ 233 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC------------------
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence 45668999999999998755568999999999999999999999999888777777654211
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 234 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0112578899999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=395.13 Aligned_cols=286 Identities=39% Similarity=0.664 Sum_probs=233.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeeeec----
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-ETGKIVALKKVRFANMDPESVRFMAREIHILRKL---DHPNVMKLEGLVTS---- 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~---- 228 (665)
.++|++++.||+|+||.||+|++. .+|+.||||+++...........+.+|+.+++.+ .||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468999999999999999999995 6789999999975443222223455777777766 89999999998862
Q ss_pred cCCcEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 229 RSGSLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
....+|+||||+.+++...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 23478999999999877766543 33599999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....|...
T Consensus 170 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQM--ALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGGG--GGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCCC--CccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 64322 2345678999999999986 56899999999999999999999999999999999999999998888777643
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.......+.... ...+......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 247 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 247 VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhcccC--cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 222111111110 1123344567899999999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=425.84 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=219.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++|+||||+++++++.... .+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-EEEEEE
Confidence 4799999999999999999999999999999999754322233566889999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc---CCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN---NAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld---~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 9998755543333345799999999999999999999999999999999999995 45679999999998765432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+......+...
T Consensus 179 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 244 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------------ 244 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG------------
T ss_pred ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc------------
Confidence 3456689999999999875 58999999999999999999999999999988888876643222221
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+++.+++||.+||.+||.+|||+.++|+||||+..
T Consensus 245 -------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 -------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 224689999999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=407.31 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++.|+||||+++++++.... .+|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-EEEEE
Confidence 46899999999999999999999999999999999764432 234679999999999999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc--EEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV--LKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~--lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.......
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 999987555444444457999999999999999999999999999999999999987765 9999999998543222
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+........
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 238 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-------------- 238 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC--------------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC--------------
Confidence 234568999999999998754445569999999999999999999987654333332222110000
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
... .....+++.+.+||.+||.+||.+|||+.|+|+||||...
T Consensus 239 --~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 239 --YSI-------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --CCC-------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --CCC-------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000 0112578999999999999999999999999999999653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=407.98 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=214.3
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEe
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey 239 (665)
|...+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+|++|+||||+++++++.... .+||||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-DIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEEEeC
Confidence 444778999999999999999999999999998643 344567889999999999999999999998755 79999999
Q ss_pred ccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE--cCCCcEEEEecccceecCCCCCCCc
Q 006004 240 MEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI--NNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 240 ~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl--d~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.... ..
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 986 4555555555579999999999999999999999999999999999999 567899999999999875433 23
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..|......+..
T Consensus 246 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS---------------
T ss_pred ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh---------------
Confidence 45579999999999875 67899999999999999999999999999999888888764322211
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+..+++.+++||.+||.+||.+|||+.|+|+||||+.
T Consensus 310 ----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 310 ----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp ----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 123468999999999999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=421.20 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=211.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.... .+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-EEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-EEEE
Confidence 4579999999999999999999999999999999975422 2334556788999999999999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||+.++.+..+......+++.+++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+|...... ..
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 304 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GA 304 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-Cc
Confidence 99999987665555555579999999999999999999998 99999999999999999999999999999864322 22
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+.....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------- 366 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------- 366 (446)
T ss_dssp --CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred ccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 3456789999999999976 6789999999999999999999999999988877777654211
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||.+||.+|| |+.|+|+||||+..
T Consensus 367 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 367 ------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 01135789999999999999999999 99999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=406.39 Aligned_cols=280 Identities=26% Similarity=0.413 Sum_probs=227.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC--------CCCcceeeeeeec-
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD--------HPNVMKLEGLVTS- 228 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIV~l~~~~~~- 228 (665)
++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4899999999999999999999999999999999743 345667889999999995 7889999999873
Q ss_pred --cCCcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCC---------
Q 006004 229 --RSGSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAG--------- 295 (665)
Q Consensus 229 --~~~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g--------- 295 (665)
....+||||||+.++++..+.... ..+++.+++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 234789999999999888776543 5699999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------cEEEEecccceecCCCCCCCcccccccccccCcccccCCc
Q 006004 296 ----------------------------------------VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335 (665)
Q Consensus 296 ----------------------------------------~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~ 335 (665)
.+||+|||++...... ....+||+.|+|||++.+ .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~ 268 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG-S 268 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-S
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC-C
Confidence 7999999999886532 345689999999999987 5
Q ss_pred ccCcccchhhhHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhHHhhhccccccC--------CCCCCcc
Q 006004 336 KYGAAIDMWSAGCILAELFAGKPIMPGRT------EVEQMHKIFKLCGSPSEDYWRKSKSAHATS--------FKPQQPY 401 (665)
Q Consensus 336 ~~~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~--------~~~~~p~ 401 (665)
.|+.++|||||||+||+|++|++||.+.+ ..+.+..+...+|.++...+.......... .....+.
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 68999999999999999999999998765 577888999999998887765432211000 0000000
Q ss_pred --hhhhh---hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 402 --KRKVL---ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 402 --~~~~~---~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...+. ......++.+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00000 111234677899999999999999999999999999963
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.01 Aligned_cols=256 Identities=31% Similarity=0.472 Sum_probs=221.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-DIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eEEEEE
Confidence 469999999999999999999999999999999976433 23456889999999999999999999998754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999876554444444579999999999999999999999999999999999999 788999999999998875433
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++...|
T Consensus 164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 231 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---------- 231 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH----------
T ss_pred chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh----------
Confidence 2345679999999999875 4899999999999999999999999999988888887765444333322
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 232 ---------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ---------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 367899999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=396.31 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=218.9
Q ss_pred CeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 159 AFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.|.+. +.||+|+||.||+|++..+++.||||++............+.+|+.+++.+ .||||+++++++.... .+|+|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~-~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS-EIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-eEEEE
Confidence 68888 899999999999999999999999999986554444566788999999999 5699999999998754 79999
Q ss_pred EEeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~~~~~ 311 (665)
|||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999855544442 2357999999999999999999999999999999999999998 789999999999987543
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+...
T Consensus 188 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 255 (327)
T 3lm5_A 188 C--ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE--------- 255 (327)
T ss_dssp --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred c--ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch---------
Confidence 2 2345689999999999876 578999999999999999999999999999888888776643332221
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.+..+++.+.+||.+||..||.+|||+.++|+||||+...+
T Consensus 256 ----------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 256 ----------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ----------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ----------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 22468899999999999999999999999999999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=404.85 Aligned_cols=256 Identities=28% Similarity=0.389 Sum_probs=211.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ..+|+++|.++ +||||+++++++.+.. .+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~-~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGK-YVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSS-EEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCC-EEEE
Confidence 34799999999999999999999999999999999765432 34688888887 7999999999998754 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC----CcEEEEecccceecCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA----GVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~----g~lKL~DFGlA~~~~~~ 311 (665)
||||+.|+.+.........+++.+++.++.||+.||.|||++||+||||||+|||+.+. +.+||+|||++..+...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999875544444445579999999999999999999999999999999999998543 35999999999876543
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR---TEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~---~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+. +..+.+..|..........
T Consensus 174 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------ 245 (342)
T 2qr7_A 174 NG-LLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG------ 245 (342)
T ss_dssp TC-CBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST------
T ss_pred CC-ceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc------
Confidence 22 3445689999999999976 56899999999999999999999999863 4445555554322111111
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+++.+++||.+||..||.+|||+.++|+||||..+
T Consensus 246 -------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 246 -------------------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------------------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 224689999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.37 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=221.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+.|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.... .+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-eEEEE
Confidence 359999999999999999999999999999999986543 3445677899999999999999999999998754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||+.|++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~ 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----C
Confidence 99999988887765566899999999999999999999999999999999999999999999999999987643 2
Q ss_pred ccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 317 TSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~-------------- 272 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA-------------- 272 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC--------------
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC--------------
Confidence 34589999999999863 35789999999999999999999999999888777766644210 00
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 273 ------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113578899999999999999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=420.35 Aligned_cols=260 Identities=31% Similarity=0.478 Sum_probs=219.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH-----------HHHHHHHHHHHHHHhCCCCCcceeeee
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP-----------ESVRFMAREIHILRKLDHPNVMKLEGL 225 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIV~l~~~ 225 (665)
.++|+++++||+|+||+||+|++..+++.||||++....... ...+.+.+|+.+|++|+||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 357999999999999999999999999999999997654321 234668899999999999999999999
Q ss_pred eeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEec
Q 006004 226 VTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDF 302 (665)
Q Consensus 226 ~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DF 302 (665)
+.+.. .+|||||||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 115 ~~~~~-~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKK-YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSS-EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCC-EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 98754 7999999998755443333345799999999999999999999999999999999999999876 6999999
Q ss_pred ccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 303 GLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 303 GlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
|++..+.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9999875432 3456689999999999864 58999999999999999999999999999998888887644333333
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.| ..+++.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 270 ~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 270 DW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred cc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 32 4689999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=391.93 Aligned_cols=280 Identities=30% Similarity=0.519 Sum_probs=222.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeecc-CCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~l~ 234 (665)
.++|++++.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+|++|. ||||+++++++... ...++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 357999999999999999999999999999999987432 355789999999997 99999999999874 44789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+..+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+.....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999876665553 489999999999999999999999999999999999999777 899999999987754332
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChhH-Hhhhcccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIM-PGRTEVEQMHKIFKLCGSPSEDY-WRKSKSAH 391 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF-~g~~~~e~l~kI~~~~g~p~~~~-~~~~~~~~ 391 (665)
....+||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+.... +.......
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 455688999999999987677999999999999999999999888 56677788888777766433211 11110000
Q ss_pred ccC------CCCCCcchh-hhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATS------FKPQQPYKR-KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~------~~~~~p~~~-~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
... ......+.. ........+++.+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000 000000000 0111223479999999999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=400.09 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=215.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC---CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN---MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|++++||||+++++++.+.. .+|
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-YIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC-eEE
Confidence 47999999999999999999999999999999997532 23445677899999999999999999999998754 799
Q ss_pred EEEEeccccchhhhcC----------------------------------------CCCCCChhHHHHHHHHHHHHHHHH
Q 006004 235 LVFEYMEHDLAGLATT----------------------------------------PGIKFTEPQIKCYMQQLLRGLEHC 274 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~----------------------------------------~~~~lse~~i~~i~~QIl~aL~~L 274 (665)
|||||+.|+.+..+.. ....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999998755543332 022357888999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCC--cEEEEecccceecCCCC---CCCcccccccccccCcccccCC-cccCcccchhhhHH
Q 006004 275 HSRGILHRDIKGSNLLINNAG--VLKIGDFGLATTYDPSQ---NLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGC 348 (665)
Q Consensus 275 H~~gIiHrDLKPeNILld~~g--~lKL~DFGlA~~~~~~~---~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~ 348 (665)
|++||+||||||+||||+.++ .+||+|||++..+.... ........||+.|+|||++.+. ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999998764321 1224556899999999998742 57899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCc
Q 006004 349 ILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEP 428 (665)
Q Consensus 349 iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP 428 (665)
++|+|++|+.||.+.+..+.+..+......... ..+..+++.+.+||.+||..||
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHHHcCCCh
Confidence 999999999999999988888877653221111 1123578999999999999999
Q ss_pred CCCcCHHHHHhCcCCCCCC
Q 006004 429 ENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 429 ~~RpTa~eaL~Hp~f~~~~ 447 (665)
.+|||+.++|+||||+...
T Consensus 320 ~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 320 DERFDAMRALQHPWISQFS 338 (345)
T ss_dssp TTSCCHHHHHHSHHHHTTS
T ss_pred hHCCCHHHHhcChhhccCh
Confidence 9999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=392.50 Aligned_cols=264 Identities=27% Similarity=0.352 Sum_probs=206.2
Q ss_pred CCCCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCc
Q 006004 155 RRADAFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 155 ~~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~ 232 (665)
+..+.|++. +.||+|+||.||+|++..+++.||||++..... .....+.+|+.+|.++ +||||+++++++.... .
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-R 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-E
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-E
Confidence 445689996 789999999999999999999999999975432 2345678999999995 7999999999998754 8
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc---EEEEecccceecC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV---LKIGDFGLATTYD 309 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~---lKL~DFGlA~~~~ 309 (665)
+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999986555444444457999999999999999999999999999999999999998776 9999999998654
Q ss_pred CCC------CCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChH-------------
Q 006004 310 PSQ------NLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV------------- 366 (665)
Q Consensus 310 ~~~------~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~------------- 366 (665)
... .......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 112234569999999999864 145889999999999999999999999876431
Q ss_pred --HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 367 --EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 367 --e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.....+.......+. ..+..+++.+++||.+||..||.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred HHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 122222221111111 12246889999999999999999999999999999998
Q ss_pred CC
Q 006004 445 TE 446 (665)
Q Consensus 445 ~~ 446 (665)
..
T Consensus 301 ~~ 302 (316)
T 2ac3_A 301 GC 302 (316)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=438.24 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=222.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
..++|++++.||+|+||.||+|+++.+++.||||+++.... .......+..|+.+|..+ .||||++++++|.+.. .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~-~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS-EE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC-EE
Confidence 45789999999999999999999999999999999975321 122345677899999988 7999999999998755 79
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+.|+.+..++.....|++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|.......
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 9999999986665555544579999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+.+|.....
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------- 559 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------------- 559 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------------
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 23456789999999999976 6789999999999999999999999999999888888865211
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCH-----HHHHhCcCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA-----ASALRSEFFKTEP 447 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa-----~eaL~Hp~f~~~~ 447 (665)
.....+++++.+||.+||.+||.+|+++ .++++||||+...
T Consensus 560 -------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 560 -------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred -------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 1123689999999999999999999997 9999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=391.72 Aligned_cols=257 Identities=23% Similarity=0.419 Sum_probs=219.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.... .+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-ELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-EEEEEEe
Confidence 48888999999999999999999999999999976543 23456789999999999999999999998755 7999999
Q ss_pred eccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCccc
Q 006004 239 YMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318 (665)
Q Consensus 239 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~ 318 (665)
|+.++.+..+.... .+++.++..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+..... ....
T Consensus 123 ~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cccc
Confidence 99987776666543 699999999999999999999999999999999999999999999999999987754322 2345
Q ss_pred ccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 319 ~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......
T Consensus 201 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 260 (321)
T 2c30_A 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------------------- 260 (321)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-------------------
T ss_pred ccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 689999999999976 678999999999999999999999999988877776664421000
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
......+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 261 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 261 -------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 011235788999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=387.68 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=209.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..++..||+|++..... ....+.+.+|+.+|++++||||+++++++.... .+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-NMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCC-eEEEE
Confidence 3579999999999999999999999999999999976542 223566889999999999999999999998754 79999
Q ss_pred EEecccc-chhhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecC
Q 006004 237 FEYMEHD-LAGLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~ 309 (665)
|||+.++ +...+.. .+..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999874 4444432 23579999999999999999999999999999999999999 456789999999998764
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------- 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY---------- 244 (285)
T ss_dssp ----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred Ccc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc----------
Confidence 432 2345678999999998864 68999999999999999999999999988766665543311100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
......+++.+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 245 ----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 ----------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0112347899999999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=398.63 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=192.4
Q ss_pred CeeEE---EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEE
Q 006004 159 AFEKI---DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 159 ~y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~ 234 (665)
+|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+.. .+|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-HTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-EEE
Confidence 56665 7899999999999999999999999999743 3455778999999997 999999999998754 789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEecccceecCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPS 311 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~~~~~ 311 (665)
|||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999998865554444456799999999999999999999999999999999999998766 8999999999876543
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCChhHH
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-------VEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-------~e~l~kI~~~~g~p~~~~~ 384 (665)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+. .+.+..+......+..+
T Consensus 163 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 238 (325)
T 3kn6_A 163 N-QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE-- 238 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH--
T ss_pred C-CcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc--
Confidence 2 23455688999999999876 6789999999999999999999999987543 33344443322112222
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+++++++||.+||..||.+|||+.++|+||||+..
T Consensus 239 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 239 -----------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -----------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -----------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 224689999999999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=386.03 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=201.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||||+++.........+.+.++..+++.++||||+++++++.... .+|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEEE
Confidence 45899999999999999999999999999999999765444444455555666688889999999999998754 79999
Q ss_pred EEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+++++...+. ..+..+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 9999987755443 3556899999999999999999999998 99999999999999999999999999998765432
Q ss_pred CCCcccccccccccCcccc---cCCcccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 NLPLTSRVVTLWYRAPELL---LGATKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l---~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. .....||+.|+|||++ .....++.++|||||||++|+|++|+.||... .....+..+......
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 232 (290)
T 3fme_A 165 A--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP---------- 232 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC----------
T ss_pred c--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC----------
Confidence 2 2344789999999997 33467899999999999999999999999863 444444444331100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
. .....+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 233 ---------~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 233 ---------Q--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------C--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 0 011357899999999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=401.21 Aligned_cols=281 Identities=29% Similarity=0.458 Sum_probs=226.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CC-----CcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HP-----NVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIV~l~~~~~~~~ 230 (665)
.++|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 35899999999999999999999999999999999742 344566778999998885 55 4999999988764
Q ss_pred CcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHH--hCCccccCCCcccEEEc--CCCcEEEEecccc
Q 006004 231 GSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCH--SRGILHRDIKGSNLLIN--NAGVLKIGDFGLA 305 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH--~~gIiHrDLKPeNILld--~~g~lKL~DFGlA 305 (665)
.+||||||+.++|...+.... ..+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|||++
T Consensus 130 -~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 -HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp -EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred -ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 899999999998887776543 46999999999999999999999 57999999999999995 4788999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
...... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+++.+|...++.++...+.
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecccc----cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 887432 345689999999999987 568999999999999999999999999999999999999999999887765
Q ss_pred hhccccc--cCCC---------------CCCcchhhhhhhcc------------------CCcHHHHHHHHHhcccCcCC
Q 006004 386 KSKSAHA--TSFK---------------PQQPYKRKVLETFR------------------NFPQSALALVDKLLTIEPEN 430 (665)
Q Consensus 386 ~~~~~~~--~~~~---------------~~~p~~~~~~~~~~------------------~~s~~a~dLI~~lL~~DP~~ 430 (665)
....... .... ...+..+.+...+. ..++.+++||.+||.+||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 4211000 0000 00000000100000 01147899999999999999
Q ss_pred CcCHHHHHhCcCCCCC
Q 006004 431 RGSAASALRSEFFKTE 446 (665)
Q Consensus 431 RpTa~eaL~Hp~f~~~ 446 (665)
|||+.|+|+||||+..
T Consensus 364 Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 364 RIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCCHHHHTTSGGGCC-
T ss_pred CCCHHHHhcCcccccC
Confidence 9999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=386.45 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=215.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.++++++||||+++++++.... .+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-EEE
Confidence 456899999999999999999999999999999998653321 122456889999999999999999999998754 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 999999976555444444579999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 164 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 225 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 225 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------------
T ss_pred -ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC----------------
Confidence 345578999999999876 67899999999999999999999999998887777776542111
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
....+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 226 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 226 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp -------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 113478899999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=397.77 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=220.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--CH----HHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DP----ESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~----~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
++|++.+.||+|+||.||+|++..+|+.||||+++.... .. +..+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 469999999999999999999999999999999976532 22 2245678999999999 8999999999988754
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+|+||||+.|+.+..+......+++..+..++.||+.||.|||+.||+|+||||+||||+.+|.+||+|||++..+..
T Consensus 174 -~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 -FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp -EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred -EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 7999999999865555544445799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCCCcccccccccccCcccccC-----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLG-----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~-----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
.. .....+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 253 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 328 (365)
T 2y7j_A 253 GE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE-- 328 (365)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH--
T ss_pred Cc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc--
Confidence 33 2455689999999999863 23588999999999999999999999999888887777765432222222
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
+..+++.+.+||.+||..||.+|||+.++|+||||+
T Consensus 329 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 -----------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -----------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 246789999999999999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=408.45 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=204.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC------CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM------DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++|+||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 3579999999999999999999999999999999975432 112233478999999999999999999998643
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEeccccee
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGDFGLATT 307 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~DFGlA~~ 307 (665)
.+||||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 213 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp -EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred -ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 5899999998866655555556899999999999999999999999999999999999997554 599999999987
Q ss_pred cCCCCCCCcccccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCChhHH
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH-KIFKLCGSPSEDYW 384 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~-kI~~~~g~p~~~~~ 384 (665)
+... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+......+. .+.........
T Consensus 292 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~--- 366 (419)
T 3i6u_A 292 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP--- 366 (419)
T ss_dssp CC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH---
T ss_pred cCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc---
Confidence 6533 22455689999999999863 3568899999999999999999999998765433332 22221111111
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+..+++.+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 367 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 367 ----------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 223468999999999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.45 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=216.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~ 234 (665)
..|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|++++||||+++++++... ...+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 358999999999999999999999999999999987776777788899999999999999999999988653 34689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEc-CCCcEEEEecccceecCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld-~~g~lKL~DFGlA~~~~~~ 311 (665)
+||||++++.+..+......+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999988666555554457999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+....... ..+.
T Consensus 186 ---~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~---------- 249 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA---------- 249 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG----------
T ss_pred ---ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCcc----------
Confidence 2345679999999998864 58999999999999999999999998866655544432211 0000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 250 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 ---------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 1123567889999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=390.28 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=202.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS------- 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~------- 230 (665)
++|++++.||+|+||.||+|++..+|+.||||+++... .....+.+.+|+.+|++|+||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999998654 2345567899999999999999999999886532
Q ss_pred -------------------------------------------------CcEEEEEEeccccchhhhcCCCCC---CChh
Q 006004 231 -------------------------------------------------GSLYLVFEYMEHDLAGLATTPGIK---FTEP 258 (665)
Q Consensus 231 -------------------------------------------------~~l~lV~Ey~~g~ll~~~~~~~~~---lse~ 258 (665)
..+|+|||||.++.+..+...... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 138999999998655554444323 4555
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-----------CCcccccccccccC
Q 006004 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-----------LPLTSRVVTLWYRA 327 (665)
Q Consensus 259 ~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-----------~~~~~~~gT~~Y~A 327 (665)
.++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 6899999999999999999999999999999999999999999999998754321 12344579999999
Q ss_pred cccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhh
Q 006004 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLE 407 (665)
Q Consensus 328 PE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 407 (665)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+..+.. +..+ .
T Consensus 245 PE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~--------------------------~ 293 (332)
T 3qd2_B 245 PEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP--------------------------L 293 (332)
T ss_dssp HHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC--------------------------H
T ss_pred hHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC--------------------------c
Confidence 999986 5789999999999999999998765421 1111111111 0100 1
Q ss_pred hccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 408 TFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 408 ~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.+...++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 12245678899999999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.64 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=215.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-EEEEEE
Confidence 4799999999999999999999999999999999765432 34567889999999999999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CCCc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~~~ 316 (665)
||+.++.+..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 999986555555556689999999999999999999999999999999999999999999999999998764322 1223
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ-MHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~-l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.... +..+.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 226 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------ 226 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------------------
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------------------
Confidence 4567899999999998755558899999999999999999999987654322 222211000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
....+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 ---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ---------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001124688999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=382.15 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=217.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++++.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.... .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-DV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC-eE
Confidence 46999999999999999999999999999999997654321 13567889999999999999999999998754 78
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceecC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTYD 309 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~~ 309 (665)
|+||||+.+..+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999998765555444445799999999999999999999999999999999999999877 89999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 164 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 233 (283)
T 3bhy_A 164 AGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE------- 233 (283)
T ss_dssp ----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH-------
T ss_pred CCC--cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch-------
Confidence 432 2345578999999999876 578999999999999999999999999998887777765533222222
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 234 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 234 ------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 23467899999999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=392.98 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=214.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC---c
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG---S 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~---~ 232 (665)
.++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 3579999999999999999999999999999999986543 45556778999999999999999999999876532 3
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+||||||++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 59999999876665555444579999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 N--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 240 (311)
T ss_dssp -----------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---------
T ss_pred cccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---------
Confidence 2 12334578999999999986 57899999999999999999999999999887776666543221111
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++++.+||.+||+.||.+||++.++|.|+|+..
T Consensus 241 ----------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 123468999999999999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=379.86 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=220.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---C----HHHHHHHHHHHHHHHhCC-CCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---D----PESVRFMAREIHILRKLD-HPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~ 228 (665)
.++|++.+.||+|+||.||+|++..+|+.||||+++.... . ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4589999999999999999999999999999999976531 1 123456789999999995 9999999999987
Q ss_pred cCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 229 RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
.. .+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 96 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SS-EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CC-eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 54 79999999997555544444457999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCcccccccccccCccccc-----CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLL-----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~-----~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
.... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 250 (298)
T 1phk_A 175 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-- 250 (298)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred CCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc--
Confidence 5433 234567899999999985 2356889999999999999999999999998887777776553221111
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 251 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 -----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -----------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1123688999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=384.75 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=213.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-CYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-EEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-eEEEE
Confidence 489999999999999999999999999999999865443 4566778999999999999999999999988754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99999866655554445799999999999999999999999999999999999999999999999999987654433334
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+...++..... +.
T Consensus 170 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~---------------- 231 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PN---------------- 231 (294)
T ss_dssp -----CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CC----------------
T ss_pred CccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CC----------------
Confidence 45679999999999987 5689999999999999999999999999887776655443110 00
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
........+|+.+.+||.+||+.||.+||+..+.|.+.|..
T Consensus 232 -------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 232 -------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp -------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred -------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 01122346899999999999999999999777777777754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=382.35 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=223.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-EEE
Confidence 34579999999999999999999999999999999976543 4556677899999999999999999999998754 789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999766655555555799999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------------- 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------------
T ss_pred ccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-----------------
Confidence 2344578999999999876 5689999999999999999999999999887766655533100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
.....+++.+.+||.+||..||.+|||+.++|+||||+....+
T Consensus 233 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 233 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1113578899999999999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=427.69 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=215.2
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+.. .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-AL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-EE
Confidence 445689999999999999999999999999999999975432 1123455789999999999999999999998765 89
Q ss_pred EEEEEeccccchh-hhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 234 YLVFEYMEHDLAG-LATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 234 ~lV~Ey~~g~ll~-~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
||||||+.|+.+. .+...+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999875554 443322 34999999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhHHhhh
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE----VEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~----~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
. .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+. .+....+... +
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~------- 405 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----P------- 405 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----C-------
T ss_pred c--cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----c-------
Confidence 2 2455689999999999986 5789999999999999999999999988643 2222222210 0
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
......+++++++||.+||.+||.+|+ ++.|+++||||+..
T Consensus 406 ------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 ------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 011236899999999999999999999 89999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=380.03 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=207.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+++.||||+++...........+.+|+.++..+ +||||+++++++.... .+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-HMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-EEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-eEEE
Confidence 4579999999999999999999999999999999987655455566788999999999 9999999999998755 8999
Q ss_pred EEEecccc-chhhhcCC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-----------------
Q 006004 236 VFEYMEHD-LAGLATTP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA----------------- 294 (665)
Q Consensus 236 V~Ey~~g~-ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~----------------- 294 (665)
||||++++ |...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999874 44444332 2469999999999999999999999999999999999999844
Q ss_pred --CcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006004 295 --GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372 (665)
Q Consensus 295 --g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI 372 (665)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.++|...... ..+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~ 240 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEI 240 (289)
T ss_dssp -CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHH
T ss_pred CceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHH
Confidence 47999999999887543 23468999999999987557788999999999999999999887654322 222
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
... . .......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 241 ~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQG--R--------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTT--C--------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcC--C--------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 110 0 001123688999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=387.34 Aligned_cols=279 Identities=24% Similarity=0.414 Sum_probs=227.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE-CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCC------CcceeeeeeeccC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP------NVMKLEGLVTSRS 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIV~l~~~~~~~~ 230 (665)
++|++++.||+|+||.||+|++ ..+++.||||+++.. ......+.+|+.+++.++|+ +|+++++++....
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 4899999999999999999998 568899999999642 34556788999999998765 4999999988754
Q ss_pred CcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC----------------
Q 006004 231 GSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---------------- 293 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---------------- 293 (665)
.+||||||+.+++...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 91 -~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 -HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp -EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred -cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 899999999888887776543 46899999999999999999999999999999999999987
Q ss_pred ---CCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH
Q 006004 294 ---AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370 (665)
Q Consensus 294 ---~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 370 (665)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999875432 245578999999999986 578999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhHHhhhcccccc-----CCCCCCcchhh----------hhhhccCCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHAT-----SFKPQQPYKRK----------VLETFRNFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~-----~~~~~~p~~~~----------~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
.+....+..+...+.+....... .+......... ........++.+.+||.+||..||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 99999998888776654321110 00000000000 0011123467889999999999999999999
Q ss_pred HHHhCcCCCC
Q 006004 436 SALRSEFFKT 445 (665)
Q Consensus 436 eaL~Hp~f~~ 445 (665)
|+|+||||+.
T Consensus 325 ell~hp~f~~ 334 (339)
T 1z57_A 325 EALKHPFFDL 334 (339)
T ss_dssp HHTTSGGGGG
T ss_pred HHhcCHHHHH
Confidence 9999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=383.28 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=216.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.++++++||||+++++++.... .+|+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-RIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-EEEE
Confidence 46899999999999999999999999999999999753221 112356889999999999999999999998754 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 99999875444444334479999999999999999999999999999999999999999999999999997764322
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------ 229 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL------------------ 229 (284)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------
T ss_pred cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc------------------
Confidence 245578999999999886 5689999999999999999999999999887777666543210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 230 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 -----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0113578999999999999999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=391.47 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=223.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-FVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-eEE
Confidence 34579999999999999999999999999999999976543 4556677899999999999999999999998754 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999766655555455799999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------------- 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------------
T ss_pred cccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-----------------
Confidence 2345678999999999986 5689999999999999999999999998887776666543110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.....+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 259 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 259 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 011357889999999999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=386.54 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=215.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTT-HYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCC-EEEEEE
Confidence 379999999999999999999999999999999985432 22345789999999999999999999988754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 999875544333334479999999999999999999999999999999999999 77899999999999765322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 228 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES------------- 228 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-------------
T ss_pred ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-------------
Confidence 2345578999999999876 67899999999999999999999999999888877777653221111
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 ------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1124688999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=394.35 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=208.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeeeeccCCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~~~l~ 234 (665)
.++|++++.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|+.|.| |||+++++++.... .+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-EEE
Confidence 35799999999999999999998 568999999998777677777889999999999986 99999999988754 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||+..++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+......
T Consensus 86 lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99998777777766654 4799999999999999999999999999999999999997 588999999999876543321
Q ss_pred -CcccccccccccCcccccC----------CcccCcccchhhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChh
Q 006004 315 -PLTSRVVTLWYRAPELLLG----------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSED 382 (665)
Q Consensus 315 -~~~~~~gT~~Y~APE~l~~----------~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~kI~~~~g~p~~~ 382 (665)
.....+||+.|+|||++.+ ...++.++|||||||+||+|++|++||.+.... ..+..+.....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----- 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH----- 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS-----
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc-----
Confidence 2345689999999999863 256899999999999999999999999875432 33333221000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
. .......+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 239 -------------~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 -------------E---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp -------------C---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -------------c---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 0 011124567899999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=386.36 Aligned_cols=280 Identities=23% Similarity=0.373 Sum_probs=228.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC------cceeeeeeeccC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-KIVALKKVRFANMDPESVRFMAREIHILRKLDHPN------VMKLEGLVTSRS 230 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~~~~~~~~ 230 (665)
++|++++.||+|+||.||+|++..++ +.||||+++.. ......+.+|+.+++.+.|++ |+.+++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 48999999999999999999998877 68999999642 345566888999999997766 899999887754
Q ss_pred CcEEEEEEeccccchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE------------------
Q 006004 231 GSLYLVFEYMEHDLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI------------------ 291 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl------------------ 291 (665)
.+||||||+.++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 96 -~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 96 -HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp -EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred -eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 899999999998888776544 569999999999999999999999999999999999999
Q ss_pred -cCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHH
Q 006004 292 -NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMH 370 (665)
Q Consensus 292 -d~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 370 (665)
+.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999999875432 245689999999999986 578999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhHHhhhcccccc-----CCCCCCcchhhhh----------hhccCCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHAT-----SFKPQQPYKRKVL----------ETFRNFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~-----~~~~~~p~~~~~~----------~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
.+.+.++.++..++......... .+........... ......+..+.+||.+||.+||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 99999999888776543221110 0000000000000 00112356789999999999999999999
Q ss_pred HHHhCcCCCCC
Q 006004 436 SALRSEFFKTE 446 (665)
Q Consensus 436 eaL~Hp~f~~~ 446 (665)
|+|+||||+..
T Consensus 330 e~l~hp~f~~~ 340 (355)
T 2eu9_A 330 EALLHPFFAGL 340 (355)
T ss_dssp HHTTSGGGGGC
T ss_pred HHhcChhhcCC
Confidence 99999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.43 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred CCCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh-CCCCCcceeeeeeec---cCC
Q 006004 157 ADAFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK-LDHPNVMKLEGLVTS---RSG 231 (665)
Q Consensus 157 ~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~---~~~ 231 (665)
.++|.++ +.||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.+ ++||||++++++|.. ...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4568887 6899999999999999999999999999632 235688888754 589999999998865 234
Q ss_pred cEEEEEEecccc-chhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccce
Q 006004 232 SLYLVFEYMEHD-LAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLAT 306 (665)
Q Consensus 232 ~l~lV~Ey~~g~-ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~ 306 (665)
.+|||||||.|+ |...+.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 689999999874 555554432 46999999999999999999999999999999999999997 7899999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCChh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE----QMHKIFKLCGSPSED 382 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e----~l~kI~~~~g~p~~~ 382 (665)
...... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+... ....+.......+
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-- 287 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-- 287 (400)
T ss_dssp ECC-------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC--
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC--
Confidence 764322 2456789999999999876 678999999999999999999999998765422 2222222110000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...+..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 288 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 -----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -----------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 01234689999999999999999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=387.60 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=208.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC------CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM------DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++|+||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 479999999999999999999999999999999975432 112234578999999999999999999998754
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc---EEEEecccceec
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV---LKIGDFGLATTY 308 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~---lKL~DFGlA~~~ 308 (665)
.+|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 48999999987555544455568999999999999999999999999999999999999987664 999999999876
Q ss_pred CCCCCCCcccccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCChhHHh
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM-HKIFKLCGSPSEDYWR 385 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l-~kI~~~~g~p~~~~~~ 385 (665)
.... ......||+.|+|||++. +...++.++|||||||++|+|++|.+||.+......+ ..+.........
T Consensus 168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 241 (322)
T 2ycf_A 168 GETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP---- 241 (322)
T ss_dssp CCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH----
T ss_pred cccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc----
Confidence 4321 234457899999999984 3457899999999999999999999999876543222 222221111111
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 ---------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 242 ---------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 223468999999999999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=396.21 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=209.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHH------HHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPE------SVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
++|++++.||+|+||.||+|++..+++.||||+++....... ....+.+|+.+|++++||||+++++++....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~- 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG- 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC-
Confidence 479999999999999999999999999999999986543211 2345678999999999999999999998754
Q ss_pred cEEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+|+||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 799999998653 4444445555799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 183 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~---------------- 238 (335)
T 3dls_A 183 GK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE---------------- 238 (335)
T ss_dssp TC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT----------------
T ss_pred CC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh----------------
Confidence 33 2445689999999999987555589999999999999999999999652210 00
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
........+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 239 -------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 -------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000112247899999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=417.41 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=216.8
Q ss_pred cCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 154 PRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 154 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
+...++|++++.||+|+||.||+|+++.+|+.||||++...... ......+.+|+.+|++++||||++++++|.... .
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-D 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-E
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-E
Confidence 34567899999999999999999999999999999999754321 123456789999999999999999999998765 7
Q ss_pred EEEEEEeccccchhhhc-CC---CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 233 LYLVFEYMEHDLAGLAT-TP---GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~-~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
+||||||+.|+.+..+. .. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999976554333 22 346999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhHH
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE----VEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~----~e~l~kI~~~~g~p~~~~~ 384 (665)
..... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+. .+....+....
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-------- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--------
T ss_pred cCCCc-ccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--------
Confidence 54332 2345689999999999987 6789999999999999999999999987642 33333333210
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||.+||.+||+ +.++++||||+..
T Consensus 410 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 410 ---------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ---------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 0112368999999999999999999995 5899999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=400.42 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=209.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC--CCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD--HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~~~l~l 235 (665)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|++|. ||||+++++++.... .+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEEE
Confidence 369999999999999999999865 899999999877667777788999999999996 599999999988755 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-C
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-L 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~ 314 (665)
|||+..++|...+... ..+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+..... .
T Consensus 134 v~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 9997767776666554 4789999999999999999999999999999999999996 58999999999987654322 1
Q ss_pred CcccccccccccCcccccC----------CcccCcccchhhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhH
Q 006004 315 PLTSRVVTLWYRAPELLLG----------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTE-VEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~----------~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~kI~~~~g~p~~~~ 383 (665)
.....+||+.|+|||++.+ ...|+.++||||||||||+|++|++||.+... ...+..+.....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~------ 285 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------ 285 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc------
Confidence 2345689999999999864 13689999999999999999999999987643 333333322100
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
. .......+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 286 ------------~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 ------------E---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ------------C---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ------------c---------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0 001123477899999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=380.71 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=191.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.++++++||||+++++++.... .+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-YVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-EEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-eEEE
Confidence 4579999999999999999999999999999999974321 1122466889999999999999999999998754 7899
Q ss_pred EEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||+.++.+ ..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 9999987544 44444446799999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------~- 227 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------------A- 227 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------------S-
T ss_pred cceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------------c-
Confidence 2234578999999999876 5689999999999999999999999987654433322210 0
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ......++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 228 -~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 -D---------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -C---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -c---------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 01123578899999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=378.30 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=208.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ..+....+.+|+.+++.++||||+++++++.... .+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-DFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-eEEE
Confidence 3589999999999999999999999999999999975321 1123456889999999999999999999988754 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+..+..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 99999875554444444579999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 228 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------------------ 228 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------------
Confidence 34457899999999998754457899999999999999999999998877666665543110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 229 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 -----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0113478899999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=377.96 Aligned_cols=263 Identities=29% Similarity=0.475 Sum_probs=219.6
Q ss_pred CCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 155 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
...++|++++.||+|+||.||+|++..+|+.||+|++..........+.+.+|+.++++++||||+++++++... ...+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 445689999999999999999999999999999999987776777778899999999999999999999987543 4579
Q ss_pred EEEEEecccc-chhhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCC-----ccccCCCcccEEEcCCCcEEEEeccc
Q 006004 234 YLVFEYMEHD-LAGLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRG-----ILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~g-----IiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
|+||||++++ |...+.. ....+++.+++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999874 4444432 2345999999999999999999999999 99999999999999999999999999
Q ss_pred ceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 305 ATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 305 A~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------ 234 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred heeecccc-ccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc------
Confidence 98764322 11234578999999999986 57899999999999999999999999998877666665442100
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
.....+++.+.+||.+||..||.+|||+.++|+|+|+....
T Consensus 235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 235 ----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 11135789999999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=380.18 Aligned_cols=263 Identities=28% Similarity=0.403 Sum_probs=218.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l 233 (665)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3579999999999999999999999999999999975421 123456788999999999999999999998543 4478
Q ss_pred EEEEEeccccchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.+++...+.. ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999886665543 34579999999999999999999999999999999999999999999999999998765322
Q ss_pred C-CCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 313 N-LPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 313 ~-~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
. .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....-
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------------
Confidence 2 223455789999999998753 3357899999999999999999999999887776666544110
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
.....+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 112357889999999999999999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=390.71 Aligned_cols=282 Identities=27% Similarity=0.431 Sum_probs=223.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-----------CCCcceeeee
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-----------HPNVMKLEGL 225 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l~~~ 225 (665)
.++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++++. ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 35899999999999999999999999999999999742 344566789999999886 8999999999
Q ss_pred eeccC---CcEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEc------CC
Q 006004 226 VTSRS---GSLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLIN------NA 294 (665)
Q Consensus 226 ~~~~~---~~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld------~~ 294 (665)
+.... ..+++||||+.+++...+... ...+++.+++.++.||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87542 268999999977777766543 34699999999999999999999998 999999999999995 34
Q ss_pred CcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC------hHHH
Q 006004 295 GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT------EVEQ 368 (665)
Q Consensus 295 g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e~ 368 (665)
+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|++||.+.+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 48999999999876532 344578999999999987 568999999999999999999999998765 5678
Q ss_pred HHHHHHhcCCCChhHHhhhccccc----------cCCCCCCcchhhhh---hhccCCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 369 MHKIFKLCGSPSEDYWRKSKSAHA----------TSFKPQQPYKRKVL---ETFRNFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 369 l~kI~~~~g~p~~~~~~~~~~~~~----------~~~~~~~p~~~~~~---~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
+..+...+|.++...|...+.... .......+....+. .....+++.+.+||.+||..||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 888999999988876654321100 00000011111111 11224567899999999999999999999
Q ss_pred HHHhCcCCCCC
Q 006004 436 SALRSEFFKTE 446 (665)
Q Consensus 436 eaL~Hp~f~~~ 446 (665)
|+|+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=377.58 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=217.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.... .+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-eEEEEE
Confidence 4799999999999999999999999999999999765444445667889999999999999999999988754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC---CcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA---GVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~---g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+.........+++.+++.++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-- 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence 999875544333333479999999999999999999999999999999999999764 479999999998765432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 179 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 243 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------------- 243 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-------------
T ss_pred ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-------------
Confidence 2345578999999999875 4899999999999999999999999998888777766542211110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 ------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1224688999999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=380.82 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=206.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||+||+|++ +|+.||||++.......+..+.+.+|+.+|++++||||+++++++.... .+|+||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~ 113 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSIVT 113 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceEEEE
Confidence 4799999999999999999987 6889999999877767777788999999999999999999999998755 689999
Q ss_pred EeccccchhhhcCCCC---CCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 238 EYMEHDLAGLATTPGI---KFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
||+.++.+..+..... .+++.+++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9998755544443332 3999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------- 257 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------------- 257 (309)
T ss_dssp ---------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC--------------
T ss_pred -cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 22345689999999999986 56899999999999999999999999998887766665332111
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh--CcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~--Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.++++ .++++..
T Consensus 258 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 -------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0122468899999999999999999999999998 5666643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=391.47 Aligned_cols=284 Identities=25% Similarity=0.343 Sum_probs=214.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++.... .+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-EEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-EEEEE
Confidence 458999999999999999999999999999999998653 4556677899999999999999999999998754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+..+......+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+... .
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 99998855555444445799999999999999999999996 9999999999999999999999999999765322 1
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhHHhhhcc-cccc
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLC-GSPSEDYWRKSKS-AHAT 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~-g~p~~~~~~~~~~-~~~~ 393 (665)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... +......+..... ....
T Consensus 187 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 244578999999999986 578999999999999999999999999877655433321111 1111100000000 0000
Q ss_pred CCC----CCCcchh----h-----hhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFK----PQQPYKR----K-----VLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~----~~~p~~~----~-----~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+. +...... . .......++.++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000 0000000 0 000112478899999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=397.02 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=209.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
.++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+++ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357999999999999999999984 5899999999864321 112233466899999999 6999999999998755
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+||||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 133 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 133 -KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred -eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 7999999999765554444445799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.........+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+.......+.... ..
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------~~---- 280 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------LK---- 280 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-------HH----
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH-------hc----
Confidence 333334556899999999999852 457899999999999999999999997654322222221110 00
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
. .......++..+.+||.+||..||.+|| |+.++|+||||...
T Consensus 281 -----~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 281 -----S---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -----C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -----c---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0 0011235788999999999999999999 99999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=404.85 Aligned_cols=251 Identities=18% Similarity=0.275 Sum_probs=199.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHH---HHHhCCCCCcceee-------ee
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIH---ILRKLDHPNVMKLE-------GL 225 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~---iL~~L~HpnIV~l~-------~~ 225 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+. +|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 3579999999999999999999999999999999975532 3445677889994 55556899999998 55
Q ss_pred eeccCC----------------cEEEEEEeccccchhhhcCCC------CCCChhHHHHHHHHHHHHHHHHHhCCccccC
Q 006004 226 VTSRSG----------------SLYLVFEYMEHDLAGLATTPG------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRD 283 (665)
Q Consensus 226 ~~~~~~----------------~l~lV~Ey~~g~ll~~~~~~~------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrD 283 (665)
+..... ..||||||++|+|...+...+ ..+++..+..|+.||+.||.|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 554321 389999999887776665422 1233488889999999999999999999999
Q ss_pred CCcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccccCC----------cccCcccchhhhHHHHHHH
Q 006004 284 IKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA----------TKYGAAIDMWSAGCILAEL 353 (665)
Q Consensus 284 LKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----------~~~~~~sDIWSLG~iLyeL 353 (665)
|||+||||+.++.+||+|||+|..... .....+| +.|+|||++.+. ..|+.++|||||||+||+|
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999986432 2345677 999999999863 2789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC
Q 006004 354 FAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS 433 (665)
Q Consensus 354 ltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT 433 (665)
++|+.||.+.+..+.+..+ ......+++.+.+||.+||..||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999765432211111 1122468999999999999999999999
Q ss_pred HHHHHhCcCCCC
Q 006004 434 AASALRSEFFKT 445 (665)
Q Consensus 434 a~eaL~Hp~f~~ 445 (665)
+.++|+||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.18 Aligned_cols=269 Identities=23% Similarity=0.352 Sum_probs=194.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++.... .+|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-CEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEE
Confidence 3579999999999999999999999999999999865432 234556789999999999999999999998765 78999
Q ss_pred EEeccccchhhhcC--------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 237 FEYMEHDLAGLATT--------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
|||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99998754443332 2456999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC----CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 309 DPSQN----LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 309 ~~~~~----~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 246 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS----- 246 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC-----
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc-----
Confidence 43221 122345789999999998754568999999999999999999999999877665554433211000
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.............+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 247 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 247 --------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp --------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred --------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 000001112335688999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=375.38 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=211.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEEEE
Confidence 357999999999999999999999999999999987543 234566889999999999999999999998754 79999
Q ss_pred EEeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+..+. .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 9999986665443 334579999999999999999999999999999999999999999999999999976432110 11
Q ss_pred cccccccccccCccccc----CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 316 LTSRVVTLWYRAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~----~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.....||+.|+|||++. ....++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------------ 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------------
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc------------
Confidence 23457899999999984 33578999999999999999999999999988777766654421000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 242 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 --------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred --------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 01123578899999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=374.61 Aligned_cols=257 Identities=29% Similarity=0.436 Sum_probs=202.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc--------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-------- 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-------- 229 (665)
++|++++.||+|+||.||+|++..+|+.||||+++.. ....+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4799999999999999999999999999999999642 35567788999999999999999999987542
Q ss_pred ----CCcEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 230 ----SGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 230 ----~~~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
...+|+||||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 2468999999987 55555554556788999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCC-------------CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC-CChHHHHH
Q 006004 305 ATTYDPSQ-------------NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG-RTEVEQMH 370 (665)
Q Consensus 305 A~~~~~~~-------------~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~ 370 (665)
+....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 98764321 1223456789999999999875678999999999999999998 4443 22333333
Q ss_pred HHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.+.......+. ......++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 240 KLRSVSIEFPP-------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHSTTCCCCT-------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hccccccccCc-------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 33221111000 112356788999999999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=386.95 Aligned_cols=277 Identities=22% Similarity=0.338 Sum_probs=211.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+|+.||||+++.... ....+.+.+|+.+|++++||||+++++++... ...+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3579999999999999999999999999999999975432 22345678999999999999999999998765 337899
Q ss_pred EEEeccccchh-hhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE----cCCCcEEEEecccceec
Q 006004 236 VFEYMEHDLAG-LATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTY 308 (665)
Q Consensus 236 V~Ey~~g~ll~-~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl----d~~g~lKL~DFGlA~~~ 308 (665)
||||+.++.+. .+.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999865544 443322 239999999999999999999999999999999999999 78888999999999987
Q ss_pred CCCCCCCcccccccccccCcccccC-------CcccCcccchhhhHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcC
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLG-------ATKYGAAIDMWSAGCILAELFAGKPIMPGRT----EVEQMHKIFKLCG 377 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~----~~e~l~kI~~~~g 377 (665)
..... ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.... ..+.+.++...
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 242 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-- 242 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH--
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC--
Confidence 54432 345679999999999862 3578999999999999999999999997533 24444444432
Q ss_pred CCChhHHhhhccccccC--CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 378 SPSEDYWRKSKSAHATS--FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 378 ~p~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
.+...|.......... +....+. .......++..+.+||.+||++||.+|||+.|+|+||-
T Consensus 243 -~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 -KPSGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp -CCTTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred -CCcccchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2222222111000000 0000110 01122346778999999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=373.62 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=218.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|++++.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-KLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 4699999999999999999999999999999999865432 34567889999999999999999999988754 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||++++.+..+... ..+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ....
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 177 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 177 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccC
Confidence 99998666655554 379999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
...||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+.... +
T Consensus 178 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 236 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P------------------ 236 (303)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C------------------
T ss_pred ccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C------------------
Confidence 5678999999999976 578999999999999999999999999887766555543310 0
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 237 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 --------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp --------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred --------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01123678899999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=394.91 Aligned_cols=263 Identities=17% Similarity=0.228 Sum_probs=195.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhC--CCCCcceee-------eeeec
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKL--DHPNVMKLE-------GLVTS 228 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L--~HpnIV~l~-------~~~~~ 228 (665)
.|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.| +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 59999999999999999999999999999999987654 334566777885555444 699988755 33332
Q ss_pred cC----------------CcEEEEEEeccccchhhhcCCCCCCChhHH------HHHHHHHHHHHHHHHhCCccccCCCc
Q 006004 229 RS----------------GSLYLVFEYMEHDLAGLATTPGIKFTEPQI------KCYMQQLLRGLEHCHSRGILHRDIKG 286 (665)
Q Consensus 229 ~~----------------~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i------~~i~~QIl~aL~~LH~~gIiHrDLKP 286 (665)
.. ..+|||||||+++|...+...+..+++..+ ..++.||+.||.|||++||+||||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 21 248999999998888777654444555555 57779999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCcccccC-CcccCcccchhhhHHHHHHHHhCCCCCCCCCh
Q 006004 287 SNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG-ATKYGAAIDMWSAGCILAELFAGKPIMPGRTE 365 (665)
Q Consensus 287 eNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~ 365 (665)
+||||+.+|.+||+|||+|...... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|++||.+.+.
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred HHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 9999999999999999999976432 124567899999999974 24789999999999999999999999987642
Q ss_pred HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 366 VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 366 ~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.. ...|......... ...........+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 299 ~~-------------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 299 GI-------------KGSWKRPSLRVPG-------TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TC-------------TTCCCBCCTTSCC-------CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cc-------------ccchhhhhhhhcc-------ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 10 0001100000000 000111223478999999999999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=382.94 Aligned_cols=274 Identities=22% Similarity=0.362 Sum_probs=214.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH---------------HHHHHHHHHHHHHHhCCCCCcce
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP---------------ESVRFMAREIHILRKLDHPNVMK 221 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIV~ 221 (665)
.++|++++.||+|+||.||+|++ +|+.||||++....... .....+.+|+.++++|+||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45899999999999999999998 89999999997432111 11266889999999999999999
Q ss_pred eeeeeeccCCcEEEEEEeccccchhhh------cCC--CCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEc
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHDLAGLA------TTP--GIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLIN 292 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ll~~~------~~~--~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld 292 (665)
+++++.... .+|+||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+||||||+||||+
T Consensus 108 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSS-EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCC-eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999998754 89999999998544443 333 5679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCc-ccchhhhHHHHHHHHhCCCCCCCCCh-HHHHH
Q 006004 293 NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA-AIDMWSAGCILAELFAGKPIMPGRTE-VEQMH 370 (665)
Q Consensus 293 ~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~-~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~ 370 (665)
.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999999876433 2345678999999999987545666 99999999999999999999998877 55555
Q ss_pred HHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+.......+... .....+.. ..........+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 264 ~i~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 264 NIRTKNIEYPLDR--------NHFLYPLT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHTSCCCCCCCSS--------SSSTTTTC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHhccCcCCccch--------hhhhcccc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 5533211111000 00000000 001112235689999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=376.08 Aligned_cols=259 Identities=25% Similarity=0.472 Sum_probs=207.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc-----C
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR-----S 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-----~ 230 (665)
.++|++++.||+|+||.||+|++..+|+.||||++...... ...+.+|+.+++++ .||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 45899999999999999999999999999999999755432 34578899999999 899999999998763 3
Q ss_pred CcEEEEEEeccccch-hhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 231 GSLYLVFEYMEHDLA-GLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll-~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
..+|+||||+.++.+ ..+... ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 478999999987444 444332 246999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~ 384 (665)
..... ......||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.+..+.+..+..... +
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----- 252 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P----- 252 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c-----
Confidence 43221 2344578999999999863 35688999999999999999999999998887766655433110 0
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123578999999999999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=373.94 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=210.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++++++||||+++++++.... .+|+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNT-DLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCC-EEEEE
Confidence 3579999999999999999999999999999999976432 345788999999999999999999988754 78999
Q ss_pred EEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+. .+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ..
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 181 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AK 181 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SC
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cc
Confidence 9999985554 443345579999999999999999999999999999999999999999999999999998764332 12
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..... .
T Consensus 182 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-------------- 243 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP---P-------------- 243 (314)
T ss_dssp BCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---C--------------
T ss_pred cCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC---c--------------
Confidence 344578999999999876 5689999999999999999999999998877665554432110 0
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 --~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 --T-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --C-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --c-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 01123478899999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=374.12 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=197.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+..+..+++.++||||+++++++.... .+|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-DVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-cEEEE
Confidence 45799999999999999999999999999999999876544444455556666788899999999999998755 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.+.+..+.......+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..+.... .
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 180 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A 180 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence 99996544444444355799999999999999999999995 99999999999999999999999999998764332 2
Q ss_pred cccccccccccCccccc----CCcccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 316 LTSRVVTLWYRAPELLL----GATKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~----~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.....||+.|+|||++. ....++.++|||||||++|+|++|+.||... +..+.+..+......
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 248 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP------------ 248 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC------------
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC------------
Confidence 34457899999999985 2356889999999999999999999999874 445555555432100
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.. .....+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 249 -------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 -------LL-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp -------CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred -------CC-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00 111357899999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=364.85 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=210.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++. +++.||+|++....... +.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceEEE
Confidence 357999999999999999999986 57789999998654433 45789999999999999999999988754 79999
Q ss_pred EEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 999987544 4454555679999999999999999999999999999999999999999999999999998765433223
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 226 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------- 226 (269)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------
T ss_pred ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC----------------
Confidence 344467889999999976 568999999999999999999 99999998888777766442110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.++++|
T Consensus 227 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0113478899999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=381.67 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=208.6
Q ss_pred CCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+.+|+++ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3579999999999999999999 56677999999997543 445567789999999999 7999999999998766
Q ss_pred CcEEEEEEeccccchh-hhcCCC---------------------------------------------------------
Q 006004 231 GSLYLVFEYMEHDLAG-LATTPG--------------------------------------------------------- 252 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~-~~~~~~--------------------------------------------------------- 252 (665)
..+|+||||+.++.+. .+....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 6689999999975444 433321
Q ss_pred --------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-CCcccccccc
Q 006004 253 --------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTL 323 (665)
Q Consensus 253 --------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~ 323 (665)
..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .......||+
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 1289999999999999999999999999999999999999999999999999987643322 2234557899
Q ss_pred cccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcch
Q 006004 324 WYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYK 402 (665)
Q Consensus 324 ~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~ 402 (665)
.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.........+
T Consensus 260 ~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 315 (359)
T 3vhe_A 260 KWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------- 315 (359)
T ss_dssp GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------------
T ss_pred eeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------------
Confidence 9999999986 678999999999999999998 999999877555544443321100
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 403 RKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 403 ~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.++++|
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123578899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=374.63 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=209.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++..+++ .||||+++... .....+.+.+|+.+|++|+||||+++++++.... .+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-cc
Confidence 3579999999999999999999986655 59999997543 4556677899999999999999999999998754 78
Q ss_pred EEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
||||||++++.+ ..+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999987544 5554555689999999999999999999999999999999999999999999999999999875432
Q ss_pred CCC--cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 NLP--LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~~--~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 274 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---------- 274 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----------
T ss_pred cceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC----------
Confidence 221 223356788999999976 578999999999999999999 999999998887777765421110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 275 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12357899999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=368.98 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=205.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||+||+|++..+++.||+|++.. ......+.+.+|+.+|++|+||||+++++++.... .+|+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-RLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-eeEEE
Confidence 4589999999999999999999999999999998853 34566778999999999999999999999998754 79999
Q ss_pred EEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++.+ ..+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999987544 4554446679999999999999999999999999999999999999999999999999998764332211
Q ss_pred -------------cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 316 -------------LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 316 -------------~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------- 233 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------- 233 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----------
Confidence 125579999999999986 6789999999999999999999999875422100000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..............+++.+.+||.+||+.||.+|||+.++++
T Consensus 234 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 234 ---------------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---------------BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000001113467889999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=376.47 Aligned_cols=261 Identities=19% Similarity=0.279 Sum_probs=193.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC--
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG-- 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-- 231 (665)
.++|++.+.||+|+||.||+|++..++. .||||+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3579999999999999999999887775 89999997665555567788999999999999999999999876532
Q ss_pred ---cEEEEEEeccccchhhhcC------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEec
Q 006004 232 ---SLYLVFEYMEHDLAGLATT------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302 (665)
Q Consensus 232 ---~l~lV~Ey~~g~ll~~~~~------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DF 302 (665)
.+|+||||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 2389999999855443331 1225899999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 006004 303 GLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPS 380 (665)
Q Consensus 303 GlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~ 380 (665)
|++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 257 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--- 257 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC---
Confidence 99987644322 12233456889999999986 568999999999999999999 9999999887777666544210
Q ss_pred hhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-------HHHHHhCcCCCCC
Q 006004 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-------AASALRSEFFKTE 446 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-------a~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+||| +.+++.|+|+...
T Consensus 258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0112367889999999999999999999 8889999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.84 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=209.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++. ++..||+|+++...... +.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEY-PIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC-ceEEE
Confidence 458999999999999999999875 57789999997654433 45789999999999999999999987654 78999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||++++ +...+...+..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999875 444554444569999999999999999999999999999999999999999999999999998775543333
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 224 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------------- 224 (268)
T ss_dssp CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----------------
T ss_pred ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----------------
Confidence 334456788999999976 568999999999999999999 99999998887777665432110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.++|++
T Consensus 225 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112468889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=381.25 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=208.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-------ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~ 228 (665)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 357999999999999999999975 345689999997543 455667789999999999 89999999999887
Q ss_pred cCCcEEEEEEeccccch-hhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc
Q 006004 229 RSGSLYLVFEYMEHDLA-GLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN 292 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll-~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld 292 (665)
.. .+|+||||+.++.+ ..+.... ..+++.++..++.||+.||.|||++||+||||||+||||+
T Consensus 159 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 159 DG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred CC-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 54 78999999987544 4443321 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHH
Q 006004 293 NAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMH 370 (665)
Q Consensus 293 ~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 370 (665)
.++.+||+|||++..+..... .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+.
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999987654322 22334467899999999986 678999999999999999999 999999887666555
Q ss_pred HHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 371 KIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 371 kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+..... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 317 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 317 LLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4432100 01123578899999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=364.52 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=206.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|.+. ++..||||++....... +.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC-CeEEE
Confidence 457999999999999999999875 67789999998654433 45789999999999999999999987754 78999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.++ +...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999865 444444435579999999999999999999999999999999999999999999999999998764432222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.......
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC---------------
Confidence 334456889999999986 568999999999999999998 999999988887777765421111
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
....+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 242 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 -------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 112467889999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=364.07 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=197.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.++++++||||+++++++.. +.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--Ccc
Confidence 35799999999999999999998654 4579999886533 34556778999999999999999999998854 368
Q ss_pred EEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.++ |...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999974 445554455579999999999999999999999999999999999999999999999999998775443
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------------- 236 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 236 (281)
T ss_dssp --------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred ccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC-------------
Confidence 333334466889999999876 578999999999999999996 99999998877766665431100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 237 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123688999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.17 Aligned_cols=251 Identities=20% Similarity=0.217 Sum_probs=205.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.| +||||+++++++.... .+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-YNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT-EEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC-ccEEE
Confidence 4799999999999999999999999999999999754322 2467899999999 9999999999988754 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc-----EEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-----LKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~-----lKL~DFGlA~~~~~~ 311 (665)
|||+.++|..++......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+...
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999966677766655568999999999999999999999999999999999999999887 999999999976433
Q ss_pred CCC------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChh
Q 006004 312 QNL------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSPSED 382 (665)
Q Consensus 312 ~~~------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~kI~~~~g~p~~~ 382 (665)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+. .+.+..+.......+.
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI- 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence 221 1245689999999999987 6789999999999999999999999988543 3444444321110100
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+| .+.+||..||..||.+||++.++++
T Consensus 242 -----------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 -----------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11122455 8999999999999999999988876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=382.51 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=209.7
Q ss_pred CCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++++.||+|+||.||+|+ +..+++.||||+++... .......+.+|+.+|++++|||||++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 3579999999999999999999 45678899999986433 4455567889999999999999999999988754
Q ss_pred cEEEEEEeccc-cchhhhcCC------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---cEEEEe
Q 006004 232 SLYLVFEYMEH-DLAGLATTP------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG---VLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g---~lKL~D 301 (665)
..||||||+.+ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.+| .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 67999999986 444444332 13589999999999999999999999999999999999999555 599999
Q ss_pred cccceecCCC-CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPS-QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~-~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||++..+... .........||+.|+|||++.+ ..++.++|||||||+||+|++ |.+||.+.+..+.+..+......
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~- 305 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM- 305 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999765221 1122344578999999999976 578999999999999999998 99999999888777766442110
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.....+++.+.+||.+||+.||.+|||+.+++++.++-
T Consensus 306 ---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 306 ---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11235788999999999999999999999999998864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=363.86 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=204.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFE 238 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~E 238 (665)
.|.....||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... .+|+|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-FIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-cEEEEEE
Confidence 4555568999999999999999999999999997543 234566889999999999999999999998754 7999999
Q ss_pred eccccchhh-hcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecCCCCCC
Q 006004 239 YMEHDLAGL-ATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 239 y~~g~ll~~-~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|+.++.+.. +... ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 998655544 3332 235678999999999999999999999999999999999997 8999999999998765322 1
Q ss_pred CcccccccccccCcccccCC-cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~-~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..................
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 243 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV--------------- 243 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC---------------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc---------------
Confidence 23445789999999998753 34789999999999999999999999765443321111110000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 --~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 --H---------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp --C---------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred --c---------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0 01123678999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.58 Aligned_cols=252 Identities=17% Similarity=0.209 Sum_probs=208.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+ .|+||+++++++.... .+|+|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-eeEEE
Confidence 479999999999999999999999999999999875432 23367899999999 8999999999987654 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc-----EEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV-----LKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~-----lKL~DFGlA~~~~~~ 311 (665)
|||+.++|...+...+..+++.++..++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+...
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999966777777665667999999999999999999999999999999999999987776 999999999877543
Q ss_pred CC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChh
Q 006004 312 QN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT---EVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 312 ~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~kI~~~~g~p~~~ 382 (665)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+......+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 240 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST--- 240 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---
T ss_pred cccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc---
Confidence 22 12345679999999999876 568999999999999999999999998853 334444443321101
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
........+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 241 ---------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ---------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 112233478999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=368.35 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=206.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC--CCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD--HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~~~l~l 235 (665)
++|++++.||+|+||.||+|++. +++.||||++............+.+|+.+++++. ||||+++++++.... .+|+
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-~~~l 105 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYM 105 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-EEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-EEEE
Confidence 47999999999999999999985 5889999999877667777788999999999997 599999999988755 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-C
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-L 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-~ 314 (665)
|||+..++|...+... ..+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++..+..... .
T Consensus 106 v~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 106 VMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 9997777777666554 47999999999999999999999999999999999999965 8999999999987654322 1
Q ss_pred CcccccccccccCcccccCC----------cccCcccchhhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhH
Q 006004 315 PLTSRVVTLWYRAPELLLGA----------TKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~----------~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~kI~~~~g~p~~~~ 383 (665)
......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+.....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------ 257 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------ 257 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc------
Confidence 22345789999999998641 36889999999999999999999999876432 33332221000
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
. .......++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 258 ------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 258 ------------E---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ------------C---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ------------c---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 0 0111245788999999999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=366.16 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=198.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++++++||||+++++++.... .+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-QLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-eEEE
Confidence 4579999999999999999999999999999999975432 3445677899999999999999999999988754 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.+..+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999985555444444579999999999999999999999999999999999999999999999999998765544334
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ..........
T Consensus 192 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~---------------- 253 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPR---------------- 253 (309)
T ss_dssp -----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCC----------------
T ss_pred ccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCC----------------
Confidence 456689999999999876 6789999999999999999999999988765432 2222211000
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-CHHHHHh
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-SAASALR 439 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-Ta~eaL~ 439 (665)
.......+|+.+.+||.+||..||.+|| |+.++++
T Consensus 254 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ---------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122346889999999999999999999 7777765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.38 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=189.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHH-HHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIH-ILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|++..+|+.||||+++.... ......+.+|+. +++.++||||+++++++.... .+||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-DCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-EEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-ceEE
Confidence 4589999999999999999999999999999999986543 334445556666 677789999999999998754 7899
Q ss_pred EEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhC-CccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 236 VFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
||||+.+++...+.. ....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+..
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 999999976665542 245799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCccccc---CCcccCcccchhhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhHHhh
Q 006004 311 SQNLPLTSRVVTLWYRAPELLL---GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~---~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~kI~~~~g~p~~~~~~~ 386 (665)
.. ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+.. +.+..+..
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 244 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK------------ 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC------------
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc------------
Confidence 32 223447899999999984 2356899999999999999999999999875432 11111100
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...+..+ ......+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 245 -------~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 245 -------GDPPQLS-----NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp -------SCCCCCC-----CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------CCCCCCC-----CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0000000 0112468899999999999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.42 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=198.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||.||+|++.. .||+|+++.........+.+.+|+.+|++++||||++++++... ..+++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv~ 98 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT 98 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEEE
Confidence 479999999999999999998643 59999998776677778889999999999999999999996543 3689999
Q ss_pred Eeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CCC
Q 006004 238 EYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NLP 315 (665)
Q Consensus 238 Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~~ 315 (665)
||+.++.+ ..+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 99986544 4554556679999999999999999999999999999999999999999999999999998654321 223
Q ss_pred cccccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 316 LTSRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+..+.......+.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 246 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------------ 246 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC------------
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc------------
Confidence 34557899999999986 2356888999999999999999999999988777666655442111100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+......+++.+.+||.+||..||.+|||+.++++
T Consensus 247 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -----------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122367899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=365.45 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=207.7
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|++.+.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|++|+||||+++++++.... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 100 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-P 100 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-S
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-c
Confidence 57999999999999999999983 456899999997543 4566778899999999999999999999987754 7
Q ss_pred EEEEEEeccccchh-hhcCCC-----------------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCccc
Q 006004 233 LYLVFEYMEHDLAG-LATTPG-----------------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSN 288 (665)
Q Consensus 233 l~lV~Ey~~g~ll~-~~~~~~-----------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeN 288 (665)
+|+||||+.++.+. .+.... ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 89999999865444 433221 248999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChH
Q 006004 289 LLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEV 366 (665)
Q Consensus 289 ILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 366 (665)
|||+.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987644322 12233467889999999986 578999999999999999999 99999988766
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+....+..... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 260 RLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55544432100 01123688999999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=377.97 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=207.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCC--CCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLD--HPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++++. ||||+++++++....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 357999999999999999999999999999999997654321 11234668999999996 599999999998755
Q ss_pred CcEEEEEEeccc--cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-CCCcEEEEeccccee
Q 006004 231 GSLYLVFEYMEH--DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATT 307 (665)
Q Consensus 231 ~~l~lV~Ey~~g--~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-~~g~lKL~DFGlA~~ 307 (665)
.+++|||++.+ ++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ +++.+||+|||++..
T Consensus 122 -~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 122 -SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp -EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -cEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 78999999974 45554443 45799999999999999999999999999999999999999 789999999999988
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
+... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+. +... .
T Consensus 200 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~--------- 259 (320)
T 3a99_A 200 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q--------- 259 (320)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C---------
T ss_pred cccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c---------
Confidence 7533 234567999999999998755568899999999999999999999976321 1110 0
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
......+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 260 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 001135789999999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=371.40 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=208.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK- 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC-
Confidence 457999999999999999999987 456899999997543 4555677899999999999999999999988754
Q ss_pred cEEEEEEeccccch-hhhcCC-----------------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcc
Q 006004 232 SLYLVFEYMEHDLA-GLATTP-----------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGS 287 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~-----------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPe 287 (665)
.+|+||||+.++.+ ..+... ...+++.+++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 78999999987444 443332 157999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCCh
Q 006004 288 NLLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTE 365 (665)
Q Consensus 288 NILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~ 365 (665)
||||+.++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 99999999999999999987643221 12234567999999999886 568999999999999999999 9999999887
Q ss_pred HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 366 VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 366 ~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+.+..+..... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 283 ~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 776666543110 01123578899999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=375.05 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=179.4
Q ss_pred CCeeEEE-EeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcE
Q 006004 158 DAFEKID-KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSL 233 (665)
Q Consensus 158 ~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l 233 (665)
++|++++ .||+|+||.||+|++..+|+.||||++... ... .......++.+.||||+++++++... ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4799976 599999999999999999999999999642 122 12233346778999999999998752 2358
Q ss_pred EEEEEeccc-cchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccceec
Q 006004 234 YLVFEYMEH-DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATTY 308 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~~ 308 (665)
||||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999987 4555554432 46999999999999999999999999999999999999986 456999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG--------- 248 (336)
T ss_dssp --------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred cccc---cccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc---------
Confidence 4322 345578999999999865 678999999999999999999999998766543322211100000
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. ..+ ....+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 249 --~-~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 --Q-YGF---------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CC---------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred --c-ccc---------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 000 011234689999999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.15 Aligned_cols=270 Identities=22% Similarity=0.240 Sum_probs=202.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC---CcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS---GSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~l~ 234 (665)
++|++++.||+|+||.||+|++. ++.||||++.... .......+|+.+|++++|||||++++++.... ..+|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 47999999999999999999874 7899999997542 23344567999999999999999999988753 2479
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC----------CccccCCCcccEEEcCCCcEEEEeccc
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR----------GILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~----------gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
+||||+.++.+..+.... .+++.+++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999875554444333 599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC-CCcccccccccccCcccccCC----cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 006004 305 ATTYDPSQN-LPLTSRVVTLWYRAPELLLGA----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 305 A~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~----~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
+..+..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+................+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 987754332 223446899999999999763 456778999999999999999999998765432222222222233
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+....... ...+..+ ... .....++.+.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~--~~~~~~~--~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 258 SLEDMQEVVVHK--KKRPVLR--DYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CHHHHHHHHTTS--CCCCCCC--GGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhhhhhcc--cCCCCcc--ccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 332222111000 0000000 000 00123456999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.94 Aligned_cols=248 Identities=17% Similarity=0.234 Sum_probs=208.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~l 235 (665)
.++|++++.||+|+||.||+|++ +++.||||++..........+.+.+|+.++++++||||+++++++... ...+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 45799999999999999999998 488999999988776777778899999999999999999999998875 357899
Q ss_pred EEEeccc-cchhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 236 VFEYMEH-DLAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g-~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999997 4545554433 25899999999999999999999999 99999999999999999999999998765332
Q ss_pred CCCCcccccccccccCcccccCCc--ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGAT--KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~--~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 230 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---------- 230 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----------
Confidence 3457899999999998632 23348999999999999999999999988877766654421110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 -----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112368899999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.48 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=197.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC--HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD--PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
.++|++.+.||+|+||.||+|++ +|+.||||+++..... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ceE
Confidence 45899999999999999999997 4889999998754321 233567889999999999999999999988754 689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC---ccccCCCcccEEEcC--------CCcEEEEecc
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG---ILHRDIKGSNLLINN--------AGVLKIGDFG 303 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g---IiHrDLKPeNILld~--------~g~lKL~DFG 303 (665)
+||||+.++.+..+... ..+++.+++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999998777666543 47999999999999999999999999 999999999999986 7789999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
++..+.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 232 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA----- 232 (271)
T ss_dssp C----------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC-----
T ss_pred ccccccccc---ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC-----
Confidence 998765432 234578999999999886 56899999999999999999999999998877666554331100
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ----------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01123578899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=360.45 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=210.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..++..||+|++.... ...+.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CEEEE
Confidence 457999999999999999999999999999999997543 34566889999999999999999999987754 78999
Q ss_pred EEecccc-chhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHD-LAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++ |...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999964 4444443 3346999999999999999999999999999999999999999999999999999877544433
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------------- 230 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------- 230 (288)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------
T ss_pred cccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------------
Confidence 3444567889999999976 568999999999999999999 9999998876655555433110
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 ------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112367899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.16 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=207.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+.|++++..+..+......+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 45899999999999999999999999999999998765432 24678999999999999887777776666688999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.++|...+......+++.++..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++........
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9999767777766555679999999999999999999999999999999999999 4889999999999988654332
Q ss_pred C------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhHH
Q 006004 314 L------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 314 ~------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~kI~~~~g~p~~~~~ 384 (665)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+. .+.+..+.......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 237 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----- 237 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----
T ss_pred ccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----
Confidence 1 1345679999999999986 5689999999999999999999999987432 22333332211000
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
........+|+.+.+||.+||+.||.+|||+.++++
T Consensus 238 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 -------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011223468999999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=361.52 Aligned_cols=247 Identities=19% Similarity=0.245 Sum_probs=201.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCC-------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETG-------KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS 228 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~ 228 (665)
..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4568999999999999999999998877 469999986543 3445678899999999999999999999987
Q ss_pred cCCcEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc--------EEE
Q 006004 229 RSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV--------LKI 299 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~--------lKL 299 (665)
.. ..|+||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++. +||
T Consensus 84 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 84 GD-ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp TT-CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CC-CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 55 67999999986 455555554445999999999999999999999999999999999999998887 999
Q ss_pred EecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCC
Q 006004 300 GDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGS 378 (665)
Q Consensus 300 ~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~kI~~~~g~ 378 (665)
+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+....... .....
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~- 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRH- 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTC-
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhccC-
Confidence 99999875432 234568999999999987567899999999999999999954 55555554433322 22100
Q ss_pred CChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 379 PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 379 p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++.+.+||.+||+.||.+|||+.++++|
T Consensus 236 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 ----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1112457789999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.05 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=204.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH--HH---HHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP--ES---VRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~---~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++.+.||+|+||.||+|++..+++.||||++....... .. .+.+.+|+.++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 458999999999999999999999999999999987544321 11 167889999999999999999999986543
Q ss_pred cEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCc-----EEEEecc
Q 006004 232 SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGV-----LKIGDFG 303 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~-----lKL~DFG 303 (665)
++||||+.+ ++...+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 799999985 565667666678999999999999999999999999 999999999999988876 9999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccC-CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLG-ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQ--MHKIFKLCGSPS 380 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~-~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~--l~kI~~~~g~p~ 380 (665)
++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+. ...+... +.
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~-- 247 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL-- 247 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC--
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC--
Confidence 9985432 2345689999999999842 35678999999999999999999999987654332 2222221 00
Q ss_pred hhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+ .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ---------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 ---------------RP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 112367899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.98 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=204.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+..+.......|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 45899999999999999999999999999999987654322 23678999999999998888877776666688999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||+.+++...+......+++.++..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999777777766556679999999999999999999999999999999999999 7889999999999988754322
Q ss_pred ------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhHH
Q 006004 314 ------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV---EQMHKIFKLCGSPSEDYW 384 (665)
Q Consensus 314 ------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~---e~l~kI~~~~g~p~~~~~ 384 (665)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. +.+..+......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 236 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------ 236 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH------
T ss_pred CccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc------
Confidence 12335678999999999986 56899999999999999999999999875432 222222221000
Q ss_pred hhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 385 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.........+++.+.+||.+||+.||.+|||+.++++
T Consensus 237 ------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 ------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0111223468999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=364.17 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=207.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 35799999999999999999985 4577899999997543 445566788999999999 7999999999988766
Q ss_pred CcEEEEEEeccccch-hhhcCCCC---------------CCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC
Q 006004 231 GSLYLVFEYMEHDLA-GLATTPGI---------------KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll-~~~~~~~~---------------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~ 294 (665)
..+|+||||+.++.+ ..+..... .+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 678999999997544 44433322 28999999999999999999999999999999999999999
Q ss_pred CcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 006004 295 GVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKI 372 (665)
Q Consensus 295 g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI 372 (665)
+.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+...
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999987644322 12234567899999999976 568999999999999999998 99999887654444333
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+ .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 264 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 264 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211000 1123578899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=373.69 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=209.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET-------GKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
++|++.+.||+|+||.||+|++..+ +..||||+++.. ........+.+|+.+++++ +||||+++++++...
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 5799999999999999999997543 357999999754 3455667789999999999 999999999999875
Q ss_pred CCcEEEEEEeccccch-hhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHDLA-GLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll-~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+||||||+.++.+ ..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 148 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 148 G-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred C-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 4 78999999987444 4443322 35999999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987654322 22344467899999999986 678999999999999999999 9999999887766665
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+..... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 306 ~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 306 LKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543210 01123678999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.21 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred CCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~ 231 (665)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3579999999999999999999 6678999999998743 355667789999999999999999999988654 33
Q ss_pred cEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+|+||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 68999999976 55555555555699999999999999999999999999999999999999999999999999987644
Q ss_pred CCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh--
Q 006004 311 SQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-- 386 (665)
Q Consensus 311 ~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~-- 386 (665)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... ... ..+......+..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~---~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR---MIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---HHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---hhcCccccchhHHH
Confidence 322 12233457888999999986 56899999999999999999999988653221 111 111111100000
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......... .......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000000 01112468899999999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=378.62 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=209.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ...+....+.+|+.+|++++||||+++++++.... .+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-SCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-CcEEE
Confidence 45799999999999999999999999999999998743 34455667889999999999999999999987654 78999
Q ss_pred EEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+.+ +|...+...+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999986 5555555445569999999999999999999999999999999999999999999999999998754321111
Q ss_pred -cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 316 -LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 316 -~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+....+......
T Consensus 271 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 334 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL--------------- 334 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---------------
T ss_pred cCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 122245788999999976 578999999999999999998 99999998877665554331100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 335 -------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 -------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011357889999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=367.58 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=200.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhC----CCCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKL----DHPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIV~l~~~~~~ 228 (665)
.++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 357999999999999999999999999999999997654322 1223456799999998 89999999999877
Q ss_pred cCCcEEEEEEe-ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc-CCCcEEEEecccce
Q 006004 229 RSGSLYLVFEY-MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLAT 306 (665)
Q Consensus 229 ~~~~l~lV~Ey-~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld-~~g~lKL~DFGlA~ 306 (665)
.. ..++|||| +.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 110 ~~-~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 110 QE-GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred CC-eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 54 68999999 66654444444445799999999999999999999999999999999999999 88999999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
.+.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+... +....
T Consensus 189 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~---------- 249 (312)
T 2iwi_A 189 LLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE---------- 249 (312)
T ss_dssp ECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC----------
T ss_pred hcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc----------
Confidence 875432 34567899999999988655556799999999999999999999975321 11100
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 250 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 -------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 01123578999999999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.57 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=199.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEE----EEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIV----ALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||.||+|++..+++.+ |+|.++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--C
Confidence 457999999999999999999998888765 677665332 234456788999999999999999999998864 4
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.++||||+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 7899999986 455555555667999999999999999999999999999999999999999999999999999877543
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred cccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-----------
Confidence 322 2233456889999999986 678999999999999999999 99999988766555444321100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+..+.+||.+||..||.+|||+.+++++
T Consensus 239 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123578899999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.21 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=208.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++. +++.||+|++....... +.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEEE
Confidence 357999999999999999999986 67889999998654332 45789999999999999999999988754 78999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||++++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999865 445555555679999999999999999999999999999999999999999999999999998764322222
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---------------- 224 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------- 224 (267)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------
T ss_pred cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC----------------
Confidence 234467889999999976 568999999999999999999 89999998877776665432100
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 225 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 ------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112468899999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.18 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=208.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++ ..+++.||||+++... .....+.+.+|+.+|++| +||||+++++++....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 5799999999999999999985 4578899999997543 344567789999999999 9999999999998754
Q ss_pred cEEEEEEeccc-cchhhhcCCC-----------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPG-----------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~-----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
.+|+||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 78999999987 4444444332 24899999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 999999999999877544322 1234467889999999876 578999999999999999999 9999998776555554
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+......+ .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 43321100 0113578899999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.82 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=188.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeee-------cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVT-------SR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~-------~~ 229 (665)
.+|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3799999999999999999999999999999998654 3455667889999999995 999999999884 22
Q ss_pred CCcEEEEEEeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCcEEEEecccc
Q 006004 230 SGSLYLVFEYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
...+|+||||+.|+|...+.. ....+++.+++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 345899999999988776653 3457999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCCCC-----------CcccccccccccCccccc--CCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 006004 306 TTYDPSQNL-----------PLTSRVVTLWYRAPELLL--GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372 (665)
Q Consensus 306 ~~~~~~~~~-----------~~~~~~gT~~Y~APE~l~--~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI 372 (665)
..+...... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+......+...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 265 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence 876543221 112456899999999984 2356889999999999999999999999765443222111
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
.. .......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 266 ~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 266 YS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00 0011346677899999999999999999999998744
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.50 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=205.1
Q ss_pred CCeeEEE-EeeccCceEEEEEE--ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKID-KIGQGTYSSVYKAR--DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~-~LG~G~fg~Vy~a~--~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|++.+ .||+|+||.||+|. +..+++.||||+++.........+.+.+|+.+++.++||||+++++++. ...+|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCcE
Confidence 4799998 99999999999995 4567889999999866544555677899999999999999999999984 34689
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
+||||+.++.+..+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999997665555554557999999999999999999999999999999999999999999999999999887543321
Q ss_pred --CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 315 --PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 315 --~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.... .
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~------------ 238 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R------------ 238 (291)
T ss_dssp EEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C------------
T ss_pred ccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C------------
Confidence 1222346789999999976 568999999999999999999 999999988776655553310 0
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 --------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112367899999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.11 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=209.9
Q ss_pred CCeeEEE-EeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKID-KIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|.+++ .||+|+||.||+|++. .++..||||+++... .....+.+.+|+.++++|+||||+++++++.. ..+|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcE
Confidence 4688887 9999999999999864 467889999997643 45567788999999999999999999999853 3689
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
+||||+.++.+. .+......+++.++..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999975554 4444556799999999999999999999999999999999999999999999999999988754322
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.... .
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~----------- 231 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R----------- 231 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--C-----------
T ss_pred eeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--c-----------
Confidence 11233456899999999976 568999999999999999998 999999988777666554311 0
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
......+++.+.+||.+||..||.+|||+.+++++.+
T Consensus 232 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ---------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0112368899999999999999999999999998744
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.70 Aligned_cols=252 Identities=18% Similarity=0.264 Sum_probs=204.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CC
Confidence 4579999999999999999999654 34569999987543 445667789999999999999999999998753 56
Q ss_pred EEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.++.+ ..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 899999996544 4444445569999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------------- 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------------- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-------------
T ss_pred ccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-------------
Confidence 333344567889999999875 578999999999999999998 99999887766665555432110
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ---------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0113578899999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.83 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=204.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++ ..++..||||+++... .....+.+.+|+.+|++| +||||+++++++....
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC-
Confidence 5799999999999999999997 3466789999997543 233456788999999999 9999999999988754
Q ss_pred cEEEEEEeccc-cchhhhcCCC----------------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCccc
Q 006004 232 SLYLVFEYMEH-DLAGLATTPG----------------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSN 288 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~----------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeN 288 (665)
.+||||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 78999999987 4545444432 237999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChH
Q 006004 289 LLINNAGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEV 366 (665)
Q Consensus 289 ILld~~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 366 (665)
|||+.++.+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||+||+|++ |..||.+....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999876433221 2234467889999999876 568999999999999999998 99999987765
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
+.+..+...... . .....+++.+.+||.+||..||.+|||+.++++|-.
T Consensus 282 ~~~~~~~~~~~~------------------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 282 ANFYKLIQNGFK------------------M---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHHHTTCC------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCC------------------C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 555544331100 0 111357889999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=359.91 Aligned_cols=254 Identities=19% Similarity=0.264 Sum_probs=200.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC---
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG--- 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~--- 231 (665)
++|++.+.||+|+||.||+|++.. ++..||||+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 579999999999999999998765 55689999998776666777889999999999999999999999876532
Q ss_pred -cEEEEEEeccccchhhhc------CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 232 -SLYLVFEYMEHDLAGLAT------TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 232 -~l~lV~Ey~~g~ll~~~~------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
..|+||||+.++.+..+. .....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 469999999975544333 2345799999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 305 ATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 305 A~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
+..+..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 267 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR----- 267 (313)
T ss_dssp C----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----
T ss_pred ceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-----
Confidence 987643321 12233457889999999976 678999999999999999999 9999998887766665543210
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 -----------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123678899999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=356.39 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=204.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++....+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 346999999999999999999976543 368999887532 4556677899999999999999999999876655678
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999998 5555555556679999999999999999999999999999999999999999999999999998764322
Q ss_pred C---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 N---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 251 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------- 251 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----------
T ss_pred hhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----------
Confidence 1 12334567889999999976 578999999999999999999 77888887766665555432110
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 252 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011347889999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.51 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=203.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcE----EEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKI----VALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||.||+|++..+++. ||+|.+.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 45899999999999999999999988876 6777664332 12223446789999999999999999998864 36
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|+||||+.+ +|...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 8999999986 555555555568999999999999999999999999999999999999999999999999999987544
Q ss_pred CC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 235 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER------------ 235 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB------------
T ss_pred cccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------
Confidence 32 22345567889999999986 568999999999999999999 9999998876665555433110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++.++.+||.+||..||.+|||+.+++++
T Consensus 236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112467788999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=364.10 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=205.2
Q ss_pred CccCCCCCeeEEEEeeccCceEEEEEEECCCCcEE--EEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 006004 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIV--ALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTS 228 (665)
Q Consensus 152 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~ 228 (665)
|.....++|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+|+++ +||||+++++++..
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 33344568999999999999999999999999865 999887432 234456688999999999 99999999999987
Q ss_pred cCCcEEEEEEeccc-cchhhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc
Q 006004 229 RSGSLYLVFEYMEH-DLAGLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN 292 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g-~ll~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld 292 (665)
.. .+|+||||+++ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+
T Consensus 98 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 98 RG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp TT-EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CC-ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 54 79999999987 4444444322 3699999999999999999999999999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 293 NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 293 ~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCeEEEcccCcCccccccc--cccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 99999999999997543221 1233456889999999876 568999999999999999998 9999999887666555
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.... .. .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGY-------------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTC-------------------CC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC-------------------CC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43210 00 1123578999999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=382.22 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=196.9
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+|++.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.+.. .+||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQ-FQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCC-EEEEEE
Confidence 699999999999999764 3456889999999965332 2246899999999 7999999999988754 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---C--CcEEEEecccceecCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---A--GVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~--g~lKL~DFGlA~~~~~~~ 312 (665)
|||.++|...+......+++.++..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|..+....
T Consensus 98 E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 98 ELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp ECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred ECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99999888888877767788889999999999999999999999999999999953 2 358899999998765332
Q ss_pred C--CCcccccccccccCcccccC--CcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 313 N--LPLTSRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 313 ~--~~~~~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
. ......+||++|+|||++.+ ...++.++|||||||++|+|++ |.+||........ ..+. +......
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~~~~---- 249 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACSLDC---- 249 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCCCTT----
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCCccc----
Confidence 1 22345689999999999974 3567889999999999999999 8999966543322 2211 1111000
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
. ......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 250 ----------~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 ----------L--------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------S--------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------c--------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0 001134566899999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.93 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=205.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||.||+|++. ++..||||++...... .+.+.+|+++|++++||||+++++++.. +.+|+||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~ 86 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT 86 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEE
Confidence 57999999999999999999975 5678999999765433 3557899999999999999999998864 3589999
Q ss_pred EeccccchhhhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAGLATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||+.++.+..+.... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999875555444432 269999999999999999999999999999999999999999999999999998875443323
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 167 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------- 228 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------- 228 (279)
T ss_dssp CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred ccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-----------------
Confidence 334466889999999975 568999999999999999999 9999999888776666543110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 229 --~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 --M---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --C---------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 112357899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.88 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=206.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.-.|++.+.||+|+||.||+|++..++. .||+|++.... .....+.+.+|+.++++++||||+++++++....+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 3458888999999999999999766554 79999986432 4456677899999999999999999999998776566
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
++||||+.+ ++...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999975 5555665556679999999999999999999999999999999999999999999999999998654321
Q ss_pred ---CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 ---NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ---~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
........+|+.|+|||++.+ ..++.++|||||||++|+|++ +.+||...+..+....+......
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---------- 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---------- 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC----------
T ss_pred ccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC----------
Confidence 122334567999999999976 578999999999999999999 55667766665555554332110
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 248 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012357889999999999999999999999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=361.67 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-------CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-------ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+++++ +||||+++++++...
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 57999999999999999999986 467789999987543 455667789999999999 899999999998775
Q ss_pred CCcEEEEEEeccccch-hhhcCCC---------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHDLA-GLATTPG---------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll-~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+|+||||+.++.+ ..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 114 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp S-CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred C-ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 4 78999999987544 4443322 24899999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 99999999999987654322 11233456889999999876 568999999999999999999 9999999887766665
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+..... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 272 ~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 272 LKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 543210 01123578899999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.53 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=208.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC-
Confidence 357999999999999999999886 467889999987543 3445567889999999999999999999987754
Q ss_pred cEEEEEEecccc-chhhhcCC---------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEe
Q 006004 232 SLYLVFEYMEHD-LAGLATTP---------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g~-ll~~~~~~---------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~D 301 (665)
.+|+||||+.++ |...+... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence 789999999874 44433321 13579999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....-
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 258 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-- 258 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--
T ss_pred CccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc--
Confidence 999986543221 11233467899999999876 568999999999999999999 8999999887776665543110
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......+++.+.+||.+||..||.+|||+.++++|
T Consensus 259 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 --------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123678999999999999999999999999997
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=356.63 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=202.4
Q ss_pred CCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~ 232 (665)
..|++++.||+|+||.||+|+ +..+++.||||+++... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 369999999999999999999 67789999999997543 233456788999999999999999999998865 246
Q ss_pred EEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+|+||||+.++ |...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 89999999874 44554455557999999999999999999999999999999999999999999999999999887544
Q ss_pred CC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh-hhc
Q 006004 312 QN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR-KSK 388 (665)
Q Consensus 312 ~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~-~~~ 388 (665)
.. .......||..|+|||++.+ ..++.++|||||||++|+|++|..|+.... . .+....+........ ...
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCGGGHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCcccccCHHHHH
Confidence 32 12334568899999999986 568899999999999999999998764321 1 111111222111100 000
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....... .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000000 01122468899999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=381.06 Aligned_cols=274 Identities=23% Similarity=0.355 Sum_probs=207.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-CcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-GSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~~l~lV 236 (665)
++|++.+.||+|+||.||+|++..+|+.||||+++.... ....+.+.+|+++|++++||||+++++++.... ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 479999999999999999999999999999999975432 223456789999999999999999999987653 368999
Q ss_pred EEeccccchhhhcCCC---CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE----cCCCcEEEEecccceecC
Q 006004 237 FEYMEHDLAGLATTPG---IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI----NNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~---~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl----d~~g~lKL~DFGlA~~~~ 309 (665)
|||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999875554444332 239999999999999999999999999999999999999 778889999999998875
Q ss_pred CCCCCCcccccccccccCcccccCC-------cccCcccchhhhHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCC
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGA-------TKYGAAIDMWSAGCILAELFAGKPIMPGR----TEVEQMHKIFKLCGS 378 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~-------~~~~~~sDIWSLG~iLyeLltG~~pF~g~----~~~e~l~kI~~~~g~ 378 (665)
... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+. ...+.+.++.. +.
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~ 243 (396)
T 4eut_A 168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GK 243 (396)
T ss_dssp CGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SC
T ss_pred CCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CC
Confidence 432 23456799999999998641 46789999999999999999999999753 33455555543 22
Q ss_pred CChhHHhhhcccccc--CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 379 PSEDYWRKSKSAHAT--SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 379 p~~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
| ...|......... .+....+. .......++..+.+||.+||..||++|+|+.+++++
T Consensus 244 p-~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 244 P-SGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp C-TTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred C-cccchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2 2222111100000 00000110 011123466788999999999999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=363.00 Aligned_cols=257 Identities=20% Similarity=0.306 Sum_probs=205.0
Q ss_pred CCCeeEEEEeeccCceEEEEEE-----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ 231 (665)
.++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 4589999999999999999999 56678899999996433 4455667889999999999999999999988754
Q ss_pred cEEEEEEecccc-chhhhcCCC------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEe
Q 006004 232 SLYLVFEYMEHD-LAGLATTPG------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGD 301 (665)
Q Consensus 232 ~l~lV~Ey~~g~-ll~~~~~~~------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~D 301 (665)
.+||||||+.++ |...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. +..+||+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 689999999764 444444322 35899999999999999999999999999999999999994 44699999
Q ss_pred cccceecCCCC-CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 006004 302 FGLATTYDPSQ-NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSP 379 (665)
Q Consensus 302 FGlA~~~~~~~-~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p 379 (665)
||++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~- 264 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM- 264 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC-
Confidence 99997653222 122334577999999999876 568999999999999999998 99999998877766655432100
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.....+++.+.+||.+||..||.+|||+.++++|.|+-
T Consensus 265 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 265 ---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11235788999999999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=371.67 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=197.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC---CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|++|+||||+++++++.... .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-PV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-ce
Confidence 347999999999999999999987 467789999997543 4556677899999999999999999999987654 78
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
||||||+++ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999976 4555555555679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCc--ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 NLPL--TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~~~--~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.... ....+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+.+..+......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~----------- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL----------- 269 (373)
T ss_dssp ------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-----------
T ss_pred ccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 2111 22245788999999986 578999999999999999998 99999998877766665432100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++..+.+||.+||..||.+|||+.++++
T Consensus 270 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 -----------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 011257889999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=363.26 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=199.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEE----EEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIV----ALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||.||+|++..+++.| |+|.+.... .....+.+.+|+.+|++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--C
Confidence 458999999999999999999999888765 666654332 233456788999999999999999999998864 4
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.++||||+.+ ++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 7899999986 455555555667999999999999999999999999999999999999999999999999999876433
Q ss_pred CC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred cccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 22 12233456889999999986 678999999999999999999 99999988776655554331100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....++.++.+||.+||..||.+|||+.++|+
T Consensus 239 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 -----------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=370.07 Aligned_cols=263 Identities=18% Similarity=0.167 Sum_probs=200.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-----CcEEEEEEEecCCCCH-HHH--------HHHHHHHHHHHhCCCCCccee
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-----GKIVALKKVRFANMDP-ESV--------RFMAREIHILRKLDHPNVMKL 222 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~-~~~--------~~~~~Ei~iL~~L~HpnIV~l 222 (665)
.++|++++.||+|+||.||+|++..+ ++.||||++....... ... ..+..|+.+++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34799999999999999999998765 5789999987543100 001 123356667778889999999
Q ss_pred eeeeecc---CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc--CCCcE
Q 006004 223 EGLVTSR---SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN--NAGVL 297 (665)
Q Consensus 223 ~~~~~~~---~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld--~~g~l 297 (665)
++++... ...+||||||+.++|..++......+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 9998764 235899999996666666666656899999999999999999999999999999999999999 88999
Q ss_pred EEEecccceecCCCCC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 006004 298 KIGDFGLATTYDPSQN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHK 371 (665)
Q Consensus 298 KL~DFGlA~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~k 371 (665)
||+|||++..+..... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999987643221 11244569999999999986 5689999999999999999999999986443332222
Q ss_pred HHHh-cCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 372 IFKL-CGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 372 I~~~-~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.... .......... .++ ....+++++.+||..||..||.+||++.++++
T Consensus 273 ~~~~~~~~~~~~~~~-----------------~~~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMD-----------------KCF--PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHH-----------------HHS--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHH-----------------Hhc--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111 0000000000 000 01468999999999999999999999998876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.94 Aligned_cols=254 Identities=32% Similarity=0.487 Sum_probs=194.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC-CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN-MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++.+.||+|+||.||+|++..+|+.||||+++... ........+.+|+.++++++||||+++++++.... .+|+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-cEEE
Confidence 457999999999999999999999999999999998643 34566777899999999999999999999988754 7999
Q ss_pred EEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 236 VFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
||||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999854443332 3457999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE--VEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+....+.. ...+
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~---------- 256 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP---------- 256 (310)
T ss_dssp ----------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC----------
T ss_pred Cc-cccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC----------
Confidence 22 2334578999999999876 5789999999999999999999999976532 222222211 1100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+ .....+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 -------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 257 -------P---------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------C---------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------C---------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0013578999999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=377.45 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=194.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~l 235 (665)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.... .+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDR-FLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-EEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-eEEE
Confidence 346777899999999999875 4567999999998743 234567899999886 8999999999987754 7999
Q ss_pred EEEeccccchhhhcCCCCC------CChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC-------------Cc
Q 006004 236 VFEYMEHDLAGLATTPGIK------FTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA-------------GV 296 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~------lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~-------------g~ 296 (665)
|||||+|+|...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+ +.
T Consensus 87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999998777766544311 2445678899999999999999999999999999999754 48
Q ss_pred EEEEecccceecCCCCCC---CcccccccccccCcccccC------CcccCcccchhhhHHHHHHHHh-CCCCCCCCChH
Q 006004 297 LKIGDFGLATTYDPSQNL---PLTSRVVTLWYRAPELLLG------ATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEV 366 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~~---~~~~~~gT~~Y~APE~l~~------~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 366 (665)
+||+|||++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999987543321 2334589999999999865 2568999999999999999999 99999776544
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
+ ..+......... . + ......+++++.+||.+||..||.+|||+.++|+||||..
T Consensus 247 ~--~~i~~~~~~~~~-------------~----~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDE-------------M----K-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCC-------------C----T-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCccc-------------c----c-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 222221100000 0 0 0001245788999999999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.56 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=202.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCC----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETG----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
..+|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|+.++++++||||+++++++.... .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-P 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC-C
Confidence 357999999999999999999987653 459999997543 4455667889999999999999999999987654 7
Q ss_pred EEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
+||||||+.++ |...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999874 44455455567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 312 QNL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 312 ~~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---------- 269 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---------- 269 (333)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred cccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC----------
Confidence 221 1222346889999999976 578999999999999999998 99999988877766665432100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+||++.+++++
T Consensus 270 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.38 Aligned_cols=268 Identities=23% Similarity=0.283 Sum_probs=204.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.... .+|+|
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 113 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN-EMILI 113 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-CCEEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-eEEEE
Confidence 45799999999999999999996 468999999886543 234567889999999999999999999987654 78999
Q ss_pred EEeccccchhhhcCCC----CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 237 FEYMEHDLAGLATTPG----IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||+.++.+..+.... ..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999875554443322 358999999999999999999999999999999999999999999999999998754322
Q ss_pred C-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 N-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+... ....... ..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~--~~ 265 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNG--QL 265 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTT--CC
T ss_pred ccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhccccc--cH
Confidence 2 22344568999999999876 57899999999999999999999999875432211111000 0000000 00
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCc
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp 441 (665)
.....+.. ........+..+.+||.+||..||.+|||+.+++++-
T Consensus 266 ~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSC-----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhh-----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000000 0111124567899999999999999999999999763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.25 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=196.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh--CCCCCcceeeeeeecc---CC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK--LDHPNVMKLEGLVTSR---SG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~---~~ 231 (665)
.++|++++.||+|+||.||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45899999999999999999987 6899999998643 23445667777777 7999999999986543 23
Q ss_pred cEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH--------hCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 232 SLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH--------SRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH--------~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
.+|+||||+.++.+..+... ..+++..+..++.||+.||.||| +.||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 58999999997555555443 37999999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCCC---CcccccccccccCcccccCCc-----ccCcccchhhhHHHHHHHHhC----------CCCCCCCC-
Q 006004 304 LATTYDPSQNL---PLTSRVVTLWYRAPELLLGAT-----KYGAAIDMWSAGCILAELFAG----------KPIMPGRT- 364 (665)
Q Consensus 304 lA~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~-----~~~~~sDIWSLG~iLyeLltG----------~~pF~g~~- 364 (665)
++......... .....+||+.|+|||++.+.. .++.++|||||||++|+|++| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99876443221 123458999999999997642 456799999999999999999 88886532
Q ss_pred ---hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 365 ---EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 365 ---~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..+.+..+....+.. +..+. .......++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQR-----------------PNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCCC-----------------CCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCCC-----------------CCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 223333332211100 00110 0011235678999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=383.74 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=209.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++..++..||||+++..... .+.+.+|+.+|++|+|||||++++++.... .+|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC-cEEEE
Confidence 35799999999999999999999999999999999765433 456889999999999999999999987754 78999
Q ss_pred EEeccc-cchhhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEH-DLAGLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||.+ +|...+.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999996 45454443 3346999999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+++.|+|||++.+ ..++.++|||||||+||||++ |.+||.+.+..+....+.....
T Consensus 375 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------- 437 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------------- 437 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------
T ss_pred ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2334456789999999976 578999999999999999999 9999999876665554432110
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 438 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112367899999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=360.54 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=206.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc-----EEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK-----IVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~ 230 (665)
.++|++.+.||+|+||.||+|++..+++ .||+|++.... .....+.+.+|+.+|++| +||||+++++++....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3579999999999999999999987764 79999997543 445567789999999999 8999999999987754
Q ss_pred CcEEEEEEeccc-cchhhhcCC-------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc
Q 006004 231 GSLYLVFEYMEH-DLAGLATTP-------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV 296 (665)
Q Consensus 231 ~~l~lV~Ey~~g-~ll~~~~~~-------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~ 296 (665)
.+|+||||+.+ +|...+... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.
T Consensus 124 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 124 -PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp -SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred -ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 78999999987 444443321 335899999999999999999999999999999999999999999
Q ss_pred EEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 006004 297 LKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFK 374 (665)
Q Consensus 297 lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~ 374 (665)
+||+|||++..+...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+..
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999876433221 1234467889999999886 568999999999999999998 9999998776555555443
Q ss_pred hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 375 ~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+ ......++.+.+||.+||+.||.+|||+.++++
T Consensus 282 ~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 282 DGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 21100 011246888999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=364.42 Aligned_cols=259 Identities=17% Similarity=0.156 Sum_probs=196.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECC---CCcEEEEEEEecCCCCH-H--------HHHHHHHHHHHHHhCCCCCcceeeee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDP-E--------SVRFMAREIHILRKLDHPNVMKLEGL 225 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~-~--------~~~~~~~Ei~iL~~L~HpnIV~l~~~ 225 (665)
++|++.+.||+|+||.||+|++.. ++..||||++....... . ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 78899999987543211 0 11235678899999999999999999
Q ss_pred eecc---CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC--cEEEE
Q 006004 226 VTSR---SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG--VLKIG 300 (665)
Q Consensus 226 ~~~~---~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g--~lKL~ 300 (665)
+... ...+||||||+.++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 8763 347899999994455554443 34899999999999999999999999999999999999999887 99999
Q ss_pred ecccceecCCCCC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 006004 301 DFGLATTYDPSQN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR--TEVEQMHKI 372 (665)
Q Consensus 301 DFGlA~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~--~~~e~l~kI 372 (665)
|||++..+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+. +........
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 9999987643211 12245579999999999986 57899999999999999999999999653 222222222
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhc--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETF--RNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.......+... .... ..+++.+.+||.+||..||.+|||+.++++.
T Consensus 275 ~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 275 TNLLDELPQSV----------------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHTTTHHH----------------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HhhcccccHHH----------------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22111111111 1111 2689999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=361.78 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=205.4
Q ss_pred CCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~ 231 (665)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++|+||||+++++++... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 3579999999999999999999 5778999999999754 355567789999999999999999999988643 45
Q ss_pred cEEEEEEeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+||||||++++.+ ..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 68999999976544 44444345699999999999999999999999999999999999999999999999999998754
Q ss_pred CCC--CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hhHHhh
Q 006004 311 SQN--LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS--EDYWRK 386 (665)
Q Consensus 311 ~~~--~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~--~~~~~~ 386 (665)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC--ERDVPALSRLLEL 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc--ccccccHHHHHHH
Confidence 332 12334568899999999876 568999999999999999999999987643321110000 00000 000000
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.. ... .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~----~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LE----EGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hh----ccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 000 011124688999999999999999999999999654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=378.02 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=205.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++. ++..||||+++.... ..+.+.+|+.+|++|+|||||++++++.. ..+|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC--CccEEE
Confidence 357999999999999999999985 467899999986543 35568899999999999999999998863 368999
Q ss_pred EEeccccch-hhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLA-GLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||.++.+ ..+... ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999987544 444432 236899999999999999999999999999999999999999999999999999876432221
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+|+.|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+......+
T Consensus 341 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------- 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------------- 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------------
T ss_pred ccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 2233356788999999976 568999999999999999999 999999998888777765421110
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+++.+.+||.+||..||.+|||+.+++.
T Consensus 406 --------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 --------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11357899999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.83 Aligned_cols=269 Identities=22% Similarity=0.262 Sum_probs=202.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++ .+|+.||||++...... .....+.+|+.+++.++||||+++++++.... ..|+|
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 105 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLV 105 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-CCEEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCC-ceEEE
Confidence 35799999999999999999985 46899999998754321 12225789999999999999999999998755 67999
Q ss_pred EEeccccchhh-hcCC---CCCCChhHHHHHHHHHHHHHHHHHhC---CccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 237 FEYMEHDLAGL-ATTP---GIKFTEPQIKCYMQQLLRGLEHCHSR---GILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 237 ~Ey~~g~ll~~-~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~---gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
|||+.++.+.. +... ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 99998755443 3332 23499999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCChhHHh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT----EVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~----~~e~l~kI~~~~g~p~~~~~~ 385 (665)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.... ....+....... ...
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~---- 258 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LKE---- 258 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TSS----
T ss_pred cccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hhc----
Confidence 544444455679999999999976 568999999999999999999999995211 000011110000 000
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
....... ............+..+.+||.+||..||.+|||+.++|+|-.-
T Consensus 259 ----~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 259 ----KKLEALV----DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ----CCSTTSS----CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ----hhhhhhc----ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000000 0000011112345789999999999999999999999998664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=367.45 Aligned_cols=254 Identities=14% Similarity=0.167 Sum_probs=200.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCC--------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcce--------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLET--------GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMK-------- 221 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~-------- 221 (665)
++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 5799999999999999999999874 889999999753 24678999999999999998
Q ss_pred -------eeeeeeccCCcEEEEEEeccccchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 222 -------LEGLVTSRSGSLYLVFEYMEHDLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 222 -------l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
+++++......+||||||+.++|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred CccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 566666545689999999955666665543 357999999999999999999999999999999999999999
Q ss_pred CC--cEEEEecccceecCCCCC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC-
Q 006004 294 AG--VLKIGDFGLATTYDPSQN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT- 364 (665)
Q Consensus 294 ~g--~lKL~DFGlA~~~~~~~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~- 364 (665)
++ .+||+|||++..+..... .......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+..
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 98 999999999987643221 12244589999999999986 578999999999999999999999998764
Q ss_pred hHHHHHHHHH-hcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 365 EVEQMHKIFK-LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 365 ~~e~l~kI~~-~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
..+.+..... ....+.. + . .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~-~------------~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGP-F------------V-------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHHHSCCC-E------------E-------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhccCChhh-h------------h-------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 3333333222 1111000 0 0 000112367899999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=351.46 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=201.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec---------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS--------- 228 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--------- 228 (665)
.+|++++.||+|+||.||+|++..+++.||||+++... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 36999999999999999999999999999999997543 235689999999999999999998854
Q ss_pred ------cCCcEEEEEEeccccch-hhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEE
Q 006004 229 ------RSGSLYLVFEYMEHDLA-GLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIG 300 (665)
Q Consensus 229 ------~~~~l~lV~Ey~~g~ll-~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~ 300 (665)
....+|+||||++++.+ ..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 12358999999998544 44432 23579999999999999999999999999999999999999999999999
Q ss_pred ecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 006004 301 DFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPS 380 (665)
Q Consensus 301 DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~ 380 (665)
|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+..
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~------ 233 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD------ 233 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT------
T ss_pred cchhheeccccc--cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc------
Confidence 999998875432 2344578999999999986 568999999999999999999998874211 11111100
Q ss_pred hhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 381 EDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
. .....++..+.+||.+||..||.+|||+.++++|.|+-
T Consensus 234 ---------~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 234 ---------G----------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---------T----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------c----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01135788999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=374.12 Aligned_cols=245 Identities=21% Similarity=0.396 Sum_probs=202.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++|+|||||++++++....+.+||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3457999999999999999999874 7899999997543 345678999999999999999999998776557999
Q ss_pred EEEecccc-chhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 236 VFEYMEHD-LAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 236 V~Ey~~g~-ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||||.++ |...+...+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999874 444444333 247999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+++.|+|||++.+ ..++.++|||||||+||||++ |..||.+.+..+.+..+.....
T Consensus 344 ---~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------------- 404 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 404 (450)
T ss_dssp ------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---------------
T ss_pred ---cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 23367889999999986 678999999999999999998 9999998877666665533110
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 405 -------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 -------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112367899999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.15 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=198.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-CCc--EEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-TGK--IVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++++.||+|+||.||+|++.. +++ .||||+++.... ..+..+.+.+|+.++++++||||+++++++... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--Cc
Confidence 479999999999999999998643 333 689999876533 335567789999999999999999999998764 47
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
++||||+.+ ++...+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 999999986 5555555444579999999999999999999999999999999999999999999999999998875433
Q ss_pred CC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 NL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 244 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------- 244 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------
T ss_pred cchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC----------
Confidence 21 1233467889999999876 568999999999999999999 999999988877776664321100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 245 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 -----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123678999999999999999999999999973
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=372.82 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=204.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++.. +..||||+++..... .+.+.+|+.+|++|+||||+++++++.. ..+|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEE
Confidence 3579999999999999999999865 467999999865433 3457899999999999999999999865 368999
Q ss_pred EEeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++.+..+.. .+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 99998754444433 2346899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+.+..+......
T Consensus 337 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------- 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 400 (452)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2334456889999999886 578999999999999999999 99999999888777766432100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh--CcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~--Hp~f~~~ 446 (665)
.....+++.+.+||.+||..||.+|||+.++++ ..+|...
T Consensus 401 -------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 -------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 012357889999999999999999999999987 3666543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=351.88 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=193.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++ .++.||||++... ...+.+.+|+.+|++++||||+++++++.+ .+|+|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEE
Confidence 45799999999999999999997 4788999998632 345668899999999999999999998763 46999
Q ss_pred EEeccccchhhhcCCCC---CCChhHHHHHHHHHHHHHHHHHh---CCccccCCCcccEEEcCCCc-EEEEecccceecC
Q 006004 237 FEYMEHDLAGLATTPGI---KFTEPQIKCYMQQLLRGLEHCHS---RGILHRDIKGSNLLINNAGV-LKIGDFGLATTYD 309 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~---~gIiHrDLKPeNILld~~g~-lKL~DFGlA~~~~ 309 (665)
|||+.++.+..+..... .+++.++..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99998755544443332 37889999999999999999999 89999999999999998886 7999999998654
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhHHhhh
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV--EQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~--e~l~kI~~~~g~p~~~~~~~~ 387 (665)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.. +..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------- 222 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR-------- 222 (307)
T ss_dssp -----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC--------
T ss_pred cc----cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC--------
Confidence 32 234578999999999986 57899999999999999999999999864322 22222111 000
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh-----CcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR-----SEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~-----Hp~f~~~ 446 (665)
......+++.+.+||.+||..||.+|||+.++++ ..+|...
T Consensus 223 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 223 ------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp ------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 0112468899999999999999999999999998 4566543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.50 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~ 234 (665)
++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...+|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 4799999999999999999999999999999998653 345667788999999999999999999998632 33689
Q ss_pred EEEEeccccch-hhhcC---CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 235 LVFEYMEHDLA-GLATT---PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 235 lV~Ey~~g~ll-~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
+||||+.++.+ ..+.. .+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999998444 43332 356799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC--------CcccccccccccCcccccCCc--ccCcccchhhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCC
Q 006004 311 SQNL--------PLTSRVVTLWYRAPELLLGAT--KYGAAIDMWSAGCILAELFAGKPIMPGRTEV-EQMHKIFKLCGSP 379 (665)
Q Consensus 311 ~~~~--------~~~~~~gT~~Y~APE~l~~~~--~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~kI~~~~g~p 379 (665)
.... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... +.+......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---- 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---- 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC----
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc----
Confidence 1110 012345799999999987532 3789999999999999999999999531100 000111000
Q ss_pred ChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCc
Q 006004 380 SEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441 (665)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp 441 (665)
.. .......+++.+.+||.+||..||.+|||+.+++++-
T Consensus 263 --------------~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 --------------QL---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --------------C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------cC---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 00 0011235789999999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.16 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=197.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
...|++.+.||+|+||.||+|++..++ ..||+|.++... .....+.+.+|+.+|++++||||+++++++....+..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 346899999999999999999976443 468999886433 3455677899999999999999999999876555578
Q ss_pred EEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999987 5555555556679999999999999999999999999999999999999999999999999998764322
Q ss_pred C---CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 313 N---LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 313 ~---~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---------- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC----------
T ss_pred cccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 1 11233467889999999986 578999999999999999999 78899887765555544331100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 316 ------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 ------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.30 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=200.3
Q ss_pred eeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 160 FEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
|++++.||+|+||.||++. +..+++.||||+++.. ......+.+.+|+.+|++|+||||+++++++... ...+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4999999999999998875 4457899999999754 3455667789999999999999999999999875 35789
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC-
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~- 313 (665)
+||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999875555544433 499999999999999999999999999999999999999999999999999998754332
Q ss_pred -CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHH-hhhcccc
Q 006004 314 -LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW-RKSKSAH 391 (665)
Q Consensus 314 -~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~-~~~~~~~ 391 (665)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+......- .......
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHHHHHHHHHH
T ss_pred cccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchhHHHHHHHH
Confidence 12234467889999999986 5688999999999999999999999976432110 00011100000 0000000
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.... .......+++.+.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGE---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccc---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 01122468899999999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=370.74 Aligned_cols=248 Identities=18% Similarity=0.220 Sum_probs=191.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC------CHHHHHHHHHHHHHHHhCC---------CCCccee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM------DPESVRFMAREIHILRKLD---------HPNVMKL 222 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------~~~~~~~~~~Ei~iL~~L~---------HpnIV~l 222 (665)
++|++++.||+|+||+||+|++ +|+.||||+++.... .....+.+.+|+.+|+.|+ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4799999999999999999998 789999999986532 2233466889999999886 6666665
Q ss_pred eee-----------------eec------------cCCcEEEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHH
Q 006004 223 EGL-----------------VTS------------RSGSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLE 272 (665)
Q Consensus 223 ~~~-----------------~~~------------~~~~l~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~ 272 (665)
.++ |.. ....+||||||+.++ ++..+.. ..+++.+++.++.||+.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 554 332 145799999999865 6666644 46899999999999999999
Q ss_pred HHH-hCCccccCCCcccEEEcCCC--------------------cEEEEecccceecCCCCCCCcccccccccccCcccc
Q 006004 273 HCH-SRGILHRDIKGSNLLINNAG--------------------VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331 (665)
Q Consensus 273 ~LH-~~gIiHrDLKPeNILld~~g--------------------~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l 331 (665)
||| ++||+||||||+||||+.++ .+||+|||+|+..... ..+||+.|+|||++
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 999 99999999999999999887 8999999999976532 44899999999999
Q ss_pred cCCcccCcccchhhhHHH-HHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhc
Q 006004 332 LGATKYGAAIDMWSAGCI-LAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETF 409 (665)
Q Consensus 332 ~~~~~~~~~sDIWSLG~i-LyeLltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 409 (665)
.+.. +.++|||||+++ ++++++|..||.+..... ....+...... ... .....+
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~-----~~~~~~ 305 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-----------------KTK-----CNTPAM 305 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-----------------SSC-----CCSHHH
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-----------------Ccc-----cchhhh
Confidence 8633 889999998777 778899999985432211 12222211000 000 001123
Q ss_pred cCCcHHHHHHHHHhcccCcCCCcCHHHHH-hCcCCC
Q 006004 410 RNFPQSALALVDKLLTIEPENRGSAASAL-RSEFFK 444 (665)
Q Consensus 410 ~~~s~~a~dLI~~lL~~DP~~RpTa~eaL-~Hp~f~ 444 (665)
..+++++++||.+||.+| ||.|+| +||||+
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 457899999999999987 999999 999995
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.64 Aligned_cols=244 Identities=22% Similarity=0.404 Sum_probs=194.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||++.+ +|+.||||+++... ..+.+.+|+.++++++||||+++++++....+.+|+|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 45799999999999999999987 48899999987432 3456889999999999999999999876655578999
Q ss_pred EEecccc-chhhhcCCC-CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHD-LAGLATTPG-IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+.++ |...+.... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999874 444443322 138999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 172 --~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------------- 231 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------- 231 (278)
T ss_dssp ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------------
T ss_pred --cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 23367899999999876 578999999999999999998 999998877655554442210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 232 --~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 --K---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp --C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --C---------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 0112367899999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=385.48 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=204.2
Q ss_pred eeEE-EEeeccCceEEEEEEE--CCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 160 FEKI-DKIGQGTYSSVYKARD--LETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 160 y~~~-~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+.+. +.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|++|+|||||++++++... .+|||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEE
Confidence 4443 4899999999999954 56678999999986655555667899999999999999999999998643 58999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC--C
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--L 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~--~ 314 (665)
||||.++.+..++.....+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... .
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999866655555556799999999999999999999999999999999999999999999999999987754332 1
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......+|+.|+|||++.+ ..|+.++|||||||+||||++ |+.||.+.+..+....+......
T Consensus 528 ~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------- 591 (635)
T ss_dssp -------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2233456889999999976 578999999999999999998 99999999888777766442100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++++.+||..||..||.+|||+.++++
T Consensus 592 -------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 -------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112367899999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.23 Aligned_cols=237 Identities=23% Similarity=0.340 Sum_probs=186.4
Q ss_pred CCeeEE-EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHH-HhCCCCCcceeeeeeec---cCCc
Q 006004 158 DAFEKI-DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL-RKLDHPNVMKLEGLVTS---RSGS 232 (665)
Q Consensus 158 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~---~~~~ 232 (665)
++|.++ +.||+|+||.||+|++..+++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 468888 7799999999999999999999999999632 2356889888 55699999999999875 2347
Q ss_pred EEEEEEeccc-cchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEeccccee
Q 006004 233 LYLVFEYMEH-DLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATT 307 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~ 307 (665)
+||||||+.+ +|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 8999999987 555555443 246999999999999999999999999999999999999998 78999999999875
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
.. ...|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~----------- 214 (299)
T 3m2w_A 170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----------- 214 (299)
T ss_dssp CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS-----------
T ss_pred cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH-----------
Confidence 42 1357889999999999999999999998765433211110000
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
. .... ......+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 215 -----~--~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 215 -----R--MGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp -----C--TTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred -----h--hccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0 0000 00112235689999999999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=373.81 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=205.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.|++++..+.++.......||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 346899999999999999999999999999999998755432 2367899999999886655555555445558899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE---cCCCcEEEEecccceecCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILl---d~~g~lKL~DFGlA~~~~~~~ 312 (665)
||||+.++|..++......|++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999777777776556689999999999999999999999999999999999999 688999999999998875433
Q ss_pred CC------CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhH
Q 006004 313 NL------PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTE---VEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 313 ~~------~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~kI~~~~g~p~~~~ 383 (665)
.. .....+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+... .+.+.++.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------ 233 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------ 233 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH------
T ss_pred cccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc------
Confidence 21 1235689999999999987 5789999999999999999999999987554 333333322110
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
...+......+++++.+||..||..||.+||++.++++
T Consensus 234 ------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 ------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01112233578999999999999999999999988765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=374.57 Aligned_cols=250 Identities=17% Similarity=0.235 Sum_probs=197.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCC-CCcceee------------
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH-PNVMKLE------------ 223 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIV~l~------------ 223 (665)
..|.+.+.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+++.|.| .|+..+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358999999999999999999999999999999874432 23345678899999999987 3221111
Q ss_pred ---------eeeecc----CCcEEEEEEeccccchhhhc------CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCC
Q 006004 224 ---------GLVTSR----SGSLYLVFEYMEHDLAGLAT------TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDI 284 (665)
Q Consensus 224 ---------~~~~~~----~~~l~lV~Ey~~g~ll~~~~------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL 284 (665)
.++... ...++++|+++.++|..++. .....+++..+..++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111110 12478899999888877662 33456889999999999999999999999999999
Q ss_pred CcccEEEcCCCcEEEEecccceecCCCCCCCcccccccccccCccccc---------CCcccCcccchhhhHHHHHHHHh
Q 006004 285 KGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL---------GATKYGAAIDMWSAGCILAELFA 355 (665)
Q Consensus 285 KPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~---------~~~~~~~~sDIWSLG~iLyeLlt 355 (665)
||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||+||+|++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999875432 345578 9999999983 33568899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH
Q 006004 356 GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA 435 (665)
Q Consensus 356 G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ 435 (665)
|+.||.+.+..+.... +......+|+.+.+||.+||..||.+|||+.
T Consensus 313 g~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999987653221111 1112236889999999999999999999999
Q ss_pred HHHhCcCCCC
Q 006004 436 SALRSEFFKT 445 (665)
Q Consensus 436 eaL~Hp~f~~ 445 (665)
++|+||||+.
T Consensus 360 ~~l~~~~~~~ 369 (413)
T 3dzo_A 360 QAMETPEYEQ 369 (413)
T ss_dssp HHTTSHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=359.21 Aligned_cols=246 Identities=18% Similarity=0.216 Sum_probs=193.1
Q ss_pred CCCeeEEEEeeccCceEEEEE-----EECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKA-----RDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---HPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~ 228 (665)
.++|++.+.||+|+||.||+| .+..+++.||||+++... ...+.+|+.+++.|. |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 357999999999999999999 467889999999997532 334678888888886 9999999999887
Q ss_pred cCCcEEEEEEeccccchhhhcC-----CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC----------
Q 006004 229 RSGSLYLVFEYMEHDLAGLATT-----PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---------- 293 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~~~-----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---------- 293 (665)
.+ ..|||||||.++.+..+.. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 139 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 139 QN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp SS-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CC-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 65 7899999998654443332 3457999999999999999999999999999999999999998
Q ss_pred -CCcEEEEecccceecCC-CCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 006004 294 -AGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 -~g~lKL~DFGlA~~~~~-~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~k 371 (665)
++.+||+|||+|+.+.. .........+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999976532 12233456689999999999987 568999999999999999999999986532100
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcC
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~ 442 (665)
|. ....+ .+ ...++...+|+..||+.+|.+|++..+.|.+.+
T Consensus 293 ------------~~-----~~~~~------~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 293 ------------CK-----PEGLF------RR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ------------EE-----ECSCC------TT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ------------ee-----echhc------cc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 00 00000 00 024667889999999999999977666655443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.28 Aligned_cols=278 Identities=25% Similarity=0.300 Sum_probs=192.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHH--HHhCCCCCcceeeeeeec----c
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI--LRKLDHPNVMKLEGLVTS----R 229 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~i--L~~L~HpnIV~l~~~~~~----~ 229 (665)
..++|++++.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++||||+++++.+.. .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 356899999999999999999986 78999999997532 2233444444 455899999999975432 2
Q ss_pred CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC---------CccccCCCcccEEEcCCCcEEEE
Q 006004 230 SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR---------GILHRDIKGSNLLINNAGVLKIG 300 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---------gIiHrDLKPeNILld~~g~lKL~ 300 (665)
...+||||||++++.+..+.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 33578999999875554444333 468999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCC-------CCCcccccccccccCcccccCC------cccCcccchhhhHHHHHHHHhCCCC-CCCCChH
Q 006004 301 DFGLATTYDPSQ-------NLPLTSRVVTLWYRAPELLLGA------TKYGAAIDMWSAGCILAELFAGKPI-MPGRTEV 366 (665)
Q Consensus 301 DFGlA~~~~~~~-------~~~~~~~~gT~~Y~APE~l~~~------~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~~~ 366 (665)
|||++..+.... .......+||+.|+|||++.+. ..++.++|||||||++|||++|..| |++....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 1123355799999999999752 3567899999999999999999654 4443322
Q ss_pred HHHHHHHHhcC-CCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHH------Hh
Q 006004 367 EQMHKIFKLCG-SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA------LR 439 (665)
Q Consensus 367 e~l~kI~~~~g-~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea------L~ 439 (665)
+....+....+ .+..+.+..... .....+..|. ........++.+.+||.+||..||.+|||+.|+ |.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVS--REKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHT--TSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhc--ccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11111111111 121111111000 0000011110 000112255689999999999999999999999 55
Q ss_pred CcCCCCC
Q 006004 440 SEFFKTE 446 (665)
Q Consensus 440 Hp~f~~~ 446 (665)
++|-++.
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 7887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=349.50 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=200.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCC--CCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFAN--MDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
|...+.||+|+||.||+|++ +++.||||++.... ...+..+.+.+|+.++++++||||+++++++.... .+|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-DLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-ceEEEE
Confidence 45558999999999999986 68899999986532 23345677899999999999999999999988754 789999
Q ss_pred Eeccccch-hhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLA-GLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll-~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||+.++.+ ..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99986544 43332 2346999999999999999999999999999999999999999999999999999876543221
Q ss_pred -CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 -PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 -~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+..........+ ...
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~------ 260 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI-EDY------ 260 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH-HHH------
T ss_pred ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh-hhh------
Confidence 1234578999999998875 589999999999999999999999987654433333322111110000 000
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
... .+.......+..+.+||.+||..||.+|||+.+++++
T Consensus 261 -~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 -IDK------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp -SCS------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -ccc------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0001112356778999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=376.77 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=208.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.. ..+|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEe
Confidence 4579999999999999999999865 467999999865543 3457899999999999999999998865 368999
Q ss_pred EEeccccch-hhhcC-CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLA-GLATT-PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll-~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||.++.+ ..+.. .+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999987544 44432 2346899999999999999999999999999999999999999999999999999876432211
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
......++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+.+..+......
T Consensus 420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------------- 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 1223356789999999886 578999999999999999999 99999999888777766432100
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC--cCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS--EFFKT 445 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H--p~f~~ 445 (665)
.....+++.+.+||.+||..||.+|||+.++++. .+|..
T Consensus 484 -------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0123578899999999999999999999999874 56654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.12 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=201.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||.||+|++.. .||+|++..........+.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceEEE
Confidence 4579999999999999999999854 4999999765444444455778999999999999999999998765 79999
Q ss_pred EEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC----
Q 006004 237 FEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS---- 311 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~---- 311 (665)
|||+.++.+. .+......+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 9999865554 4444445799999999999999999999999999999999999998 689999999998765321
Q ss_pred CCCCcccccccccccCcccccC--------CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 312 QNLPLTSRVVTLWYRAPELLLG--------ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 312 ~~~~~~~~~gT~~Y~APE~l~~--------~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 262 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN---- 262 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC----
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC----
Confidence 1122344568999999999874 2457899999999999999999999999888776665553311000
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....++..+.+||.+||..||.+|||+.++++.
T Consensus 263 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 -----------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp -----------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred -----------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012578889999999999999999999999973
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.45 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=203.1
Q ss_pred CCCeeEEEEeeccCceEEEEEE----ECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKAR----DLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SG 231 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~ 231 (665)
.++|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3479999999999999999999 4678999999999753 345567789999999999999999999987654 33
Q ss_pred cEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+|+||||+.+ +|...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 68999999987 55555555555799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh--
Q 006004 311 SQNL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK-- 386 (665)
Q Consensus 311 ~~~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~-- 386 (665)
.... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... . +....+......+..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhccccchhhhHHH
Confidence 3321 1223456888999999886 5689999999999999999999998864311 1 111111111100000
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
......... .......+++.+.+||.+||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000000 00112467899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=378.40 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=204.4
Q ss_pred CCeeEEE-EeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKID-KIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|++|+|||||++++++.. ..+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeE
Confidence 4567776 8999999999999875 356679999997543 23345678899999999999999999999875 3689
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||.++.+. .+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999976554 4444556799999999999999999999999999999999999999999999999999987643322
Q ss_pred CC--cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 LP--LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 ~~--~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.. .....+|+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+.+..+.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------- 557 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------- 557 (613)
T ss_dssp ----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------------
T ss_pred eeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 11 122345689999999976 578999999999999999998 9999999988887776644210
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHH---hCcCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL---RSEFFK 444 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL---~Hp~f~ 444 (665)
......+++.+.+||.+||..||.+|||+.+++ ++.|+.
T Consensus 558 ---------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 ---------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 011236889999999999999999999999874 444443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.00 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=189.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC--CCCCcceeeeeeeccC---Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL--DHPNVMKLEGLVTSRS---GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIV~l~~~~~~~~---~~ 232 (665)
++|++++.||+|+||.||+|++. ++.||||++.... ...+.+|.+++..+ +||||+++++++.... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 47999999999999999999984 8999999986432 23345566666554 9999999999987652 47
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC--------CccccCCCcccEEEcCCCcEEEEeccc
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR--------GILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
+|+||||+.++.+..+.... .+++.+++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 89999999875444444332 699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCC---CcccccccccccCcccccCCcccCc------ccchhhhHHHHHHHHhC----------CCCCCCCC-
Q 006004 305 ATTYDPSQNL---PLTSRVVTLWYRAPELLLGATKYGA------AIDMWSAGCILAELFAG----------KPIMPGRT- 364 (665)
Q Consensus 305 A~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~~~~~------~sDIWSLG~iLyeLltG----------~~pF~g~~- 364 (665)
+..+...... .....+||+.|+|||++.+. .+.. ++|||||||++|||++| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9876443221 12356899999999999763 3333 49999999999999999 66665432
Q ss_pred ---hHHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 365 ---EVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 365 ---~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
..+.+..+..... ..+..+.. .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKK-----------------LRPSFPNR----WSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSC-----------------CCCCCCGG----GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhc-----------------cCcccccc----chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221100 01111100 0112456789999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=389.96 Aligned_cols=279 Identities=24% Similarity=0.313 Sum_probs=207.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeec-----cCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTS-----RSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----~~~~ 232 (665)
++|++.+.||+|+||.||+|++..+|+.||||+++.. ........+.+|+.+|++++||||+++++++.. ..+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4799999999999999999999999999999998754 345667778999999999999999999998754 1346
Q ss_pred EEEEEEeccccchh-hhcCCC--CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCc---EEEEecccce
Q 006004 233 LYLVFEYMEHDLAG-LATTPG--IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGV---LKIGDFGLAT 306 (665)
Q Consensus 233 l~lV~Ey~~g~ll~-~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~---lKL~DFGlA~ 306 (665)
.|+||||+.|+.+. .+.... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 89999999875444 443322 36999999999999999999999999999999999999997764 9999999998
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..............+......+..
T Consensus 173 ~~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 173 ELDQGE--LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp BTTSCC--CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccc--ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 875433 2355689999999999876 6789999999999999999999999987654433221111000000000000
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
. .....+....+. .......+++.+.+||.+||.+||.+|||+.++|+||||+.
T Consensus 250 l--~g~~~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 L--TGAVKFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp C--SSSCCCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred h--ccccccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 000001111110 11223357889999999999999999999999999999963
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=377.22 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=205.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC---CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||.||+|++..+ +..||||+++... .....+.+.+|+.+|++++||||+++++++.. +.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence 35799999999999999999998654 4679999886433 44556778999999999999999999998854 368
Q ss_pred EEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||+.++ |...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999965 444554455579999999999999999999999999999999999999999999999999998775443
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------- 611 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 611 (656)
T ss_dssp --------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-------------
T ss_pred ceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 333334467889999999976 578999999999999999997 99999999888877776542100
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 612 ---------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112367899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.06 Aligned_cols=254 Identities=23% Similarity=0.280 Sum_probs=196.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh--CCCCCcceeeeeeeccC---Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK--LDHPNVMKLEGLVTSRS---GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~~---~~ 232 (665)
++|++.+.||+|+||.||+|++ +|+.||||++... ....+.+|+++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3799999999999999999998 5899999998642 24557789999988 79999999999988754 27
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHH--------hCCccccCCCcccEEEcCCCcEEEEeccc
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH--------SRGILHRDIKGSNLLINNAGVLKIGDFGL 304 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH--------~~gIiHrDLKPeNILld~~g~lKL~DFGl 304 (665)
+|+||||+.++.+..+... ..+++.+++.++.||+.||.||| +.||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 8999999998544444333 36999999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCC---CcccccccccccCcccccCCc-----ccCcccchhhhHHHHHHHHhC----------CCCCCCCCh-
Q 006004 305 ATTYDPSQNL---PLTSRVVTLWYRAPELLLGAT-----KYGAAIDMWSAGCILAELFAG----------KPIMPGRTE- 365 (665)
Q Consensus 305 A~~~~~~~~~---~~~~~~gT~~Y~APE~l~~~~-----~~~~~sDIWSLG~iLyeLltG----------~~pF~g~~~- 365 (665)
+......... ......||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876543321 234557999999999987632 234789999999999999999 678865421
Q ss_pred ---HHHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 366 ---VEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 366 ---~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+.+....... ...+..+.. ......++.+.+||.+||..||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~-----------------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQ-----------------KLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTS-----------------CCCCCCCGG----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHH-----------------HhCCCCccc----ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22222221100 000111100 0012345678999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=379.82 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=199.1
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc----
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS---- 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~---- 232 (665)
++|++++.||+|+||.||+|++.. +|+.||||++.... .......+.+|+.+|++|+|||||++++++......
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 489999999999999999999976 78999999886533 455666788999999999999999999999875432
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+||||||++|+.+..+... .+++.+++.|+.||+.||.|||++||+||||||+||||+.+ .+||+|||++......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 7999999998776655443 69999999999999999999999999999999999999985 8999999999886543
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+.... +.+
T Consensus 235 ----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~------------- 285 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP------------- 285 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC-------------
T ss_pred ----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc-------------
Confidence 45579999999999875 3589999999999999999999988652100 000
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
... .....++.+.+||.+||.+||.+||++.++|.|+|+.
T Consensus 286 ----~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ----EDD--------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----TTC--------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ccc--------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 0112467899999999999999999999999998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.47 Aligned_cols=227 Identities=15% Similarity=0.112 Sum_probs=184.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||.||+|++..+|+.||||+++.... ..+..+.+.+|+.++.+++||||+++++++.... .+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-GGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-cEEEE
Confidence 479999999999999999999999999999999986544 3566678899999999999999999999998754 79999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||++|+.+..+...+ ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 9999976666555443 4566789999999999999999999999999999999999999997443
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
|++ .++.++|||||||+||+|++|+.||.+.+..+.+....+ ...
T Consensus 175 --------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-------------------~~~ 219 (286)
T 3uqc_A 175 --------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------------DTA 219 (286)
T ss_dssp --------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-------------------CTT
T ss_pred --------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-------------------Hhc
Confidence 333 368999999999999999999999988654221100000 000
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.. ..........+++.+.+||.+||+.||.+| |+.++++
T Consensus 220 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 220 GQ---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SC---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cC---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00 001123345789999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=319.47 Aligned_cols=188 Identities=17% Similarity=0.085 Sum_probs=135.4
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCC----C----HHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANM----D----PESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l~ 234 (665)
..++.|++|.+..++..-.|+.||+|++..... . ....+.+.+|+++|+++ .|+||+++++++++.. .+|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-SGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-EEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-EEE
Confidence 456788888888888888899999999975421 1 22345689999999999 7999999999998865 899
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
||||||+|+.+..++..+.++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999998777777777778765 578999999999999999999999999999999999999999998765432 3
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKP 358 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~ 358 (665)
...+.+||+.|||||++.+ .+..++|+||+|+++|+|+++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 3566799999999999976 46788999999999998877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=263.60 Aligned_cols=186 Identities=16% Similarity=0.119 Sum_probs=139.3
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HH-----HHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PE-----SVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~-----~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..+.||+|+||.||+|. ..++.+|+|++...... .. ..+.+.+|+++|++|+||||+++..++.... ..||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-NKRI 416 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-TTEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-ccEE
Confidence 35689999999999994 46788999987543322 11 2345789999999999999994444443433 5699
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC-
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL- 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~- 314 (665)
||||++|+.+..+... +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999986555544433 5689999999999999999999999999999999 9999999999987543211
Q ss_pred -----CcccccccccccCcccccC-CcccCcccchhhhHHHHHHHHhCCCCC
Q 006004 315 -----PLTSRVVTLWYRAPELLLG-ATKYGAAIDMWSAGCILAELFAGKPIM 360 (665)
Q Consensus 315 -----~~~~~~gT~~Y~APE~l~~-~~~~~~~sDIWSLG~iLyeLltG~~pF 360 (665)
.....+||+.|||||++.. ...|+..+|+||..+-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999999874 145788899999999888888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=223.04 Aligned_cols=161 Identities=18% Similarity=0.163 Sum_probs=124.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----------------HHHHHHHHHHHHHHhCCCCCcce
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----------------ESVRFMAREIHILRKLDHPNVMK 221 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIV~ 221 (665)
..|.+.+.||+|+||.||+|++ .+|+.||||+++...... .....+.+|+.+|++|+ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3567779999999999999999 889999999997532211 13456889999999999 5 66
Q ss_pred eeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEe
Q 006004 222 LEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGD 301 (665)
Q Consensus 222 l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~D 301 (665)
+.+++... .+|+||||++|+.+..+. ..+...++.||+.||.|||++||+||||||+||||+ ++.+||+|
T Consensus 166 v~~~~~~~--~~~lvmE~~~g~~L~~l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 166 VPKVYAWE--GNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SCCEEEEE--TTEEEEECCCCEEGGGCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred cCeEEecc--ceEEEEEecCCCcHHHcc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 66665542 469999999885554431 234668999999999999999999999999999999 99999999
Q ss_pred cccceecCCCCCCCcccccccccccCcccccCC---------cccCcccchhhh
Q 006004 302 FGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA---------TKYGAAIDMWSA 346 (665)
Q Consensus 302 FGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---------~~~~~~sDIWSL 346 (665)
||+|+. +..|+|||++... ..|+..+|+|.+
T Consensus 236 FG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999874 3457899987531 235555666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-21 Score=195.80 Aligned_cols=140 Identities=16% Similarity=0.203 Sum_probs=108.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcE--EEEEEEecCCCCH----------------------HHHHHHHHHHHHHHhC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKI--VALKKVRFANMDP----------------------ESVRFMAREIHILRKL 214 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~----------------------~~~~~~~~Ei~iL~~L 214 (665)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|++|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999999788999 9999976432110 1123578899999999
Q ss_pred CCCCc--ceeeeeeeccCCcEEEEEEeccc-c----chhhhcCCCCCCChhHHHHHHHHHHHHHHHHH-hCCccccCCCc
Q 006004 215 DHPNV--MKLEGLVTSRSGSLYLVFEYMEH-D----LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH-SRGILHRDIKG 286 (665)
Q Consensus 215 ~HpnI--V~l~~~~~~~~~~l~lV~Ey~~g-~----ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKP 286 (665)
.|++| ..++.+ . ..||||||+++ + .+..+.. .+++.++..++.||+.||.||| ..||+||||||
T Consensus 128 ~~~~i~~p~~~~~--~---~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY--M---KNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE--E---TTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc--C---CCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88764 333332 1 45899999953 1 2222211 2456788999999999999999 99999999999
Q ss_pred ccEEEcCCCcEEEEecccceec
Q 006004 287 SNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 287 eNILld~~g~lKL~DFGlA~~~ 308 (665)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=177.87 Aligned_cols=140 Identities=18% Similarity=0.215 Sum_probs=101.4
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC---------------CHHHHH-----HHHHHHHHHHhCCCCC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---------------DPESVR-----FMAREIHILRKLDHPN 218 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---------------~~~~~~-----~~~~Ei~iL~~L~Hpn 218 (665)
-|++...||.|+||.||+|.+ .+|+.||||+++.... ...... ...+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 499999999999999999997 4699999999864210 001111 1235677777775444
Q ss_pred cceeeeeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC---
Q 006004 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG--- 295 (665)
Q Consensus 219 IV~l~~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g--- 295 (665)
+.-. ..+.... .+|||||++|..+..+. ..+++..++.||+.+|.+||+.|||||||||.||||+++|
T Consensus 175 v~vp-~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVP-EPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCC-CEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCC-eeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3221 1122222 37999999986664432 2235678899999999999999999999999999999877
Q ss_pred -------cEEEEecccceec
Q 006004 296 -------VLKIGDFGLATTY 308 (665)
Q Consensus 296 -------~lKL~DFGlA~~~ 308 (665)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.6e-12 Score=126.69 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=108.3
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++...++.|+++.||++.. .+..+++|+....... ....+.+|+.+|+.|. +..+.++++++... +..|+||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceEEEE
Confidence 589999999999999999975 3678999998742111 1224788999999984 67788888887654 4789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS----------------------------------------- 276 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~----------------------------------------- 276 (665)
||++|..+.... .+..+...++.++..+|..||+
T Consensus 90 e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999997665432 1233455788999999999998
Q ss_pred ------------------CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 ------------------RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 ------------------~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766667999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=5.8e-11 Score=119.33 Aligned_cols=134 Identities=12% Similarity=0.113 Sum_probs=97.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC--cceeeeeeeccCCcEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN--VMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~~~~~l~lV 236 (665)
.|.+....+.|..+.||++.. .+|..|++|+..... ...+.+|+.+++.|.+.+ +.+++.+.... +..|+|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEE
Confidence 466544444666799999964 567789999876431 134678999999985444 45678776654 468999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG-------------------------------------- 278 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g-------------------------------------- 278 (665)
|||++|..+. +.. . ....++.+++..|..||...
T Consensus 94 ~e~i~G~~l~-~~~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL-SSH----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT-TSC----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC-cCc----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999997664 211 1 22366778888888888754
Q ss_pred --------------------ccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 279 --------------------ILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 279 --------------------IiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998876677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.4e-10 Score=121.85 Aligned_cols=143 Identities=17% Similarity=0.256 Sum_probs=106.0
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEe--cCCCCHHHHHHHHHHHHHHHhCC--CCCcceeeeeeeccC--CcEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKLD--HPNVMKLEGLVTSRS--GSLY 234 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~--~~l~ 234 (665)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+.+++.++.+.+ +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 45688999999999999853 4578899775 33211 22345788999999996 456788888776542 4579
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh--------------------------------------
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-------------------------------------- 276 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-------------------------------------- 276 (665)
+||||++|..+.... -..+++.+...++.+++..|..||.
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999986553211 1247888899999999999999997
Q ss_pred --------------------CCccccCCCcccEEEcCCCc--EEEEecccceec
Q 006004 277 --------------------RGILHRDIKGSNLLINNAGV--LKIGDFGLATTY 308 (665)
Q Consensus 277 --------------------~gIiHrDLKPeNILld~~g~--lKL~DFGlA~~~ 308 (665)
.+++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999997753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1.6e-10 Score=120.40 Aligned_cols=182 Identities=17% Similarity=0.178 Sum_probs=120.4
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCC--cceeeeeeeccC--CcEEEEE
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPN--VMKLEGLVTSRS--GSLYLVF 237 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn--IV~l~~~~~~~~--~~l~lV~ 237 (665)
++.|+.|....||++. ..+++|+... ......+.+|..+|+.| .+.. +.+++....... ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3468999999999974 3589998642 24456788999999988 3333 334444332222 2348999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS----------------------------------------- 276 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~----------------------------------------- 276 (665)
++++|..+..... ..++..+...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999966543211 246788888889999999988886
Q ss_pred -----------------CCccccCCCcccEEEcC--CCcEEEEecccceecCCCCCCCcccccccccc---cCccccc--
Q 006004 277 -----------------RGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY---RAPELLL-- 332 (665)
Q Consensus 277 -----------------~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y---~APE~l~-- 332 (665)
..++|+|++|.|||++. .+.+.|+||+.+..-+.... ......+ ..|+.+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence 13799999999999998 55689999999876433211 0001111 2222211
Q ss_pred -C-C---------cccCcccchhhhHHHHHHHHhCCCCC
Q 006004 333 -G-A---------TKYGAAIDMWSAGCILAELFAGKPIM 360 (665)
Q Consensus 333 -~-~---------~~~~~~sDIWSLG~iLyeLltG~~pF 360 (665)
. . .....-.+.|+++.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 0 01122358999999999999998655
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=3.7e-07 Score=95.38 Aligned_cols=136 Identities=15% Similarity=0.187 Sum_probs=95.9
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCC---CcceeeeeeeccCCcEEEEEEe
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP---NVMKLEGLVTSRSGSLYLVFEY 239 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~~~~~~~~~~l~lV~Ey 239 (665)
+..++.|....||+. |..+++|+.+ .......+.+|..+|+.|.+. .+.+++.+.....+..|+||||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888999999998 4568999853 234456788999999999653 2455565554344567899999
Q ss_pred ccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 006004 240 MEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR------------------------------------------ 277 (665)
Q Consensus 240 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~------------------------------------------ 277 (665)
++|..+....- ..++..+...++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99966543211 1245556666666666666666642
Q ss_pred ------------------CccccCCCcccEEEcC---CCc-EEEEecccceecC
Q 006004 278 ------------------GILHRDIKGSNLLINN---AGV-LKIGDFGLATTYD 309 (665)
Q Consensus 278 ------------------gIiHrDLKPeNILld~---~g~-lKL~DFGlA~~~~ 309 (665)
.++|+|++|.|||++. ++. +.|+||+.+..-+
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3589999999999997 455 5899999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2.8e-06 Score=86.12 Aligned_cols=133 Identities=14% Similarity=0.097 Sum_probs=92.6
Q ss_pred EeeccCce-EEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEEEeccc
Q 006004 165 KIGQGTYS-SVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 165 ~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~Ey~~g 242 (665)
.+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.+..+. +..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCC
Confidence 34444444 699988877788899998763 23456788999999884 33356677776654 478999999998
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR--------------------------------------------- 277 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------------------------------------------- 277 (665)
..+..... ....+...+..++...|..||..
T Consensus 105 ~~~~~~~~----~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLE----EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHH----HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccc----CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 65443221 12223345556666666666631
Q ss_pred -------------CccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 278 -------------GILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 278 -------------gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5.3e-06 Score=89.36 Aligned_cols=78 Identities=17% Similarity=0.186 Sum_probs=49.1
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC--CH---HHHHHHHHHHHHHHhCCC--CCc-ceeeeeeeccCCcE
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM--DP---ESVRFMAREIHILRKLDH--PNV-MKLEGLVTSRSGSL 233 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~---~~~~~~~~Ei~iL~~L~H--pnI-V~l~~~~~~~~~~l 233 (665)
.++.||.|.++.||++....+++.|+||....... .. .....+..|..+|+.+.. +.+ .+++.+ . .. ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d-~~-~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-TE-MA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-TT-TT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c-CC-cc
Confidence 46789999999999997665678899998653211 00 112345779999988732 333 355543 2 22 35
Q ss_pred EEEEEeccc
Q 006004 234 YLVFEYMEH 242 (665)
Q Consensus 234 ~lV~Ey~~g 242 (665)
++||||+++
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 799999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=5.8e-06 Score=87.47 Aligned_cols=86 Identities=10% Similarity=0.133 Sum_probs=54.9
Q ss_pred eeEEEEe-eccCceEEEEEEEC--C----CCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCC-C--CCcceeeeeeec
Q 006004 160 FEKIDKI-GQGTYSSVYKARDL--E----TGKIVALKKVRFANM-DPESVRFMAREIHILRKLD-H--PNVMKLEGLVTS 228 (665)
Q Consensus 160 y~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIV~l~~~~~~ 228 (665)
...++.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456788 88889999998753 1 256799997653220 0000123577888888873 2 356677776554
Q ss_pred cC--CcEEEEEEeccccch
Q 006004 229 RS--GSLYLVFEYMEHDLA 245 (665)
Q Consensus 229 ~~--~~l~lV~Ey~~g~ll 245 (665)
.. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 32 356899999998543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-05 Score=82.99 Aligned_cols=31 Identities=16% Similarity=0.231 Sum_probs=27.8
Q ss_pred CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00014 Score=79.12 Aligned_cols=79 Identities=9% Similarity=0.037 Sum_probs=46.4
Q ss_pred HhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc--cccccCcccccCCc--ccCcccchhhhHHHH
Q 006004 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGAT--KYGAAIDMWSAGCIL 350 (665)
Q Consensus 275 H~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g--T~~Y~APE~l~~~~--~~~~~sDIWSLG~iL 350 (665)
+...++|+|++|.|||++.++ ++|+||+.+..-.+... +..... ...|.+|+...... .-....++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 456899999999999999877 99999998876432111 011111 23455655443110 111223444666677
Q ss_pred HHHHhC
Q 006004 351 AELFAG 356 (665)
Q Consensus 351 yeLltG 356 (665)
|.++++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00067 Score=71.11 Aligned_cols=75 Identities=20% Similarity=0.250 Sum_probs=57.0
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC---CCCcceeeeeeeccCCcEEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD---HPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.-++.|+.|....+|+... ++..+++|+.... ....+.+|...|+.|. ...+.+++.+.... +..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEE
Confidence 4567899999999999975 4668899987632 2456788999998883 35677777766543 4789999
Q ss_pred Eecccc
Q 006004 238 EYMEHD 243 (665)
Q Consensus 238 Ey~~g~ 243 (665)
||++|.
T Consensus 111 e~l~G~ 116 (312)
T 3jr1_A 111 EALNKS 116 (312)
T ss_dssp ECCCCC
T ss_pred EeccCC
Confidence 999974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00061 Score=70.59 Aligned_cols=142 Identities=13% Similarity=0.126 Sum_probs=77.5
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC--cceeeee-----eeccCCc
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN--VMKLEGL-----VTSRSGS 232 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~-----~~~~~~~ 232 (665)
...++.|+.|....+|++... +| .+++|+..... ....+..|+.+++.|.... +.+++.. +..-.+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 445678888998999999753 34 68899886421 1123456777777763211 2233221 1111245
Q ss_pred EEEEEEeccccchh---------------hhcC--CC--CC----CChhHHHH---------------HHHHHHHHHHHH
Q 006004 233 LYLVFEYMEHDLAG---------------LATT--PG--IK----FTEPQIKC---------------YMQQLLRGLEHC 274 (665)
Q Consensus 233 l~lV~Ey~~g~ll~---------------~~~~--~~--~~----lse~~i~~---------------i~~QIl~aL~~L 274 (665)
.+++|+|++|.... .+.. .. .+ .....-.. +...+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999974211 0110 00 00 00000000 001133444555
Q ss_pred Hh-------CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 275 HS-------RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 275 H~-------~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 42 3799999999999999876668999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00098 Score=68.72 Aligned_cols=133 Identities=17% Similarity=0.103 Sum_probs=73.4
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEEEEEEec-
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLYLVFEYM- 240 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~lV~Ey~- 240 (665)
++.|+.|....+|++ ..+++|+..... ...-...+|+.+++.+....+ .+++.+... .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~---~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDPA---TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT---TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEECC---CCEEEEeecC
Confidence 678989999999999 458999876421 111112468877777742223 455554322 236899999
Q ss_pred cccchhh-------------------hcCCCCCCC-----hhHHHHHHHH--------------HHHHHHH----HH---
Q 006004 241 EHDLAGL-------------------ATTPGIKFT-----EPQIKCYMQQ--------------LLRGLEH----CH--- 275 (665)
Q Consensus 241 ~g~ll~~-------------------~~~~~~~ls-----e~~i~~i~~Q--------------Il~aL~~----LH--- 275 (665)
+|..+.. +......+. ...+..+..+ +...+.. |.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6633211 111111111 1111111111 1111111 11
Q ss_pred -hCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 276 -SRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 276 -~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
...++|+|+.+.||| ..++.+.|+||..+..-
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 55677899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0019 Score=70.50 Aligned_cols=72 Identities=21% Similarity=0.233 Sum_probs=49.1
Q ss_pred EEEEeeccCceEEEEEEECC-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcE
Q 006004 162 KIDKIGQGTYSSVYKARDLE-------TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSL 233 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l 233 (665)
.++.|+.|....||++.... ++..|++|+..... . ...+.+|..+++.|...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---
Confidence 45788889899999998643 25789999874321 1 1334579999988843333 56666543 2
Q ss_pred EEEEEeccc
Q 006004 234 YLVFEYMEH 242 (665)
Q Consensus 234 ~lV~Ey~~g 242 (665)
.+||||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 389999987
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=71.50 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=82.1
Q ss_pred EEeeccCceEEEEEEECC-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEE
Q 006004 164 DKIGQGTYSSVYKARDLE-------TGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~l 235 (665)
+.|..|-...+|++.... +++.|+||+.... ......+.+|..+++.|. +.-..++++++. + .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---cc
Confidence 567668888899998642 3578999985321 112344568999998884 333356666553 2 28
Q ss_pred EEEeccccchh------------------hhcCCC----CCC--ChhHHHHHHHHHHH-------------------HHH
Q 006004 236 VFEYMEHDLAG------------------LATTPG----IKF--TEPQIKCYMQQLLR-------------------GLE 272 (665)
Q Consensus 236 V~Ey~~g~ll~------------------~~~~~~----~~l--se~~i~~i~~QIl~-------------------aL~ 272 (665)
||||++|..+. .+.... ... -..++..|+.++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999984321 011111 111 23566667665532 233
Q ss_pred HHH----h----CCccccCCCcccEEEcCC----CcEEEEeccccee
Q 006004 273 HCH----S----RGILHRDIKGSNLLINNA----GVLKIGDFGLATT 307 (665)
Q Consensus 273 ~LH----~----~gIiHrDLKPeNILld~~----g~lKL~DFGlA~~ 307 (665)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 259999999999999876 7899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0023 Score=65.53 Aligned_cols=76 Identities=14% Similarity=0.163 Sum_probs=53.1
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC---CCcceeeeeeeccCCcEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH---PNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~~~~~~~~l~l 235 (665)
...-+..+|.|..+.||+++. .+|+.|++|+...... .....+.+|...|+.|.- -.+.+++.+ . .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~---~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D---DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E---TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c---CceE
Confidence 456788999999999999984 6789999998653321 122346789999998842 123444443 2 2378
Q ss_pred EEEeccc
Q 006004 236 VFEYMEH 242 (665)
Q Consensus 236 V~Ey~~g 242 (665)
||||+.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=70.07 Aligned_cols=74 Identities=12% Similarity=0.143 Sum_probs=43.6
Q ss_pred EEEEeeccCceEEEEEEECC--------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCC-cceeeeeeeccCCc
Q 006004 162 KIDKIGQGTYSSVYKARDLE--------TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN-VMKLEGLVTSRSGS 232 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~~ 232 (665)
.+..|+.|....+|++.... .+..|++|+..... ........|..+++.|...+ +.++++.+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF---NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec---CC-
Confidence 35678888888999998643 12678888765321 11112357888888874333 34666543 22
Q ss_pred EEEEEEecccc
Q 006004 233 LYLVFEYMEHD 243 (665)
Q Consensus 233 l~lV~Ey~~g~ 243 (665)
++||||++|.
T Consensus 110 -~~v~e~i~G~ 119 (369)
T 3c5i_A 110 -GRIEEWLYGD 119 (369)
T ss_dssp -EEEEECCCSE
T ss_pred -cEEEEEecCC
Confidence 6899999873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0045 Score=64.14 Aligned_cols=137 Identities=15% Similarity=0.095 Sum_probs=77.5
Q ss_pred EEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCC--Ccceeeee----eeccCCcEEEEE
Q 006004 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP--NVMKLEGL----VTSRSGSLYLVF 237 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~----~~~~~~~l~lV~ 237 (665)
..|+ |....||++.. .+|+.+++|+.+...... ..+..|..+++.|... .+.+++.. +....+..++||
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 88889998864 456679999987433232 3456688888777321 23444432 011134568899
Q ss_pred Eeccccchh---------------hhc---CC-----CCCCChhH----------------------HHHHHHHHHHHHH
Q 006004 238 EYMEHDLAG---------------LAT---TP-----GIKFTEPQ----------------------IKCYMQQLLRGLE 272 (665)
Q Consensus 238 Ey~~g~ll~---------------~~~---~~-----~~~lse~~----------------------i~~i~~QIl~aL~ 272 (665)
+|++|..+. .+. .. ...+.... ....+.+++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999973211 000 00 00111110 0111122222222
Q ss_pred HH----HhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 273 HC----HSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 273 ~L----H~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
.+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22 234689999999999999 4 899999997754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0054 Score=67.61 Aligned_cols=73 Identities=19% Similarity=0.192 Sum_probs=47.8
Q ss_pred EEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeeeeccCCcEEEEEEec
Q 006004 162 KIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-MKLEGLVTSRSGSLYLVFEYM 240 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~~l~lV~Ey~ 240 (665)
.++.|+.|-...+|++.....+..|++|+..... ...+. ..+|..+|+.|...++ .++++++. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~---G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIIN-REREKKISCILYNKNIAKKIYVFFT--N---GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T---EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C---eEEEEee
Confidence 4578888989999999875445789999874321 11111 2579999999865445 56776652 2 2599999
Q ss_pred cc
Q 006004 241 EH 242 (665)
Q Consensus 241 ~g 242 (665)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 87
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0015 Score=68.22 Aligned_cols=32 Identities=28% Similarity=0.244 Sum_probs=28.1
Q ss_pred CCccccCCCcccEEEcCC----CcEEEEecccceec
Q 006004 277 RGILHRDIKGSNLLINNA----GVLKIGDFGLATTY 308 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~----g~lKL~DFGlA~~~ 308 (665)
..++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999875 68999999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0094 Score=62.74 Aligned_cols=32 Identities=25% Similarity=0.307 Sum_probs=28.4
Q ss_pred CCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 277 ~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
..++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0072 Score=59.93 Aligned_cols=97 Identities=14% Similarity=0.032 Sum_probs=63.2
Q ss_pred cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcccccc
Q 006004 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV 321 (665)
Q Consensus 243 ~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~~~~g 321 (665)
.|...+...+.+|+|+++|.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|-+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 3555666677899999999999999999877622 1212333447899999999987753 1110 11
Q ss_pred cccccCcccccCCcccCcccchhhhHHHHHHHHh
Q 006004 322 TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA 355 (665)
Q Consensus 322 T~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt 355 (665)
...+.|||... ...+.+.=|||||++||.-|-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 23466888763 345678899999999999874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.025 Score=61.67 Aligned_cols=137 Identities=10% Similarity=0.099 Sum_probs=81.6
Q ss_pred EEEEeeccCceEEEEEEECCC-------CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcE
Q 006004 162 KIDKIGQGTYSSVYKARDLET-------GKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 162 ~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l 233 (665)
.++.|..|-...+|++..... +..|++|+..... +..-...+|..+++.|. +.-..++++.+. .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C---
Confidence 446677788889999986521 5789999864321 11112357888888874 333445555332 2
Q ss_pred EEEEEeccccchhh------------------hcC------------CCCCCChhHHHHHHHHHH---------------
Q 006004 234 YLVFEYMEHDLAGL------------------ATT------------PGIKFTEPQIKCYMQQLL--------------- 268 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~------------------~~~------------~~~~lse~~i~~i~~QIl--------------- 268 (665)
++||||++|..+.. +.. ...+.-..++..|..++-
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 68999999843210 000 011112344444443321
Q ss_pred ----HHHHHHH------------------------hCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 269 ----RGLEHCH------------------------SRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 269 ----~aL~~LH------------------------~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
..+.+|. ...++|+|+.+.||| +.++.+.|+||..|..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 1223322 125899999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.88 E-value=0.27 Score=52.68 Aligned_cols=29 Identities=24% Similarity=0.405 Sum_probs=25.0
Q ss_pred ccccCCCcccEEE------cCCCcEEEEeccccee
Q 006004 279 ILHRDIKGSNLLI------NNAGVLKIGDFGLATT 307 (665)
Q Consensus 279 IiHrDLKPeNILl------d~~g~lKL~DFGlA~~ 307 (665)
++|+|+.+.|||+ +.++.+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.57 E-value=0.074 Score=58.56 Aligned_cols=62 Identities=10% Similarity=0.199 Sum_probs=17.0
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEE------EEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVAL------KKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVT 227 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~ 227 (665)
.+.|| ||.||++........||+ |..+......+....+.+|..+++.++|||+++.+.+..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34566 999999998765567898 776654555555667888999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 665 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-87 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-85 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-78 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-77 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-75 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-75 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-75 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-73 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-70 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-70 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-67 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-65 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-62 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-51 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-29 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (697), Expect = 5e-87
Identities = 133/311 (42%), Positives = 182/311 (58%), Gaps = 13/311 (4%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
+EK+ KIGQGT+ V+KAR +TG+ VALKKV N REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 215 DHPNVMKLEGLVTSRS-------GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQL 267
H NV+ L + +++ GS+YLVF++ EHDLAGL + +KFT +IK MQ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL---PLTSRVVTLW 324
L GL + H ILHRD+K +N+LI GVLK+ DFGLA + ++N T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384
YR PELLLG YG ID+W AGCI+AE++ PIM G TE Q+ I +LCGS + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 385 RK-SKSAHATSFKPQQPYKRKVLETFRNFPQSALA--LVDKLLTIEPENRGSAASALRSE 441
+ + KRKV + + + + A L+DKLL ++P R + AL +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 442 FFKTEPLPCDP 452
FF ++P+P D
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (685), Expect = 2e-85
Identities = 114/300 (38%), Positives = 166/300 (55%), Gaps = 6/300 (2%)
Query: 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM---DPESVRFMAREIHILRKLDHP 217
EK+D +G+G +++VYKARD T +IVA+KK++ + R REI +L++L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
N++ L ++ LVF++ME DL + + T IK YM L+GLE+ H
Sbjct: 61 NIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
ILHRD+K +NLL++ GVLK+ DFGLA ++ T +VVT WYRAPELL GA Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMY 178
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
G +DMW+ GCILAEL P +PG ++++Q+ +IF+ G+P+E+ W S
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPK 457
P + F L L+ L P R +A AL+ ++F P P LP+
Sbjct: 239 SFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 3e-78
Identities = 113/329 (34%), Positives = 166/329 (50%), Gaps = 14/329 (4%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH 216
+ + IG+G Y V A D VA+KK+ R + REI IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 217 PNVMKLEGLVTSRS----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
N++ + ++ + + +YLV M DL L T + I ++ Q+LRGL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP--LTSRVVTLWYRAPEL 330
+ HS +LHRD+K SNLL+N LKI DFGLA DP + LT V T WYRAPE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
+L + Y +ID+WS GCILAE+ + +PI PG+ ++Q++ I + GSPS++ +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 391 HATSFKPQQPYKRKVL--ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
A ++ P+K KV F N AL L+DK+LT P R AL + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 449 PCDPSNLPKYPPSKELDAKLRDQEARKQE 477
DPS+ P + D +L D K +
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 1e-77
Identities = 116/295 (39%), Positives = 172/295 (58%), Gaps = 5/295 (1%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ F+K++KIG+GTY VYKAR+ TG++VALKK+R REI +L++L+HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++KL ++ + LYLVFE++ DL + + P IK Y+ QLL+GL CHS
Sbjct: 62 NIVKLLDVIHTE-NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+LHRD+K NLLIN G +K+ DFGLA + T VVTLWYRAPE+LLG
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKY 179
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y A+D+WS GCI AE+ + + PG +E++Q+ +IF+ G+P E W S
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK--TEPLP 449
+ ++ + + +L+ ++L +P R SA +AL FF+ T+P+P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (633), Expect = 4e-77
Identities = 112/352 (31%), Positives = 171/352 (48%), Gaps = 19/352 (5%)
Query: 139 SWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP 198
S +T+V +G + ++ IG G++ VY+A+ ++G++VA+KKV
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------ 54
Query: 199 ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS-----LYLVFEYMEHDLAGLA---TT 250
+ RF RE+ I+RKLDH N+++L S L LV +Y+ + +A +
Sbjct: 55 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 251 PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYD 309
+K YM QL R L + HS GI HRDIK NLL++ + VLK+ DFG A
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQM 369
+ P S + + +YRAPEL+ GAT Y ++ID+WSAGC+LAEL G+PI PG + V+Q+
Sbjct: 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 370 HKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPE 429
+I K+ G+P+ + R+ + PQ P A+AL +LL P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 430 NRGSAASALRSEFFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQEAEAV 481
R + A FF L LP + L + + +
Sbjct: 293 ARLTPLEACAHSFFD--ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 7e-77
Identities = 102/325 (31%), Positives = 163/325 (50%), Gaps = 14/325 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + +G G Y +V A D TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 218 NVMKLEGLVTSRS-----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
NV+ L + T YLV +M DL L K E +I+ + Q+L+GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ H+ GI+HRD+K NL +N LKI DFGLA D +T VVT WYRAPE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL 191
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
+Y +D+WS GCI+AE+ GK + G ++Q+ +I K+ G+P ++ ++ +S A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 393 TSFKPQQPY--KRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
++ P K+ N A+ L++K+L ++ E R +A AL +F++
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 451 DPSNLPKYPPSKELDAKLRDQEARK 475
D + KY S + D E ++
Sbjct: 312 DEPQVQKYDDSFD-DVDRTLDEWKR 335
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 3e-75
Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 22/305 (7%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
+ D FEKI ++G G V+K +G ++A K + + P + RE+ +L + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECN 62
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ G S G + + E+M+ + E + +++GL +
Sbjct: 63 SPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 276 SR-GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
+ I+HRD+K SN+L+N+ G +K+ DFG++ S S V T Y +PE L G
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG- 177
Query: 335 TKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
T Y D+WS G L E+ G+ PI P + ++ ++ G +E R
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 394 SFKPQQPYKRKVLETFRN--------------FPQSALALVDKLLTIEPENRGSAASALR 439
S + + F V+K L P R +
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 440 SEFFK 444
F K
Sbjct: 298 HAFIK 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 3e-75
Identities = 79/293 (26%), Positives = 125/293 (42%), Gaps = 30/293 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ ++ + +G+G Y V A + T + VA+K V +EI I + L+H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHE 63
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
NV+K G YL EY P I EP + + QL+ G+ + H
Sbjct: 64 NVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATK 336
GI HRDIK NLL++ LKI DFGLAT + + L +++ TL Y APELL
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
+ +D+WS G +L + AG+ ++ Q + +K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---------------------- 220
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
K+ L ++ + LAL+ K+L P R + + ++ +PL
Sbjct: 221 ----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLK 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 240 bits (614), Expect = 4e-75
Identities = 107/287 (37%), Positives = 155/287 (54%), Gaps = 3/287 (1%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + ++KIG+GTY VYKA++ G+ ALKK+R D REI IL++L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSR 277
N++KL V L LVFE+++ DL L K ++ QLL G+ +CH R
Sbjct: 61 NIVKLYD-VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 278 GILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKY 337
+LHRD+K NLLIN G LKI DFGLA + T +VTLWYRAP++L+G+ KY
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKY 178
Query: 338 GAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
ID+WS GCI AE+ G P+ PG +E +Q+ +IF++ G+P+ W
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ +S + L+ K+L ++P R +A AL +FK
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 243 bits (620), Expect = 4e-75
Identities = 76/352 (21%), Positives = 136/352 (38%), Gaps = 37/352 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
D ++ +++G G + V++ + TG A K V + D E+VR +EI + L H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRH 82
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
P ++ L + +++E+M +L K +E + YM+Q+ +GL H H
Sbjct: 83 PTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 276 SRGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
+H D+K N++ + LK+ DFGL DP Q++ T + APE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEG 199
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
G DMWS G + L +G G + E + + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPS 453
+ + KLL +P R + AL + P S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 454 NLPKYPPSKELDAKLRDQEARKQEAEAV-RGRGPESVRRGSRDFSAVRTPEF 504
+P +K D+ +A + + R S+R+ ++R +
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFW 345
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 6e-75
Identities = 104/321 (32%), Positives = 158/321 (49%), Gaps = 13/321 (4%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ ++ + +G G Y SV A D +TG VA+KK+ + RE+ +L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 218 NVMKLEGLVTSRS-----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
NV+ L + T +YLV M DL + K T+ ++ + Q+LRGL+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLK 135
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+ HS I+HRD+K SNL +N LKI DFGLA D T V T WYRAPE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIML 191
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
Y +D+WS GCI+AEL G+ + PG ++Q+ I +L G+P + +K S A
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 393 TSFKPQQPYKRKV--LETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
++ K+ F A+ L++K+L ++ + R +AA AL +F P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 451 DPSNLPKYPPSKELDAKLRDQ 471
D Y S E L D+
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 237 bits (607), Expect = 8e-74
Identities = 83/326 (25%), Positives = 145/326 (44%), Gaps = 38/326 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPN 218
F + +IG G++ +VY ARD+ ++VA+KK+ ++ E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++ G R + +LV EY + L E +I L+GL + HS
Sbjct: 77 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT--K 336
++HRD+K N+L++ G++K+GDFG A+ P+ S V T ++ APE++L +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQ 190
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
Y +D+WS G EL KP + + ++ I + SP+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQ-------------- 235
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456
++ + VD L P++R ++ L+ F E P +L
Sbjct: 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
Query: 457 KYPPS--KELDAKLRDQEARKQEAEA 480
+ +ELD + + EA
Sbjct: 284 QRTKDAVRELDNLQYRKMKKILFQEA 309
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (607), Expect = 3e-73
Identities = 80/371 (21%), Positives = 150/371 (40%), Gaps = 50/371 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D ++ ++++G G + V++ + TG++ K + P + EI I+ +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHP 86
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
++ L + + L+ E++ +L K +E ++ YM+Q GL+H H
Sbjct: 87 KLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 277 RGILHRDIKGSNLLI--NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
I+H DIK N++ A +KI DFGLAT +P + + +T T + APE++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR- 202
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
G DMW+ G + L +G G ++E + + + ED +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF---------- 252
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
+ A + LL EP R + AL + K D SN
Sbjct: 253 ---------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHSN 292
Query: 455 LPKYPPSKELDAKLRDQEARKQEAEAVRGRGPESVRRGSRDFSAVRTPEFIPSGQSKPTS 514
L PS + + + + + A P+ +FS++R + +
Sbjct: 293 LTSRIPSSRYNKIRQKIKEKYADWPA-----PQPAIGRIANFSSLR------KHRPQEYQ 341
Query: 515 ISHKFHNQEDS 525
I + +++++
Sbjct: 342 IYDSYFDRKEA 352
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 6e-72
Identities = 111/286 (38%), Positives = 161/286 (56%), Gaps = 3/286 (1%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+EK++KIG+GTY +V+KA++ ET +IVALK+VR + D REI +L++L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
++L ++ S L LVFE+ + DL + +K ++ QLL+GL CHSR +
Sbjct: 64 VRLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
LHRD+K NLLIN G LK+ +FGLA + ++ VVTLWYR P++L GA Y
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 340 AIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+IDMWSAGCI AEL P+ PG +Q+ +IF+L G+P+E+ W P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
P ++ + L+ LL P R SA AL+ +F
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 2e-71
Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 37/302 (12%)
Query: 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIH 209
+ P D +E I ++G G + VYKA++ ET + A K + E + EI
Sbjct: 6 RDLNPE--DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEID 61
Query: 210 ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLL 268
IL DHPN++KL +L+++ E+ + + TE QI+ +Q L
Sbjct: 62 ILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
L + H I+HRD+K N+L G +K+ DFG++ + S + T ++ AP
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAP 179
Query: 329 ELLLGAT----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYW 384
E+++ T Y D+WS G L E+ +P + + KI K
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---------- 229
Query: 385 RKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ L + + + K L + R + + L+ F
Sbjct: 230 ----------------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
Query: 445 TE 446
+
Sbjct: 274 VD 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 2e-70
Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 40/297 (13%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD 215
RA+ +E + IG G+Y K R GKI+ K++ + +M + + E+++LR+L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 216 HPNVMKLEGLVTSRS-GSLYLVFEYMEH-DLAGL---ATTPGIKFTEPQIKCYMQQLLRG 270
HPN+++ + R+ +LY+V EY E DLA + T E + M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 271 LEHCHSRG-----ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
L+ CH R +LHRD+K +N+ ++ +K+GDFGLA + + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYY 180
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
+PE + Y D+WS GC+L EL A P ++ E KI
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------ 227
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEF 442
+ K + ++ ++L ++ +R S L +
Sbjct: 228 ----------------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-70
Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 36/305 (11%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + +KIGQG +VY A D+ TG+ VA++++ + EI ++R+ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNI 79
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ L++V EY+ E QI ++ L+ LE HS +
Sbjct: 80 VNYLDSYLV-GDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGA 339
+HRDIK N+L+ G +K+ DFG P Q+ ++ V T ++ APE++ YG
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYGP 195
Query: 340 AIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399
+D+WS G + E+ G+P + ++ I G+P K
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK------------- 241
Query: 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TEPLPCDPSNLPKY 458
+++ L ++ E RGSA L+ +F K +PL S P
Sbjct: 242 ------------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---SSLTPLI 286
Query: 459 PPSKE 463
+KE
Sbjct: 287 AAAKE 291
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 9e-70
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 35/288 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
+ FE +G+G + +VY AR+ ++ I+ALK + A + + RE+ I L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
PN+++L G + +YL+ EY KF E + Y+ +L L +CHS
Sbjct: 66 PNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
+ ++HRDIK NLL+ +AG LKI DFG + S+ T+ TL Y PE++ G
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEG-RM 180
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
+ +D+WS G + E GKP T E +I ++ + +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------- 225
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ A L+ +LL P R L +
Sbjct: 226 --------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 6e-69
Identities = 112/299 (37%), Positives = 163/299 (54%), Gaps = 14/299 (4%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLET-GKIVALKKVRFANMDPESVRFMAREIHILRK 213
R +E + +IG+G Y V+KARDL+ G+ VALK+VR + RE+ +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 214 L---DHPNVMKLEGLVTSRS----GSLYLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQ 265
L +HPNV++L + T L LVFE+++ D L P IK M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 266 QLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWY 325
QLLRGL+ HS ++HRD+K N+L+ ++G +K+ DFGLA Y LTS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWY 181
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
RAPE+LL + Y +D+WS GCI AE+F KP+ G ++V+Q+ KI + G P E+ W
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ + +F + + + + + L+ K LT P R SA SAL +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-69
Identities = 74/343 (21%), Positives = 130/343 (37%), Gaps = 41/343 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + + +G+G + V++ + + K K V+ D V+ +EI IL H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ L S L ++FE++ D+ T + E +I Y+ Q+ L+ HS
Sbjct: 62 NILHLHESFESM-EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 277 RGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
I H DI+ N++ + +KI +FG A P N Y APE+
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH- 177
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
A DMWS G ++ L +G T + + I + E+ +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------- 227
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSN 454
+ A+ VD+LL E ++R +A+ AL+ + K +
Sbjct: 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 455 LPK------YPPSKELDAKLRDQEARKQEAEAVRGRGPESVRR 491
+ Y + D + AR A+R + SV +
Sbjct: 273 IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAK 315
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 2e-67
Identities = 83/325 (25%), Positives = 134/325 (41%), Gaps = 35/325 (10%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
D ++ D +G G +S V A D T K+VA+K + ++ + EI +L K+ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ L+ + S G LYL+ + + +L G +TE + Q+L +++ H
Sbjct: 68 NIVALDDIYESG-GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHD 125
Query: 277 RGILHRDIKGSNLLI---NNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
GI+HRD+K NLL + + I DFGL+ DP L++ T Y APE+L
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ 183
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
Y A+D WS G I L G P + + +I K YW
Sbjct: 184 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW--------- 233
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPS 453
+ SA + L+ +PE R + AL+ + +
Sbjct: 234 ----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277
Query: 454 NLPKYPPSKELDAKLRDQEARKQEA 478
+ K+ AK + ++A A
Sbjct: 278 HQSVSEQIKKNFAKSKWKQAFNATA 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-67
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 35/299 (11%)
Query: 153 QPR--RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIH 209
QPR R + F+ +G+G++S+V AR+L T + A+K + ++ V ++ RE
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 210 ILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLR 269
++ +LDHP +KL LY Y ++ F E + Y +++
Sbjct: 61 VMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP-SQNLPLTSRVVTLWYRAP 328
LE+ H +GI+HRD+K N+L+N ++I DFG A P S+ S V T Y +P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
ELL + D+W+ GCI+ +L AG P E KI KL E ++ K++
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447
LV+KLL ++ R K P
Sbjct: 239 D-----------------------------LVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 4e-67
Identities = 93/335 (27%), Positives = 158/335 (47%), Gaps = 24/335 (7%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ + IG G V A D + VA+KK+ + + RE+ +++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 220 MKLEGLVTSRS-----GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ L + T + +YLV E M+ L ++ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGA 334
HS GI+HRD+K SN+++ + LKI DFGLA T S +T VVT +YRAPE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG- 192
Query: 335 TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
Y +D+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 395 FKPQQPYKRKVL-------------ETFRNFPQSALALVDKLLTIEPENRGSAASALRSE 441
+ + Y E + A L+ K+L I+P R S AL+
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 442 FFKTEPLPCDPSNLPKYPPSKELDAKLRDQEARKQ 476
+ P + P K+LD + E K+
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 217 bits (553), Expect = 2e-66
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPES-------VRFMAREIHI 210
+ +E + +G+G S V + T K A+K + S +E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 211 LRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLL 268
LRK+ HPN+++L+ + + +LVF+ M+ +L T +E + + M+ LL
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALL 120
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
+ H I+HRD+K N+L+++ +K+ DFG + DP + L T Y AP
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAP 178
Query: 329 ELLLGAT-----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383
E++ + YG +DMWS G I+ L AG P R ++ + I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443
W ++ + LV + L ++P+ R +A AL FF
Sbjct: 239 W-------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
Query: 444 K 444
+
Sbjct: 274 Q 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 215 bits (548), Expect = 5e-65
Identities = 91/301 (30%), Positives = 150/301 (49%), Gaps = 24/301 (7%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DH 216
D ++ + K+G+G YS V++A ++ + V +K + P + + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKREIKILENLRGG 89
Query: 217 PNVMKLEGLVTSR-SGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
PN++ L +V S + LVFE++ + D L T+ I+ YM ++L+ L++C
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 275 HSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
HS GI+HRD+K N++I++ L++ D+GLA Y P Q RV + +++ PELL+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVD 203
Query: 334 ATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLCGSPS-EDYWRKSKSAH 391
Y ++DMWS GC+LA + K P G +Q+ +I K+ G+ DY K
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 392 ATSFKPQQPYKRKVL-------ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
F + E AL +DKLL + ++R +A A+ +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 445 T 445
T
Sbjct: 324 T 324
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-63
Identities = 70/312 (22%), Positives = 129/312 (41%), Gaps = 40/312 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRK 213
D ++ +++G G ++ V K R+ TG A K ++ S + RE+ IL++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
+ HPNV+ L + ++ + L+ E + TE + +++Q+L G+ +
Sbjct: 70 IQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 274 CHSRGILHRDIKGSNLLINNAGV----LKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
HS I H D+K N+++ + V +KI DFGLA D + T + APE
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPE 186
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
++ G DMWS G I L +G G T+ E + + + ++Y+
Sbjct: 187 IVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF----- 240
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK---TE 446
N A + +LL +P+ R + +L+ + K T+
Sbjct: 241 --------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
Query: 447 PLPCDPSNLPKY 458
+ P++
Sbjct: 281 QALSSAWSHPQF 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 38/292 (13%)
Query: 160 FEKID-KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPN 218
F K D +IG+G++ +VYK D ET VA +++ + + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 219 VMKLEGL---VTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+++ + LV E M ++ + +Q+L+GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 276 SRG--ILHRDIKGSNLLINNA-GVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLL 332
+R I+HRD+K N+ I G +KIGD GLAT S + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 333 GATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
KY ++D+++ G + E+ + Q+++ P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--------- 235
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
+ +++ + + R S L FF+
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 6e-62
Identities = 60/287 (20%), Positives = 118/287 (41%), Gaps = 32/287 (11%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+IG G++ +VYK + VA+K + P+ ++ E+ +LRK H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
N++ G T+ L +V ++ E L KF ++ +Q +G+++ H+
Sbjct: 65 NILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPELLLG-- 333
+ I+HRD+K +N+ ++ +KIGDFGLAT ++ ++ + APE++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
Y D+++ G +L EL G+ +Q+ +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------- 223
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440
+ + + N P++ L+ + L + + R L S
Sbjct: 224 ----RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 203 bits (517), Expect = 5e-60
Identities = 69/312 (22%), Positives = 128/312 (41%), Gaps = 41/312 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMA----REIHILRK 213
+ F IG+G + VY R +TGK+ A+K + + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
D P ++ + + L + + M + F+E ++ Y +++ GLEH
Sbjct: 64 GDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
H+R +++RD+K +N+L++ G ++I D GLA + + + V T Y APE+L
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQK 179
Query: 334 ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393
Y ++ D +S GC+L +L G + H+I ++ + + +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVELP--------- 229
Query: 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFKTEPL 448
+F +L++ LL + R A S FF+ L
Sbjct: 230 ----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR--SL 271
Query: 449 PCDPSNLPKYPP 460
L KYPP
Sbjct: 272 DWQMVFLQKYPP 283
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 200 bits (509), Expect = 7e-60
Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 32/294 (10%)
Query: 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLD 215
+D +E + +G G S V+ ARDL + VA+K +R DP RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 216 HPNVMKLEGLV---TSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLE 272
HP ++ + T Y+V EY++ T + + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN--LPLTSRVVTLWYRAPEL 330
H GI+HRD+K +N++I+ +K+ DFG+A S N + + T Y +PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
G A D++S GC+L E+ G+P G + V ++ + P
Sbjct: 186 ARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444
A+V K L PENR A+ +R++ +
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 63/333 (18%), Positives = 120/333 (36%), Gaps = 42/333 (12%)
Query: 158 DAFEKIDK-IGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL-D 215
D ++ + +G G V + + T + ALK ++ RE+ + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQ 63
Query: 216 HPNVMKLEGL---VTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLLRG 270
P+++++ + + + L +V E ++ +L + FTE + M+ +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 271 LEHCHSRGILHRDIKGSNLLIN---NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRA 327
+++ HS I HRD+K NLL +LK+ DFG A +L + T +Y A
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVA 181
Query: 328 PELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
PE+L KY + DMWS G I+ L G P + + ++
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK-TE 446
+ + L+ LL EP R + + + +
Sbjct: 241 ---------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
Query: 447 PLPCDPSNLPKYPPSKELDAKLRDQEARKQEAE 479
+P P + + + + +E A
Sbjct: 280 KVPQTPLHTSRVLKEDKERWEDVKEEMTSALAT 312
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-57
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 49/305 (16%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLD 215
++ +G G + SVY + VA+K V + + + + E+ +L+K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 216 --HPNVMKLEGLVTSRSGSLYLVFEYME--HDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
V++L R S L+ E E DL T G E + + Q+L +
Sbjct: 66 SGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAV 123
Query: 272 EHCHSRGILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPEL 330
HCH+ G+LHRDIK N+LI+ N G LK+ DFG + T T Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEW 180
Query: 331 LLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
+ +G + +WS G +L ++ G E+ + F+
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------- 224
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450
+ L+ L + P +R + + + LP
Sbjct: 225 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
Query: 451 DPSNL 455
+ + +
Sbjct: 266 ETAEI 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 35/290 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVR--FANMDPESVRFMAREIHILRKLD 215
+ F +G+G++ V+ A +T + A+K ++ MD + M + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
HP + + ++ +L+ V EY+ KF + Y +++ GL+ H
Sbjct: 62 HPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
S+GI++RD+K N+L++ G +KI DFG+ + T Y APE+LLG
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ- 178
Query: 336 KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
KY ++D WS G +L E+ G+ G+ E E H I
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------------------D 218
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS-EFFK 444
P P R + A L+ KL EPE R +R F+
Sbjct: 219 NPFYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-56
Identities = 66/295 (22%), Positives = 126/295 (42%), Gaps = 41/295 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ + ++++G G + V+ VA+K ++ +M P++ E +++++L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQ 68
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAG--LATTPGIKFTEPQIKCYMQQLLRGLEHCH 275
+++L +VT +Y++ EYME+ L T GIK T ++ Q+ G+
Sbjct: 69 RLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
R +HRD++ +N+L+++ KI DFGLA + ++ + + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG- 185
Query: 336 KYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
+ D+WS G +L E+ G+ PG T E + + +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------------------G 226
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA---SALRSEFFKTE 446
++ +P N P+ L+ PE+R + S L F TE
Sbjct: 227 YRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 2e-55
Identities = 54/322 (16%), Positives = 110/322 (34%), Gaps = 40/322 (12%)
Query: 155 RRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
R + + KIG G++ +Y D+ G+ VA+K P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
+ + +V E + L L KF+ + Q++ +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 275 HSRGILHRDIKGSNLLINNAG---VLKIGDFGLATTYDPSQNL------PLTSRVVTLWY 325
HS+ +HRD+K N L+ ++ I DFGLA Y ++ + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 326 RAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385
+ LG + D+ S G +L G G + K ++
Sbjct: 180 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS--------- 229
Query: 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFF 443
++ + + +P ++ ++ +++ + + F
Sbjct: 230 ------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
Query: 444 KTEPLPCDPS---NLPKYPPSK 462
+ D N+ K+ S+
Sbjct: 278 HRQGFSYDYVFDWNMLKFGASR 299
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 189 bits (481), Expect = 2e-55
Identities = 61/291 (20%), Positives = 114/291 (39%), Gaps = 41/291 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPN 218
F+ + +G G++ V+ R G+ A+K ++ + + V E +L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 219 VMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++++ G ++++ +Y+E +F P K Y ++ LE+ HS+
Sbjct: 66 IIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
I++RD+K N+L++ G +KI DFG A + T Y APE++ Y
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST-KPYN 179
Query: 339 AAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
+ID WS G ++ E+ AG ++ KI + +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------------------AELR 219
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFK 444
P F + L+ +L+T + R +FK
Sbjct: 220 FP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-55
Identities = 57/292 (19%), Positives = 111/292 (38%), Gaps = 43/292 (14%)
Query: 151 GWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHI 210
GW + + + IG+G + V G VA+K ++ + + + E +
Sbjct: 1 GWALNMKE-LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 211 LRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAG-LATTPGIKFTEPQIKCYMQQLL 268
+ +L H N+++L G++ G LY+V EYM L L + + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 269 RGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAP 328
+E+ +HRD+ N+L++ V K+ DFGL +Q + + + + AP
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAP 169
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387
E L K+ D+WS G +L E+++ G+ P + + ++ K
Sbjct: 170 EALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 215
Query: 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+K P P + ++ ++ R S
Sbjct: 216 ------GYKMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-54
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 38/293 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDH 216
+ F+ + +G+GT+ V R+ TG+ A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 217 PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
P + L+ L V EY + FTE + + Y +++ LE+ HS
Sbjct: 65 PFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
R +++RDIK NL+++ G +KI DFGL S + + T Y APE+L
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED-ND 181
Query: 337 YGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396
YG A+D W G ++ E+ G+ + I +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------EE 221
Query: 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFK 444
+ P R A +L+ LL +P+ R A + FF
Sbjct: 222 IRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-53
Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 36/284 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
+ +IG G + V+ L VA+K +R M E E ++ KL HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHP 60
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS 276
+++L G+ + LVFE+MEH L+ T F + + G+ +
Sbjct: 61 KLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 277 RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATK 336
++HRD+ N L+ V+K+ DFG+ Q T + + +PE+ ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178
Query: 337 YGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
Y + D+WS G ++ E+F+ GK R+ E + I +T F
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STGF 219
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ +P R +++ PE+R + + LR
Sbjct: 220 RLYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 7e-53
Identities = 69/312 (22%), Positives = 125/312 (40%), Gaps = 48/312 (15%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHP 217
++ K+GQG + V+ T + VA+K ++ M PE+ +E +++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 218 NVMKLEGLVTSRSGSLYLVFEYMEHDLAGLAT--TPGIKFTEPQIKCYMQQLLRGLEHCH 275
+++L +V+ +Y+V EYM G PQ+ Q+ G+ +
Sbjct: 73 KLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 276 SRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGAT 335
+HRD++ +N+L+ V K+ DFGLA + ++ + + APE L
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 189
Query: 336 KYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394
++ D+WS G +L EL G+ PG E + ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------------------G 230
Query: 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFFKTEPLPCDP 452
++ P P+S L+ + EPE R + ++F
Sbjct: 231 YRMPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-------- 273
Query: 453 SNLPKYPPSKEL 464
S P+Y P + L
Sbjct: 274 STEPQYQPGENL 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 9e-53
Identities = 59/286 (20%), Positives = 110/286 (38%), Gaps = 36/286 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLET---GKIVALKKVRFANM-DPESVRFMAREIHILRKLD 215
++K+G G++ V + VA+K ++ + PE++ RE++ + LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 216 HPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHC 274
H N+++L G+V + + +V E L F + Y Q+ G+ +
Sbjct: 70 HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 275 HSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NLPLTSRVVTLWYRAPELLLG 333
S+ +HRD+ NLL+ ++KIGDFGL + + + + L
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 334 ATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
+ A D W G L E+F G+ G + +HKI K
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------ 229
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASAL 438
+ +P + PQ ++ + +PE+R + +
Sbjct: 230 EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (460), Expect = 9e-53
Identities = 44/283 (15%), Positives = 92/283 (32%), Gaps = 37/283 (13%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
++ +IG+G++ +++ +L + VA+K + P+ + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTG 62
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
+ LV + + L L G KF+ + +Q+L ++ H + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 280 LHRDIKGSNLLINN-----AGVLKIGDFGLATTYDPS------QNLPLTSRVVTLWYRAP 328
++RDIK N LI A ++ + DFG+ Y + T Y +
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 329 ELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
LG + D+ + G + G G K ++
Sbjct: 183 NTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------------ 229
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
++ + E FP+ + + +
Sbjct: 230 ---------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-52
Identities = 59/289 (20%), Positives = 113/289 (39%), Gaps = 39/289 (13%)
Query: 165 KIGQGTYSSVYKA--RDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
++G G + +V K + + K VA+K ++ DP + E +++++LD+P ++++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 223 EGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHR 282
G+ + S LV E E + I + Q+ G+++ +HR
Sbjct: 74 IGICEA--ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 283 DIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGAA 340
D+ N+L+ KI DFGL+ +N + + APE + K+ +
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSK 190
Query: 341 IDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQ 399
D+WS G ++ E F+ G+ G E + K +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------------GERMGC 231
Query: 400 PYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS---ALRSEFFKT 445
P P+ L++ T + ENR A+ LR+ ++
Sbjct: 232 P---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 66/299 (22%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANM--DPESVRFMAREIHILR 212
+ FE + +G G Y V+ R + +TGK+ A+K ++ A + ++ E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 213 KLDH-PNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
+ P ++ L + L+L+ +Y+ + +FTE +++ Y+ +++ L
Sbjct: 84 HIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELL 331
EH H GI++RDIK N+L+++ G + + DFGL+ + + T+ Y AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 332 LGA-TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390
G + + A+D WS G ++ EL G E +I + Y
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP------ 256
Query: 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR-----GSAASALRSEFFK 444
+ A L+ +LL +P+ R A FF+
Sbjct: 257 -------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-51
Identities = 52/282 (18%), Positives = 109/282 (38%), Gaps = 36/282 (12%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ ++G G + V + VA+K ++ +M + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 220 MKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG 278
++L G+ T ++++ EYM + L +F Q+ + + +E+ S+
Sbjct: 62 VQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 279 ILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYG 338
LHRD+ N L+N+ GV+K+ DFGL+ + + + PE+L+ +K+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFS 179
Query: 339 AAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397
+ D+W+ G ++ E+++ GK T E I A +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------------AQGLRL 220
Query: 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+P + ++ + + R + L
Sbjct: 221 YRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 5e-51
Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 46/318 (14%)
Query: 139 SWLTSVAGEAIKGWQPRRA-----DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRF 193
+L + +K W+ D F++I +G G++ V + E+G A+K +
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76
Query: 194 ANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPG 252
+ + + E IL+ ++ P ++KLE S ++ ++ G
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136
Query: 253 IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312
+F+EP + Y Q++ E+ HS +++RD+K NLLI+ G +++ DFG A
Sbjct: 137 -RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
+ T APE++L Y A+D W+ G ++ E+ AG P ++ KI
Sbjct: 196 ----WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR- 431
+F L+ LL ++ R
Sbjct: 251 VSGKVRFPS-----------------------------HFSSDLKDLLRNLLQVDLTKRF 281
Query: 432 ----GSAASALRSEFFKT 445
++F T
Sbjct: 282 GNLKNGVNDIKNHKWFAT 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 7e-51
Identities = 63/307 (20%), Positives = 128/307 (41%), Gaps = 44/307 (14%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKL 214
+ IG G + V GK VA+K ++ + + F+ E I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
DHPNV+ LEG+VT S + ++ E+ME+ L +FT Q+ ++ + G+++
Sbjct: 85 DHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV----TLWYRAPE 329
+HRD+ N+L+N+ V K+ DFGL+ + + P + + + + APE
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 330 LLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388
+ K+ +A D+WS G ++ E+ + G+ T + ++ I +
Sbjct: 204 AIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------------- 248
Query: 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448
++ P + P + L+ + +R + + + +
Sbjct: 249 -----DYRLPPP---------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT----LDKM 290
Query: 449 PCDPSNL 455
+P++L
Sbjct: 291 IRNPNSL 297
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 178 bits (451), Expect = 8e-51
Identities = 73/341 (21%), Positives = 133/341 (39%), Gaps = 50/341 (14%)
Query: 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV 219
+ + K+G G +S+V+ A+D+ VA+K VR + E+ EI +L++++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 220 MKLEGLVTSRSGSLYLVFEYMEHD---------------LAGLATTPGIKFTEPQIKCYM 264
K + + + L F + + LA + +K
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 265 QQLLRGLEHC-HSRGILHRDIKGSNLLINNAGV------LKIGDFGLATTYDPSQNLPLT 317
+QLL GL++ GI+H DIK N+L+ +KI D G A YD +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT------EVEQMHK 371
+R YR+PE+LLGA +G D+WS C++ EL G + + + + +
Sbjct: 192 TR----EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 372 IFKLCGSPSEDYWRKSKSA-------------HATSFKPQQPYKRKVLETFRNFPQSALA 418
I +L G R K F P + + + ++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 419 LVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYP 459
+ +L ++P R A + + K + L + +P
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 346
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-50
Identities = 57/287 (19%), Positives = 111/287 (38%), Gaps = 37/287 (12%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDL---ETGKIVALKKVRFANMDPESVRFMAREIHILRKL 214
+ E IG+G + V++ + VA+K + D +F+ +E +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQF 65
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEH 273
DHP+++KL G++T ++++ E +L + Y QL L +
Sbjct: 66 DHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 274 CHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLG 333
S+ +HRDI N+L+++ +K+GDFGL+ + S + + + + APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 334 ATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392
++ +A D+W G + E+ G G + + +I
Sbjct: 184 -RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------------------- 223
Query: 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
+ L N P + +L+ K +P R
Sbjct: 224 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 5e-50
Identities = 57/290 (19%), Positives = 112/290 (38%), Gaps = 35/290 (12%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHIL 211
W+ R D K+G G Y VY+ + VA+K ++ M+ E +E ++
Sbjct: 12 WEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVM 67
Query: 212 RKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH--DLAGLATTPGIKFTEPQIKCYMQQLLR 269
+++ HPN+++L G+ T Y++ E+M + L L + + + Q+
Sbjct: 68 KEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 270 GLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPE 329
+E+ + +HRD+ N L+ ++K+ DFGL+ + + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 330 LLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
L K+ D+W+ G +L E+ ++ Q++++ +
Sbjct: 187 SLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------- 230
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
K +E P+ L+ P +R S A +
Sbjct: 231 ------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-49
Identities = 58/289 (20%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 165 KIGQGTYSSVYKARDLETGK--IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKL 222
++G G + SV + K VA+K ++ ++ M RE I+ +LD+P +++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 223 EGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILH 281
G ++ +L LV E L + + + Q+ G+++ + +H
Sbjct: 75 IG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 282 RDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV--TLWYRAPELLLGATKYGA 339
RD+ N+L+ N KI DFGL+ + L + APE + K+ +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSS 191
Query: 340 AIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398
D+WS G + E + G+ E M I
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------------------------- 226
Query: 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS---ALRSEFFK 444
+ K +E P AL+ + E+R + +R+ ++
Sbjct: 227 ---QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-48
Identities = 72/319 (22%), Positives = 119/319 (37%), Gaps = 62/319 (19%)
Query: 152 WQPRRADAFEKIDKIGQGTYSSVYKARDLETGKI-----VALKKVRFANMDPESVRFMAR 206
W+ R + E +G G + V A K VA+K ++ E M
Sbjct: 32 WEFPREN-LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-S 89
Query: 207 EIHILRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKF--------- 255
E+ ++ +L H N++ L G T SG +YL+FEY + DL + KF
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 256 -------------TEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302
T + C+ Q+ +G+E + +HRD+ N+L+ + V+KI DF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 303 GLATTYDPSQNLPL-TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIM 360
GLA N + + + + + APE L Y D+WS G +L E+F+ G
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 361 PGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALV 420
PG +K+ + FK QP+ + ++
Sbjct: 268 PGIPVDANFYKLIQ------------------NGFKMDQPF---------YATEEIYIIM 300
Query: 421 DKLLTIEPENRGSAASALR 439
+ R S +
Sbjct: 301 QSCWAFDSRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-48
Identities = 57/317 (17%), Positives = 111/317 (35%), Gaps = 41/317 (12%)
Query: 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALK---KVRFANMDPESVRFMAREIHILR 212
+ F+KI +G G + +VYK + G+ V + K P++ + + E +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGL 271
+D+P+V +L L + ++ L+ + M L + + Q+ +G+
Sbjct: 67 SVDNPHVCRL--LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 272 EHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSRVV-TLWYRAPEL 330
+ R ++HRD+ N+L+ +KI DFGLA + + + A E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 331 LLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
+L Y D+WS G + EL G G E + K
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------------- 228
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449
+ QP ++ K I+ ++R + + +
Sbjct: 229 ----GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII----EFSKMA 271
Query: 450 CDPSNLPKYPPSKELDA 466
DP + +
Sbjct: 272 RDPQRYLVIQGDERMHL 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 4e-48
Identities = 67/317 (21%), Positives = 117/317 (36%), Gaps = 64/317 (20%)
Query: 154 PRRADAFEKIDKIGQGTYSSVYKAR-----DLETGKIVALKKVRFANMDPESVRFMAREI 208
PR + E + IG+G + V++AR E +VA+K ++ F RE
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 67
Query: 209 HILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEH-DLAGL-------------------- 247
++ + D+PN++KL G V + + L+FEYM + DL
Sbjct: 68 ALMAEFDNPNIVKLLG-VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 248 ---ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGL 304
++ + + C +Q+ G+ + R +HRD+ N L+ V+KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 305 ATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPG 362
+ + + + PE + +Y D+W+ G +L E+F+ G G
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 363 RTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDK 422
E ++ + +L N P L+
Sbjct: 246 MAHEEVIYYVR----------------------------DGNILACPENCPLELYNLMRL 277
Query: 423 LLTIEPENRGSAASALR 439
+ P +R S S R
Sbjct: 278 CWSKLPADRPSFCSIHR 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 44/304 (14%)
Query: 164 DKIGQGTYSSVYKARDLE---TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVM 220
+ IG+G + VY L+ A+K + E +F+ E I++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 221 KLEGLVTSRSGSLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGI 279
L G+ GS +V YM+H DL T + + Q+ +G++ S+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 280 LHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ---NLPLTSRVVTLWYRAPELLLGATK 336
+HRD+ N +++ +K+ DFGLA + T + + + A E L K
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QK 210
Query: 337 YGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395
+ D+WS G +L EL G P P + + +
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------------GR 251
Query: 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA------SALRSEFFKTEPLP 449
+ QP P ++ K + E R S + SA+ S F +
Sbjct: 252 RLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302
Query: 450 CDPS 453
+ +
Sbjct: 303 VNAT 306
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 34/296 (11%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLE 223
+ IG+G + V++ + G+ VA+K + E F EI+ L H N++
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 224 GLVTSRSGS---LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS--- 276
+G+ L+LV +Y EH L T + GL H H
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 277 -----RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN---LPLTSRVVTLWYRAP 328
I HRD+K N+L+ G I D GLA +D + + + RV T Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 329 ELLLGA-----TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383
E+L + + D+++ G + E+ I G E Q+ + PS +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVEE 240
Query: 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
RK +P P + + E R ++ + R +A +
Sbjct: 241 MRKVVCEQK--LRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIKK 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 69/323 (21%), Positives = 121/323 (37%), Gaps = 55/323 (17%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKL- 214
+ + D IG+G + V KAR + G A+K+++ + F E+ +L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLG 68
Query: 215 DHPNVMKLEGLVTSRSGSLYLVFEYMEH----------------DLAGLATTPGIKFTEP 258
HPN++ L G G LYL EY H +A + +
Sbjct: 69 HHPNIINLLG-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 259 QIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTS 318
Q+ + + RG+++ + +HRD+ N+L+ V KI DFGL+ + T
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTM 185
Query: 319 RVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCG 377
+ + + A E L + Y D+WS G +L E+ + G G T E K+ +
Sbjct: 186 GRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 241
Query: 378 SPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA 437
++ ++P N L+ + +P R S A
Sbjct: 242 ----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQI 276
Query: 438 LR--SEFFKTEPLPCDPSNLPKY 458
L + + + + K+
Sbjct: 277 LVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-45
Identities = 58/308 (18%), Positives = 106/308 (34%), Gaps = 56/308 (18%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILR 212
+ +G G + V +A + VA+K ++ + E M E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 213 KL-DHPNVMKLEGLVTSRSGSLYLVFEYMEH------------------DLAGLATTPGI 253
L +H N++ L G T G ++ EY + + +
Sbjct: 82 YLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313
+ + Q+ +G+ S+ +HRD+ N+L+ + + KI DFGLA N
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 314 LPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371
+ + + APE + Y D+WS G L ELF+ G PG + +K
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENR 431
+ K F+ P + P ++ +P R
Sbjct: 260 MIK------------------EGFRMLSP---------EHAPAEMYDIMKTCWDADPLKR 292
Query: 432 GSAASALR 439
+ ++
Sbjct: 293 PTFKQIVQ 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 60/305 (19%), Positives = 102/305 (33%), Gaps = 51/305 (16%)
Query: 158 DAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVRFANMDPESVRFMAREIHILR 212
D + +G+G + V +A T + VA+K ++ E M+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 213 KLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDL----------------AGLATTPGIKFT 256
H NV+ L G T G L ++ E+ + T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 257 EPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316
+ CY Q+ +G+E SR +HRD+ N+L++ V+KI DFGLA +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 317 TSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKIFK 374
L + APE + Y D+WS G +L E+F+ PG E+ + K
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 375 LCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSA 434
+ + + EP R +
Sbjct: 252 ---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 435 ASALR 439
+ +
Sbjct: 285 SELVE 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 61/290 (21%), Positives = 115/290 (39%), Gaps = 39/290 (13%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETG----KIVALKKVRFANMDPESVRFMAREIHILRK 213
+ IG G + VYK + VA+K ++ + + V F+ E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQ 65
Query: 214 LDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLE 272
H N+++LEG V S+ + ++ EYME+ +F+ Q+ ++ + G++
Sbjct: 66 FSHHNIIRLEG-VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 273 HCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY--DPSQNLPLTSRVVTLWYRAPEL 330
+ + +HRD+ N+L+N+ V K+ DFGL+ DP + + + + APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 331 LLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389
+ A+ D+WS G ++ E+ G+ + E M I
Sbjct: 185 ISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND--------------- 228
Query: 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439
F+ P + P + L+ + E R A +
Sbjct: 229 ----GFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 6e-43
Identities = 57/333 (17%), Positives = 118/333 (35%), Gaps = 49/333 (14%)
Query: 138 PSWLTSVAGEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARD-----LETGKIVALKKVR 192
P + ++ W+ R ++GQG++ VY+ E VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAREK-ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 193 FANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME----------H 242
A E + F+ E ++++ + +V++L G V S+ ++ E M
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSL 117
Query: 243 DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDF 302
A + ++ ++ G+ + ++ +HRD+ N ++ +KIGDF
Sbjct: 118 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 303 GLATTYDPSQNLPLTSRVV-TLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIM 360
G+ + + + + + +PE L + D+WS G +L E+ +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 361 PGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALV 420
G + + + + + +L+ N P L+
Sbjct: 237 QGLSNEQVLRFVM----------------------------EGGLLDKPDNCPDMLFELM 268
Query: 421 DKLLTIEPENRGSAASALRSEFFKTEPLPCDPS 453
P+ R S + S + EP + S
Sbjct: 269 RMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 59/307 (19%), Positives = 108/307 (35%), Gaps = 55/307 (17%)
Query: 158 DAFEKIDKIGQGTYSSVYKARDLETGK-------IVALKKVRFANMDPESVRFMAREIHI 210
D +G+G + V A + K VA+K ++ + + + E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 71
Query: 211 LRKL-DHPNVMKLEGLVTSRSGSLYLVFEYMEH----------------DLAGLATTPGI 253
++ + H N++ L G T G LY++ EY + P
Sbjct: 72 MKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 254 KFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313
+ + + Q+ RG+E+ S+ +HRD+ N+L+ V+KI DFGLA
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 314 LPLT-SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKI 372
T + + + + APE L Y D+WS G +L E+F VE++ K+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG 432
K + ++ N ++ P R
Sbjct: 250 LK---------------------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 433 SAASALR 439
+ +
Sbjct: 283 TFKQLVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 111 bits (279), Expect = 5e-29
Identities = 31/208 (14%), Positives = 66/208 (31%), Gaps = 41/208 (19%)
Query: 164 DKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFM----------------ARE 207
+G+G S+V+ E +K + + + V+ E
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 208 IHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQL 267
L+KL V K+ + ++ E ++ + + +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN-----AVLMELIDAK-------ELYRVRVENPDEVLDMI 112
Query: 268 LRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLTSR---VVTLW 324
L + + RGI+H D+ N+L++ G+ I DF + + R + +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 325 YRAPELLLGATKYGAAIDMWSAGCILAE 352
+ Y D+ SA + +
Sbjct: 172 FS--------RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=489.98 Aligned_cols=294 Identities=39% Similarity=0.694 Sum_probs=247.0
Q ss_pred eEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH---HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 161 EKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP---ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 161 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.++.||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++...+ .+||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehh
Confidence 46789999999999999999999999999997654321 22346889999999999999999999998865 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.... ....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 999999888888777789999999999999999999999999999999999999999999999999998765433 2344
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|.+.+|.+..+.|.............
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 56899999999999876778999999999999999999999999999999999999999999988776543322211111
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPK 457 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~ 457 (665)
..+ ...+...+..+++++++||.+||.+||++||||.|+|+||||++.+.|+.+..+|.
T Consensus 239 ~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 239 SFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred cCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 111 12234455678999999999999999999999999999999999988887777664
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=476.05 Aligned_cols=262 Identities=29% Similarity=0.426 Sum_probs=217.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|++++.||+|+||+||+|+++.+|+.||||+++.... .+..+.+.+|+.+|++|+|||||++++++.+.+ .+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETT-EEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-eeEE
Confidence 35689999999999999999999999999999999986543 233456889999999999999999999998865 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NL 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~ 314 (665)
|||||+|+.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999976555555556689999999999999999999999999999999999999999999999999999764332 22
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
..+..+||+.|||||++.+...++.++|||||||+||+|++|++||.+.+.......+......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------- 224 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 224 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence 3456789999999999987555678999999999999999999999876654443333221110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
....+..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 01123468999999999999999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-57 Score=471.46 Aligned_cols=290 Identities=39% Similarity=0.715 Sum_probs=242.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
|+|++++.||+|+||+||+|++..+|+.||||+++...........+.+|+++|++++|||||+++++|.+.. .+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-KLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-ceeEEE
Confidence 6899999999999999999999999999999999766544445667889999999999999999999998865 899999
Q ss_pred Eeccccchhhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++++..+. .....+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|....... ...
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~ 159 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 159 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-ccc
Confidence 999988776554 345679999999999999999999999999999999999999999999999999998765432 334
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+++.++....+.+....|............
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 55689999999999887677799999999999999999999999999999999999999999988877654322111111
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
...............+++++++||.+||.+||.+|||+.|+|+||||++...|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 11111222344556889999999999999999999999999999999976544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=469.73 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=221.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC-HHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD-PESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|++++|||||++++++.+.. .+||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-EEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-EEEE
Confidence 46899999999999999999999999999999999754321 223456889999999999999999999998765 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||+++.+..+......+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|.......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 99999986665555555579999999999999999999999999999999999999999999999999998764332
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++.+...
T Consensus 161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------------ 221 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------------ 221 (263)
T ss_dssp CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------
T ss_pred ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 356689999999999987 6789999999999999999999999999998888877754210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 222 -----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 011358899999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-56 Score=475.87 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=231.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+.. .+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-EMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-EEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEE
Confidence 357999999999999999999999999999999997543 344567889999999999999999999998765 89999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC--CCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN--AGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~--~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||+|+ |...+......+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999975 44555556668999999999999999999999999999999999999964 6889999999999875433
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++..
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----------- 247 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----------- 247 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-----------
T ss_pred -ccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-----------
Confidence 3456789999999999987 678999999999999999999999999999999998887643332221
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLP 456 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p 456 (665)
.+..+|+++++||.+||.+||.+|||++|+|+||||+....+..+..+|
T Consensus 248 --------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 248 --------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp --------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred --------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 2246899999999999999999999999999999999876655544444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=472.36 Aligned_cols=262 Identities=29% Similarity=0.441 Sum_probs=221.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
+.++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+++|++|+|||||+++++|.+.+ .+|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-EEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-EEE
Confidence 34689999999999999999999999999999999975432 2234567889999999999999999999998765 799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-C
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-N 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~ 313 (665)
||||||+|+.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999976555444445589999999999999999999999999999999999999999999999999999875432 2
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+.+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.+...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------------- 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence 33456789999999999987 6789999999999999999999999999998888888754210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHH------HHhCcCCCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAAS------ALRSEFFKTEPL 448 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~e------aL~Hp~f~~~~~ 448 (665)
.....+++++++||.+||++||.+|||++| +++||||++..+
T Consensus 228 -------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 228 -------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp -------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 011358899999999999999999999987 588999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=469.16 Aligned_cols=256 Identities=27% Similarity=0.481 Sum_probs=222.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|.+.+ .+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEE
Confidence 3799999999999999999999999999999999865432 2456889999999999999999999998865 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||.|+.+..+...+ .+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+.... ....
T Consensus 97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~ 174 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS 174 (293)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccc
Confidence 999987666555443 69999999999999999999999999999999999999999999999999999875433 2345
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..+.... .+..
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~---------------- 236 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL---------------- 236 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCC----------------
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCC----------------
Confidence 6689999999999987 678999999999999999999999999999888877765521 1100
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+++++++||.+||.+||.+|||+.|+|+||||+.
T Consensus 237 ---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ---------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112368999999999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=464.17 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=212.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-CCcEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~~~l~ 234 (665)
+.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+++|++|+|||||++++++.+. ++.+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999988777777788899999999999999999999998754 45789
Q ss_pred EEEEeccccchhhhcC----CCCCCChhHHHHHHHHHHHHHHHHHhCC-----ccccCCCcccEEEcCCCcEEEEecccc
Q 006004 235 LVFEYMEHDLAGLATT----PGIKFTEPQIKCYMQQLLRGLEHCHSRG-----ILHRDIKGSNLLINNAGVLKIGDFGLA 305 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~g-----IiHrDLKPeNILld~~g~lKL~DFGlA 305 (665)
||||||+++.+..+.. .+..+++.+++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999755544332 3457999999999999999999999976 999999999999999999999999999
Q ss_pred eecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHh
Q 006004 306 TTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWR 385 (665)
Q Consensus 306 ~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~ 385 (665)
+.+..... .....+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|.... .
T Consensus 162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~------ 231 (269)
T d2java1 162 RILNHDTS-FAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--F------ 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C------
T ss_pred eecccCCC-ccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C------
Confidence 98754322 2456789999999999976 678999999999999999999999999999888777775421 0
Q ss_pred hhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 386 KSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 386 ~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
......+|+++.+||.+||+.||.+|||+.|+|+|||+
T Consensus 232 --------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01123588999999999999999999999999999995
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-56 Score=462.66 Aligned_cols=285 Identities=37% Similarity=0.680 Sum_probs=241.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++++||+|+||+||+|+++ +|+.||||+++.........+.+.+|+.+|++++|||||+++++|...+ .+|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEE
Confidence 58999999999999999999985 7899999999766544444567889999999999999999999998865 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
||+.++++..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|........ ...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccc
Confidence 9999999988888778899999999999999999999999999999999999999999999999999988754322 234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKP 397 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~ 397 (665)
..++|+.|+|||++.+...++.++|||||||++|||++|++||.+.++.+++.++.+..+.+....|.............
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 55789999999999877788999999999999999999999999999999999999999999888876543322211111
Q ss_pred CCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 398 QQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 398 ~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
...........+..+++++++||++||.+||++|||+.|+|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111222234455678999999999999999999999999999999973
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-56 Score=469.87 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=205.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|++++.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|++|+|||||++++++.+.. .+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGG-HLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 46999999999999999999999999999999998655432 2355789999999999999999999998765 899999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc---CCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN---NAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld---~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+|+.+..+......|++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|.......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999755544444455899999999999999999999999999999999999995 57899999999998765432
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
...+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....|......++.
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 230 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------- 230 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-------------
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-------------
Confidence 2456789999999999987 67899999999999999999999999999988888887653222111
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+..+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus 231 ------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 ------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1224689999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=462.38 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=225.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++++.||+|+||+||+|+++.+|+.||||++....... ...+.+.+|+.+|++|+|||||+++++|.+.. .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-DV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-EE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EE
Confidence 57999999999999999999999999999999997654321 23567889999999999999999999998865 89
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----cEEEEecccceecC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG----VLKIGDFGLATTYD 309 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g----~lKL~DFGlA~~~~ 309 (665)
|||||||+|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..+.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999766655544445799999999999999999999999999999999999999877 49999999999875
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|......++...
T Consensus 169 ~~~--~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 239 (293)
T d1jksa_ 169 FGN--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------ 239 (293)
T ss_dssp TSC--BCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH------
T ss_pred CCc--cccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh------
Confidence 433 2455689999999999986 6789999999999999999999999999999998888876443333322
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+.++|+.+++||.+||++||.+|||++|+|+||||+..
T Consensus 240 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 240 -------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 24689999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-56 Score=469.44 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=223.8
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|++++.||+|+||+||+|++..+|+.||||+++.... ..+..+.+.+|+.+|++|+|||||++++++.+.. .+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-EEEEEE
Confidence 49999999999999999999999999999999987654 3455677899999999999999999999998764 799999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|||.++++..+.....++++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CC
Confidence 9999988877666666899999999999999999999999999999999999999999999999999987543 24
Q ss_pred cccccccccCcccccC--CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 318 SRVVTLWYRAPELLLG--ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~--~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
..+||+.|||||++.+ ...|+.++|||||||+||||++|++||.+.+..+.+.++......+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~---------------- 233 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---------------- 233 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 5689999999999874 2468999999999999999999999999999888887776521100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.....+|+.+++||.+||++||.+|||++|+|+||||...
T Consensus 234 -----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 -----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -----------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0113578999999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-55 Score=473.06 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=226.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+.. .+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-EMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-EEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEEEE
Confidence 57999999999999999999999999999999997643 334556889999999999999999999998754 899999
Q ss_pred Eeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc--CCCcEEEEecccceecCCCCCC
Q 006004 238 EYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLIN--NAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 238 Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld--~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||+|+.+ ..+...+.+|++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|..+....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 99997554 55666666899999999999999999999999999999999999998 57899999999999876543
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
......||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|......++..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 250 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------------ 250 (352)
T ss_dssp CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS------------
T ss_pred ceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------
Confidence 3456689999999999986 679999999999999999999999999999999988887644333222
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.+..+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus 251 -------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 -------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 224689999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=456.04 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=215.7
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc---CCcEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR---SGSLYLV 236 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---~~~l~lV 236 (665)
|++.++||+|+||+||+|++..+++.||+|++..........+.+.+|+++|++|+|||||+++++|.+. ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4777899999999999999999999999999987766677778899999999999999999999998753 3468999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEc-CCCcEEEEecccceecCCCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRG--ILHRDIKGSNLLIN-NAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKPeNILld-~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||+++.+..+......+++.+++.|+.||+.||+|||++| |+||||||+||||+ .++.+||+|||+|+.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 999998776665555568999999999999999999999998 99999999999997 5789999999999865432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
...+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+....+.+.+.... +..+..
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~~----------- 233 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPAS----------- 233 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGG-----------
T ss_pred -ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCcc-----------
Confidence 2456789999999999875 5899999999999999999999999887665554433221 111111
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFK 444 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~ 444 (665)
.....++++.+||.+||++||++|||++|+|+||||+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1235788999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=471.99 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=225.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||+++++|.+.. .+||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-EEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-cccc
Confidence 4689999999999999999999999999999999975432 2234566889999999999999999999999865 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||.|+.+..+......+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~ 161 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Ccc
Confidence 9999998777666666668999999999999999999999999999999999999999999999999999876432 233
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.++....-
T Consensus 162 ~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~------------------ 222 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------ 222 (337)
T ss_dssp BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred cccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC------------------
Confidence 566799999999999987 6789999999999999999999999999998888777755210
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
..+..+|+++++||.+||++||.+|+ ++.|+|+||||+..
T Consensus 223 -----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 11246899999999999999999999 49999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=466.02 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=220.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
+.|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|++|+|||||++++++.+.+ .+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-eEEEEE
Confidence 46999999999999999999999999999999997653 234566889999999999999999999998765 799999
Q ss_pred Eeccccchhhh-cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLAGLA-TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||.|+.+..+ ......|++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|....... ...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 99998666544 4445679999999999999999999999999999999999999999999999999998653211 123
Q ss_pred ccccccccccCcccccC----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 317 TSRVVTLWYRAPELLLG----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.+.+||+.|+|||++.. ...|+.++|||||||+||+|++|++||.+.+..+.+.++.... ++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~------------ 233 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP------------ 233 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC------------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------------
Confidence 45689999999999852 3568999999999999999999999999999888887776521 10
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.......+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 234 ------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00112468999999999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=476.40 Aligned_cols=284 Identities=25% Similarity=0.354 Sum_probs=214.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 156 RADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 156 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
..++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|++|+|||||+++++|.+.. .+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-EEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEEE
Confidence 3568999999999999999999999999999999998653 3344567889999999999999999999998865 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||||.|+.+..+......+++.+++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|..+....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999986666555555579999999999999999999997 599999999999999999999999999998764322
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhHHhhhc--ccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVE-QMHKIFKLCGSPSEDYWRKSK--SAH 391 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~kI~~~~g~p~~~~~~~~~--~~~ 391 (665)
..+.+||++|||||++.+ ..|+.++||||||||+|||++|+.||.+.+..+ +...+....+.+......... ...
T Consensus 160 -~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 356799999999999987 679999999999999999999999998876433 232233333322211100000 000
Q ss_pred ---ccCCCCCCcchhhh----h-----hhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 392 ---ATSFKPQQPYKRKV----L-----ETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 392 ---~~~~~~~~p~~~~~----~-----~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
.....+........ . .....++.++++||.+||.+||.+||||+|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000000000000 0 001246889999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=462.37 Aligned_cols=294 Identities=45% Similarity=0.734 Sum_probs=239.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-------
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR------- 229 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~------- 229 (665)
.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++|+||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3589999999999999999999999999999999876655444556678999999999999999999987553
Q ss_pred CCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecC
Q 006004 230 SGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYD 309 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~ 309 (665)
.+.+|+||||+.++++.........+++.+++.+++||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 24689999999999988888877889999999999999999999999999999999999999999999999999998765
Q ss_pred CCC---CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 310 PSQ---NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 310 ~~~---~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
... .....+.+||++|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+...++.+..+.|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 22344568999999999998777899999999999999999999999999999999999999999998876654
Q ss_pred hccccccC-CCCCCcchhhhhhhc--cCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCC
Q 006004 387 SKSAHATS-FKPQQPYKRKVLETF--RNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPC 450 (665)
Q Consensus 387 ~~~~~~~~-~~~~~p~~~~~~~~~--~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~ 450 (665)
........ ..............+ ...++++++||.+||.+||++|+||.|+|+||||++.|.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 32211111 000000011111111 23578899999999999999999999999999999876654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=460.51 Aligned_cols=285 Identities=39% Similarity=0.679 Sum_probs=235.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCC-CcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC---CCCCcceeeeeeecc---
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLET-GKIVALKKVRFANMDPESVRFMAREIHILRKL---DHPNVMKLEGLVTSR--- 229 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~--- 229 (665)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999766 67899999976544333333456788887766 799999999998632
Q ss_pred -CCcEEEEEEeccccchhhh-cCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 230 -SGSLYLVFEYMEHDLAGLA-TTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 230 -~~~l~lV~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
...+|++|||+.++++... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3468999999998876543 34556799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 308 YDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 308 ~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
.... ......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+++.+|...++.+....|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 23456789999999999987 67999999999999999999999999999999999999999999988877654
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.......+.... ..........+++.+++||.+||.+||.+||||.|+|+||||++.
T Consensus 243 ~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 332222221111 112334456789999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=466.30 Aligned_cols=296 Identities=33% Similarity=0.578 Sum_probs=238.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC-----Cc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS-----GS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----~~ 232 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|++|+|||||+++++|.... ..
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5899999999999999999999999999999999876666677788999999999999999999999987643 25
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+||||||++.++...... ..|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 98 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 799999996665555433 36999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
.+..+||+.|+|||++.+...++.++|||||||+||+|++|++||.+.+..+.+..+....+.++.++|........
T Consensus 175 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 45678999999999998767789999999999999999999999999999999999999999999988765432211
Q ss_pred cCCCCC--CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCCCCCCCCCCCC
Q 006004 393 TSFKPQ--QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLPCDPSNLPKYP 459 (665)
Q Consensus 393 ~~~~~~--~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~~~p~~~p~~~ 459 (665)
...... ......+...+.++++++++||.+||.+||.+||||.|+|+||||++...+.+....+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~ 320 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 320 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCC
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCC
Confidence 100000 0011123344567899999999999999999999999999999999765544444444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-55 Score=464.75 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=225.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+.. .+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-EEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-eeee
Confidence 3579999999999999999999999999999999975432 1234567889999999999999999999998765 8999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999887777777778999999999999999999999999999999999999999999999999999986533
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
..+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|.....
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------ 218 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------ 218 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------------
Confidence 345689999999999986 6789999999999999999999999999999888888765211
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
.....+++++.+||.+||.+||.+|+ |++++|+||||++.
T Consensus 219 -----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 -----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 11135889999999999999999996 99999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-55 Score=467.74 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=223.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||+++++|.... .+|+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-cccc
Confidence 4689999999999999999999999999999999975332 1233566889999999999999999999998765 7899
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
||||+.++.+.........|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999998766655555558999999999999999999999999999999999999999999999999999987532
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.+|......
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 256 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----------------- 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC-----------------
Confidence 345689999999999987 67899999999999999999999999999988888887653111
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
....+++++.+||.+||.+||.+|+ |++++|+||||+..
T Consensus 257 ------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 257 ------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 1235899999999999999999995 99999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=445.49 Aligned_cols=287 Identities=38% Similarity=0.673 Sum_probs=248.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||++++++.... .+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEEe
Confidence 5799999999999999999999999999999999877655566778899999999999999999999998865 789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCcc
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPLT 317 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~~ 317 (665)
|++.++++..+......+++.+++.++.|++.||+|||++||+||||||+||||+.++.+||+|||+|........ ...
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~ 159 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence 9999988888777778899999999999999999999999999999999999999999999999999998754332 234
Q ss_pred cccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCC
Q 006004 318 SRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFK 396 (665)
Q Consensus 318 ~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~ 396 (665)
...+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++.++....+.+....|............
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 456789999999998766789999999999999999999866 6788888999999999999988877654333322222
Q ss_pred CCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 397 PQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 397 ~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
+..+...........+++.+++||.+||++||.+||||+|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 33333444555667889999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-54 Score=446.89 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=222.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC---H----HHHHHHHHHHHHHHhCC-CCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD---P----ESVRFMAREIHILRKLD-HPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~----~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~ 228 (665)
.++|++++.||+|+||+||+|++..+|+.||||+++..... . ...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999999999999999999765432 1 22346789999999997 9999999999987
Q ss_pred cCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceec
Q 006004 229 RSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTY 308 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~ 308 (665)
.. .+|||||||+++.+..++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 82 ~~-~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NT-FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SS-EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred Cc-ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 54 89999999987544444444558999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccccccccccCcccccC-----CcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhH
Q 006004 309 DPSQNLPLTSRVVTLWYRAPELLLG-----ATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDY 383 (665)
Q Consensus 309 ~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~ 383 (665)
.... ..+..+||+.|+|||++.+ ...|+.++||||+||+||+|++|+.||.+.+..+.+..|....-.++.
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 236 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS-- 236 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC--
Confidence 6533 2455789999999999863 245788999999999999999999999999988888877653211111
Q ss_pred HhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCC
Q 006004 384 WRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKT 445 (665)
Q Consensus 384 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~ 445 (665)
..+.++|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus 237 -----------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 -----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 123478999999999999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=460.58 Aligned_cols=280 Identities=37% Similarity=0.580 Sum_probs=234.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCcE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGSL 233 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~l 233 (665)
+|+.+++||+|+||+||+|+++.+|+.||||++..... .+.+|+.+|++|+|||||+++++|... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 59999999999999999999999999999999976432 134799999999999999999998542 2358
Q ss_pred EEEEEeccccchhhhc---CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecC
Q 006004 234 YLVFEYMEHDLAGLAT---TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYD 309 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~ 309 (665)
|||||||++++...+. .....+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999987655443 3556799999999999999999999999999999999999999775 89999999998875
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ...+.+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.+|.+.+|.+..+.|.....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 433 345678999999999998767899999999999999999999999999999999999999999999998876543
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
.......+..............+++++++||.+||.+||.+||||.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 322221111111111122334689999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=457.21 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=225.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|++++|||||+++++|.+.. .+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESME-ELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-EEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-EEEEE
Confidence 468999999999999999999999999999999997643 23345789999999999999999999998765 89999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC--CcEEEEecccceecCCCCC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA--GVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~--g~lKL~DFGlA~~~~~~~~ 313 (665)
||||+|+ |...+...+..+++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999974 555555555679999999999999999999999999999999999999854 489999999999875432
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
.....++|+.|+|||++.+ ..|+.++|||||||+||+|++|.+||.+.+..+.+.+|.+....++...|
T Consensus 159 -~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 227 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH---------
T ss_pred -cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc---------
Confidence 2455688999999999876 67899999999999999999999999999999999998875544444433
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
..+|+++++||.+||.+||.+|||+.|+|+||||+..
T Consensus 228 ----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 4689999999999999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-54 Score=462.43 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=214.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC----CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM----DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .........+|+.+++.++|||||+++++|.+.. .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-K 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-E
Confidence 5689999999999999999999999999999999975432 1122222334577778889999999999998765 7
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|||||||.|+.+..++.....+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999976665555555689999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
....+||+.|+|||++.....|+.++|||||||+||+|++|++||.+.+..+....+..... ..
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~------------ 225 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA------------ 225 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS-CC------------
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC------------
Confidence 34568999999999998657799999999999999999999999987654433322211111 00
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcC-----HHHHHhCcCCCCC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGS-----AASALRSEFFKTE 446 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpT-----a~eaL~Hp~f~~~ 446 (665)
...+..+|+++++||.+||.+||.+||| |+|+|+||||++.
T Consensus 226 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 -------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 0112468999999999999999999999 8999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=451.06 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=220.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHH-hCCCCCcceeeeeeeccCCcEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILR-KLDHPNVMKLEGLVTSRSGSLYL 235 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~~~~~~~~l~l 235 (665)
++|++++.||+|+||+||+|+++.+|+.||||+++.... ..+..+.+.+|+.++. .++|||||++++++.+.. .+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-EEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-ceeE
Confidence 689999999999999999999999999999999975421 1223445667777765 689999999999998865 7999
Q ss_pred EEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 236 VFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 236 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||||+++.+..+......+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~ 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AK 159 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-cc
Confidence 99999986666656556689999999999999999999999999999999999999999999999999998765332 33
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
.+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+.+|... .+
T Consensus 160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~---------------- 220 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP---------------- 220 (320)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC----------------
T ss_pred ccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------
Confidence 455689999999999987 67899999999999999999999999999988888877541 11
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH-HHHhCcCCCCC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA-SALRSEFFKTE 446 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~-eaL~Hp~f~~~ 446 (665)
.....+|+++.+||.+||.+||.+|||+. ++++||||+..
T Consensus 221 -----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 -----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 01135899999999999999999999995 89999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=458.58 Aligned_cols=285 Identities=30% Similarity=0.508 Sum_probs=229.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|++++|||||+++++|... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 479999999999999999999999999999999987766777777899999999999999999999998643 257
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|+|||||.++++..+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 89999999999887764 368999999999999999999999999999999999999999999999999988765432
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
..+..++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++.++....+.+..++|........
T Consensus 174 --~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --ccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3456689999999999987 6789999999999999999999999999999999999999999999988865321110
Q ss_pred ---cCC--CCCCcchh--------hhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCC
Q 006004 393 ---TSF--KPQQPYKR--------KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPL 448 (665)
Q Consensus 393 ---~~~--~~~~p~~~--------~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~ 448 (665)
... ....+... ........+++++++||++||.+||++||||+|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 000 00000000 001112245788999999999999999999999999999987543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=449.49 Aligned_cols=285 Identities=35% Similarity=0.586 Sum_probs=231.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeecc-----CCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSR-----SGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~~~ 232 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++.........+.+.+|+++|++|+|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 579999999999999999999999999999999987666667777889999999999999999999998642 223
Q ss_pred EEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 233 LYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
+|++++++.|+|..++ .. .+|++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~-~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIV-KC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CEEEEECCSEEHHHHH-TT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EEEEEeecCCchhhhc-cc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 4555544445555544 33 3699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 313 NLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 313 ~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......|....+.+..+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 245668999999999988877789999999999999999999999999999999999999999988876654322111
Q ss_pred cCC---CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 393 TSF---KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 393 ~~~---~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
..+ .... ....+...+..+++++++||.+||.+||.+||||.|+|+||||+....+
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 252 RNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHTTSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhhcccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 100 0011 1112334456789999999999999999999999999999999976443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=446.12 Aligned_cols=289 Identities=35% Similarity=0.568 Sum_probs=233.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC----CcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS----GSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----~~l 233 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 47999999999999999999999999999999997644 3455667889999999999999999999986542 346
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||+|+++.++|...+... .+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|........
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 777777767777666443 699999999999999999999999999999999999999999999999999987644322
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......+||+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...++.+............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 234556899999999998776788999999999999999999999999999999999999888888776543221111
Q ss_pred ccCC--CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCCCC
Q 006004 392 ATSF--KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEPLP 449 (665)
Q Consensus 392 ~~~~--~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~~~ 449 (665)
...+ .............+.++++.+++||.+||.+||.+||||.|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 1000 000111112334566889999999999999999999999999999999966443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=443.42 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=208.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCH----HHHHHHHHHHHHHHhCC--CCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDP----ESVRFMAREIHILRKLD--HPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|++++ |||||+++++|.+.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 47999999999999999999999999999999997643321 11233568999999996 899999999998765
Q ss_pred cEEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCcEEEEecccceecC
Q 006004 232 SLYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-AGVLKIGDFGLATTYD 309 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-~g~lKL~DFGlA~~~~ 309 (665)
.+|+||||+.+ +++..+......+++.+++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 79999999975 444444444457999999999999999999999999999999999999985 5799999999998764
Q ss_pred CCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 310 PSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 310 ~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ..++.+||+.|+|||++.+...++.++|||||||+||+|++|+.||.+.+ .+.+. .
T Consensus 163 ~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~----------- 220 (273)
T d1xwsa_ 163 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q----------- 220 (273)
T ss_dssp SS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C-----------
T ss_pred cc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c-----------
Confidence 33 24567899999999999876667888999999999999999999997632 12211 0
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
......+|+++++||.+||.+||.+|||++|+|+||||+..
T Consensus 221 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01113589999999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-52 Score=437.91 Aligned_cols=281 Identities=30% Similarity=0.512 Sum_probs=226.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeecc-CCcEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSR-SGSLY 234 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~-~~~l~ 234 (665)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.|. ||||++++++|... ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 468999999999999999999999999999999997432 355789999999995 99999999999754 45799
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-cEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG-VLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g-~lKL~DFGlA~~~~~~~~ 313 (665)
+|||||.++.+..+. ..|++.+++.+++||+.||.|||++||+||||||+||||+.++ .+||+|||+|..+....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999987765543 3699999999999999999999999999999999999998655 69999999999875443
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhHHhh-hcccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPG-RTEVEQMHKIFKLCGSPSEDYWRK-SKSAH 391 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~kI~~~~g~p~~~~~~~-~~~~~ 391 (665)
.....++|+.|+|||++.+...|+.++|||||||++|+|++|+.||.. .+..++...+...+|.+....|.. .....
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 245668999999999998877789999999999999999999999865 456778888888887654433322 11111
Q ss_pred ccCC------CCCCcchh-hhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCCC
Q 006004 392 ATSF------KPQQPYKR-KVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTEP 447 (665)
Q Consensus 392 ~~~~------~~~~p~~~-~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~~ 447 (665)
...+ ........ ........+++++++||++||.+||.+||||+|||+||||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000 00111111 11222345889999999999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-52 Score=432.47 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=213.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC---CcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS---GSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~l 233 (665)
++|++++.||+|+||+||+|++..+|+.||||+++.... +.+....+.+|+.+|++++|||||++++++.... ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 579999999999999999999999999999999986644 4566778999999999999999999999987653 248
Q ss_pred EEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 234 YLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||||||+|+.+..+......+++.+++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++........
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 99999999877665555556899999999999999999999999999999999999999999999999999887643322
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+.++......++.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 235 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---------- 235 (277)
T ss_dssp ------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG----------
T ss_pred cccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc----------
Confidence 23456689999999999986 67899999999999999999999999999988888777653222111
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFF 443 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f 443 (665)
.....+|+.+.+||.+||++||.+||+..+.|.|+|+
T Consensus 236 ---------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ---------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 2234789999999999999999999965556667664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=447.14 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=207.7
Q ss_pred CCCeeEEE-EeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHh-CCCCCcceeeeeeecc---CC
Q 006004 157 ADAFEKID-KIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRK-LDHPNVMKLEGLVTSR---SG 231 (665)
Q Consensus 157 ~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~---~~ 231 (665)
.++|+++. .||+|+||+||+|+++.+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+. +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 45799986 499999999999999999999999999642 346789998765 5899999999998752 34
Q ss_pred cEEEEEEeccc-cchhhhcCC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccce
Q 006004 232 SLYLVFEYMEH-DLAGLATTP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLAT 306 (665)
Q Consensus 232 ~l~lV~Ey~~g-~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~ 306 (665)
.+|||||||+| +|...+... ...|++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 68999999986 555555544 357999999999999999999999999999999999999985 5679999999999
Q ss_pred ecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhh
Q 006004 307 TYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRK 386 (665)
Q Consensus 307 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~ 386 (665)
...... .....+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+........
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCCC--ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 875433 2456689999999999876 6799999999999999999999999998776555544433211000
Q ss_pred hccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhCcCCCCC
Q 006004 387 SKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRSEFFKTE 446 (665)
Q Consensus 387 ~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~Hp~f~~~ 446 (665)
...| ...+..+|+++++||.+||++||.+|||+.|+|+||||...
T Consensus 234 ----------~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ----------YEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------SSCC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------CCCC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0001 01223589999999999999999999999999999999653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=427.28 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=209.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..+|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEE
Confidence 357999999999999999999853 359999998776666777889999999999999999999998654 368999
Q ss_pred EEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC-CC
Q 006004 237 FEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ-NL 314 (665)
Q Consensus 237 ~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~-~~ 314 (665)
||||+++ |...+......+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999965 445555556679999999999999999999999999999999999999999999999999998765332 22
Q ss_pred CcccccccccccCcccccCC--cccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGA--TKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~--~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
......||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+..+.+..+......++.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~----------- 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD----------- 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC-----------
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc-----------
Confidence 34566899999999998742 45899999999999999999999999998877766665442211110
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.....++|+++.+||.+||+.||.+|||+.+++++
T Consensus 231 ------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112234688999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=420.43 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=211.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.+|++|+|||||++++++.. +.+||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEE
Confidence 57999999999999999999975 6788999999765443 3458899999999999999999998754 3579999
Q ss_pred EeccccchhhhcCC--CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLAGLATTP--GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+++.+..+... ..++++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99998766543322 2359999999999999999999999999999999999999999999999999999876554444
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....||+.|+|||++.+ ..|+.++|||||||+||||+| |++||...+..+.+..+.....
T Consensus 167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------------- 228 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------- 228 (272)
T ss_dssp CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence 455678999999999986 578999999999999999999 5677777777776666643110
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh--CcCCC
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFFK 444 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~--Hp~f~ 444 (665)
+ .....+++++.+||.+||+.||++|||+.++++ |+||+
T Consensus 229 --~---------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 --M---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C---------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0 112368899999999999999999999999998 78885
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-51 Score=424.05 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=206.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++.+.||+|+||+||+|+++.+|+.||||+++..... .+.+.+|+.+|++|+|||||++++++.+.. .+||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC-eeEEEe
Confidence 5799999999999999999999999999999998765433 456889999999999999999999998754 789999
Q ss_pred Eeccccch-hhhc-CCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCC
Q 006004 238 EYMEHDLA-GLAT-TPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLP 315 (665)
Q Consensus 238 Ey~~g~ll-~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~ 315 (665)
|||+++.+ ..+. .....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99997554 4443 344679999999999999999999999999999999999999999999999999999876544433
Q ss_pred cccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhHHhhhccccccC
Q 006004 316 LTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPI-MPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATS 394 (665)
Q Consensus 316 ~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~ 394 (665)
.....||+.|+|||++.+ ..|+.++|||||||+||||++|..| |.+.+..+....+....
T Consensus 173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------------ 233 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------------ 233 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------------
Confidence 444568999999999986 5789999999999999999996655 55555444333332210
Q ss_pred CCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 395 FKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.+ .....+|+++.+||.+||+.||.+|||+.++++
T Consensus 234 -~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 -RM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 112468899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=415.46 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++. +++.||||+++...... +.+.+|+++|++++|||||++++++...+ .+||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEE
Confidence 57999999999999999999975 57789999998655433 45789999999999999999999988755 789999
Q ss_pred Eeccccch-hhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDLA-GLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
|||.++.+ ..+......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+........
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99997655 44555666799999999999999999999999999999999999999999999999999988755444444
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+......
T Consensus 160 ~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------------- 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------- 221 (263)
T ss_dssp -----CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------------
T ss_pred cceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------------
Confidence 45678999999999986 579999999999999999999 57888888877777766542100
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
......++++.+||.+||+.||.+|||++++|+|
T Consensus 222 -----------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -----------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0113568899999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=420.15 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=204.4
Q ss_pred EEeeccCceEEEEEEEC--CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEEEecc
Q 006004 164 DKIGQGTYSSVYKARDL--ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 164 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|++|+|||||++++++..+ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEEEEcCC
Confidence 46999999999999864 4567899999976555556667899999999999999999999998653 5899999999
Q ss_pred ccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC--Ccccc
Q 006004 242 HDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL--PLTSR 319 (665)
Q Consensus 242 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~--~~~~~ 319 (665)
++.+..+......+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...... .....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 8766655555668999999999999999999999999999999999999999999999999999987544322 22345
Q ss_pred cccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCCCCC
Q 006004 320 VVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQ 398 (665)
Q Consensus 320 ~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~ 398 (665)
.||+.|||||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+.+. .. +
T Consensus 171 ~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~-----------------~- 229 (277)
T d1xbba_ 171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER-----------------M- 229 (277)
T ss_dssp CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC-----------------C-
T ss_pred CCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC-----------------C-
Confidence 78999999999986 678999999999999999998 89999998887766666431 10 0
Q ss_pred CcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHH---HhCcCC
Q 006004 399 QPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA---LRSEFF 443 (665)
Q Consensus 399 ~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea---L~Hp~f 443 (665)
.....+|+++.+||.+||+.||.+|||++++ |+|+|+
T Consensus 230 --------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1123678999999999999999999999998 566665
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-50 Score=420.91 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=200.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc---EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK---IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|++|+|||||++++++.... .+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EE
Confidence 3579999999999999999999987765 58888876433 4556677899999999999999999999987654 78
Q ss_pred EEEEEeccccchhh-hcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLAGL-ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~-~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|||||||+++.+.. +......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999866654 55555679999999999999999999999999999999999999999999999999998775432
Q ss_pred CC----CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhh
Q 006004 313 NL----PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKS 387 (665)
Q Consensus 313 ~~----~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~ 387 (665)
.. ......||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+......+
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-------- 253 (299)
T ss_dssp -------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--------
T ss_pred CcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 21 1223467999999999886 678999999999999999998 899999999888777765421100
Q ss_pred ccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 388 KSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 388 ~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 254 --------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 --------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123578999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=416.51 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=212.9
Q ss_pred CCeeEEEE-eeccCceEEEEEEECC--CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDK-IGQGTYSSVYKARDLE--TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~-LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|.+.+. ||+|+||+||+|+++. ++..||||+++... .....+.+.+|+++|++|+|||||++++++.++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--eEE
Confidence 57888885 9999999999998764 45579999997543 456677889999999999999999999998753 589
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
||||||+++.+. .+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999976554 4455556899999999999999999999999999999999999999999999999999998754332
Q ss_pred --CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccc
Q 006004 314 --LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSA 390 (665)
Q Consensus 314 --~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~ 390 (665)
.......||+.|+|||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..|.+.. .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--~----------- 230 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R----------- 230 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--C-----------
T ss_pred ccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C-----------
Confidence 22334568999999999986 578999999999999999998 999999988877776664311 0
Q ss_pred cccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHH---HhCcCCC
Q 006004 391 HATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASA---LRSEFFK 444 (665)
Q Consensus 391 ~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~ea---L~Hp~f~ 444 (665)
......+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 231 ---------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ---------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01124688999999999999999999999887 6778764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=411.46 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=214.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|+++++||+|+||+||+|+++ +++.||||+++...... +.+.+|+.++++++|||||++++++.+.. .+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSS-SEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEE
Confidence 57999999999999999999984 78899999998765543 45789999999999999999999988754 799999
Q ss_pred Eeccccc-hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCCCc
Q 006004 238 EYMEHDL-AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNLPL 316 (665)
Q Consensus 238 Ey~~g~l-l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~~~ 316 (665)
||+.++. ...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+........
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9998654 455455566799999999999999999999999999999999999999999999999999987765544445
Q ss_pred ccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccccCC
Q 006004 317 TSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHATSF 395 (665)
Q Consensus 317 ~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~~~ 395 (665)
....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+...+|......+
T Consensus 159 ~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---------------- 221 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---------------- 221 (258)
T ss_dssp CCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----------------
T ss_pred cccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 55689999999999986 568999999999999999998 899999999888877775421110
Q ss_pred CCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 396 KPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 396 ~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+...++.+.+||.+||+.||++|||+.++|+|
T Consensus 222 ------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 ------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113578899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=424.62 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=206.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCc-----EEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGK-----IVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 579999999999999999999876554 69999886543 233445688999999998 8999999999998765
Q ss_pred cEEEEEEeccccch-hhhcCCC----------------------CCCChhHHHHHHHHHHHHHHHHHhCCccccCCCccc
Q 006004 232 SLYLVFEYMEHDLA-GLATTPG----------------------IKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSN 288 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll-~~~~~~~----------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeN 288 (665)
.+|||||||+++.+ ..+.... ..+++.+++.|+.||+.||.|||++|||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 78999999997544 4443322 248999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecccceecCCCCCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChH
Q 006004 289 LLINNAGVLKIGDFGLATTYDPSQNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEV 366 (665)
Q Consensus 289 ILld~~g~lKL~DFGlA~~~~~~~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 366 (665)
||++.++.+||+|||+|+........ ...+..||+.|||||++.+ ..|+.++|||||||+||||++ |++||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543332 2345678999999999986 678999999999999999997 89999998777
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+.+.++......+ .....+|+++.+||.+||+.||++|||++|+++|
T Consensus 274 ~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7666665421110 1123578999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=413.49 Aligned_cols=265 Identities=24% Similarity=0.379 Sum_probs=210.1
Q ss_pred cccccCCccCCCCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeee
Q 006004 146 GEAIKGWQPRRADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGL 225 (665)
Q Consensus 146 g~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~ 225 (665)
|...+.|... .++|++.+.||+|+||+||+|++..+ +.||||+++...... +.+.+|+.+|++++|||||+++++
T Consensus 6 ~~~~~~~~i~-~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 6 GLAKDAWEIP-RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp SSSTTCSBCC-GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCcceEcC-HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEE
Confidence 3344556543 46799999999999999999998655 579999997655443 457899999999999999999998
Q ss_pred eeccCCcEEEEEEeccccchhhhcC--CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 226 VTSRSGSLYLVFEYMEHDLAGLATT--PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 226 ~~~~~~~l~lV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
+.. +.+|+|||||.++.+..+.. ....+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||
T Consensus 81 ~~~--~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 81 VSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp ECS--SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred Eec--CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence 854 35799999999875544332 23469999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChh
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKIFKLCGSPSED 382 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~kI~~~~g~p~~~ 382 (665)
+|+.+............||+.|+|||++.. ..++.++|||||||+||||++| ++||.+....+.+..+......
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---- 233 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---- 233 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----
T ss_pred hhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----
Confidence 998875554444555678999999999986 6789999999999999999995 5667777777777666442111
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh--CcCCCCC
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR--SEFFKTE 446 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~--Hp~f~~~ 446 (665)
.....+++.+++||.+||+.||++|||+.+++. ++||+..
T Consensus 234 ------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 112367899999999999999999999999988 8999764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=430.69 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=217.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE---CCCCcEEEEEEEecCCC--CHHHHHHHHHHHHHHHhCCC-CCcceeeeeeeccC
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARD---LETGKIVALKKVRFANM--DPESVRFMAREIHILRKLDH-PNVMKLEGLVTSRS 230 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~ 230 (665)
.++|++++.||+|+||+||+|++ +.+|+.||||+++.... +....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999997 44789999999865432 12234557899999999977 89999999998865
Q ss_pred CcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCC
Q 006004 231 GSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDP 310 (665)
Q Consensus 231 ~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~ 310 (665)
.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+..
T Consensus 103 -~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 103 -KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred -ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 7999999999876666665556789999999999999999999999999999999999999999999999999988755
Q ss_pred CCCCCcccccccccccCcccccCCc-ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 311 SQNLPLTSRVVTLWYRAPELLLGAT-KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 311 ~~~~~~~~~~gT~~Y~APE~l~~~~-~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
..........||+.|+|||++.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+....+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~---------- 251 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------- 251 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC----------
Confidence 4444456678999999999997543 57889999999999999999999999876655555554321000
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCc-----CHHHHHhCcCCCCC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRG-----SAASALRSEFFKTE 446 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~Rp-----Ta~eaL~Hp~f~~~ 446 (665)
....+..+++.+++||.+||++||.+|+ |++|+|+||||+..
T Consensus 252 ---------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 252 ---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 0011246899999999999999999999 59999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=410.84 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=199.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~ 234 (665)
++|++.+.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence 57999999999999999999987654 468888876433 44556778999999999999999999999864 3689
Q ss_pred EEEEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC
Q 006004 235 LVFEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN 313 (665)
Q Consensus 235 lV~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~ 313 (665)
|||||+.++.+. .+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999975554 4455566899999999999999999999999999999999999999999999999999988765444
Q ss_pred CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhccccc
Q 006004 314 LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHA 392 (665)
Q Consensus 314 ~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~ 392 (665)
...+...||+.|+|||++.+ ..|+.++|||||||+||||++ |.+||.+.+..+.+.++.... .
T Consensus 164 ~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--~------------- 227 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--R------------- 227 (273)
T ss_dssp -------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--C-------------
T ss_pred eeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-------------
Confidence 44455678999999999986 678999999999999999998 899999998888777765421 0
Q ss_pred cCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 393 TSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
...+.++|+.+.+||.+||+.||.+|||+.|+++|
T Consensus 228 -------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 -------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01124689999999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=401.82 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=198.9
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC----cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG----KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
+.|++.+.||+|+||+||+|+++.++ ..||||+++... .......+.+|+.+|++|+|||||++++++.... .+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ce
Confidence 46999999999999999999987665 479999997543 4455567889999999999999999999987754 78
Q ss_pred EEEEEeccccchhh-hcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHDLAGL-ATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~-~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
++|||||.++++.. +......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999999876554 44455679999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 NL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ......||+.|||||++.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..+.....
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------ 231 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------------ 231 (283)
T ss_dssp ---------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------
T ss_pred ccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC------------
Confidence 21 2234468999999999986 6799999999999999999995 566666666665555433110
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+ ....++++.+.+||.+||+.||.+|||+.++++
T Consensus 232 -------~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 -------L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------C---------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 0 112357889999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=412.02 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=204.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCc----EEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGK----IVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
.++|++++.||+|+||+||+|++..+|+ .||+|+++... .....+.+.+|+.+|++|+|||||++++++.+. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--C
Confidence 3579999999999999999999988886 57888776432 334456789999999999999999999998764 4
Q ss_pred EEEEEEeccc-cchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCC
Q 006004 233 LYLVFEYMEH-DLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 233 l~lV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~ 311 (665)
.+++|||+.+ +++..+......+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 6788888774 566666666778999999999999999999999999999999999999999999999999999987544
Q ss_pred CCC-CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 312 QNL-PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 312 ~~~-~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred cccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 332 2334568999999999987 578999999999999999998 89999988776665555431100
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 233 -----------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1123678999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=406.43 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=198.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++++.||+|+||.||+|++.. +++.||||+++... .....+.+.+|+.++.++ .|+|||.+++++.....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 579999999999999999999754 45789999987543 344456677888888776 68999999998877666
Q ss_pred cEEEEEEeccccchhhhcC-C---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC
Q 006004 232 SLYLVFEYMEHDLAGLATT-P---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAG 295 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~-~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g 295 (665)
.+|+|||||+++.+..+.. . ...+++.++..|+.||+.||.|||++||+||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 7999999999765544332 1 23589999999999999999999999999999999999999999
Q ss_pred cEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 006004 296 VLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKIF 373 (665)
Q Consensus 296 ~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~kI~ 373 (665)
.+||+|||+|+....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987654332 23445689999999999987 6789999999999999999986 57898877665555544
Q ss_pred HhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 374 KLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 374 ~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.....+ .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 251 ~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 321100 1123578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=399.45 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=200.2
Q ss_pred CCeeEEEEeeccCceEEEEEEECC-CC--cEEEEEEEecCCC-CHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLE-TG--KIVALKKVRFANM-DPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~-~g--~~vAiK~i~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l 233 (665)
++|++++.||+|+||.||+|++.. ++ ..||||++..... ..+..+.+.+|+.+|++|+|||||++++++.+. .+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence 479999999999999999998653 33 3689999876543 334567789999999999999999999999753 57
Q ss_pred EEEEEecccc-chhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCC
Q 006004 234 YLVFEYMEHD-LAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQ 312 (665)
Q Consensus 234 ~lV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~ 312 (665)
|+||||++++ +...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999864 444555555679999999999999999999999999999999999999999999999999999875443
Q ss_pred CC--CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcc
Q 006004 313 NL--PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKS 389 (665)
Q Consensus 313 ~~--~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~ 389 (665)
.. ......||..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+.+.++.+....+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~---------- 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------- 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC----------
T ss_pred CcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC----------
Confidence 21 2233467889999999987 678999999999999999998 899999999998888875521111
Q ss_pred ccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 390 AHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 390 ~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
.....+|+.+.+||.+||..||.+|||+.+++.
T Consensus 235 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 -----------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112468899999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=399.68 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=208.1
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGS 232 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~ 232 (665)
++|++++.||+|+||+||+|+++ .+++.||||+++... .....+.+.+|+++|++|+||||+++++++.... .
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-P 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-S
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-c
Confidence 57999999999999999999975 356889999987543 4555677899999999999999999999998754 7
Q ss_pred EEEEEEeccccchhhhc-CC-----------------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCccc
Q 006004 233 LYLVFEYMEHDLAGLAT-TP-----------------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSN 288 (665)
Q Consensus 233 l~lV~Ey~~g~ll~~~~-~~-----------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeN 288 (665)
+++||||+.++.+..+. .. ...|++.++..|+.||+.||+|||++|||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 89999999865444332 11 1248999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChH
Q 006004 289 LLINNAGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEV 366 (665)
Q Consensus 289 ILld~~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~ 366 (665)
|||+.++.+||+|||+|+.+..... ...++..||+.|+|||++.+ ..|+.++|||||||+||||++|. +||.+.+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 9999999999999999987644322 23345678999999999986 67999999999999999999985 789999988
Q ss_pred HHHHHHHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 367 EQMHKIFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 367 e~l~kI~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.+..+..... .....++++++.+||.+||+.||.+|||+.|+++
T Consensus 250 e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88877654210 0112468899999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-47 Score=394.36 Aligned_cols=261 Identities=19% Similarity=0.259 Sum_probs=207.8
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+|+|.++..+.......++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998765432 236789999999988877666555555555889999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC---CCcEEEEecccceecCCCCC-
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN---AGVLKIGDFGLATTYDPSQN- 313 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~---~g~lKL~DFGlA~~~~~~~~- 313 (665)
||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99999988887777778999999999999999999999999999999999999864 45799999999998754322
Q ss_pred -----CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhHHhhhc
Q 006004 314 -----LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSK 388 (665)
Q Consensus 314 -----~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~ 388 (665)
......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+....+....+......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---------- 231 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------- 231 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----------
T ss_pred cceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----------
Confidence 12345689999999999987 66899999999999999999999999887665544443321100
Q ss_pred cccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHH---HHHhCcCCC
Q 006004 389 SAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAA---SALRSEFFK 444 (665)
Q Consensus 389 ~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~---eaL~Hp~f~ 444 (665)
...........++|+++.+||..||..||.+||++. ++|+|+|.+
T Consensus 232 -----------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 232 -----------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000011223457899999999999999999999986 557888764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=390.95 Aligned_cols=245 Identities=21% Similarity=0.362 Sum_probs=197.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
.++|++++.||+|+||.||+|++ +|..||||+++... ..+.+.+|+++|++|+|||||++++++....+.+|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 35799999999999999999998 47899999997543 3456789999999999999999999886655578999
Q ss_pred EEeccccchhhhc-CC-CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCCC
Q 006004 237 FEYMEHDLAGLAT-TP-GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQNL 314 (665)
Q Consensus 237 ~Ey~~g~ll~~~~-~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~~ 314 (665)
|||++++.+..++ .. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999876555443 22 2358999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhHHhhhcccccc
Q 006004 315 PLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHKIFKLCGSPSEDYWRKSKSAHAT 393 (665)
Q Consensus 315 ~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~kI~~~~g~p~~~~~~~~~~~~~~ 393 (665)
....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+..|....
T Consensus 158 --~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------------- 217 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------- 217 (262)
T ss_dssp ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------------
T ss_pred --ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 33467999999999986 578999999999999999998 789998887777666653210
Q ss_pred CCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 394 SFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
.+ +....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 218 --~~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 --KM---------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CC---------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 1123678999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=397.03 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=203.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCCCcE--EEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCCcE
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLETGKI--VALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSGSL 233 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~~l 233 (665)
.++|++.+.||+|+||+||+|+++.+|.. ||||.++... ..+..+.+.+|+.+|+++ +|||||++++++.... .+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-EE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-ee
Confidence 46899999999999999999999988875 6677765433 234456789999999999 7999999999998754 89
Q ss_pred EEEEEeccccchhhhcC----------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcE
Q 006004 234 YLVFEYMEHDLAGLATT----------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVL 297 (665)
Q Consensus 234 ~lV~Ey~~g~ll~~~~~----------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~l 297 (665)
||||||++++.+..++. ....|++.++..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 99999999755544432 23579999999999999999999999999999999999999999999
Q ss_pred EEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhc
Q 006004 298 KIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGK-PIMPGRTEVEQMHKIFKLC 376 (665)
Q Consensus 298 KL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~kI~~~~ 376 (665)
||+|||+|+....... .....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+....
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999987543322 234468999999999986 67899999999999999999965 6898888777766653310
Q ss_pred CCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 377 GSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 377 g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
. ......+++++.+||.+||+.||++|||+.++|+|
T Consensus 244 -------------------~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 -------------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -------------------C---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------C---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 01123688999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=392.60 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=203.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCC-------cEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeecc
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETG-------KIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSR 229 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~ 229 (665)
++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 58999999999999999999976654 479999997544 445566788899999888 899999999999875
Q ss_pred CCcEEEEEEeccccchhhhcC-C---------------CCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 230 SGSLYLVFEYMEHDLAGLATT-P---------------GIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 230 ~~~l~lV~Ey~~g~ll~~~~~-~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
. .+|+|||||.++.+..++. . ...+++.++..|+.||+.||+|||++|||||||||+|||++.
T Consensus 92 ~-~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 92 G-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp S-SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred C-eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 4 7899999999765544432 2 235899999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||+++....... .......+|+.|+|||++.+ ..|+.++||||||||||||++ |++||.+.+..+....
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 99999999999997754332 23445678999999999986 679999999999999999998 7999998887665555
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+.... .+ .....+++++.+||.+||+.||.+|||+.|+|+
T Consensus 250 i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 250 LKEGH-RM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTC-CC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCC-CC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 43210 00 112368899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=393.48 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=209.5
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhC-CCCCcceeeeeeeccCC
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDL-----ETGKIVALKKVRFANMDPESVRFMAREIHILRKL-DHPNVMKLEGLVTSRSG 231 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~ 231 (665)
++|++.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++.| +|||||++++++....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 58999999999999999999863 467899999997654 345566788999999999 6999999999998765
Q ss_pred cEEEEEEeccccchhhhcC------------------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC
Q 006004 232 SLYLVFEYMEHDLAGLATT------------------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN 293 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~~~~~------------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~ 293 (665)
.+|||||||+++.+..+.. ....+++.++..|+.||+.||.|||++||+||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 6899999999765544332 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 006004 294 AGVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFA-GKPIMPGRTEVEQMHK 371 (665)
Q Consensus 294 ~g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~k 371 (665)
++.+||+|||+++....... ...+..+||+.|+|||++.+ ..++.++|||||||+||||+| |.+||.+.+..+.+.+
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998754332 23345688999999999986 678999999999999999998 7788888877777666
Q ss_pred HHHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 372 IFKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 372 I~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+......+ .....+++.+.+||.+||+.||.+|||+.++|+
T Consensus 260 ~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 260 MIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 65421110 112357899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=393.07 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=214.8
Q ss_pred cCCccCCCCCeeEEEEeeccCceEEEEEEECC-----CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeee
Q 006004 150 KGWQPRRADAFEKIDKIGQGTYSSVYKARDLE-----TGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEG 224 (665)
Q Consensus 150 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~ 224 (665)
+.|... .++|++.++||+|+||+||+|++.. ++..||||+++... .......+.+|++++++++|||||++++
T Consensus 13 ~~~ei~-~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVA-REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCC-GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeec-HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 456433 3689999999999999999998752 45789999997543 4455567899999999999999999999
Q ss_pred eeeccCCcEEEEEEeccccchhhhcC----------CCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCC
Q 006004 225 LVTSRSGSLYLVFEYMEHDLAGLATT----------PGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNA 294 (665)
Q Consensus 225 ~~~~~~~~l~lV~Ey~~g~ll~~~~~----------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~ 294 (665)
++.... .+++|||||.++.+..+.. ....+++.++..++.||+.||.|||+++|+||||||+||||+.+
T Consensus 91 ~~~~~~-~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 91 VVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EECSSS-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEecCC-ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 987654 7899999998754443221 11347889999999999999999999999999999999999999
Q ss_pred CcEEEEecccceecCCCCC-CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 006004 295 GVLKIGDFGLATTYDPSQN-LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAG-KPIMPGRTEVEQMHKI 372 (665)
Q Consensus 295 g~lKL~DFGlA~~~~~~~~-~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~kI 372 (665)
+++||+|||+|+.+..... ......+||+.|+|||.+.+ ..++.++|||||||+||||+|| .+||.+.+..+.+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987643322 22344578999999999986 6789999999999999999998 5889998888887776
Q ss_pred HHhcCCCChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh------CcCCC
Q 006004 373 FKLCGSPSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR------SEFFK 444 (665)
Q Consensus 373 ~~~~g~p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~------Hp~f~ 444 (665)
.+... ......+++.+.+||.+||+.||.+|||+.++++ +|+|+
T Consensus 249 ~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 249 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 54210 0112367899999999999999999999999998 56654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-45 Score=391.22 Aligned_cols=281 Identities=25% Similarity=0.407 Sum_probs=216.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-----------CCCcceeeeee
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-----------HPNVMKLEGLV 226 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l~~~~ 226 (665)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.+. |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3699999999999999999999999999999999753 334456788999998875 57899999988
Q ss_pred ecc-CCcEEEEEEecccc--c-hhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCc-----
Q 006004 227 TSR-SGSLYLVFEYMEHD--L-AGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS-RGILHRDIKGSNLLINNAGV----- 296 (665)
Q Consensus 227 ~~~-~~~l~lV~Ey~~g~--l-l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKPeNILld~~g~----- 296 (665)
... ....+++|+++... . ..........+++..++.++.||+.||.|||+ .||+||||||+||||+.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 654 33566777776532 2 22333445679999999999999999999998 89999999999999987653
Q ss_pred -EEEEecccceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCC------hHHHH
Q 006004 297 -LKIGDFGLATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRT------EVEQM 369 (665)
Q Consensus 297 -lKL~DFGlA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e~l 369 (665)
+||+|||.+...... ....+||+.|+|||++.+ ..|+.++|||||||++++|++|+.||.+.. ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999876432 345689999999999986 678999999999999999999999997543 45677
Q ss_pred HHHHHhcCCCChhHHhhhcccc----------ccCCCCCCcchhhhh---hhccCCcHHHHHHHHHhcccCcCCCcCHHH
Q 006004 370 HKIFKLCGSPSEDYWRKSKSAH----------ATSFKPQQPYKRKVL---ETFRNFPQSALALVDKLLTIEPENRGSAAS 436 (665)
Q Consensus 370 ~kI~~~~g~p~~~~~~~~~~~~----------~~~~~~~~p~~~~~~---~~~~~~s~~a~dLI~~lL~~DP~~RpTa~e 436 (665)
..++..+|.++...+....... ........+...... ......++.+++||.+||.+||.+||||+|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 8888899998877665432111 000001111111111 122345788999999999999999999999
Q ss_pred HHhCcCCCCC
Q 006004 437 ALRSEFFKTE 446 (665)
Q Consensus 437 aL~Hp~f~~~ 446 (665)
||+||||++.
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999954
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=384.97 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=200.4
Q ss_pred eeEEEEeeccCceEEEEEEECCCC---cEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccCCcEEEE
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETG---KIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~~l~lV 236 (665)
+.+-++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+++|++|+|||||++++++....+.+++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 344678999999999999987654 36899998743 35566778999999999999999999999987666689999
Q ss_pred EEeccccchh-hhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecccceecCCCCC--
Q 006004 237 FEYMEHDLAG-LATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFGLATTYDPSQN-- 313 (665)
Q Consensus 237 ~Ey~~g~ll~-~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFGlA~~~~~~~~-- 313 (665)
||||+++.+. ++......+++.++..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999976665 4555556788899999999999999999999999999999999999999999999999987654322
Q ss_pred -CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhHHhhhcccc
Q 006004 314 -LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGR-TEVEQMHKIFKLCGSPSEDYWRKSKSAH 391 (665)
Q Consensus 314 -~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~kI~~~~g~p~~~~~~~~~~~~ 391 (665)
.......||+.|+|||++.. ..++.++|||||||+||||++|..||... +..+....+... ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~------------ 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR------------ 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC------------
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC------------
Confidence 22334578999999999886 67899999999999999999977666543 333333333221 10
Q ss_pred ccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHhC
Q 006004 392 ATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALRS 440 (665)
Q Consensus 392 ~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~H 440 (665)
+ .....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 253 -----~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -----L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----C---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 0113578899999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-44 Score=376.91 Aligned_cols=252 Identities=17% Similarity=0.215 Sum_probs=206.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC-CCcceeeeeeeccCCcEEEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH-PNVMKLEGLVTSRSGSLYLV 236 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~~l~lV 236 (665)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +||+.+++++.... ..|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-HNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT-EEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC-ccEEE
Confidence 4799999999999999999999999999999998754322 235689999999965 89999999887654 78999
Q ss_pred EEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-----CCcEEEEecccceecCCC
Q 006004 237 FEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINN-----AGVLKIGDFGLATTYDPS 311 (665)
Q Consensus 237 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~-----~g~lKL~DFGlA~~~~~~ 311 (665)
|||+.+++...+...+..+++.++..++.|++.||+|||++||+||||||+||||+. ++.+||+|||+|+.+...
T Consensus 80 me~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 999998888888777778999999999999999999999999999999999999974 578999999999986433
Q ss_pred CC------CCcccccccccccCcccccCCcccCcccchhhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChh
Q 006004 312 QN------LPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGCILAELFAGKPIMPGRTEV---EQMHKIFKLCGSPSED 382 (665)
Q Consensus 312 ~~------~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~---e~l~kI~~~~g~p~~~ 382 (665)
.. ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+.. +.+.++....-.
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS---- 234 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH----
T ss_pred ccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC----
Confidence 21 12345689999999999987 67999999999999999999999999875443 333333221000
Q ss_pred HHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 383 YWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 383 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
....+...++|+++.+||..|+..+|++||+...+.+
T Consensus 235 --------------------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 --------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0122334578999999999999999999998766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=378.39 Aligned_cols=269 Identities=22% Similarity=0.243 Sum_probs=189.3
Q ss_pred CCeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCcceeeeeeeccC---CcEE
Q 006004 158 DAFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNVMKLEGLVTSRS---GSLY 234 (665)
Q Consensus 158 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~---~~l~ 234 (665)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ........|+..+.+++|||||++++++.... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3699999999999999999986 68999999986432 11112234555556789999999999987653 2589
Q ss_pred EEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh--------CCccccCCCcccEEEcCCCcEEEEecccce
Q 006004 235 LVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS--------RGILHRDIKGSNLLINNAGVLKIGDFGLAT 306 (665)
Q Consensus 235 lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~--------~gIiHrDLKPeNILld~~g~lKL~DFGlA~ 306 (665)
||||||.++.+..++... .+++.++..++.|++.||.|||. +||+||||||+||||+.++.+||+|||++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999876665555443 69999999999999999999996 599999999999999999999999999998
Q ss_pred ecCCCCC---CCcccccccccccCcccccCCc-----ccCcccchhhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 006004 307 TYDPSQN---LPLTSRVVTLWYRAPELLLGAT-----KYGAAIDMWSAGCILAELFAGKPIMPGRTEVEQMHKIFKLCGS 378 (665)
Q Consensus 307 ~~~~~~~---~~~~~~~gT~~Y~APE~l~~~~-----~~~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~kI~~~~g~ 378 (665)
.+..... ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||........... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hccccc
Confidence 8754332 1234568999999999987532 367899999999999999999988754221100000 000000
Q ss_pred CChhHHhhhccccccCCCCCCcchhhhhhhccCCcHHHHHHHHHhcccCcCCCcCHHHHHh
Q 006004 379 PSEDYWRKSKSAHATSFKPQQPYKRKVLETFRNFPQSALALVDKLLTIEPENRGSAASALR 439 (665)
Q Consensus 379 p~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~s~~a~dLI~~lL~~DP~~RpTa~eaL~ 439 (665)
+......+. .....+.+..+.. ......+..+.+||.+||..||.+|||+.|+++
T Consensus 236 ~~~~~~~~~--~~~~~~~p~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKV--VCEQKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHH--HTTSCCCCCCCGG----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHH--HhccccCCCCCcc----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000000000 0000111111100 001123456889999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.6e-24 Score=210.08 Aligned_cols=170 Identities=18% Similarity=0.173 Sum_probs=123.2
Q ss_pred eeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCC----------------HHHHHHHHHHHHHHHhCCCCCcceee
Q 006004 160 FEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMD----------------PESVRFMAREIHILRKLDHPNVMKLE 223 (665)
Q Consensus 160 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIV~l~ 223 (665)
|.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|..++.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999998 47899999987642110 11123355789999999999999988
Q ss_pred eeeeccCCcEEEEEEeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCcEEEEecc
Q 006004 224 GLVTSRSGSLYLVFEYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHSRGILHRDIKGSNLLINNAGVLKIGDFG 303 (665)
Q Consensus 224 ~~~~~~~~~l~lV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKPeNILld~~g~lKL~DFG 303 (665)
++. . .+++|||+++.... .+++..+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||
T Consensus 81 ~~~---~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 81 AWE---G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp EEE---T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred Eec---C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECC
Confidence 753 1 27999999986543 256667889999999999999999999999999999999754 8999999
Q ss_pred cceecCCCCCCCcccccccccccCcccccCCcccCcccchhhhHH
Q 006004 304 LATTYDPSQNLPLTSRVVTLWYRAPELLLGATKYGAAIDMWSAGC 348 (665)
Q Consensus 304 lA~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~~~~~sDIWSLG~ 348 (665)
+|..........+... .... -.+.+. ..|+..+|+||+.-
T Consensus 148 ~a~~~~~~~~~~~l~r--d~~~-~~~~f~--r~y~~~~d~~s~~~ 187 (191)
T d1zara2 148 QSVEVGEEGWREILER--DVRN-IITYFS--RTYRTEKDINSAID 187 (191)
T ss_dssp TCEETTSTTHHHHHHH--HHHH-HHHHHH--HHHCCCCCHHHHHH
T ss_pred CcccCCCCCcHHHHHH--HHHH-HHHHHc--CCCCCcccHHHHHH
Confidence 9987643221100000 0000 012222 46899999999853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=1.6e-06 Score=85.04 Aligned_cols=139 Identities=17% Similarity=0.132 Sum_probs=89.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeeccCCcEEEEE
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTSRSGSLYLVF 237 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~~l~lV~ 237 (665)
.|+.++..+-++.+.||+.. .++..++||+...... .....+.+|..+|+.|. +--+.+++.+.... +..|+||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecC-CceEEEE
Confidence 57777766556667999986 3566788898754321 11223567888888773 33355666665543 4789999
Q ss_pred EeccccchhhhcCCCCCCChhHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 006004 238 EYMEHDLAGLATTPGIKFTEPQIKCYMQQLLRGLEHCHS----------------------------------------- 276 (665)
Q Consensus 238 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~----------------------------------------- 276 (665)
++++|..+..... +......++.++...|..||+
T Consensus 90 ~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 9999865532221 111222333444444444442
Q ss_pred ------------------CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 277 ------------------RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 277 ------------------~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876677999997764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=3.4e-05 Score=74.81 Aligned_cols=73 Identities=14% Similarity=0.118 Sum_probs=48.3
Q ss_pred EeeccC-ceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCC--CCcceeeeeeeccCCcEEEEEEecc
Q 006004 165 KIGQGT-YSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDH--PNVMKLEGLVTSRSGSLYLVFEYME 241 (665)
Q Consensus 165 ~LG~G~-fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~~~l~lV~Ey~~ 241 (665)
.+..|. -+.||+... .++..+++|....... ..+.+|..+|+.|.. -.+.+++.+..+. +..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeee
Confidence 444444 368999874 4566789997654321 235678888887732 3355667665554 47899999998
Q ss_pred ccc
Q 006004 242 HDL 244 (665)
Q Consensus 242 g~l 244 (665)
|..
T Consensus 90 G~~ 92 (255)
T d1nd4a_ 90 GQD 92 (255)
T ss_dssp SEE
T ss_pred ccc
Confidence 743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.87 E-value=1.7e-05 Score=83.17 Aligned_cols=77 Identities=19% Similarity=0.212 Sum_probs=47.8
Q ss_pred EEEeeccCceEEEEEEECCCCcEEEEEEEecC-CC----CHHHHHHHHHHHHHHHhC-CC--CCcceeeeeeeccCCcEE
Q 006004 163 IDKIGQGTYSSVYKARDLETGKIVALKKVRFA-NM----DPESVRFMAREIHILRKL-DH--PNVMKLEGLVTSRSGSLY 234 (665)
Q Consensus 163 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~----~~~~~~~~~~Ei~iL~~L-~H--pnIV~l~~~~~~~~~~l~ 234 (665)
++.||.|....||++.+..+++.|+||.-... .. .+-...+...|..+|+.+ .+ ..+.+++.+ .. . ..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~-~-~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT-E-MAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET-T-TTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cC-C-CCE
Confidence 56799999999999998777889999975421 11 111233456788888776 22 345555554 22 2 347
Q ss_pred EEEEeccc
Q 006004 235 LVFEYMEH 242 (665)
Q Consensus 235 lV~Ey~~g 242 (665)
+|||++.+
T Consensus 108 lvmE~L~~ 115 (392)
T d2pula1 108 TVMEDLSH 115 (392)
T ss_dssp EEECCCTT
T ss_pred EEEeccCC
Confidence 89999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.0011 Score=66.88 Aligned_cols=70 Identities=19% Similarity=0.241 Sum_probs=43.7
Q ss_pred cCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceeee-eeeccCCcEEEEEEeccc
Q 006004 169 GTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLDHPNV-----MKLEG-LVTSRSGSLYLVFEYMEH 242 (665)
Q Consensus 169 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~~-~~~~~~~~l~lV~Ey~~g 242 (665)
+.--.||+++. ++|..|++|+.+..... ...+..|...+..|....| +..-+ ......+..+.+++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999985 67889999998765433 3346678888887742222 11111 111124467889999987
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.81 E-value=0.0027 Score=65.66 Aligned_cols=77 Identities=18% Similarity=0.134 Sum_probs=50.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEECC-------CCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-CCCcceeeeeeec
Q 006004 157 ADAFEKIDKIGQGTYSSVYKARDLE-------TGKIVALKKVRFANMDPESVRFMAREIHILRKLD-HPNVMKLEGLVTS 228 (665)
Q Consensus 157 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~ 228 (665)
.+.+++ +.|+.|-.-.+|++.... ..+.|.+++.-. ... .....+|..+++.+. +.-..++++++.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~- 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFS- 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC-
Confidence 344554 678878888999998653 235677776642 111 223568999999885 433457777653
Q ss_pred cCCcEEEEEEecccc
Q 006004 229 RSGSLYLVFEYMEHD 243 (665)
Q Consensus 229 ~~~~l~lV~Ey~~g~ 243 (665)
+ .+||||++|.
T Consensus 116 -~---g~I~efi~g~ 126 (395)
T d1nw1a_ 116 -G---GRLEEYIPSR 126 (395)
T ss_dssp -T---EEEECCCCEE
T ss_pred -C---ceEEEEeccc
Confidence 2 5899999974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0027 Score=63.24 Aligned_cols=143 Identities=15% Similarity=0.155 Sum_probs=75.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCCCcEEEEEEEecCCCCHHHHHHHHHHHHHHHhCC-----CCCcceeee--eeeccCC
Q 006004 159 AFEKIDKIGQGTYSSVYKARDLETGKIVALKKVRFANMDPESVRFMAREIHILRKLD-----HPNVMKLEG--LVTSRSG 231 (665)
Q Consensus 159 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l~~--~~~~~~~ 231 (665)
...-++.|..|---+.|++... +| .|++|+..... + ...+..|+.+|..|. .|..+...+ .+..-.+
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-C---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence 4555667778888889998753 44 49999986432 2 223445677777763 233322111 0011123
Q ss_pred cEEEEEEeccccchh------------------hhcCC-C----C------------------CCChhHHHHHHHHHHHH
Q 006004 232 SLYLVFEYMEHDLAG------------------LATTP-G----I------------------KFTEPQIKCYMQQLLRG 270 (665)
Q Consensus 232 ~l~lV~Ey~~g~ll~------------------~~~~~-~----~------------------~lse~~i~~i~~QIl~a 270 (665)
..+.++.++.|.... ..... . . ..........+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence 456677776652110 00000 0 0 00111222233333333
Q ss_pred HHHHHh----CCccccCCCcccEEEcCCCcEEEEeccccee
Q 006004 271 LEHCHS----RGILHRDIKGSNLLINNAGVLKIGDFGLATT 307 (665)
Q Consensus 271 L~~LH~----~gIiHrDLKPeNILld~~g~lKL~DFGlA~~ 307 (665)
+...+. .||||+|+.++|||++.+...-|+||+.+..
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333332 4799999999999999988788999998763
|